Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,modulation by symbiont of host process (GO:0044003),-0.8226167324479674,-2.0942540992278107,0.0,0.2102841059808476,0.129,6/10,12.90%,MRC1;TLR2;ENO1;UBC;UBA52;B2M
prerank,cytoplasmic translation (GO:0002181),-0.48094961581569123,-2.090446322945712,0.0,0.11667376202808319,0.144,37/91,15.78%,RPS26;RPL39;RPL5;RPS23;RPS24;RPS16;RPL28;ETF1;RPS29;RPS14;RPS20;RPS12;RPL35A;RPL18A;RPS13;RPL27;RPL21;RPS7;EIF3I;RPS5;RPL30;RPL6;RPL37A;TMA7;RPL10;RPL15;UBA52;RPS10;RPL14;RPL9;RPL32;RPL36;RPL23A;RPL31;RPL3;RPL41;RPL8
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.4855535899006528,-2.0792457648868266,0.0,0.08908810511446662,0.166,42/87,20.04%,RPS26;RPL39;RPL5;RPS23;RPS24;RPS16;RPL28;RPS29;RPS14;RPS20;RPS12;RPL35A;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;RPL9;SEC63;RPL32;RPL36;SRP72;RPL23A;RPL31;SEC61A1;RPL3;RPL41;RPL8;RPL37;RPL36A;RPL26;SRP9;RPL11
prerank,regulation of phagocytosis (GO:0050764),-0.5234472624294403,-2.050596537143743,0.0,0.09903703055872176,0.235,18/53,15.91%,FCGR2B;IL15;PIP4P2;GAS6;PTPRC;CD47;TLR2;DOCK2;SYK;HCK;IL1B;DYSF;CYBA;SLC11A1;RACK1;TNF;TUB;FCER1G
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4524841771909141,-2.018247301487209,0.0,0.1180304336795725,0.329,49/110,20.04%,PPP2R2A;UPF3A;RPS26;RPL39;RPL5;RPS23;RPS24;RPS16;NCBP1;RPL28;ETF1;RPS29;RBM8A;RPS14;RPS20;RPS12;RPL35A;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;RPL9;RPL32;RPL36;RPL23A;RPL31;RPL3;RPL41;RPL8;UPF3B;UPF2;HELZ2;RPL37;MAGOHB;MAGOH;RPL36A;RPL26;SMG6;RPL11
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5536337151197183,-1.9795093021387602,0.0,0.16641838924935895,0.485,17/34,25.30%,NEDD9;NRP1;CASS4;CRK;LIMS1;CRKL;CARMIL1;CIB1;S100A10;MYOC;MYADM;FLNA;DOCK1;RREB1;OLFM4;RAC1;ILK
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6892229616021819,-1.9687916309732123,0.0,0.16280059817872072,0.529,5/15,13.14%,FCGR2B;CD300A;CD300LF;ZC3H12A;NR1H3
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.7367511894125838,1.94829914214204,0.0,0.4564454522397156,0.414,7/15,3.80%,YWHAE;KCNJ3;KCNH2;KCNA5;ATP1B1;KCNE2;KCNJ8
prerank,heterochromatin assembly (GO:0031507),-0.6216771573043443,-1.94274643207864,0.0,0.19112111890356068,0.615,10/20,20.67%,ZNFX1;SMCHD1;MBD2;H3-3A;HDAC1;HMGA2;CDKN2A;POLE3;HMGA1;SIRT2
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.44860577131032436,-1.9392291501596912,0.0,0.17832695152354314,0.63,42/91,20.04%,RPS26;RPL39;RPL5;RPS23;RPS24;RPS16;RPL28;RPS29;RPS14;RPS20;RPS12;RPL35A;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;RPL9;SEC63;RPL32;RPL36;SRP72;RPL23A;RPL31;SEC61A1;RPL3;RPL41;RPL8;RPL37;RPL36A;RPL26;SRP9;RPL11
prerank,regulation of stem cell proliferation (GO:0072091),-0.6563411129355722,-1.9249142471638898,0.0,0.19006969837365645,0.698,10/17,25.34%,PTPRC;HMGB2;SOX11;YAP1;GJA1;HMGA2;HNRNPU;EIF2AK2;TERT;FBLN1
prerank,response to interferon-alpha (GO:0035455),-0.665567648362123,-1.9225697943494755,0.0,0.17686064983961022,0.705,8/16,6.99%,IFNAR1;GAS6;AXL;KLHL20;IFNAR2;IFITM3;BST2;RO60
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.663200682662896,1.918229715039942,0.001658374792703151,0.380371210199763,0.578,11/20,22.22%,LACC1;KCNMA1;ATP1B1;SLC12A2;ATP1B3;SLC8A1;NEDD4L;ATP1A4;ATP1A3;ATP1A1;SLC9A1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4885311213992652,-1.912938542379758,0.003076923076923077,0.18281150503818847,0.748,18/45,14.27%,SP100;OAS2;CD44;TRIM25;IRF9;CIITA;IRF7;OASL;IRF4;TRIM62;HCK;MID1;CAMK2D;STAT1;B2M;OAS3;TRIM5;IRF2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5337147746521768,1.8965928706031125,0.0,0.3497301960447821,0.677,20/54,16.59%,YWHAE;KCNMA1;KCNJ3;KCNH2;BIN1;GABBR1;NOS1AP;KCNE2;KCNIP3;KCNIP4;FHL1;NEDD4;CACNA1D;STK39;GABBR2;KCNN4;NEDD4L;KCNJ5;KCNMB3;KCNN3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.718313495342115,-1.8939479174896166,0.002242152466367713,0.2069446065310277,0.832,7/12,16.22%,PIBF1;ERLIN2;WDTC1;BRCA1;CEACAM1;APOC1;ACADL
prerank,protein targeting to ER (GO:0045047),-0.42723517027795505,-1.8872411578247419,0.0,0.207958383149723,0.856,38/99,13.76%,CHMP4A;CHMP4B;RPS26;RPL39;RPL5;RPS23;RPS24;RPS16;RPL28;RPS29;RPS14;RPS20;RPS12;RPL35A;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;RPL10;RPL15;UBA52;RPS10;RPL14;RPL9;SEC63;RPL32;RPL36;SRP72;RPL23A;EDEM1;RPL31;SEC61A1;RPL3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.6891510918804967,-1.8807886569618755,0.002386634844868735,0.20784209700816678,0.873,7/13,16.26%,OAS2;IL6ST;IL27;OASL;STAT1;EBI3;IL27RA
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.7464298404998028,-1.877847652537041,0.004962779156327543,0.20095698837685838,0.886,5/11,16.97%,ALOX5;THBS1;SEMA6A;CREB3L1;KLF2
prerank,type I interferon signaling pathway (GO:0060337),-0.5156732415316694,-1.8776956818378008,0.00303951367781155,0.1788545460546779,0.886,14/41,6.71%,SP100;IFNAR1;OAS2;IFIT2;IRF9;IRF7;STAT2;IFNAR2;IFITM3;IFIT1;OASL;IRF4;BST2;IFIT3
prerank,cellular response to type I interferon (GO:0071357),-0.5156732415316694,-1.8776956818378008,0.00303951367781155,0.1788545460546779,0.886,14/41,6.71%,SP100;IFNAR1;OAS2;IFIT2;IRF9;IRF7;STAT2;IFNAR2;IFITM3;IFIT1;OASL;IRF4;BST2;IFIT3
prerank,regulation of macrophage activation (GO:0043030),-0.5506542565639,-1.8758850282149662,0.0,0.17301133745045627,0.891,13/30,18.47%,FCGR2B;CD74;PJA2;THBS1;HSPD1;GPR137B;ZC3H12A;SHPK;NR1H3;LBP;WNT5A;TLR4;MMP8
prerank,ribosome biogenesis (GO:0042254),-0.3855918468803714,-1.8727871082524687,0.0,0.17033012584448654,0.904,69/187,20.04%,UTP6;NOL11;EIF2A;RPL39;RPL5;RPS24;CUL4A;URB2;RPS16;WDR43;DHX29;MALSU1;RPL28;RPS14;RPL35A;DDX49;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;RPL30;MRM2;RPF2;RPL6;RPL37A;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;METTL17;UBA52;UTP11;UTP15;EXOSC10;XPO1;DDX27;RPL14;MPHOSPH6;RPL9;XRN2;RPL32;RPL36;NOP58;RPL23A;RPL31;MDN1;RPL3;EXOSC9;NPM1;WDR3;UTP18;RPL41;TBL3;TEX10;RPL8;FBL;NOP53;RPL37;GTF3A;RPL36A;RPL26;DKC1;SDAD1;EMG1;RPL11
prerank,toll-like receptor signaling pathway (GO:0002224),-0.42773627219685834,-1.8564411200113948,0.0,0.1913553062719725,0.933,38/84,24.82%,MAP3K1;RFTN1;UBE2D3;PIK3C3;SFTPA2;SFTPA1;TLR2;PIK3R4;CD36;MAPKAPK2;TLR7;CD14;HSPD1;TNIP3;RIPK1;CTSL;UBC;EPG5;TLR8;CTSB;TAB1;UBA52;S100A1;MAPKAPK3;BIRC2;IRAK4;LBP;SCIMP;TLR4;TLR1;MYD88;TNIP1;TLR5;NR1H4;TICAM2;RPS6KA3;FADD;TLR9
prerank,response to interferon-beta (GO:0035456),-0.5906563851564643,-1.8552183460981566,0.0024449877750611247,0.1851856804282948,0.935,13/22,23.23%,UBE2K;IFNAR2;IFITM3;SHFL;BST2;CDC34;STAT1;ACOD1;AIM2;IFITM1;XAF1;NDUFA13;PLSCR1
prerank,cellular potassium ion homeostasis (GO:0030007),0.7248831282591175,1.8548476062270458,0.0,0.4617944223831499,0.859,7/13,20.12%,KCNMA1;ATP1B1;SLC12A2;ATP1B3;ATP1A4;ATP1A3;ATP1A1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.7041548027728415,-1.8518781307743521,0.007009345794392523,0.18285574433117183,0.94,5/11,10.69%,FCGR2B;CD300A;TYROBP;LYN;RC3H1
prerank,cellular sodium ion homeostasis (GO:0006883),0.6953711125153489,1.8494853422612447,0.0017699115044247787,0.3952690825992538,0.881,9/15,22.22%,ATP1B1;SLC12A2;ATP1B3;SLC8A1;NEDD4L;ATP1A4;ATP1A3;ATP1A1;SLC9A1
prerank,negative regulation of phagocytosis (GO:0050765),-0.6314958695836757,-1.8451900162423343,0.002680965147453083,0.18936875135372028,0.949,8/17,13.29%,FCGR2B;PIP4P2;CD300A;CD47;TLR2;CD300LF;DYSF;RACK1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.5411523610872718,-1.8424239791242356,0.0,0.1868408198431118,0.952,16/31,23.87%,NBR1;NOCT;CDK6;LIMD1;PPARG;NOTCH1;TRPM4;SMAD6;GREM1;RIOX1;BAMBI;PTCH1;SEMA4D;TWIST1;TNN;GDF10
prerank,natural killer cell mediated immunity (GO:0002228),-0.6354970299414595,-1.8339946206384607,0.0025906735751295338,0.19619559267691983,0.964,10/15,28.03%,ULBP1;LYST;SLAMF7;CEBPG;RAET1E;KLRD1;KLRK1;PLEKHM2;TUBB4B;KLRC2
prerank,rRNA metabolic process (GO:0016072),-0.38359089460722556,-1.8312521791848364,0.0,0.194406022948602,0.968,59/160,20.04%,UTP6;NOL11;RPL39;RPL5;RPS24;RPS16;WDR43;RPL28;RPS14;RPL35A;DDX49;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;RPL30;MRM2;RPL6;RPL37A;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;UTP11;UTP15;EXOSC10;DDX27;RPL14;MPHOSPH6;RPL9;XRN2;RPL32;RPL36;NOP58;RPL23A;RPL31;MDN1;RPL3;EXOSC9;WDR3;UTP18;RPL41;TBL3;TEX10;RPL8;FBL;NOP53;TRIR;RPL37;RPL36A;RPL26;DKC1;EMG1;RPL11
prerank,cellular response to increased oxygen levels (GO:0036295),-0.7080120157714287,-1.8283578867118957,0.004524886877828055,0.1931319001013038,0.971,6/11,12.27%,ATP6V0D1;ATG7;FAS;CAV1;FOXO1;ATP6V1A
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5976774611663423,1.8265525049088454,0.0033277870216306157,0.44640787863722187,0.946,11/26,18.03%,YWHAE;ATP1B1;KCNE2;ATP1B3;FHL1;ACTN2;NEDD4;CACNA1D;STK39;NEDD4L;ANK2
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.6602892858172319,1.8224771381821288,0.0,0.4028991479467133,0.949,7/17,10.85%,SLC4A8;SCAMP5;SYT4;RAB3A;DOC2B;CACNA1G;RAB3D
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6034013802693705,1.8206614726886061,0.0,0.3594706046393073,0.952,16/25,24.53%,ATP1B1;DMD;ATP1B3;NDUFA4;ACTN2;CFTR;STK39;TRPC6;ANK2;WNK1;COX17;SLC6A9;CTSS;GLRX;PDZK1;ANK3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.4726283504110941,-1.8174098330554058,0.003194888178913738,0.2073368537724397,0.98,19/48,17.43%,BCL2;FNIP2;BCL2L1;MCL1;BAX;AEN;USP28;BCL3;BAG6;BRCA1;TMEM109;SNW1;HIPK1;EP300;TNFRSF1B;CRIP1;EPHA2;BCL2L11;HIPK2
prerank,positive regulation of T cell activation (GO:0050870),-0.4475803886149252,-1.8080101621117126,0.0,0.21855980305493256,0.985,19/62,10.56%,IL15;FLOT2;CD274;CCDC88B;SLC7A1;PTPRC;CD47;CCR2;IL6ST;NCK1;NOD2;HSPD1;TFRC;ZMIZ1;ANXA1;PRKCQ;IL1B;CD28;LCK
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5341511262594774,-1.7945222922157191,0.0,0.2440258428614373,0.991,14/27,22.13%,MAP3K1;TLR2;CD36;CD14;HSPD1;UBC;TAB1;UBA52;IRAK4;TLR4;TLR1;MYD88;TNIP1;TLR5
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.5543889825123379,-1.7924502534974653,0.005,0.2417843258888657,0.991,11/25,20.22%,RBPJ;HIP1;CNOT9;HIP1R;BCAR3;PLAUR;ARAP1;CBL;NUP62;AFAP1L2;PDE6H
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.6075558363707259,-1.791273129475453,0.004975124378109453,0.23782865163229777,0.991,6/17,9.63%,APOE;KPNB1;ERLIN2;MBTPS1;FGF1;ABCG1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.653617760276038,-1.786168650019769,0.012285012285012284,0.24288412772398846,0.992,7/13,18.88%,RBPJ;CPE;NOTCH1;NPY5R;HEY2;SMAD4;NPY2R
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5688434495246757,-1.7816275546815337,0.007462686567164179,0.24625528576890773,0.994,9/21,13.51%,FCGR2B;PTPN22;STAP1;PRKCH;CD300A;SLC39A10;LYN;PAX5;FOXP1
prerank,positive regulation of phagocytosis (GO:0050766),-0.46596161352824117,-1.777774771217561,0.0,0.24894924804829374,0.994,18/47,19.98%,FCGR2B;IL15;GAS6;STAP1;PTPRC;CD47;DOCK2;CD300LF;IL1B;C4B;CYBA;SLC11A1;TNF;TUB;FCER1G;RAB31;APPL2;C2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5642632819911362,1.7758931189653264,0.003289473684210526,0.550481668094657,0.993,9/31,9.43%,SCAMP5;SYT4;CBARP;SYT13;SYT1;SYT6;DOC2B;ADRA2A;CACNA1G
prerank,cardiac muscle cell action potential (GO:0086001),0.5563095699289102,1.7698148906782474,0.0032102728731942215,0.5283197621670459,0.995,14/30,22.55%,YWHAE;KCNH2;FGF12;ATP1B1;KCNE2;DMD;CACNA1G;SLC8A1;CACNA1D;CACNA2D1;ANK2;ATP1A1;SCN3B;SCN1B
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.658059505597118,-1.7673964872865309,0.0136986301369863,0.265027640458512,0.995,10/12,27.98%,PTPN22;CD300A;PTPRC;LYN;RC3H1;PAX5;ELF2;BLK;CBFB;CD19
prerank,response to interferon-gamma (GO:0034341),-0.428841713445898,-1.7634772802092826,0.0,0.267835545512448,0.995,29/67,25.20%,SP100;CD74;CD47;TLR2;CIITA;IFITM3;CXCL16;CCL25;SHFL;BST2;GBP3;STAT1;ACOD1;SLC11A1;DAPK1;GBP4;SYNCRIP;WNT5A;TLR4;GBP6;CASP1;TRIM21;IFITM1;KYNU;GBP7;MEFV;CCL7;SLC26A6;IL12RB1
prerank,regulation of leukocyte activation (GO:0002694),-0.6293541840692142,-1.7623508305818003,0.005037783375314861,0.26385524298837537,0.995,8/14,23.23%,CD74;PJA2;GPR137B;LYN;LCK;SHPK;CD33;PLSCR1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.7346874093498057,1.7616271505070284,0.005208333333333333,0.5258920141019452,0.997,5/10,6.94%,YWHAE;CBARP;BIN1;VDAC1;ADRA2A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.369696053070353,-1.7608125745570906,0.0,0.2614306272419957,0.995,75/168,25.73%,DIS3L2;PPP2R2A;UPF3A;RPS26;RPL39;RPL5;RPS23;RPS24;CNOT9;RPS16;NCBP1;RPL28;ETF1;RPS29;RBM8A;RPS14;RPS20;SAMD4A;RPS12;RPL35A;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;TENT2;RPL10;RPL15;EXOSC8;ZC3H12A;UBA52;EXOSC10;RPS10;RPL14;RPL9;RC3H1;XRN2;RPL32;RPL36;DCP1B;RPL23A;RPL31;RPL3;EXOSC9;RPL41;RPL8;UPF3B;RC3H2;UPF2;HELZ2;TENT4B;RPL37;MAGOHB;MAGOH;RPL36A;RPL26;SMG6;RPL11;PAN3;CNOT6L;RPS15;CTIF;EIF3E;PYM1;RPS6;EXOSC7;RPLP2;RPS17;TNKS1BP1;CSDE1;RPS18
prerank,membrane repolarization during action potential (GO:0086011),0.6834406357037424,1.7602894258387976,0.005309734513274336,0.49038829981656945,0.997,4/13,3.05%,YWHAE;KCNH2;ATP1B1;KCNE2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5402027551064318,-1.7588866667092566,0.007751937984496124,0.2591242854344638,0.996,12/26,16.08%,BCL2;PPP2R1B;BCL2L1;MCL1;PF4;IL1B;EYA1;RET;EYA3;EYA2;TNF;MAPK7
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.7058491918639657,-1.75834298099852,0.004694835680751174,0.2539237107704213,0.996,6/11,16.26%,STAT4;IL12RB2;IL6ST;STAT1;EBI3;IL27RA
prerank,microtubule polymerization or depolymerization (GO:0031109),0.590242794099701,1.7559176747513312,0.004966887417218543,0.4764393235450878,0.998,14/24,22.97%,TPPP;STMN4;STMN3;STMN2;NCKAP5;CKAP5;FGF13;NCKAP5L;KIF2A;KIF14;HDGFL3;PIN1;MAP7D3;TPPP3
prerank,receptor-mediated endocytosis (GO:0006898),-0.37896313620954786,-1.7513207464893443,0.0,0.2646771740545132,0.998,41/132,16.74%,DAB2;MRC1;FCGR2B;CD163;APOE;AP2A2;DNAJC6;TPCN2;MSR1;CD36;GAK;SNX1;CXCL16;M6PR;FCHO2;AP2B1;HIP1R;TFRC;PICALM;LDLRAP1;SYK;CAV1;LDLR;SNX9;CTSL;EPS15;STAB2;DNM2;IGF2R;CLTA;GRB2;LRP1;LILRB1;DNAJC13;RAMP2;CLN3;CALCRL;WASF1;FCER1G;CLTB;RAB31
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4312570588395507,-1.7492935829941478,0.0,0.26399597000117553,0.998,32/67,26.03%,NEDD9;NRP1;CASS4;CRK;CDK6;CD36;LIMS1;CCL25;UTRN;CRKL;CARMIL1;CIB1;S100A10;SKAP1;EMP2;MYOC;PTK2B;CCL28;MYADM;FLNA;FN1;PPM1F;ECM2;DOCK1;CD3E;RREB1;ARL2;OLFM4;RAC1;ILK;CSF1;ALOX15
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4571621533863582,-1.7475251013229212,0.0,0.2620486665498964,0.998,24/47,29.42%,NEDD9;NRP1;CASS4;CRK;CORO1C;LIMS1;CRKL;CARMIL1;CIB1;S100A10;MYOC;SPRY4;MYADM;FLNA;DOCK1;RREB1;OLFM4;RAC1;ILK;FBLN1;PDPN;TESK1;ACTN4;C1QBP
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.6175123568267623,-1.7458338928753336,0.019230769230769232,0.26006805701810853,0.999,8/16,20.71%,ERLIN2;WDTC1;BRCA1;CEACAM1;APOC1;ACADL;APPL2;NCOR1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.6150381749987857,1.7418040589468238,0.0033112582781456954,0.5178595538865524,0.999,6/20,5.99%,STARD3;TSPOAP1;STAR;AKR1C1;FDX2;AKR1B1
prerank,dendrite morphogenesis (GO:0048813),0.5434297795413698,1.7417752640808801,0.001589825119236884,0.4835997303011987,0.999,25/35,29.05%,MAP6;CTNNA2;SHANK3;CTNND2;KLF7;BTBD3;MINK1;DOCK10;EPHB2;WNT7A;SHANK1;CHRNA7;SDC2;CDC42;FARP1;MAP2;WASL;MEF2A;TAOK2;DLG4;PHACTR1;DIP2A;PTEN;CELSR2;DCDC2
prerank,positive regulation of histone deacetylation (GO:0031065),0.700025296372177,1.7399127819613687,0.008347245409015025,0.4612000923672127,0.999,8/12,22.00%,CTBP1;AKAP8L;PRKD2;SAP30BP;AKAP8;PRKD1;ZBTB7B;ING2
prerank,B cell receptor signaling pathway (GO:0050853),-0.4951400282650286,-1.7362145987558266,0.0027472527472527475,0.27803109249245356,0.999,15/32,20.74%,VAV3;BCL2;RFTN1;CD38;PTPRC;TEC;BAX;SYK;BLNK;LCK;CD79B;BCAR1;NFATC2;CD79A;PIK3CD
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.49903398962081186,-1.7357102152962085,0.008287292817679558,0.27345412975331995,0.999,10/30,11.57%,UBE2D3;IRF7;TBK1;CD300LF;CD14;TNIP3;RIPK1;UBC;UBA52;BIRC2
prerank,negative regulation of macrophage activation (GO:0043031),-0.6071814692277995,-1.732842372273016,0.01804123711340206,0.2741861094836516,0.999,5/16,13.14%,FCGR2B;PTPRC;LDLR;ZC3H12A;NR1H3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5650503826430655,-1.727043768366649,0.010554089709762533,0.28321877396491446,1.0,8/19,10.79%,AEN;USP28;BCL3;BAG6;TMEM109;SNW1;HIPK1;EP300
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.5281714599926431,-1.7268488298902454,0.0049382716049382715,0.2780644857454522,1.0,8/25,9.70%,FBXL17;VCP;CUL3;YME1L1;UGGT1;KLHL15;BAG6;CLPP
prerank,ncRNA processing (GO:0034470),-0.3510863362948524,-1.7251622593749478,0.0,0.27710018481669757,1.0,68/200,20.04%,UTP6;NOL11;RPL39;RPL5;RPS24;INTS2;RPS16;WDR43;RPL28;RPS14;RPL35A;DDX49;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;SMAD3;FARS2;RPL30;MRM2;RPL6;RPL37A;SRRT;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;UTP11;UTP15;EXOSC10;RPP21;DDX27;SSB;RPL14;MPHOSPH6;RPL9;XRN2;RPL32;RPL36;NOP58;RPL23A;RPL31;HNRNPA2B1;AGO2;INTS12;MDN1;RPL3;EXOSC9;WDR3;UTP18;RPL41;TBL3;TEX10;RPL8;FBL;NOP53;POP1;RPL37;RPL36A;RPL26;DKC1;EMG1;RPL11
prerank,regulation of multicellular organismal development (GO:2000026),-0.5312563854844785,-1.7249357993476926,0.008,0.2726654043710272,1.0,13/25,17.77%,OAS2;CD24;BAG6;RACGAP1;HPSE;MYSM1;TRIP12;CDK1;CCSAP;PTN;SCX;EHMT1;GATA3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.4084050399623046,-1.7244693143892451,0.0,0.26879685183860075,1.0,28/69,18.91%,OAS2;PTPRC;IFIH1;TLR2;LILRA5;CCR2;TYROBP;CD14;PF4;THBS1;NOD2;RIPK1;SYK;PSEN1;LPL;CYBA;CD2;OAS3;SPHK2;LBP;AGER;HSPB1;WNT5A;SPN;TLR4;ARHGEF2;MMP8;TLR1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5356788748342749,-1.7221765655314651,0.0025380710659898475,0.268768987538688,1.0,10/24,16.97%,RBPJ;ATF3;CEBPB;HIF1A;HSF1;NOTCH1;CREB3L1;MAPK7;SESN2;KLF2
prerank,cellular response to interferon-gamma (GO:0071346),-0.39508353987967826,-1.7209904342148306,0.0,0.26702205254849104,1.0,27/88,15.36%,SP100;OAS2;CD44;TRIM25;CD47;TLR2;IRF9;CIITA;IRF7;OASL;CCL25;IRF4;TRIM62;GBP3;HCK;MID1;CAMK2D;STAT1;ACOD1;DAPK1;B2M;OAS3;TRIM5;GBP4;SYNCRIP;IRF2;WNT5A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.667534602845725,-1.7208052689701692,0.012254901960784314,0.2627658777621457,1.0,5/11,16.11%,ANXA1;SOCS5;ZC3H12A;RC3H1;RC3H2
prerank,neuromuscular junction development (GO:0007528),0.5849643997928639,1.7198582479620164,0.009724473257698542,0.5377870897150325,1.0,13/24,24.53%,AGRN;CACNB4;CACNB2;PDZRN3;PPFIBP1;NEDD4;UNC13B;DCTN1;DNAJA3;UNC13C;DOK7;ZC4H2;ANK3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.6146852531887452,-1.7183317118672172,0.009708737864077669,0.26345160018490393,1.0,10/14,24.93%,DDX60;ANKRD17;TLR2;PUM2;OASL;USP15;PUM1;TLR5;TLR9;DHX58
prerank,regulation of B cell proliferation (GO:0030888),-0.4638943081815073,-1.7182063812714925,0.0060790273556231,0.25937722421694487,1.0,14/44,10.69%,VAV3;FCGR2B;BCL2;CD74;CD38;CD300A;PTPRC;TYROBP;AHR;GPR183;TFRC;LYN;IKZF3;RC3H1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5579707220902791,-1.7167643696122181,0.015345268542199489,0.25808417050165533,1.0,9/17,19.10%,CD300A;PTPRC;PTPA;PPP1R12A;CALM3;CALM2;ITGA1;PPP1R15A;CD33
prerank,chloride transmembrane transport (GO:1902476),0.4988531170314006,1.7125805890960435,0.0015174506828528073,0.5499533747471574,1.0,19/48,16.91%,SLC4A8;GABRQ;GLRA3;GABRG1;GABRD;GABRG2;SLC12A2;SLC1A1;GLRB;GABRA2;ANO2;SLC12A6;GLRA2;CFTR;SLC1A3;SLC6A1;GABRB1;GABRR2;ANO3
prerank,synapse organization (GO:0050808),0.423368365811772,1.7106505725961196,0.0,0.5302257889549986,1.0,45/125,21.16%,AGRN;PCDHB9;CACNB4;PCDHB4;OBSL1;CACNB2;PTPRD;PDZRN3;PCDHB5;CNTN2;SPOCK2;CBLN2;NRXN1;DSCAM;PPFIBP1;RYK;SHANK3;ADGRL3;ACHE;SDK1;CX3CR1;NEDD4;CTNND2;UNC13B;PPFIA4;PCDHB3;DCTN1;NRCAM;GPC4;CYFIP1;CHCHD10;SLC6A1;SLC8A3;REST;PTPRS;NTNG1;SNCB;CHRNA7;PIN1;UNC13C;DOK7;LRRC4C;CDC42;FARP1;GPM6A
prerank,response to copper ion (GO:0046688),0.6141688738554226,1.7088768447327964,0.0016835016835016834,0.5139765977824298,1.0,12/20,17.76%,PRNP;AOC1;MT2A;IL1A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.555037333179984,-1.70737364998336,0.010666666666666666,0.27495953487479835,1.0,8/21,13.36%,APOE;EEPD1;PPARG;PLTP;CAV1;NR1H2;NR1H3;LRP1
prerank,fatty acid transport (GO:0015908),-0.5806107156740634,-1.7049913008078519,0.010471204188481676,0.2757763358664539,1.0,6/17,5.61%,APOE;PPARG;CD36;FABP4;SLC27A4;PPARD
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.5304037469017592,-1.7046309894631158,0.007371007371007371,0.27213110571223464,1.0,9/22,14.78%,SASH1;XDH;PJA2;RELL1;IL1B;ZC3H12A;GADD45G;BMP2;AGER
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.6423337196029457,-1.7028249698408053,0.013793103448275862,0.27152511224885856,1.0,5/12,11.89%,CCR2;PRKCQ;CLEC6A;IL1B;SLC11A1
prerank,transferrin transport (GO:0033572),-0.480421921781335,-1.7027007278820108,0.0,0.26753564967369764,1.0,10/33,12.27%,ATP6V0D1;ATP6V0D2;STEAP3;ATP6V1B2;ATP6V0A1;ATP6V0B;LMTK2;TFRC;DNM2;ATP6V1A
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6639483704778661,1.7005052967168361,0.003401360544217687,0.5337649571702032,1.0,5/13,9.43%,SCAMP5;SYT4;SYT1;DOC2B;CACNA1G
prerank,cellular response to copper ion (GO:0071280),0.6330962951610671,1.6955331731016972,0.008620689655172414,0.5360856743752911,1.0,11/16,17.76%,PRNP;AOC1;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,epidermal cell differentiation (GO:0009913),-0.46242568479241225,-1.6947590377823851,0.0,0.28132436700428937,1.0,24/41,36.43%,ST14;ADAM9;CLIC4;ANXA1;TXNIP;CTNNB1;HDAC2;HDAC1;WNT5A;EPHA2;OPN3;BCR;DSP;EVPL;SCEL;SPINK5;KRT10;ASAH1;UGCG;OVOL2;OVOL1;PITX2;GLI1;SPRR1A
prerank,rRNA processing (GO:0006364),-0.35264202590089627,-1.6928964462520488,0.0,0.2810335201644857,1.0,60/172,20.04%,UTP6;NOL11;RPL39;RPL5;RPS24;RPS16;WDR43;RPL28;RPS14;RPL35A;DDX49;RPL18A;RPL27;RPL21;RPS7;DDX52;RPF1;RPL30;MRM2;RPL6;RPL37A;RRP12;BYSL;UTP4;RPL10;RPL15;EXOSC8;UBA52;UTP11;UTP15;EXOSC10;DDX27;RPL14;MRPL1;MPHOSPH6;RPL9;XRN2;RPL32;RPL36;NOP58;RPL23A;RPL31;MDN1;RPL3;EXOSC9;WDR3;UTP18;RPL41;TBL3;TEX10;RPL8;FBL;NOP53;RPL37;NAT10;RPL36A;RPL26;DKC1;EMG1;RPL11
prerank,positive regulation of potassium ion transport (GO:0043268),0.5120232214555904,1.6902884074504665,0.006134969325153374,0.5388592144496642,1.0,14/38,18.03%,KCNMA1;KCNJ3;KCNH2;GABBR1;NOS1AP;ADRA2A;FHL1;ACTN2;GABBR2;KCNN4;KCNJ5;KCNMB3;KCNN3;ANK2
prerank,cytosolic transport (GO:0016482),-0.3731222221397415,-1.6887944648181146,0.0,0.2858985994976799,1.0,41/108,17.88%,STX6;RIC1;PIK3C3;KLHL20;VPS26A;KIF16B;PTPN23;STX5;TMEM87B;GAK;RAB7A;SNX1;VPS35;GBF1;LMTK2;EPS15;CLN5;RAB6A;AP4M1;DENND2A;WDR91;VPS26B;WDR81;AKTIP;TBC1D10C;LAMP1;DENND5A;TBC1D10A;EMP2;VPS54;YKT6;RBSN;EEA1;RGP1;CORO7;CLN3;VPS52;DOP1B;ERC1;GCC2;RILP
prerank,modulation by host of viral genome replication (GO:0044827),0.6636150796446383,1.6843951240385076,0.013961605584642234,0.5483024580362208,1.0,8/13,16.67%,NUCKS1;YTHDC2;PPIB;PRKN;IFI27;CCNK;EIF2AK4;FBXL2
prerank,synapse assembly (GO:0007416),0.45797533311383165,1.680281845838373,0.0055248618784530384,0.5492877251293078,1.0,20/67,13.10%,PCDHB9;PCDHB4;PLXNB2;OBSL1;PCDHB5;SPOCK2;GABRG2;NRXN1;DSCAM;RYK;LRRTM3;GRID2;SHANK3;GABRA2;ADGRL3;ACHE;SDK1;FGF13;PCDHB3;NRCAM
prerank,negative regulation of viral genome replication (GO:0045071),-0.4535037680832989,-1.6797145601016303,0.0,0.3035798594057304,1.0,21/40,24.81%,OAS2;IFIH1;IFITM3;IFIT1;PROX1;OASL;SHFL;BST2;OAS3;INPP5K;BANF1;TNF;ZC3HAV1;HMGA2;LTF;TNIP1;IFITM1;PLSCR1;TASOR;ILF3;EIF2AK2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.46654804709754305,1.6791113723209126,0.005979073243647235,0.5337997896986098,1.0,20/59,16.03%,PLXNB2;OBSL1;ROBO4;CADM1;MYPN;PTPRT;CNTN2;DSCAM;IGSF21;IGSF11;SDK1;NECTIN3;TENM3;BSG;FAT2;CDH4;PKD1;CADM3;DSCAML1;HMCN1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5211694408375046,1.6789755188980027,0.0030257186081694403,0.5146164197255128,1.0,9/35,11.45%,PCDHB9;PCDHB4;PCDHGB4;CDH23;DCHS1;PCDHB5;CDH18;ATP2C1;PCDHB3
prerank,positive regulation of viral life cycle (GO:1903902),-0.5332678139544568,-1.6788685102252046,0.013368983957219251,0.30139429789015304,1.0,4/22,3.99%,CD74;AXL;LGALS1;KPNA2
prerank,retinoic acid metabolic process (GO:0042573),0.6375678005379819,1.6779299178660074,0.013136288998357963,0.5017277391682589,1.0,3/14,4.37%,CYP2S1;CYP26C1;BCO2
prerank,stabilization of membrane potential (GO:0030322),0.6143695725082055,1.6763497760246238,0.015410958904109588,0.492241880785814,1.0,7/16,18.64%,KCNK12;KCNK3;KCNK6;KCNN4;CHCHD10;KCNK9;KCNK2
prerank,sterol transport (GO:0015918),-0.5512607609677622,-1.6759777046095277,0.011574074074074073,0.30448679952792423,1.0,8/19,9.27%,MSR1;NPC2;OSBP;CD36;LDLRAP1;CAV1;LDLR;OSBPL2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.6462630839601595,1.6759518455611173,0.011686143572621035,0.4777092594765774,1.0,6/14,17.26%,WRAP53;FUS;TIMELESS;PARP1;ERCC6;MRNIP
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.6846234925305431,1.6757773455264158,0.0142602495543672,0.4631172859670099,1.0,4/11,2.54%,YWHAE;KCNJ3;KCNH2;ATP1B1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6691214920910757,1.6728587167890219,0.005042016806722689,0.4618191861338139,1.0,5/13,9.87%,B3GNT9;B3GNT6;B4GAT1;B3GALT2;B3GALNT1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.47777079920087706,1.6710428903288421,0.0015337423312883436,0.45608525223005675,1.0,22/57,18.02%,CACNG5;CACNG2;DLG2;NPTXR;CNIH2;GRIA2;MEF2C;NPTX1;GRIA1;ACTN2;GRIA4;GRIN1;GRIN2B;CACNG7;MINK1;CRHBP;DLGAP1;OPRM1;DLGAP2;CACNG3;DLGAP3;SHANK1
prerank,negative regulation of immune effector process (GO:0002698),-0.6306786192248921,-1.668623238921572,0.02631578947368421,0.3188178380999947,1.0,6/13,14.75%,CD300A;CD47;ENPP3;RC3H1;CD55;LILRB1
prerank,actin filament network formation (GO:0051639),-0.6426002469655108,-1.6668623644233245,0.014423076923076924,0.318669161754626,1.0,6/11,17.38%,ACTN1;CARMIL1;LCP1;COBL;PLS1;CARMIL2
prerank,bicarbonate transport (GO:0015701),0.5612354032567196,1.6649216915857843,0.008183306055646482,0.47031315261158196,1.0,10/25,13.49%,SLC4A8;CA1;CA3;CA4;CFTR;CYB5R2;SLC26A7;SLC39A8;SLC4A10;SLC4A7
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.5987412371579199,-1.6644718062098323,0.01937046004842615,0.3208528455772287,1.0,6/13,15.91%,PPARG;CD36;SYK;LDLR;LPL;FCER1G
prerank,myelin assembly (GO:0032288),0.7035551413470597,1.6634219566270416,0.017793594306049824,0.46346420671363986,1.0,3/10,5.18%,TPPP;CNTNAP1;GPC1
prerank,lysosome localization (GO:0032418),0.513010382189961,1.6617932874455192,0.004846526655896607,0.4573919778206526,1.0,13/37,17.46%,MAP6;BLOC1S2;RAB3A;SYTL4;BORCS6;SNAPIN;PIK3CG;S100A13;TFEB;RAB34;FLCN;BORCS5;VPS33B
prerank,homocysteine metabolic process (GO:0050667),-0.6482267408263803,-1.661375409166987,0.022988505747126436,0.3245701259023095,1.0,6/11,24.01%,MTHFR;MTRR;MPST;CBS;CTH;NOX4
prerank,sodium ion homeostasis (GO:0055078),0.5778432754243108,1.6597455290263088,0.006896551724137931,0.45430372245255485,1.0,10/21,22.22%,ATP1B1;SCNN1A;SLC12A2;ATP1B3;SLC8A1;NEDD4L;ATP1A4;ATP1A3;ATP1A1;SLC9A1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6706766865153395,1.6595658848947363,0.0016556291390728477,0.4431616550414016,1.0,5/12,9.87%,B3GNT9;B3GNT6;B4GAT1;B3GALT2;B3GALNT1
prerank,defense response to symbiont (GO:0140546),-0.3820015168245294,-1.6577051940067178,0.0,0.3290285773717303,1.0,32/92,14.75%,BCL2;OAS2;BCL2L1;PTPRC;IFIH1;TLR2;IFIT2;IRF7;LYST;ZBP1;STAT2;IFNAR2;IFITM3;IFIT1;TLR7;ATG7;OASL;SHFL;BST2;IFIT3;TLR8;AGBL5;STAT1;ACOD1;NDUFAF4;NLRC5;OAS3;TRIM5;IRF2;PMAIP1;IFNLR1;LILRB1
prerank,intracellular cholesterol transport (GO:0032367),-0.5896914561321734,-1.656235031090115,0.016867469879518072,0.32834977788513414,1.0,7/15,9.63%,NPC2;OSBP;LDLRAP1;LDLR;SERAC1;OSBPL2;ABCG1
prerank,chloride transport (GO:0006821),0.4416188913179892,1.6539942576577704,0.004310344827586207,0.45530758964510093,1.0,22/74,15.20%,SLC4A8;GABRQ;GLRA3;GABRG1;NMUR1;GABRD;GABRG2;SLC12A2;SLC1A1;GLRB;GABRA2;ANO2;CLCN6;SLC12A6;GLRA2;CFTR;SLC26A7;SLC1A3;SLC4A10;SLC6A1;GABRB1;GABRR2
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6358996240439382,1.6527116626272338,0.013377926421404682,0.44959084605590743,1.0,8/15,22.74%,HOGA1;GGT7;GGT5;ABHD12;ALDH4A1;GGACT;CHAC2;PRODH
prerank,protein depolymerization (GO:0051261),0.5369184192935293,1.6511880514148911,0.009419152276295133,0.44455885192097305,1.0,12/27,16.43%,STMN4;STMN3;STMN2;NCKAP5;MICAL3;TWF2;CKAP5;CFL1;NCKAP5L;KIF2A;TWF1;KIF14
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5680206322260489,-1.650606571139874,0.022113022113022112,0.33817649897316954,1.0,6/18,14.82%,DAB2;PTPN23;MTMR2;MSN;RAB21;DNAJC13
prerank,regulation of neuron projection development (GO:0010975),0.39248286050325576,1.650219495415732,0.0,0.4375967003057096,1.0,55/163,19.74%,CSMD3;ABI3;TANC2;PLXNB2;DCC;ARHGAP44;CHN1;PAK1;CTNNA2;ARSB;NTRK1;STMN2;PTPRO;PLA2G3;CRMP1;NTRK3;FBXO7;ITM2C;PTK7;RTN4RL1;PRKCI;GPC2;RIT2;PRAG1;MINAR1;DAB2IP;SHANK3;TWF2;CDKL5;SRCIN1;TENM3;IL1RAPL1;CFL1;MAG;ARHGAP35;MYLIP;NDRG4;LZTS3;EPHA4;NDNF;STYXL1;NTRK2;SETX;ITGA6;PRKD1;TWF1;SCARB2;PTPRS;ULK4;NTNG2;NTNG1;FES;MAGI2;LRRC4C;ROR1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.6422282961912453,-1.6498365682518281,0.020089285714285716,0.3359565508618474,1.0,5/11,12.00%,DAB2;PTPN23;MTMR2;MSN;RAB21
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5420103179835757,-1.6483530923294865,0.017543859649122806,0.3355727329958881,1.0,10/18,21.13%,DDX60;ANKRD17;PUM2;OASL;BIRC2;NOP53;NPLOC4;USP15;RNF125;PUM1
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.5086352494929262,-1.6481228977892293,0.015584415584415584,0.33199932686199607,1.0,12/27,18.74%,CD74;GAS6;IGF1;CDK6;NDUFS4;S100A6;BMI1;PDGFC;LIG4;WNT5A;PDGFRA;FN1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3964003718021403,1.6469852692462836,0.0,0.44074408251635333,1.0,38/159,13.29%,PCDHB9;PCDHB4;PCDHGB4;PLXNB2;OBSL1;CDH23;PTPRD;DCHS1;MPZ;CLDN16;ROBO4;CADM1;TENM1;MYPN;PCDHB5;PTPRT;CNTN2;DSCAM;IGSF21;IGSF11;CDH18;GRID2;ADGRL3;SDK1;NECTIN3;TENM3;BSG;IL1RAPL1;FAT2;ATP2C1;CRTAM;ICAM1;PCDHB3;MAG;CDH4;PKD1;CADM3;GPC4
prerank,neuron projection development (GO:0031175),0.39256902642852665,1.645459399493133,0.0,0.43668848170992686,1.0,73/168,26.67%,CTTN;PLP1;STMN4;STMN3;WHRN;CNTNAP1;SRGAP2;NYAP2;PQBP1;BLOC1S2;PAK1;STMN2;SNAPIN;NCKAP1;NCKAP1L;OMG;IL6;LGI1;MAP1S;RYK;MANF;DAB2IP;SHANK3;SAMD14;ADCYAP1;SH3GL2;MAP4K4;GPRIN1;NEDD4;CTNND2;EHD1;STX3;RASGRF1;MINK1;BTG2;VASH2;DOCK10;CAMSAP1;ANKRD27;MICALL1;IFT88;HMGB1;EPHA4;EPHB2;ERCC6;WNT7A;PPP1R9A;TAOK1;ROCK1;HDGFL3;ALS2;SHANK1;PLXNB1;CDC42;GPM6A;ZFYVE27;MAP2;ULK1;WASL;OPHN1;PTPRM;BDNF;VAPA;RAPGEF2;TAOK2;DCLK1;MAPT;CNTNAP2;FLRT3;MYO16;GRM7;TBC1D24;DLG4
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6198534562601274,-1.6418596116810644,0.03571428571428571,0.3439493532050229,1.0,8/12,35.77%,CAV1;CAMK2D;CALM3;CALM2;PDE4D;CALM1;SRI;IRX3
prerank,negative regulation of reproductive process (GO:2000242),-0.5476703924949777,-1.6413872021201863,0.015503875968992248,0.34091687512184515,1.0,7/17,20.42%,PAEP;IGF1;ARHGDIB;DUSP1;GJA1;HYAL3;TIMP1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.5568605539961532,-1.640832613307657,0.02511415525114155,0.3383926719286266,1.0,10/17,14.07%,BUB3;MIS12;BOD1;ZWILCH;CENPA;HASPIN;CTCF;CDK1;RB1;SPDL1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.6304319092753317,-1.6381874628918025,0.023195876288659795,0.3411630182421721,1.0,3/11,4.89%,APOE;PIK3C3;ATG7
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5812646052332424,-1.6379619702794292,0.02891566265060241,0.33785856697613,1.0,4/15,9.39%,IQGAP2;ACTR3;ARPC2;ARPC5
prerank,regulation of interleukin-12 production (GO:0032655),-0.42754339398937113,-1.637541431575648,0.0061162079510703364,0.3351602736259813,1.0,16/47,16.57%,CD47;TLR2;LILRA5;PIBF1;IL16;THBS1;HSPD1;SYK;TLR8;LTB;SLAMF1;FOXP1;LILRB1;AGER;SCIMP;TLR4
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.6028702298806431,-1.6366884843407097,0.012048192771084338,0.3335099754166918,1.0,6/13,13.03%,CD74;CD44;DYRK1A;YJU2;PTTG1IP;PSMD10
prerank,defense response to virus (GO:0051607),-0.3716765231179296,-1.635030549379368,0.0,0.33368025225956893,1.0,33/100,14.75%,BCL2;OAS2;BCL2L1;PTPRC;ATAD3A;IFIH1;TLR2;IFIT2;IRF7;LYST;ZBP1;STAT2;IFNAR2;IFITM3;IFIT1;TLR7;ATG7;OASL;SHFL;BST2;IFIT3;TLR8;AGBL5;STAT1;ACOD1;NDUFAF4;NLRC5;OAS3;TRIM5;IRF2;PMAIP1;IFNLR1;LILRB1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.6368385454827992,-1.6342339893920004,0.028639618138424822,0.33199262724890233,1.0,5/11,17.43%,SP100;RPS6KA6;MAD2L2;KAT5;HIPK2
prerank,regulation of response to stress (GO:0080134),0.6942595938244798,1.6333711478253132,0.0156794425087108,0.4780526501524522,1.0,5/10,17.12%,ADCY8;SLC38A2;CORO2B;CRHBP;OPRM1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4919494055125532,-1.63198983997151,0.007281553398058253,0.33412884673823157,1.0,10/26,13.51%,DAB2;CNOT9;KANK2;SMARCA4;CRY2;BRCA1;PIAS2;CRY1;HDAC1;FOXP1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5175192359566604,-1.631935191403427,0.010443864229765013,0.3306444757575431,1.0,12/22,20.36%,FLOT2;GCNT2;CD44;IL1B;LCK;SKAP1;AGER;TNF;MAPK7;MYADM;BMP7;KLF4
prerank,purine-containing compound salvage (GO:0043101),0.6463565916973906,1.6307534246170334,0.016363636363636365,0.4786854537056528,1.0,7/12,21.60%,ADA;PNP;HPRT1;AMPD3;DCK;GMPR;DGUOK
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.6078214622974679,-1.6284632831181474,0.02729528535980149,0.3362211636938311,1.0,8/12,19.95%,GCNT2;CD44;IL1B;LCK;SKAP1;AGER;TNF;BMP7
prerank,inorganic anion transmembrane transport (GO:0098661),0.44844530224894985,1.6269438402369276,0.0014577259475218659,0.4855465474881549,1.0,22/63,17.91%,SLC4A8;GABRQ;GLRA3;GABRG1;GABRD;SLC37A4;GABRG2;SLC12A2;SLC1A1;GLRB;SLC20A1;GABRA2;ANO2;SLC12A6;GLRA2;CFTR;SLC1A3;SLC6A1;GABRB1;GABRR2;ANO3;SLC37A1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.6675677542006289,1.6258177642197142,0.01896551724137931,0.48026818037852886,1.0,6/12,13.29%,STARD3;TSPOAP1;STAR;FDX2;AKR1B1;TSPO
prerank,positive regulation of binding (GO:0051099),-0.37549389330305694,-1.6257673045815508,0.0036900369003690036,0.3394421337380614,1.0,37/84,21.52%,STK3;APOE;IGF1;HMGB2;PPARG;DTX3L;RARA;MET;NCBP1;CEBPG;TAF1;HIP1R;PLAUR;CAV1;STMN1;CLN5;TXN;PSEN1;AKTIP;SPPL3;B2M;RALB;LRP1;BMP2;LRRK2;PARP9;CDT1;NMD3;HIPK2;MMP8;HES1;DPH3;RPL11;BAMBI;SIRT2;TRIM21;APP
prerank,sarcomere organization (GO:0045214),0.5374152349694465,1.6255082711920692,0.0220125786163522,0.4717605685687622,1.0,4/27,9.08%,CAPN3;SIX4;MYPN;ACTN2
prerank,protein heterotetramerization (GO:0051290),0.6346251938328049,1.6252487710428514,0.021015761821366025,0.4634506220275612,1.0,7/13,14.46%,CPSF6;CBR4;PKD2;GRIN1;GRIN2B;PKD1;NUDT21
prerank,inositol phosphate metabolic process (GO:0043647),0.47191219572097454,1.6244607189177913,0.007704160246533128,0.45762634325177376,1.0,14/46,11.95%,PLCH1;INPP4B;ITPK1;IP6K1;INPP5D;NUDT10;PLCD1;INPP5B;PLCG1;NUDT3;PLD4;OCRL;FGF2;IPMK
prerank,dendritic spine morphogenesis (GO:0060997),0.6074852774139641,1.6237847200237352,0.018456375838926176,0.4515993767251513,1.0,11/15,28.13%,SHANK3;CTNND2;DOCK10;EPHB2;WNT7A;SHANK1;CDC42;WASL;DLG4;DIP2A;PTEN
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.4757912168163103,-1.6224444374290277,0.016901408450704224,0.34392340402966065,1.0,9/29,11.57%,UBE2D3;IRF7;TBK1;CD300LF;CD14;RIPK1;UBC;UBA52;BIRC2
prerank,calcium ion import (GO:0070509),0.5181380074174615,1.621284751851454,0.011419249592169658,0.4533354989487742,1.0,11/28,16.45%,ATP2A2;CACNB2;CACNA1S;MICU2;SMDT1;CACNA1G;SLC8A1;CACNA1D;CACNA1B;SLC25A23;CACNA1A
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5132994020335231,-1.6188421083825892,0.02195121951219512,0.3455176956535323,1.0,10/21,16.08%,BCL2;BCL2L1;MCL1;PF4;IL1B;EYA1;EYA3;EYA2;TNF;MAPK7
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5132994020335231,-1.6188421083825892,0.02195121951219512,0.3455176956535323,1.0,10/21,16.08%,BCL2;BCL2L1;MCL1;PF4;IL1B;EYA1;EYA3;EYA2;TNF;MAPK7
prerank,clathrin-dependent endocytosis (GO:0072583),-0.48481607376542785,-1.6186347576270292,0.012690355329949238,0.34258727917761916,1.0,8/26,6.26%,ITSN1;AP2A2;DNAJC6;SIGLEC1;GAK;FCHO2;AP2B1;PICALM
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.3768025964801619,-1.6182384888163597,0.0,0.34005865688593895,1.0,29/73,18.91%,OAS2;PTPRC;IFIH1;TLR2;LILRA5;CCR2;TYROBP;CD14;PF4;THBS1;NOD2;RIPK1;SYK;PSEN1;LPL;ADAM8;CYBA;CD2;OAS3;SPHK2;LBP;AGER;HSPB1;WNT5A;SPN;TLR4;ARHGEF2;MMP8;TLR1
prerank,positive regulation of macrophage activation (GO:0043032),-0.5669747543928454,-1.6178362163647542,0.01728395061728395,0.3377569743547859,1.0,7/17,18.47%,STAP1;THBS1;HSPD1;LBP;WNT5A;TLR4;MMP8
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5312756988146066,-1.6174175199049874,0.0267639902676399,0.33525908662893483,1.0,9/20,16.57%,PTPN22;PRKCE;CD14;LYN;HCK;IL1B;LBP;TNF;TLR4
prerank,response to cytokine (GO:0034097),-0.34382699994838545,-1.617048496041368,0.0,0.3330894918455639,1.0,55/141,23.98%,PID1;SP100;BCL2;CD74;CD274;BCL2L1;KLHL20;PTPN23;LIFR;CIITA;MCL1;TBK1;IFNAR2;IFITM3;IL6ST;MAPKAPK2;CXCL16;ADAM9;SHFL;BST2;RIPK1;SMAD3;LDLRAP1;ANXA1;IL1B;PTPN7;STAT1;MAPKAPK3;SLC11A1;TIMP4;ASAH2;IFNLR1;RELB;CRNN;IL18R1;MAP2K7;MAPK8;COL3A1;OSMR;MYD88;TIMP1;CASP1;TRIM21;PTPN4;HDAC4;CDK9;SETD2;APP;IFITM1;KYNU;XAF1;MEFV;PLSCR1;ALDH1A2;TIMP3
prerank,early endosome to Golgi transport (GO:0034498),-0.6479948177937572,-1.616997012076845,0.033860045146726865,0.3299346427005482,1.0,6/11,14.11%,SNX8;STX5;SNX1;RAB6A;TMED9;RBSN
prerank,organophosphate ester transport (GO:0015748),-0.4982579824743275,-1.6166791794152584,0.01201923076923077,0.32744053003878754,1.0,8/24,10.02%,OSBPL8;NPC2;PLTP;LDLR;EPG5;PCTP;OSBPL2;SLC25A19
prerank,axonal fasciculation (GO:0007413),0.646823394146387,1.616283249296711,0.015985790408525755,0.4652650161799185,1.0,5/12,14.23%,MEGF8;ARHGAP35;NRCAM;EPHA4;EPHB2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6420318012035562,-1.6162540512276304,0.03755868544600939,0.32547198953349005,1.0,6/10,28.25%,MAD2L2;NOTCH1;NOTCH4;PPM1F;RGCC;PLG
prerank,membrane organization (GO:0061024),-0.32285704657788133,-1.6162053889127148,0.0,0.32245269422285294,1.0,70/227,16.58%,DAB2;ITSN1;MYOF;RABEP1;TMCC1;HIP1;SYNJ2;ACTR3;CHMP4A;CHMP4B;AP2A2;DNAJC6;REPS2;CORO1C;AGFG1;GAK;TOR1AIP1;SH3GLB1;AP3D1;M6PR;FCHO2;AP2B1;HIP1R;PLEKHA3;CHRM2;ARPC2;TFRC;PICALM;LDLRAP1;LDLR;SNX9;GAPVD1;EPS15;UBC;SLC2A8;CTDNEP1;FNBP1;LEMD3;AMPH;TOR1B;SNAP23;OSBPL2;UBA52;ARPC5;DYSF;SNAP29;DNM2;IGF2R;CLTA;GRB2;NEMP1;CBL;REEP1;CHMP1B;PACSIN2;FER1L6;PDCD6IP;STAM;GCA;EGFR;TIMM50;UBXN2B;WNT5A;CHP1;CLN3;RTP4;KIF20A;CLTB;USO1;STX18
prerank,error-prone translesion synthesis (GO:0042276),-0.5165731137578804,-1.613494289659381,0.013404825737265416,0.3253729712198077,1.0,7/21,16.92%,PCNA;POLI;UBC;UBA52;MAD2L2;RPA1;RPA2
prerank,pentose-phosphate shunt (GO:0006098),-0.6421651781792987,-1.6123232291865972,0.036855036855036855,0.3250736018263067,1.0,4/11,12.41%,RBKS;TALDO1;TKT;SHPK
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.596132872195925,-1.6118683136467287,0.026066350710900472,0.32304965793032847,1.0,6/14,14.75%,LILRA5;PIBF1;THBS1;TLR8;SLAMF1;LILRB1
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.5217538169438427,-1.6100249352925882,0.027472527472527472,0.3244171920070507,1.0,7/21,14.62%,RBKS;TALDO1;TKT;HK1;SHPK;GPI;PGM2L1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.402378038609041,-1.6089024518062647,0.0064516129032258064,0.32430563604160473,1.0,23/56,19.66%,ALPK1;SFTPA2;SFTPA1;TLR2;CD36;MAPKAPK2;TLR7;CD14;NOD2;CTSL;UBC;TLR8;CTSB;TAB1;UBA52;S100A1;MAPKAPK3;IRAK4;LBP;TLR4;CLEC4E;TLR1;MYD88
prerank,protein localization to cilium (GO:0061512),0.5012169904338003,1.608397096309752,0.00933125972006221,0.4897855651337403,1.0,8/32,10.33%,IFT20;WDR19;ODAD4;ROPN1;MAPK15;TMEM107;BBS9;EHD1
prerank,regulation of aerobic respiration (GO:1903715),-0.5696856664348545,-1.604892437994306,0.020785219399538105,0.3314276165749983,1.0,6/15,16.71%,VCP;CBFA2T3;ATP7A;UQCC2;SLC25A33;NOP53
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.5802691524342583,-1.6046431638121987,0.022388059701492536,0.328998878458074,1.0,4/14,11.86%,IGF1;PTPRC;LDLR;TNFRSF1B
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.6097639581552123,-1.6016126117302594,0.037037037037037035,0.33356271683854993,1.0,3/11,1.64%,BCL2;CD74;CD44
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.3561242481599598,-1.5998142038951828,0.0,0.3352276665106179,1.0,48/112,24.82%,PTPN22;GAS6;OAS2;IGF1;PTPRC;CD47;IFIH1;TLR2;LILRA5;RARA;CCR2;MAPKAPK2;TYROBP;CD14;PF4;THBS1;NOD2;RIPK1;SYK;PSEN1;LPL;ZC3H12A;CYBA;CD2;OAS3;SLAMF1;FOXP1;SPHK2;LBP;LILRB1;AGER;HSPB1;WNT5A;SPN;TLR4;ARHGEF2;MMP8;TLR1;CD33;LTF;NLRC3;APP;NR1H4;TWIST1;TNFRSF8;GSTP1;FADD;TLR9
prerank,regulation of embryonic development (GO:0045995),-0.4491567213065061,-1.597297194710971,0.005479452054794521,0.338536358827676,1.0,15/34,20.84%,PHLDB1;B4GALT5;RPS6KA6;BAG6;RACGAP1;DAG1;WDPCP;TRIP12;CDK1;CCSAP;EHMT1;LHX1;NIBAN2;NPHP3;POGLUT1
prerank,steroid hormone biosynthetic process (GO:0120178),0.520469760896126,1.595396754376323,0.017241379310344827,0.5395950516122531,1.0,8/29,13.29%,STARD3;HSD17B2;TSPOAP1;STAR;FDX2;AKR1B1;HSD17B11;TSPO
prerank,regulation of p38MAPK cascade (GO:1900744),-0.4456317457803317,-1.5941968655253305,0.011019283746556474,0.34323792782680285,1.0,11/35,14.78%,SASH1;PTPN22;XDH;PJA2;RELL1;IL1B;ZC3H12A;GADD45G;BMP2;DUSP1;AGER
prerank,negative regulation of interleukin-17 production (GO:0032700),0.6680455206872611,1.5935170569413222,0.02586206896551724,0.5393458004276245,1.0,3/10,5.56%,VSIR;NCKAP1L;PRNP
prerank,phagosome acidification (GO:0090383),-0.48001403767434697,-1.592325755443184,0.01749271137026239,0.34529592973880785,1.0,6/26,4.03%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;RAB7A;ATP6V0B
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4650888518619985,1.5916961006738284,0.01327433628318584,0.538777237895742,1.0,15/44,19.06%,KCNMA1;KCNJ3;KCNH2;GABBR1;NOS1AP;ATP1B1;ATP1B3;ACTN2;GABBR2;KCNN4;KCNJ5;KCNMB3;KCNN3;ANK2;WNK1
prerank,negative regulation of cell development (GO:0010721),-0.49382611580874425,-1.5901132211356939,0.005494505494505495,0.3478551716827119,1.0,14/25,23.59%,IGF1;PCM1;FBXW7;IL1B;NOTCH1;B2M;LILRB1;TNF;PTHLH;APPL2;RFLNA;LTF;PAX6;HOOK3
prerank,neurotransmitter biosynthetic process (GO:0042136),0.6252200544532217,1.5896861569899303,0.02533783783783784,0.5390741134384777,1.0,6/14,22.74%,ALDH9A1;ACHE;CHAT;MOXD1;DAGLA;DAGLB
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.5931011502093557,-1.589435280693224,0.029213483146067417,0.34664091255262197,1.0,7/13,24.82%,PIK3C3;PIK3R4;TLR7;EPG5;IRAK4;MYD88;TLR9
prerank,spermatid development (GO:0007286),0.5049232881892816,1.5886385671520245,0.011128775834658187,0.5350951243487292,1.0,7/32,6.14%,YTHDC2;TDRD5;ACRBP;DDX25;JAM2;NME5;ZMYND15
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6287127899715013,-1.588478205379491,0.04017857142857143,0.3460409684290535,1.0,5/10,14.75%,BTLA;CD24;LYN;BAG6;LILRB1
prerank,regulation of cation channel activity (GO:2001257),0.42185196420018534,1.5860158685840033,0.004213483146067416,0.5377549947479231,1.0,28/89,18.03%,FGF14;CACNB4;CACNG5;CACNG2;DLG2;FGF12;CACNB2;FGF11;KCNE2;CNIH2;DMD;GRIA2;MEF2C;GRIA1;ACTN2;GRIA4;GRIN1;GRIN2B;CACNG7;MINK1;FGF13;CRHBP;JPH1;HPCA;OPRM1;CACNG3;SHANK1;ANK2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4537444500703975,-1.5857463931209657,0.030726256983240222,0.34973215933885016,1.0,15/32,19.01%,CLSPN;CDC14B;TOPBP1;NBN;ABRAXAS1;TAOK3;BRCA1;CDK1;TICRR;NOP53;BRCC3;UIMC1;DTL;HMGA2;PLK1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5567285614801909,1.5842859669259446,0.02385008517887564,0.5371337402098468,1.0,10/21,24.33%,KCNH2;KCNA5;NOS1AP;KCNE2;GJA5;CACNA1D;CACNA2D1;ANK2;SCN1B;SNTA1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6551047039060472,1.5824716675936867,0.02276707530647986,0.5364944727989515,1.0,2/11,0.87%,P3H2;P4HA3
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.5623192329902486,1.5817986931836718,0.011475409836065573,0.5312072154944738,1.0,7/19,11.93%,MAF1;PRDX5;RPTOR;TENM1;AR;ZC3H8;POLR3F
prerank,regulation of cytokinesis (GO:0032465),-0.36544687244197466,-1.5814615259758131,0.006493506493506494,0.3575215846453288,1.0,31/78,21.65%,SVIL;PIK3C3;BCL2L1;PRKCE;CUL3;PIK3R4;GIT1;KIF23;BIRC6;CDC14B;SH3GLB1;PRC1;KIF20B;CIT;RACGAP1;UVRAG;DRD2;KLHL21;CALM3;AHCTF1;CALM2;E2F8;PRPF40A;E2F7;KIF20A;ECT2;PLK1;DRD3;MAP10;SETD2;CDC14A
prerank,positive regulation of transport (GO:0051050),-0.36488143881940216,-1.5809185966273562,0.0,0.35598407681055344,1.0,22/85,15.91%,DAB2;FCGR2B;IL15;APOE;GAS6;CD47;DOCK2;BAX;HIP1R;ANXA1;IL1B;KCTD7;CYBA;SLC11A1;NR1H3;LRP1;INPP5K;NUMA1;TNF;CHP1;TUB;FCER1G
prerank,retrograde axonal transport (GO:0008090),0.5879402605273507,1.579860827983206,0.03436988543371522,0.5316541059487649,1.0,5/16,14.98%,ACTR10;DST;DLG2;KIF1C;HAP1
prerank,negative regulation of axonogenesis (GO:0050771),0.5175684560999573,1.5787923119527443,0.014423076923076924,0.5286535475093298,1.0,17/27,28.13%,DIP2B;DCC;THY1;OMG;EFNB3;ARHGDIA;GDI1;FGF13;MAG;PTPRS;ULK2;MAP2;ULK1;RHOA;NGFR;LINGO1;PTEN
prerank,regulation of T cell proliferation (GO:0042129),-0.3962529795698926,-1.5773057158308885,0.006920415224913495,0.36181890276560086,1.0,16/61,11.86%,IL15;CD274;CCDC88B;TNFSF8;SLC7A1;PTPRC;DLG5;IL6ST;NCK1;IL27;CEBPB;TFRC;ANXA1;IL1B;CD28;TNFRSF1B
prerank,regulation of exocytosis (GO:0017157),0.4676166178654227,1.5769208468090123,0.013953488372093023,0.5284747019323947,1.0,15/46,14.98%,LGI3;RAB3A;CADPS2;SYTL4;SYT1;RAB26;RAB8A;CLASP2;CFTR;IL1RAPL1;RAB5A;RAB3D;CPLX2;RAB12;HAP1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.47208391743177586,1.5735224702029873,0.016819571865443424,0.5355146514188024,1.0,13/38,18.03%,YWHAE;KCNJ3;KCNH2;BIN1;KCNA5;CACNB2;KCNE2;CACNA1G;CACNA1D;KCNJ5;CACNA2D1;CTNNA3;ANK2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.46704461721916724,-1.5723181141097342,0.022556390977443608,0.3723632993925065,1.0,11/26,22.94%,CUL3;CDK5RAP2;NSMCE2;CDC27;ESPL1;RB1;DUSP1;UBE2C;PLK1;ANAPC7;CCNB1
prerank,negative regulation of neuron projection development (GO:0010977),0.4364685240783877,1.5720451724717275,0.0029717682020802376,0.5343457517199389,1.0,17/56,13.98%,DCC;STMN2;THY1;PTPRO;CRMP1;OMG;EFNB3;ITM2C;RTN4RL1;PRAG1;MINAR1;ARHGDIA;GDI1;EFNA1;MAG;MYLIP;EPHA4
prerank,regulation of potassium ion transport (GO:0043266),0.491839199947091,1.5715932236494692,0.02471169686985173,0.528749943892867,1.0,9/31,11.28%,KCNH2;KCNA5;KCNE2;KCNIP3;KCNIP4;ADRA2A;FHL1;ACTN2;CACNA1D
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.6323624711397675,1.5706897350869544,0.042735042735042736,0.5250305780225074,1.0,5/12,11.42%,AAAS;BMP4;TGFB1;NEDD4;IFI27
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.5315326077475941,-1.5702155962392235,0.030612244897959183,0.3746229775281861,1.0,9/16,27.09%,ULBP1;LYST;SLAMF7;CEBPG;RAET1E;KLRK1;PLEKHM2;VAMP7;TUBB4B
prerank,clathrin coat assembly (GO:0048268),-0.5618859846476929,-1.5702047060123279,0.02284263959390863,0.37172803250807895,1.0,8/15,18.20%,HIP1;FCHO2;HIP1R;PICALM;EPS15;CLTA;CLTB;FCHO1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5726867015124394,1.569796539525829,0.023931623931623933,0.5218217539927998,1.0,8/17,24.33%,KCNH2;NOS1AP;KCNE2;GJA5;CACNA2D1;ANK2;SCN1B;SNTA1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5056881769893069,-1.5697441346777654,0.024630541871921183,0.3701715410009439,1.0,9/21,28.18%,OSBPL8;PLA2G4E;PLAAT3;LPCAT4;PLA1A;PLA2G4F;PLA2G2D;MBOAT1;PLA2G12A
prerank,regulation of Rac protein signal transduction (GO:0035020),0.5872412999531398,1.569294483544087,0.031413612565445025,0.5171051075649518,1.0,9/16,20.51%,SH3BP1;STMN3;ARHGAP44;PIK3CG;OGT;RASGRF1;CADM4;ALS2;GABARAP
prerank,endothelial cell migration (GO:0043542),-0.4414208887798761,-1.5689485080131391,0.014577259475218658,0.36947387037945045,1.0,13/37,15.79%,NRP1;PXN;DPP4;PLEKHG5;PIK3CA;STAT1;EGR3;ADGRA2;ID1;EMP2;CCN3;PRKX;MYH9
prerank,negative regulation of transport (GO:0051051),-0.4061960491339311,-1.5680139867624077,0.013333333333333334,0.36886970139501746,1.0,21/51,24.66%,FCGR2B;MCTP1;ARL6IP5;PIP4P2;TLR2;MTMR2;RAB7A;BST2;NR1H2;DYSF;NR1H3;RACK1;LILRB1;YRDC;RSC1A1;PPM1F;ITGB3;NDFIP1;PLSCR1;EGF;PRTN3
prerank,negative regulation of B cell activation (GO:0050869),-0.5019660437842677,-1.5663409931059413,0.03282828282828283,0.37040219430321436,1.0,7/21,12.01%,FCGR2B;CD300A;TYROBP;LYN;BANK1;RC3H1;FOXJ1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.491359672394239,-1.5646031168383363,0.03412073490813648,0.371850438972875,1.0,13/24,29.49%,EPC1;RBBP7;PPHLN1;DNMT1;BMI1;H3-3A;PHF19;EED;TASOR;MTF2;EZH2;DNMT3A;PPM1D
prerank,synaptic vesicle endocytosis (GO:0048488),-0.4471627501608289,-1.5636255630379527,0.0084985835694051,0.37124206057321707,1.0,9/33,10.60%,ITSN1;SYNJ2;DNAJC6;GAK;FCHO2;PICALM;AMPH;DNM2;SNCG
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5966641383653934,-1.5634833656078944,0.046153846153846156,0.368843849071209,1.0,5/11,20.67%,BCL2L1;ZC3H12A;PTGIS;DFFA;SIRT2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4365480833624724,-1.5611274355513085,0.007936507936507936,0.3718078367228725,1.0,10/35,9.94%,APOE;ALOX5;XDH;PPARG;AIMP1;THBS1;FLT1;PDCD10;CAV1;STAT1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5644964256876782,-1.5610991880036333,0.04081632653061224,0.36916322989686917,1.0,7/13,21.32%,SOX11;TAF1;PSEN1;MAD2L2;HEY2;PER2;TMSB4X
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.4143182872370439,-1.5602071676119031,0.002932551319648094,0.3687492534472002,1.0,18/47,16.22%,FBXW7;PROX1;NFKB1;CAV1;FYN;ERLIN2;WDTC1;BRCA1;ZC3H12A;PTGIS;EP300;C1QTNF3;CRY1;CEACAM1;APOC1;GLA;SIK1;ACADL
prerank,regulation of response to biotic stimulus (GO:0002831),-0.4581819707851571,-1.5589312286773866,0.030534351145038167,0.36928797558093984,1.0,12/28,24.93%,FCGR2B;PTPN22;CD36;ERAP1;BIRC2;TRIM5;CD55;FOXP1;APPL2;XIAP;APPL1;DHX58
prerank,endocytic recycling (GO:0032456),-0.40346639979935933,-1.5589084630679686,0.01466275659824047,0.36671803790936475,1.0,11/50,8.41%,DENND1A;EHD4;STX6;VPS26A;PTPN23;DENND1B;RAB7A;VPS35;LMTK2;EPS15;CCDC22
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.4111251188298748,-1.5583634111204279,0.020527859237536656,0.3654450070582737,1.0,14/45,16.95%,IQGAP1;KIF16B;REPS2;BRAF;GAB1;PIK3CA;GRB2;CBL;EGFR;SHC1;PTK2B;BCAR1;AAMP;ADAM17
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.4260771194882129,-1.5565359706521837,0.007894736842105263,0.36710388406215755,1.0,9/38,9.03%,UBE2D3;ATG13;FBXW7;TOMM7;SH3GLB1;BAG4;ARIH2;PARL;UBE2L3
prerank,peptidyl-proline modification (GO:0018208),0.5209911677783452,1.555840643271917,0.021806853582554516,0.5675476849486836,1.0,6/25,7.35%,P3H2;PPIC;PPIB;PPWD1;PPIL1;PPIG
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5646775657452716,1.5554836984285618,0.02079722703639515,0.5613856427870503,1.0,11/18,32.86%,HHEX;MCM3AP;DDX25;SARNP;NUP133;NXF1;DDX19A;PCID2;ZC3H11A;POLDIP3;NUP93
prerank,N-glycan processing (GO:0006491),-0.5104254107867477,-1.55469231837198,0.034912718204488775,0.3690052019907542,1.0,8/18,14.87%,MAN2A1;GANAB;ST8SIA6;FUT8;ST8SIA4;GNPTAB;PRKCSH;ST8SIA2
prerank,DNA packaging (GO:0006323),-0.5302049661142271,-1.5526912491598646,0.030303030303030304,0.37146423524251154,1.0,8/16,29.64%,NAA10;H1-0;HAT1;BANF1;PRM1;M1AP;AIFM1;BANF2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.47616506555125127,-1.552595097543616,0.02717391304347826,0.36913632183592343,1.0,10/27,13.14%,PRKCH;MSR1;PPARG;CD36;NFKB1;PF4;NR1H2;LPL;ABCG1;NR1H3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4726215920091674,-1.551476678429538,0.017326732673267328,0.36908902737778465,1.0,12/26,16.85%,NR1H2;PRKAG2;ERLIN2;WDTC1;BRCA1;CEACAM1;APOC1;NR1H3;MID1IP1;PRKAB2;ACADL;ADIPOR2
prerank,regulation of endocytic recycling (GO:2001135),0.6222593620946099,1.5512069876538692,0.039316239316239315,0.5741332222376522,1.0,6/11,11.40%,ATP9A;PLA2G3;ACTN2;INPP5F;EHD1;EHD2
prerank,mitotic sister chromatid segregation (GO:0000070),-0.3496413455652218,-1.5496589730034833,0.0038461538461538464,0.3709897077997854,1.0,36/98,19.52%,DIS3L2;CHMP4A;CHMP4B;KPNB1;MIS12;CUL3;PDS5B;PIBF1;KIF23;PRC1;NCAPD2;NCAPH;BOD1;CDCA8;TEX14;NCAPG2;KIFC1;PDS5A;HASPIN;NUSAP1;SMC2;CDK1;ESPL1;RAD21;CHMP1B;PDCD6IP;RB1;SPDL1;NUP62;NDC80;KIF18B;DCTN2;MCPH1;PLK1;TENT4A;REC8
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3627071929396772,1.5491271883327922,0.001201923076923077,0.5757848611541219,1.0,59/224,18.57%,PLP1;SNAP25;GABRQ;PCDHB9;CACNB4;GLRA3;PCDHB4;HTR1F;DLG2;KCND2;GABRG1;CACNB2;MPZ;GABRD;GIPC1;SYT1;PCDHB5;GRIA2;GABRG2;NRXN1;SLC1A1;GLRB;KCNK3;GRM3;RIT2;NPTX1;GRIA1;GRIK2;GABRA2;CPNE6;GRIA4;GRIN1;SST;SLC12A6;GRIN2B;GLRA2;ASIC2;MINK1;UNC13B;SLC1A3;PCDHB3;GAD2;CACNA1B;GABBR2;SLC6A1;DLGAP1;NOVA1;SPG11;GABRB1;HAP1;GABRR2;CACNA1A;HTR6;PRKAR1A;MTNR1B;SNCB;MBP;CHRNA7;CHRFAM7A
prerank,regulation of viral genome replication (GO:0045069),-0.3893541945496588,-1.5485183641796796,0.0060790273556231,0.37123303068929225,1.0,31/56,33.04%,OAS2;IFIH1;IFITM3;IFIT1;PROX1;OASL;SHFL;BST2;CD28;PPIH;OAS3;LARP1;BANF1;TNF;ZC3HAV1;STAU1;LTF;TNIP1;IFITM1;VAPB;PLSCR1;ILF3;EIF2AK2;ISG20;BTBD17;NR5A2;SLPI;SRPK1;PDE12;PPIA;ISG15
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.4411941722680849,-1.5480811008398458,0.016216216216216217,0.36985236566105345,1.0,16/34,23.66%,IGF1;CUL3;NSMCE2;IL1B;NUSAP1;CD28;CDC27;IGF2;ESPL1;RB1;NUP62;DRD3;RGCC;TGFA;ANAPC7;EGF
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.5537876098799609,-1.5470279173983186,0.0410958904109589,0.36966589159781515,1.0,8/15,15.08%,APOE;ADAM9;NRDC;SNX9;IL1B;ADAM8;TNFRSF1B;TNF
prerank,negative regulation of receptor binding (GO:1900121),0.6629592501082706,1.5453380519661346,0.02882882882882883,0.5857147705779043,1.0,3/10,9.80%,ATP2A3;ATP2A2;ADAM15
prerank,chemical synaptic transmission (GO:0007268),0.3525963523945181,1.5444457130534215,0.0,0.5823431067549378,1.0,76/284,19.11%,PLP1;SNAP25;GABRQ;PCDHB9;CACNB4;GLRA3;PCDHB4;HTR1F;DLG2;KCND2;GABRG1;TSPOAP1;CACNB2;RAB3A;MPZ;GABRD;GIPC1;SYT1;SNAPIN;PCDHB5;NAPB;ERC2;GRIA2;GABRG2;CBLN2;NRXN1;SLC1A1;GLRB;KCNK3;GRM3;FCHSD2;RIT2;NPTX1;GRIA1;GRIK5;GRIK2;GRID2;GABRA2;CPNE6;GRIA4;GRIN1;SST;CHAT;SLC12A6;GRIN2B;GLRA2;ASIC2;MINK1;UNC13B;SLC1A3;RIMS1;PCDHB3;SLC1A4;GAD2;CRHBP;CACNA1B;GABBR2;STXBP2;SLC6A1;DLGAP1;NOVA1;SPG11;GABRB1;HAP1;GABRR2;CACNA1A;HTR6;PRKAR1A;DLGAP2;MTNR1B;SNCB;MBP;CHRNA7;CHRFAM7A;UNC13C;LIN7A
prerank,determination of heart left/right asymmetry (GO:0061371),0.45887909180789466,1.5435492703025686,0.016176470588235296,0.57888734102303,1.0,11/42,13.14%,DNAAF1;VANGL2;CCDC39;MEGF8;MEF2C;DAND5;BBS5;PKD2;TBX2;NDRG4;TBX6
prerank,keratinocyte differentiation (GO:0030216),-0.45368816561794917,-1.5417997587156242,0.03553299492385787,0.38024541479689944,1.0,18/29,38.41%,ST14;ADAM9;CLIC4;ANXA1;TXNIP;WNT5A;EPHA2;OPN3;BCR;DSP;EVPL;SCEL;KRT10;ASAH1;UGCG;EXPH5;SPRR1A;PIP5K1A
prerank,polyol metabolic process (GO:0019751),0.449208781520035,1.5404349031156797,0.02157164869029276,0.5859262384278294,1.0,13/46,11.95%,PLCH1;INPP4B;ITPK1;IP6K1;INPP5D;NUDT10;PLCD1;INPP5B;PLCG1;NUDT3;PLD4;OCRL;IPMK
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5022468235139759,1.5397331565567591,0.020338983050847456,0.581786270234912,1.0,15/28,26.65%,STMN4;STMN3;STMN2;MAP1S;CLASP2;MAPRE2;CAMSAP3;CAMSAP1;MAP2;GBA2;MAPRE3;GAS2L1;MAPT;FKBP4;MAP1B
prerank,regulation of cell motility (GO:2000145),0.3879616826085586,1.5395091589138563,0.0026455026455026454,0.5759129460456804,1.0,39/121,19.11%,CCDC25;FGF10;SPOCK3;ABI3;FRMD5;FGF16;PLXNB2;FGF9;LDB2;LDB1;PKN1;PARD6B;ROBO4;NRG4;BEX4;SPOCK2;FGF7;SPINT2;PRAG1;SRCIN1;ENPP2;ERBB4;SST;TGFB1;CAMSAP3;INPP5F;MINK1;FGF2;DOCK10;HACE1;KIF2A;RCC2;CADM4;SERPINE2;KIF14;ROCK1;PIN1;FES;PLXNB1
prerank,neuron projection fasciculation (GO:0106030),0.6473093500509415,1.5390679169926575,0.029250457038391225,0.5712360496035728,1.0,4/10,14.23%,ARHGAP35;NRCAM;EPHA4;EPHB2
prerank,membrane repolarization (GO:0086009),0.5770146607014558,1.538680967636971,0.04409171075837742,0.566249670713559,1.0,4/15,7.11%,KCNH2;ATP1B1;KCNE2;ATP1B3
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5344522649728274,1.538161702776568,0.024509803921568627,0.5618952615790105,1.0,9/22,20.07%,FGF10;FGF7;SRSF6;AREG;SNAI2;TGM1;PRKD1;STXBP4;EPB41L4B
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.4787855330278277,-1.538157798650602,0.03367875647668394,0.3867228244455927,1.0,6/22,12.33%,OS9;UGGT1;UBC;UBA52;RNF103;EDEM1
prerank,potassium ion transport (GO:0006813),0.3806808513605261,1.537368073327562,0.006596306068601583,0.5591165317744793,1.0,31/120,18.70%,HCN1;KCNMA1;KCNK12;KCNJ3;KCNH2;KCND2;KCNA5;KCNE2;KCNJ8;KCNH7;KCNC1;KCNK3;ATP1B3;KCNJ13;SLC9A4;PKD2;KCNK6;SLC1A3;KCNN4;SLC9A5;ABCC8;HPN;KCNJ5;KCNC3;KCNMB3;SLC24A3;KCNN3;KCNK9;KCNQ4;KCNK2;SLC24A4
prerank,inner dynein arm assembly (GO:0036159),0.6562184281910728,1.5368818862839073,0.043993231810490696,0.5550952298850378,1.0,4/10,8.64%,DNAAF1;CCDC39;DNAI3;CFAP100
prerank,regulation of catabolic process (GO:0009894),0.5557435226143657,1.535779297539411,0.03104575163398693,0.5533190188823519,1.0,8/18,20.33%,RARRES2;FAF1;CENATAC;ZDHHC2;TMEM9;NEDD4L;HPGD;SNF8
prerank,translesion synthesis (GO:0019985),-0.41459971320388866,-1.5340177293150077,0.017595307917888565,0.39510180030759456,1.0,16/42,19.40%,VCP;TRIM25;PCNA;POLI;UBC;PCLAF;UBA52;MAD2L2;POLD4;RPA1;FAAP20;UBE2L6;RPA2;DTL;USP43;NPLOC4
prerank,establishment of protein localization to extracellular region (GO:0035592),0.46675039164437127,1.532916704422432,0.01938610662358643,0.5592073132175266,1.0,15/39,19.42%,LTBP2;RAB3A;TVP23A;RAB8A;COPG1;PPY;TANGO2;ARL4D;RAB3D;MTTP;RAB12;MIA3;COPG2;PREB;OLFM2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.38033281176438877,-1.5311694758597398,0.006622516556291391,0.3999890887287141,1.0,15/63,8.00%,VAV3;IL15;BCL2;CD74;CD38;CD274;CCDC88B;SLC7A1;PTPRC;IL6ST;NCK1;GPR183;TFRC;ANXA1;IL1B
prerank,neurotransmitter uptake (GO:0001504),0.6209446086490403,1.5311224108689914,0.040492957746478875,0.5604031332691288,1.0,3/12,11.07%,SNAP25;SLC29A2;SLC1A3
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3869887890563135,-1.530290220431559,0.0029585798816568047,0.399657963088095,1.0,19/55,16.26%,IL15;CD274;IGF1;CCDC88B;SLC7A1;PTPRC;CCR2;IL6ST;NCK1;TFRC;SYK;CD24;ANXA1;IL1B;CD28;IGF2;EBI3;AGER;IL27RA
prerank,potassium ion export across plasma membrane (GO:0097623),0.5978020839235614,1.5291734221456945,0.02707581227436823,0.5627357768290515,1.0,3/13,3.05%,KCNH2;KCNA5;KCNE2
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5040238578062002,-1.528727523696556,0.05995203836930456,0.40129651722002607,1.0,9/18,16.95%,APOE;ADAM19;LDLRAP1;PSEN1;ABCG1;TMCC2;APH1B;CLN3;ADAM17
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5392900807796207,-1.5278139680694534,0.03389830508474576,0.4008921524047447,1.0,5/15,12.43%,PLIN2;OSBPL8;PPARG;LPL;PNPLA2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5722559364282616,-1.5266509098859855,0.0477326968973747,0.40140307825204824,1.0,3/12,1.64%,BCL2;CD74;CD44
prerank,sulfur amino acid metabolic process (GO:0000096),-0.46855964130712235,-1.5254004299070216,0.038461538461538464,0.40221474829909415,1.0,12/24,24.01%,MSRA;MTHFR;MTHFD1;GCLC;MTRR;MPST;ADI1;CBS;GADL1;CTH;ADO;NOX4
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5875217577412802,-1.5251771844553386,0.05542168674698795,0.40020965799153324,1.0,4/11,14.00%,EP300;C1QTNF3;CRY1;SIK1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.4127807504574126,-1.5249153711233174,0.018404907975460124,0.39822104910610684,1.0,12/41,15.08%,PTPN23;ADAM19;GCNT2;CD44;CD47;AFDN;PLAUR;IL1B;LCK;SKAP1;AGER;TNF
prerank,natural killer cell activation (GO:0030101),-0.4725590635422773,-1.523826522173958,0.03278688524590164,0.3988782145706002,1.0,8/23,15.40%,AXL;PTPRC;ULBP1;SLAMF7;TOX;BAG6;CD2;KAT7
prerank,regulation of cholesterol storage (GO:0010885),-0.5399389684690581,-1.522163015847151,0.03953488372093023,0.40070087924939424,1.0,7/15,13.14%,MSR1;PPARG;PPARD;NR1H2;LPL;ABCG1;NR1H3
prerank,regulation of histone methylation (GO:0031060),0.5880055603328699,1.521691860127162,0.04576271186440678,0.5896009383909633,1.0,6/13,18.54%,CTR9;TET1;NSD1;TTLL12;PAF1;CHTOP
prerank,lipid droplet organization (GO:0034389),0.5253672396203616,1.520754453014369,0.02936378466557912,0.5875268340525728,1.0,4/22,15.28%,PLA2G4C;HILPDA;PNPLA3;FITM2
prerank,potassium ion import across plasma membrane (GO:1990573),0.45122464360969416,1.520744579174035,0.013740458015267175,0.5813840484320851,1.0,14/41,20.12%,KCNJ3;KCNH2;ATP1B1;KCNE2;KCNJ8;SLC12A2;ATP1B3;KCNJ13;SLC12A6;KCNJ5;KCNK9;ATP1A4;ATP1A3;ATP1A1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.617788057464168,-1.520623937790782,0.06619385342789598,0.4022283275022326,1.0,7/10,29.70%,TLR2;NAMPT;NOD2;KDR;TLR4;TLR9;IL33
prerank,negative regulation of defense response (GO:0031348),-0.36092366282236754,-1.5204960696189223,0.006369426751592357,0.40011947016015587,1.0,39/77,29.71%,AOAH;ITCH;APOE;ALOX5;PPARG;METRNL;PTGER4;VPS35;PPARD;ENPP3;PTGIS;ACOD1;C1QTNF3;NR1H3;CCN3;CXCL17;RB1;OTULIN;MAPK7;MUL1;GATA3;TRAF3IP1;KLF4;NLRC3;SIRT2;TRIM21;MVK;FFAR4;NR1H4;MEFV;SMPDL3B;DHX58;FEM1A;RNF26;ISL1;FPR2;C1QBP;TNFAIP3;MFHAS1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.40895458726152834,-1.519716632554686,0.028409090909090908,0.3995806649675709,1.0,15/42,15.52%,NRP1;CDK6;CD36;LIMS1;CCL25;UTRN;CIB1;S100A10;EFEMP2;SKAP1;KDR;EMP2;MYOC;PTK2B;CCL28
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6090123897366699,-1.5189349413753541,0.049528301886792456,0.3991457979199144,1.0,3/10,9.36%,DIS3L2;UBC;UBA52
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.45421449840550043,1.5183639126487949,0.025411061285500747,0.5863478336397518,1.0,17/41,24.53%,KCNMA1;KCNJ3;KCNH2;GABBR1;NOS1AP;ACTN2;GABBR2;KCNN4;KCNJ5;KCNMB3;KCNN3;ANK2;CTSS;KCNN2;PDZK1;GNG2;ANK3
prerank,negative regulation of TOR signaling (GO:0032007),0.462205047216669,1.5183345556065184,0.021035598705501618,0.5804418918533755,1.0,11/36,16.82%,TSC2;STK11;MINAR1;ITFG2;EPM2A;DDIT4;PDCD6;FLCN;SH3BP4;RNF152;MAPKAPK5
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.5257844470793169,-1.5177592216217868,0.051470588235294115,0.3999354972619615,1.0,12/17,30.81%,CEBPB;CAV1;CD24;CEACAM1;PRKX;AJAP1;MAFG;GATA3;DSPP;FOXN1;APOLD1;DLL1
prerank,tryptophan catabolic process (GO:0006569),0.6207954453237614,1.5171779088171733,0.06076388888888889,0.5796860477893454,1.0,4/11,11.74%,IL4I1;IDO2;AFMID;KYAT1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.5622340526730643,1.5166645003125454,0.04047217537942664,0.576007842112482,1.0,7/16,23.99%,SRSF12;CWC15;CACTIN;SRSF1;PSIP1;SART1;WBP4
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.6047234625254202,1.5141512853149426,0.030716723549488054,0.5810407967807755,1.0,7/13,22.92%,KCNJ3;KCNA5;CACNB2;KCNJ5;ANK2;SCN3B;KCNN2
prerank,regulation of interleukin-6 production (GO:0032675),-0.34872456483372316,-1.512169111689204,0.006872852233676976,0.4119304681924495,1.0,36/96,20.39%,CD74;PTPN22;GAS6;CD47;IFIH1;TLR2;LILRA5;RAB7B;IL16;MAPKAPK2;TYROBP;TLR7;NOD2;HSPD1;SYK;TLR8;IL1B;LPL;ZC3H12A;C1QTNF3;CYBA;FOXJ1;SLAMF1;SPHK2;LBP;AGER;TNF;SCIMP;WNT5A;TLR4;ARHGEF2;MMP8;TLR1;AFAP1L2;MYD88;NLRC3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.5923016311227243,-1.5121686482060435,0.05868544600938967,0.40950734779131737,1.0,4/11,16.71%,NOL11;SMARCA4;IPPK;NOP53
prerank,positive regulation of cell division (GO:0051781),-0.41850548959105205,-1.5111908530019846,0.03170028818443804,0.4094212899129085,1.0,16/38,22.21%,SVIL;PRKCE;CUL3;KIF23;CDC14B;KIF20B;CIT;RACGAP1;FGF1;DRD2;ECT2;DRD3;MAP10;SIRT2;CDC14A;SHH
prerank,regulation of amyloid-beta formation (GO:1902003),0.46798356962001264,1.5104429100492867,0.030959752321981424,0.5917094717084432,1.0,17/34,18.67%,RTN1;GGA3;BIN1;RELA;PRNP;CLU;LRRTM3;EFNA1;CASP3;EPHA4;ABCA2;HAP1;NTRK2;IFNGR1;ROCK1;CHRNA7;PIN1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.6020636437185367,-1.509927529329097,0.04470588235294118,0.4103695116978828,1.0,8/10,28.45%,SOX11;BMP5;NOTCH1;LRP6;BMP7;LIN7C;DLL4;PHACTR4
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5385900385892728,-1.5097807348288461,0.052884615384615384,0.4083503250656235,1.0,6/15,9.33%,PRKCH;MSR1;CD36;NFKB1;PF4;LPL
prerank,neutrophil degranulation (GO:0043312),-0.2822477387762058,-1.5093453369304193,0.0,0.40718082560763086,1.0,125/425,20.13%,IQGAP1;IQGAP2;ADGRE5;CYBB;ATP8B4;CLEC12A;GALNS;PLAU;ITGAX;AP2A2;KPNB1;CD300A;ERP44;ALOX5;RNASE3;VCP;FUCA1;CD44;HGSNAT;GMFG;ANPEP;NPC2;PTPRC;SDCBP;CD47;PSAP;CAPN1;TLR2;PAFAH1B2;C3AR1;ATP6V0A1;MAGT1;CD36;DNASE1L1;EEF1A1;DOCK2;RAB7A;TYROBP;GYG1;IDH1;NFKB1;ATG7;PLEKHO2;CD14;C5AR1;AGL;MOSPD2;BST2;PSMD11;TMEM30A;PLAUR;ILF2;ITGAL;NHLRC3;CTSB;SLC2A5;PSEN1;RAB6A;LAMP2;CTSA;SNAP23;ARPC5;HPSE;PRCP;RAB10;ADAM8;SNAP29;IGF2R;GDI2;GLIPR1;PTGES2;DOK3;PGAM1;STOM;OLR1;CYBA;LTA4H;TNFRSF1B;SLC11A1;CD53;TBC1D10C;CEACAM1;LAMP1;PLD1;FRK;B2M;LCN2;GPI;GLA;CD55;IMPDH1;CPPED1;GCA;GAA;ORMDL3;LILRB3;DNAJC13;RAB4B;FCER1G;BST1;RAP1B;VCL;FTL;RAP1A;RAB31;CRACR2A;PFKL;GSN;GM2A;NRAS;PTX3;AGPAT2;PLAC8;MMP8;MCEMP1;TOM1;PSMD1;CD33;CFP;CAMP;HSPA1B;PA2G4;HVCN1;LTF;OSCAR
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.48445551900775774,1.5089502538957527,0.03826955074875208,0.5926363696172043,1.0,13/30,24.33%,KCNH2;FGF12;KCNA5;KCNE2;CACNA1G;CACNA1D;NEDD4L;CACNA2D1;ANK2;ATP1A1;SCN3B;SCN1B;SNTA1
prerank,negative regulation of programmed cell death (GO:0043069),-0.2883659389711363,-1.5081877938573804,0.0,0.40778448879994705,1.0,124/355,24.40%,DAB2;ARHGAP10;BCL2;ITCH;CD74;CD38;GAS6;IGF1;AXL;BCL2L1;KLHL20;RAF1;CD44;TNFAIP8;ATAD3A;YME1L1;KANK2;BRAF;MCL1;BIRC6;NUAK2;MET;SIAH2;RAB7A;IL6ST;BCL3;PIM1;CIAPIN1;NFKB1;RASA1;BAG4;VHL;THBS1;FAS;HSPD1;RIPK1;TFRC;PRDM9;PDCD10;PLAUR;IFIT3;ANXA1;UBC;HNRNPK;CIB1;HCK;NAA16;RPL10;PSEN1;TPT1;PIDD1;UBA52;HYPK;GCLC;RNF157;SH3RF1;ANXA4;CD28;BIRC5;SPRY2;EGR3;FOXO1;ATF5;CTNNB1;BARD1;MIEN1;CDK1;MAD2L1;BIRC2;HDAC2;FHL2;CBL;HDAC1;KDR;CCND2;SMAD6;PSMD10;PTMA;SCX;GREM1;NPM1;EGFR;SHC1;PTK2B;HSPB1;WNT5A;NUP62;CLN3;TM7SF3;MAPK8;SQSTM1;ERC1;HMGA2;NIBAN2;FLNA;TFAP2B;PLK1;OPN3;WFS1;MYD88;HSPA1B;PA2G4;LTF;FMN2;NOTCH2;DHCR24;PPIF;FFAR4;SEMA4D;HMGN5;MECOM;NR1H4;SHH;XIAP;BFAR;RPS6KA3;ANXA5;GSTP1;NTSR1;PKHD1;PIM2;HTATIP2;BABAM2;TJP1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.28136314814024965,-1.507416518816112,0.0,0.4076721229108903,1.0,126/428,20.13%,IQGAP1;IQGAP2;ADGRE5;CYBB;ATP8B4;CLEC12A;GALNS;PLAU;ITGAX;AP2A2;KPNB1;CD300A;ERP44;ALOX5;RNASE3;VCP;FUCA1;CD44;HGSNAT;GMFG;ANPEP;NPC2;PTPRC;SDCBP;CD47;PSAP;CAPN1;TLR2;PAFAH1B2;C3AR1;ATP6V0A1;MAGT1;CD36;DNASE1L1;EEF1A1;DOCK2;RAB7A;TYROBP;GYG1;IDH1;NFKB1;ATG7;PLEKHO2;CD14;C5AR1;AGL;MOSPD2;BST2;PSMD11;TMEM30A;SYK;PLAUR;ILF2;ITGAL;NHLRC3;CTSB;SLC2A5;PSEN1;RAB6A;LAMP2;CTSA;SNAP23;ARPC5;HPSE;PRCP;RAB10;ADAM8;SNAP29;IGF2R;GDI2;GLIPR1;PTGES2;DOK3;PGAM1;STOM;OLR1;CYBA;LTA4H;TNFRSF1B;SLC11A1;CD53;TBC1D10C;CEACAM1;LAMP1;PLD1;FRK;B2M;LCN2;GPI;GLA;CD55;IMPDH1;CPPED1;GCA;GAA;ORMDL3;LILRB3;DNAJC13;RAB4B;FCER1G;BST1;RAP1B;VCL;FTL;RAP1A;RAB31;CRACR2A;PFKL;GSN;GM2A;NRAS;PTX3;AGPAT2;PLAC8;MMP8;MCEMP1;TOM1;PSMD1;CD33;CFP;CAMP;HSPA1B;PA2G4;HVCN1;LTF;OSCAR
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5636136706574657,-1.5061427184258724,0.050119331742243436,0.40880272617053054,1.0,7/13,23.47%,PTPN1;NCK1;DNAJB9;RACK1;PPP1R15A;WFS1;BFAR
prerank,positive regulation of protein sumoylation (GO:0033235),-0.59356815442498,-1.5057064311008885,0.05543237250554324,0.40766458777084436,1.0,6/10,24.00%,RWDD3;UBA2;MUL1;HDAC4;PIAS4;PIAS3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5693169487293737,-1.5055967921556779,0.041758241758241756,0.40127499190128874,1.0,5/12,13.54%,CUL3;NSMCE2;CDC27;ESPL1;RB1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5693169487293737,-1.5055967921556779,0.041758241758241756,0.40127499190128874,1.0,5/12,13.54%,CUL3;NSMCE2;CDC27;ESPL1;RB1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5693169487293737,-1.5055967921556779,0.041758241758241756,0.40127499190128874,1.0,5/12,13.54%,CUL3;NSMCE2;CDC27;ESPL1;RB1
prerank,positive regulation of cellular protein localization (GO:1903829),-0.3672276105593272,-1.5055489090491798,0.017006802721088437,0.3991745436112864,1.0,23/69,16.48%,DTX3L;GNL3L;LAMTOR5;TYROBP;CEP250;TRAPPC12;TFRC;GPR137B;YAP1;FYN;TM9SF4;CDK1;SLC5A3;PARP9;NUMA1;CDT1;ORMDL3;TNF;KAT7;NUP62;NDC80;PARD6A;SESN2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.4144014927274991,-1.5054150426675896,0.034574468085106384,0.3973046292164846,1.0,21/36,26.35%,CD74;GAS6;AXL;PARP14;UBE2K;ZBP1;CD300LF;RIPK1;HIF1A;TRIM44;NLRC5;PARP9;WNT5A;ADAM17;AGPAT2;HSPA1B;CASP1;TICAM2;FADD;CSF1;TSLP
prerank,prostanoid metabolic process (GO:0006692),0.5928413533861986,1.5052620597286048,0.04903677758318739,0.6025313854774401,1.0,7/13,21.86%,CYP2S1;PTGS1;AKR1C1;ACOX1;HPGD;PTGR2;HPGDS
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.4978266298948728,-1.505033603678982,0.055825242718446605,0.39607439007991474,1.0,5/18,11.65%,OS9;UGGT1;UBC;UBA52;RNF103
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.6099058407485217,-1.5045944121094792,0.06082725060827251,0.3951507852370354,1.0,4/10,17.43%,SP100;RPS6KA6;KAT5;HIPK2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.370449227466028,1.5037912042018788,0.006675567423230975,0.6035802292621,1.0,35/124,17.62%,CTTN;PLP1;STMN4;STMN3;ARMC2;CFAP126;PQBP1;BLOC1S2;ROPN1;STMN2;CATIP;SNAPIN;IL6;LGI1;RYK;MANF;SAMD14;ADCYAP1;PKD2;SH3GL2;GPRIN1;NEDD4;EHD1;STX3;RASGRF1;BTG2;CAMSAP1;MICALL1;CYFIP1;HMGB1;ERCC6;CFAP61;PPP1R9A;ROCK1;HDGFL3
prerank,cGMP biosynthetic process (GO:0006182),0.630017562342919,1.5035097117318788,0.0634648370497427,0.5991676735906625,1.0,3/10,10.39%,GUCY2F;GUCY2C;GUCY2D
prerank,regulation of anoikis (GO:2000209),-0.4808238969472166,-1.503409229605266,0.043037974683544304,0.395870952757701,1.0,7/19,14.00%,BCL2;MCL1;CAV1;PIK3CA;NOTCH1;BRMS1;SIK1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.41193789482381427,-1.5011569899711281,0.0221606648199446,0.39946362461312573,1.0,12/40,15.42%,PID1;BCL2;ARL6IP5;BCL2L1;VCP;BAX;MTLN;TUSC2;STOML2;LRRK2;PMAIP1;SLC25A33
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.3825707392883484,-1.4998501685547319,0.02346041055718475,0.4007377135665212,1.0,24/57,26.02%,RPL5;RPS24;CUL4A;URB2;RPS16;MALSU1;RPL35A;RPS7;RPF2;BYSL;METTL17;XPO1;RPL14;NPM1;GTF3A;RPL26;SDAD1;EMG1;RPL11;NAF1;RPS15;RPS6;RPS17;LTO1
prerank,inflammatory response (GO:0006954),-0.30294692966451964,-1.4975462733633758,0.005263157894736842,0.4044747842228639,1.0,84/195,30.35%,FCGR2B;ADGRE5;CYBB;ITCH;NRROS;PARP4;HRH1;CD44;TLR2;C3AR1;PJA2;CIITA;SIGLEC1;CCR2;TBK1;PTGER4;MAPKAPK2;NLRC4;NFKB1;CD14;CCL25;PF4;C5AR1;THBS1;CEBPB;GPR68;ITGAL;TUSC2;ANXA1;BLNK;IL1B;SCUBE1;ADAM8;ADCY1;OLR1;CYBA;SLC11A1;CCRL2;BMP2;FOS;TNF;RELB;TLR4;HYAL3;TRAF3IP2;LIAS;LY75;PTX3;TLR1;AFAP1L2;NFATC3;LTB4R;PIK3CD;HDAC4;HP;HPR;MMP25;TLR5;MEFV;PLA2G2D;FPR3;CRH;CCL7;TAC4;NOX4;CD96;RAC1;ADORA2A;NFX1;ALOX15;IL36G;CCL24;FPR2;XCR1;PTGDR;LAT;PTGIR;FOLR2;TBXA2R;MFHAS1;IL10RB;AGTR2;ITGB2;CXCR2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6010522637751782,1.4966624465268703,0.047872340425531915,0.6240913718295287,1.0,5/11,15.18%,KCNH2;BIN1;ACTN2;STK39;NEDD4L
prerank,carbohydrate derivative transport (GO:1901264),-0.4980470275842436,-1.4963957998382464,0.04116222760290557,0.4050021898551333,1.0,13/18,27.14%,NPC2;SLC15A3;PLTP;ABCG1;SLC25A19;LBP;CLN3;MFSD2A;SLC15A4;SLC15A2;VLDLR;SLC28A1;CPTP
prerank,neutrophil mediated immunity (GO:0002446),-0.280644143723062,-1.4956053957649547,0.0,0.4048208766143032,1.0,127/432,20.13%,IQGAP1;IQGAP2;ADGRE5;CYBB;ATP8B4;CLEC12A;GALNS;PLAU;ITGAX;AP2A2;KPNB1;CD300A;ERP44;ALOX5;RNASE3;VCP;FUCA1;CD44;HGSNAT;GMFG;ANPEP;NPC2;PTPRC;SDCBP;CD47;PSAP;CAPN1;TLR2;PAFAH1B2;C3AR1;ATP6V0A1;MAGT1;CD36;DNASE1L1;EEF1A1;DOCK2;RAB7A;TYROBP;GYG1;IDH1;NFKB1;ATG7;PLEKHO2;CD14;C5AR1;AGL;MOSPD2;BST2;PSMD11;TMEM30A;PLAUR;ILF2;ITGAL;NHLRC3;CTSB;SLC2A5;PSEN1;RAB6A;LAMP2;CTSA;SNAP23;ARPC5;HPSE;PRCP;RAB10;ADAM8;SNAP29;IGF2R;GDI2;GLIPR1;PTGES2;DOK3;PGAM1;STOM;OLR1;CYBA;LTA4H;TNFRSF1B;SLC11A1;CD53;TBC1D10C;CEACAM1;LAMP1;PLD1;FRK;B2M;LCN2;GPI;GLA;CD55;IRAK4;IMPDH1;CPPED1;GCA;GAA;ORMDL3;LILRB3;DNAJC13;RAB4B;FCER1G;BST1;RAP1B;VCL;FTL;RAP1A;RAB31;CRACR2A;PFKL;ADAM17;GSN;GM2A;NRAS;PTX3;AGPAT2;PLAC8;MMP8;MCEMP1;TOM1;PSMD1;CD33;CFP;CAMP;HSPA1B;PA2G4;HVCN1;LTF;OSCAR
prerank,regulation of AMPA receptor activity (GO:2000311),0.49733554441766326,1.4946180893544139,0.038338658146964855,0.627642120755637,1.0,9/25,18.02%,CACNG5;CACNG2;CNIH2;MEF2C;SHANK3;CACNG7;MINK1;CACNG3;SHANK1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.5194493938126863,-1.49436188058207,0.04081632653061224,0.4058356057463032,1.0,6/16,14.66%,KPNB1;DNASE2;HMGB2;H1-0;ENDOG;DFFA
prerank,defense response to protozoan (GO:0042832),-0.5763366095242554,-1.492083348140969,0.05687203791469194,0.4095812804006701,1.0,9/12,22.61%,LYST;IRF4;PF4;SLC11A1;GBP4;BATF2;MYD88;GBP6;GBP7
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.5942176998190898,-1.4919891716366616,0.057736720554272515,0.40775675595381644,1.0,6/10,32.03%,NFKBIZ;ZC3H12A;RC3H1;RC3H2;TBX21;MALT1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5669587013964256,-1.490745122068401,0.06413301662707839,0.4089982378261733,1.0,5/11,21.13%,LIMD1;PUM2;AJUBA;WTIP;PUM1
prerank,regulation of autophagy (GO:0010506),-0.30533963109859713,-1.4905353029927761,0.0,0.4074375684776376,1.0,57/216,15.84%,BCL2;ATP6V0D1;PTPN22;ABL2;VPS26A;TRIM65;ATP6V0D2;TPCN2;PSAP;CAPN1;TRIM14;ATP6V1B2;ATP6V0A1;ATG13;PRKAB1;MCL1;RRAGC;DRAM2;MET;EEF1A1;PRKACA;FBXW7;LAMTOR5;ATP6V0B;SH3GLB1;VPS35;EXOC4;ERN1;TPCN1;MTMR4;ITPR1;UBQLN1;GPR137B;CISD2;PRKAG2;DRAM1;SMCR8;CTSA;ZC3H12A;DCAF12;FOXO1;EP300;VPS26B;RRAGA;ATP6V1A;KAT5;DAPK1;EXOC8;TRIM5;LRRK2;GPR137;ORMDL3;PRKAB2;HSPB1;MTMR3;FOXK2;OPTN
prerank,positive regulation of chemotaxis (GO:0050921),0.4480927662345099,1.4905166986937715,0.012759170653907496,0.6410326153376215,1.0,15/43,12.26%,F3;P2RY12;PRSS56;MEGF8;RARRES2;SMOC2;IL6;DSCAM;NTRK3;LGMN;PRKD2;TGFB1;STX3;FGF2;PDGFB
prerank,receptor metabolic process (GO:0043112),-0.38023447739452476,-1.489796301740999,0.0243161094224924,0.40721498184881283,1.0,21/53,16.74%,KIF16B;PIK3R4;CD36;SNX1;SH3GLB1;LMTK2;TFRC;PICALM;LDLRAP1;SYK;CAV1;SNX25;UVRAG;DNM2;GRB2;LRP1;LILRB1;RAMP2;CALCRL;FCER1G;RAB31
prerank,regulation of keratinocyte migration (GO:0051547),0.6051130479017192,1.4894249673987394,0.052901023890784986,0.6401097848711493,1.0,5/12,10.47%,FGF10;FGF7;MAPRE2;MAP4K4;IQSEC1
prerank,vascular transport (GO:0010232),0.394668342109851,1.4893017009564213,0.017241379310344827,0.6348669250241386,1.0,28/81,22.07%,SLC2A3;SLC4A8;ATP2A3;SLCO2B1;ABCC3;SLC29A2;AVPR1A;KCNJ8;SLC38A2;SLC22A8;LRP2;SLC12A2;SLC1A1;SLC1A3;SLC1A4;ABCA2;SLC6A1;SLC19A1;INSR;SLC24A3;ATP8A1;SLC16A12;SLC13A3;ATP1A4;ABCG2;SLC6A9;SLC38A3;SLC22A5
prerank,regulation of protein localization (GO:0032880),-0.3636987758729343,-1.4892058781316764,0.018808777429467086,0.4067205684886651,1.0,20/58,20.69%,STX6;TRIM25;TRIM14;DVL3;AFDN;FBXW7;BORA;TRIM17;PICALM;USP8;TMEM231;WDPCP;RACK1;TRIM5;DNAJB6;MAPK8;PPM1F;ITGB3;ZDHHC7;TRIM21
prerank,central nervous system myelination (GO:0022010),0.6197597285827092,1.4890794741214874,0.06445993031358885,0.6302039898720735,1.0,6/11,14.11%,PLP1;CNTNAP1;SOX10;CLU;MYRF;ABCA2
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.45270876462939375,-1.487945818758563,0.0398936170212766,0.4078127714595014,1.0,14/26,29.76%,APOE;ATP7A;HIF1A;IL1B;S100A1;TNF;TERF2;NUS1;POR;DHFR;CDH3;TERT;GCH1;AGTR2
prerank,protein heterooligomerization (GO:0051291),0.5417504580996026,1.4861881838977877,0.04317789291882556,0.6378010113885312,1.0,8/17,14.46%,CPSF6;MAT2A;CBR4;PKD2;GRIN1;GRIN2B;PKD1;NUDT21
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5827990638302984,1.484399934265102,0.05400696864111498,0.6401021930937273,1.0,6/14,21.98%,CARD14;COPS8;ZFP91;MAP3K7;TLR3;TIRAP
prerank,neurotransmitter transport (GO:0006836),0.4003597690739471,1.4842499972686083,0.02145922746781116,0.6352588479118411,1.0,17/73,14.27%,SNAP25;TSPOAP1;RAB3A;SLC29A2;SYT1;SNAPIN;SLC38A2;NRXN1;SLC1A1;GABRA2;CHAT;UNC13B;PPFIA4;SLC1A3;RIMS1;GAD2;STXBP2
prerank,diterpenoid metabolic process (GO:0016101),0.42146800733912226,1.4839730329628484,0.02586206896551724,0.6309614172672373,1.0,14/55,15.56%,AGRN;RDH10;AKR1C1;BCO2;RARRES2;LRP2;AWAT2;GPC1;AKR1B1;GPC2;GPC5;RDH5;GPC4;NAPEPLD
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.44907661819829675,1.4835448955836321,0.04032258064516129,0.6277081361425184,1.0,20/37,27.20%,TPPP;STMN4;STMN3;MAP6;STMN2;CLASP2;MAPRE2;CAMSAP3;BICD2;PHLDB2;TAOK1;ROCK1;BICD1;CYLD;CDK2AP2;MAPRE3;GAS2L1;MAPT;PRKAA2;EPHA3
prerank,excitatory postsynaptic potential (GO:0060079),0.5270767807144485,1.483418488834218,0.05181347150259067,0.6229459055933619,1.0,6/19,9.74%,MPP2;MEF2C;ARRB2;GRID2;GRIN1;GRIN2B
prerank,potassium ion transmembrane transport (GO:0071805),0.3612219078327856,1.4832909747264933,0.010376134889753566,0.6182711064096255,1.0,36/135,20.12%,HCN1;KCNK12;KCNJ3;KCNH2;KCND2;KCNA5;ATP1B1;KCNE2;KCNJ8;KCNH7;KCNC1;SLC12A2;KCNK3;ATP1B3;KCNJ13;SLC9A4;PKD2;SLC12A6;KCNK6;SLC1A3;KCNN4;SLC9A5;ABCC8;HPN;KCNJ5;KCNC3;SLC24A3;KCNN3;KCNT2;KCNK9;KCNQ4;KCNK2;SLC24A4;ATP1A4;ATP1A3;ATP1A1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6035033441063266,-1.4828218635027515,0.08441558441558442,0.4188723723973335,1.0,6/10,21.28%,TYROBP;CD24;LILRB1;LAPTM4B;FN1;CDH3
prerank,response to molecule of bacterial origin (GO:0002237),-0.35453331647975767,-1.4824199444205834,0.006644518272425249,0.4178616182689229,1.0,20/69,17.18%,FCGR2B;IFNAR1;PTPN22;NOCT;HMGB2;MAPKAPK2;CD14;CD24;IL1B;C4B;ACOD1;MAPKAPK3;SLC11A1;SMAD6;FOXP1;PELI1;LBP;TLR4;ADAM17;LIAS
prerank,oligodendrocyte development (GO:0014003),0.5526911186672621,1.4820552107884708,0.06478405315614617,0.618489447845476,1.0,7/15,15.26%,TPPP;PLP1;CNTNAP1;SOX10;EIF2B3;MYRF;EIF2B1
prerank,mammary gland epithelium development (GO:0061180),0.5765237420227138,1.4817557089276026,0.056239015817223195,0.6145174254784609,1.0,4/14,9.08%,WNT4;SCRIB;WNT3;ERBB4
prerank,peptide biosynthetic process (GO:0043043),-0.31353466419711173,-1.4815358652612332,0.0,0.418076503136435,1.0,40/153,13.76%,RPS26;RPL39;RPL5;RPS23;RPS24;RPS16;EEF1A1;RPL28;RPS29;RPS14;RPS20;RPS12;RPL35A;RPL18A;RPS13;RPL27;GGTA1;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;DHPS;EIF4EBP2;IGHMBP2;RHD;RPL10;RPL15;RPS10;YARS2;RPL14;RPL9;RPL32;RPL36;RPL23A;MRPL35;RPL31;AGO2;RPL3
prerank,ganglion development (GO:0061548),-0.5717747348973168,-1.480999928889638,0.06206896551724138,0.41742046640577657,1.0,3/11,10.78%,NRP1;NRP2;CTNNB1
prerank,iron ion transport (GO:0006826),-0.3857232001931151,-1.4800794349172939,0.01875,0.41761545601433603,1.0,17/47,21.84%,ATP6V0D1;ATP6V0D2;STEAP3;ATP6V1B2;ATP6V0A1;ATP6V0B;LMTK2;TFRC;DNM2;SLC11A1;ATP6V1A;CP;MCOLN1;ATP6V0A4;LTF;HEPH;ATP6V1G2
prerank,negative regulation of blood pressure (GO:0045776),-0.5518694742885557,-1.4790790982528326,0.05707196029776675,0.41796737313713267,1.0,8/13,40.31%,DRD2;PRCP;DRD3;BMPR2;NOS1;NOS2;NPPA;SCPEP1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4544592006840853,1.4789842857626356,0.0288,0.6214367039367307,1.0,15/37,16.57%,PTPRD;DCHS1;CADM1;TENM1;IGSF21;GRID2;NECTIN3;TENM3;IL1RAPL1;CRTAM;ICAM1;CADM3;FAT4;HMCN1;CXADR
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6159188300493872,1.4787741293883945,0.05699481865284974,0.617245822453263,1.0,4/11,12.07%,UQCRC1;CYC1;UQCC3;UQCR11
prerank,regulation of mast cell activation (GO:0033003),-0.5933306954735462,-1.4787403897749956,0.06046511627906977,0.416728699472286,1.0,5/10,26.35%,CD300LF;LYN;CD226;PLSCR1;TSLP
prerank,regulation of inflammatory response (GO:0050727),-0.3043020509366047,-1.478609275677927,0.0,0.41504976978510566,1.0,62/190,22.80%,AOAH;IL15;APOE;PSMA6;CELF1;ALOX5;CD47;TLR2;LILRA5;PPARG;METRNL;ZBP1;CCR2;IL16;PTGER4;VPS35;TLR7;NFKBIZ;PPARD;USP18;NOD2;RIPK1;ANXA1;ENPP3;HCK;IL1B;LPL;GPSM3;GPRC5B;PTGIS;ACOD1;C1QTNF3;BIRC2;TNFRSF1B;SHPK;NR1H3;CCN3;FOXP1;CXCL17;RB1;TNF;WNT5A;OTULIN;BST1;PDE2A;MAPK7;TLR4;GATA3;MMP8;MYD88;KLF4;NLRC3;CASP1;MVK;ADAMTS12;TNIP1;TMSB4X;APP;FFAR4;NR1H4;XIAP;MEFV
prerank,positive regulation of protein catabolic process (GO:0045732),-0.34521661426607897,-1.478451623104885,0.009584664536741214,0.4135239553097313,1.0,25/84,17.88%,ITCH;APOE;WWP1;VCP;STX5;RAB7A;SMURF2;VPS35;ADAM9;ATG7;MSN;HECW1;NRDC;SNX9;IL1B;ADAM8;PTTG1IP;FOXO1;BARD1;TNFRSF1B;TNF;WNT5A;TIPARP;DTL;RILP
prerank,regulation of regulated secretory pathway (GO:1903305),0.4584367292910651,1.4774134554821896,0.03571428571428571,0.6180645609638222,1.0,9/34,11.27%,SYT4;RAB3A;SYT13;SYT1;SNAPIN;SYT6;RAB5A;RAB3D;RIMS1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4557516139751148,1.47732347387027,0.0457516339869281,0.6133933109644465,1.0,9/34,9.74%,MPP2;GABRG1;GABRG2;MEF2C;ARRB2;GRID2;GABRA2;GRIN1;GRIN2B
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.45641338174898277,-1.4762201350205,0.05084745762711865,0.4171862697108533,1.0,11/23,23.57%,GAS6;IGF1;GIT1;ZC3H12A;CEACAM1;FFAR1;PYDC1;CD33;FFAR4;MEFV;GSTP1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.43553793746425673,-1.476102799804,0.031088082901554404,0.41562605094555544,1.0,7/30,9.03%,UBE2D3;ATG13;FBXW7;TOMM7;SH3GLB1;ARIH2;UBE2L3
prerank,diacylglycerol metabolic process (GO:0046339),0.4975432948066245,1.4748760434140273,0.0499194847020934,0.6190858422009644,1.0,11/23,20.78%,DGKI;ANG;DGAT2;DGKQ;DGKZ;DGKE;DAGLA;PGS1;PLA2G15;DGKH;LIPE
prerank,Golgi inheritance (GO:0048313),-0.5641266532077361,-1.4745250941768095,0.06666666666666667,0.41759124999657876,1.0,5/11,11.22%,VCPIP1;STX5;GBF1;PDCD10;CDK1
prerank,regulation of interferon-gamma production (GO:0032649),-0.3498350256251279,-1.4734657359214853,0.0070921985815602835,0.4182132347553363,1.0,23/71,16.65%,PTPN22;GAS6;CD274;AXL;CD47;IL12RB2;RARA;CCR2;TLR7;CEBPG;CD14;IL27;HSPD1;TLR8;IL1B;CD226;ZC3H12A;SLC11A1;CD2;EBI3;LILRB1;TLR4;IL18R1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5057351875246467,-1.4731379012649812,0.052884615384615384,0.4170459611482041,1.0,10/18,29.70%,THBS1;HSPD1;CD226;CD2;LBP;WNT5A;TLR4;CEBPA;TSLP;IL33
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4310153499726726,1.4720700887543148,0.022556390977443608,0.6269395517321986,1.0,7/47,7.76%,GAPDH;SPOCK3;ANXA8;ANXA8L1;BIN1;SPOCK2;SERPINH1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6316721271239031,1.4720000980771544,0.05944055944055944,0.6223337231447501,1.0,5/10,10.47%,FGF10;FGF7;MAPRE2;MAP4K4;IQSEC1
prerank,potassium ion homeostasis (GO:0055075),0.4991913402227109,1.4702322095292142,0.0432,0.6250370667605482,1.0,9/23,20.12%,KCNMA1;KCNH2;ATP1B1;SLC12A2;ATP1B3;SLC12A6;ATP1A4;ATP1A3;ATP1A1
prerank,neuron development (GO:0048666),0.35976105843337997,1.4699963402277667,0.010738255033557046,0.6212791196055141,1.0,55/141,26.06%,ATP8A2;PLP1;STMN4;STMN3;PQBP1;BLOC1S2;STMN2;SNAPIN;TENM1;PBX2;IL6;LGI1;MEF2C;RYK;MANF;SAMD14;ADCYAP1;SH3GL2;GPRIN1;TENM3;NEDD4;EHD1;STX3;RASGRF1;BTG2;PBX3;CAMSAP1;HS6ST1;MICALL1;HMGB1;NTRK2;ERCC6;PPP1R9A;ROCK1;HDGFL3;XBP1;WNK1;EPHA5;SRF;SRRM4;GPM6A;ZFYVE27;MAP2;GBA2;ULK1;OPHN1;PTPRM;RUNX1;VAPA;RAPGEF2;TBCD;MAPT;CNTNAP2;FLRT3;LGI4
prerank,activation of phospholipase C activity (GO:0007202),0.470677252339879,1.4689855556584974,0.04669887278582931,0.6208401824941614,1.0,8/29,7.24%,ANG;P2RY12;TXK;NMUR1;AVPR1A;CD86;PLCG1;GNA15
prerank,T cell activation involved in immune response (GO:0002286),-0.5544330155956062,-1.4689147112852232,0.060674157303370786,0.42538629820062923,1.0,6/12,15.91%,CD74;ITGAL;LCP1;SLC11A1;LILRB1;FCER1G
prerank,positive regulation of synaptic transmission (GO:0050806),0.3993390886314412,1.4677643909539413,0.03183791606367583,0.6215330905597177,1.0,26/72,18.84%,ADCY8;CACNG5;CACNG2;MPP2;SYT1;PRKCZ;NRXN1;LGI1;LGMN;GRIK2;SHANK3;CLSTN2;GRIN2B;CACNG7;ZDHHC2;RIMS1;KCTD13;EPHB2;BAIAP3;HAP1;SLC8A3;EIF2AK4;PLK2;CACNG3;CHRNA7;RIMS3
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.4982737910754892,-1.4666465180399466,0.054373522458628844,0.4293644923439098,1.0,9/16,21.98%,HFM1;TOP2A;RMI1;MSH4;EME1;CENPX;SLX4;FANCM;TOP2B
prerank,motile cilium assembly (GO:0044458),0.6011710355126018,1.4664925957926398,0.0706896551724138,0.6220233933464022,1.0,4/12,16.62%,DNAAF1;CCDC39;BBS5;DNAAF3
prerank,microtubule depolymerization (GO:0007019),0.5440139968599322,1.4663801942805272,0.04745762711864407,0.6178350977704328,1.0,8/17,16.43%,STMN4;STMN3;STMN2;NCKAP5;CKAP5;NCKAP5L;KIF2A;KIF14
prerank,sodium ion export across plasma membrane (GO:0036376),0.5742736579507666,1.4662177023007847,0.06980802792321117,0.6140227418383302,1.0,6/13,22.22%,ATP1B1;ATP1B3;ATP1A4;ATP1A3;ATP1A1;SLC9A1
prerank,positive regulation of cell cycle process (GO:0090068),-0.3333512962393791,-1.464473148549894,0.003472222222222222,0.4327908185996501,1.0,35/91,23.66%,SVIL;IGF1;PRKCE;CUL3;KIF23;CDC14B;KIF20B;CIT;IL1B;RACGAP1;DRD2;NUSAP1;CD28;RHNO1;MAD2L1;IGF2;RAD21;E2F8;NUMA1;UBXN2B;NUP62;E2F7;NDC80;ECT2;CEP295;DRD3;RGCC;MAP10;SIRT2;CDC14A;TGFA;MAP3K20;CCNB1;PLSCR1;EGF
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.49757757083015625,-1.4642253538365768,0.06310679611650485,0.43150286043383734,1.0,8/17,17.77%,RARA;IRF4;CEBPB;SYK;PRKCQ;CD28;FCER1G;GATA3
prerank,macroautophagy (GO:0016236),-0.3210062210229568,-1.4635952329444564,0.003816793893129771,0.4312535570332878,1.0,31/118,17.60%,VIPAS39;VPS37C;PIK3C3;CHMP4A;CHMP4B;NBR1;MAP1LC3B;VCP;PIK3R4;ATG13;PRKAB1;LIX1;MTMR14;TOMM7;ATG7;UBQLN1;PRKAG2;EPG5;UVRAG;LAMP2;SNAP29;TOMM20;ATG3;STAM;PRKAB2;MTMR3;CLN3;AMBRA1;MAP1LC3A;PGAM5;SQSTM1
prerank,positive regulation of locomotion (GO:0040017),0.489492213750501,1.4633689973501323,0.04487179487179487,0.6213375458465296,1.0,7/27,12.26%,CCDC25;P2RY12;SPOCK2;RARRES2;TGFB1;STX3;PDGFB
prerank,positive regulation of cytokinesis (GO:0032467),-0.4231653833758818,-1.4631088221909168,0.05698005698005698,0.4305976704263584,1.0,9/32,9.18%,SVIL;PRKCE;CUL3;KIF23;CDC14B;KIF20B;CIT;RACGAP1;DRD2
prerank,synaptic vesicle cycle (GO:0099504),0.4703338143303373,1.4628372103591647,0.04538341158059468,0.6190354989525555,1.0,8/30,15.59%,SNAP25;RAB3A;SNAPIN;OTOF;RAB5A;RIMS1;CPLX2;WNT7A
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6013927410309079,1.4624830021694917,0.05759162303664921,0.6160903032359666,1.0,4/11,9.53%,DDX5;IL6;BMP4;TGFB1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5144574945808833,-1.461425721142475,0.0665024630541872,0.43295092412619784,1.0,9/14,32.04%,XDH;CAV1;SPRY2;SPRY1;NOTCH4;GDF3;SPRED1;DLL1;MMP9
prerank,intracellular sterol transport (GO:0032366),-0.5590197105147806,-1.459983444679152,0.06467661691542288,0.4346996967658963,1.0,5/13,9.63%,NPC2;OSBP;SERAC1;OSBPL2;ABCG1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.46071536866038665,-1.4581126664535489,0.05013192612137203,0.43560719098627654,1.0,9/23,17.91%,ZEB2;DAB2;SDCBP;THBS1;SNW1;EP300;ADAM17;HIPK2;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.46071536866038665,-1.4581126664535489,0.05013192612137203,0.43560719098627654,1.0,9/23,17.91%,ZEB2;DAB2;SDCBP;THBS1;SNW1;EP300;ADAM17;HIPK2;SMAD4
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.35348279613707173,-1.458014285169886,0.01812688821752266,0.43385632626244347,1.0,26/68,19.66%,CD74;IFIH1;TLR2;LILRA5;RAB7B;IL16;TYROBP;TLR7;NOD2;HSPD1;SYK;TLR8;IL1B;LPL;CYBA;SPHK2;LBP;AGER;TNF;SCIMP;WNT5A;TLR4;ARHGEF2;MMP8;TLR1;MYD88
prerank,regulation of macroautophagy (GO:0016241),-0.3252081884832432,-1.4577020720025489,0.007751937984496124,0.43265163413762686,1.0,34/105,17.20%,ATP6V0D1;VPS26A;ATP6V0D2;CAPN1;PAFAH1B2;ATP6V1B2;ATP6V0A1;ATG13;PRKAB1;RRAGC;TBK1;PRKACA;LAMTOR5;ATP6V0B;SH3GLB1;VPS35;EXOC4;ERN1;UBQLN1;PRKAG2;SMCR8;PIK3CA;VPS26B;RRAGA;ATP6V1A;EXOC8;KDR;LARP1;LRRK2;PRKAB2;WAC;CLN3;SESN2;MAPK8
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.48115831030000655,-1.4573318449150576,0.06217616580310881,0.4316256862185242,1.0,10/19,28.25%,ADAM19;AFDN;MAD2L2;NOTCH1;NOTCH4;PPM1F;RGCC;SERPINF2;TJP1;PLG
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.4641140861413373,-1.4572983859688258,0.061696658097686374,0.4298079228568604,1.0,12/21,29.26%,RPL5;RAB1A;CDC14B;RPS7;MAD2L2;MAD2L1;UBE2C;PLK1;RPL11;GORASP1;CDC20;RPL23
prerank,lipoprotein localization (GO:0044872),-0.5695864709311574,-1.4565428374592677,0.06651376146788991,0.4299518575511631,1.0,5/11,13.36%,ZDHHC3;PPARG;CD36;ZDHHC17;LRP1
prerank,primary neural tube formation (GO:0014020),0.472207775905672,1.4564710186501757,0.05669291338582677,0.6379544133388145,1.0,9/30,10.59%,TSC2;VANGL2;PLXNB2;SCRIB;LRP2;MTHFD1L;PRICKLE1;TGFB1;GRHL3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.42610217187029653,-1.4554945096532954,0.03611111111111111,0.4308765467808718,1.0,11/31,15.76%,FCGR2B;CD274;CD300A;DLG5;TYROBP;SOX11;CEBPB;LYN;RC3H1;LILRB1;SPN
prerank,positive regulation of cholesterol transport (GO:0032376),-0.43584339745912615,-1.4538919750388508,0.06521739130434782,0.43280774968708813,1.0,8/27,13.36%,APOE;EEPD1;PPARG;PLTP;CAV1;NR1H2;NR1H3;LRP1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.411900173650246,-1.453535766509575,0.03430079155672823,0.4316565066717033,1.0,6/33,5.87%,SP100;APOE;PTPN23;MCC;CORO1C;THBS1
prerank,negative regulation of endocytosis (GO:0045806),-0.4505786913684157,-1.4534866231327577,0.05483028720626632,0.4299011772883201,1.0,9/24,14.75%,MCTP1;CD300A;MTMR2;PICALM;CAV1;NR1H2;APOC1;NR1H3;LILRB1
prerank,mammary gland development (GO:0030879),0.5133062721289156,1.4527592293979912,0.06598984771573604,0.6491395005723294,1.0,5/21,12.38%,WNT4;PRLR;WNT3;ERBB4;ARHGAP35
prerank,regulation of interleukin-1 production (GO:0032652),-0.5148115440422373,-1.452367903167485,0.07339449541284404,0.4310023561654243,1.0,6/15,16.57%,GAS6;ANXA1;TMED10;CEACAM1;FOXP1;TLR4
prerank,myelination (GO:0042552),0.4213283307621059,1.4503448951643234,0.04888888888888889,0.6550931847093687,1.0,17/46,18.50%,TPPP;PLP1;CNTNAP1;MPZ;SOX10;GPC1;NFASC;CMTM8;CXCR4;MYRF;GAL3ST1;SCN2A;MAL2;SLC8A3;ACSBG1;ABCD2;MBP
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5236299735832007,1.4495507126689737,0.05201342281879195,0.6536730952589279,1.0,8/17,22.55%,CACNB2;CACNA1G;SLC8A1;CACNA1D;CACNA2D1;ANK2;SCN3B;SCN1B
prerank,positive regulation of synapse assembly (GO:0051965),0.4728096262435716,1.448923979852017,0.05799373040752351,0.6520553650906853,1.0,10/27,15.59%,AGRN;PTPRD;SRPX2;IL1RAP;NRXN1;GRID2;CLSTN2;IL1RAPL1;EPHB2;WNT7A
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.35257297599902115,-1.4485407606495302,0.025936599423631124,0.4389354589357047,1.0,27/66,23.57%,IGF1;GIT1;LILRA5;CD36;TYROBP;NLRC4;NOD2;TLR8;LPL;ZC3H12A;FOXP1;AGER;TNF;HSPB1;WNT5A;TLR4;FFAR1;PYDC1;TRIM16;CD33;MYD88;CASP1;AIM2;APP;FFAR4;MEFV;GSTP1
prerank,myofibril assembly (GO:0030239),0.4306170131890771,1.4478646258398034,0.04580152671755725,0.6520395990230903,1.0,8/42,12.97%,OBSL1;CAPN3;LMOD1;SIX4;MYPN;TMOD2;ACTN2;LMOD3
prerank,defense response to fungus (GO:0050832),0.5376291625579678,1.4472356051570665,0.07401315789473684,0.6503786382734229,1.0,5/17,13.84%,GAPDH;RARRES2;CX3CR1;RNASE7;FAM3A
prerank,heart contraction (GO:0060047),0.42455066106081485,1.4466075337513649,0.03293413173652695,0.6486968664984407,1.0,9/41,11.71%,KCNH2;ATP1B1;TNNI3;TNNC1;DMD;MYBPC3;SLC8A1;SGCZ;SGCG
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5107908491067733,-1.4458873968549555,0.06419753086419754,0.443804822162736,1.0,5/15,11.31%,RPL5;DTX3L;RPS7;MAD2L2;MAD2L1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.42913483526015467,-1.4458066520394814,0.05142857142857143,0.4421944778638261,1.0,9/29,10.51%,IL15;IFNAR1;STAT5B;STAT4;CCR2;STAT2;IFNAR2;STAT1;GHR
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.5938371199806737,-1.4455699077442603,0.07045454545454545,0.44103277379323275,1.0,6/10,25.00%,GAS6;AXL;LYN;LILRB1;CXCL12;BLK
prerank,cellular response to alcohol (GO:0097306),-0.3895315910561761,-1.445297091149833,0.046242774566473986,0.43992643435017326,1.0,19/42,21.06%,PTGER4;AHR;CTNNA1;BRCA1;ADCY5;ADCY6;CTNNB1;KLF9;ADCY1;LARP1;GRAMD1C;ADCY3;SPHK2;GRAMD1B;MAP4K1;CDH1;LRP6;MLC1;PTCH1
prerank,energy reserve metabolic process (GO:0006112),-0.4794912678307441,-1.4452965614664326,0.06004618937644342,0.4380857379721391,1.0,4/19,11.70%,PID1;PHKB;PRKAG2;PPP1R3C
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.33660594082639,-1.4448972290235618,0.019801980198019802,0.43722700928227476,1.0,26/80,17.81%,STX6;RIC1;VPS26A;SNX8;STX5;TMEM87B;RAB7B;RAB7A;SNX1;VPS35;GBF1;CLN5;RAB6A;DENND2A;TMED9;VPS26B;TBC1D10C;DENND5A;TBC1D10A;VPS54;YKT6;RBSN;RGP1;VPS52;ERC1;GCC2
prerank,receptor catabolic process (GO:0032801),-0.4439492761064526,-1.4448513755996522,0.038461538461538464,0.43554789355760026,1.0,9/24,10.81%,AP2A2;KIF16B;PIK3R4;SH3GLB1;AP2B1;ZNRF3;SNX25;UVRAG;CLTA
prerank,positive regulation of response to external stimulus (GO:0032103),-0.30830375979984553,-1.4446556588867279,0.0,0.4342750805067011,1.0,41/128,21.87%,SASH1;IL15;DDX60;ANKRD17;CD47;TLR2;LILRA5;ZBP1;CCR2;IL16;PTGER4;TLR7;NFKBIZ;PUM2;OASL;THBS1;RIPK1;TLR8;IL1B;LPL;GPSM3;GPRC5B;ADAM8;ACOD1;CYBA;PTN;TNF;SCIMP;WNT5A;OPTN;PDE2A;TLR4;POLR3G;PPM1F;USP15;TNIP1;PUM1;APOH;SLC15A4;APP;SERPINF2
prerank,sensory perception of sound (GO:0007605),0.3793724454812767,1.444458009496805,0.036885245901639344,0.6537684452022211,1.0,19/88,15.59%,LHFPL3;LHFPL4;WHRN;LHFPL5;CDH23;LRTOMT;COL2A1;PJVK;LRP2;MARVELD2;GSDME;SLC26A4;SNAI2;HOMER2;CACNA1D;POU3F4;TIMM13;EPS8L2;HPN
prerank,negative regulation of anoikis (GO:2000811),-0.5160049340639674,-1.4431614914348079,0.07579462102689487,0.436262055633862,1.0,5/14,10.70%,BCL2;MCL1;CAV1;PIK3CA;NOTCH1
prerank,positive regulation of protein polymerization (GO:0032273),0.3969785511521467,1.4430279573157163,0.029717682020802376,0.6557575944550762,1.0,12/65,7.32%,TPPP;CTTN;BIN1;PAK1;LMOD1;PSRC1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;NAV3;FCHSD2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5190245425528597,1.44297076896359,0.06335616438356165,0.6516105790947461,1.0,4/18,4.80%,PAG1;ADTRP;IL4I1;PPARA
prerank,retinoid metabolic process (GO:0001523),0.3884906714075234,1.441623327360357,0.01925722145804677,0.6529386671731671,1.0,12/71,8.63%,AGRN;CYP2S1;RDH10;AKR1C1;BCO2;RARRES2;LRP2;AWAT2;GPC1;AKR1B1;GPC2;GPC5
prerank,negative regulation of viral process (GO:0048525),-0.3600792695380427,-1.4410026683043553,0.03353658536585366,0.44037895415127104,1.0,34/57,33.04%,OAS2;IFIH1;TRIM14;IFITM3;IFIT1;PROX1;OASL;SHFL;BST2;TRIM62;STAT1;OAS3;TRIM5;BANF1;TNF;ZC3HAV1;PTX3;LTF;TRIM21;TNIP1;IFITM1;PLSCR1;ILF3;EIF2AK2;TRIM13;LARP7;ISG20;BTBD17;SLPI;SRPK1;TRIM11;TRIM32;PPIA;ISG15
prerank,regulation of ion transmembrane transport (GO:0034765),0.4483929349070345,1.440941138271043,0.04113924050632911,0.651639278273894,1.0,9/33,15.88%,YWHAE;KCNJ3;KCNH2;KCNE2;KCNJ8;KCNJ13;NEDD4;NEDD4L;KCNJ5
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.5698456521680371,-1.4407380682025923,0.08373205741626795,0.4394121043291165,1.0,7/11,35.12%,NFKBIZ;PRKCQ;CLEC6A;IL12RB1;MALT1;IL23R;IL12B
prerank,inositol lipid-mediated signaling (GO:0048017),0.41218676575324553,1.4398879889928795,0.03829160530191458,0.6518265250285841,1.0,12/50,10.96%,PLCH1;PIK3C2G;PLCL1;ADAP2;NTRK1;PLCD1;PIK3CG;RPS6KB1;TNFAIP8L3;OGT;INPP5F;IRS1
prerank,mitochondrial transport (GO:0006839),0.40641106010376404,1.4396495255964632,0.03139013452914798,0.6484974621264874,1.0,21/53,19.45%,SLC25A4;STARD3;FIS1;TMEM14C;FBXO7;TMEM14A;FLVCR1;SLC25A31;BAK1;TOMM34;SLC25A5;PITRM1;TIMM13;TSPO;TIMM22;TOMM70;OXA1L;MFF;BCS1L;TIMM23;MTX2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5891785941032794,1.4394934772020056,0.0712979890310786,0.6449581284058482,1.0,4/11,11.00%,PRDX5;PRDX2;PXDN;PRDX4
prerank,neuron projection morphogenesis (GO:0048812),0.35195160394081193,1.4393369677160073,0.011764705882352941,0.6414544686293568,1.0,67/137,28.42%,CTTN;MAP6;CNTNAP1;SRGAP2;DCC;NYAP2;RAB3A;PAK1;CTNNA2;PARD6B;NCKAP1;NCKAP1L;ATL1;LRP2;MAP1S;RYK;RAB8A;DAB2IP;SHANK3;APBB1;MAP4K4;CTNND2;KLF7;BTBD3;MINK1;DOCK10;SLITRK4;ANKRD27;NRCAM;EPHB2;DSCAML1;EIF2AK4;WNT7A;PLPPR4;TAOK1;ROCK1;ALS2;SHANK1;NTNG2;NTNG1;ACTB;PLXNB1;SDC2;CDC42;FARP1;GPM6A;IMPACT;MAP2;WASL;MEF2A;CCK;BDNF;ANK3;TAOK2;DCLK1;CNTNAP2;FLRT3;MYO16;MAP1B;DLG4;LLGL1;EPB41L3;BRSK2;DIP2A;PTEN;SLITRK1;CELSR2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5157506570822838,1.4392614522581646,0.07768595041322314,0.6376688163250785,1.0,7/17,24.33%,KCNH2;KCNE2;KCNJ8;NEDD4L;ANK2;SCN3B;SNTA1
prerank,negative regulation of catalytic activity (GO:0043086),-0.44090760987864935,-1.439102173536704,0.06315789473684211,0.4415194136040041,1.0,16/24,34.42%,IFIT1;PPP1R12A;NOSIP;NOTCH1;PHPT1;PARP9;CLN3;NES;TIMP1;HP;APBA3;TMBIM1;CAND1;NOS1;HDAC6;GZMA
prerank,regulation of glucose metabolic process (GO:0010906),0.446496524378839,1.4389840006872219,0.054313099041533544,0.6347241380459507,1.0,13/34,24.48%,SELENOS;GNB3;SLC45A3;DGKQ;OGT;PRKN;IRS1;KHK;RORA;RUBCNL;PDK1;GPLD1;USP7
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5892292660886704,-1.438836818618619,0.07547169811320754,0.4404019825427801,1.0,6/10,21.23%,MTRR;MPST;CBS;GADL1;CTH;ADO
prerank,regulation of mitochondrial translation (GO:0070129),-0.45932641736253915,-1.4381837610900503,0.04962779156327544,0.44017977595600677,1.0,13/21,30.65%,RCC1L;TRUB2;MALSU1;TRMT10C;MTG2;UQCC2;MTG1;MRPS27;RPUSD3;TSFM;C1QBP;SHMT2;MPV17L2
prerank,glial cell differentiation (GO:0010001),0.46647101154928267,1.4376132815116474,0.052547770700636945,0.6363596213953759,1.0,6/28,5.18%,TPPP;FGF10;NFIB;SOX10;SOX4;GPC1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.528190769428776,-1.4371251732041883,0.06310679611650485,0.44093463217561946,1.0,5/13,13.84%,APOE;NFKB1;ERLIN2;BMP5;BMP2
prerank,protein localization to chromosome (GO:0034502),-0.4058190977951757,-1.4363384288746306,0.04145077720207254,0.441460955394631,1.0,19/34,29.63%,ESR1;IFFO1;BOD1;CENPA;HASPIN;CTCF;RPA1;RAD21;RB1;MCM9;MCM8;TERF2;RPA2;PLK1;TINF2;SLF1;TNKS;FAM47E;PINX1
prerank,kinetochore organization (GO:0051383),-0.5291973344962088,-1.436245037823235,0.07125307125307126,0.439907539328344,1.0,6/13,17.01%,MIS12;CENPA;CDT1;CENPW;NDC80;NUF2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5808838579297158,-1.4360072860886943,0.06864988558352403,0.4386302492265632,1.0,5/10,13.78%,NBR1;FAS;LYN;RNF13;GREM1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.38833904195806834,-1.4352695311133417,0.05202312138728324,0.4388323370406386,1.0,12/45,11.52%,CD74;GAS6;IGF1;CD300A;CDK6;NDUFS4;CDC73;S100A6;BMI1;PDGFC;CTNNB1;LIG4
prerank,cellular response to interleukin-15 (GO:0071350),-0.5313401011897788,-1.4350361159464835,0.08188585607940446,0.4360023471027562,1.0,4/13,14.77%,IL15;STAT5B;GRB2;SHC1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.5313401011897788,-1.4350361159464835,0.08188585607940446,0.4360023471027562,1.0,4/13,14.77%,IL15;STAT5B;GRB2;SHC1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.5278653369201805,-1.4344665293073386,0.07913669064748201,0.43580957004639576,1.0,5/14,12.09%,TFRC;CD226;MAD2L2;PAXIP1;SHLD1
prerank,anterior/posterior pattern specification (GO:0009952),0.40876601386547246,1.4344492142117204,0.03765060240963856,0.6457834474434505,1.0,9/53,9.10%,HOXA5;HHEX;HOXD4;CYP26C1;HOXB9;HOXC6;HOXB7;TGFBR1;HEY1
prerank,dendritic spine organization (GO:0097061),0.47262507536561327,1.4324529375935948,0.04588607594936709,0.6503390785711043,1.0,16/26,28.13%,PRNP;LGMN;SHANK3;CTNND2;DOCK10;EPHB2;INSR;WNT7A;SHANK1;CHRNA7;CDC42;ARF1;WASL;DLG4;DIP2A;PTEN
prerank,tube closure (GO:0060606),0.46293725894738,1.4322837382768046,0.05669291338582677,0.6470569938510188,1.0,9/31,10.59%,TSC2;VANGL2;PLXNB2;SCRIB;LRP2;MTHFD1L;PRICKLE1;TGFB1;GRHL3
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.507029145213957,-1.432152628566262,0.06220095693779904,0.43992585766601966,1.0,7/16,11.86%,PTPN22;TNFSF8;SOX11;AHR;IL27;IKZF3;TNFRSF1B
prerank,positive regulation of inflammatory response (GO:0050729),-0.33040143620963863,-1.430765998597284,0.006920415224913495,0.4418542850052178,1.0,34/86,28.39%,IL15;CD47;TLR2;LILRA5;ZBP1;CCR2;IL16;IL6ST;PTGER4;TLR7;NFKBIZ;RIPK1;IL1B;LPL;GPSM3;GPRC5B;ADAM8;LBP;TNF;WNT5A;PDE2A;TLR4;MMP8;OSMR;TNIP1;APP;TLR9;PLA2G7;CEBPA;FEM1A;TSLP;VAMP7;GPR4;RPS19
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.536824946263583,1.430733749172442,0.0667779632721202,0.6498795692279492,1.0,11/17,20.86%,RTN1;GGA3;BIN1;PRNP;CLU;HAP1;NTRK2;ROCK1;CHRNA7;PIN1;ABCA7
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3404834482510752,-1.4304330937533776,0.021341463414634148,0.44097066787888045,1.0,20/72,16.05%,CD74;GAS6;AXL;PTPRC;LIFR;ZBP1;PTPN1;IFNAR2;USP18;RIPK1;SYK;CD24;STAT1;HIPK1;TRIM44;BIRC2;RACK1;TNF;OTULIN;TRAF1
prerank,transport across blood-brain barrier (GO:0150104),0.3769503286197158,1.4301454592189502,0.03,0.6481963709618184,1.0,28/83,22.07%,SLC2A3;SLC4A8;ATP2A3;SLCO2B1;ABCC3;SLC29A2;AVPR1A;KCNJ8;SLC38A2;SLC22A8;LRP2;SLC12A2;SLC1A1;SLC1A3;SLC1A4;ABCA2;SLC6A1;SLC19A1;INSR;SLC24A3;ATP8A1;SLC16A12;SLC13A3;ATP1A4;ABCG2;SLC6A9;SLC38A3;SLC22A5
prerank,regulation of cholesterol efflux (GO:0010874),-0.41608726151685227,-1.4285663100598338,0.04986149584487535,0.4440229776287896,1.0,9/30,13.36%,APOE;EEPD1;PPARG;PLTP;CAV1;NAXE;NR1H2;NR1H3;LRP1
prerank,response to fatty acid (GO:0070542),-0.4814352166256581,-1.4284079192319405,0.0792838874680307,0.44272198429367815,1.0,7/17,22.68%,PID1;CD36;LPL;FOXO1;FFAR1;NR1H4;GLDC
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3423443324472059,-1.4282690104663038,0.02711864406779661,0.44131182507568867,1.0,20/72,13.57%,ARHGEF3;APOE;NRP1;STARD8;EPS8;ABL2;RAF1;RIPOR2;CUL3;KANK2;MET;CCDC125;ARHGEF18;PDCD10;STMN1;ARHGDIB;GPR18;GPR65;MYOC;ARHGEF28
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.29665736589020175,-1.4275997804367693,0.009216589861751152,0.441521825073291,1.0,49/182,16.28%,APOBEC1;APOE;FLOT2;PTPN22;MECP2;IGF1;CELF1;SETDB2;PARP14;NOCT;MSR1;SDCBP;XDH;MTMR2;FBXW7;SOX11;ESR1;NFKB1;ANKRD13A;TAF1;YY1;VHL;CRKL;PICALM;PDCD10;LDLR;YAP1;DNMT1;HIF1A;PSEN1;SMCR8;HINFP;ZC3H12A;CD28;NOTCH1;ZNF148;HDAC1;KDR;AGO2;RACK1;FOXP1;RB1;BMP2;CREB3L1;PARP9;TNF;TERF2;OPTN;TIPARP
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.5065316887611193,1.4274757202868313,0.07308377896613191,0.6555715309535717,1.0,7/19,15.32%,POLD3;ADA;PNP;HPRT1;AMPD3;DCK;GMPR
prerank,negative regulation of gene expression (GO:0010629),-0.28309357964765486,-1.4273246236967954,0.0,0.44062023008332923,1.0,93/302,21.64%,FCGR2B;APOE;FLOT2;PTPN22;MECP2;IGF1;DIS3L2;EPC1;CELF1;SETDB2;PARP14;NOCT;MSR1;RPS26;XDH;ZC3H12D;RBBP7;CNOT9;PPHLN1;MALSU1;FBXW7;PTGER4;SOX11;NPTN;ESR1;NFKB1;SAMD4A;ERN1;TAF1;RPS13;YY1;VHL;CRKL;PICALM;PDCD10;YAP1;SRGN;DNMT1;HIF1A;BMI1;DDX6;PSEN1;EIF4ENIF1;H3-3A;CAPRIN1;SMCR8;HINFP;ZC3H12A;CD28;NOTCH1;ZNF148;SLC11A1;DAPK1;HDAC1;LSM2;KDR;PAIP2B;AGO2;TYMS;LARP1;RACK1;LSM5;FOXP1;RB1;BMP2;CREB3L1;PARP9;SYNCRIP;TNF;TRIM71;TERF2;TIPARP;FXR2;HEY2;IGFBP5;MMP8;PHF19;RNH1;MYADM;EED;RGCC;HSPA1B;KLF4;NCOR1;DHFR;CPEB3;NOTCH2;ANXA7;PTBP3;APP;ID2;NDFIP1;FFAR4
prerank,myoblast fusion (GO:0007520),0.5787696437130174,1.4272134173013646,0.07082630691399663,0.6527289799421391,1.0,4/12,11.59%,JAM2;CD81;ADAMTS15;ADAM12
prerank,inorganic cation import across plasma membrane (GO:0098659),0.38228503213041565,1.4269222472219858,0.021246458923512748,0.6500313454307769,1.0,24/75,20.12%,KCNJ3;KCNH2;ATP1B1;KCNE2;SLC39A4;KCNJ8;SLC12A2;TRPM2;ATP1B3;KCNJ13;SLC9A4;SLC12A6;SLC8A1;SLC39A8;SLC9A5;SLC6A1;SLC8A3;KCNJ5;CACNA2D1;KCNK9;TRPV6;ATP1A4;ATP1A3;ATP1A1
prerank,positive chemotaxis (GO:0050918),0.5219391684668874,1.4268353929996953,0.085,0.6465355826382417,1.0,4/17,5.58%,FGF10;TSC2;SCRIB;FGF7
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3860440281388729,-1.4268050322910004,0.038922155688622756,0.44015035938413566,1.0,12/44,15.21%,APOE;PTPN22;CD300A;STK38;PTPN1;LYN;IL1B;SPRY2;SPRY1;INPP5K;DUSP1;SPRY4
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.5340384069752508,-1.4247960975976632,0.1,0.44357552707398246,1.0,4/13,12.38%,GAS6;AXL;TYROBP;LAMP1
prerank,cAMP metabolic process (GO:0046058),-0.5286040096883431,-1.4242475299951955,0.09411764705882353,0.44329119183233306,1.0,8/13,17.28%,ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;ADCY10;EPHA2;PTHLH
prerank,regulation of synapse maturation (GO:0090128),0.6071016489785189,1.423931868753575,0.08876811594202899,0.6552150333781622,1.0,6/10,23.12%,NEUROD2;NRXN1;DAB2IP;ANAPC2;ADGRL1;CAMK2B
prerank,synaptic vesicle exocytosis (GO:0016079),0.43573931930368526,1.4237037399567978,0.06015037593984962,0.6522630417763348,1.0,10/40,11.97%,SNAP25;RAB3A;SYT1;SNAPIN;DOC2B;OTOF;STX3;UNC13B;RIMS1;CPLX2
prerank,neuron differentiation (GO:0030182),0.34048415201512966,1.4236252580505304,0.010165184243964422,0.6487786166871254,1.0,45/165,24.22%,ATP8A2;WNT4;LDB1;PTPRD;NEUROG2;ATOH7;NEUROD2;TENM1;SOX4;PBX2;WNT3;MEF2C;ITM2C;RYK;TGFBR1;MANF;NRBP2;LHX3;TENM3;WNT8B;IL1RAPL1;DDIT4;CASP3;PBX3;HS6ST1;LHX5;LMX1B;NTRK2;ERCC6;WNT7A;LHX2;EN2;XBP1;PIN1;WNK1;EPHA5;SRF;IRX5;LHX4;OPHN1;RUNX1;ACSL3;ERCC2;VXN;NIF3L1
prerank,negative regulation of insulin secretion (GO:0046676),0.520677713976738,1.4228567031407997,0.08828522920203735,0.6483278112674491,1.0,9/17,27.29%,ADRA2A;PRKN;KLF7;IRS1;SFRP1;REST;MIDN;CHGA;KCNB1
prerank,early endosome to late endosome transport (GO:0045022),-0.45555122332510417,-1.422679257312511,0.05759162303664921,0.44537809167792375,1.0,10/20,14.49%,PIK3C3;KIF16B;PTPN23;RAB7A;LMTK2;WDR91;WDR81;AKTIP;EMP2;EEA1
prerank,axonemal dynein complex assembly (GO:0070286),0.47447333728788765,1.4226772090313577,0.0654490106544901,0.645305689818677,1.0,10/27,16.62%,DNAAF1;ODAD4;CCDC39;DNAI3;CCDC65;CFAP100;SPAG1;DNAL1;DNAAF2;DNAAF3
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.3686282457156025,-1.4225246767281192,0.03003003003003003,0.44413596894091334,1.0,19/49,19.79%,CD74;TLR2;RAB1A;LAMTOR5;TLR7;CD14;NOD2;RIPK1;SYK;TLR8;IL1B;CD2;LBP;TNF;TLR4;TLR1;AFAP1L2;MYD88;HSPA1B
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.5343615351716745,-1.4209675464032911,0.09375,0.4462645779828673,1.0,9/13,32.29%,SYK;GAB2;LAMP1;SPHK2;CD177;KLRC2;FGR;ITGB2;STX4
prerank,body fluid secretion (GO:0007589),0.5392941555017002,1.4202966615529797,0.09661016949152543,0.6520214923678642,1.0,6/15,22.81%,PRLR;ERBB4;SLC22A4;ZBTB7B;GUCA1B;NPR1
prerank,primary alcohol metabolic process (GO:0034308),-0.4358283723347739,-1.4199042452152872,0.04509283819628647,0.44750139825325475,1.0,11/25,24.26%,IGF1;GPD2;RDH11;GDPD3;GDE1;CYP1A1;ALDH3A2;DHRS9;CYP1B1;DHRS3;RDH12
prerank,chromatin assembly (GO:0031497),-0.3883874195616438,-1.4196419973198025,0.06201550387596899,0.446524532823278,1.0,10/38,10.49%,LIN54;HMGB2;KAT6B;PADI4;PRDM9;ANP32B;H3-3A;H1-0;CTCF;GRWD1
prerank,magnesium ion transport (GO:0015693),-0.5377931646672551,-1.4195594924200974,0.07088607594936709,0.44513738648537027,1.0,7/12,27.91%,MAGT1;MRS2;NIPAL4;NIPAL3;MMGT1;SLC41A1;NIPAL1
prerank,mRNA splice site selection (GO:0006376),0.4492954896368936,1.4194367748805339,0.08099688473520249,0.6520407201436184,1.0,12/30,18.40%,SRSF12;SRSF5;ISY1;SRSF6;SF3A1;SRSF1;YTHDC1;CELF6;SETX;SRSF9;PSIP1;PUF60
prerank,cellular response to purine-containing compound (GO:0071415),0.5911862496245526,1.4192233156638665,0.09246575342465753,0.6492998495950697,1.0,4/10,12.17%,CACNA1S;TRPM2;SLC8A1;P2RY1
prerank,regulation of receptor binding (GO:1900120),0.6024661748234048,1.4187384647426953,0.0843585237258348,0.6475638724503252,1.0,4/10,12.59%,ATP2A3;ATP2A2;ADAM15;GREM2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.5078997728821796,1.4179149057210545,0.0722495894909688,0.6473289448583113,1.0,6/19,10.45%,FBXW8;OBSL1;PTPRD;CDKL5;SS18L1;IL1RAPL1
prerank,retinal metabolic process (GO:0042574),0.5684049293993844,1.4174502666088395,0.07731958762886598,0.645561039457797,1.0,3/12,4.37%,RDH10;AKR1C1;BCO2
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.46501528197390257,-1.4171810364251982,0.08312958435207823,0.44967228483561605,1.0,7/19,9.94%,IFIH1;IRF7;TBK1;TLR7;HSPD1;TLR8;STAT1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.528721505975587,-1.416653438185526,0.09839816933638444,0.4492901841615895,1.0,7/13,18.00%,CD74;GAS6;AXL;IFIH1;TRIM44;WNT5A;AGPAT2
prerank,innate immune response (GO:0045087),-0.28757031858928406,-1.4165704816378417,0.0051813471502590676,0.4478933485944098,1.0,67/217,21.59%,SP100;CYBB;CD74;NRROS;ANKRD17;RNASE3;ALPK1;RPL39;TRIM25;ATAD3A;IFIH1;TLR2;TRIM14;PJA2;CIITA;PPARG;IRF7;TBK1;IFITM3;TYROBP;CXCL16;IFIT1;TRIM17;SHFL;BST2;NOD2;SYK;TRIM62;LYN;FYN;TLR8;HCK;CLEC6A;LCK;CYBA;SLC11A1;NLRC5;FRK;KLRD1;B2M;LCN2;TRIM5;IRAK4;IFNLR1;LBP;AGER;PTK2B;RELB;OTULIN;FCER1G;TLR4;ZAP70;MSRB1;ANKHD1;PYDC1;PTX3;CLEC4E;CFP;CAMP;MYD88;CD300E;LTF;TRIM21;PIK3CD;SETD2;APP;IFITM1
prerank,eye photoreceptor cell development (GO:0042462),0.5361273491858236,1.4162054169309877,0.0943089430894309,0.6469293353251236,1.0,3/15,12.51%,NRL;THY1;RPGRIP1
prerank,protein tetramerization (GO:0051262),0.3810499036691117,1.4157881388373588,0.03857566765578635,0.6450727395324473,1.0,20/67,20.00%,HCN1;CPSF6;KCNC1;TRPM2;ALDH9A1;CBR4;PKD2;GRIN1;ACOT13;HPRT1;GRIN2B;PKD1;NUDT21;OXA1L;KCNC3;ACACB;TK1;HSD17B10;ALDOA;SSBP1
prerank,regulation of interleukin-10 production (GO:0032653),-0.3785099215884007,-1.41546275652063,0.03278688524590164,0.44921014632237977,1.0,10/44,6.31%,FCGR2B;CD274;CD47;LILRA5;PIBF1;TYROBP;IRF4;NOD2;HSPD1;SYK
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3760173397312749,1.4153181118756297,0.03389830508474576,0.6433028092503492,1.0,18/85,14.38%,LHFPL3;LHFPL4;WHRN;LHFPL5;CDH23;LRTOMT;COL2A1;PJVK;LRP2;MARVELD2;GSDME;SLC26A4;SNAI2;HOMER2;CACNA1D;POU3F4;TIMM13;EPS8L2
prerank,aminoglycan biosynthetic process (GO:0006023),0.40531514259923823,1.4140365761993607,0.053545586107091175,0.6449279680121603,1.0,13/49,13.29%,AGRN;B3GNT9;HS3ST6;HS3ST5;B3GNT6;B4GAT1;B3GALT2;GPC1;GPC2;GPC5;B3GALNT1;HS6ST1;GPC4
prerank,regulation of immune response (GO:0050776),-0.3059325680116428,-1.4132116590077097,0.004310344827586207,0.45342601854255027,1.0,53/135,24.99%,ITGA4;FCGR2B;IL15;PTPN22;CD300A;CSK;ULBP1;DENND1B;IRF7;CD300LF;SLAMF7;TYROBP;AHR;IRF4;ITGB7;SYK;LYN;ITGAL;PDCD1;CD226;ERAP1;HCST;JAML;RAET1E;BIRC2;KLRD1;B2M;FOXP1;LILRB1;SPN;GPR108;CLEC2D;TREML2;CD247;CD33;COL3A1;APPL2;PILRA;CD300E;OSCAR;CD300LG;IFITM1;CD3E;XIAP;KLRK1;PLSCR1;TREML4;CD96;APPL1;DHX58;FCRLB;CD300C;BCL6
prerank,error-free translesion synthesis (GO:0070987),-0.44643008149261,-1.4127681049964007,0.05804749340369393,0.4529581398132023,1.0,7/22,19.40%,VCP;PCNA;UBC;UBA52;RPA1;RPA2;NPLOC4
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5596078582569982,-1.4127576233701473,0.11486486486486487,0.4513743489622995,1.0,7/11,29.71%,PJA2;LYN;ACOD1;CYBA;TLR1;TNFAIP3;MFHAS1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3453400813834704,-1.4126970612564314,0.03067484662576687,0.4499418430209875,1.0,20/67,16.47%,VAV3;CYBB;NRP1;NRP2;PXN;AXL;CRK;MAPKAPK2;NCK1;FLT1;FYN;PIK3CA;MAPKAPK3;CYBA;KDR;PTK2B;HSPB1;ELMO2;BCAR1;AAMP
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.44295281434795664,-1.4123410510744718,0.09024390243902439,0.4493181048315544,1.0,9/21,22.94%,RAD51B;MECP2;CCND1;CDK1;NPM1;CDC25A;DTL;CDC25C;CCNB1
prerank,response to leucine (GO:0043201),0.5907957855056288,1.4120039899854382,0.10545454545454545,0.6463495895724866,1.0,2/10,2.45%,KLHL22;RPTOR
prerank,cellular response to leucine (GO:0071233),0.5907957855056288,1.4120039899854382,0.10545454545454545,0.6463495895724866,1.0,2/10,2.45%,KLHL22;RPTOR
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.37564463169649664,1.4115601426881532,0.04397163120567376,0.6447059448966703,1.0,37/75,29.05%,MAP6;DCC;RAB3A;CTNNA2;PARD6B;ATL1;MEF2C;MAP1S;RYK;RAB8A;APBB1;KLF7;BTBD3;MINK1;SLITRK4;NRCAM;DSCAML1;WNT7A;PLPPR4;NTNG2;NTNG1;ACTB;SDC2;FARP1;MAP2;OPHN1;MEF2A;CCK;ANK3;TAOK2;TBCD;MAP1B;LLGL1;BRSK2;SLITRK1;CELSR2;DCDC2
prerank,regulation of hippo signaling (GO:0035330),-0.4753457351614082,-1.4107769020313063,0.08311688311688312,0.4513785607395114,1.0,8/17,19.51%,LIMD1;DLG5;SOX11;CIT;MOB3B;AJUBA;WTIP;NEK8
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4427229245408831,-1.4107605722199135,0.06947890818858561,0.4498417467515778,1.0,7/22,14.67%,NOL11;WDR43;SMARCA4;DHX33;IPPK;UTP15;UBTF
prerank,membrane raft organization (GO:0031579),-0.4964092277042953,-1.4106911338669317,0.09113924050632911,0.4483871211943397,1.0,7/15,18.57%,RFTN1;FLOT2;NAXE;S100A10;EMP2;CLN3;MYADM
prerank,metanephros development (GO:0001656),0.46630229291945735,1.4076199930573636,0.06581059390048154,0.6572883047605094,1.0,6/26,12.74%,FGF10;SIX4;FOXD1;BMP4;PKD2;PKD1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.5575860633176617,-1.4074467389847374,0.09425287356321839,0.45545744271940175,1.0,5/11,36.34%,RTP4;PKD1L3;LPO;RTP2;TAS1R3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5564065811944645,-1.4073458635508376,0.10411622276029056,0.45415883480310015,1.0,5/11,16.12%,LDLR;NR1H2;CTDNEP1;NR1H3;MFSD2A
prerank,regulation of cell aging (GO:0090342),0.5821443867180516,1.406541696708787,0.08962264150943396,0.6586028662627752,1.0,4/11,22.00%,VASH1;NEK4;NUAK1;ING2
prerank,nervous system development (GO:0007399),0.3083141721929162,1.406496653196763,0.0033333333333333335,0.6552334810996854,1.0,98/429,15.64%,NAV2;ROGDI;STMN3;PCDHB9;FUT10;PCDHB4;GDF11;LSAMP;MERTK;OBSL1;LDB2;LDB1;ECRG4;FGF12;WWTR1;FGF11;DCHS1;MPZ;ACAN;CNTFR;NEUROD2;SOX10;CYP26C1;TENM1;MAB21L2;NCKAP1;PCDHB5;CRMP1;SPOCK2;NFASC;LY6H;EFNB3;GSS;NRXN1;DSCAM;TMOD2;GLRB;NAV3;LGI1;MEF2C;DPF2;MAP1S;RYK;SEMA6B;NDP;TGFBR1;NPTX1;ADAM22;PCDH1;SHANK3;LIMK1;ADGRL3;PKD2;SH3GL2;CPNE6;ACHE;COX7B;SDK1;RAPGEFL1;ERBB4;PCDHA5;RAPGEF5;TGFB1;WNT8B;APLP1;PRKN;ASIC2;BTBD3;FGF13;FGF2;FEZ2;PCDHB3;ACVR1B;LRCH4;CXCR4;HAPLN2;DCTN1;SEMA4F;SH3GL3;MYLIP;PKD1;VCAN;NRCAM;EVL;TBX6;RBFOX3;GFRA1;RBFOX2;ALDH5A1;HAPLN1;EPHB2;SCN2A;DPYSL2;HAP1;DSCAML1;ERCC6;FAT4;APC2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4561514919497276,1.4057726821458751,0.07487520798668885,0.6547451373444125,1.0,10/25,15.32%,ADA;PNP;GART;PRPSAP2;HPRT1;AMPD3;DCK;PRPSAP1;ADSL;GMPR
prerank,Golgi to endosome transport (GO:0006895),-0.4986356294823092,-1.4057695554759706,0.08018867924528301,0.4564540614097708,1.0,7/16,16.25%,KLHL20;KIF16B;GBF1;EPS15;AP4M1;CORO7;DOP1B
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4902484668277132,1.4055874507696213,0.0718954248366013,0.6520020397058438,1.0,5/22,4.87%,CACNB4;CBARP;NOS1AP;CACNB2;DMD
prerank,cellular response to zinc ion (GO:0071294),0.535153696447669,1.405283817766758,0.08517887563884156,0.6498758906897661,1.0,10/15,17.76%,GLRA2;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,insulin receptor signaling pathway (GO:0008286),-0.3338687719437782,-1.4051807910947816,0.029605263157894735,0.4563815269416681,1.0,15/69,12.27%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;NAMPT;ATP6V0B;GAB1;BCAR3;AP3S1;PIK3CA;FOXO1;GRB2;SORBS1;IGF2;ATP6V1A
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3493274364997555,-1.4048398540558655,0.038461538461538464,0.4557106859133776,1.0,19/64,16.29%,PEAK1;SLK;PLAU;CDK6;CORO1C;CD36;RASA1;CCL25;UTRN;THBS1;CIB1;SKAP1;EMP2;MYOC;AJAP1;PTK2B;CCL28;BST1;VCL
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.4674321658707806,-1.4041183966047648,0.0725,0.4561027526065465,1.0,5/20,5.93%,BCL2;BCL2L1;MCL1;BAX;FAS
prerank,immunoglobulin mediated immune response (GO:0016064),-0.5616243595719292,-1.4039384882633803,0.12559241706161137,0.4549496168282058,1.0,3/10,7.35%,FCGR2B;CD74;TLR8
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.26037897927191356,-1.4038160154409587,0.0,0.45369785587434436,1.0,132/532,17.91%,F13A1;SP100;IL15;BCL2;IFNAR1;PSMA6;POU2F1;ITGAX;OAS2;BCL2L1;ABL2;CSK;ALOX5;CRK;TNFSF8;CD44;TRIM25;STAT5B;TEC;TALDO1;LIFR;MAP3K8;STAT4;IFIT2;IRF9;CIITA;PSMB2;IRF7;IL12RB2;MCL1;CD36;CCR2;PRKACA;CD300LF;SMARCA4;IL16;STAT2;IFNAR2;IFITM3;IL6ST;PSME2;JUNB;IFIT1;PIM1;GRAP2;NFKB1;LIMS1;IL27;OASL;LMNB1;CCL25;IRF4;MSN;BAG4;PF4;CRKL;BST2;PSMD11;NOD2;RIPK1;SYK;CCND1;PSMC6;TRIM62;IFIT3;YAP1;FYN;ANXA1;UBC;GAB2;PSMA3;HIF1A;HCK;IL1B;MID1;IL1RL1;TAB1;PIK3CA;SOCS5;LCP1;UBA52;VIM;CAMK2D;STAT1;BIRC5;GHR;LCK;LTB;FOXO1;GRB2;BIRC2;TNFRSF1B;CEACAM1;CBL;HNRNPA2B1;B2M;OAS3;PSMD10;LCN2;EDA;TRIM5;IRAK4;PELI1;TNFRSF17;FOS;IRF2;AIP;IFNLR1;LBP;EBI3;SHC1;PTK2B;PSMB5;TNF;FCER1G;RAP1B;TRAF1;BCL2L11;IL27RA;SDC1;HMOX1;IL18R1;ADIPOR2;ADAM17;TRAF3IP2;TNFRSF9;TNFRSF25;SQSTM1;PSMD5;GATA3;PYDC1;SMAD4
prerank,protein polyglutamylation (GO:0018095),0.5769359640384143,1.4034713268613732,0.10344827586206896,0.6539206757549656,1.0,8/11,30.39%,TTLL6;TTLL7;TPGS1;TTLL5;TTLL1;TTLL11;CFAP20;CEP41
prerank,maintenance of blood-brain barrier (GO:0035633),0.44987656081456406,1.4029847061029364,0.0732824427480916,0.6525537210400817,1.0,6/30,5.97%,F11R;JAM2;DMD;IL6;SLC12A2;SLC1A1
prerank,neural tube closure (GO:0001843),0.4400224092033879,1.4028733182599062,0.0730593607305936,0.6495749925480733,1.0,10/34,11.20%,TSC2;VANGL2;PLXNB2;SCRIB;LRP2;MTHFD1L;PRICKLE1;TGFB1;GRHL3;KDM2B
prerank,negative regulation of hippo signaling (GO:0035331),-0.5170637858260638,-1.402827719642646,0.08,0.4547341878379777,1.0,6/12,23.95%,LIMD1;DLG5;CIT;AJUBA;WTIP;MAP2K3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4237090733243666,-1.402608702130893,0.07162534435261708,0.4536526047102183,1.0,14/26,24.82%,PTPN22;TLR2;PJA2;CAV1;CYBA;NR1H3;LBP;TLR1;LTF;SLC15A4;TLR5;TICAM2;TREML4;TLR9
prerank,positive regulation of secretion by cell (GO:1903532),0.38430769490013916,1.4011508672820918,0.05103448275862069,0.6527132387398059,1.0,21/70,17.51%,FRMD4A;MYOM1;ANG;RAB3A;CADPS2;SYTL4;MYH10;SLC12A2;CLASP2;APBB1;ACHE;TGFB1;CFTR;RAB5A;UNC13B;DNM1L;BAIAP3;APBB3;IER3IP1;STXBP5;IL1A
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.599499190261872,1.4001703284748666,0.10086956521739131,0.6500070135525734,1.0,4/10,20.78%,CDC42EP5;CDC42;CDC42EP4;CDC42EP1
prerank,regulation of pseudopodium assembly (GO:0031272),0.599499190261872,1.4001703284748666,0.10086956521739131,0.6500070135525734,1.0,4/10,20.78%,CDC42EP5;CDC42;CDC42EP4;CDC42EP1
prerank,axon development (GO:0061564),0.37324844075303654,1.399028163501493,0.035398230088495575,0.6513776523907363,1.0,25/78,19.01%,PLP1;DCC;RAB3A;CTNNA2;PARD6B;ATL1;MAP1S;RYK;RAB8A;RTN4RL1;APBB1;KLF7;VASH2;SLITRK4;ARHGAP35;NRCAM;EPHB2;DSCAML1;WNT7A;PLPPR4;MTR;NTNG2;NTNG1;NREP;ACTB
prerank,positive regulation of lipid kinase activity (GO:0090218),0.45427761702127967,1.398795752027316,0.06688417618270799,0.6490604062936297,1.0,14/29,19.50%,P2RY12;TNFAIP8L3;CD81;TGFB1;FGF2;IRS1;PDGFB;EEF1A2;TEK;DGKZ;PRKD1;PTK2;FLT3;PDGFRB
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.3921180064129455,-1.3987545933772294,0.047619047619047616,0.46210253123803424,1.0,22/36,31.35%,APOE;CAV1;HIF1A;IL1B;NOSIP;DNM2;S100A1;GLA;EGFR;TNF;TERF2;NUS1;DHFR;NOSTRIN;TERT;CYGB;ZDHHC21;HSP90AA1;GCH1;AGTR2;CALM1;DDAH1
prerank,neuron projection extension (GO:1990138),-0.40981620272737773,-1.3979427044159023,0.05817174515235457,0.46248342769929174,1.0,8/32,12.23%,IQGAP1;ALCAM;NRP1;NRP2;CDKL3;USP9X;CTNNB1;SEMA5B
prerank,regulation of mast cell degranulation (GO:0043304),-0.5087591779979784,-1.3969804553908163,0.0945273631840796,0.46331247416247845,1.0,5/14,13.94%,CD300A;SYK;LYN;GAB2;SPHK2
prerank,cell junction assembly (GO:0034329),0.35964471593486286,1.3969273231220034,0.03195739014647137,0.6534683413420362,1.0,39/100,26.73%,SH3BP1;PCDHB9;PCDHB4;FSCN1;OBSL1;DCHS1;PARD6B;PCDHB5;SPOCK2;PKP4;NRXN1;DSCAM;RYK;CDH18;SHANK3;ADGRL3;ACHE;SDK1;CTNND2;PCDHB3;NRCAM;FLCN;ITGA6;ACTB;CDC42;FARP1;GRHL2;GPM6A;VMP1;OPHN1;LIMS2;BDNF;RHOA;FLRT3;CDH10;FZD5;CDHR3;SDK2;MYO9A
prerank,heterochromatin organization (GO:0070828),-0.5034919343584023,-1.396544063948934,0.08788598574821853,0.4628110650565639,1.0,7/14,22.05%,SETDB2;SETD7;SMCHD1;HP1BP3;HMGA2;POLE3;MECOM
prerank,calcium-mediated signaling (GO:0019722),0.36607695771514664,1.3964017403419142,0.025174825174825177,0.6523722852935497,1.0,27/93,16.26%,ACKR4;P2RY12;ATP2A2;ACKR3;KSR2;ATP1B1;NMUR1;TNNI3;FIS1;PRNP;PLCG1;TRPM2;CCR1;RCAN3;SAMD14;CXCR6;CX3CR1;SLC8A1;BTK;CXCR4;PPP3CC;CCR6;RCAN2;PPP1R9A;CCR9;ACKR2;DMPK
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.5063181819154742,-1.3961956338769181,0.08395061728395062,0.46211402016913705,1.0,5/14,19.65%,IL6ST;IL1B;ADAM8;TNF;OSMR
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5244242225337239,-1.396009247802844,0.09523809523809523,0.4610114502634023,1.0,5/13,15.45%,MDFIC;SP100;NUP153;BARD1;CHP1
prerank,microtubule polymerization (GO:0046785),0.4560731385700044,1.3956548034964669,0.0688,0.6523003546060487,1.0,13/28,25.59%,TPPP;CLASP2;CCDC57;CKAP5;FGF13;TUBGCP2;HDGFL3;PIN1;TUBGCP6;MAP7D3;TPPP3;TUBGCP5;MAPT
prerank,B cell mediated immunity (GO:0019724),-0.5516726748217909,-1.395382936995597,0.11504424778761062,0.46115156196022067,1.0,3/10,7.35%,FCGR2B;CD74;TLR8
prerank,cellular response to cytokine stimulus (GO:0071345),-0.2657026743028634,-1.3944130595496897,0.0,0.4621459444888569,1.0,104/416,16.85%,F13A1;PID1;BCL2;IFNAR1;GAS6;POU2F1;ITGAX;AXL;BCL2L1;ABL2;CSK;ALOX5;CRK;PTPN23;RIPOR2;STAT5B;CD47;TEC;LIFR;TLR2;STAT4;UBE2K;IL12RB2;MCL1;CD36;CCR2;TBK1;PRKACA;IL16;STAT2;IFNAR2;IL6ST;JUNB;IFIT1;PIM1;GRAP2;NFKB1;CCL25;IRF4;BAG4;PF4;CRKL;RIPK1;SMAD3;LDLRAP1;SYK;CDC34;CCND1;RO60;FYN;ANXA1;UBC;GBP3;GAB2;CIB1;HIF1A;HCK;IL1B;PTPN7;PIK3CA;BRCA1;SOCS5;ZC3H12A;UBA52;VIM;STAT1;BIRC5;GHR;PTGIS;LCK;FOXO1;RC3H1;ACOD1;GRB2;TNFRSF1B;DAPK1;CBL;TCF7;SHPK;ASAH2;LCN2;IRAK4;INPP5K;GBP4;HAS2;FOS;DUSP1;SYNCRIP;IFNLR1;LBP;EBI3;SHC1;TNF;WNT5A;RBMX;PDE2A;BCL2L11;IL27RA;SDC1;HMOX1;TLR4;CRNN;IL18R1;HYAL3
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.36654558755180305,-1.3943186905469407,0.03134796238244514,0.4609158053864159,1.0,17/48,16.65%,PTPN22;IL12RB2;CCR2;TLR7;CEBPG;CD14;IL27;HSPD1;TLR8;IL1B;CD226;SLC11A1;CD2;EBI3;LILRB1;TLR4;IL18R1
prerank,regulation of viral life cycle (GO:1903900),-0.45015154405000324,-1.394019120436493,0.08356545961002786,0.46017857608140855,1.0,5/21,6.59%,AXL;TRIM25;TRIM14;KPNA2;TRIM62
prerank,fat cell differentiation (GO:0045444),-0.35585753016169386,-1.3936411567244291,0.04843304843304843,0.4596235079681317,1.0,21/57,21.82%,PID1;OSBPL8;PPARG;METRNL;BBS7;EGR2;ERAP1;TMEM120B;FOXO1;ATF5;EP300;C1QTNF3;SMAD6;ALOXE3;TMEM120A;HMGA2;PER2;TFAP2B;KLF4;FFAR4;CLIP3
prerank,regulation of defense response (GO:0031347),-0.3285569704560719,-1.3928079346243756,0.01639344262295082,0.46016799915712175,1.0,27/76,24.99%,FCGR2B;APOE;PSMA6;PTPN22;CELF1;ALOX5;ZBP1;CCR2;USP18;NOD2;ANXA1;HCK;ERAP1;BIRC2;SHPK;FOXP1;WNT5A;BST1;APPL2;MYD88;CASP1;ADAMTS12;TMSB4X;XIAP;APPL1;DHX58;BCL6
prerank,neuropeptide signaling pathway (GO:0007218),0.39085146725666225,1.392316280786752,0.039660056657223795,0.6628564629232009,1.0,14/58,19.03%,GLRA3;NMUR1;NXPH3;LTB4R2;GLRB;PPY;SORCS1;NXPH2;ADCYAP1;GLRA2;SORT1;GAL;OPRM1;OPRD1
prerank,sodium ion transport (GO:0006814),0.3651053898510094,1.3922603024449443,0.02710413694721826,0.6598800299116209,1.0,34/85,29.57%,HCN1;SLC4A8;ATP1B1;SCNN1A;SLC5A12;SLC12A2;ATP1B3;SLC38A7;PKD2;SLC8A1;ASIC1;ASIC2;FGF13;SLC6A1;SCN2A;SLC8A3;NEDD4L;SLC24A3;ASIC3;SLC24A4;ATP1A4;SLC6A9;SCN3B;SCN1B;SLC6A7;SCN8A;SCN7A;SLC6A2;SLC6A5;KCNK1;NDUFA9;SCN1A;NALCN;SLC6A15
prerank,actomyosin structure organization (GO:0031032),0.3731404154319353,1.3919507973284415,0.033566433566433566,0.6579621727414834,1.0,16/75,12.97%,EPB41L2;FRMD5;CAPN3;F11R;LMOD1;SIX4;MYPN;MYH10;ITGB5;TMOD2;EPB41;FRMD3;CDC42BPA;ACTN2;KCTD13;LMOD3
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.49546712489261613,1.391342380007776,0.10161290322580645,0.6572536191854198,1.0,5/20,7.35%,PPIC;PPIB;PPWD1;PPIL1;PPIG
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5166442393612927,-1.3908850507305224,0.09395973154362416,0.46366896556501724,1.0,7/12,21.60%,DAB2;SMARCA4;PIAS2;HDAC1;FOXP1;NCOR1;HEYL
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5794774302232478,1.3906639371648442,0.1059245960502693,0.6568212205254707,1.0,3/10,8.77%,SELENOS;DGKQ;OGT
prerank,negative regulation of nervous system development (GO:0051961),-0.4722591748527002,-1.3900076761734452,0.07272727272727272,0.4643373371840163,1.0,10/17,23.59%,PCM1;TLR2;SLIT1;IL1B;NOTCH1;B2M;TNF;APPL2;PAX6;HOOK3
prerank,response to lipid (GO:0033993),-0.31029055910508824,-1.3883385640189319,0.011764705882352941,0.46704515692562026,1.0,30/105,18.54%,IFNAR1;PTPN22;NOCT;STAT5B;HMGB2;PPARG;CD36;RARA;MAPKAPK2;ESR1;PPARD;ANXA1;IL1B;ABCG1;FOXO1;CTNNB1;MAPKAPK3;SLC11A1;RXRB;SMAD6;OVCA2;FOXP1;PELI1;LBP;TLR4;ADAM17;LIAS;FFAR1;PAQR7;TRIM16
prerank,cellular protein metabolic process (GO:0044267),-0.26549369008771867,-1.388209456944466,0.0,0.46591419851227933,1.0,115/396,20.42%,MSRA;APOE;PARP4;GAS6;UBE2D3;IGF1;ABL2;STK38;RPN2;RPS26;RPL39;YME1L1;SFTPA2;SFTPA1;RPL5;RPS23;RPS24;IGFBP4;RPS16;LGALS1;EEF1A1;RPL28;SIAH2;RPS29;RPS14;NAGPA;SHISA5;RPS20;RPS12;RPL35A;RPL18A;RPS13;RPL27;RPL21;RPS7;UBL4A;RPS5;RIPK1;PADI4;RPL30;CDC34;RPL6;PARL;RPL37A;DHPS;EIF4EBP2;CLN5;IGHMBP2;CPE;RPL10;RPL15;CDKL3;PSEN1;MBTPS1;ST8SIA4;SERPINC1;UBE2L3;GOLM1;UBA52;LOX;SERPIND1;RPS10;YARS2;PPP4R2;RPL14;ICMT;RPL9;RPL32;RPL36;CCN1;IGF2;LTA4H;RPL23A;RPN1;SPPL3;MRPL35;PNPLA2;RPL31;PRKCSH;CP;FAM20C;STOML2;APH1B;ATG3;AGO2;FBXO2;RPL3;MXRA8;UBE2L6;RPL41;ST8SIA2;MAGEC2;CDH2;ADPRH;RPL8;ADAM17;CCDC59;IGFBP7;MSRB1;GNMT;ANO8;MFGE8;RPL37;IGFBP5;SRBD1;FN1;MRPS33;RPL36A;RPL26;WFS1;NAPSA;RPL11;F5;WARS1;TIMP1
prerank,protein secretion (GO:0009306),0.39193952258800513,1.3880076856496595,0.060514372163388806,0.6642523202275753,1.0,19/56,20.17%,LTBP2;PTPRN;RAB3A;TVP23A;RAB8A;COPG1;PPY;ADCYAP1;TANGO2;ARL4D;RAB3D;MTTP;RAB12;GAL;MIA3;COPG2;PREB;OLFM2;SNX19
prerank,steroid metabolic process (GO:0008202),0.37397670718349224,1.3871879547245343,0.04195804195804196,0.6644838166644779,1.0,19/72,22.37%,STARD3;STAR;AKR1C1;NR1I2;CYP26C1;PRLR;LRP2;FDX2;LGMN;CYP39A1;LSS;RDH5;TSPO;CYP27A1;AMACR;HSD17B10;FDX1;GBA2;SULT1A1
prerank,cellular response to interferon-beta (GO:0035458),-0.4964424220253146,-1.386554049509696,0.09029345372460497,0.46866917929751273,1.0,7/14,27.70%,UBE2K;CDC34;STAT1;ACOD1;AIM2;NDUFA13;IRGC
prerank,organic anion transport (GO:0015711),0.3728563104102463,1.3863573457591778,0.04195804195804196,0.6646334746644423,1.0,16/76,14.60%,SLC25A4;SLC4A8;SLC35A1;SLCO2B1;CA1;CA3;CA4;SLC2A2;CFTR;CYB5R2;SLC26A7;MFSD10;SLC39A8;SLC4A10;SLC4A7;SLC19A1
prerank,intracellular pH reduction (GO:0051452),-0.3911715099394029,-1.3847549994396997,0.06069364161849711,0.4719613613920756,1.0,12/33,22.10%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;RAB7A;ATP6V0B;SLC11A1;ATP6V1A;ATP6V0A4;ATP6V1G2;GPR89B;GPR89A
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3968882449150386,-1.3846525850068137,0.07142857142857142,0.4706959333011197,1.0,10/29,16.17%,UBE2K;ZBP1;PTPN1;STAT2;IFNAR2;USP18;NLRC5;OAS3;WNT5A;MUL1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.510133934234771,-1.3839914928651222,0.11032863849765258,0.47095025951446434,1.0,4/13,3.99%,CBLB;KPNB1;RANBP2;KPNA2
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.5514139370540311,-1.3839064417275129,0.0944206008583691,0.469687453622105,1.0,2/10,9.05%,DNMT1;BRCA1
prerank,filopodium assembly (GO:0046847),-0.4822024188661307,-1.3817793748308895,0.09919571045576407,0.4734869658123755,1.0,5/16,8.41%,FGD4;FGD6;S1PR2;SPEF1;FGD1
prerank,negative regulation of potassium ion transport (GO:0043267),0.5258380924306146,1.3814176269026888,0.10912343470483005,0.6819625617155929,1.0,5/13,15.18%,KCNH2;BIN1;ACTN2;STK39;NEDD4L
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.541956227328236,1.3812808063416566,0.08347529812606473,0.6792976132866502,1.0,4/14,6.10%,SRSF12;RNPS1;SRSF6;PTBP1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.40960765683454275,-1.3809003055849933,0.058666666666666666,0.47417380724774405,1.0,10/27,15.08%,CCDC88B;CD44;CD47;CCR2;HSPD1;PRKCQ;LCK;SKAP1;HAS2;TNF
prerank,regulation of chemokine production (GO:0032642),-0.3817697263673637,-1.3806888714888519,0.06923076923076923,0.47320622146164354,1.0,19/36,30.18%,CD74;TLR2;TLR7;HIF1A;LPL;FOXP1;AGER;TNF;WNT5A;HMOX1;TLR4;ADAM17;APP;EIF2AK2;TLR9;TSLP;SIGIRR;IL33;EGR1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.44573674496193033,-1.3794826391715007,0.09043927648578812,0.47481811962562515,1.0,8/21,13.51%,STAP1;PRKCH;SLC39A10;PTPRC;TESPA1;CD226;LCK;FOXP1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.44986890881329533,1.3793172210178,0.07248764415156507,0.6839729243786659,1.0,6/29,9.53%,ZFPM1;TNNI3;TNNC1;MYBPC3;TGFBR3;TGFB1
prerank,protein autoubiquitination (GO:0051865),-0.33487141979175017,-1.3792116221380626,0.03896103896103896,0.47401515808236244,1.0,14/61,10.54%,ITCH;UBE2D3;CUL3;DTX3L;RNF213;OBI1;TRIM17;UHRF2;RNF146;RNF13;BRCA1;RNF157;SH3RF1;RNF220
prerank,heart development (GO:0007507),0.3368137435368054,1.3789540622735537,0.020151133501259445,0.682261095290332,1.0,47/150,24.13%,TSC2;ZFPM1;FGF12;KDM6B;ADAP2;TNNI3;SOX4;MEGF8;MYBPC3;TCF25;ZFPM2;NTRK3;MEF2C;DAND5;TGFBR1;TGFBR3;BMP4;PKD2;FOXC1;ERBB4;LDB3;TGFB1;TBX2;SGCZ;CRELD1;SGCG;PDGFB;AKAP13;PKD1;TEK;NDRG4;INSR;BORCS8;CXADR;SGCD;PTK2;DVL2;CASP8;SRF;RBM20;SMG9;FLRT2;MEF2A;RBP4;PDLIM3;POPDC3;POU6F1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5849224036420655,1.3786304180260114,0.09156193895870736,0.6804097389930457,1.0,5/10,21.11%,ALOX12;SH2B3;PRKG1;SERPINE2;RDX
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4888828614554223,1.3784179311498397,0.1012216404886562,0.678103826369595,1.0,9/18,18.56%,RELA;CLU;LRRTM3;EFNA1;CASP3;EPHA4;ABCA2;IFNGR1;CHRNA7
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.49003033875661495,-1.3775160003864066,0.09954751131221719,0.4767900334445329,1.0,7/14,13.37%,CPSF1;NCBP1;FIP1L1;ERN1;CPSF4;CSTF2;CPSF2
prerank,positive regulation of defense response (GO:0031349),-0.3156616176670917,-1.3769231733873368,0.014285714285714285,0.47683858383476846,1.0,35/89,27.95%,IL15;CD47;TLR2;LILRA5;ZBP1;CCR2;IL16;PTGER4;TLR7;NFKBIZ;RIPK1;TLR8;IL1B;LPL;GPSM3;GPRC5B;ADAM8;CYBA;TNF;WNT5A;OPTN;PDE2A;TLR4;POLR3G;TNIP1;SLC15A4;APP;PLSCR1;TLR9;PLA2G7;CEBPA;FEM1A;TSLP;FPR2;GPR4
prerank,cGMP metabolic process (GO:0046068),0.5514410323487441,1.3768978599692834,0.10884353741496598,0.681256283823638,1.0,3/12,10.39%,GUCY2F;GUCY2C;GUCY2D
prerank,cholesterol transport (GO:0030301),-0.36608504856153473,-1.3768962041933455,0.04129793510324484,0.4754422304578921,1.0,13/45,9.63%,APOE;MSR1;NPC2;OSBP;STX12;CD36;LDLRAP1;CAV1;LDLR;SERAC1;OSBPL2;ABCG4;ABCG1
prerank,thymus development (GO:0048538),0.5371939866162669,1.376235714544181,0.10906040268456375,0.6808374429573121,1.0,3/13,7.48%,FGF10;RIPK3;TGFBR1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4931614298880255,1.3747420359184859,0.10088495575221239,0.6838793733842929,1.0,6/18,20.04%,ADCY8;CRTC1;PRKD2;PRKD1;OPRD1;EPHA5
prerank,regulation of cardiac conduction (GO:1903779),0.39084722293359997,1.3736763901112103,0.061313868613138686,0.6849685095091794,1.0,20/54,22.83%,ATP2A3;ATP2A2;ITPR2;ATP1B1;ASPH;ATP1B3;SLC8A1;GJA5;ITPR3;ATP2B3;SLC8A3;DMPK;AGT;ANK2;TMEM65;ATP1A4;ATP1A3;ATP1A1;NPR1;RYR3
prerank,regulation of cilium movement (GO:0003352),0.5865943514420101,1.373541486899772,0.11993243243243243,0.6824889683011373,1.0,4/10,6.87%,DNAAF1;CFAP43;CCDC39;CCDC65
prerank,positive regulation of immune effector process (GO:0002699),-0.41591288785543523,-1.3734637775096818,0.06944444444444445,0.4825660192476019,1.0,12/27,28.39%,DDX60;ANKRD17;PTPRC;CCR2;IL1B;LBP;LILRB1;APPL2;DHX58;IL12RB1;MYB;RPS19
prerank,megakaryocyte differentiation (GO:0030219),0.5714926938050456,1.373436872080572,0.09330985915492958,0.6798489956059113,1.0,3/11,14.67%,ZFPM1;SH2B3;THPO
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5264156045813215,-1.3734066690180162,0.10823529411764705,0.4812230871778213,1.0,5/11,21.70%,P2RX4;FOXO1;NOTCH1;SMAD4;LMNA
prerank,regulation of interleukin-8 production (GO:0032677),-0.330073119282676,-1.3722687344698847,0.044444444444444446,0.482767665781659,1.0,28/69,22.13%,CD74;PTPN22;PTPRC;TLR2;RAB1A;LAMTOR5;BCL3;TLR7;CD14;NOD2;RIPK1;SYK;ANXA1;TLR8;IL1B;ANXA4;CD2;LBP;TNF;TLR4;TLR1;CD33;AFAP1L2;MYD88;HSPA1B;KLF4;TMSB4X;TLR5
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4220179344328865,-1.3722359789443528,0.07377049180327869,0.48139094560544743,1.0,5/23,5.75%,CD74;DPP4;RIPOR2;MPP1;MOSPD2
prerank,response to iron ion (GO:0010039),-0.5266418682394847,-1.3721186728983459,0.10098522167487685,0.4802658882492671,1.0,3/12,12.90%,BCL2;HIF1A;B2M
prerank,proteoglycan biosynthetic process (GO:0030166),-0.40668613439874485,-1.3719068579204534,0.07692307692307693,0.47936142798578313,1.0,8/31,10.83%,CHST11;IGF1;EXT1;XYLT1;CHST9;FAM20B;UGDH;NDST3
prerank,regulation of NMDA receptor activity (GO:2000310),0.43043087933317914,1.3716839392701443,0.07568438003220612,0.6840435071716515,1.0,14/32,23.12%,DLG2;GRIA2;MEF2C;GRIA1;ACTN2;GRIA4;GRIN1;GRIN2B;CRHBP;EPHB2;OPRM1;SLC6A9;NEFL;CAMK2B
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5390007431289179,1.3714038648092415,0.0907563025210084,0.6821842520149394,1.0,3/13,5.87%,GCHFR;FPGS;MTHFD1L
prerank,membrane protein proteolysis (GO:0033619),-0.3807956480647685,-1.3713139203369225,0.07692307692307693,0.47945841827166147,1.0,16/37,16.95%,ADAM19;NFKB1;ADAM9;PARL;PRKCQ;PSEN1;DAG1;MBTPS1;ERAP1;RET;CLPP;SPPL3;APH1B;RBMX;MYH9;ADAM17
prerank,monoacylglycerol metabolic process (GO:0046462),0.5449126217352305,1.370716716400849,0.11004784688995216,0.6818168093545418,1.0,3/13,7.09%,DGAT2;AWAT2;ABHD12
prerank,regulation of cation transmembrane transport (GO:1904062),0.44123629898110306,1.370114686341011,0.0867430441898527,0.6812307496451755,1.0,11/29,24.56%,KCNH2;FGF12;KCNE2;KCNIP3;KCNIP4;CACNA1D;WNK1;KCNN2;PDZK1;SNTA1;CD63
prerank,protein-containing complex disassembly (GO:0032984),-0.3500996600113131,-1.3700532355723405,0.0486322188449848,0.48112807303118915,1.0,13/54,12.08%,VIPAS39;MAP1LC3B;VCP;DVL3;LIX1;CAV1;UBQLN1;EPG5;UVRAG;LAMP2;SNAP29;CTNNB1;FZD2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.46938268679808925,1.3700414598223856,0.07833333333333334,0.678500470406574,1.0,6/23,9.43%,KCNH2;SCNN1A;OTC;SLC12A2;SLC26A4;SLC12A6
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3856063524374408,1.3695161367593867,0.06932153392330384,0.6777631283065711,1.0,13/62,6.91%,POLR2L;CDK7;CTR9;RTF1;POLR2F;NELFB;ELP2;GTF2H2;NELFCD;ELOC;SSRP1;GTF2H4;GTF2F1
prerank,lung development (GO:0030324),0.4206670911944915,1.3684041563933564,0.09501557632398754,0.679183659265136,1.0,8/33,12.74%,FGF10;DNAAF1;FGF9;CCDC39;FGF7;BMP4;FGF2;PKD1
prerank,regulation of endocytosis (GO:0030100),-0.34168568662741494,-1.3683219838391445,0.03927492447129909,0.48416474193091014,1.0,10/61,6.26%,DAB2;MCTP1;APOE;HIP1;ABL2;MTMR2;PTPN1;ZFYVE16;HIP1R;PICALM
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2654753574145455,-1.3672911218292831,0.00684931506849315,0.48532288102769233,1.0,78/306,15.40%,APOE;B4GALT5;EPC1;EXT1;RBBP8;RPS26;RPL39;RPL5;RPS23;RPS24;RPS16;RRAGC;CLSPN;EEF1A1;RPL28;POLR2E;RPS29;TOPBP1;RPS14;BCL3;RPS20;RPS12;EEFSEC;RPL35A;ORC5;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;RPL30;RPL6;RPL37A;DHPS;EIF4EBP2;IGHMBP2;NBN;RPL10;RPL15;RMI1;ATRIP;PCLAF;EEF1D;BRCA1;ALAS1;ORC2;RPS10;YARS2;RPL14;GRWD1;RPL9;RHNO1;BARD1;RPL32;RPL36;RPA1;CDK1;RPL23A;RMI2;MCM2;KAT5;MRPL35;RPL31;TICRR;POLR2B;AGO2;TYMS;PTMA;SCX;RPL3;ORC4;POLR2H;RPL41;MCM9;POLR2J;MCM8;KAT7
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.45970532470197234,-1.3660522178408874,0.10379746835443038,0.48733670604558993,1.0,7/17,8.68%,ARL6IP5;NOD2;PDCD10;LYN;RNF13;MID1;TAOK3
prerank,regulation of establishment of cell polarity (GO:2000114),-0.47235524835173615,-1.3658843917634544,0.10396039603960396,0.4862860327939585,1.0,8/16,19.20%,RIPOR2;KIF20B;SHTN1;RACK1;PTK2B;RAP1B;GSN;BCAS3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3598873604671924,1.365383774600313,0.04847645429362881,0.6886857454542052,1.0,38/84,25.71%,SRSF12;RNPS1;PRDX6;SMU1;DDX5;TRA2B;CWC22;ZC3H10;SRSF6;PTBP1;CIRBP;RBM5;SON;YTHDC1;KHDRBS2;METTL16;CELF6;QKI;RBFOX3;RBFOX2;NOVA1;RBM3;RBMXL1;REST;HNRNPA1;SRSF9;PUF60;TRA2A;SRRM4;TIA1;RBFOX1;FXR1;RBM39;RBM15B;ZBTB7A;SF1;SRSF3;CELF4
prerank,embryonic heart tube morphogenesis (GO:0003143),0.4034859032014244,1.3652742892328118,0.08052708638360176,0.6861186881375997,1.0,10/43,13.14%,DNAAF1;VANGL2;CCDC39;MEGF8;MEF2C;BBS5;PKD2;TBX2;NDRG4;TBX6
prerank,circulatory system development (GO:0072359),0.34259270287996424,1.3645731739562634,0.04252577319587629,0.6860300774437121,1.0,25/118,13.02%,TSC2;ZFPM1;FGF12;KDM6B;ADAP2;FLT4;TNNI3;SOX4;STK11;TCF25;ZFPM2;NTRK3;NXN;MEF2C;TGFBR1;PKD2;FOXC1;ERBB4;HEY1;LDB3;TGFB1;PDGFB;AKAP13;PKD1;TEK
prerank,regulation of macrophage migration (GO:1905521),0.567015560664789,1.3636753764666683,0.11876075731497418,0.6866321999639633,1.0,3/10,9.53%,P2RY12;CD81;CX3CR1
prerank,response to glucagon (GO:0033762),-0.4565795265814324,-1.36260219467568,0.09974424552429667,0.4935949886917148,1.0,8/19,15.19%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;CRY1;ADCY3;PRKACB
prerank,regulation of membrane repolarization (GO:0060306),0.5250038580866444,1.3613933012324058,0.12390924956369982,0.6933476072618427,1.0,5/13,16.05%,YWHAE;KCNH2;KCNE2;NEDD4L;CACNA2D1
prerank,cGMP-mediated signaling (GO:0019934),-0.49969067244520565,-1.3613087727511208,0.14925373134328357,0.4956146316891987,1.0,8/13,35.43%,APOE;CD36;IRAG1;PDE2A;AQP1;HTR2C;PDE3A;NPPA
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.49402575092169115,-1.3609522244333458,0.09210526315789473,0.4950650933554239,1.0,7/14,18.90%,PPP2R2A;NCK1;PPP2R2C;PPP3CA;DUSP1;PPP2CB;PPM1F
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.4523111275012036,-1.3605171600216437,0.12740384615384615,0.4946504645544924,1.0,8/18,22.94%,RAD51B;MECP2;CCND1;CDK1;CDC25A;DTL;CDC25C;CCNB1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.5129809850455775,-1.3604881725985385,0.12009237875288684,0.49325557581128526,1.0,6/12,19.50%,PCGF3;SMCHD1;CDYL;BRCA1;PCGF5;HNRNPU
prerank,fluid transport (GO:0042044),-0.5215982418699645,-1.3603061585776308,0.11214953271028037,0.4922774325581068,1.0,5/12,36.37%,AQP11;SLC26A6;PDPN;AQP1;SLC4A11
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.4683417163053504,1.3601585294399228,0.10518053375196232,0.6953390266799033,1.0,5/23,9.53%,TNNI3;TNNC1;MYBPC3;TGFBR3;TGFB1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5074469034573026,-1.358845921716697,0.11670480549199085,0.4948647726076886,1.0,3/13,3.73%,PID1;VCP;ENO1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.49233827469474184,1.358382729287317,0.10737179487179487,0.6995694228442609,1.0,7/18,15.34%,DNAAF1;ODAD4;CCDC39;ROPN1L;SPA17;SPEF2;DNAAF2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.48737736494678024,1.3581346327387547,0.11409395973154363,0.6976326314190833,1.0,8/17,21.90%,CTNNA2;NCKAP1;DNAI3;FCHSD2;WASF3;CYFIP1;WASF2;ARF1
prerank,heart looping (GO:0001947),0.41055007492824847,1.3576724134693225,0.07957957957957958,0.6965815277085692,1.0,9/39,13.14%,DNAAF1;VANGL2;CCDC39;MEF2C;BBS5;PKD2;TBX2;NDRG4;TBX6
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.45295220165390604,-1.3575626154878009,0.09210526315789473,0.4969243743003146,1.0,6/18,15.00%,RIC1;VPS35;MSN;PTTG1IP;WDR91;RGP1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.41216059981092956,-1.3573716411606915,0.07122507122507123,0.4958733195733498,1.0,7/29,6.15%,VAV3;BCL2;CD74;CD38;PTPRC;GPR183;TFRC
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3288254756569205,-1.3572634118475895,0.03180212014134275,0.49470678880088714,1.0,22/66,19.82%,CCT6A;DTX3L;ZPR1;LAMTOR5;TFRC;SMAD3;YAP1;PSEN1;ZC3H12A;CDK1;CCT3;PARP9;ORMDL3;NMD3;KAT7;SESN2;ECT2;CDH1;FLNA;PLK1;DKC1;CHP2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3937695207898748,-1.3569368244172928,0.07303370786516854,0.4940200572542895,1.0,14/33,23.66%,HIP1;CNOT9;FBXW7;HIP1R;BCAR3;PLAUR;ARAP1;CBL;NUP62;ADAM17;AFAP1L2;PDE6H;TGFA;EGF
prerank,positive regulation of endocytosis (GO:0045807),-0.3579564864835757,-1.356092321313842,0.06,0.49477191372735063,1.0,16/45,21.82%,DAB2;APOE;HIP1;STAP1;AXL;LDLRAP1;HNRNPK;RAB21;CBL;B2M;LRP1;CLN3;RAB31;APPL2;ABCA13;CLIP3
prerank,positive regulation of protein processing (GO:0010954),-0.44709371453427343,-1.3553042867679805,0.1089588377723971,0.4953678564257578,1.0,11/19,31.06%,CCBE1;ENO1;NLRC4;ADAM8;MYH9;GSN;NKD2;KLKB1;CLEC3B;RHBDD1;F12
prerank,protein oxidation (GO:0018158),-0.519014547345023,-1.354820487561622,0.1360381861575179,0.4952549244785426,1.0,5/11,35.31%,SUMF1;LOX;LOXL1;PRDX3;APOA2
prerank,negative regulation of ossification (GO:0030279),-0.4284832746860048,-1.3547588890584827,0.0891089108910891,0.49399854824373074,1.0,8/23,14.90%,RBPJ;BCOR;SRGN;NOTCH1;TRPM4;SMAD6;GREM1;PTK2B
prerank,nucleotide catabolic process (GO:0009166),-0.4739259104308042,-1.3547432649806939,0.10275689223057644,0.4926491018087225,1.0,4/16,5.60%,GDA;VCP;XDH;NT5E
prerank,autophagosome maturation (GO:0097352),-0.3916085856191634,-1.3545856706463344,0.09289617486338798,0.4917070002593373,1.0,9/32,10.13%,VIPAS39;MAP1LC3B;VCP;LIX1;UBQLN1;EPG5;UVRAG;LAMP2;SNAP29
prerank,regulation of protein secretion (GO:0050708),0.34265809340941633,1.353265457132524,0.03877005347593583,0.7120206774123663,1.0,35/119,19.69%,FRMD4A;MYOM1;SNAP25;ANG;ADTRP;ITPR2;KCNA5;SYTL4;DISP1;MYH10;IL6;SLC12A2;RFX6;SLC2A2;ADRA2A;APBB1;PRKCA;RAPGEF3;ACHE;TGFB1;CACNA2D2;UNC13B;CACNA1D;ITPR3;DNM1L;ABCC8;APBB3;IER3IP1;CACNA1A;STXBP5;MTNR1B;IL1A;LLGL2;CCL5;ERP29
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.35353632235918925,-1.3531042905127417,0.05722070844686648,0.4940430958666489,1.0,17/47,22.32%,NOCT;PPARG;ASXL2;METRNL;PIM1;PPARD;CEBPB;LPL;ZC3H12A;AAMDC;TRPM4;BMP2;HNRNPU;GDF3;BMP7;ID2;RREB1
prerank,translation (GO:0006412),-0.27372065054590305,-1.3526601145523847,0.0,0.49383612436269125,1.0,76/208,26.22%,RPS26;RPL39;RPL5;RPS23;RPS24;RPS16;EEF1A1;RPL28;ETF1;RPS29;AIMP1;RPS14;RPS20;RPS12;EEFSEC;RPL35A;RPL18A;RPS13;RPL27;RPL21;RPS7;RPS5;FARS2;RPL30;RPL6;RPL37A;DHPS;EIF4EBP2;TMA7;IGHMBP2;IARS2;RPL10;RPL15;EEF1D;UBA52;RPS10;YARS2;RPL14;RPL9;RPL32;RPL36;RPL23A;MRPL35;RPL31;AGO2;RPL3;QARS1;NARS1;RPL41;RPL8;WARS2;MRPL47;RPL37;SRBD1;MRPS33;RPL36A;NDUFA7;RPL26;RPL11;WARS1;TNIP1;RPS15;LARS1;PPA2;MRPL52;FARSA;MRPS24;NOA1;MRPS18B;RPS6;MRRF;RPLP2;RPS17;RPS18;MRPS18C;RPS21
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3608915378416209,-1.3526076938586342,0.06489675516224189,0.4925632705008429,1.0,13/47,13.83%,PID1;XDH;CD36;TYROBP;DHRS4;THBS1;RIPK1;SYK;ZC3H12A;ACOD1;GRB2;CYBA;SLC5A3
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3388571587202383,-1.3514920520512714,0.0486322188449848,0.4941818998076335,1.0,15/59,11.22%,MED13;MECP2;MITF;MED26;MED7;CDK8;BAX;MED16;NFKB1;CEBPB;CCND1;MED10;MED15;CTNNB1;CDK1
prerank,mismatch repair (GO:0006298),-0.40678459139122086,-1.3514724962201776,0.09343434343434344,0.4928621368093548,1.0,13/27,24.48%,PCNA;MSH5;POLD4;RPA1;MSH4;MCM9;PMS1;RPA2;MUTYH;RNASEH2A;XPC;SETD2;TDG
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3576352036875435,-1.350753967189857,0.0659025787965616,0.4932616266916365,1.0,15/43,19.01%,CLSPN;CDC14B;TOPBP1;NBN;ABRAXAS1;TAOK3;BRCA1;CDK1;TICRR;NOP53;BRCC3;UIMC1;DTL;HMGA2;PLK1
prerank,sodium ion transmembrane transport (GO:0035725),0.35304861749450245,1.3507014228938445,0.04815864022662889,0.7200395178854719,1.0,35/84,29.57%,HCN1;SLC4A8;ATP1B1;SCNN1A;SLC12A2;ATP1B3;SLC9A4;PKD2;SLC8A1;ASIC1;ASIC2;SLC9A5;SLC6A1;SCN2A;SLC8A3;SLC24A3;ASIC3;SLC24A4;ATP1A4;ATP1A3;ATP1A1;SLC6A9;SLC9A1;SCN3B;SCN1B;SLC6A7;SCN8A;SCN7A;SLC6A2;SLC6A5;KCNK1;ATP1B2;SCN1A;NALCN;SLC6A15
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.4488479847906195,-1.3506823616209138,0.11032863849765258,0.4920874191893749,1.0,3/18,3.72%,AOAH;FUCA1;BPGM
prerank,negative regulation of coagulation (GO:0050819),0.5267640616187146,1.3502490949235333,0.10631229235880399,0.7189313037783489,1.0,6/14,15.75%,ADTRP;HS3ST5;CD34;THBD;VTN;SERPINE2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.4814049613901048,1.3498915468125374,0.10420168067226891,0.7175363545106526,1.0,6/19,14.80%,FSCN1;DLG2;SCRIB;PRKCI;MTCL1;PATJ
prerank,bile acid and bile salt transport (GO:0015721),0.44919837700529147,1.3495382789965207,0.10366826156299841,0.7161300119305043,1.0,5/24,8.44%,SLCO2B1;ABCC3;AKR1C1;SLC10A2;STARD5
prerank,cytosolic calcium ion transport (GO:0060401),0.4416155171271241,1.349439969981205,0.10929853181076672,0.7135808253900184,1.0,10/28,16.05%,ATP2A3;ATP2A2;MICU2;SMDT1;SLC8A1;ITPR3;JPH1;ATP2B3;SLC25A23;CACNA2D1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.33553922326175434,-1.3488995904334855,0.059800664451827246,0.495320444149436,1.0,16/60,12.16%,MED13;MECP2;MED26;MED7;CDK8;BAX;MED16;NFKB1;CEBPB;CCND1;MED10;MED15;PAXIP1;CTNNB1;CDK1;ATF7IP
prerank,alpha-amino acid catabolic process (GO:1901606),0.44155510748892524,1.3483884168597886,0.09305993690851735,0.7149822568773722,1.0,9/29,18.00%,HOGA1;IL4I1;IDO2;OTC;ACADSB;KYAT1;ALDH4A1;DAO;HSD17B10
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.48018734034605337,-1.3481817767371187,0.09405940594059406,0.4958559931958646,1.0,5/14,14.63%,PTPN22;CCR2;SYK;CD55;EBI3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.42726969541480375,1.3473891824371982,0.10832025117739404,0.7159744108725284,1.0,9/31,13.98%,ABI3;TANC2;ARHGAP44;SHANK3;SRCIN1;CFL1;EFNA1;LZTS3;EPHA4
prerank,cilium-dependent cell motility (GO:0060285),0.47261028448243764,1.3470080285323789,0.10517799352750809,0.714642383228381,1.0,8/22,21.74%,CCDC39;DNAH3;DNAI3;CCDC65;DNAAF2;CFAP44;CFAP54;DNAH2
prerank,protein homooligomerization (GO:0051260),0.33338167049473943,1.3460911177533985,0.04521276595744681,0.7156150465578436,1.0,35/114,22.91%,HCN1;GLRA3;ADCY8;MPP2;IKZF4;NACC2;FUS;C9;DISP1;ATL1;TRPM2;TRMT61B;ALDH9A1;CBR4;PKD2;ACOT13;HPRT1;SIGMAR1;ASIC1;EHD1;RNF135;CHMP2A;ACACB;TK1;EHD3;ALS2;HSD17B10;ALAD;ALDOA;SSBP1;ALOX5AP;STEAP4;SPAST;RYR3;ATL2
prerank,nucleosome assembly (GO:0006334),-0.39189032330360357,-1.3459094375326488,0.09620253164556962,0.5004772934506582,1.0,9/31,14.32%,HMGB2;KAT6B;PADI4;CABIN1;ANP32B;H3-3A;HAT1;GRWD1;NPM1
prerank,metanephric mesenchyme development (GO:0072075),0.572505506036679,1.3452290520624817,0.12347826086956522,0.7164200996948813,1.0,3/10,8.85%,WNT4;SIX4;PKD2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3113798180024892,-1.345122301863955,0.03597122302158273,0.5012268141866424,1.0,29/88,21.52%,MYO5A;RABEP1;DNAJC6;KLHL20;KIF16B;GOLGB1;GBF1;EXOC4;AP1S3;CLINT1;EPS15;CCDC22;AP4M1;SNAP23;RAB10;DNM2;CLTA;EXOC8;STXBP6;CORO7;DOP1B;FTL;EXOC6;GOPC;CCDC93;NAPA;DTNBP1;PUM1;APP
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.44156130109863717,-1.3450120219765318,0.11671087533156499,0.49878811685166247,1.0,6/20,13.84%,MGST3;GSTA3;GSTO2;GSTZ1;GSTM1;GSTM5
prerank,glutathione derivative metabolic process (GO:1901685),-0.44156130109863717,-1.3450120219765318,0.11671087533156499,0.49878811685166247,1.0,6/20,13.84%,MGST3;GSTA3;GSTO2;GSTZ1;GSTM1;GSTM5
prerank,positive regulation of exosomal secretion (GO:1903543),-0.48267636014946713,-1.3446939583136577,0.1415525114155251,0.49826816139672087,1.0,7/15,24.95%,SDCBP;RAB7A;PDCD6IP;STAM;SDC1;SDC4;ATP13A2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4866884107644529,-1.343951170950684,0.11737089201877934,0.49887913375771836,1.0,6/13,19.65%,FCGR2B;ALOX5;NR1H2;NR1H3;AQP11;WFS1
prerank,cell projection assembly (GO:0030031),0.4512767717677758,1.3433062323295175,0.11813643926788686,0.7215627854533305,1.0,8/22,20.64%,RHOV;NCKAP1;NCKAP1L;CYFIP1;RHOQ;RHOU;CDC42;CAPG
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5301609993802412,1.3428656043309948,0.14091680814940577,0.720568881082261,1.0,5/13,15.69%,HHEX;DAB2IP;NEDD4;PDCD6;CADM4
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.29324012094833335,-1.3428619337147816,0.01556420233463035,0.5002331478545705,1.0,44/125,23.87%,MECP2;KPNB1;BUB3;MIS12;TACC3;KIF11;RANBP2;PMF1;PTPA;ZWILCH;CDCA8;STMN1;CENPA;NUP43;XPO1;NUSAP1;MAPRE1;BIRC5;MAD2L1;ESPL1;AHCTF1;BUB1;BUB1B;DYNC1LI2;KNTC1;SPDL1;KIF4A;INCENP;NDC80;WDR62;NUF2;DCTN2;ERCC6L;PLK1;PAFAH1B1;MAP4;SETD2;B9D2;ZWINT;RCC1;CCNB1;NDE1;SPC24;NUP98
prerank,regulation of T cell cytokine production (GO:0002724),-0.470804072856383,-1.3425715857008496,0.10926365795724466,0.49961450240171457,1.0,5/15,13.35%,CCR2;TRPM4;TNFRSF1B;B2M;CD55
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.31154256765874194,-1.3425467120949306,0.030303030303030304,0.4983592525065273,1.0,30/88,20.41%,FNIP2;VCP;SDCBP;GNL3L;BAX;RAB7A;SH3GLB1;SYNPO2;MTLN;TFRC;SMAD3;SYK;AJUBA;PDCD6IP;SYNPO;RACK1;STAM;CDT1;ICE1;TNF;PFN2;BCL2L11;SDC1;STX18;SLX4;HAS3;RGCC;SDC4;BMP7;WARS1
prerank,action potential (GO:0001508),0.39371092952831355,1.3418467929260742,0.08923076923076922,0.7220138875681806,1.0,18/44,28.62%,KCNH2;KCND2;KCNE2;DMD;GNA15;CACNA1G;SCN2A;GNA11;KCNMB3;SCN3B;SCN8A;ANK3;SCN7A;GNAQ;KCNB1;CACNA1H;SCN1A;SLC4A3
prerank,icosanoid biosynthetic process (GO:0046456),-0.5416382584397089,-1.3417966648175075,0.14349775784753363,0.49891235286839947,1.0,4/10,18.33%,ALOX5;MGST3;LTA4H;LTC4S
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.43227610768221736,-1.3416182613878327,0.10886075949367088,0.4980803555672965,1.0,9/21,17.19%,GAS6;BCOR;SRGN;NOTCH1;TRPM4;GREM1;PTK2B;ASPN;HEY2
prerank,positive regulation of developmental growth (GO:0048639),0.38600261067023267,1.3413273215404085,0.10291858678955453,0.721280794103256,1.0,13/49,15.18%,AGRN;SEMA7A;SYT4;PPIB;SYT1;LIMK1;TWF2;CDKL5;CPNE6;RIMS1;MAP3K13;INSR;NEDD4L
prerank,cAMP biosynthetic process (GO:0006171),-0.5478528215158743,-1.3406060972750242,0.12121212121212122,0.4993748740702671,1.0,6/10,14.21%,ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;ADCY10
prerank,negative regulation of inflammatory response (GO:0050728),-0.27755925525224,-1.340399621587363,0.010256410256410256,0.49860034756429134,1.0,74/182,29.71%,AOAH;CD163;APOE;IGF1;ALOX5;GIT1;PPARG;METRNL;PRKACA;ADCY9;PTGER4;VPS35;PPARD;SYK;LYN;FYN;ENPP3;HCK;VIPR1;ADCY5;ADCY6;PTGIS;ACOD1;ADCY1;C1QTNF3;TNFRSF1B;NR1H3;CCN3;CXCL17;RB1;ADCY3;NPSR1;PRKACB;RAMP2;GPR27;CALCRL;MYH9;OTULIN;MAPK7;ADAM17;PTHLH;GATA3;CD247;KLF4;NLRC3;MVK;FFAR4;VIPR2;NR1H4;MEFV;RXFP2;PTH1R;CALCA;CRH;SMPDL3B;GSTP1;GLP1R;RAMP3;SCTR;ADORA2A;VIP;FEM1A;ISL1;FPR2;GPR83;PTGDR;RPS19;CREB1;PTGIR;FGR;RHBDF2;GPR15;TNFAIP3;MFHAS1
prerank,sulfur compound transport (GO:0072348),-0.3963690082134481,-1.3397884408149172,0.07162534435261708,0.4988690936344881,1.0,7/27,12.51%,LRRC8D;SLC26A11;SLC6A6;RACGAP1;SLC25A19;SLC13A4;SLC25A11
prerank,cardiac muscle contraction (GO:0060048),0.4120578568038944,1.339318298923798,0.09230769230769231,0.7267959186196756,1.0,7/34,9.62%,KCNH2;ATP1B1;TNNI3;TNNC1;DMD;MYBPC3;SLC8A1
prerank,pinocytosis (GO:0006907),-0.5351095169911545,-1.3391753759662057,0.12296983758700696,0.49914720979172494,1.0,4/10,10.99%,DOCK2;MAPKAPK2;CARMIL1;MAPKAPK3
prerank,myotube differentiation (GO:0014902),0.4937647198497903,1.339145440948496,0.11735537190082644,0.7247768748681706,1.0,6/17,14.01%,SIX4;JAM2;MEF2C;ADAMTS15;ADAM12;SORT1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5324130790461752,1.339075701572668,0.13379073756432247,0.722242265798506,1.0,6/12,13.93%,ADA;GART;PRPSAP2;HPRT1;PRPSAP1;ADSL
prerank,regulation of protein sumoylation (GO:0033233),-0.459880448606502,-1.3387608221881526,0.11320754716981132,0.4989429179235277,1.0,9/17,24.00%,RWDD3;GNL3L;ZMIZ1;UBA2;CTNNB1;MUL1;HDAC4;PIAS4;PIAS3
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.5078162117530698,-1.3384670893198942,0.13203463203463203,0.49834952677755756,1.0,6/12,13.54%,CTCF;CTNNB1;ESPL1;BUB1;RAD21;RB1
prerank,protein modification process (GO:0036211),-0.32393726339006174,-1.3384538455746358,0.05054151624548736,0.49708092291713735,1.0,24/76,15.55%,MSRA;PARP4;UBE2D3;ABL2;STK38;RPN2;NAGPA;UBL4A;PADI4;CDC34;CPE;CDKL3;ST8SIA4;UBE2L3;UBA52;LOX;PPP4R2;ICMT;RPN1;ATG3;FBXO2;UBE2L6;ST8SIA2;ADPRH
prerank,renal filtration (GO:0097205),0.5600048968555347,1.3383287279569762,0.14568345323741008,0.7224143253092472,1.0,3/10,6.54%,TMEM63C;CD34;XPNPEP3
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.4477030358433931,-1.3377229116393365,0.11989795918367346,0.4977204551974419,1.0,12/18,27.98%,C3AR1;C5AR1;LYN;BAG6;SPG21;FCER1G;BCAR1;LAX1;FPR3;BLK;FPR2;CD19
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5750852480659722,1.3376605007973503,0.13798977853492334,0.7224771259882172,1.0,3/10,13.73%,WHRN;STRC;IFT88
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3763288635503869,1.3370323897133662,0.0830860534124629,0.7222752931664687,1.0,13/64,6.91%,POLR2L;CDK7;CTR9;RTF1;POLR2F;NELFB;ELP2;GTF2H2;NELFCD;ELOC;SSRP1;GTF2H4;GTF2F1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.36365742946786156,-1.336922034241618,0.07386363636363637,0.49855552294351296,1.0,16/38,24.93%,SASH1;DDX60;ANKRD17;PUM2;OASL;TLR8;ADAM8;ACOD1;CYBA;SCIMP;POLR3G;USP15;PUM1;SLC15A4;PLSCR1;DHX58
prerank,ether lipid biosynthetic process (GO:0008611),0.5691745020945222,1.33677981083258,0.1346153846153846,0.7204901388568292,1.0,3/10,11.46%,PLA2G4C;DHRS7B;LPCAT2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.49709237566519826,1.3364777432845982,0.1273344651952462,0.718953400663557,1.0,9/16,31.83%,C3;MRAP;PRKCA;PRMT5;GRP;CHGA;NECAB2;SLC39A14;PDE6G
prerank,prostaglandin metabolic process (GO:0006693),0.4419567202251907,1.3359172148467022,0.10685805422647528,0.7184425185755869,1.0,12/26,24.88%,CYP2S1;PTGS1;PTGDS;AKR1C1;PRXL2B;ACOX1;HPGD;PTGR2;HPGDS;PNPLA8;DAGLB;PLA2G4A
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.345363206259439,-1.335745802924163,0.0743801652892562,0.5003532570743476,1.0,20/51,21.52%,LILRA5;CD36;IL16;TYROBP;NLRC4;NOD2;TLR8;LPL;TMED10;AGER;TNF;HSPB1;WNT5A;TLR4;PYDC1;TRIM16;MYD88;CASP1;AIM2;APP
prerank,vacuolar acidification (GO:0007035),-0.4212783078679639,-1.3347922303458781,0.11004784688995216,0.5015728151527045,1.0,7/21,19.77%,ATP6V0D1;ATP6V0D2;ATP6V0A1;CLN5;SLC11A1;CLN3;ATP6V0A4
prerank,defense response to bacterium (GO:0042742),-0.3032222139614394,-1.334750659690246,0.02888086642599278,0.5003686956490395,1.0,32/105,20.11%,ANKRD17;OAS2;MPEG1;RNASE3;RPL39;TLR2;HMGB2;LYST;RAB1A;NLRC4;NOD2;CEBPB;SYK;RPL30;STAB2;LYZL4;SLC11A1;OAS3;LCN2;GBP4;LBP;SHC1;SPN;OPTN;FCER1G;TLR4;ADAM17;CFP;CAMP;MYD88;GBP6;LTF
prerank,regulation of cellular respiration (GO:0043457),-0.4583617147268985,-1.3338879182645085,0.1330166270783848,0.5011777050365863,1.0,10/17,34.67%,IFNAR1;VCP;CBFA2T3;IFNLR1;NOP53;NOA1;IL10RB;SHMT2;TRAP1;NOS2
prerank,sphingolipid catabolic process (GO:0030149),-0.4645448458311976,-1.3337505937804595,0.1377551020408163,0.5002367389687926,1.0,5/15,13.30%,ACER3;SGPL1;SMPDL3A;ASAH2;GLA
prerank,mitotic cytokinesis (GO:0000281),-0.34959864079961334,-1.3324472835627486,0.08430232558139535,0.5023216652696133,1.0,18/47,19.01%,CHMP4B;KIF23;RASA1;SNX9;STMN1;CIT;RACGAP1;USP8;CENPA;NUSAP1;ESPL1;PDCD6IP;KIF4A;CKAP2;INCENP;KIF20A;ECT2;PLK1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.4501871400321521,-1.3322183017499623,0.12144702842377261,0.501692991615406,1.0,9/19,23.89%,GNL3L;EXOSC10;TERF2;TENT4B;NAT10;HNRNPU;HNRNPC;TINF2;PIF1
prerank,zinc ion homeostasis (GO:0055069),0.4301560648805732,1.3320894383722204,0.13174603174603175,0.7315370736621778,1.0,13/28,17.76%,SLC39A4;TMC8;PRKN;SLC39A8;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,negative regulation of protein metabolic process (GO:0051248),-0.34848235744795564,-1.3320091475475953,0.06796116504854369,0.5009457893445483,1.0,18/48,21.86%,APOE;FLOT2;NFKB1;LDLR;PFDN5;EDNRB;MAD2L2;AGAP2;MAD2L1;EGFR;RILP;PTX3;FLNA;ITGB3;FMN2;SIRT2;PFDN2;ADGRB1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.45482099989091596,-1.331587735467501,0.12151898734177215,0.5007506293383374,1.0,8/18,18.13%,FCGR2B;BAX;ERN1;NCK1;BAG6;PMAIP1;BCL2L11;RNFT1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5694026518722592,1.3306044146583798,0.1408199643493761,0.735034822447812,1.0,6/10,17.65%,CACNG5;NPTXR;NPTX1;DLGAP1;DLGAP2;DLGAP3
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.4453100195798477,-1.3303233502198302,0.1223529411764706,0.5027437519947637,1.0,8/18,15.91%,DOCK2;TYROBP;SYK;ENPP3;DYSF;SLAMF1;LBP;FCER1G
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.33809481707287353,-1.32994297645708,0.0781758957654723,0.5024483516606154,1.0,20/57,19.01%,CLSPN;CDC14B;TOPBP1;MDC1;CCND1;NBN;ABRAXAS1;TAOK3;BRCA1;CDK1;TICRR;WAC;EME1;NOP53;BRCC3;RPA2;UIMC1;DTL;HMGA2;PLK1
prerank,histone modification (GO:0016570),-0.30298484827316813,-1.3297832855034961,0.040293040293040296,0.5015690848795511,1.0,26/109,14.80%,BAZ1B;KAT6B;SIN3B;ATXN7;RCOR1;PADI4;PHF20;HLCS;TBL1X;EYA1;EYA3;TRRAP;PRMT2;EP300;BRMS1;BRMS1L;CCNA2;RCOR3;EYA2;HDAC2;MIDEAS;KAT5;HDAC1;EHMT1;MSL3;INCENP
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5078265961676115,-1.329757503348775,0.11633663366336634,0.500354243516372,1.0,7/12,35.12%,CCR2;IL1B;SLC11A1;IL18R1;IL12RB1;IL23R;IL12B
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4145252281823465,1.3288201641045798,0.11338582677165354,0.7396767231679767,1.0,8/34,9.53%,ZFPM1;WWTR1;E2F1;IL6;ZFPM2;TRIB2;ZFP36L2;TGFB1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.39366832113284106,-1.3287574074064221,0.10540540540540541,0.501660176584808,1.0,10/29,16.12%,APOE;LDLR;NR1H2;CTDNEP1;SORBS1;NR1H3;ZBTB20;MID1IP1;CHP1;MFSD2A
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3556399640048749,-1.3282799792158586,0.09226190476190477,0.5016575359369863,1.0,12/39,14.73%,RBPJ;IL6ST;NOD2;PDCD10;ZMIZ1;YAP1;SNW1;NOTCH1;EP300;TSPAN5;CCN3;NOTCH4
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.29881323668277787,-1.3279884746743988,0.03088803088803089,0.5011061041972193,1.0,27/93,18.62%,FCGR2B;SASH1;ARL6IP5;SDCBP;XDH;PJA2;NOD2;RIPK1;PDCD10;RELL1;IL1B;MID1;TAOK3;ZC3H12A;SH3RF1;MAP3K11;TNFRSF19;GADD45G;SLAMF1;BMP2;AGER;PTK2B;SCIMP;TRAF1;HIPK2;MMP8;TRAF4
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.39086073443569264,-1.3274257753125065,0.11168831168831168,0.5012850749559444,1.0,8/30,11.97%,RPN2;MAGT1;UGGT1;MGAT2;MCFD2;ST6GAL1;FUT8;RPN1
prerank,basement membrane organization (GO:0071711),0.5082139990238808,1.3271175218629694,0.14991482112436116,0.744283590675159,1.0,8/14,23.55%,LAMB3;PXDN;HPN;NTNG2;NTNG1;FLRT2;CTSS;LAMB2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.35889834567734846,-1.326982894610122,0.0921409214092141,0.5012257333218652,1.0,11/39,14.55%,NOL11;RPS24;RPS16;RPS14;RPS7;DDX52;RPS5;UTP4;METTL17;NPM1;WDR3
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.4266707563396953,-1.326480009858089,0.12433862433862433,0.5011802205403397,1.0,6/22,14.06%,APOE;PPARG;PPARD;IL1B;SORBS1;ZBTB20
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.46108406950101266,-1.3261344612601205,0.135,0.5008683245874099,1.0,6/16,16.12%,LDLR;NR1H2;CTDNEP1;PNPLA2;NR1H3;MFSD2A
prerank,collagen fibril organization (GO:0030199),0.35229696406355937,1.3260894784806778,0.07605633802816901,0.745826077593525,1.0,27/88,23.82%,P3H2;PLOD3;P4HA3;COL5A1;DST;PPIB;LAMB3;COL2A1;TGFBR1;SERPINH1;PXDN;COL4A5;COL28A1;ADAMTS14;COL4A2;COL15A1;COL18A1;ITGA6;PLOD1;ADAMTS3;P4HA2;COL4A4;LAMC2;COL6A1;COL27A1;COL20A1;COL13A1
prerank,indolalkylamine catabolic process (GO:0046218),0.563445464689387,1.3256029636199393,0.13604240282685512,0.7449856261193252,1.0,3/10,11.74%,IL4I1;IDO2;KYAT1
prerank,metal ion export (GO:0070839),0.41771233454425294,1.3254737710792168,0.11589403973509933,0.7427025824530961,1.0,10/31,22.22%,KCNH2;KCNA5;ATP1B1;KCNE2;ATP1B3;KCNT2;ATP1A4;ATP1A3;ATP1A1;SLC9A1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.5251301097467443,-1.3243307727683644,0.1476510067114094,0.5041499582723089,1.0,3/11,8.14%,VCP;UGGT1;BAG6
prerank,negative regulation of lipid storage (GO:0010888),-0.4346867142512607,-1.324237004879656,0.11764705882352941,0.5031304130100043,1.0,8/19,15.08%,OSBPL8;PPARG;PPARD;NR1H2;ABCG1;PNPLA2;NR1H3;TNF
prerank,mitotic metaphase plate congression (GO:0007080),-0.345051869462143,-1.3241288908628517,0.0603448275862069,0.5022063473158845,1.0,17/51,18.01%,CHMP4A;CHMP4B;KPNB1;MIS12;CUL3;PIBF1;BOD1;CDCA8;KIFC1;CHMP1B;PDCD6IP;SPDL1;CDT1;NUP62;NDC80;NUF2;DCTN2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5434010137097958,-1.3240848662268832,0.14035087719298245,0.5010629494314653,1.0,5/10,14.75%,FCGR2B;PTPRC;CEACAM1;KLRD1;LILRB1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.43594975095536165,1.3235633880061355,0.1174496644295302,0.7481252434069178,1.0,10/22,25.59%,NTRK1;STMN2;NTRK3;SH3GL2;EHD1;NTRK2;MAGI2;BDNF;RAPGEF2;MAPT
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.5140099084757067,-1.3228414390440868,0.141280353200883,0.5030518483648984,1.0,4/11,19.18%,CIITA;PF4;HDAC2;TAF7
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.4319098558500802,-1.3222049446813073,0.11764705882352941,0.5033617596343252,1.0,6/21,12.01%,FCGR2B;PTPN22;PIBF1;SOX11;BANK1;FOXJ1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4873063854925548,-1.3218964942502824,0.14454976303317535,0.5028740645005827,1.0,8/13,28.76%,NRP1;CTNNB1;KDR;NOTCH4;SHH;SEMA3E;DLL4;NRARP
prerank,positive regulation of immune response (GO:0050778),-0.32619344126416394,-1.3215799123229572,0.06040268456375839,0.5024152200094728,1.0,14/64,14.75%,FCGR2B;IL15;CD74;PTPRC;IL6ST;NOD2;TLR8;CD226;ADAM8;SKAP1;CYBA;SASH3;SPHK2;LILRB1
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.32074527564332367,-1.321468207140488,0.06325301204819277,0.5015691016354102,1.0,10/70,6.25%,PEAK1;ITGA4;NRP1;PXN;ATRNL1;RILPL2;ACTN1;PROX1;ARL13B;ITGB7
prerank,regulation of adaptive immune response (GO:0002819),-0.4438840264677878,-1.3208112877377363,0.12219451371571072,0.502067297821795,1.0,6/18,13.56%,FCGR2B;IRF7;IL6ST;AHR;SKAP1;SASH3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3553790408674595,-1.3208083587582973,0.08870967741935484,0.5008647781820472,1.0,18/45,21.52%,LILRA5;CD36;TYROBP;NLRC4;NOD2;TLR8;LPL;AGER;TNF;HSPB1;WNT5A;TLR4;PYDC1;TRIM16;MYD88;CASP1;AIM2;APP
prerank,epithelial tube morphogenesis (GO:0060562),0.41347111163784034,1.3193998619837355,0.10641627543035993,0.7628379840112748,1.0,8/32,8.85%,FGF10;SCRIB;PAK1;MEGF8;MEF2C;BMP4;PRKD2;PKD2
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.4224838253786136,-1.3191125945014313,0.13861386138613863,0.5038134534176943,1.0,10/21,16.95%,ADAM19;ADAM9;PRKCQ;PSEN1;DAG1;ERAP1;SPPL3;RBMX;MYH9;ADAM17
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.2879016202009495,-1.3182763517864455,0.03879310344827586,0.5046818543540342,1.0,35/132,15.84%,ITCH;APOE;IGF1;TRIM65;TRIM14;DTX3L;PTPN1;SH3GLB1;VPS35;ADAM9;MSN;MTLN;TPCN1;NRDC;SNX9;HIF1A;IL1B;PSEN1;ZC3H12A;ADAM8;PTTG1IP;FOXO1;RC3H1;TNFRSF1B;KAT5;DAPK1;PNPLA2;TRIM5;ENTPD5;LRRK2;ZBTB20;ORMDL3;TNF;ZC3H18;OPTN
prerank,cellular response to misfolded protein (GO:0071218),-0.4266134360254202,-1.3181816594908666,0.11943793911007025,0.5036643506154171,1.0,5/20,8.14%,VCP;CUL3;UGGT1;KLHL15;BAG6
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3790614332377845,-1.3180775399831401,0.11286089238845144,0.5027037815384334,1.0,11/32,21.52%,PID1;IGF1;VCP;ENO1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;TMSB4X;APP
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.457003746980828,-1.3174077585184116,0.14496314496314497,0.5031434276487567,1.0,3/15,1.64%,BCL2;CD74;CD44
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.4672385679810829,-1.317060134006731,0.13947990543735225,0.5027747431303415,1.0,8/16,32.64%,VCP;ATP7A;UQCC2;SLC25A33;PPIF;ABCD1;SHMT2;PDE12
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.37855689890565564,1.3168490017566319,0.08592592592592592,0.7712225127838738,1.0,17/52,15.82%,SRSF12;RNPS1;SMU1;DDX5;TRA2B;ZC3H10;SRSF6;PTBP1;RBM5;YTHDC1;KHDRBS2;CELF6;RBFOX3;RBFOX2;NOVA1;REST;HNRNPA1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.49302089698241175,-1.316412775770682,0.1523809523809524,0.5032153569021862,1.0,3/13,0.73%,PLXNC1;NRP1;NRP2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.44728724356271926,-1.3159599980126309,0.1225,0.5032671777388232,1.0,6/17,13.03%,CD74;CD44;DYRK1A;YJU2;PTTG1IP;PSMD10
prerank,negative regulation of mRNA processing (GO:0050686),0.5045273579745644,1.3153141004635347,0.12776831345826234,0.7750296478414657,1.0,4/15,6.10%,SRSF12;RNPS1;SRSF6;PTBP1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.5123865761283035,-1.3148700708570853,0.13875598086124402,0.5048490271641703,1.0,4/11,12.16%,SETDB2;PPHLN1;DNMT1;ATF7IP
prerank,regulation of exit from mitosis (GO:0007096),-0.36025177524257007,-1.3147006506797383,0.0790273556231003,0.5040949254835317,1.0,15/38,22.68%,BUB3;CDC14B;UBC;UBA52;CDC27;MAD2L1;BUB1B;KNTC1;UBE2C;MAD2L1BP;RGCC;SIRT2;CDC14A;ANAPC7;ANAPC10
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.4888996984323748,-1.3144971019011555,0.14640198511166252,0.5035139648427285,1.0,5/12,9.85%,APOE;FLOT2;RANBP9;PICALM;TMED10
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4720178175435975,1.3142307061232437,0.131175468483816,0.77661153979942,1.0,6/18,15.18%,CBARP;KCNH2;BIN1;COMMD1;STK39;NEDD4L
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.323124658953016,-1.3141619215382019,0.06514657980456026,0.5031847272845082,1.0,16/66,12.90%,MTSS1;APOE;ALOX5;CDK6;MCC;CDC73;XDH;RUNX3;FBXW7;AIMP1;THBS1;CAV1;STAT1;KLF9;CEACAM1;B2M
prerank,regulation of T cell activation (GO:0050863),-0.35593336082169313,-1.3135620440795113,0.09329446064139942,0.503554479319698,1.0,11/42,12.05%,PTPN22;CCDC88B;TNFSF8;CD47;CCR2;IL27;HSPD1;PRKCQ;LCK;TNFRSF1B;CD2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.5216582343782828,1.3132331229425425,0.14912280701754385,0.7779331630502818,1.0,7/13,18.56%,ADCY8;LGMN;SHANK3;ZDHHC2;EPHB2;EIF2AK4;CHRNA7
prerank,mitochondrial genome maintenance (GO:0000002),0.5352150491593288,1.3130529887206945,0.15026833631484796,0.7759370976069757,1.0,2/11,0.37%,TOP3A;SLC25A4
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.2793702365220386,-1.3126400072870552,0.02390438247011952,0.5047136265238583,1.0,48/136,21.60%,SP100;ITCH;GAS6;RWDD3;PROX1;PIM1;ESR1;CEBPG;TAF1;ZC3H12A;ID3;MAD2L2;ANXA4;PTGIS;PAXIP1;PRMT2;NFKBIE;ACOD1;BRMS1;ID1;HDAC2;FOXJ1;NLRC5;PSMD10;RB1;SIK1;SFRP5;CHP1;OTULIN;PYDC1;GLIS2;NWD1;FLNA;TRIM37;HES1;CDKN2A;WFS1;BMP7;BHLHE40;KLF4;NLRC3;TRIM21;AIM2;PTCH1;HDAC4;TMSB4X;ID2;HEYL
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.4812212073329607,-1.3125677556723583,0.13131313131313133,0.5037309162805603,1.0,5/13,13.93%,CHMP4A;CHMP4B;SMCR8;MTM1;LRRK2
prerank,transepithelial transport (GO:0070633),0.4994351058673007,1.3123911964724873,0.14065180102915953,0.7760657986365138,1.0,6/15,23.75%,SLC12A2;SLC1A1;SLC1A3;CXADR;ABCG2;GPLD1
prerank,negative regulation of apoptotic process (GO:0043066),-0.24527692124426373,-1.3122344303633402,0.0,0.5033283451073269,1.0,105/444,15.92%,DAB2;ARHGAP10;BCL2;ITCH;CD74;APOE;CD38;GAS6;IGF1;AXL;BCL2L1;PRKCH;KLHL20;RAF1;CD44;TNFAIP8;ATAD3A;YME1L1;BRAF;MCL1;BIRC6;NUAK2;RNF213;SIAH2;IL6ST;LAMTOR5;BCL3;PIM1;CIAPIN1;NFKB1;RASA1;BAG4;VHL;THBS1;FAS;HSPD1;RIPK1;TFRC;PRDM9;PDCD10;PLAUR;CAV1;IFIT3;YAP1;ANXA1;UBC;HNRNPK;CIB1;HCK;NAA16;RPL10;PSEN1;TPT1;CPEB4;PIK3CA;PIDD1;ZC3H12A;UBA52;HYPK;GCLC;RNF157;SH3RF1;ANXA4;ADAM8;CD28;BIRC5;SPRY2;EGR3;AGAP2;FOXO1;NOTCH1;ATF5;CTNNB1;BARD1;MIEN1;CDK1;MAD2L1;LIG4;BIRC2;HDAC2;FHL2;CBL;HDAC1;ASAH2;KDR;CCND2;SMAD6;PSMD10;PTMA;SCX;RB1;GREM1;QARS1;NPM1;EGFR;DFFA;SHC1;PTK2B;DNAJB6;TNF;HSPB1;WNT5A;NUP62;CLN3;GPX1
prerank,ion transport (GO:0006811),0.3326138508038327,1.3121965925342243,0.04736129905277402,0.774062278662839,1.0,37/111,22.96%,TMEM63C;SLC24A5;SLC5A12;TRPM3;VDAC1;SLC12A2;SLC1A1;GLRB;SLC20A1;CNGB1;SLC25A18;SLC9A4;SLC26A4;GRIN1;SLC12A6;SLC8A1;SLC26A7;SLC1A3;CTNS;TRPC6;PANX1;TSPO;KCNN4;SLC9A5;GABRB1;SLC8A3;SLC24A3;KCNN3;CHRNA7;SLC24A4;WNK1;ATP1A4;SLC9A1;PANX2;SLC25A10;KCNN2;SLC25A26
prerank,regulation of monocyte differentiation (GO:0045655),-0.4758222738437882,-1.3120817464051926,0.15404040404040403,0.5025521953662312,1.0,3/14,2.82%,CD74;CDK6;IRF7
prerank,positive regulation of cellular respiration (GO:1901857),-0.5067558558775185,-1.3118426710824305,0.13800424628450106,0.501937033750557,1.0,2/11,1.52%,IFNAR1;VCP
prerank,arachidonic acid secretion (GO:0050482),-0.5251359518119165,-1.3118115256365053,0.1543778801843318,0.49968128170789805,1.0,3/10,19.67%,ANXA1;DRD2;DRD3
prerank,arachidonate transport (GO:1903963),-0.5251359518119165,-1.3118115256365053,0.1543778801843318,0.49968128170789805,1.0,3/10,19.67%,ANXA1;DRD2;DRD3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.47217400762986006,1.3115237321067013,0.13095238095238096,0.7741825452203585,1.0,6/18,9.53%,DDX5;ZC3H10;IL6;NCOR2;BMP4;TGFB1
prerank,regulation of interferon-alpha production (GO:0032647),-0.4161578931252101,-1.3113155295827188,0.10554089709762533,0.4997271894517056,1.0,7/23,9.94%,IFIH1;IRF7;TBK1;TLR7;HSPD1;TLR8;STAT1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.399768231531783,-1.3110002847598983,0.11959287531806616,0.4993019495291627,1.0,4/26,3.68%,IQGAP1;STAT5B;EEF1A1;ZPR1
prerank,development of primary male sexual characteristics (GO:0046546),0.40948586878256654,1.3109829410996316,0.11642743221690591,0.7736401628242358,1.0,6/34,9.16%,WNT4;FGF9;SIX4;LRP2;AR;MEA1
prerank,regulation of microtubule depolymerization (GO:0031114),0.4408787260098595,1.3107639561851583,0.12258064516129032,0.7717969586959567,1.0,10/25,17.62%,STMN2;NAV3;MAP1S;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,cellular metal ion homeostasis (GO:0006875),0.34113345846386556,1.3104074870808402,0.054274084124830396,0.7706493307007699,1.0,28/102,20.12%,ATP2A3;KCNMA1;ATP13A4;ATP2A2;SLC24A5;ATP1B1;CLDN16;TNNI3;ATP13A5;SLC12A2;ATP1B3;CCR1;SLC8A1;RMDN3;ATP2C1;ATP2B3;SLC8A3;NEDD4L;DMPK;SLC24A3;ANK2;CHRNA7;SLC24A4;CCL15;CCL5;ATP1A4;ATP1A3;ATP1A1
prerank,chromosome condensation (GO:0030261),-0.3693110185808188,-1.309971655210025,0.11797752808988764,0.5006460673540762,1.0,20/36,27.01%,TOP2A;NCAPD2;NCAPH;NCAPG2;H1-0;NUSAP1;SMC2;CDK1;RB1;BANF1;INCENP;MCPH1;PLK1;TENT4A;ACIN1;NCAPH2;CCNB1;ERN2;AIFM1;CDCA5
prerank,regulation of neuron migration (GO:2001222),0.4252976251161869,1.3099132498938826,0.1289308176100629,0.7699454029158103,1.0,13/26,26.86%,SRGAP2;PLXNB2;CTNNA2;DAB2IP;IGSF10;ULK4;NTNG2;NTNG1;NSMF;CAMK2B;SEMA3A;RAPGEF2;PHACTR1
prerank,synaptic membrane adhesion (GO:0099560),0.506503379240162,1.308454486017096,0.1440972222222222,0.7735362665376497,1.0,9/14,32.22%,PTPRD;GPC4;PTPRS;NTNG1;LRRC4C;LRRC4B;SLITRK1;LRFN5;PTPRF
prerank,sensory perception of chemical stimulus (GO:0007606),-0.46754091756727933,-1.3080981139937364,0.16467780429594273,0.5042627452626129,1.0,4/15,13.83%,CD36;C5AR1;DRD2;ADCY3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.44593925165157133,1.3078682326426456,0.12111292962356793,0.7733461231318642,1.0,6/23,18.03%,CBARP;NOS1AP;PRNP;UBASH3B;CACNA2D1;ANK2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.4701619612968614,-1.3077543798642686,0.14285714285714285,0.503851744759059,1.0,7/14,16.95%,ADAM19;DYRK1A;PSEN1;ABCG1;APH1B;CLN3;ADAM17
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5586249912281567,1.3065954030882774,0.13756613756613756,0.7763020497290427,1.0,3/11,2.36%,BIN1;NOS1AP;CACNB2
prerank,lung epithelium development (GO:0060428),0.5574142145670191,1.306489799373651,0.13863216266173753,0.7740033222935825,1.0,4/10,21.15%,FGF10;BMP4;PKD1;GRHL2
prerank,skeletal muscle contraction (GO:0003009),0.4672061019536282,1.3058156708172781,0.14098360655737704,0.7742829286371832,1.0,2/19,4.02%,TNNI3;TNNC1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.4320589678584088,-1.3054794778743348,0.12755102040816327,0.508479916904559,1.0,10/20,16.22%,FBXW7;ERLIN2;WDTC1;BRCA1;BMP5;CEACAM1;APOC1;BMP2;SIK1;ACADL
prerank,muscle cell differentiation (GO:0042692),0.40616405697553554,1.3051945093046424,0.1143740340030912,0.7742441675671349,1.0,12/32,25.73%,NEBL;DUSP29;LBX2;DMD;MEF2C;SGCZ;RORA;NRAP;MRTFA;POPDC3;TMEM204;WNT5B
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.3454833055775449,-1.3045769621448655,0.09221902017291066,0.5095843723673706,1.0,14/42,18.43%,VCP;TRIM25;PCNA;POLI;UBC;PCLAF;UBA52;POLD4;RPA1;FAAP20;UBE2L6;RPA2;DTL;USP43
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5020195890739586,1.304470318657528,0.16243654822335024,0.7745621356489985,1.0,9/14,26.73%,SH3BP1;FSCN1;SCRIB;CAMSAP3;PATJ;CDC42;OPHN1;RHOA;MYO9A
prerank,cellular response to glucagon stimulus (GO:0071377),-0.4509661673706325,-1.3043713095424043,0.13559322033898305,0.508954908603283,1.0,7/17,15.19%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;PRKACB
prerank,regulation of nervous system process (GO:0031644),0.47273547735064203,1.3035776872036047,0.13846153846153847,0.7758151761140512,1.0,8/18,18.56%,CACNG5;NPTXR;NPTX1;DLGAP1;SLC8A3;DLGAP2;DLGAP3;CHRNA7
prerank,response to nutrient levels (GO:0031667),0.4760607084940716,1.3032381089692928,0.1464226289517471,0.7745706349284093,1.0,8/17,30.54%,RPTOR;RPS6KB1;ULK1;MEAK7;ATF4;PRKAA2;KCNB1;FAM107A
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4920274391238232,1.302860986423266,0.15736040609137056,0.77358700471656,1.0,5/15,9.53%,FSCN1;CST3;IL6;CLASP2;TGFB1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.40867214243354333,-1.3023874181051165,0.11658031088082901,0.5128034679057102,1.0,12/24,32.83%,RTEL1;ZRANB3;H1-0;DACH1;DFFA;TERF2;NIBAN2;KMT2A;BMPR2;RPS3;MSH6;MSH3
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5187409580502254,-1.3021292036725447,0.16584158415841585,0.5122492034529736,1.0,4/10,10.51%,STAT5B;PTPN1;LYN;GHR
prerank,positive regulation of cell projection organization (GO:0031346),0.3259610496099633,1.301875425217333,0.05858854860186418,0.7752227066581263,1.0,55/115,29.28%,MAP6;FBXW8;PLXNB2;OBSL1;PTPRD;ARSB;NTRK1;STMN2;PLA2G3;NTRK3;PTK7;PRKCI;GPC2;RIT2;DAB2IP;TWF2;ARHGDIA;CDKL5;TENM3;SS18L1;IL1RAPL1;ARHGAP35;NDRG4;NDNF;MAP3K13;STYXL1;NTRK2;SETX;ITGA6;PRKD1;TWF1;SCARB2;FES;PLXNB1;DVL2;MAGI2;ROR1;SCN1B;SERPINI1;CAMK2B;BDNF;TIAM1;RAPGEF2;RHOA;CAMK1;ROR2;DLG4;NGFR;CUX1;EPHA3;SLITRK1;ATP1B2;ROBO1;MDK;CUL7
prerank,negative regulation of cytokine production (GO:0001818),-0.27171112400685143,-1.3018463846576913,0.021645021645021644,0.5118441028925275,1.0,50/163,21.64%,FCGR2B;ITCH;PTPN22;GAS6;CD274;AXL;PTPRC;TRIM25;IFIH1;LILRA5;PIBF1;RARA;TBK1;PTGER4;TYROBP;NPTN;BCL3;RNF216;THBS1;HOMER3;ANXA1;TLR8;SRGN;ZC3H12A;ANXA4;ACOD1;C1QTNF3;SLC11A1;FOXJ1;NLRC5;CEACAM1;KAT5;SLAMF1;LILRB1;AGER;UBE2L6;TNF;TLR4;MMP8;TRAF3IP1;FN1;CD33;APPL2;NPLOC4;RGCC;KLF4;NLRC3;RNF125;TMSB4X;FFAR4
prerank,DNA alkylation (GO:0006305),-0.42682166942035515,-1.3017865399591824,0.1318407960199005,0.5096978892269174,1.0,6/19,13.99%,DNMT1;ATF7IP;MTRR;GATAD2A;EHMT1;FOS
prerank,DNA methylation or demethylation (GO:0044728),-0.42682166942035515,-1.3017865399591824,0.1318407960199005,0.5096978892269174,1.0,6/19,13.99%,DNMT1;ATF7IP;MTRR;GATAD2A;EHMT1;FOS
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.45354148216567175,-1.3001295553272298,0.1414141414141414,0.5127369025935257,1.0,8/17,23.28%,RBPJ;SNW1;STAT1;NOTCH1;EP300;NOTCH4;HEYL;KAT2B
prerank,lymphocyte differentiation (GO:0030098),-0.3207979825313328,-1.29981245189887,0.06309148264984227,0.5122919343991073,1.0,25/68,22.10%,ITGA4;PTPN22;AXL;PTPRC;CEBPG;KLF6;LYL1;TOX;DNAJB9;BLNK;LFNG;LCK;CD79B;NHEJ1;KAT7;RELB;IKZF1;ADAM17;ZAP70;GATA3;CD79A;PIK3CD;HDAC4;GPR89B;GPR89A
prerank,heterocycle biosynthetic process (GO:0018130),-0.4627612036263332,-1.299538399130737,0.14823529411764705,0.5118882282711881,1.0,4/14,7.97%,ALOX5;MOCS2;MOCS1;PYCR2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.41872901036306615,-1.2994566789555309,0.14182692307692307,0.5109737959910525,1.0,11/19,29.65%,IGF1;GIT1;ZC3H12A;FFAR1;PYDC1;CD33;FFAR4;MEFV;GSTP1;CPTP;TNFAIP3
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.4632862208592767,-1.2991716406276,0.15577889447236182,0.510535697001037,1.0,5/14,10.51%,PXN;STAT5B;PTPN1;LYN;GHR
prerank,positive regulation of histone modification (GO:0031058),0.4133079412113918,1.2986598886322238,0.1184,0.7864643765994718,1.0,14/33,22.00%,TET1;PPARGC1A;CTBP1;AKAP8L;UBE2N;SAP30BP;AKAP8;MAPK3;PAF1;ZBTB7B;CHTOP;ARRB1;BRD7;ING2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.39066194492057815,1.2984304249929663,0.104,0.7847896172477483,1.0,15/40,19.90%,ANG;P2RY12;TXK;NMUR1;AVPR1A;CD86;NTRK3;PLCG1;GNA15;FGF2;NTRK2;HRAS;ITK;PDGFRB;PLCB2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.31235528857476824,-1.2983977946867908,0.0627062706270627,0.5113901754626153,1.0,20/71,16.35%,VAV3;FCGR2B;ACTR3;CRK;PRKCE;NCK1;WIPF1;ARPC2;SYK;LYN;FYN;HCK;PIK3CA;ARPC5;GRB2;MYO10;WIPF3;ELMO2;FCER1G;PLD2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4925532291769561,-1.2982488047567844,0.13793103448275862,0.5106056877461885,1.0,5/12,12.16%,APOBEC1;SETDB2;PPHLN1;DNMT1;ATF7IP
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3354740497796817,-1.2973107037005964,0.08682634730538923,0.5117939216019298,1.0,13/48,13.46%,NEDD9;NRP1;CASS4;CRK;LIMS1;CRKL;CARMIL1;CIB1;CDKL3;CAPRIN1;S100A10;CUX2;MYOC
prerank,membrane depolarization during action potential (GO:0086010),0.41967218072298207,1.2970498090779963,0.12582781456953643,0.7879852232922118,1.0,14/26,34.35%,KCNH2;CACNA1G;SLC8A1;CACNA1D;SCN2A;SCN3B;SCN1B;SCN8A;SCN7A;CACNA1H;SCN1A;CACNA1I;SCN4B;KCNJ2
prerank,establishment of protein localization to membrane (GO:0090150),-0.3207179794148961,-1.2964841299515752,0.08722741433021806,0.5128785364857797,1.0,21/66,19.80%,RFTN1;VPS37C;SDCBP;ZDHHC14;ZDHHC3;AFDN;BRAF;ZDHHC4;RABGEF1;RAB10;ICMT;SEC63;REEP1;ATG3;NACAD;EGFR;RTP4;RAB3GAP2;AQP11;ZDHHC7;GRIN3B
prerank,regulation of viral entry into host cell (GO:0046596),-0.37460061105891995,-1.2963257902409784,0.1278409090909091,0.5121762751656607,1.0,7/30,6.59%,CD74;TRIM25;TRIM14;CIITA;LGALS1;IFITM3;TRIM62
prerank,regulation of nervous system development (GO:0051960),-0.3643568717941587,-1.2962345199599785,0.10803324099722991,0.5113256862053103,1.0,16/37,21.60%,HMGB2;DOCK7;ZPR1;YAP1;IL1B;CTNNB1;TNFRSF1B;PTN;HEY2;PER2;NPHP3;HES1;PTPRZ1;BHLHE40;SIRT2;HEYL
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.42716165269005535,1.2960548410774482,0.13398692810457516,0.7897745411780307,1.0,6/25,9.74%,MPP2;MEF2C;ARRB2;GRID2;GRIN1;GRIN2B
prerank,positive regulation of nervous system development (GO:0051962),0.3873746198815408,1.2958274817966924,0.1059001512859304,0.7881081930796558,1.0,17/42,23.96%,PTPRD;SRPX2;NUMB;IL1RAP;LRP2;NRXN1;GRID2;CLSTN2;CX3CR1;IL1RAPL1;EPHB2;WNT7A;OPRM1;GHRL;NAP1L1;BDNF;LRRC4B
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.4424051377261148,-1.2954839765801518,0.13075060532687652,0.5121198511158022,1.0,6/18,6.89%,ABL2;RIPOR2;CUL3;MET;CCDC125;STMN1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5215570719949163,1.2949457083262388,0.1695501730103806,0.7891615988204574,1.0,2/12,0.46%,IDH3B;IREB2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.42225298413687473,1.2946015436433012,0.13174603174603175,0.7854923494352956,1.0,9/29,15.84%,ACSF2;ACSL6;ACOT13;OXSM;DBI;ACOT4;ACBD6;ACOT11;ACLY
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.42225298413687473,1.2946015436433012,0.13174603174603175,0.7854923494352956,1.0,9/29,15.84%,ACSF2;ACSL6;ACOT13;OXSM;DBI;ACOT4;ACBD6;ACOT11;ACLY
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.40848014537564037,-1.2942649032632305,0.14133333333333334,0.5140307703315087,1.0,8/23,21.09%,GIT1;CBFA2T3;EP300;C1QTNF3;CRY1;SIK1;NCOR1;HDAC4
prerank,DNA damage checkpoint signaling (GO:0000077),-0.38334129435039493,-1.2941098016767036,0.1246684350132626,0.5132790236237982,1.0,8/28,10.59%,PRPF19;CLSPN;USP28;DOT1L;NBN;ATRIP;HINFP;RHNO1
prerank,cell projection organization (GO:0030030),0.41091027924304024,1.2939959089086157,0.13562091503267973,0.7854943631824619,1.0,10/30,21.44%,P2RY12;RHOV;NCKAP1;NCKAP1L;CYFIP1;RHOQ;RHOU;CDC42;CAPG;KIF17
prerank,purine nucleotide catabolic process (GO:0006195),-0.46800534960693735,-1.2939855036454704,0.16203703703703703,0.5124922807380965,1.0,3/13,5.60%,GDA;XDH;NT5E
prerank,B cell proliferation (GO:0042100),-0.4418394974826828,-1.2938269323667828,0.15789473684210525,0.511835213970978,1.0,3/17,5.94%,BCL2;PTPRC;HSPD1
prerank,response to organonitrogen compound (GO:0010243),0.39510584435055485,1.2935085434887574,0.12519561815336464,0.7848974568228279,1.0,10/38,12.03%,UBXN6;GLRA3;IL6;INAVA;TRPM2;GLRB;GLRA2;PRKN;CCDC47;DERL1
prerank,determination of left/right symmetry (GO:0007368),0.39739264619177544,1.2929422657432648,0.13063763608087092,0.7848362464403458,1.0,7/36,8.85%,DNAAF1;ODAD4;CCDC39;PKD1L1;MEGF8;DAND5;PKD2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.33005194811850647,-1.2928420795024747,0.09763313609467456,0.5131324829563998,1.0,20/55,25.12%,PID1;ALOX5;XDH;DHRS4;THBS1;RIPK1;PARL;BRCA1;ZC3H12A;ACOD1;GRB2;SPHK2;SLC25A33;BST1;SIRT2;NOXO1;CYP1B1;CCN6;RNF41;RAC1
prerank,transport along microtubule (GO:0010970),0.5129879737693005,1.2925358400632416,0.15870307167235495,0.7840375588602576,1.0,9/13,30.05%,COPG1;CAMSAP3;BORCS5;SPG11;COPG2;CDC42;APBA1;DYNC1I1;BAG3
prerank,proteoglycan metabolic process (GO:0006029),-0.3980833584863066,-1.2922573647127467,0.12628865979381443,0.5134183519718147,1.0,6/26,9.42%,CHST11;IGF1;XYLT1;CHST9;FAM20B;HPSE
prerank,regulation of GTPase activity (GO:0043087),0.3096071672083731,1.2921875410947332,0.040740740740740744,0.7830162002124901,1.0,57/177,20.04%,AGRN;SH3BP1;STMN3;SRGAP2;PLXNB2;ARHGAP44;CHN1;F11R;SGSM2;CHN2;NTRK1;SGSM3;THY1;PKP4;FGD2;TMED2;MAPRE2;DAB2IP;RAPGEF3;CDKL5;ADCYAP1;EPHA1;MAP4K4;ITGB1BP1;RGS10;OCRL;RASGRF1;RAP1GAP;DOCK10;SFRP1;RAP1GDS1;VAV1;DOCK9;PRKG1;ARFGEF1;RALBP1;EPHA4;FLCN;RSU1;RCC2;NTRK2;SH3BP4;RRP1B;ITGA6;HRAS;PTK2;ALS2;ARHGAP12;ZC3H15;ASAP3;PIN1;CCL15;WNK1;PLXNB1;CCL5;CAV2;EPHA5
prerank,positive regulation of axon extension (GO:0045773),0.4466246239962456,1.2910841444258736,0.14214046822742474,0.7850241248942951,1.0,6/22,8.76%,SEMA7A;MEGF8;DSCAM;LIMK1;TWF2;CDKL5
prerank,response to exogenous dsRNA (GO:0043330),-0.42963609635145894,-1.2905403596405856,0.12532637075718014,0.5166905866497978,1.0,7/18,17.24%,RFTN1;IFIH1;IFIT1;CAV1;RALB;MUL1;SLC3A2
prerank,protein deacetylation (GO:0006476),-0.35170755448665586,-1.2900718197513203,0.09340659340659341,0.5168249390286308,1.0,14/41,23.26%,SIN3B;RCOR1;TBL1X;BRMS1;BRMS1L;RCOR3;HDAC2;MIDEAS;HDAC1;MSL3;FLNA;SIRT2;HDAC4;TBL1XR1
prerank,regulation of cellular catabolic process (GO:0031329),-0.32302130809582347,-1.2897660873557975,0.07076923076923076,0.5164648526804598,1.0,20/62,15.58%,ABL2;TPCN2;PSAP;RRAGC;DRAM2;MTMR4;ITPR1;GPR137B;CISD2;DRAM1;SMCR8;DCAF12;EP300;WDR91;RRAGA;DAPK1;LRRK2;GPR137;HSPB1;MTMR3
prerank,acylglycerol biosynthetic process (GO:0046463),0.43565144269457234,1.2894343924594402,0.14603174603174604,0.7896098783164723,1.0,4/23,6.63%,ANG;DGAT2;AWAT2;PNPLA3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4175313521030114,-1.2887411767446797,0.14214463840399003,0.517935492795507,1.0,9/22,15.08%,APOE;ADAM9;NRDC;SNX9;IL1B;ADAM8;TNFRSF1B;TIMP4;TNF
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.535630239712663,1.288481199263196,0.17465753424657535,0.7910192711790461,1.0,6/12,19.06%,SYT1;DOC2B;UNC13B;RIMS1;RIMS3;UNC13C
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.424844899312596,-1.2883700321415574,0.14092140921409213,0.5178840919177812,1.0,6/20,6.26%,DAB2;PID1;BCL2L1;CSK;PPP2R5A;PICALM
prerank,response to ATP (GO:0033198),0.4673838614840805,1.2882441761926764,0.15754560530679934,0.7894900993639518,1.0,6/18,16.33%,P2RY12;TRPC3;DGKQ;HSP90B1;P2RY1;SSH1
prerank,negative regulation of phosphatase activity (GO:0010923),-0.39261081463822234,-1.2880882423451978,0.12401055408970976,0.5174374544134627,1.0,15/25,36.13%,PTPA;BOD1;CRY2;PPP1R35;CHP1;PPP1R15A;SEMA4D;SH2D4A;BOD1L1;MASTL;PPP1R26;FKBP1A;TGFB2;SH3RF2;PPP1R36
prerank,cholesterol efflux (GO:0033344),-0.42205657913127725,-1.2874369561752175,0.13953488372093023,0.5180872680823386,1.0,6/20,12.77%,APOE;NPC2;STX12;ABCG4;ABCG1;APOC1
prerank,positive regulation of signaling (GO:0023056),0.3986354644694731,1.2863648724306875,0.130298273155416,0.7949498393232388,1.0,10/37,13.68%,CD80;SCRIB;SYT1;LGI1;GRIK2;CLSTN2;INPP5F;RIMS1;KCTD13;VAMP3
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5226229619772005,1.2859997318357401,0.16455696202531644,0.7940604594980871,1.0,4/11,20.44%,GTF2H2;ARRB2;ADM;ARRB1
prerank,negative regulation of cell projection organization (GO:0031345),0.3690598718930643,1.2858911808176543,0.1058282208588957,0.7920020272441511,1.0,13/48,13.98%,DCC;STMN2;PTPRO;CRMP1;PRNP;ITM2C;RTN4RL1;PRAG1;MINAR1;GRIN2B;MAG;MYLIP;EPHA4
prerank,cellular response to mechanical stimulus (GO:0071260),-0.33997217044975414,-1.2855875868778281,0.093841642228739,0.521740850649774,1.0,19/46,24.48%,MAP3K1;PTGER4;NFKB1;TLR7;FAS;TLR8;IL1B;PIEZO2;PDE2A;TLR4;MAP2K4;MAPK8;TMEM150C;MYD88;CASP1;MAP3K2;TLR5;TNFRSF8;FADD
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.44318454693682924,1.2855301523252824,0.1474036850921273,0.7910065628671188,1.0,4/22,6.81%,IL2RA;IL4I1;VSIR;IL2
prerank,peptidyl-asparagine modification (GO:0018196),-0.3763162996884363,-1.2843340851846021,0.1220159151193634,0.5237699089854541,1.0,8/31,11.97%,RPN2;MAGT1;UGGT1;MGAT2;MCFD2;ST6GAL1;FUT8;RPN1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5016733492880686,1.284301088292948,0.1829059829059829,0.793645033218327,1.0,7/13,20.22%,RELA;NFIB;PPARA;BMP4;PDGFB;REST;SRF
prerank,activation of protein kinase A activity (GO:0034199),-0.4526621297470763,-1.2841487410503016,0.1414141414141414,0.523057027355219,1.0,7/16,15.19%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;PRKACB
prerank,negative regulation of bone mineralization (GO:0030502),-0.47992977495030376,-1.283455634259227,0.1658878504672897,0.5237695104527779,1.0,6/13,19.78%,BCOR;SRGN;TRPM4;GREM1;PTK2B;RFLNA
prerank,negative regulation of protein transport (GO:0051224),-0.39411600307403666,-1.2830689442981213,0.10655737704918032,0.5236581565717149,1.0,13/25,30.22%,APOE;CSK;DRD2;RSC1A1;PKDCC;PPM1F;DPH3;DRD3;SERGEF;NDFIP1;SNX3;RHBDF2;NDFIP2
prerank,cellular response to ketone (GO:1901655),-0.3661251081969089,-1.2829788174854369,0.11235955056179775,0.5227821864087053,1.0,12/35,13.94%,NR3C1;PTGER4;AHR;MSN;ADCY5;ADCY6;ACOD1;KLF9;ADCY1;LARP1;ADCY3;SPHK2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4402879142072772,-1.2826806409344462,0.14420803782505912,0.5224236001562514,1.0,3/17,5.79%,PLBD1;PLA2G4E;PLAAT3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.347635152755669,1.2825394759584745,0.1001410437235543,0.7984435067269472,1.0,12/69,10.96%,PLCH1;TPTE;PIK3C2G;PLCL1;NYAP2;NTRK1;PLCD1;PIK3CG;RPS6KB1;OGT;INPP5F;IRS1
prerank,striated muscle contraction (GO:0006941),0.3599224519098501,1.2821991433506115,0.10740203193033382,0.7973871468080326,1.0,9/53,12.97%,KCNH2;ATP1B1;TNNI3;TNNC1;DMD;MYBPC3;PGAM2;SLC8A1;LMOD3
prerank,regulation of cell division (GO:0051302),-0.3046516980477645,-1.281317521477757,0.05351170568561873,0.5246325748406541,1.0,25/72,22.21%,PIK3C3;BCL2L1;PIK3R4;GIT1;BIRC6;SH3GLB1;PRC1;MLLT3;TXNIP;CIB1;UVRAG;FGF1;KLHL21;CALM3;AHCTF1;CALM2;RACK1;PRPF40A;KIF20A;KIF18B;PLK1;ESRRB;SIRT2;SETD2;SHH
prerank,signal release from synapse (GO:0099643),0.384905449367104,1.28100631322226,0.1044776119402985,0.7998186844662353,1.0,10/43,14.27%,SNAP25;RAB3A;SYT1;SNAPIN;NRXN1;OTOF;RIMS1;CPLX2;GAD2;STXBP2
prerank,lipid droplet formation (GO:0140042),0.5485184388163429,1.2807309388179786,0.1848013816925734,0.7984590876178059,1.0,3/10,27.59%,PLA2G4C;FITM2;CDS2
prerank,cation transport (GO:0006812),0.30529470894173577,1.2796801292789426,0.045931758530183726,0.8002752719596109,1.0,33/167,16.27%,KCNMA1;TMEM63C;KCNJ3;KCNA5;ATP1B1;SLC5A12;KCNJ8;LRP2;TRPM3;KCNC1;SLC12A2;TRPM2;SLC1A1;KCNK3;CNGB1;KCNJ13;SLC38A7;GRIN1;SLC8A1;ASIC1;KCNK6;FGF13;SLC66A1;TRPC6;PANX1;KCNN4;SCN2A;ABCC8;SLC22A4;SLC8A3;NEDD4L;KCNJ5;KCNMB3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4469063732696101,-1.2796731329733966,0.16923076923076924,0.5276661332496828,1.0,10/16,29.76%,APOE;HIF1A;S100A1;TNF;TERF2;NUS1;DHFR;TERT;GCH1;AGTR2
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5262295021361846,-1.2794980288392304,0.15296803652968036,0.5269780901233132,1.0,5/10,20.03%,THBS1;IL1B;INPP5K;RSC1A1;IRS2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3052806775001365,-1.2793570008352844,0.0756578947368421,0.5262253498322488,1.0,20/73,16.35%,VAV3;FCGR2B;ACTR3;CRK;PRKCE;NCK1;WIPF1;ARPC2;SYK;LYN;FYN;HCK;PIK3CA;ARPC5;GRB2;MYO10;WIPF3;ELMO2;FCER1G;PLD2
prerank,response to glucocorticoid (GO:0051384),-0.38781559967442025,-1.2789659591681637,0.12886597938144329,0.5261245694419631,1.0,12/26,28.20%,NR3C1;ADAM9;GOT1;ANXA1;UBE2L3;TNF;BCL2L11;HNRNPU;ISL1;SLIT3;SLIT2;HSD3B2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3803160609801449,-1.2789517754475,0.12176165803108809,0.5250711716948058,1.0,12/30,24.57%,GNL3L;EXOSC10;DACH1;TERF2;TENT4B;NIBAN2;NAT10;HNRNPU;HNRNPC;TINF2;PIF1;BMPR2
prerank,mitochondrial protein processing (GO:0034982),-0.5122153982686855,-1.278494376244432,0.18666666666666668,0.5251997647945997,1.0,3/11,15.78%,YME1L1;STOML2;IMMP2L
prerank,positive regulation of cytokine production (GO:0001819),-0.24893040804109084,-1.278404371678993,0.006535947712418301,0.5243284697515279,1.0,88/292,19.79%,IL15;RFTN1;PAEP;CD74;PTPN22;CD274;CCDC88B;PTPRC;CCBE1;IFIH1;TLR2;LILRA5;PIBF1;IRF7;IL12RB2;RAB1A;RARA;ZBP1;CCR2;TBK1;POLR2E;RAB7B;IL16;IL6ST;LAMTOR5;PTGER4;TYROBP;DHX33;NFKB1;TLR7;CEBPG;CD14;IL27;IRF4;NOD2;HSPD1;RIPK1;CEBPB;SYK;DDX41;ANXA1;TLR8;PRKCQ;HIF1A;CLEC6A;IL1B;CD226;BRCA1;DRD2;LPL;HPSE;TMED10;CD28;LTB;CTNNB1;EP300;C1QTNF3;CYBA;SLC11A1;CD2;STOML2;LRRFIP1;FOXP1;CXCL17;SPHK2;POLR2H;LBP;EBI3;LILRB1;AGER;TNF;SCIMP;WNT5A;FCER1G;HMOX1;TLR4;IL18R1;ADAM17;GATA3;ARHGEF2;AGPAT2;MMP8;POLR3G;TLR1;AFAP1L2;MYD88;RGCC;HSPA1B
prerank,actin nucleation (GO:0045010),-0.41236430630265947,-1.2777338207047175,0.15326633165829145,0.5250096429390808,1.0,4/21,9.39%,IQGAP2;ACTR3;ARPC2;ARPC5
prerank,regulation of apoptotic process (GO:0042981),-0.2311603102329025,-1.2775904579321118,0.0,0.5243396929763315,1.0,146/676,16.35%,VAV3;DAB2;ARHGEF3;FGD4;ITSN1;ARHGAP10;BCL2;STK3;ITCH;CD74;SLK;ARL6IP5;DDX42;CD38;HIP1;GAS6;IGF1;AXL;BCL2L1;KLHL20;STK17B;RAF1;VCP;CD44;TNFAIP8;ATAD3A;YME1L1;STEAP3;IFIT2;ACTN1;BRAF;MCL1;BIRC6;NUAK2;LGALS1;ZBP1;SIAH2;BAX;TOP2A;IL6ST;PTPA;NLRC4;BCL3;PIM1;ARHGEF18;CIAPIN1;NFKB1;RASA1;ATG7;ARHGEF6;SLC27A4;HIP1R;BAG4;VHL;THBS1;FAS;HSPD1;RIPK1;TFRC;PRDM9;PDCD10;PLAUR;IFIT3;ANXA1;UBC;TMEM219;HNRNPK;CIB1;CTSB;ANP32B;PLEKHG5;HCK;NAA16;RPL10;PSEN1;FGD1;TPT1;IKZF3;PIDD1;PNMA2;UBA52;ABR;HYPK;GCLC;RNF157;GNA13;UTP11;SH3RF1;STAT1;ANXA4;CD28;MAP3K11;BIRC5;SPRY2;EGR3;DNM2;PRMT2;FOXO1;ATF5;CTNNB1;BARD1;MIEN1;CDK1;STPG1;BRMS1;MAD2L1;BIRC2;HDAC2;GRM4;ARHGEF26;GADD45G;FHL2;DAPK1;CBL;HDAC1;KDR;CCND2;RPS6KA2;APH1B;SMAD6;PSMD10;RYBP;RACK1;PTMA;SCX;GREM1;BMP2;SPHK2;PMAIP1;NPM1;EGFR;DFFA;LILRB1;SHC1;PTK2B;TNF;HS1BP3;HSPB1;WNT5A;NUP62;CLN3;DDX20;ARHGEF5;BCL2L11;KLF11;BCAR1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.39811832341398173,-1.2772027320727726,0.14173228346456693,0.5242162615076874,1.0,10/25,18.08%,IGF1;SOX11;DOT1L;H1-0;MAD2L2;RB1;HEY2;GATA3;PER2;NIBAN2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.5323276324792443,1.276814777477189,0.18388791593695272,0.8099452928715631,1.0,6/11,26.85%,TIMM29;TIMM13;TIMM22;TOMM70;TIMM10;TIMM10B
prerank,axon extension (GO:0048675),-0.40584382682651776,-1.2767786082497805,0.12594458438287154,0.5241653205000147,1.0,6/23,12.23%,ALCAM;NRP1;NRP2;SLIT1;USP9X;SEMA5B
prerank,mRNA processing (GO:0006397),0.28906336928646226,1.2765669768403842,0.03169014084507042,0.8084684742258977,1.0,94/287,24.00%,POLR2L;SRSF12;RNPS1;CDK7;DHX35;SMU1;CWC15;PQBP1;SRSF5;FUS;DHX15;POLR2F;BCAS2;DDX5;TRA2B;HNRNPH1;CWC22;CASC3;XAB2;PPARGC1A;PPWD1;CTNNBL1;SF3B2;GTF2H2;CPSF6;CWF19L2;PPIL1;ISY1;PRPF40B;SRRM2;SRSF6;SF3B6;SRSF11;PTBP1;RBM5;GTF2H4;GTF2F1;CACTIN;AKAP8L;DDX46;PRMT9;SNRNP70;SON;SF3B5;SF3A1;SRSF1;SNRPD2;CPSF3;YTHDC1;GPKOW;POLR2G;LSM8;RAMAC;TBRG4;SF3B3;CRNKL1;IK;CSTF1;NUDT21;NOVA1;CDC40;THOC5;DDX39B;SARNP;HNRNPA1;ELAVL2;GEMIN5;GEMIN6;SRSF9;PUF60;TRA2A;CHTOP;UBL5;GCFC2;SNRPD3;SNRNP27;ALYREF;SRSF2;SRRM4;RBM10;USP49;SART1;POLR2C;GTF2H3;LSM4;LSM3;ALKBH5;PRPF38A;SNRPB2;RBM15B;POLR2D;SNU13;WBP4;ERCC2
prerank,regulation of biosynthetic process (GO:0009889),-0.4974216414140936,-1.2758814306161637,0.1793103448275862,0.5253386308642873,1.0,6/11,24.12%,ALOX5;SPHK2;MID1IP1;SLC25A33;GSTP1;CCN6
prerank,regulation of mitochondrial fusion (GO:0010635),-0.502016676029522,-1.2747551674395792,0.1662870159453303,0.5270366045138393,1.0,2/11,6.15%,PID1;TFRC
prerank,negative regulation of type I interferon production (GO:0032480),-0.3423896384546293,-1.274327430809032,0.11488250652741515,0.5270435457130654,1.0,15/40,20.78%,ITCH;TRIM25;IFIH1;TBK1;RNF216;YY1;ACOD1;NLRC5;LILRB1;UBE2L6;RELB;TRAF3IP1;NPLOC4;NLRC3;RNF125
prerank,mucosal immune response (GO:0002385),-0.4535873049219432,-1.2740622882811738,0.15892420537897312,0.5267099177479532,1.0,5/15,20.11%,RNASE3;RPL39;IFNLR1;CAMP;LTF
prerank,apoptotic nuclear changes (GO:0030262),-0.3862183933647224,-1.2740146380713844,0.12814070351758794,0.5257691910945573,1.0,7/24,14.66%,KPNB1;DNASE2;HMGB2;TOP2A;H1-0;ENDOG;DFFA
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5249707446735499,-1.2739816542230284,0.19444444444444445,0.5247857588670315,1.0,5/10,13.93%,BCL2;KDR;RACK1;MYOC;LRRK2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.43100050481135477,1.2735568805224853,0.13682432432432431,0.8192308727419044,1.0,4/25,5.92%,CAPN3;CACNB2;THY1;PLCG1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.30714840160945434,-1.273543994447241,0.09395973154362416,0.5249172808177976,1.0,16/70,12.10%,VAV3;FCGR2B;ACTR3;CRK;PRKCE;NCK1;WIPF1;ARPC2;SYK;LYN;FYN;HCK;PIK3CA;ARPC5;GRB2;MYO10
prerank,thyroid hormone generation (GO:0006590),-0.5031156319455049,-1.273274752452468,0.18018018018018017,0.5245333931580559,1.0,7/10,37.05%,CPQ;FOXE1;TG;SLC5A5;TPO;DUOX1;DIO2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.39998437537973675,1.2727852542901745,0.14913657770800628,0.8200506860639682,1.0,5/31,7.48%,HOXD4;COL2A1;MEGF8;HOXB9;TGFBR1
prerank,central nervous system development (GO:0007417),0.29153387860147195,1.2725433826008066,0.043583535108958835,0.8186100481666477,1.0,53/250,15.46%,TPPP;ZFHX3;ROGDI;PLXNB2;C3;DNAJC30;ECRG4;BPTF;NNAT;ACAN;NFIB;SOX10;CYP26C1;ABCB6;NCKAP1;SOX4;PBX2;UBE3A;MAP1S;SEMA6B;NPTX1;ADAM22;ADGRL3;PKD2;SH3GL2;COX7B;GRIN1;CX3CR1;GRIN2B;PRKN;ASIC2;DDIT4;CTNS;PBX3;CXCR4;HAPLN2;SH3GL3;PKD1;VCAN;PHF8;NRCAM;NDRG4;TBX6;MYRF;ALDH5A1;HAPLN1;APOD;NKX2-2;HAP1;SLC8A3;DSCAML1;TUBGCP2;IER3IP1
prerank,male gonad development (GO:0008584),0.39730434402267745,1.2724693086983616,0.13765822784810128,0.8164465784576663,1.0,6/34,9.16%,WNT4;FGF9;SIX4;LRP2;AR;MEA1
prerank,mitochondrion transport along microtubule (GO:0047497),0.4965020575046235,1.2724684439231058,0.16815742397137745,0.8139497999302728,1.0,8/13,25.59%,MAP1S;RHOT1;LRPPRC;SYBU;UXT;SPAST;NEFL;MAPT
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.24899609507099754,-1.2724141051394606,0.009009009009009009,0.5256382172592042,1.0,85/336,18.55%,VAV3;BCL2;VCPIP1;FNIP2;RAD51B;PARP4;BCL2L1;RBBP8;VCP;SETD7;ETAA1;BAZ1B;PDS5B;CUL4A;IRF7;UBA6;DTX3L;MCL1;BAX;TOP2A;MAPKAPK2;TOPBP1;USP28;DOT1L;BCL3;ZBTB40;RTEL1;TAF1;ZRANB3;YY1;CHD1L;CCND1;POLI;YAP1;LYN;IGHMBP2;NBN;CIB1;USP45;PSEN1;UVRAG;TAOK3;ATRIP;HINFP;PCLAF;PDS5A;BRCA1;PIDD1;ZC3H12A;TRRAP;ALKBH8;FOXO1;BARD1;RPA1;TRIP12;CDK1;GRB2;CRY1;TNFRSF1B;AKTIP;BRAT1;RMI2;ALKBH7;TICRR;FOXP1;NPM1;FAAP20;MCM9;MNAT1;WAC;MCM8;CRIP1;EPHA2;BCL2L11;NOP53;MUTYH;NUPR2;DTL;PPP1R15A;SLX4;HPF1;XPC;WDHD1;RBBP5;MAPK12
prerank,negative regulation of histone methylation (GO:0031061),-0.4943096958628844,-1.2719020340467377,0.20562770562770563,0.5259191923864484,1.0,5/10,23.79%,BCOR;DNMT1;BRCA1;AASS;MTF2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.41139987619185114,1.2718141960616094,0.14285714285714285,0.814130650855537,1.0,12/32,19.49%,FBXW8;OBSL1;PTPRD;CDKL5;HECW2;SS18L1;NEDD4;IL1RAPL1;NEDD4L;SARM1;NSMF;SDC2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.24067643081294207,-1.2716123962308636,0.017094017094017096,0.5256033018179197,1.0,128/417,22.39%,RBPJ;MDFIC;NR3C1;WWP1;CD38;GAS6;POU2F1;MECP2;EPC1;SETDB2;SP3;LIMD1;ZHX2;HMGB2;KAT6B;CIITA;CBFA2T3;PPARG;RARA;SMARCA4;SMURF2;ENO1;PATZ1;BCL3;AHR;PROX1;LIMS1;NAB1;PPARD;MBD2;CIART;ATXN1;RCOR1;DPF3;BCL7A;BCOR;PFDN5;NR1H2;KDM8;ID4;FOXE1;CRY2;HINFP;BRCA1;SNW1;ID3;GCLC;MBD1;L3MBTL4;CTCF;BIRC5;ZBTB18;PRMT2;FOXO1;NOTCH1;ATF5;CTNNB1;L3MBTL3;BRMS1;RCOR3;ID1;SPEN;HDAC2;ZNF148;CRY1;ATF7IP;DEPDC1;MIDEAS;KAT5;HDAC1;GATAD2A;INPP5K;FOXP1;RB1;FOXP2;BMP2;L3MBTL2;CREB3L1;EHMT1;QARS1;DACH1;RIOX1;SHC1;LHX1;TNF;KDM5C;WNT5A;ZNF318;KAT7;FOXK2;DEAF1;THAP7;SAP18;IKZF1;HEY2;UIMC1;ARID5B;GATA3;HMGA2;SMAD4;GLIS2;PER2;NIBAN2;LANCL2;HES1;TFAP2B;PPM1F;EED;CDKN2A;TAF7;PA2G4;BMP7;BHLHE40;HMGA1;YEATS2;KLF4;SIRT2;NCOR1;BASP1;TRIM33;HDAC4;SCMH1;ID2;HEYL;RBAK;MECOM;TWIST1;PSPC1
prerank,neuron projection organization (GO:0106027),0.4747036033206939,1.271592758624018,0.15181518151815182,0.8125641439775902,1.0,8/15,21.90%,PRNP;LGMN;DCTN1;INSR;ABCD2;CHRNA7;ATP1A3;ARF1
prerank,cellular response to glucose starvation (GO:0042149),-0.34035978449223886,-1.271215798348189,0.1132596685082873,0.5255940560257962,1.0,13/41,16.48%,PIK3C3;PIK3R4;NUAK2;SH3GLB1;PRKAG2;CPEB4;ZC3H12A;SZT2;SIK2;SIK1;PMAIP1;MTMR3;SESN2
prerank,inorganic ion transmembrane transport (GO:0098660),0.5129726106962326,1.2710433637551868,0.18666666666666668,0.8123326671162666,1.0,4/12,14.48%,KCNJ8;PKD2;ASIC2;ABCC8
prerank,photoreceptor cell development (GO:0042461),-0.46410816363981955,-1.2706851093313085,0.17026378896882494,0.5258545630303589,1.0,10/14,44.72%,MFSD2A;RP1;DCX;TH;CDHR1;AHI1;CEP290;MYO7A;TOPORS;VEGFA
prerank,negative regulation of developmental growth (GO:0048640),0.409850429205174,1.2703294799774643,0.14018691588785046,0.8128974230065367,1.0,14/30,30.57%,DIP2B;DCC;FGF13;MAG;WWC1;PTPRS;ULK2;MAP2;ULK1;NKD1;DUSP10;PTEN;RTN4R;FGFR3
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5064460955788588,1.270197815076045,0.15619694397283532,0.8109501789747772,1.0,3/13,7.55%,DDX5;HIC1;EEF1E1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4600398288451321,1.2700854656636265,0.16859504132231404,0.809076502296219,1.0,8/18,18.56%,PRKCZ;NRXN1;SHANK3;GRIN1;RIMS1;WNT7A;SHANK1;CHRNA7
prerank,regulation of protein polymerization (GO:0032271),0.397343729260422,1.269955328607176,0.134375,0.8072306532628879,1.0,11/35,22.97%,TPPP;CTTN;FCHSD2;CAMSAP3;CAMSAP1;PLEKHG2;MAP2;GBA2;LATS1;MAPRE3;TPPP3
prerank,respiratory system development (GO:0060541),0.3996760869559192,1.2698889110803735,0.14084507042253522,0.805095406663491,1.0,8/32,12.99%,DNAAF1;FGF9;CCDC39;DISP1;FGF7;BMP4;FGF2;SPEF2
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.525177477194962,1.2698234134925142,0.1865671641791045,0.8030106051043882,1.0,3/11,8.34%,SOX4;ZFPM2;BMP4
prerank,determination of bilateral symmetry (GO:0009855),-0.3850888255925037,-1.269690777589975,0.14393939393939395,0.5274114881341453,1.0,14/24,35.76%,BBS7;DNAH5;ODAD2;NOTCH1;FOXJ1;ODAD3;NPHP3;GALNT11;KIF3B;DLL1;TBX1;DNAAF4;LEFTY1;PITX2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.44256130688750656,1.2692920053648458,0.18076285240464346,0.802962778208235,1.0,5/20,9.57%,GATM;FPGS;GSS;PTDSS2;GGCT
prerank,regulation of neurotransmitter transport (GO:0051588),-0.44394422492652386,-1.269270571134849,0.1741424802110818,0.5274470733138771,1.0,2/16,1.00%,MCTP1;MCTP2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3845541042121249,-1.2691054277071006,0.14705882352941177,0.5268283125384254,1.0,7/26,9.36%,ITCH;ALPK1;IFIH1;NOD2;UBC;TAB1;UBA52
prerank,innate immune response in mucosa (GO:0002227),-0.5046685264708075,-1.2681806329516778,0.18807339449541285,0.5280690540266512,1.0,4/10,20.11%,RNASE3;RPL39;CAMP;LTF
prerank,positive regulation of DNA binding (GO:0043388),-0.36091815256034826,-1.2677084827181502,0.15508021390374332,0.5282500183784307,1.0,15/31,23.66%,IGF1;HMGB2;PPARG;CEBPG;PLAUR;TXN;H1-0;RB1;GATA3;NIBAN2;MMP8;HES1;SIRT2;TWIST1;EGF
prerank,negative regulation of immune response (GO:0050777),-0.2693030446037811,-1.267082903776954,0.03167420814479638,0.5288007576434782,1.0,61/154,29.65%,FCGR2B;ITCH;CD163;CD300A;CCR2;PRKACA;ADCY9;PTGER4;SYK;LYN;FYN;ENPP3;PDCD1;HCK;VIPR1;ADCY5;ADCY6;RC3H1;ACOD1;ADCY1;ADCY3;NPSR1;LILRB1;PRKACB;RAMP2;GPR27;CALCRL;MYH9;MUL1;ADAM17;PTHLH;CD247;TRAF3IP1;COL3A1;NLRC3;SIRT2;TRIM21;VIPR2;RXFP2;PTH1R;CALCA;CRH;GLP1R;RAMP3;DHX58;FCRLB;SCTR;ADORA2A;VIP;ALOX15;RNF26;SPINK5;GPR83;PTGDR;CREB1;PTGIR;FGR;RHBDF2;C1QBP;GPR15;TNFAIP3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.36895555876405073,1.2666926085522425,0.13949843260188088,0.8116789644872976,1.0,11/46,10.44%,DGKI;CACNG5;CACNG2;SYT1;NRXN1;MEF2C;ATAD1;GRM3;TPRG1L;SHANK3;CACNG7
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4402039427042757,-1.266537460639689,0.16901408450704225,0.5292349511054981,1.0,5/15,23.66%,RBPJ;CEACAM1;EGFR;WDR54;EGF
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3003912831270955,-1.265940143521852,0.07317073170731707,0.5297338185486592,1.0,26/76,21.52%,SASH1;PTPN22;TLR2;BCL3;TLR7;LIMS1;CD14;NOD2;UACA;IL1B;ZC3H12A;EP300;TRIM44;C1QTNF3;CCN3;EGFR;AGER;TNF;TLR4;NR3C2;MMP8;BMP7;PTP4A3;NLRC3;TMSB4X;APP
prerank,apical protein localization (GO:0045176),0.5463231575779348,1.2658684046240523,0.17537313432835822,0.8130364490584426,1.0,6/10,21.99%,VANGL2;INSC;JAM3;ATP8B1;ACTB;MAL
prerank,inorganic anion transport (GO:0015698),-0.3240537032554983,-1.2656801441564203,0.0972644376899696,0.5294066652525635,1.0,21/53,28.48%,SLC26A11;CLIC4;CLCN1;ENPP3;RACGAP1;FXYD1;SLC13A4;SLC11A1;SLC25A11;ANO5;ANO8;ANO1;PACC1;CLIC5;SLC26A6;GLRA1;ANO10;CLIC1;ANO4;SLC4A1;SLC5A5
prerank,acyl-CoA metabolic process (GO:0006637),0.39644401344806607,1.2656364738663604,0.16118935837245696,0.8116357154113032,1.0,9/35,16.39%,ACSF2;ACSL6;ACOT13;OXSM;DBI;ACOT4;ACBD6;ACOT11;ACACB
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.485824448936428,1.265436055619846,0.17636986301369864,0.8100526397863099,1.0,4/16,13.64%,DDX5;AR;TADA3;RBFOX2
prerank,protein deneddylation (GO:0000338),0.5380408044428856,1.2647893241350305,0.18983050847457628,0.8104135804449228,1.0,4/10,20.35%,COPS8;COPS3;COPS6;COPS5
prerank,mitochondrion localization (GO:0051646),-0.4188557872091724,-1.2645983036410284,0.1830601092896175,0.5312625693035847,1.0,6/19,16.17%,TRAK1;MARK2;MTM1;BRAT1;LRRK2;MUL1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5127020395627919,1.264516586642477,0.18604651162790697,0.8091829158092592,1.0,9/12,32.56%,ATP1B1;DMD;ATP1B3;WNK1;GLRX;ANK3;ATP1B2;WNK4;WNK3
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.36928697725185544,-1.2644560763143617,0.12658227848101267,0.5305641932927588,1.0,8/30,10.17%,CD274;LILRA5;PIBF1;IRF4;NOD2;HSPD1;SYK;CD28
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.23584197680606883,-1.263272324014558,0.0,0.5324396197748947,1.0,151/476,22.32%,MDFIC;SP100;MED13;CD74;CREB5;APOE;CD38;IGF1;EPC1;MITF;SP3;ARID1B;CDK5RAP2;HMGB2;KAT6B;RUNX3;DVL3;CIITA;PPARG;IRF7;DTX3L;RARA;SMARCA4;MED16;SOX11;BCL3;AHR;ESR1;NFKB1;KLF6;SETD3;LYL1;IRF4;VHL;PPARD;DYRK1A;MLLT3;NCOA1;JMJD6;CEBPB;HNRNPAB;SMAD3;PICALM;EGR2;SP1;ZMIZ1;ILF2;NR1H2;KDM8;YAP1;PCBD2;TBL1X;SMARCA1;HIF1A;FOXE1;IL1B;NAA16;RNF14;PSEN1;HINFP;RNF6;BRCA1;RET;MAD2L2;PBX4;STAT1;CTCF;DNM2;PRMT2;FOXO1;NOTCH1;ATF5;CTNNB1;EP300;TRIM44;HDAC2;SKAP1;NFE2;FZD2;ATF7IP;RXRB;KAT5;HDAC1;NR1H3;RYBP;INPP5K;SCX;BMP2;FOS;PARP9;TESC;NPM1;BICRAL;EGFR;NOTCH4;SHC1;LHX1;TNF;TRIM45;WAC;ING1;WNT5A;ZNF318;PHF5A;NUP62;FOXK2;DEAF1;EDRF1;TNNI2;KLF2;MAP2K7;HEY2;HIPK2;NAT14;GATA3;HMGA2;SMAD4;GLIS2;NIBAN2;HNRNPD;RNF20;XPC;TRIM16;HAS3;CDH1;HES1;LRP6;TFAP2B;AFAP1L2;NFATC2;BMP7;EHF;ESRRB;BAMBI;ELF2;HMGA1;KLF4;KMT2B;EPO;ACVR1;POU3F1;HDAC4;MAP3K2;ID2;HMGN5;FZD4;MECOM;NR1H4;SHH;CAND2;RREB1
prerank,negative regulation of hemostasis (GO:1900047),0.5147987066206977,1.2628303841547448,0.17567567567567569,0.8138589378703723,1.0,5/12,15.75%,ADTRP;CD34;THBD;VTN;SERPINE2
prerank,arachidonic acid metabolic process (GO:0019369),0.3934571632541268,1.2621215566781607,0.15203761755485892,0.8145984817857208,1.0,6/35,5.38%,CYP2S1;CYP2U1;PTGS1;PTGDS;ALOX12;PLA2G4C
prerank,brain development (GO:0007420),0.30850983381827113,1.2618976216476814,0.08843537414965986,0.813208362615664,1.0,30/136,15.46%,ZFHX3;ROGDI;PLXNB2;DNAJC30;BPTF;NNAT;CTNNA2;NFIB;ABCB6;PBX2;UBE3A;MAP1S;SHANK3;ADGRL3;GRIN1;CX3CR1;GRIN2B;DDIT4;CTNS;PBX3;CXCR4;PHF8;SPEF2;NDRG4;APOD;NKX2-2;HAP1;DSCAML1;TUBGCP2;IER3IP1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4517934020868469,1.2613972431182354,0.17667238421955403,0.8129452631826456,1.0,7/18,17.04%,IL4I1;NCKAP1L;XRCC6;ZFP36L2;CRTAM;PRDM1;PRELID1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3048935262110213,-1.261158096416083,0.09748427672955975,0.5367371659334103,1.0,19/73,16.01%,FNIP2;GAS6;RAF1;CD44;CNOT9;DOCK7;BRAF;TBK1;TFRC;BCAR3;PDCD10;CAV1;TXN;MAD2L2;SPRY2;MTCP1;EGFR;TNF;PFN2
prerank,apoptotic cell clearance (GO:0043277),-0.3631184623066483,-1.261077633209086,0.12742382271468145,0.535898422953874,1.0,13/30,27.75%,GAS6;RARA;TYROBP;THBS1;ANXA1;NR1H3;LRP1;ITGB3;ADGRB1;XKR7;RAC1;ALOX15;XKR9
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.3856651248820518,-1.2602580947109978,0.14974619289340102,0.537045544696609,1.0,6/24,11.44%,ITGA4;MSN;NT5E;SYK;ITGAL;OLR1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.44399112046711586,1.2599908859657183,0.17166666666666666,0.8165730078736508,1.0,9/21,17.62%,STMN2;NAV3;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,DNA geometric change (GO:0032392),-0.38108684244656166,-1.2593031259186196,0.14871794871794872,0.5384052088354677,1.0,8/24,14.86%,ASCC3;HMGB2;RTEL1;ZRANB3;ANXA1;NBN;HNRNPA2B1;MCM9
prerank,positive regulation of lipid storage (GO:0010884),-0.4074051936363753,-1.2592022315074696,0.15789473684210525,0.5376411485333896,1.0,5/21,9.35%,PLIN2;MSR1;NFKB1;LPL;ZC3H12A
prerank,regulation of microtubule-based process (GO:0032886),0.38555052431543685,1.2587403011798908,0.1540983606557377,0.8195532771054959,1.0,17/36,27.20%,TPPP;MAP6;CLASP2;CAMSAP3;BICD2;PHLDB2;KLHL42;TAOK1;ROCK1;BICD1;CYLD;CDK2AP2;MEMO1;AURKA;MAPT;PRKAA2;EPHA3
prerank,positive regulation of hydrolase activity (GO:0051345),0.30789142375639966,1.2585197655036882,0.06794871794871794,0.8181422473101475,1.0,38/137,19.68%,AGRN;SH3BP1;SRGAP2;F11R;SGSM2;NTRK1;SGSM3;THY1;MTMR9;PKP4;RIPK3;MAPRE2;RAPGEF3;CDKL5;ADCYAP1;MAP4K4;RGS10;RASGRF1;RAP1GAP;DOCK10;SFRP1;RAP1GDS1;MTCL1;DOCK9;RALBP1;FLCN;RSU1;ITGA6;HRAS;WRN;ALS2;ZC3H15;ASAP3;PIN1;CCL15;PLXNB1;CCL5;CAV2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.37056034748098143,1.2580732624583117,0.14666666666666667,0.8178342245515419,1.0,10/44,13.10%,CTTN;BIN1;LMOD1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;FCHSD2;LMOD3;EVL
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.26625779276300654,-1.2570615411849495,0.061611374407582936,0.542048914236706,1.0,52/163,20.97%,VAV3;BCL2;RFTN1;CD38;PSMA6;PTPN22;CSK;PTPRC;DENND1B;TEC;PSMB2;PSME2;GRAP2;NFKB1;NFKBIZ;NCK1;PSMD11;SYK;PSMC6;FYN;PSMA3;BLNK;PRKCQ;THEMIS;EIF2B2;PIK3CA;ZC3H12A;CD28;LCP2;LCK;RC3H1;SKAP1;SPPL3;STOML2;PSMD10;CD79B;PSMB5;EIF2B4;SPG21;RC3H2;BCAR1;ZAP70;PSMD5;GATA3;CD247;PSMD1;THEMIS2;NFATC2;CD79A;PRAM1;PIK3CD;LAX1
prerank,phagosome maturation (GO:0090382),-0.3481559376567623,-1.2564667040670645,0.14714714714714713,0.5425231172768019,1.0,6/35,4.03%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;RAB7A;ATP6V0B
prerank,brain morphogenesis (GO:0048854),0.5088026246915982,1.2562479192635398,0.20804195804195805,0.8232191120748565,1.0,7/12,32.99%,CTNNA2;SHANK3;SPEF2;PTEN;FBXW11;BBS4;PAX2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4081912856873188,1.2553087330760322,0.15764331210191082,0.8248402672174783,1.0,12/26,20.47%,VSIR;USP50;GRIN1;GRIN2B;EFNA1;PSME3;PSENEN;EFNA3;EPHA4;PRELID1;MBP;PSME1
prerank,muscle filament sliding (GO:0030049),0.38009648334867513,1.2551514422805727,0.1537290715372907,0.820842857391418,1.0,6/38,9.24%,TNNI3;TNNC1;DMD;MYBPC3;ACTN2;MYL6
prerank,actin-myosin filament sliding (GO:0033275),0.38009648334867513,1.2551514422805727,0.1537290715372907,0.820842857391418,1.0,6/38,9.24%,TNNI3;TNNC1;DMD;MYBPC3;ACTN2;MYL6
prerank,triglyceride metabolic process (GO:0006641),-0.3229138684084721,-1.2551352757175813,0.08978328173374613,0.5448424480602635,1.0,11/48,17.16%,APOE;FABP4;PLAAT3;CAV1;LPL;FABP7;PNPLA2;APOC1;GK5;GK;GPAM
prerank,protein polyubiquitination (GO:0000209),-0.2430393565072992,-1.2549964933788171,0.006993006993006993,0.5441703200573079,1.0,70/297,16.28%,SASH1;BCL2;ITCH;HECTD2;WWP1;PSMA6;UBE2D3;KLHL20;HERC6;FBXL17;UNKL;CUL3;ARIH1;PRPF19;TRIM14;UBE2K;PSMB2;DTX3L;FBXL14;RNF213;SIAH2;FBXO30;FBXW7;SMURF2;FBXL8;PSME2;TAF1;UBE2Q1;RNF216;RNF146;HECW1;PSMD11;ARIH2;CDC34;PSMC6;TRIM62;UBC;PSMA3;NHLRC3;FBXW4;RNF14;TTC3;LMO7;RNF6;UBE2L3;BRCA1;UBA52;CDC27;RC3H1;CTNNB1;BARD1;UBE2Q2;TRIP12;BIRC2;AKTIP;UBE2E3;PSMD10;FBXO32;TRIM5;FBXO2;PELI1;UBE2L6;PSMB5;TRIM71;MKRN1;TRAF1;RC3H2;LONRF1;MUL1;UBE2C
prerank,negative regulation of developmental process (GO:0051093),0.3379545729360939,1.254442409747646,0.125,0.8215799996713525,1.0,15/69,11.58%,DCC;CST3;NEUROD2;NFIB;THY1;BMP4;RAPGEF3;FOXC1;HEY1;VASH1;TGFB1;TBX2;PRKN;KLF7;SFRP1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.4045559028444618,-1.2544287646457146,0.16494845360824742,0.5445680009078208,1.0,7/22,15.45%,MDFIC;SP100;BAG4;BARD1;INPP5K;LRRK2;CHP1
prerank,positive regulation of insulin secretion (GO:0032024),0.3914172835213099,1.254376556369989,0.1512481644640235,0.8195561201278927,1.0,7/36,10.02%,ADCY8;NNAT;SOX4;RFX6;DOC2B;TCF7L2;CFTR
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.2614475008160959,-1.2538109221371805,0.04245283018867924,0.5451808244522958,1.0,32/170,10.02%,APOE;NOVA2;IGF1;KIF16B;AFF1;CDK6;PTPRC;ZUP1;TRIM14;PEG3;MTMR2;AHR;PROX1;TRIM17;RASA1;NFKBIZ;TAPBP;MTMR4;ZFP64;PRDM9;HNRNPAB;LDLR;SLC8A2;RO60;HNRNPK;HIF1A;BMI1;PSEN1;KDM6A;HINFP;ZC3H12A;CTCF
prerank,superoxide metabolic process (GO:0006801),-0.3682827362519651,-1.2536995245578422,0.16216216216216217,0.5444140560031546,1.0,10/29,24.01%,CYBB;NRROS;ATP7A;SH3PXD2B;CYBA;CYB5R4;SOD3;TAFA4;NOXO1;NOX4
prerank,positive regulation of B cell activation (GO:0050871),-0.32973622214953846,-1.2529106187927486,0.13529411764705881,0.545464226423047,1.0,18/50,20.68%,VAV3;BCL2;CD74;CD38;PTPRC;GPR183;NOD2;TFRC;SYK;MAD2L2;PAXIP1;SHLD1;SASH3;BST1;CHRNB2;NFATC2;IRS2;PPP2R3C
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4916033375580368,-1.2524022833236763,0.20044543429844097,0.5458179853368111,1.0,2/11,4.01%,STAP1;TYROBP
prerank,sodium-independent organic anion transport (GO:0043252),0.5322102591716058,1.2523371142423851,0.19429590017825313,0.8258840890736928,1.0,2/10,10.50%,SLCO2B1;MFSD10
prerank,negative regulation of GTPase activity (GO:0034260),0.43035294102222565,1.2519506870119748,0.1859706362153344,0.8251044430724873,1.0,12/22,23.32%,F11R;TMED2;DAB2IP;ARFGEF1;RCC2;SH3BP4;RRP1B;HRAS;WNK1;GMIP;RDX;GPSM1
prerank,modification-dependent protein catabolic process (GO:0019941),-0.2576716292200378,-1.2519089560857177,0.043478260869565216,0.5460065848099661,1.0,42/193,12.35%,ITCH;RNF149;BUB3;TRIM25;CUL3;ARIH1;UBE2K;UBA6;DTX3L;FBXL14;BIRC6;RNF213;SIAH2;SMURF2;OS9;TAF1;RNF146;PSMD11;ARIH2;CDC34;UBL7;UBQLN1;RNF13;UBC;ZNRF3;KLHL15;FBXW4;BAG6;RNF14;TTC3;RNF150;RNF6;UBE2L3;UBA52;CDC27;SPSB2;RC3H1;WDR91;TRIP12;MAD2L1;WDR81;CBL
prerank,DNA replication initiation (GO:0006270),-0.3430775654465101,-1.2518446420127742,0.11904761904761904,0.5451469496766108,1.0,16/37,26.28%,TOPBP1;POLE4;ORC5;CDC34;ORC2;RPA1;MCM2;ORC4;CDT1;PRIM2;MCM8;RPA2;POLE3;CDC45;POLE;PURA
prerank,purine-containing compound catabolic process (GO:0072523),-0.45983496295618986,-1.251662137364243,0.19902912621359223,0.5446093130896895,1.0,3/13,5.60%,GDA;XDH;NT5E
prerank,regulation of axonogenesis (GO:0050770),0.3597638780262936,1.2514204850076307,0.13957055214723926,0.8249322633430173,1.0,13/51,15.27%,MAP6;PLXNB2;CHN1;PAK1;THY1;OMG;EFNB3;ARHGDIA;GDI1;MAG;ARHGAP35;EPHA4;NTRK2
prerank,nucleoside salvage (GO:0043174),0.5253306675746594,1.2513903313050938,0.19464285714285715,0.8227393276575587,1.0,5/10,19.84%,HPRT1;DCK;TK1;TK2;UCK1
prerank,regulation of defense response to virus by host (GO:0050691),-0.35984070479830943,-1.2511698462143939,0.1484375,0.5448525710591088,1.0,11/30,16.99%,PTPN22;DTX3L;RNF216;ZC3H12A;STAT1;TRIM44;PARP9;IFNLR1;LILRB1;MUL1;TRAF3IP2
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4175271766189758,-1.2510341214449698,0.1543942992874109,0.5441167932574378,1.0,10/18,29.71%,ENSA;PTPA;PPP1R35;INPP5K;ARPP19;CHP1;PPP1R15A;SH2D4A;PPP1R26;MFHAS1
prerank,covalent chromatin modification (GO:0016569),-0.4563654518818635,-1.2508490384733117,0.18246445497630331,0.5435739536416828,1.0,3/14,12.37%,MBD2;HLCS;HDAC1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.3504329003632389,-1.2491931928362998,0.1532033426183844,0.5468044842497163,1.0,10/35,16.08%,APOE;ADGRG6;PDE7B;CD36;AHR;ADCY1;IRAG1;RIMS2;PDE2A;MAPK7
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5281077449279594,1.248964296765513,0.19133574007220217,0.8305274906686227,1.0,5/10,30.07%,DIP2B;FLCN;PRKAA2;DIP2A;SETD5
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.331115889017641,-1.2482980589167751,0.1339031339031339,0.548100399982518,1.0,5/46,1.89%,PEAK1;ITGA4;NRP1;PXN;ATRNL1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.35842417682134553,1.2482735427832166,0.1458966565349544,0.8311691628940998,1.0,12/51,12.25%,CTTN;CNTNAP1;SRGAP2;NYAP2;PAK1;NCKAP1;NCKAP1L;MAP1S;DAB2IP;MAP4K4;MINK1;ANKRD27
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.38624832832322403,-1.248195908225447,0.18598382749326145,0.547399359514312,1.0,9/22,21.55%,PROX1;TOX;LRRK2;TRIM71;PTPRZ1;NES;APPL2;SHCBP1;ID2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.35022571805711683,-1.2477399812442793,0.14540059347181009,0.547664937456972,1.0,12/35,17.71%,CD300A;PPP6R1;PTPA;PPP6R3;PPP1R12A;BOD1;CRY2;CALM3;CALM2;PPP1R2;ITGA1;PPP1R15A
prerank,negative regulation of MAPK cascade (GO:0043409),-0.28614000635789305,-1.2473470244738838,0.08865248226950355,0.5477109569004377,1.0,31/87,25.49%,APOE;CD300A;STK38;PTPRC;PTPN1;RANBP9;RPS6KA6;CAV1;LYN;IL1B;DAG1;SPRY2;FOXO1;SEMA6A;SPRY1;PSMD10;INPP5K;DUSP1;QARS1;SPRY4;PEBP1;TLR4;SMAD4;BMP7;TNIP1;GSTP1;TIMP3;DUSP7;FBLN1;PIK3R2;DUSP3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.35547531500466567,-1.247143824410742,0.14484679665738162,0.5472151406403755,1.0,10/30,13.51%,DAB2;SMARCA4;RNF14;H3-3A;RNF6;PRMT2;PIAS2;EP300;HDAC1;FOXP1
prerank,regulation of cell cycle process (GO:0010564),-0.28052024215888294,-1.247014508672746,0.09881422924901186,0.5465384288119765,1.0,28/104,17.80%,PIK3C3;BCL2L1;PIK3R4;GIT1;BIRC6;KIF11;MKI67;SH3GLB1;BORA;PRC1;CEP250;KIF20B;RACGAP1;UVRAG;KLHL21;ATF5;CTNNB1;CALM3;RMI2;AHCTF1;BUB1;CALM2;NUMA1;PRPF40A;KIF20A;CUL9;ECT2;HMGA2
prerank,V(D)J recombination (GO:0033151),0.5080647809457263,1.2465417467080624,0.19439579684763572,0.8361831458290842,1.0,5/11,20.69%,DCAF1;LIG3;HMGB1;TCF3;XRCC4
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4420577087143989,1.2464712511069118,0.17247386759581881,0.8342374330004528,1.0,5/19,14.19%,PRDX5;PRDX2;PXDN;PRDX4;ACOX1
prerank,lipoprotein transport (GO:0042953),-0.5061570876285015,-1.245970265605608,0.19489559164733178,0.5482002831305375,1.0,4/10,13.36%,PPARG;CD36;ZDHHC17;LRP1
prerank,negative regulation of peptidase activity (GO:0010466),0.36586002177633886,1.2459103834314518,0.15313935681470137,0.8344674891524412,1.0,14/47,26.23%,GAPDH;SPOCK3;CST3;SPOCK2;SERPINH1;VTN;UBXN1;SERPINE2;AGT;TIMP2;SERPINI1;CST7;SERPINF1;SERPINB8
prerank,T cell activation (GO:0042110),-0.3068065735743846,-1.2456304841206745,0.10802469135802469,0.5481502125993636,1.0,26/69,22.10%,CD74;PTPN22;CD44;DPP4;PTPRC;NCK1;IRF4;MSN;HSPD1;KIF13B;JAML;LFNG;LCP1;CD28;LCK;PPP3CA;CD2;NHEJ1;ZAP70;GATA3;TREML2;NLRC3;PIK3CD;CD3E;GPR89B;GPR89A
prerank,mesonephric tubule development (GO:0072164),0.4674963049986261,1.2454870505203142,0.17412935323383086,0.8340679535919292,1.0,5/15,12.74%,BMP4;PKD2;FOXC1;NPNT;PKD1
prerank,cellular response to interleukin-6 (GO:0071354),0.405994408241168,1.2450593756022463,0.173109243697479,0.8336275220278739,1.0,6/26,5.63%,SELPLG;CTR9;RELA;PTPRT;SOCS3;IL6
prerank,positive regulation of leukocyte migration (GO:0002687),0.4028754454917217,1.2447150782267882,0.1819620253164557,0.832768560975914,1.0,7/27,16.15%,PRSS56;THY1;NCKAP1L;IL6;ICAM1;MIA3;JAM3
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3426776042545745,-1.243429895324731,0.1529745042492918,0.5529470041718816,1.0,17/40,21.87%,SUCO;APOE;CD36;LARP6;VIM;HDAC2;SORBS1;CYBA;SCX;SLC5A3;CREB3L1;ZBTB20;TLR4;MMP8;RGCC;ADGRB1;SERPINF2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4765589667022908,1.242544886188763,0.17627118644067796,0.8397079976521458,1.0,8/14,30.65%,ATP1B1;ATP1B3;ACTN2;GAL;ANK2;LRRC55;ATP1B2;KCNIP2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3628748136981367,-1.242312625463613,0.12176165803108809,0.5548141020471642,1.0,11/26,24.82%,FLOT2;TLR2;IRF7;CD36;BIRC2;GPR108;APPL2;TLR5;SMPDL3B;APPL1;TLR9
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4442214507016806,1.2421262798730954,0.1885245901639344,0.8392901005651038,1.0,6/20,12.65%,ATP2A2;ATP1B1;TNNI3;DMD;SLC8A1;GSTO1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.272204855175931,-1.2418323010012653,0.06746031746031746,0.5550027156649431,1.0,15/121,3.85%,NEDD9;IL15;CD74;NRP1;GAS6;IGF1;CASS4;PARP14;CD44;PTPRC;TEC;LILRA5;PIBF1;PTPN1;IL6ST
prerank,epithelial cell migration (GO:0010631),-0.3514981897727252,-1.2413279467632894,0.14076246334310852,0.555398597880331,1.0,10/37,13.55%,ZEB2;NRP1;PXN;DPP4;KANK2;PLEKHG5;PIK3CA;STAT1;ADGRA2;PRKX
prerank,regulation of erythrocyte differentiation (GO:0045646),0.37936941795454143,1.2390572039958117,0.16823899371069181,0.8499217458016479,1.0,7/35,11.51%,HOXA5;ANKRD54;ZFPM1;LDB1;NCKAP1L;HSPA9;ACVR1B
prerank,respiratory tube development (GO:0030323),0.40189372394652895,1.238224615803109,0.1763779527559055,0.8513567683521639,1.0,6/28,10.90%,DNAAF1;FGF9;CCDC39;FGF7;BMP4;FGF2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3983310190899756,-1.2379964445079543,0.18983957219251338,0.5628828210860505,1.0,10/20,22.80%,C3AR1;P2RX4;NT5E;TXNIP;IL1B;TXN;ENTPD5;CASP1;APP;MEFV
prerank,intestinal lipid absorption (GO:0098856),0.5142125697933899,1.2379699207146098,0.21530249110320285,0.8501991522100986,1.0,3/11,5.61%,ABCG8;AKR1C1;SOAT2
prerank,regulation of cellular metabolic process (GO:0031323),0.3612656486537506,1.2362390951606872,0.16592592592592592,0.8553977960577369,1.0,15/45,16.39%,MKLN1;GNB3;BCO2;PPARA;CNDP1;EIF6;NCOR2;PRKN;COQ7;TBC1D16;AGPAT1;ABCA2;ACLY;SSH1;ACACB
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.44936553710994537,-1.2360109886730184,0.203579418344519,0.567184950676013,1.0,6/13,13.37%,CPSF1;NCBP1;FIP1L1;CPSF4;CSTF2;CPSF2
prerank,membrane fusion (GO:0061025),-0.35224837056424313,-1.2358024056597283,0.14594594594594595,0.5667218826708706,1.0,12/33,19.68%,MYOF;RABEP1;SNAP23;DYSF;SNAP29;DNM2;GCA;UBXN2B;CHP1;USO1;NAPG;NAPA
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.4185237747493566,-1.2353528878198747,0.1848101265822785,0.5669560324435938,1.0,9/18,20.73%,TCTA;FBXW7;GPR137B;GPR137;LILRB3;LILRB1;TLR4;LTF;TMEM178A
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.42033752071152247,1.235302023757538,0.18543046357615894,0.8572472836256294,1.0,8/24,15.69%,HHEX;DAB2IP;PRKD2;NEDD4;ITGA5;PDCD6;VTN;CADM4
prerank,ceramide transport (GO:0035627),-0.46692977737377855,-1.2351577496252313,0.20941176470588235,0.5664410806733698,1.0,8/12,28.26%,PSAP;PLEKHA3;PLTP;SGPP1;ABCA13;CERT1;CPTP;GLTP
prerank,response to zinc ion (GO:0010043),0.4090096891470209,1.2347280199625394,0.18923327895595432,0.8574348167324134,1.0,12/25,17.76%,GLRA2;SLC30A3;KHK;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.48357425181586444,-1.2339589043572567,0.20833333333333334,0.5685090924847529,1.0,3/11,13.91%,ATF3;CEBPB;CREB3L1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.29038040792511943,-1.2339243009144318,0.125,0.5675800854611912,1.0,23/79,18.01%,FCGR2B;CD74;AP2A2;KIF3A;KIF23;KIF11;RAB7A;AP2B1;AP1S3;OSBPL1A;CTSL;RACGAP1;SEC23A;DNM2;CLTA;DCTN4;MFSD6;DYNC1LI2;KIF4A;FCER1G;CAPZB;RILP;DCTN2
prerank,neurotransmitter secretion (GO:0007269),0.37038994812813497,1.233889756543689,0.15718562874251496,0.8589609585888399,1.0,10/44,14.27%,SNAP25;RAB3A;SYT1;SNAPIN;NRXN1;OTOF;RIMS1;CPLX2;GAD2;STXBP2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4023047497489153,1.2335116784461053,0.18309859154929578,0.8584111757362197,1.0,10/27,24.02%,SYT4;SYT13;SYT1;SYT6;DOC2B;RIMS1;SDF4;RIMS3;SYT11;SYT12
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.43853818615502027,-1.2328667657468813,0.19480519480519481,0.5692457606461347,1.0,6/16,18.47%,FCGR2B;CD274;TYROBP;LILRB1;AGER;MMP8
prerank,regulation of gastrulation (GO:0010470),-0.4456646423066353,-1.2327524824845466,0.18691588785046728,0.5685306706415415,1.0,6/14,20.84%,PHLDB1;DAG1;RACK1;SCX;LHX1;POGLUT1
prerank,negative regulation of response to external stimulus (GO:0032102),-0.27803951457517234,-1.2325813750027137,0.07560137457044673,0.5679834728453899,1.0,49/105,29.83%,AOAH;ITCH;APOE;ALOX5;CRK;PPARG;METRNL;PTGER4;VPS35;PPARD;ENPP3;DRD2;PTGIS;ACOD1;C1QTNF3;NR1H3;CCN3;CXCL17;RB1;AJAP1;OTULIN;MAPK7;MUL1;CERS2;KLK8;GATA3;TRAF3IP1;DRD3;LTF;KLF4;NLRC3;SIRT2;TRIM21;MVK;FFAR4;NR1H4;MEFV;SMPDL3B;DHX58;DUSP3;FEM1A;RNF26;ISL1;FPR2;SIGIRR;C1QBP;TNFAIP3;MFHAS1;CD109
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.333323367560402,-1.2321840068104102,0.15633423180592992,0.5680619620081382,1.0,7/41,3.59%,NEDD9;GAS6;STAP1;CASS4;LILRA5;PTPN1;FBXW7
prerank,organic cation transport (GO:0015695),0.43563043811917873,1.2316015467846613,0.1986644407345576,0.8643852337050536,1.0,10/20,29.56%,SLC44A2;RALBP1;SLC22A4;SEC14L1;SLC22A18;SLC22A5;SLC25A26;PDZK1;SLC5A7;SLC25A29
prerank,hemidesmosome assembly (GO:0031581),0.5112201430959136,1.2315246179469683,0.22302158273381295,0.8624451294784193,1.0,6/11,25.12%,DST;LAMB3;ITGA6;LAMC2;LAMC1;ITGB4
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.4592519196446219,-1.2313976900521313,0.2081447963800905,0.5690898410084905,1.0,4/13,9.16%,UBA5;UBA6;ATG7;UBA2
prerank,calcium ion transport into cytosol (GO:0060402),0.4317203634295974,1.2313641829389037,0.19516129032258064,0.860845020466005,1.0,7/21,16.05%,TRPM2;GRIN1;SLC8A1;GRIN2B;ITPR3;JPH1;CACNA2D1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.22745955267201917,-1.2312999335677601,0.011111111111111112,0.5683849642355532,1.0,171/497,26.33%,RBPJ;MDFIC;NR3C1;WWP1;CD38;GAS6;POU2F1;MECP2;EPC1;SETDB2;SP3;LIMD1;ZHX2;HMGB2;KAT6B;CNOT9;CIITA;CBFA2T3;PPARG;RARA;MALSU1;SMARCA4;SMURF2;ENO1;PATZ1;BCL3;AHR;PROX1;SAMD4A;LIMS1;NAB1;PPARD;MBD2;CIART;ATXN1;RCOR1;DPF3;BCL7A;BCOR;PFDN5;NR1H2;KDM8;ID4;FOXE1;CRY2;DDX6;EIF4ENIF1;CAPRIN1;HINFP;PDS5A;BRCA1;SNW1;ID3;GCLC;MBD1;L3MBTL4;CTCF;BIRC5;ZBTB18;PRMT2;FOXO1;NOTCH1;ATF5;CTNNB1;L3MBTL3;BRMS1;RCOR3;ID1;SPEN;HDAC2;ZNF148;CRY1;ATF7IP;DEPDC1;MIDEAS;KAT5;DAPK1;HDAC1;PAIP2B;TYMS;GATAD2A;LARP1;RACK1;INPP5K;FOXP1;RB1;FOXP2;BMP2;L3MBTL2;CREB3L1;EHMT1;QARS1;SYNCRIP;DACH1;RIOX1;SHC1;LHX1;TNF;TRIM71;KDM5C;WNT5A;ZNF318;KAT7;FOXK2;DEAF1;THAP7;SAP18;IKZF1;FXR2;HEY2;UIMC1;ARID5B;GATA3;HMGA2;SMAD4;GLIS2;PER2;NIBAN2;IGFBP5;LANCL2;HES1;TFAP2B;PPM1F;EED;CDKN2A;TAF7;PA2G4;BMP7;BHLHE40;HMGA1;YEATS2;KLF4;SIRT2;NCOR1;DHFR;CPEB3;BASP1;TRIM33;HDAC4;SCMH1;ID2;HEYL;RBAK;MECOM;TWIST1;PSPC1;NDUFA13;CALCA;RIDA;PIAS4;ILF3;BMPR2;EZH2;DPF1;ZIC2;EIF2AK1;EIF2AK2;SAMD7;BCL6;SCML4;EID2B;ERN2;GIGYF2;BTAF1;ZBTB33;CEBPA;PHC2;MYB;LEF1;PASK;PAIP2
prerank,protein N-linked glycosylation (GO:0006487),-0.2989820989735361,-1.2310955736880143,0.11356466876971609,0.567863646408181,1.0,12/66,8.34%,TMEM165;RPN2;MPDU1;MAGT1;UGGT1;MGAT2;MCFD2;ALG12;ST6GAL1;MGAT4C;FUT8;ALG13
prerank,regulation of cell cycle (GO:0051726),-0.24253820259624032,-1.2310638950355721,0.03597122302158273,0.5669562157917588,1.0,86/271,24.27%,IQGAP1;ANKRD17;FBXL17;BRINP1;LIN54;CDK6;PTPRC;SDCBP;RUNX3;PRCC;RARA;PRKACA;FBXL8;CDC14B;JUNB;PROX1;GBF1;UHRF2;ERN1;THBS1;SMAD3;CCND1;KIF20B;LIN52;NBN;MYBL2;CDKN2C;PCLAF;BRCA1;LIN37;UHMK1;BIRC5;CDKN3;NOTCH1;EP300;BARD1;BIRC2;GADD45G;ASAH2;RPS6KA2;RACK1;RB1;BMP2;PRR11;SIK1;DUSP1;LILRB1;CDC25A;MLF1;NOP53;NUDT6;HIPK2;NUPR2;DTL;PPP1R15A;GATA3;HMGA2;PER2;RNF20;MAPK12;LRP6;PLK1;CDKN2A;FBXL12;HNRNPU;AFAP1L2;RGCC;BMP7;SIRT2;TRIM21;NOTCH2;DHCR24;PUM1;CDK9;ID2;CDC14A;MECOM;MAP3K20;XIAP;RPRM;CCNB1;KAT2B;MASTL;DDIAS;PLAGL1;PIM2
prerank,myelin maintenance (GO:0043217),0.5262260817956671,1.2308100142874852,0.21565217391304348,0.860902287210668,1.0,6/10,28.13%,CLU;CXCR4;MYRF;ABCD2;EPB41L3;PTEN
prerank,regulation of oxidoreductase activity (GO:0051341),-0.4570620546049417,-1.2305162379528538,0.2164705882352941,0.5674399454663691,1.0,4/13,11.59%,ABL2;ATP7A;NOD2;SZT2
prerank,maturation of SSU-rRNA (GO:0030490),-0.3501692717323398,-1.2304474827763607,0.1531791907514451,0.566666141100133,1.0,8/34,14.55%,UTP6;NOL11;RPS16;RPS14;DDX52;UTP4;TSR1;WDR3
prerank,regulation of protein targeting to membrane (GO:0090313),0.39776404364258733,1.230395471303532,0.19085173501577288,0.8603360346326574,1.0,14/28,27.68%,FIS1;PRNP;ITGB1BP1;MYO1C;GDI1;MTCL1;HRAS;MFF;ITGAM;PDZK1;ANK3;DMTN;KCNB1;CEMIP
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.2717855092584593,-1.230298505152097,0.08438818565400844,0.5660676511643556,1.0,42/122,20.83%,IGF1;UPF3A;NIBAN1;RPL5;TLR2;CIITA;NAMPT;PCNA;BCL3;NFKB1;SAMD4A;THBS1;NOD2;BCAR3;IL1B;LARP6;VIM;CD28;PIWIL2;SORBS1;IGF2;NLRC5;PLD1;PPP1R3E;KDR;CDT1;NPM1;ZCCHC4;EGFR;NMD3;KAT7;UPF3B;LARP4B;TLR4;FXR2;HNRNPD;NAT10;RPL26;RGCC;IRS2;KLF4;CPEB3
prerank,monosaccharide transmembrane transport (GO:0015749),0.4594971020364998,1.2298413993326263,0.20869565217391303,0.8604066756434802,1.0,3/16,6.74%,SLC50A1;SLC45A3;SLC2A2
prerank,peptide metabolic process (GO:0006518),-0.2953707223929069,-1.2297893306027197,0.11,0.566406825418356,1.0,17/75,13.84%,NLN;ANPEP;CPQ;CPD;PARL;GSTA3;CLN5;RHD;CPE;PSEN1;ERAP1;CPM;GSTZ1;LTA4H;SPPL3;GSTM1;GSTM5
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.31468746387167185,-1.2290402202797657,0.14029850746268657,0.5672463917468366,1.0,21/56,22.94%,RAD51B;ANKRD17;MECP2;CUL3;NSMCE2;CCND1;ANXA1;CDC27;CDK1;ESPL1;CCND2;RB1;EGFR;CDC25A;UBE2C;ADAM17;DTL;RGCC;CDC25C;ANAPC7;CCNB1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.48470308385838956,-1.228898979983867,0.20137299771167047,0.5665999670386153,1.0,4/11,12.71%,CDC73;NCBP1;BARD1;AHCYL1
prerank,histone H2A ubiquitination (GO:0033522),0.456927385295369,1.228897886686151,0.1877076411960133,0.8622609671632258,1.0,6/17,14.10%,UBE2B;KDM2B;RNF168;RNF8;DDB2;RNF2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.39188884253484046,1.22850018065119,0.1750788643533123,0.8616751168528352,1.0,14/30,25.38%,FHIT;GIPC1;SGTA;STYX;OGT;TAF9;UBXN1;CCAR2;HSP90AB1;CAMLG;TLK2;USP7;HFE;TRIM39
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4534083338107323,-1.2281164301958483,0.21256038647342995,0.5676147581032089,1.0,3/13,12.35%,CBLB;SOCS5;CBL
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.32256658406312433,-1.2279710273291427,0.1355421686746988,0.5670008399002932,1.0,16/46,17.54%,RBPJ;IL15;NOVA2;DOCK7;NRDC;NR1H2;PCTP;NOTCH1;ID1;NR1H3;RB1;ALDH1A1;TLR4;IL18R1;ADAM17;PGAM5
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5294195732277432,1.2279708956657855,0.19930675909878684,0.8616845740341539,1.0,5/10,24.88%,ENPP2;LIPC;PLA2G15;PNPLA8;PLA2G4A
prerank,response to estrogen (GO:0043627),-0.3565550761241816,-1.2279582771427526,0.17134831460674158,0.5660356695301291,1.0,11/31,19.20%,TRIM25;RARA;ESR1;CAV1;CD24;BRCA1;EP300;KMT2D;GATA3;RBBP5;BCAS3
prerank,negative regulation of immune system process (GO:0002683),-0.4156363341407166,-1.2277062752056211,0.18274111675126903,0.5657675936357531,1.0,8/16,27.92%,FCGR2B;LYN;PDCD1;HMOX1;COL3A1;FADD;FCRLB;SPINK5
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.31582471429404185,-1.2276827505454844,0.13213213213213212,0.5648410242936825,1.0,11/48,13.14%,GAS6;STAP1;PARP14;PTPRC;PPARG;STAT2;USP18;NR1H2;NLRC5;OAS3;NR1H3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2816915293862689,1.2272733061448544,0.06634499396863691,0.8624538286796458,1.0,83/241,25.47%,POLR2L;SRSF12;RNPS1;DHX35;SMU1;CWC15;PQBP1;SRSF5;FUS;DHX15;POLR2F;BCAS2;DDX5;TRA2B;HNRNPH1;CWC22;CASC3;XAB2;PPWD1;CTNNBL1;SF3B2;CWF19L2;PPIL1;ISY1;PRPF40B;SRRM2;SRSF6;SF3B6;SRSF11;PTBP1;RBM5;GTF2F1;CACTIN;DDX46;SNRNP70;SF3B5;SF3A1;SRSF1;SNRPD2;CPSF3;YTHDC1;GPKOW;POLR2G;LSM8;SF3B3;CRNKL1;IK;CSTF1;NUDT21;NOVA1;CDC40;DDX39B;HNRNPA1;ELAVL2;GEMIN5;GEMIN6;SRSF9;PUF60;TRA2A;UBL5;GCFC2;SNRPD3;SNRNP27;ALYREF;SRSF2;RBM10;USP49;SART1;POLR2C;LSM4;LSM3;PRPF38A;SNRPB2;RBM15B;POLR2D;SNU13;WBP4;ESS2;PNN;SF1;HNRNPH3;SRSF3;DHX16
prerank,ribosome assembly (GO:0042255),-0.32052522020770224,-1.22725662019769,0.13333333333333333,0.5650643602756258,1.0,16/47,21.81%,EIF2A;RPL5;DHX29;RPS14;RPS5;RPF2;RPL6;RPL10;RPL23A;MDN1;RPL3;NPM1;NOP53;EFL1;RPL11;RPS15
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.37092023057416873,-1.226919326921603,0.17929292929292928,0.5649948595271028,1.0,12/27,24.42%,CHST11;XYLT1;CHST9;UGDH;CSPG4;CHST7;CHPF;XYLT2;PXYLP1;CHST12;CHSY3;CHST3
prerank,protein localization to cell junction (GO:1902414),-0.38556869115448417,-1.226509529880795,0.18527918781725888,0.565144265997099,1.0,10/22,29.87%,KIF3A;CGNL1;ARHGEF18;NECTIN1;MPP4;NLGN2;DSP;TJP1;NPHS1;MARVELD3
prerank,signal transduction by p53 class mediator (GO:0072331),0.3921423179962379,1.2259536234648796,0.16584564860426929,0.8657061809577491,1.0,8/30,15.43%,FHIT;USP10;DDX5;STK11;MYO6;PPP1R13B;NDRG1;BATF
prerank,positive regulation of interferon-beta production (GO:0032728),-0.34468647681410586,-1.2255051740488434,0.1452513966480447,0.5668422961297993,1.0,7/33,7.35%,OAS2;IFIH1;TLR2;IRF7;TBK1;TLR7;TLR8
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.39971774591485365,-1.2252972313235484,0.18227848101265823,0.5664279879637872,1.0,8/20,17.91%,RBPJ;SMAD9;HIF1A;NOTCH1;EP300;BMP2;SESN2;SMAD4
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4574914453855023,1.224979791741982,0.20840336134453782,0.8655688931084371,1.0,4/15,20.23%,NANOS1;ZFP36L2;TOB1;DHX36
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4574914453855023,1.224979791741982,0.20840336134453782,0.8655688931084371,1.0,4/15,20.23%,NANOS1;ZFP36L2;TOB1;DHX36
prerank,calcium ion transport (GO:0006816),0.31181768817780836,1.2248300522475442,0.11821974965229486,0.864068130345807,1.0,33/113,19.40%,ATP2A3;TRPC3;ATP2A2;CDH23;SLC24A5;CACNB2;NMUR1;CACNA1S;TRPM3;TRPM2;CCR1;PKD2;CACNA1G;SLC8A1;CACNG7;ATP2C1;CACNA1D;TRPC6;PANX1;PKD1;CACNA1B;KCNN4;SLC8A3;CACNA2D1;CACNA1A;SLC24A3;CACNG3;ANK2;CHRNA7;SELENOK;SLC24A4;TRPV6;CCL5
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.31391142057755383,1.2248287236308069,0.1303763440860215,0.8618790865633114,1.0,31/107,19.40%,ATP2A3;ATP13A4;ATP2A2;SLC24A5;ATP1B1;SLC39A4;TNNI3;ATP13A5;CCR1;SLC8A1;RMDN3;SLC39A8;ATP2C1;ATP2B3;SLC8A3;DMPK;SLC24A3;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;ANK2;CHRNA7;SLC24A4;CCL15;CCL5
prerank,detection of mechanical stimulus (GO:0050982),0.4375494679772137,1.2248252550998437,0.1921182266009852,0.8597211883194928,1.0,6/19,18.85%,LHFPL5;PKD1L1;PKD2;PKD1;PTK2;PKD2L2
prerank,protein stabilization (GO:0050821),-0.25773268339152794,-1.2239223837641309,0.046296296296296294,0.568957682476923,1.0,47/168,20.04%,STK3;FLOT2;HIP1;IGF1;RPL5;CCT6A;DVL3;STX12;FBXW7;TYROBP;TAF1;HIP1R;SEC16A;BAG4;VHL;RPS7;HSPD1;PDCD10;TBL1X;NAA16;BAG6;LAMP2;HYPK;USP9X;CCNH;EP300;TRIM44;CCT3;WDR81;RAB21;ATF7IP;LAMP1;NLK;GET1;TESC;MCM8;CHP1;PFN2;MUL1;NOP53;DNLZ;NAPG;FLNA;FKBPL;WFS1;HSPA1B;RPL11
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.49597594410326057,1.2233123053240127,0.22512234910277323,0.8640757987259957,1.0,4/12,12.28%,NELFB;NELFCD;RNF168;RNF8
prerank,sensory perception of pain (GO:0019233),-0.40207296246510726,-1.2227408405086813,0.19796954314720813,0.5709416044102502,1.0,8/21,24.26%,P2RX4;CCR2;KCNA2;ALOXE3;CHRNB2;OPRK1;CHRNA4;SCN9A
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.24490356965368718,-1.2224646312015415,0.03571428571428571,0.5707112034950772,1.0,52/259,12.97%,FGD4;MTSS1;EHD4;ATP6V0D1;FGD6;RAB8B;NRP1;ACTR3;KIF3A;PTPN23;EMP1;PCM1;FXYD5;RILPL2;SDCBP;FAM161A;PIBF1;RAB1A;MKS1;CDC14B;RPGR;SCLT1;CPLANE1;GBF1;EXOC4;ARL13B;CEP250;S1PR2;ARHGEF6;TCTN1;SSX2IP;SPEF1;BBS7;FHDC1;ASAP1;CARMIL1;DNAH5;FGD1;KIF24;TMEM231;CEP164;WDPCP;SNAP29;CCDC28B;TMEM138;NOTCH1;SHTN1;FOXJ1;EXOC8;PMP22;EMP2;IFT52
prerank,cellular response to alkaloid (GO:0071312),0.4529315517207094,1.2222271743478565,0.20847457627118643,0.8666080158831786,1.0,5/17,12.75%,CACNA1S;SLC8A1;CASP3;CASP7;CRHBP
prerank,regulation of DNA binding (GO:0051101),-0.32461120142332434,-1.222145545394264,0.1757188498402556,0.5706584489732893,1.0,9/44,8.12%,SP100;IGF1;HMGB2;PPARG;DOT1L;BCL3;CEBPG;PLAUR;TXN
prerank,multivesicular body assembly (GO:0036258),-0.35492885766710125,-1.2217761260775473,0.16272965879265092,0.5706523364755998,1.0,6/30,13.44%,VPS37C;CHMP4A;CHMP4B;CHMP1B;PDCD6IP;STAM
prerank,sphingoid biosynthetic process (GO:0046520),-0.4706802630235083,-1.2217148467152863,0.23076923076923078,0.5688760378907175,1.0,5/11,20.25%,ACER3;ASAH2;SPHK2;SPTLC2;SPTLC3
prerank,sphingosine biosynthetic process (GO:0046512),-0.4706802630235083,-1.2217148467152863,0.23076923076923078,0.5688760378907175,1.0,5/11,20.25%,ACER3;ASAH2;SPHK2;SPTLC2;SPTLC3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.42568269043021945,-1.2216585975587573,0.18,0.5680502075747066,1.0,5/16,6.57%,PARP14;PIBF1;BCL3;VHL;CAV1
prerank,base conversion or substitution editing (GO:0016553),0.5020090727888789,1.2214115460858384,0.2159468438538206,0.8678412865879958,1.0,3/11,6.23%,ADARB2;APOBEC2;ADAR
prerank,positive regulation of glucose metabolic process (GO:0010907),0.46714575819753934,1.22126104681957,0.2224231464737794,0.8663117169647329,1.0,4/14,15.32%,SLC45A3;PPARGC1A;IRS1;PTPN2
prerank,regulation of defense response to virus (GO:0050688),-0.4459925314589974,-1.2209964525235468,0.2073170731707317,0.5688099697987531,1.0,7/14,29.65%,ITCH;RNF216;IFNLR1;TRAF3IP1;RNF26;C1QBP;TNFAIP3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3994702247250906,-1.2205137882167565,0.18829516539440203,0.5691686730751667,1.0,9/20,23.54%,IGF1;LAMTOR5;H1-0;EP300;RB1;GATA3;NIBAN2;TWIST1;PAX6
prerank,protein mannosylation (GO:0035268),0.41905366267711397,1.219950039438362,0.20695102685624012,0.8698376381249455,1.0,6/22,10.14%,B4GAT1;TMTC4;DPY19L4;FKRP;DPY19L3;SDF2L1
prerank,negative regulation of defense response to virus (GO:0050687),-0.4922565420666787,-1.2198638911764588,0.20666666666666667,0.5698503819385417,1.0,5/10,29.42%,ITCH;MUL1;TRAF3IP1;RNF26;C1QBP
prerank,regulation of B cell differentiation (GO:0045577),0.44861599901536175,1.2198213457902172,0.22013651877133106,0.8682099347027447,1.0,7/17,18.05%,IL4I1;NCKAP1L;ZFP36L2;BTK;SFRP1;INHA;XBP1
prerank,regulation of insulin secretion (GO:0050796),0.31174924469221493,1.219680186476054,0.13243243243243244,0.8666021567705235,1.0,27/101,20.04%,SNAP25;ITPR2;KCNA5;NNAT;SOX4;IL6;RFX6;SLC2A2;DOC2B;ADRA2A;TCF7L2;PRKCA;RAPGEF3;PRKN;CACNA2D2;IRS1;CACNA1D;SFRP1;ITPR3;ABCC8;REST;CACNA1A;STXBP4;MTNR1B;GHRL;CCL5;EPHA5
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.34384284855932035,-1.2195103364581115,0.17333333333333334,0.5697676603348756,1.0,12/36,25.49%,ITCH;PTPN22;TAOK3;FOXO1;DUSP1;QARS1;NCOR1;DUSP19;MECOM;GSTP1;FKTN;DUSP3
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.46164322640002703,-1.2189710421758193,0.21559633027522937,0.5703337622457006,1.0,5/12,18.94%,PPARG;NR1H2;ABCG1;NR1H3;ITGB3
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.42935849040018265,-1.218060305247547,0.1738095238095238,0.5717764741233897,1.0,7/15,16.12%,FBXW7;LDLR;NR1H2;CTDNEP1;NR1H3;SIK1;MFSD2A
prerank,Golgi to lysosome transport (GO:0090160),-0.4678826493040054,-1.217953297813494,0.2328767123287671,0.5710993823427715,1.0,5/11,15.69%,GAK;AP4M1;LAMP1;RBSN;CLN3
prerank,acute inflammatory response (GO:0002526),0.41752977164880867,1.217826048784151,0.20270270270270271,0.8723722467179738,1.0,3/23,5.63%,F3;MBL2;IL6
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4887297594746722,-1.2177898498125825,0.22772277227722773,0.5706160966164161,1.0,3/10,7.31%,ATP5MG;ATP5PO;ATP5MC1
prerank,negative regulation of platelet activation (GO:0010544),0.4485087251499962,1.2175732833622717,0.22913256955810146,0.8712642655414189,1.0,6/16,15.75%,ALOX12;THBD;SH2B3;PDGFB;PRKG1;SERPINE2
prerank,establishment of mitotic spindle localization (GO:0040001),-0.36580311480973887,-1.2170276122415933,0.18133333333333335,0.5715958138627265,1.0,15/28,24.14%,KPNB1;CDK5RAP2;CENPA;NUSAP1;MAD2L1;ESPL1;SPDL1;NUMA1;UBXN2B;GJA1;NDC80;PLK1;PAFAH1B1;NDE1;PKHD1
prerank,autophagy of peroxisome (GO:0030242),-0.4621817428548243,-1.2167602538605395,0.21261682242990654,0.571395103387154,1.0,4/12,2.43%,PIK3C3;NBR1;MAP1LC3B;PIK3R4
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4647266137480175,-1.2164949272612664,0.2099056603773585,0.5702392182143997,1.0,7/12,20.15%,IGF1;CIB1;SPPL3;TNF;CAMTA1;CHP2;STIMATE
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4647266137480175,-1.2164949272612664,0.2099056603773585,0.5702392182143997,1.0,7/12,20.15%,IGF1;CIB1;SPPL3;TNF;CAMTA1;CHP2;STIMATE
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.3990379459909532,-1.216369515025948,0.1856763925729443,0.569612159594314,1.0,3/21,3.10%,PEAK1;SLK;CORO1C
prerank,Notch signaling pathway (GO:0007219),-0.311367266666169,-1.2161352579772888,0.13504823151125403,0.5693438501226068,1.0,24/59,29.12%,RBPJ;ITCH;DTX3L;PSEN1;SNW1;STAT1;NOTCH1;EP300;APH1B;BMP2;GMDS;NOTCH4;ADAM17;DTX4;HEY2;HES1;NOTCH2;HEYL;KAT2B;GALNT11;SUSD5;DLL4;NRARP;PSEN2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.2339610361445647,-1.2160669649488143,0.029850746268656716,0.5685535951289692,1.0,67/341,12.35%,PPP2R5C;ITCH;WWP1;PSMA6;VPS37C;RNF149;UBE2D3;KLHL20;PTPN23;BUB3;FBXL17;VCP;TRIM25;CUL3;ARIH1;UBE2K;CUL4A;PSMB2;UBA6;DTX3L;FBXL14;BIRC6;RNF213;SIAH2;FBXW7;SMURF2;OS9;PSME2;TAF1;RNF216;RNF146;RMND5B;HECW1;PSMD11;ARIH2;CDC34;UBL7;PSMC6;UBQLN1;RNF13;TBL1X;ZNRF3;PSMA3;NHLRC3;KLHL15;FBXW4;BAG6;RNF14;TTC3;SPOPL;RNF150;RNF6;UBE2L3;KCTD17;USP9X;RAD23B;CDC27;SPSB2;RC3H1;CTNNB1;WDR91;TRIP12;MAD2L1;BIRC2;WDR81;KAT5;CBL
prerank,regulation of axon extension (GO:0030516),0.37048353172772763,1.2151170250439955,0.1984732824427481,0.8796436431434519,1.0,9/37,14.23%,CTTN;DIP2B;SEMA7A;LIMK1;TWF2;CDKL5;MAG;NRCAM;MAP3K13
prerank,glycerol metabolic process (GO:0006071),-0.4857424323337549,-1.2146385034648324,0.23903508771929824,0.5715547424091215,1.0,4/10,14.18%,GOT1;COQ3;GK5;GK
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2888971461751043,-1.2146092580599845,0.11036789297658862,0.5706578749156176,1.0,14/71,9.87%,PSMA6;CHMP4B;FBXL17;VCP;YME1L1;PRPF19;CAPN2;CTSL;UBC;CTSB;BAG6;UBA52;CLPP;USP9X
prerank,epithelium development (GO:0060429),0.30747024931295164,1.2145531534134908,0.13280212483399734,0.8798816787666932,1.0,19/107,13.12%,WNT4;FGF10;CD34;AKR1C1;CDHR2;SOX10;MEOX2;WNT3;VDAC1;TIMELESS;PKD2;ALDOC;TGFB1;TBX2;SNAI2;PPP2R3A;UPK1B;PKD1;NDRG4
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4528747983169179,1.213952294044474,0.20654044750430292,0.8802451014418625,1.0,4/15,12.03%,SELENOS;HSP90B1;HERPUD1;DERL1
prerank,hexose transmembrane transport (GO:0008645),0.4245745599225646,1.2138975136853731,0.2218370883882149,0.8783245930623296,1.0,4/21,6.74%,SLC2A3;SLC50A1;SLC45A3;SLC2A2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.27650880195268757,1.2134054515508497,0.06375442739079103,0.8783277320122677,1.0,89/264,25.77%,POLR2L;SRSF12;RNPS1;DHX35;SMU1;CWC15;PQBP1;SRSF5;FUS;DHX15;POLR2F;BCAS2;DDX5;TRA2B;HNRNPH1;CWC22;CASC3;XAB2;PPWD1;CTNNBL1;SF3B2;CWF19L2;PPIL1;ISY1;PRPF40B;SRRM2;SRSF6;SF3B6;SRSF11;PTBP1;DDX1;RBM5;GTF2F1;CACTIN;DDX46;SNRNP70;SF3B5;SF3A1;SNUPN;SRSF1;SNRPD2;CPSF3;YTHDC1;GPKOW;POLR2G;LSM8;SF3B3;CRNKL1;IK;CSTF1;NUDT21;NOVA1;CDC40;DDX39B;HNRNPA1;ELAVL2;GEMIN5;GEMIN6;SRSF9;PUF60;TRA2A;UBL5;GCFC2;SNRPD3;SNRNP27;ALYREF;SRSF2;RBM10;PRMT5;USP49;SART1;POLR2C;LSM4;LSM3;PRPF38A;SNRPB2;RBM15B;POLR2D;SNU13;WBP4;ESS2;PNN;SF1;HNRNPH3;SRSF3;DHX16;COIL;CELF4;METTL14
prerank,positive regulation of protein transport (GO:0051222),0.33113141487704784,1.2133776667814042,0.1481994459833795,0.8763072344252588,1.0,19/67,18.04%,FRMD4A;MYOM1;ANG;SYTL4;TENM1;MYH10;APBB1;ACHE;OAZ1;TGFB1;PLK3;UNC13B;ATP2C1;DNM1L;APBB3;IER3IP1;RIPOR1;IL1A;B3GAT3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.43239493825663333,-1.2132750194248498,0.2111650485436893,0.5731388331584417,1.0,11/16,35.12%,PTPRC;CEACAM1;KLRD1;LILRB1;AGER;FADD;IL12RB1;KLRC1;IL12A;IL23R;IL12B
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.47990503932951023,-1.2132373395850626,0.2111368909512761,0.5722691763977027,1.0,5/11,14.75%,PTPRC;AHR;CEACAM1;KLRD1;LILRB1
prerank,amino acid transport (GO:0006865),-0.3115803373100481,-1.2121768552847385,0.11527377521613832,0.5742118352538395,1.0,12/49,17.24%,SLC38A6;SLC1A5;SLC7A1;SLC43A2;SLC6A6;SLC7A11;SLC6A17;SLC16A10;SLC25A47;SLC7A6;SLC38A11;SLC3A2
prerank,regulation of microglial cell activation (GO:1903978),-0.42625581678351787,-1.212140106749061,0.2078239608801956,0.5733544312392906,1.0,3/15,6.61%,STAP1;PTPRC;LDLR
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.4688537959812479,-1.2119990906775744,0.24096385542168675,0.5727382073146242,1.0,2/11,3.10%,CD44;CORO1C
prerank,glycerolipid metabolic process (GO:0046486),0.49790126618857483,1.2119060990679742,0.22280701754385965,0.880287107011477,1.0,5/11,20.61%,PNPLA3;DGKQ;GAL3ST1;DGKZ;PLA2G15
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.4137717160552994,-1.211845255325248,0.21286031042128603,0.572210741819888,1.0,6/16,10.78%,BCOR;DNMT1;BRCA1;SNW1;PAXIP1;CTNNB1
prerank,positive regulation of protein secretion (GO:0050714),0.33579268512274685,1.2108225470839542,0.15877437325905291,0.8827858772643894,1.0,19/69,19.62%,FRMD4A;MYOM1;ANG;NNAT;SYTL4;SOX4;MYH10;DOC2B;APBB1;TCF7L2;ACHE;TGFB1;UNC13B;DNM1L;APBB3;IER3IP1;IL1A;GHRL;HCAR2
prerank,cyclooxygenase pathway (GO:0019371),0.516240554456785,1.2106799496218341,0.23655913978494625,0.8812854031960853,1.0,2/10,2.12%,PTGS1;PTGDS
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4901296870947745,1.2105349445847662,0.2145214521452145,0.8798208893897508,1.0,4/12,14.67%,ADCY8;RFX6;CFTR;BAIAP3
prerank,embryonic eye morphogenesis (GO:0048048),0.5047689592373701,1.2103287349068133,0.21864406779661016,0.878541016425799,1.0,6/11,25.03%,MFAP2;FBN2;TBX2;KDM2B;MFAP5;FBN1
prerank,eye morphogenesis (GO:0048592),0.43457769151522607,1.21023341456345,0.2189655172413793,0.8768253589930926,1.0,4/19,9.45%,COL5A1;MFAP2;FBN2;TENM3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.39172562037883774,-1.2101150084271195,0.21428571428571427,0.5759504140886551,1.0,5/20,6.26%,DAB2;PID1;BCL2L1;PPP2R5A;PICALM
prerank,multivesicular body organization (GO:0036257),-0.35005995799480594,-1.2098806906638375,0.16180371352785147,0.5756544027103785,1.0,6/31,13.44%,VPS37C;CHMP4A;CHMP4B;CHMP1B;PDCD6IP;STAM
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3828066798210921,1.2097656132948678,0.2006269592476489,0.8766572021169268,1.0,15/32,27.27%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;POLR1E;RRN3;MAPK3;POLR1F;GTF2H3;POLR1G;ERCC2;POLR1A;TAF1A;GTF2H1
prerank,positive regulation of neurogenesis (GO:0050769),0.3311551239732189,1.2093508874821737,0.1625544267053701,0.8763685192895466,1.0,14/68,11.25%,MAP6;FBXW8;PLXNB2;OBSL1;PTPRD;NUMB;LRP2;SHANK3;ARHGDIA;CDKL5;CX3CR1;SS18L1;IL1RAPL1;SMARCD3
prerank,blood vessel morphogenesis (GO:0048514),-0.3046622787705239,-1.209186531854337,0.14583333333333334,0.5766540600741538,1.0,21/54,23.40%,RBPJ;NRP1;CCBE1;PROX1;RASA1;FLT1;SYK;AGGF1;CAV1;LOX;ID1;KDR;HAS2;CDH2;RAMP2;HEY2;HES1;SERPINF2;SHH;APLNR;CYP1B1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3087140610035648,-1.2083260298695129,0.15286624203821655,0.5779067705272536,1.0,10/52,9.03%,BCL2;UBE2D3;ATG13;FBXW7;TOMM7;SH3GLB1;PPP3R1;ARIH2;YWHAG;UBE2L3
prerank,regulation of MAP kinase activity (GO:0043405),-0.2772615597566307,-1.2082984625191486,0.11960132890365449,0.5770553235281192,1.0,25/92,15.21%,APOE;CD300A;STK38;PTPN1;FLT1;PDGFD;NOD2;PDCD10;CD24;LYN;IL1B;FGF1;PDGFC;ADAM8;SPRY2;PIK3R6;PIK3R5;SPRY1;INPP5K;LRRK2;DUSP1;CDK12;EGFR;TNF;SPRY4
prerank,regulation of astrocyte differentiation (GO:0048710),0.48973733452054546,1.2077553033871846,0.23518850987432674,0.8811403482103699,1.0,5/12,15.75%,BIN1;IL6;CLCF1;EPHA4;SERPINE2
prerank,regulation of muscle contraction (GO:0006937),-0.35797288155426965,-1.207584317560147,0.1791044776119403,0.5780390286524221,1.0,4/26,6.57%,PPP1R12B;ENO1;CHRM2;CAV1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.25104197528106403,-1.2066033030524204,0.057971014492753624,0.5796879862431823,1.0,55/166,21.28%,ZEB2;IGF1;UPF3A;NIBAN1;RPL5;P2RX4;ATP7A;CD36;PCNA;BCL3;SAMD4A;THBS1;SMAD3;BCAR3;SP1;LDLR;NR1H2;CTDNEP1;HIF1A;IL1B;LARP6;VIM;CD28;PIWIL2;SORBS1;IGF2;PLD1;PPP1R3E;NR1H3;CDT1;NPM1;MID1IP1;ZCCHC4;ARPP19;EGFR;TNF;NMD3;KAT7;CHP1;UPF3B;MFSD2A;LARP4B;TLR4;FXR2;KLF2;HNRNPD;MMP8;NAT10;RPL26;OPN3;RGCC;IRS2;KLF4;CPEB3;CDH3
prerank,protein K48-linked ubiquitination (GO:0070936),-0.3092494671421055,-1.206578060188431,0.1382636655948553,0.5788048613322504,1.0,14/54,13.69%,ITCH;UBE2D3;CUL3;UBE2K;DTX3L;RNF216;RNF146;ARIH2;CDC34;TTC3;RNF6;UBE2Q2;UBE2E3;PELI1
prerank,endodermal cell fate commitment (GO:0001711),0.5133767648374165,1.2063158506981853,0.23859649122807017,0.8850611656379307,1.0,2/10,1.93%,CTR9;RTF1
prerank,mitotic spindle organization (GO:0007052),-0.25549943089716376,-1.2062147478538432,0.0821917808219178,0.5787377161184498,1.0,51/153,23.87%,MECP2;KPNB1;BUB3;VCP;MIS12;PIBF1;KIF23;KIF11;RANBP2;PMF1;PTPA;PRC1;KIFC2;ZWILCH;CDCA8;STMN1;KIFC1;ABRAXAS1;CENPA;NUP43;XPO1;MAPRE1;BIRC5;MAD2L1;AHCTF1;BUB1;BUB1B;DYNC1LI2;KNTC1;SPDL1;KIF4A;INCENP;NDC80;WDR62;NUF2;MZT1;DCTN2;TPX2;FLNA;ERCC6L;PLK1;PAFAH1B1;MAP4;B9D2;ZWINT;OFD1;RCC1;CCNB1;NDE1;SPC24;NUP98
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3067830024386182,1.205534053961495,0.15555555555555556,0.8861832287988867,1.0,31/107,19.72%,DGKI;SLC4A8;CACNG5;NPTXR;SYT1;SLC12A2;LGI1;MEF2C;GRM3;NPTX1;TPRG1L;GRIK5;GRIK2;GRID2;CLSTN2;CX3CR1;NRG3;RIMS1;KCTD13;CPLX2;CACNA1B;BAIAP3;DLGAP1;SLC8A3;DGKZ;CACNA1A;DLGAP2;DLGAP3;CHRNA7;RIMS3;LRRC4C
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3971395982993711,-1.2050955709763203,0.18947368421052632,0.5805963859751949,1.0,3/19,5.75%,CD74;RIPOR2;MOSPD2
prerank,external encapsulating structure organization (GO:0045229),0.28220967135634334,1.2049909257658618,0.08669108669108669,0.8864624664247736,1.0,54/205,19.38%,AGRN;COL5A1;MMP16;LAMB3;F11R;ACAN;COL2A1;ICAM5;ITGB6;JAM2;SPOCK2;ITGB5;ADAMTS20;SMOC2;MFAP2;FBN2;ADAMTSL1;ADAMTS15;ADAM15;APLP1;BSG;PXDN;ITGA10;COL4A5;ITGA5;FGF2;NPNT;SLC39A8;ICAM1;ADAM12;ADAMTS19;COL28A1;PDGFB;THSD4;VCAN;ADAMTS14;COL4A2;MMP1;VTN;HAPLN1;NDNF;TGM1;COL15A1;COL18A1;ITGA6;JAM3;ADAMTS4;LAMA1;POSTN;MMP17;ADAMTS3;DCN;MFAP5;COL4A4
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4317786183736919,-1.204960828771963,0.1963470319634703,0.5800197318123431,1.0,5/15,9.35%,VCP;ATF3;GSTO2;HSF1;ZC3H12A
prerank,lymphocyte proliferation (GO:0046651),-0.38574020332158987,-1.2043475582443133,0.1975,0.580692546287719,1.0,4/22,5.94%,BCL2;PTPRC;MSN;HSPD1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.39645178714586987,-1.2038756500123053,0.21374045801526717,0.5810409096661909,1.0,4/18,10.07%,CD74;RIPOR2;MOSPD2;ADAM8
prerank,organic hydroxy compound transport (GO:0015850),0.36802923861334796,1.2037733601938678,0.2082695252679939,0.8896291367634617,1.0,10/36,18.82%,SLCO2B1;ABCC3;ABCG8;AKR1C1;SLC10A2;STARD5;RALBP1;ATP8B1;SLC10A1;GHRL
prerank,Fc receptor signaling pathway (GO:0038093),-0.26698454571850694,-1.2036827998073127,0.07421875,0.5806185062315473,1.0,30/110,17.76%,VAV3;MAP3K1;PSMA6;TEC;PSMB2;PSME2;GRAP2;NFKB1;PPP3R1;PSMD11;SYK;PSMC6;LYN;GAB2;PSMA3;PRKCQ;TAB1;PIK3CA;LCP2;PPP3CA;GRB2;PSMD10;FOS;SHC1;PSMB5;FCER1G;MAP2K4;MAP2K7;MAPK8;PSMD5
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.34688373146368184,-1.2035643366103332,0.1880108991825613,0.5799847283729408,1.0,9/30,13.03%,CD74;BCL2L1;CD44;RTEL1;DYRK1A;YJU2;TPT1;PTTG1IP;PSMD10
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.346698019738925,-1.203494994734954,0.18611111111111112,0.5792272773512847,1.0,15/34,17.09%,NRP1;MAPKAPK2;GAB1;ERN1;FLT1;ANXA1;PIK3CA;SPRY2;EGR3;NOTCH1;SEMA6A;KDR;RAMP2;HSPB1;NUS1
prerank,ventricular septum morphogenesis (GO:0060412),0.39664332651942924,1.2034111966241148,0.19801980198019803,0.889026124688547,1.0,7/27,9.10%,ZFPM1;SOX4;ZFPM2;TGFBR1;TGFBR3;BMP4;HEY1
prerank,phasic smooth muscle contraction (GO:0014821),-0.48189900862474844,-1.203227922041543,0.22065727699530516,0.578963413836696,1.0,7/10,37.76%,EDNRB;DRD2;HTR1D;EDN3;EDN2;EDN1;GDNF
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4413830978601053,1.2026723497927003,0.23103448275862068,0.8902979733324189,1.0,8/18,23.35%,ADRA2A;PRKN;IRS1;SFRP1;CRHBP;REST;MIDN;CHGA
prerank,epithelial cell morphogenesis (GO:0003382),-0.4075243908760483,-1.2023473532776943,0.21707317073170732,0.580394069910956,1.0,3/17,4.17%,RILPL2;MET;CCDC88C
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4217363004885551,1.2022691361637667,0.21891418563922943,0.8898431771008365,1.0,7/20,15.18%,YWHAE;ADRA2A;ACTN2;HECW2;NEDD4;STK39;NEDD4L
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4218384161668351,1.2019131194641,0.2136602451838879,0.8892791611764863,1.0,10/20,27.57%,NCKAP1;NCKAP1L;FMNL3;FMNL1;RHOQ;ROCK1;LLGL2;FHOD1;LLGL1;RAB13
prerank,glycoprotein metabolic process (GO:0009100),-0.302747192820331,-1.2019031051513298,0.1320754716981132,0.5806058588120251,1.0,12/53,14.87%,B4GALT5;ERP44;MAN2A1;GANAB;ST8SIA6;FUT8;HIF1A;ST8SIA4;HPSE;PRKCSH;FBXO2;ST8SIA2
prerank,cardiac muscle tissue development (GO:0048738),0.3455940227789557,1.201754035347888,0.18421052631578946,0.8878401720319877,1.0,10/50,12.33%,ZFPM1;KDM6B;BMP4;HEY1;CACNA1G;TBX2;GJA5;SGCZ;SGCG;AKAP13
prerank,defense response to tumor cell (GO:0002357),0.5148845062782823,1.2016491015494277,0.2534965034965035,0.8862361037646751,1.0,3/10,8.96%,ABI3;DLEC1;PRDX2
prerank,regulation of mRNA metabolic process (GO:1903311),-0.4652079808205247,-1.2015938607943353,0.24608501118568232,0.5804724238368395,1.0,2/11,4.60%,NCBP1;SLTM
prerank,amyloid fibril formation (GO:1990000),-0.31007633428893383,-1.2015475324298046,0.15151515151515152,0.5796707511220931,1.0,20/51,23.17%,TGFBI;ITM2B;CD36;SIAH2;RIPK1;GGA2;UBC;H3-3A;UBA52;USP9X;TSPAN5;APH1B;B2M;UBE2L6;GSN;MFGE8;LTF;APP;SERF1A;CALCA
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4226739771531925,-1.2014347270394552,0.22926829268292684,0.5790304661409539,1.0,9/15,27.14%,CD36;DHX33;TLR4;PYDC1;MYD88;NLRC3;MEFV;EIF2AK2;CPTP
prerank,epiboly involved in wound healing (GO:0090505),-0.4082179687673435,-1.2013991815307652,0.2111650485436893,0.5782057421965963,1.0,7/16,18.70%,CD44;PDCD10;LCP1;CCN1;CEACAM1;CARMIL2;FLNA
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.43667076246802045,1.201200465642251,0.20677966101694914,0.8860769456208724,1.0,5/18,10.44%,CACNG5;CACNG2;NRXN1;SHANK3;CACNG7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.26536143453816624,-1.2009465295399377,0.10526315789473684,0.5784770886967178,1.0,30/109,17.76%,VAV3;MAP3K1;PSMA6;TEC;PSMB2;PSME2;GRAP2;NFKB1;PPP3R1;PSMD11;SYK;PSMC6;LYN;GAB2;PSMA3;PRKCQ;TAB1;PIK3CA;LCP2;PPP3CA;GRB2;PSMD10;FOS;SHC1;PSMB5;FCER1G;MAP2K4;MAP2K7;MAPK8;PSMD5
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4355864722917699,1.1999905384429146,0.2459546925566343,0.8891011563705046,1.0,6/17,20.12%,ATP1B1;GJC3;SLC8A1;GJA5;ATP1A3;ATP1A1
prerank,cellular response to oxygen levels (GO:0071453),-0.48553873799647296,-1.1999334157929147,0.23476297968397292,0.5801768929005339,1.0,3/10,12.27%,ATP6V0D1;CPEB4;ATP6V1A
prerank,regulation of interleukin-13 production (GO:0032656),-0.4401176932454325,-1.1998984002087918,0.2161520190023753,0.5793435909480253,1.0,7/13,26.35%,LILRA5;RARA;IRF4;SPHK2;GATA3;LEF1;TSLP
prerank,protein localization to centrosome (GO:0071539),-0.41125498346459044,-1.1998516956954635,0.19607843137254902,0.5785405925047388,1.0,4/17,5.68%,PCM1;GOLGB1;PIBF1;CCDC14
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.42580916391394574,1.1997016122446942,0.22203389830508474,0.888345441691608,1.0,7/19,10.90%,ZFPM2;MEF2C;TGFBR1;TGFBR3;ERBB4;TBX2;FGF2
prerank,response to sterol (GO:0036314),0.4932432758840673,1.1996792546800208,0.2390158172231986,0.8863743606736942,1.0,5/11,20.91%,TGFBR1;TGFB1;ABCA2;RORA;SMAD2
prerank,postreplication repair (GO:0006301),-0.31176223339226694,-1.199511031627067,0.16619718309859155,0.5785290222426263,1.0,15/45,18.43%,VCP;TRIM25;PCNA;POLI;UBC;PCLAF;BRCA1;UBA52;POLD4;RPA1;FAAP20;UBE2L6;RPA2;DTL;USP43
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.4790435843352611,1.1993900127597474,0.24915824915824916,0.8855462460503238,1.0,4/13,12.28%,NELFB;NELFCD;RNF168;RNF8
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4360853372032753,1.1992115927081355,0.2229299363057325,0.8842209710209836,1.0,7/18,11.69%,NAPB;GRIA2;GRIK5;GRIK2;GRID2;UNC13B;SLC1A4
prerank,T cell differentiation (GO:0030217),-0.3222369665819391,-1.1992111492906714,0.18037135278514588,0.5784283172874962,1.0,17/40,22.21%,PTPN22;PTPRC;ANXA1;LFNG;CD28;LCK;LIG4;TCF7;NHEJ1;FCER1G;ADAM17;ZAP70;GATA3;PIK3CD;GPR89B;GPR89A;SHH
prerank,neutrophil activation (GO:0042119),-0.44652026616609064,-1.1987467905235265,0.24829157175398633,0.5787349285307976,1.0,3/12,6.31%,IL15;TYROBP;SYK
prerank,regulation of receptor internalization (GO:0002090),0.3774030212434407,1.198589324901167,0.20450885668276972,0.8849101381327886,1.0,14/35,26.67%,MKLN1;RIN3;ANKRD13D;ATAD1;ARRB2;INSR;ATXN2;RSPO1;MAGI2;ARRB1;ARF1;CD63;SCYL2;DLG4
prerank,regulation of postsynapse organization (GO:0099175),0.39323431745899184,1.1985781443323613,0.21746293245469522,0.8829178126917125,1.0,12/28,19.14%,ABI3;TANC2;ARHGAP44;SHANK3;CDKL5;SRCIN1;IL1RAPL1;CFL1;LZTS3;EPHA4;ARHGAP22;ABHD17C
prerank,negative regulation of wound healing (GO:0061045),0.3860487236455121,1.1981328675797691,0.20625,0.8828505526236623,1.0,9/28,16.08%,ADTRP;CD34;SLC12A2;CLASP2;THBD;FGF2;VTN;SERPINE2;PHLDB2
prerank,positive regulation of type I interferon production (GO:0032481),-0.28785448148119513,-1.197907353935365,0.10457516339869281,0.580014169629323,1.0,21/73,14.09%,PTPN22;OAS2;IFIH1;TLR2;IRF7;ZBP1;TBK1;POLR2E;DHX33;NFKB1;TLR7;CD14;HSPD1;DDX41;TLR8;STAT1;CTNNB1;EP300;OAS3;LRRFIP1;POLR2H
prerank,extracellular structure organization (GO:0043062),0.28040730464712255,1.1977015582916242,0.09720534629404617,0.8826716826212582,1.0,54/204,19.38%,AGRN;COL5A1;MMP16;LAMB3;F11R;ACAN;COL2A1;ICAM5;ITGB6;JAM2;SPOCK2;ITGB5;ADAMTS20;SMOC2;MFAP2;TGFBR1;FBN2;ADAMTSL1;ADAMTS15;ADAM15;APLP1;BSG;PXDN;ITGA10;COL4A5;ITGA5;FGF2;NPNT;SLC39A8;ICAM1;ADAM12;ADAMTS19;COL28A1;PDGFB;THSD4;VCAN;ADAMTS14;COL4A2;MMP1;VTN;HAPLN1;NDNF;COL15A1;COL18A1;ITGA6;JAM3;ADAMTS4;LAMA1;POSTN;MMP17;ADAMTS3;DCN;MFAP5;COL4A4
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.4050091756903543,-1.1974754475952873,0.2153846153846154,0.5802032429536075,1.0,8/18,27.71%,NR3C1;ANXA1;UBE2L3;KLF9;BCL2L11;HNRNPU;ISL1;AQP1
prerank,negative regulation of phosphorylation (GO:0042326),-0.28298910961212187,-1.1967537115993485,0.12323943661971831,0.5813812756214377,1.0,27/85,21.09%,PID1;STAP1;XDH;NIBAN1;GIT1;CBFA2T3;CORO1C;CRKL;LYN;CIB1;CDKN2C;ZC3H12A;DNAJC10;INPP5K;LRRK2;PRKRIP1;CHP1;TRAF3IP1;MYADM;LRP6;CDKN2A;HNRNPU;BMP7;IRS2;WARS1;NCOR1;HDAC4
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.4584880420929096,-1.1966742895717115,0.2224824355971897,0.5806786398004286,1.0,3/12,12.60%,CLSPN;TOPBP1;TICRR
prerank,7-methylguanosine RNA capping (GO:0009452),0.3844559664305292,1.1963481027481837,0.22075782537067545,0.8842049350934287,1.0,8/31,12.35%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;GTF2F1;POLR2G;RAMAC
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3844559664305292,1.1963481027481837,0.22075782537067545,0.8842049350934287,1.0,8/31,12.35%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;GTF2F1;POLR2G;RAMAC
prerank,vitamin D metabolic process (GO:0042359),0.46804745652843915,1.1960075619570778,0.2363013698630137,0.8836028950062821,1.0,2/13,6.72%,LRP2;LGMN
prerank,protein modification by small protein conjugation (GO:0032446),-0.22785652051124067,-1.1959747006403023,0.016129032258064516,0.5815851550079152,1.0,77/361,13.32%,ITCH;VCPIP1;WWP1;UBE2D3;MSL2;KLHL20;FBXL17;VCP;CUL3;CDC73;TRIM7;IFIH1;ARIH1;NSMCE2;TRIM14;PJA2;UBE2K;CUL4A;UBA5;UBA6;DTX3L;PEX10;BIRC6;RNF213;RANBP2;FBXW7;SMURF2;OS9;PCNA;TRIM17;UHRF2;ATG7;VHL;HECW1;EGR2;ARIH2;CDC34;TRIM62;UBC;ZNRF3;HIF1A;NUP153;EYA1;RNF14;NDC1;CCDC22;LMO7;RNF6;UBE2L3;BRCA1;NUP43;UBA2;UBA52;RNF157;PEX13;NUP210;USP9X;CDC27;SPSB2;RNF220;KLHL21;PIAS2;BARD1;UBE2Q2;UFC1;TRIM44;DCUN1D1;RNF103;TRPM4;RRAGA;CBL;RNF38;ATG3;UBE2E3;FBXO32;RACK1;TRIM5
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.2583634377601202,-1.1957954350297642,0.11673151750972763,0.5811573933462699,1.0,46/128,23.62%,PPP2R2A;PCM1;FBXL17;ENSA;PPP1R12B;CDK5RAP2;PRKACA;FBXL8;BORA;TUBA4A;PPP1R12A;CEP250;KDM8;YWHAG;HAUS2;CEP164;WEE1;MAPRE1;CCNH;DNM2;CDK1;CCNA2;AJUBA;HAUS8;ARPP19;CDK14;MNAT1;CDC25A;OPTN;DCTN2;FBXL15;PLK1;ODF2;PAFAH1B1;NES;FBXL12;MELK;CDC25C;CCNY;AKAP9;CEP78;OFD1;CCNB1;NDE1;BRSK1;MASTL
prerank,regulation of steroid biosynthetic process (GO:0050810),0.5008460705052254,1.195619291566738,0.25888324873096447,0.8832218069795569,1.0,3/11,8.56%,WNT4;STAR;DGKQ
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.455759515183934,-1.1950933962964194,0.23897911832946636,0.5821253691986336,1.0,7/12,20.36%,CD74;LPL;OAS3;FOXP1;TNF;TLR4;KLF4
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4533265817720814,1.194678845915135,0.255700325732899,0.8831592671877869,1.0,4/15,9.82%,BLOC1S2;AP3M1;SNAPIN;AP3B2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4533265817720814,1.194678845915135,0.255700325732899,0.8831592671877869,1.0,4/15,9.82%,BLOC1S2;AP3M1;SNAPIN;AP3B2
prerank,regulation of response to external stimulus (GO:0032101),-0.2656498819386267,-1.1945028063164087,0.1037037037037037,0.5828181856892712,1.0,40/121,25.06%,FCGR2B;PSMA6;PTPN22;CELF1;ALOX5;P2RX4;CD36;ZBP1;CCR2;CAMKMT;STK24;USP18;NOD2;CAV1;ANXA1;HCK;ERAP1;ADGRA2;BIRC2;FNTB;SHPK;TRIM5;CD55;FOXP1;WNT5A;BST1;PDE6B;PDGFRA;PPEF1;APPL2;MYD88;CASP1;ADAMTS12;TMSB4X;XIAP;USP14;APPL1;DHX58;BCL6;PDE6A
prerank,positive regulation of cellular component movement (GO:0051272),0.40165394702834045,1.1944506581948466,0.235,0.8821118944164151,1.0,4/24,7.48%,CCDC25;SPOCK2;STK11;TGFBR1
prerank,positive regulation of cell population proliferation (GO:0008284),-0.22857689996390027,-1.1942149373783273,0.02727272727272727,0.5825828185518797,1.0,91/423,15.42%,PID1;RBPJ;IL15;BCL2;CD74;GAS6;MECP2;ITGAX;IGF1;ACER3;PRKCH;GCNT2;CDK6;DPP4;PTPRC;NDUFS4;CUL3;SDCBP;CD47;CAPN1;LIFR;FAM98B;IL12RB2;MEIS1;RARA;NAMPT;CDCA7L;FAM98A;IL6ST;SOX11;DOT1L;PROX1;PIM1;KITLG;PRC1;S100A6;S1PR2;TOX;C5AR1;CRKL;BST2;THBS1;FLT1;PDGFD;NOD2;KIF20B;PDCD10;YAP1;LYN;DHPS;GAB2;CIB1;HCK;BMI1;IL1B;HSF1;FGF1;VIPR1;HPSE;KRAS;BMP5;STAT1;PDGFC;BIRC5;NOTCH1;CCN1;LIG4;HDAC2;IGF2;TRPM4;HDAC1;KDR;CCND2;EMP2;SLAMF1;PTN;FOXP1;SCX;GREM1;BMP2;KMT2D;HAS2;NPM1;CIAO1;EGFR;SHC1;PTK2B;TNF;GJA1;WNT5A;SLC25A33
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.3841930385721026,-1.193917201998068,0.22784810126582278,0.5824107912357488,1.0,8/21,18.14%,IGF1;MEF2D;ERN1;LDLRAP1;DNMT1;HTR1B;GJA1;IGFBP5
prerank,epithelial cell-cell adhesion (GO:0090136),0.4953825792157929,1.1934780047411513,0.25806451612903225,0.8842283311828719,1.0,3/11,10.14%,PLEKHA7;ITGB5;CAMSAP3
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.43969355788159487,1.1933859784697778,0.22635135135135134,0.8825871490239702,1.0,5/18,17.12%,AGRN;GNA15;RGS10;GNA11;OPRM1
prerank,endothelial cell proliferation (GO:0001935),0.44487600636910013,1.1929445890445574,0.2512908777969019,0.8824463825049235,1.0,5/17,13.02%,CD34;BMP4;ITGB1BP1;THAP1;TEK
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.28268916030667973,-1.1928536443986075,0.1519434628975265,0.5833167905218772,1.0,22/78,18.01%,FCGR2B;CD74;AP2A2;KIF3A;KIF23;KIF11;RAB7A;AP2B1;AP1S3;OSBPL1A;CTSL;RACGAP1;SEC23A;DNM2;CLTA;DCTN4;DYNC1LI2;KIF4A;FCER1G;CAPZB;RILP;DCTN2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.28268916030667973,-1.1928536443986075,0.1519434628975265,0.5833167905218772,1.0,22/78,18.01%,FCGR2B;CD74;AP2A2;KIF3A;KIF23;KIF11;RAB7A;AP2B1;AP1S3;OSBPL1A;CTSL;RACGAP1;SEC23A;DNM2;CLTA;DCTN4;DYNC1LI2;KIF4A;FCER1G;CAPZB;RILP;DCTN2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4390863269583103,1.1925300925133726,0.23671497584541062,0.8822639781470504,1.0,6/17,15.34%,THY1;SLA2;PRNP;PVRIG;PTPN2;DGKZ
prerank,inorganic cation transmembrane transport (GO:0098662),0.27226250650336087,1.1922938890655164,0.09307875894988067,0.8812372304598972,1.0,67/268,23.03%,HCN1;SLC4A8;ATP2A3;KCNK12;TRPC3;ATP2A2;KCNH2;KCND2;SLC24A5;KCNA5;ATP1B1;SCNN1A;KCNE2;SLC39A4;KCNJ8;KCNH7;TRPM3;KCNC1;SLC12A2;TRPM2;KCNK3;ATP1B3;SLC9A4;PKD2;CACNA1G;SLC8A1;ASIC1;ASIC2;KCNK6;SLC1A3;SLC39A8;ATP2C1;CACNA1D;TRPC6;SLC30A3;PKD1;KCNN4;SLC9A5;SLC6A1;SCN2A;ABCC8;ATP6V0E1;SLC8A3;HPN;KCNC3;CACNA1A;SLC24A3;KCNN3;ASIC3;SLC39A3;KCNK9;KCNQ4;KCNK2;SLC24A4;TRPV6;ABCB7;ATP1A4;ATP1A3;ATP1A1;SLC6A9;SLC9A1;SCN3B;SCN1B;RYR3;KCNN2;SLC6A7;SCN8A
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.43467334072238717,1.1922015738945833,0.2372322899505766,0.8796434873047063,1.0,11/19,20.86%,RTN1;GGA3;BIN1;PRNP;CLU;HAP1;NTRK2;ROCK1;CHRNA7;PIN1;ABCA7
prerank,axon guidance (GO:0007411),0.27882756188347807,1.1917886377569304,0.11435832274459974,0.8793512741760829,1.0,50/201,17.09%,SEMA7A;PLXNB2;DCC;CHN1;EFNA4;ROBO4;NFIB;SEMA6C;MYPN;PTPRO;CNTN2;GPC1;EFNB3;DOK4;NRXN1;DSCAM;PLCG1;LGI1;RYK;SEMA6B;SHANK3;SEMA3D;PRKCA;EPHA1;BSG;KLF7;EFNA1;RAP1GAP;SPTAN1;FEZ2;CXCR4;USP33;ARHGAP35;SEMA4F;EFNA3;SPTBN2;EVL;GFRA1;SPTBN1;CYFIP1;EPHA4;EPHB2;ENAH;DSCAML1;SEMA4B;MAPK3;SIAH1;SEMA3C;LAMA1;PTK2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.38092866838642037,1.191755399401042,0.20317460317460317,0.8775679778053647,1.0,8/31,9.53%,TNNI3;TNNC1;LRP2;MYBPC3;ZFPM2;TGFBR1;TGFBR3;TGFB1
prerank,receptor internalization (GO:0031623),-0.31921330648140545,-1.191694520585703,0.19607843137254902,0.5853736924431528,1.0,16/44,16.74%,CD36;SNX1;TFRC;PICALM;LDLRAP1;SYK;CAV1;DNM2;GRB2;CEACAM1;LRP1;LILRB1;RAMP2;CALCRL;FCER1G;RAB31
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.4885016822318407,-1.1914079732138216,0.24822695035460993,0.5852420127417842,1.0,4/10,12.24%,PPARG;RARA;SNW1;RXRB
prerank,regulation of cholesterol esterification (GO:0010872),-0.47303962809666605,-1.1913408502311902,0.24764150943396226,0.584532855129938,1.0,3/10,12.77%,APOE;ABCG1;APOC1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4001368062143677,1.1911379118139618,0.22204213938411668,0.8782342803413127,1.0,10/25,22.24%,LDB1;HTATSF1;EAF2;CCNK;THOC5;DDX39B;ERCC6;CCAR2;ALYREF;SCAF8
prerank,protein localization to chromatin (GO:0071168),-0.40052863055160504,-1.1909397541491828,0.2106537530266344,0.5847192775008161,1.0,11/18,32.99%,PPHLN1;ESR1;RAD21;MCM9;MCM8;PLK1;TASOR;FAM47E;RUVBL2;WAPL;SGF29
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.47104862742807796,-1.1906569155890485,0.25653206650831356,0.5845891951419839,1.0,2/11,4.56%,NOVA2;RASA1
prerank,positive regulation of neuron projection development (GO:0010976),0.3113601553773507,1.1905416320737447,0.153737658674189,0.8788298860222157,1.0,35/85,25.76%,PLXNB2;ARSB;NTRK1;STMN2;PLA2G3;NTRK3;PTK7;PRKCI;GPC2;RIT2;DAB2IP;TWF2;TENM3;ARHGAP35;NDRG4;NDNF;STYXL1;NTRK2;SETX;ITGA6;PRKD1;TWF1;SCARB2;FES;MAGI2;ROR1;DHX36;SCN1B;ZDHHC15;SERPINI1;CAMK2B;BDNF;RAPGEF2;CAMK1;ROR2
prerank,peptidyl-methionine modification (GO:0018206),0.4718529680476536,1.1902893425828578,0.24865831842576028,0.877947247349847,1.0,4/12,21.68%,NAA30;METAP1D;NAA60;METAP2
prerank,regulation of interferon-beta production (GO:0032648),-0.31031606534222494,-1.1900330533117551,0.16716417910447762,0.5853831995074448,1.0,15/46,20.39%,OAS2;IFIH1;TLR2;IRF7;TBK1;TLR7;RNF216;YY1;TLR8;OAS3;LILRB1;RELB;TLR4;POLR3G;NLRC3
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3965568717173007,1.1895100816390367,0.20096463022508038,0.8794180995643811,1.0,12/26,29.76%,ADCY8;RFX6;ADRA2A;CFTR;KLF7;BAIAP3;STXBP4;EPHA5;GPLD1;BRSK2;CDK16;LRP5
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.45701237480161483,-1.1892674764735087,0.21818181818181817,0.5864733030849468,1.0,3/12,6.81%,APOE;LDLR;PFDN5
prerank,positive regulation of chemokine production (GO:0032722),-0.31362374857110026,-1.1885720073841128,0.18611111111111112,0.5874326584055589,1.0,14/44,16.95%,CD74;TLR2;TLR7;SYK;HIF1A;IL1B;LPL;OAS3;AGER;TNF;WNT5A;HMOX1;TLR4;ADAM17
prerank,regulation of ossification (GO:0030278),-0.3301720539195641,-1.188370488407198,0.19047619047619047,0.5870919604820221,1.0,19/36,33.27%,RBPJ;NBR1;SOX11;ANKH;NOTCH1;SMAD6;PTN;BMP2;WNT5A;LRP6;ACVR1;TWIST1;BMPR2;KREMEN2;NOTUM;LRP4;TGFB2;DDR2;ECM1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.44312301552587835,-1.1882214639006952,0.24269662921348314,0.5865617020331959,1.0,5/13,19.24%,MET;TXN;RACK1;LRRK2;GPR37
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3969689386439036,1.1882102693755696,0.22058823529411764,0.8827868159161902,1.0,8/27,18.03%,YWHAE;CACNB4;CACNB2;DMD;ADRA2A;JPH1;HPCA;ANK2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.479855490249314,1.1876412017506,0.24736842105263157,0.8833053285556508,1.0,5/12,15.92%,FGF9;MEF2C;PDGFB;PRKG1;DOCK4
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4641244682813457,-1.1871831491196094,0.24349881796690306,0.5884414934345971,1.0,3/11,6.54%,ARL6IP5;STK24;PDCD10
prerank,negative regulation of protein kinase activity (GO:0006469),0.3093976520663021,1.1868759796818558,0.1623931623931624,0.8845057372974505,1.0,16/88,9.68%,TSC2;PPM1E;WWTR1;THY1;PTPRT;PTPRO;TRIB1;ADAR;TRIB2;UBASH3B;DAB2IP;SRCIN1;EPHA1;MVP;SLC8A1;ITGB1BP1
prerank,protein sumoylation (GO:0016925),-0.30666666339130333,-1.1867483185425252,0.13714285714285715,0.5887750649443929,1.0,12/49,11.79%,IFIH1;NSMCE2;RANBP2;EGR2;NUP153;EYA1;NDC1;NUP43;UBA2;NUP210;PIAS2;TRPM4
prerank,histone deacetylation (GO:0016575),-0.32192408329318584,-1.18641969956988,0.1763085399449036,0.5887220528674956,1.0,15/43,23.26%,SIN3B;RCOR1;TBL1X;BRMS1;BRMS1L;RCOR3;HDAC2;MIDEAS;HDAC1;ELK4;MSL3;PER2;SIRT2;HDAC4;TBL1XR1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3937849856581823,1.1858264599122301,0.2173202614379085,0.8867764037791634,1.0,4/25,1.77%,B3GNT9;B3GNT6;B4GAT1;B3GALT2
prerank,protein K48-linked deubiquitination (GO:0071108),0.4081896689994751,1.1857440549713647,0.23870967741935484,0.8851726190709307,1.0,7/23,15.44%,OTUD7A;USP50;USP33;OTUB1;BAP1;OTUD7B;OTUD5
prerank,protein K63-linked ubiquitination (GO:0070534),0.3606627189085656,1.1857262565554567,0.20715350223546944,0.883345188169913,1.0,13/41,16.06%,UBE2B;UBE2V1;RNF126;UBE2G1;ZFP91;PELI3;NEDD4;PRKN;UBE2N;RNF168;RNF8;RNF135;RNF152
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.36740692395779817,1.1857254718471326,0.21462639109697934,0.8814489294427572,1.0,16/36,25.38%,FHIT;GIPC1;PSMF1;OGT;TAF9;UBXN1;CCAR2;PRKCG;ALAD;HSP90AB1;CAMLG;TLK2;OPHN1;USP7;HFE;TRIM39
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.363708919878354,-1.1848943795248492,0.2283464566929134,0.5916880999672665,1.0,4/24,1.64%,BCL2;CD74;BCL2L1;CD44
prerank,regulation of amyloid fibril formation (GO:1905906),-0.42149057941622403,-1.1845732107004865,0.21994884910485935,0.5916898652022493,1.0,4/15,8.29%,APOE;LDLR;PFDN5;PSEN1
prerank,neuromuscular synaptic transmission (GO:0007274),0.4278892377533945,1.184416475098054,0.2310077519379845,0.8849888532591268,1.0,4/18,9.37%,TSPOAP1;ERC2;FCHSD2;CHAT
prerank,heart process (GO:0003015),0.4540314561097611,1.1841632918435663,0.25205930807248766,0.8841102295320803,1.0,5/14,16.91%,TNNI3;SGCZ;SGCG;PPCS;SGCD
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3915553989376802,-1.1839742315282038,0.22055137844611528,0.5923841775969446,1.0,9/18,27.57%,BRAF;PRKAG2;IL1B;INPP5K;RSC1A1;FFAR4;CLIP3;APPL1;TRIB3
prerank,axonogenesis (GO:0007409),0.2729813958517193,1.1835379916560902,0.09786700125470514,0.8847931486832469,1.0,59/237,17.09%,SEMA7A;DCC;RAB3A;CTNNA2;EFNA4;PARD6B;ROBO4;SEMA6C;MYPN;PTPRO;ATL1;CNTN2;GPC1;EFNB3;DOK4;NRXN1;DSCAM;PLCG1;LGI1;MAP1S;RYK;RAB8A;SEMA6B;SHANK3;APBB1;SEMA3D;PRKCA;EPHA1;BSG;KLF7;EFNA1;RAP1GAP;SPTAN1;FEZ2;SLITRK4;CXCR4;USP33;ARHGAP35;SEMA4F;EFNA3;SPTBN2;NRCAM;EVL;GFRA1;SPTBN1;CYFIP1;EPHA4;EPHB2;SPG11;ENAH;DSCAML1;WNT7A;SEMA4B;MAPK3;SIAH1;SEMA3C;PLPPR4;LAMA1;PTK2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4060056110945554,1.1828650913483714,0.25081967213114753,0.8857113944968736,1.0,3/22,6.72%,LRP2;VKORC1L1;LGMN
prerank,response to ionizing radiation (GO:0010212),-0.2905517392280251,-1.1826228822092224,0.15857605177993528,0.5949603425169675,1.0,28/70,25.54%,AEN;TOPBP1;USP28;ANXA1;EYA1;ABRAXAS1;EEF1D;BRCA1;EYA3;RHNO1;PAXIP1;GRB2;LIG4;BRAT1;KAT5;TICRR;SWI5;NHEJ1;BRCC3;UIMC1;ECT2;XRRA1;BRSK1;BABAM2;NET1;RAD51AP1;TRIM13;TNKS1BP1
prerank,RNA export from nucleus (GO:0006405),0.3006717740952655,1.1822894274535982,0.16733601070950468,0.8862227687004878,1.0,35/100,24.11%,HHEX;RNPS1;AAAS;SRSF5;CASC3;MCM3AP;DDX25;SRSF6;SRSF11;NUP54;SRSF1;CPSF3;NUP88;YTHDC1;RAE1;FYTTD1;UPF1;CDC40;THOC5;DDX39B;SARNP;HNRNPA1;NUP133;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;ALKBH5;RBM15B;GLE1;EIF4E
prerank,regulation of interleukin-2 production (GO:0032663),0.3515694107742972,1.1819940582311,0.20539730134932535,0.8855492000519881,1.0,11/43,13.82%,CD80;CD34;IL17F;CD86;PRNP;NAV3;PNP;PRKD2;HOMER2;MAP3K7;SPTBN1
prerank,snRNA processing (GO:0016180),0.4353437633042592,1.1819887941789144,0.24701873935264054,0.8836965410694574,1.0,6/16,20.79%,INTS6L;INTS10;INTS8;INTS5;INTS9;INTS11
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.3288352059606577,-1.1819474717561533,0.192090395480226,0.5958805625800467,1.0,7/38,6.57%,NEDD9;GAS6;CASS4;PTPRC;LILRA5;PTPN1;CAV1
prerank,bicellular tight junction assembly (GO:0070830),0.3435486223263231,1.1816720878802895,0.19099378881987578,0.8832037222880121,1.0,6/46,6.89%,F11R;CLDN16;PARD6B;MARVELD2;PARD6G;PRKCI
prerank,tRNA processing (GO:0008033),0.33429648449196053,1.1815851593116815,0.19940476190476192,0.881691504317916,1.0,13/61,10.29%,ZBTB8OS;TYW5;ADAT2;RPP40;TSEN54;ELP5;CTU1;DDX1;METTL1;ELAC2;ADAT1;DTWD2;FTSJ1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.38026731090714966,1.1815843575432523,0.2272,0.8798419848563729,1.0,13/30,27.27%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;POLR1E;POLR1F;GTF2H3;POLR1G;ERCC2;POLR1A;TAF1A;GTF2H1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.39940252659301567,1.1806858423561173,0.25842696629213485,0.8815212672516909,1.0,12/24,27.68%,FIS1;PRNP;ITGB1BP1;MYO1C;MTCL1;HRAS;MFF;ITGAM;PDZK1;ANK3;KCNB1;CEMIP
prerank,negative regulation of metabolic process (GO:0009892),-0.2974895726720575,-1.1805648179700392,0.1861198738170347,0.5987127463001067,1.0,18/54,17.54%,RBPJ;IL15;NOVA2;DOCK7;NRDC;NR1H2;IL1B;PCTP;NOTCH1;ID1;APOC1;NR1H3;RB1;ALDH1A1;TLR4;IL18R1;ADAM17;PGAM5
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4418881779917407,1.1804338092369455,0.238013698630137,0.8806583650826116,1.0,5/16,11.16%,FOXD1;BMP4;PKD2;FGF2;NPNT
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2456794643897238,-1.1802039286842794,0.07281553398058252,0.5988009501761071,1.0,27/159,9.30%,HIP1;PXN;CHMP4A;CHMP4B;MIS12;OTUD6B;HSPA4;PSMG1;EIF4B;FCHO2;NCK1;HIP1R;PSMD11;HSPD1;SMAD3;PICALM;TBCA;SNX9;EPS15;NUP153;HSF1;TESPA1;NDC1;UVRAG;CENPA;TBCEL;CCDC40
prerank,lipid phosphorylation (GO:0046834),0.4953266093043338,1.1798121112249684,0.2495511669658887,0.8813275873987422,1.0,5/10,20.67%,DGKI;DGKQ;DGKZ;DGKE;DGKH
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.32143782185878444,1.179633984380463,0.20457796852646637,0.8801626352928363,1.0,26/72,25.88%,FGF10;POLR2L;FGF16;FGF9;POLR2F;KLB;HNRNPH1;FGF7;PTBP1;GTF2F1;FGF2;POLR2G;RBFOX2;SETX;HNRNPA1;MAPK3;CEP57;TIA1;FLRT2;POLR2C;POLR2D;MAPK1;ESRP1;GALNT3;FRS3;FLRT3
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4866855595233458,-1.1792883135216827,0.24838012958963282,0.6003665149923596,1.0,5/10,23.28%,BAG6;EP300;KAT5;KAT7;KAT2B
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.283337502161807,-1.1787354149678093,0.15306122448979592,0.6009330784355138,1.0,21/74,16.33%,BCL2;IGF1;BCL2L1;MCL1;BIRC6;SIAH2;PF4;THBS1;FAS;RIPK1;IL1B;EYA1;BRCA1;EYA3;SH3RF1;BMP5;EYA2;TNF;GPX1;MAPK7;HMOX1
prerank,regulation of glucose import (GO:0046324),-0.3457020678678539,-1.178555957422567,0.20304568527918782,0.600545278190235,1.0,3/30,0.96%,PID1;OSBPL8;IGF1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.36911076169710727,-1.1785365156488667,0.22162162162162163,0.5997050634586455,1.0,12/22,29.71%,PTPN22;RAB7B;LYN;ACOD1;NR1H3;LBP;APPL2;LTF;TICAM2;APPL1;TNFAIP3;MFHAS1
prerank,regulation of synapse assembly (GO:0051963),0.34653419611782127,1.1784750280214038,0.21693907875185736,0.8829762936772624,1.0,14/46,18.82%,LHFPL4;PTPRD;SRPX2;IL1RAP;NRXN1;MEF2C;GRID2;CLSTN2;IL1RAPL1;GPC4;EPHB2;WNT7A;IL1RAPL2;GHRL
prerank,regulation of cell development (GO:0060284),-0.3295657389664371,-1.1783920165662676,0.1994535519125683,0.5992080017702116,1.0,13/36,21.60%,HMGB2;DOCK7;YAP1;IL1B;FOXO1;CTNNB1;ADGRA2;HEY2;PER2;HES1;BHLHE40;NOTCH2;HEYL
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3110341681026716,1.1783093517759742,0.17415730337078653,0.8818028728765661,1.0,31/87,25.88%,FGF10;POLR2L;FGF16;FGF9;POLR2F;KLB;HNRNPH1;FGF7;PTBP1;GTF2F1;ZFP36L2;ITGB1BP1;FGF2;SFRP1;POLR2G;RBFOX2;NDNF;SETX;HNRNPA1;MAPK3;CCL5;CEP57;TIA1;FLRT2;POLR2C;POLR2D;MAPK1;ESRP1;GALNT3;FRS3;FLRT3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4146138824108027,1.178246773357561,0.24086378737541528,0.8802709823599054,1.0,8/20,25.98%,DGAT2;CBR4;PPT2;FITM2;ACLY;ACSL3;SLC25A1;FASN
prerank,protein hydroxylation (GO:0018126),0.4440472353765172,1.1780213732253653,0.253781512605042,0.8793672461891804,1.0,3/15,5.42%,P3H2;PLOD3;ASPH
prerank,phosphate ion transport (GO:0006817),0.44135827598710103,1.177690032523756,0.2755632582322357,0.8789289553869137,1.0,6/16,25.04%,SLC37A4;SLC20A1;SLC37A1;SLC25A10;XPR1;SLC37A3
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3953733119545385,-1.177653657818619,0.2526595744680851,0.6003192018214869,1.0,4/18,10.36%,APOE;VPS35;MSN;PTTG1IP
prerank,heart morphogenesis (GO:0003007),0.33748374091816385,1.1776374183224378,0.19910846953937592,0.8773324051341673,1.0,12/50,21.71%,ZFPM1;MEGF8;MYBPC3;TGFBR1;TGFBR3;HEY1;TBX2;INSR;PTK2;ENG;FLRT2;MDM4
prerank,aorta morphogenesis (GO:0035909),-0.407089424243912,-1.1769418904712599,0.2324455205811138,0.6012812716361478,1.0,7/17,19.13%,RBPJ;PROX1;EFEMP2;LRP1;HEY2;TFAP2B;MYLK
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.45519351226834576,1.1761490793071097,0.2611683848797251,0.881625395410585,1.0,4/14,13.12%,MEF2C;TRIB1;PRKG1;NDRG4
prerank,contractile actin filament bundle assembly (GO:0030038),-0.41316311208446255,-1.1758177516058106,0.2263681592039801,0.6025972899938301,1.0,5/15,11.62%,PDLIM1;CUL3;FHDC1;PDCD10;SORBS1
prerank,stress fiber assembly (GO:0043149),-0.41316311208446255,-1.1758177516058106,0.2263681592039801,0.6025972899938301,1.0,5/15,11.62%,PDLIM1;CUL3;FHDC1;PDCD10;SORBS1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2950773621785696,1.1754540512725067,0.18070652173913043,0.8826138377948531,1.0,30/113,18.55%,FGF10;F3;ANG;FGF9;PTPRN;FLT4;FGF7;SRSF6;AREG;TGFBR1;EGFL7;BMP4;NME1;TCF7L2;PRKCA;PRKD2;PDCD6;FGF2;VASH2;SFRP1;PDGFB;TEK;TGM1;WNT7A;HPN;PRKD1;HRAS;STXBP4;XBP1;AKT3
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3635348727789203,-1.1753059144510425,0.20786516853932585,0.6030683986517046,1.0,8/25,10.51%,IFNAR1;STAT5B;STAT4;CCR2;STAT2;IFNAR2;STAT1;GHR
prerank,regulation of programmed cell death (GO:0043067),-0.24821920002998693,-1.1751714192810387,0.06030150753768844,0.602546943076184,1.0,36/161,16.71%,SLK;DDX42;HIP1;ACER3;RAF1;VCP;STEAP3;ACTN1;KANK2;LGALS1;BAX;NLRC4;BCL3;FAS;RIPK1;TMEM219;CTSB;ANP32B;TPT1;IKZF3;PIDD1;STAT1;BIRC5;BRMS1;BIRC2;DAPK1;LRRK2;PMAIP1;DFFA;TNF;HS1BP3;NUP62;TM7SF3;BCL2L11;BCAR1;NOP53
prerank,regulation of vacuole organization (GO:0044088),0.4145409986654337,1.174766704722645,0.24707846410684475,0.883650192465825,1.0,7/20,20.83%,IFT20;RAB1B;RAB5A;IFT88;UBQLN2;SCARB2;ENO3
prerank,ethanol metabolic process (GO:0006067),-0.4458338199124521,-1.174695362222627,0.26410835214446954,0.6029988968871848,1.0,4/12,22.29%,ACSS2;ALDH1A1;ALDH2;ALDH1B1
prerank,metal ion transport (GO:0030001),0.3111248834683996,1.174285710132841,0.17612809315866085,0.8837634669703542,1.0,26/86,20.00%,ATP2A3;TRPC3;CDH23;NMUR1;CACNA1S;LRP2;TRPM2;CCR1;PKD2;SLC8A1;CACNG7;SLC39A8;ATP2C1;CACNA1D;PANX1;CACNA1B;KCNN4;SLC8A3;CACNA2D1;CACNA1A;CACNG3;CHRNA7;SELENOK;TRPV6;CCL5;CNNM4
prerank,mRNA export from nucleus (GO:0006406),0.29909429412574096,1.1742240416565626,0.17069892473118278,0.8822364134533406,1.0,51/102,31.45%,HHEX;RNPS1;AAAS;SRSF5;CASC3;MCM3AP;DDX25;SRSF6;SRSF11;NUP54;SRSF1;CPSF3;NUP88;YTHDC1;RAE1;FYTTD1;UPF1;CDC40;THOC5;DDX39B;SARNP;NUP133;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;DDX19A;ALKBH5;RBM15B;POLR2D;GLE1;EIF4E;SRSF3;PCID2;NUP107;NUP155;THOC7;SRRM1;NUP85;ZC3H11A;U2AF1;SRSF7;TPR;SEC13;U2AF2;NUP205;POLDIP3
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4395157772047094,1.1740646155847032,0.2596964586846543,0.8810060876570174,1.0,7/16,27.62%,BOC;MEF2C;SMYD1;BTG1;RANBP3L;HIF1AN;PLCB1
prerank,cardiac muscle cell contraction (GO:0086003),0.4102811148411619,1.1737687531258232,0.24836601307189543,0.880376703851456,1.0,8/19,22.55%,FGF12;KCNE2;CACNA1G;CACNA1D;CACNA2D1;ATP1A1;SCN3B;SCN1B
prerank,bile acid biosynthetic process (GO:0006699),-0.36840363027744916,-1.1734268966464263,0.21303258145363407,0.6055231591821089,1.0,5/24,9.27%,ACOT8;OSBP;OSBPL9;OSBPL1A;OSBPL2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.21148059122576432,-1.173424340074527,0.018518518518518517,0.6046464053275497,1.0,233/807,22.42%,ZEB2;DAB2;RBPJ;TRPS1;MDFIC;SP100;FNIP2;NR3C1;WWP1;CD38;GAS6;UBE2D3;POU2F1;MECP2;EPC1;GATAD2B;SETDB2;MITF;SP3;IRF2BP2;LIMD1;CDC73;SDCBP;TGIF1;ZHX2;ATF3;HMGB2;KAT6B;RUNX3;ETV6;SIN3B;CIITA;PEG3;CBFA2T3;PPARG;IRF7;KANK2;TFEC;MNT;RARA;ERF;SMARCA4;SMURF2;ENO1;SOX11;RPS14;PATZ1;BCL3;N4BP2L2;AHR;PROX1;ESR1;NFKB1;ETV5;LIMS1;NAB1;TAF1;ZNF8;YY1;VHL;LCOR;PPARD;MBD2;CIART;ATXN1;RCOR1;CEBPB;DPF3;SMAD3;BCL7A;CCND1;CAV1;BCOR;PFDN5;NR1H2;KDM8;YAP1;WWOX;UBC;TBL1X;ID4;FOXE1;BMI1;EDNRB;ZMYM5;HSF1;RPL10;CRY2;PSEN1;HINFP;BRCA1;LIN37;SNW1;UBA52;ID3;GCLC;H1-0;MBD1;MAD2L2;L3MBTL4;MZF1;USP9X;ORC2;STAT1;CTCF;FOXP4;BIRC5;NFIC;ZBTB18;PRMT2;FOXO1;NOTCH1;ATF5;CTNNB1;EP300;L3MBTL3;BRMS1;BRMS1L;RCOR3;ID1;SPEN;CUX2;HDAC2;ZNF148;IGF2;CRY1;FOXJ1;ATF7IP;DEPDC1;FHL2;MIDEAS;KAT5;HDAC1;FRK;ZBTB5;CBX8;LRRFIP1;PSMD10;NR1H3;GATAD2A;INPP5K;FOXP1;RB1;E2F8;FOXP2;MOSPD1;BMP2;L3MBTL2;CREB3L1;EHMT1;QARS1;PARP9;ELK4;IRF2;DACH1;RIOX1;NOTCH4;SHC1;LHX1;TNF;KDM5C;ZBTB2;WNT5A;ZNF318;KAT7;FOXK2;DEAF1;DDX20;THAP7;E2F7;PDE2A;KLF11;NOP53;SAP18;IKZF1;KLF2;SATB1;HEY2;UIMC1;ARID5B;NUPR2;NRIP1;GATA3;HMGA2;SMAD4;GLIS2;PER2;NIBAN2;MCPH1;HIVEP1;LANCL2;FLNA;TRIM37;HES1;TFAP2B;PPM1F;MXI1;EED;PLK1;CDKN2A;TAF7;DNAJB1;MYT1L;HNRNPU;WFS1;PA2G4;BMP7;BHLHE40;HMGA1;YEATS2;KLF4;EPO;SIRT2;NCOR1;CPEB3;BASP1;TRIM33;PTCH1;HDAC4;SCMH1;ID2;HEYL;SEMA4D;RBAK;MECOM;NR1H4;SHH;RREB1;TWIST1;HOXD9;PSPC1;AASS;SKIL
prerank,selective autophagy (GO:0061912),-0.2906456627738825,-1.1727853911327835,0.16770186335403728,0.6053717730820377,1.0,15/56,13.10%,NBR1;MAP1LC3B;UBA5;ATG13;RAB7A;ARL13B;UBQLN1;UBC;WDFY3;UBA52;VIM;ATG2B;UFC1;WDR81;DYNC1LI2
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.4588860032404571,-1.1726530952386816,0.2617924528301887,0.6048231525360613,1.0,2/10,3.50%,APOE;PRKACA
prerank,response to unfolded protein (GO:0006986),-0.3040194169714118,-1.1724839902816457,0.1918918918918919,0.6044494004174041,1.0,18/48,19.79%,ERP44;HSPA4;PTPN1;BAX;ERN1;HSPD1;HSF1;TOR1B;PACRG;HSPB3;HSPB1;HSPB8;DNAJB5;OPTN;TM7SF3;DNAJB1;HSPA13;HSPA1B
prerank,positive regulation of protein deacetylation (GO:0090312),0.45767230300764916,1.1722762268873754,0.2461799660441426,0.8846395336610108,1.0,6/14,22.00%,CTBP1;AKAP8L;SAP30BP;AKAP8;ZBTB7B;ING2
prerank,positive regulation of nuclear division (GO:0051785),-0.36251591253272986,-1.1722282229241539,0.2245430809399478,0.6043087421525339,1.0,11/25,23.66%,IGF1;IL1B;NUSAP1;CD28;IGF2;NUP62;DRD3;RGCC;SIRT2;TGFA;EGF
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3981112903764795,1.171745135104256,0.24561403508771928,0.8850672766078267,1.0,10/22,18.56%,RELA;CLU;LRRTM3;EFNA1;CASP3;EFNA3;EPHA4;ABCA2;IFNGR1;CHRNA7
prerank,positive regulation of protein binding (GO:0032092),-0.3009725182505175,-1.171722542457031,0.19805194805194806,0.6047378611604013,1.0,21/56,21.52%,STK3;APOE;DTX3L;TAF1;HIP1R;CAV1;PSEN1;AKTIP;SPPL3;B2M;RALB;LRP1;BMP2;LRRK2;PPP2CB;NMD3;HIPK2;RPL11;BAMBI;TRIM21;APP
prerank,regulation of mitotic nuclear division (GO:0007088),-0.30156225215717103,-1.1716743123300541,0.20987654320987653,0.6039953165642877,1.0,22/55,24.83%,IGF1;CDK5RAP2;MKI67;BORA;KIF20B;IL1B;NUSAP1;CD28;IGF2;DUSP1;NUP62;CUL9;NME6;DRD3;RGCC;BMP7;CDC25C;RCC1;TGFA;CCNB1;EGF;CDK13
prerank,granulocyte differentiation (GO:0030851),-0.39319205592233886,-1.1711422641683873,0.2391304347826087,0.6045469831935352,1.0,4/18,10.79%,CBFA2T3;RARA;DEK;EP300
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.49065446471703483,1.1708211033986242,0.28620689655172415,0.887060561564561,1.0,5/11,20.05%,DONSON;TIMELESS;LIG3;SMARCAL1;FBXO5
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3971467914722455,-1.170656952965872,0.23273657289002558,0.6050266851070591,1.0,3/17,5.75%,CD74;RIPOR2;MOSPD2
prerank,heme biosynthetic process (GO:0006783),0.4102525685355391,1.1705515844376966,0.23529411764705882,0.8863904959462346,1.0,11/22,28.70%,ABCB6;FLVCR1;TSPO;PGRMC1;UROD;ALAD;ABCG2;SLC25A38;COX10;CPOX;ATP5IF1
prerank,cytoplasmic translational initiation (GO:0002183),-0.40437862931423063,-1.1705238287612614,0.25925925925925924,0.604489942901732,1.0,4/17,5.84%,DHX29;EIF4B;EIF2S2;EIF3I
prerank,histone H3 deacetylation (GO:0070932),-0.40417515999001785,-1.1704375974659618,0.25813953488372093,0.6038592302560135,1.0,6/15,21.09%,HDAC2;HDAC1;ELK4;PER2;SIRT2;HDAC4
prerank,positive regulation of cell adhesion (GO:0045785),0.31439660407954717,1.1699733800541559,0.1950207468879668,0.8868025672003881,1.0,15/74,14.86%,ZFHX3;FRMD5;P2RY12;NCKAP1L;MAGI1;PRKCA;PRKD2;STX3;NPNT;PDGFB;EPHA4;FLCN;FBLN2;NDNF;RSU1
prerank,calcium ion transmembrane transport (GO:0070588),0.30548522243428944,1.1696798614013666,0.19136690647482013,0.8862248203908786,1.0,25/86,18.75%,ATP2A3;TRPC3;ATP2A2;SLC24A5;TRPM3;TRPM2;MICU2;SMDT1;PKD2;GRIN1;CACNA1G;SLC8A1;GRIN2B;ATP2C1;CACNA1D;TRPC6;PKD1;ATP2B3;SLC8A3;SLC25A23;CACNA2D1;CACNA1A;SLC24A3;SLC24A4;TRPV6
prerank,cellular response to insulin stimulus (GO:0032869),-0.26271752601291043,-1.1695565419106215,0.12340425531914893,0.6053227549856788,1.0,29/124,17.31%,ATP6V0D1;MYO5A;RAB8B;DENND4C;ATP6V0D2;ATP6V1B2;ATP6V0A1;PPARG;NAMPT;ATP6V0B;GAB1;SLC27A4;BCAR3;GOT1;AP3S1;RAB15;RAB10;FOXO1;GRB2;SORBS1;IGF2;CEACAM1;ATP6V1A;INPP5K;SHC1;SLC25A33;BCAR1;RAB31;CPEB2
prerank,cilium movement (GO:0003341),0.34444900330179823,1.1695175612530755,0.2246376811594203,0.8850538681417908,1.0,12/47,15.94%,DNAAF1;ODAD4;CCDC39;ROPN1L;DNAI3;DNAH9;CFAP100;CAMSAP3;SPA17;SPEF2;DNAAF2;CFAP61
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.45875002475047905,-1.168919533547282,0.271264367816092,0.6061989895363954,1.0,4/11,7.65%,SYK;PLAUR;LYN;PRKCQ
prerank,cellular response to lipid (GO:0071396),-0.23951094457455793,-1.1675818672195204,0.08256880733944955,0.608984478890568,1.0,50/191,17.69%,PID1;NR3C1;STAP1;CD274;AXL;ABL2;BRINP1;CDC73;HMGB2;GIT1;AHR;ESR1;NFKB1;ADAM9;CD14;MSN;LCOR;PF4;NOD2;TNIP3;LYN;IL1B;UBE2L3;RET;SNW1;LPL;ZC3H12A;ADCY5;ADCY6;VIM;ACOD1;ADCY1;TNFRSF1B;KAT5;SHPK;NR1H3;ADCY3;SPHK2;TESC;LBP;EGFR;LILRB1;PTK2B;WNT5A;FAM210B;TLR4;MAPK8;MAP4K1;ADNP2;NRIP1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4560388757790881,1.167465451530598,0.27806563039723664,0.8913286115012321,1.0,3/13,9.53%,PRICKLE1;BMP4;TGFB1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.49631275892750903,1.1673069754162761,0.28546409807355516,0.890256539800628,1.0,4/10,19.06%,PDE3B;SNAI2;JAM3;WNK1
prerank,response to lipopolysaccharide (GO:0032496),-0.24947459227606733,-1.1670335669687362,0.1206896551724138,0.609630097108531,1.0,35/138,17.20%,IFNAR1;PTPN22;STAP1;CD274;AXL;NOCT;CDC73;HMGB2;GIT1;MAPKAPK2;NFKB1;ADAM9;CD14;PF4;NOD2;TNIP3;IL1B;ZC3H12A;VIM;ACOD1;MAPKAPK3;TNFRSF1B;SLC11A1;SHPK;SMAD6;NR1H3;FOXP1;PELI1;LBP;LILRB1;WNT5A;TLR4;ADAM17;LIAS;MAPK8
prerank,mitotic cell cycle phase transition (GO:0044772),-0.23851686549872597,-1.166690809372114,0.078125,0.609745526172011,1.0,70/203,24.27%,CHMP4B;EPS8;PPP2R2A;PCM1;FBXL17;ENSA;CDK6;PPP1R12B;CUL3;CDK5RAP2;CUL4A;TACC3;PRKACA;FBXL8;GPR132;BORA;TUBA4A;PPP1R12A;CEP250;CDC34;CCND1;KDM8;YWHAG;CDKN2C;HAUS2;HINFP;CEP164;WEE1;MAPRE1;CCNH;CDC27;DNM2;CDKN3;CDK1;CCNA2;AJUBA;HAUS8;CCND2;RB1;ARPP19;CDK14;TRIM71;MNAT1;CDC25A;OPTN;UBE2C;DCTN2;FBXL15;PLK1;CDKN2A;ODF2;PAFAH1B1;NES;FBXL12;CUL5;MELK;ACVR1;CDC25C;CCNY;AKAP9;CEP78;OFD1;RCC1;ANAPC7;CCNB1;NDE1;BRSK1;MASTL;CTDP1;PIM2
prerank,regulation of cell adhesion (GO:0030155),0.2899560127977367,1.1666765903609713,0.16415868673050615,0.8910009328167482,1.0,34/129,20.07%,ZFHX3;FRMD5;PLXNB2;ARHGDIG;SIPA1;PKP4;DSCAM;PDE3B;PIK3CG;ADAM22;ARHGDIA;PRKCA;PRKD2;ITGB1BP1;STX3;MINK1;EFNA1;ZDHHC2;CXCR4;EPHA4;CBLL1;FLCN;EPHB2;RSU1;MIA3;KIF14;PTK2;ROCK1;IL18;PPP2R1A;FES;PLXNB1;CCL5;EPB41L4B
prerank,regulation of histone deacetylation (GO:0031063),0.4691873484639166,1.166530768919497,0.28187919463087246,0.889809316504627,1.0,6/13,22.00%,CTBP1;AKAP8L;SAP30BP;AKAP8;ZBTB7B;ING2
prerank,positive regulation of actin nucleation (GO:0051127),0.48431899877750595,1.1665165798413808,0.27106227106227104,0.8881019969893128,1.0,5/11,17.80%,NCKAP1;FCHSD2;WASF3;CYFIP1;WASF2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.42572842280648104,1.166457189387058,0.24319727891156462,0.8865991568437175,1.0,5/17,15.63%,SELENOS;HSP90B1;HERPUD1;DERL1;HM13
prerank,regulation of leukocyte migration (GO:0002685),0.43475932865874073,1.1661949902618998,0.2620232172470978,0.8858539785370371,1.0,4/16,15.36%,ADTRP;NCKAP1L;CD81;MIA3
prerank,negative regulation of T cell differentiation (GO:0045581),0.5002185684094869,1.1653531874915115,0.2937956204379562,0.8875109418264737,1.0,6/10,29.09%,BMP4;ZC3H8;LAG3;GLI3;IRF1;MDK
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.25573734317626123,-1.1651084138744843,0.11347517730496454,0.6132870919590862,1.0,55/110,36.88%,ADGRE5;ADGRG6;ADCY9;PTGER4;S1PR2;PF4;DRD2;GNA13;ADCY5;ADCY6;ADCY1;GPR65;ADCY3;RAMP2;CALCRL;ADRA1A;PTHLH;ADGRG5;S1PR3;DRD3;ADGRL2;LPAR2;ADGRB1;GPR101;RXFP2;PTH1R;CALCA;GLP1R;RAMP3;S1PR4;ADORA2A;VIP;LPAR3;ADGRG7;GPR4;PTGIR;TBXA2R;ADGRG1;GPR26;ADGRG2;LGR4;PTGFR;MC2R;CXCL9;ADGRD1;DRD1;GPER1;GPR3;CALCR;FSHR;LHCGR;ADRA2C;GHRH;CALCB;ADCY4
prerank,gonad development (GO:0008406),0.3515381360860937,1.164925161679696,0.23338485316846985,0.8874704269473802,1.0,6/41,9.16%,WNT4;FGF9;SIX4;LRP2;AR;MEA1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.26692739134910637,-1.164747278645016,0.1684981684981685,0.6134741839145749,1.0,27/101,15.36%,PTPN22;STAP1;CD274;AXL;PRKCE;CDC73;HMGB2;GIT1;NFKB1;ADAM9;CD14;PF4;NOD2;TNIP3;LYN;HCK;IL1B;ZC3H12A;VIM;ACOD1;TNFRSF1B;SHPK;NR1H3;LBP;LILRB1;TNF;WNT5A
prerank,protein alkylation (GO:0008213),-0.3601730832869714,-1.1644011656209836,0.2196969696969697,0.6134256393283125,1.0,9/22,13.92%,FAM98B;ETF1;FAM98A;CAMKMT;SNRPB;VCPKMT;PRMT2;EEF2KMT;ETFBKMT
prerank,tight junction assembly (GO:0120192),0.3332156197334452,1.163966310476004,0.2127659574468085,0.8895598511229577,1.0,6/49,6.89%,F11R;CLDN16;PARD6B;MARVELD2;PARD6G;PRKCI
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2984828818217512,1.1636269035543672,0.1978319783197832,0.8892404543550416,1.0,34/96,24.11%,HHEX;RNPS1;AAAS;SRSF5;CASC3;MCM3AP;DDX25;SRSF6;SRSF11;NUP54;SRSF1;CPSF3;NUP88;YTHDC1;RAE1;FYTTD1;UPF1;CDC40;THOC5;DDX39B;SARNP;NUP133;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;ALKBH5;RBM15B;GLE1;EIF4E
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.37493858577162864,1.1635704011897543,0.26094003241491087,0.8877220169160663,1.0,5/32,9.18%,TRPC3;CAPN3;THY1;PLCG1;GRIN1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.26796198974029495,-1.162010362757751,0.15217391304347827,0.6190867995351585,1.0,23/88,16.87%,APOE;RIC1;DNAJC1;CNOT9;MALSU1;NFKB1;SAMD4A;CLN8;EDNRB;BAG6;DDX6;EIF4ENIF1;CAPRIN1;DAPK1;PAIP2B;TYMS;LARP1;RACK1;SYNCRIP;RGP1;TRIM71;CLN3;FXR2
prerank,cellular response to lectin (GO:1990858),-0.26296735369865676,-1.1616284264608192,0.13983050847457626,0.6183525171818617,1.0,28/104,18.89%,PSMA6;RAF1;PSMB2;PRKACA;TYROBP;PSME2;NFKB1;CLEC10A;PSMD11;SYK;PSMC6;LYN;FYN;PSMA3;CLEC6A;TAB1;KRAS;EP300;KLRD1;PSMD10;PSMB5;PRKACB;RELB;FCER1G;PSMD5;NRAS;CLEC4E;PSMD1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.26296735369865676,-1.1616284264608192,0.13983050847457626,0.6183525171818617,1.0,28/104,18.89%,PSMA6;RAF1;PSMB2;PRKACA;TYROBP;PSME2;NFKB1;CLEC10A;PSMD11;SYK;PSMC6;LYN;FYN;PSMA3;CLEC6A;TAB1;KRAS;EP300;KLRD1;PSMD10;PSMB5;PRKACB;RELB;FCER1G;PSMD5;NRAS;CLEC4E;PSMD1
prerank,positive regulation of receptor internalization (GO:0002092),0.3984599597728885,1.1614018234031231,0.2706270627062706,0.8948102710258439,1.0,7/22,25.44%,ATAD1;ARRB2;INSR;MAGI2;ARRB1;CD63;SCYL2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.4060796995465752,-1.161078410516664,0.25526315789473686,0.6189871896007038,1.0,4/15,12.77%,APOE;PLTP;ABCG1;APOC1
prerank,extracellular matrix organization (GO:0030198),0.2640135557700491,1.1610221901757873,0.13450292397660818,0.8945860034037848,1.0,76/276,21.82%,P3H2;AGRN;PLOD3;P4HA3;COL5A1;DST;MMP16;PPIB;LAMB3;F11R;ACAN;COL2A1;ICAM5;ITGB6;JAM2;SPOCK2;ITGB5;ADAMTS20;SMOC2;MFAP2;TGFBR1;SERPINH1;FBN2;TGFB1;ADAMTSL1;ADAMTS15;ADAM15;APLP1;BSG;CAPNS1;PXDN;ITGA10;COL4A5;ITGA5;FGF2;NPNT;SLC39A8;ICAM1;ADAM12;ADAMTS19;COL28A1;PDGFB;THSD4;VCAN;ADAMTS14;COL4A2;MMP1;VTN;HAPLN1;NDNF;KLK2;COL15A1;COL18A1;ITGA6;JAM3;PLOD1;ADAMTS4;LAMA1;POSTN;TMPRSS6;QSOX1;MMP17;ADAMTS3;P4HA2;CTSK;DCN;MFAP5;COL4A4;ITGAD;CAPG;ITGAM;KIF9;FLRT2;LAMC2;COL6A1;CTSS
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.330216266140595,-1.1606679037270624,0.22865013774104684,0.6192297176447342,1.0,14/32,22.30%,CDK17;ZPR1;PCNA;HINFP;TYMS;RB1;CDT1;CDK14;E2F7;KLF11;ESRRB;DHFR;ID2;CDC45
prerank,cellular response to interleukin-12 (GO:0071349),-0.3075621642456432,-1.159804251513642,0.1891891891891892,0.6206734589460868,1.0,11/48,15.99%,CD47;TALDO1;STAT4;IL12RB2;PSME2;LMNB1;MSN;LCP1;HNRNPA2B1;AIP;RAP1B
prerank,mesenchyme development (GO:0060485),0.43790774724933873,1.159333649529626,0.26495726495726496,0.8996738066152834,1.0,4/15,10.60%,TGFBR1;BMP4;PKD2;CRELD1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4454986332765227,1.1585605966343533,0.2739495798319328,0.9010396946859095,1.0,2/14,3.31%,AVPR2;AVPR1A
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2629554610114093,-1.1581200352221646,0.15350877192982457,0.6242941175681842,1.0,28/105,18.89%,PSMA6;RAF1;PSMB2;PRKACA;TYROBP;PSME2;NFKB1;CLEC10A;PSMD11;SYK;PSMC6;LYN;FYN;PSMA3;CLEC6A;TAB1;KRAS;EP300;KLRD1;PSMD10;PSMB5;PRKACB;RELB;FCER1G;PSMD5;NRAS;CLEC4E;PSMD1
prerank,protein dephosphorylation (GO:0006470),-0.25171237531733864,-1.15807488039717,0.1592920353982301,0.6235373425632343,1.0,35/135,15.58%,PPP2R5C;PTPN22;DUSP16;PPP2R1B;PPP2R2A;PTPRC;PPP2R5A;PPP4R1;MTMR2;PTPN1;CDC14B;PTPN21;PPM1H;PPP1R12A;NCK1;MTMR4;CTDNEP1;EYA1;PTPN7;TAB1;DUSP18;EYA3;PPP2R2C;PPP4R2;PHPT1;PPP3CA;EYA2;MTM1;CTDSP1;DUSP1;PPP2CB;TIMM50;RPAP2;TNS2;MTMR3
prerank,regulation of cartilage development (GO:0061035),-0.39112154649031894,-1.1580498259388898,0.24744897959183673,0.6227122880336067,1.0,5/18,17.28%,TRPS1;SOX6;SCX;BMP2;PTHLH
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.22148450506208087,-1.1578850972555779,0.0423728813559322,0.6222923658557649,1.0,70/348,15.08%,IQGAP1;DAB2;IL15;CD74;FNIP2;NRP1;GAS6;IGF1;RAF1;CD44;PTPRC;SDCBP;TEC;NIBAN1;CNOT9;UBE2K;DVL3;FAM20A;DOCK7;BRAF;TBK1;NPTN;S1PR2;CRKL;PDGFD;FAS;RIPK1;TFRC;BCAR3;CCND1;PDCD10;PLAUR;CAV1;SNX9;LYN;PRKAG2;NBN;CIB1;CLEC6A;IL1B;TXN;BANK1;FGF1;MAD2L2;KRAS;BMP5;PDGFC;SPRY2;LCP2;GHR;AGAP2;CALM3;CCN1;CSPG4;RBPMS;IGF2;AKTIP;BRAT1;KDR;CCND2;CALM2;RACK1;RALB;MTCP1;BMP2;LRRK2;EGFR;AGER;PTK2B;TNF
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.38809801051948445,1.1573644877486224,0.23801652892561984,0.9040788485842187,1.0,9/24,16.66%,SEMA7A;SEMA6C;MEGF8;DSCAM;SEMA6B;SEMA3D;SEMA4F;SEMA4B;SEMA3C
prerank,cellular protein catabolic process (GO:0044257),-0.2880091075084856,-1.157241728277853,0.18152866242038215,0.6231335203505727,1.0,12/59,10.81%,PSMA6;AP2A2;YME1L1;SIAH2;RAB7A;CAPN2;AP2B1;RIPK1;CTSL;CTSB;CLPP;CLTA
prerank,regulation of protein binding (GO:0043393),-0.2549237581118444,-1.1572058446478644,0.13654618473895583,0.622365540949497,1.0,35/114,21.52%,DAB2;STK3;CRK;MARK2;BTBD1;IFIT2;DTX3L;GNL3L;PRKACA;BAX;IFIT1;TAF1;HIP1R;LDLRAP1;CAV1;PSEN1;AKTIP;SPPL3;B2M;RACK1;RALB;LRP1;BMP2;LRRK2;CFHR2;NMD3;MAPK8;HIPK2;PLK1;NES;RPL11;BAMBI;TRIM21;HDAC4;APP
prerank,positive regulation of catabolic process (GO:0009896),-0.2830064901490329,-1.1564692006487456,0.17891373801916932,0.6235145596936227,1.0,16/65,17.88%,ITCH;WWP1;VCP;STX5;RAB7A;SMURF2;ATG7;HECW1;IL1B;FOXO1;BARD1;TNF;WNT5A;TIPARP;DTL;RILP
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3958805212855325,-1.156148227992608,0.27918781725888325,0.6234737625120889,1.0,7/16,21.73%,SMCHD1;KLHL15;MAD2L2;RMI2;SHLD1;PARPBP;FBH1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2821163006661213,-1.1560154161947394,0.18596491228070175,0.6229424882303823,1.0,16/65,15.60%,HIP1;CNOT9;HIP1R;BCAR3;PLAUR;ARAP1;EPS15;SPRY2;GRB2;CEACAM1;CBL;SPRY1;STAM;EGFR;ITGA1;NUP62
prerank,xenobiotic transport (GO:0042908),0.41904691786202597,1.1559657697753067,0.27287853577371046,0.9080136430720503,1.0,7/17,27.36%,ABCC3;NR1I2;SLC22A4;ABCG2;SLC22A18;ABCC5;ABCA3
prerank,methylguanosine-cap decapping (GO:0110156),0.49270703930291926,1.1556887648979077,0.2921146953405018,0.907368301242538,1.0,3/10,17.78%,PATL1;LSM1;PNRC2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4344129505291771,-1.155168265863702,0.2585034013605442,0.6243855164037769,1.0,2/12,6.70%,IQGAP1;CD24
prerank,chemical homeostasis (GO:0048878),0.319427541378832,1.1547744741411905,0.23154848046309695,0.9094310411111243,1.0,24/61,26.01%,TLCD3A;SLC4A8;USF2;TLCD3B;PNPLA3;ABCB4;SLC66A1;TLCD2;USF1;SLC4A10;SLC4A7;ABHD5;ACOX1;NEDD4L;FITM2;ANGPTL3;ABHD8;WNK1;EIF5A2;PNPLA8;THADA;VGF;DDX3X;KLHL3
prerank,atrial septum morphogenesis (GO:0060413),0.4921821842391316,1.1546928701915913,0.29084380610412924,0.9080295897336891,1.0,2/10,4.50%,ZFPM1;SOX4
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.29550912491007414,-1.154692202810601,0.2098360655737705,0.6248028042677325,1.0,18/56,19.01%,CHMP4B;KIF23;RASA1;SNX9;STMN1;CIT;RACGAP1;USP8;CENPA;NUSAP1;ESPL1;PDCD6IP;KIF4A;CKAP2;INCENP;KIF20A;ECT2;PLK1
prerank,positive regulation of cell killing (GO:0031343),-0.4261128306745984,-1.1546337290420106,0.28104575163398693,0.6240971453842268,1.0,8/13,34.67%,SYK;CYBA;WNT5A;MAPK8;NOXO1;RAC1;FZD7;NOS2
prerank,cell cycle G2/M phase transition (GO:0044839),-0.24967909544784694,-1.154628945914171,0.17073170731707318,0.623256457852323,1.0,46/129,23.62%,PPP2R2A;PCM1;FBXL17;ENSA;PPP1R12B;CDK5RAP2;PRKACA;FBXL8;BORA;TUBA4A;PPP1R12A;CEP250;KDM8;YWHAG;HAUS2;CEP164;WEE1;MAPRE1;CCNH;DNM2;CDK1;CCNA2;AJUBA;HAUS8;ARPP19;CDK14;MNAT1;CDC25A;OPTN;DCTN2;FBXL15;PLK1;ODF2;PAFAH1B1;NES;FBXL12;MELK;CDC25C;CCNY;AKAP9;CEP78;OFD1;CCNB1;NDE1;BRSK1;MASTL
prerank,mononuclear cell differentiation (GO:1903131),-0.354359501801813,-1.1545220096150088,0.22646310432569974,0.6226860540513955,1.0,8/24,16.80%,GAS6;AXL;PPARG;LYN;LILRB1;RELB;MYH9;IKZF1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.36626067536508994,1.1542999529427793,0.24592833876221498,0.9078776946712963,1.0,13/34,19.50%,P2RY12;TNFAIP8L3;DAB2IP;TGFB1;FGF2;IRS1;PDGFB;TEK;PIK3IP1;PRKD1;PTK2;FLT3;PDGFRB
prerank,negative regulation of centrosome duplication (GO:0010826),-0.447426613914511,-1.1541207469171102,0.25892857142857145,0.6229649096514702,1.0,6/11,25.76%,CDK5RAP2;BRCA1;NPM1;TRIM37;KAT2B;CCNF
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.2608582122209494,-1.1535570486747617,0.15333333333333332,0.6236167358012663,1.0,26/95,17.20%,FCGR2B;STAP1;CD274;AXL;CDC73;TLR2;HMGB2;GIT1;NFKB1;ADAM9;CD14;PF4;NOD2;TNIP3;IL1B;ZC3H12A;VIM;ACOD1;TNFRSF1B;SHPK;NR1H3;LBP;LILRB1;WNT5A;TLR4;MAPK8
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.30617056942737647,-1.1532007258709136,0.23939393939393938,0.6237106640082241,1.0,14/47,15.28%,ARL6IP5;NBR1;FAS;NOD2;PDCD10;MID1;TAOK3;FOXO1;MAPK8IP3;GREM1;QARS1;EGFR;AGER;SCIMP
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.402751068835679,-1.1524610364164112,0.28165374677002586,0.6248386099489217,1.0,5/16,14.62%,AOAH;PHKB;AGL;GAA;PGM2L1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.20973974172055795,-1.1524225291259949,0.0,0.6240726816923704,1.0,158/572,21.09%,ZEB2;DAB2;RBPJ;TRPS1;SP100;FNIP2;NR3C1;UBE2D3;MECP2;EPC1;GATAD2B;MITF;IRF2BP2;CDC73;SDCBP;TGIF1;ZHX2;ATF3;RUNX3;ETV6;SIN3B;CIITA;PEG3;PPARG;IRF7;KANK2;TFEC;MNT;RARA;ERF;SMARCA4;SMURF2;ENO1;SOX11;RPS14;N4BP2L2;PROX1;ESR1;NFKB1;ETV5;TAF1;ZNF8;YY1;VHL;LCOR;PPARD;MBD2;ATXN1;CEBPB;SMAD3;CCND1;CAV1;BCOR;NR1H2;YAP1;WWOX;UBC;TBL1X;ID4;FOXE1;BMI1;EDNRB;ZMYM5;HSF1;RPL10;CRY2;PSEN1;LIN37;SNW1;UBA52;ID3;H1-0;MAD2L2;MZF1;USP9X;ORC2;STAT1;CTCF;FOXP4;NFIC;ZBTB18;NOTCH1;EP300;BRMS1;BRMS1L;ID1;SPEN;CUX2;HDAC2;ZNF148;IGF2;CRY1;FOXJ1;FHL2;KAT5;HDAC1;FRK;ZBTB5;CBX8;LRRFIP1;PSMD10;NR1H3;GATAD2A;FOXP1;RB1;E2F8;FOXP2;MOSPD1;BMP2;PARP9;ELK4;IRF2;DACH1;NOTCH4;TNF;ZBTB2;DEAF1;DDX20;THAP7;E2F7;PDE2A;KLF11;NOP53;KLF2;SATB1;HEY2;ARID5B;NUPR2;NRIP1;GATA3;HMGA2;SMAD4;GLIS2;PER2;MCPH1;HIVEP1;TRIM37;HES1;TFAP2B;MXI1;EED;PLK1;TAF7;DNAJB1;MYT1L;HNRNPU;WFS1;BHLHE40;NFATC3;YEATS2;KLF4;EPO;SIRT2;NCOR1;CPEB3;TRIM33;PTCH1;HDAC4
prerank,positive regulation of catalytic activity (GO:0043085),-0.3205430845386338,-1.152398748571365,0.2200557103064067,0.6232865504175933,1.0,12/37,19.20%,ABL2;ATP7A;NOD2;CAV1;CIB1;PSEN1;IGF2;SLC5A3;MID1IP1;NHEJ1;MAPK8;BCAS3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.37912950477290286,-1.1520886064465508,0.2386634844868735,0.6232133842660309,1.0,6/18,13.84%,SOX6;FRS2;NOTCH1;HDAC1;CCN3;BMP2
prerank,vasodilation (GO:0042311),0.46069218151846886,1.152043885326396,0.2857142857142857,0.9151528501339556,1.0,1/13,0.59%,KCNMA1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.36037326955968774,-1.1516237924034953,0.2540983606557377,0.6235907885292432,1.0,7/23,16.57%,GAS6;CD274;AXL;RARA;ZC3H12A;LILRB1;TLR4
prerank,negative regulation of T cell activation (GO:0050868),-0.3274335855241071,-1.1513198292505866,0.23229461756373937,0.6235784849406968,1.0,6/35,6.14%,FCGR2B;PTPN22;CD274;RIPOR2;DLG5;CEBPB
prerank,protein homotetramerization (GO:0051289),0.32533707221336816,1.1510624776962723,0.21851289833080426,0.9173970548105901,1.0,12/49,20.00%,HCN1;TRPM2;ALDH9A1;CBR4;PKD2;ACOT13;HPRT1;ACACB;TK1;HSD17B10;ALDOA;SSBP1
prerank,monocarboxylic acid transport (GO:0015718),0.32856381770856297,1.1509793247147362,0.2378138847858198,0.9160092467004551,1.0,7/51,8.44%,SLC16A6;SLCO2B1;ABCC3;AKR1C1;SLC10A2;ABCB4;STARD5
prerank,protein ubiquitination (GO:0016567),-0.2153430245332157,-1.1509673910260807,0.031578947368421054,0.623708536017466,1.0,109/471,16.43%,SASH1;BCL2;ITCH;VCPIP1;HECTD2;WWP1;PSMA6;UBE2D3;MSL2;KLHL20;HERC6;FBXL17;VCP;UNKL;TRIM25;CUL3;CDC73;TRIM7;ARIH1;PRPF19;TRIM14;PJA2;UBE2K;CUL4A;PSMB2;UBA6;DTX3L;PEX10;FBXL14;BIRC6;RNF213;SIAH2;FBXO30;FBXW7;OBI1;SMURF2;FBXL8;OS9;PCNA;PSME2;TRIM17;UHRF2;TAF1;UBE2Q1;RNF146;VHL;HECW1;PSMD11;ARIH2;CDC34;PSMC6;TRIM62;RNF13;UBC;ZNRF3;PSMA3;NHLRC3;HIF1A;FBXW4;RNF14;CCDC22;LMO7;RNF6;UBE2L3;BRCA1;UBA52;RNF157;PEX13;SH3RF1;USP9X;CDC27;SPSB2;RNF220;KLHL21;RC3H1;KBTBD8;CTNNB1;BARD1;UBE2Q2;TRIP12;TRIM44;BIRC2;RNF103;AKTIP;RRAGA;CBL;RNF38;ATG3;UBE2E3;PSMD10;FBXO32;RACK1;TRIM5;FBXO2;PELI1;UBE2L6;PSMB5;UCHL3;TRIM71;WAC;KLHL41;MKRN1;OTULIN;RC3H2;LONRF1;MUL1;CUL9;UBE2C;ASB4
prerank,sensory perception of light stimulus (GO:0050953),0.3050089818107849,1.1505080619281005,0.22908093278463648,0.916238774893015,1.0,10/87,8.53%,GUCY2F;WHRN;ROM1;RDH10;CDH23;COL2A1;CRYGN;CNGB1;CRYBA4;CABP1
prerank,protein methylation (GO:0006479),-0.31453452267309473,-1.1504680318518208,0.2028169014084507,0.6242553866739402,1.0,13/40,13.96%,FAM98B;ETF1;FAM98A;CAMKMT;SETD3;SNRPB;RAB6A;VCPKMT;ICMT;PRMT2;EEF2KMT;ETFBKMT;EHMT1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.4453902519432373,-1.1503595014946664,0.28132387706855794,0.6237150453412292,1.0,4/11,23.22%,FAS;PLAUR;GSN;CAAP1
prerank,protein catabolic process (GO:0030163),-0.28442723634838174,-1.1503458195881213,0.19558359621451105,0.6229074131286648,1.0,14/59,14.97%,APOE;VCP;PRPF19;SIAH2;RIPK1;CLN8;CLN5;BAG6;LAMP2;CEACAM1;FBXO2;PMAIP1;MAGEC2;UCHL3
prerank,positive regulation of reproductive process (GO:2000243),-0.3409444280072988,-1.1501316816161806,0.22395833333333334,0.6226277258439475,1.0,13/31,31.73%,SMURF2;PRDM9;PGAM4;AGO2;HYAL3;SIRT2;TAC4;GLRA1;VIP;INHBB;C1QBP;SYDE1;PDE3A
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2674507007416283,-1.150057400537426,0.18543046357615894,0.6219706163865137,1.0,14/82,9.39%,VAV3;ITSN1;ACTR3;AP2A2;CRK;SDCBP;GIT1;RASA1;AP2B1;ARPC2;LYN;FYN;PSEN1;ARPC5
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.35856857452146207,-1.1499069298639202,0.27154046997389036,0.6215279503486579,1.0,3/24,5.46%,PID1;NDUFS4;MTLN
prerank,camera-type eye morphogenesis (GO:0048593),0.4907246123489294,1.1498474975025859,0.2951388888888889,0.9171981022375155,1.0,3/10,11.20%,TENM3;TBX2;KDM2B
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.24380549479213948,-1.1495214605823274,0.1318181818181818,0.6216339080029357,1.0,46/149,21.52%,PSMA6;FLOT2;PRKCH;TRIM25;TLR2;TRIM14;CD36;RAB7B;LAMTOR5;NLRC4;DHX33;NFKB1;NOD2;RIPK1;TFRC;CAV1;TRIM62;UBC;CIB1;PRKCQ;IL1B;TAB1;PIDD1;UBA52;ADAM8;EP300;EDA;TRIM5;NPM1;RIPK4;AGER;TNF;WNT5A;TRAF1;TLR4;CRNN;IL18R1;ERC1;ARHGEF2;TRIM37;MYD88;HSPA1B;LTF;TRIM21;AIM2;APP
prerank,positive regulation of proteolysis (GO:0045862),-0.2940022244479378,-1.1493465713731272,0.18691588785046728,0.6212440840765368,1.0,21/55,24.48%,APOE;CCBE1;NLRC4;ADAM9;NRDC;SNX9;IL1B;ZC3H12A;ADAM8;HDAC2;TNFRSF1B;TBC1D10A;TNF;MAPK12;PLK1;NKD2;TNIP1;NDUFA13;PERP;FGFR4;FADD
prerank,neuromuscular process controlling balance (GO:0050885),0.4599939459760409,1.1490946200120622,0.27943760984182775,0.9183913705092808,1.0,5/12,25.81%,CDH23;NRXN1;SHANK1;CLRN1;TPP1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.26982781687725044,-1.1490275706202753,0.17164179104477612,0.621278927002087,1.0,23/86,20.58%,ZEB2;DAB2;RBPJ;SDCBP;SOX11;THBS1;SNW1;BMP5;NOTCH1;EP300;CCN1;RBPMS;BMP2;NUMA1;BMP3;ADAM17;HIPK2;SMAD4;FBXL15;ACVR2A;GDF3;BMP7;ACVR1
prerank,muscle contraction (GO:0006936),0.28456354949301454,1.1485445919970372,0.20293724966622162,0.9188372063055498,1.0,17/126,9.84%,MYOM1;LMOD1;NMUR1;CACNA1S;TNNI3;TNNC1;DMD;ITGB5;MYBPC3;ASPH;TMOD2;MYL12B;PGAM2;ACTN2;MYL6;SLC8A1;EMD
prerank,dendrite self-avoidance (GO:0070593),0.42042106408605495,1.148198867606404,0.2840531561461794,0.918571306295269,1.0,6/16,15.29%,ROBO4;MYPN;CNTN2;DSCAM;BSG;DSCAML1
prerank,prostanoid biosynthetic process (GO:0046457),0.432053553125916,1.1481211808815919,0.2845394736842105,0.9171431675368531,1.0,3/15,4.40%,PTGS1;PTGDS;PRXL2B
prerank,positive regulation of protein maturation (GO:1903319),-0.44601306205029345,-1.1470862378469087,0.2630272952853598,0.6258249742017415,1.0,3/11,10.07%,CCBE1;NLRC4;ADAM8
prerank,cellular response to estrogen stimulus (GO:0071391),0.44723651905987905,1.1469590740453484,0.2995008319467554,0.9202885036985156,1.0,4/14,12.75%,WBP2;AR;SFRP1;CRHBP
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.24133050606383333,-1.1469076705455834,0.13725490196078433,0.6254638730878355,1.0,26/140,12.11%,VAV3;ARHGAP15;ARHGEF3;FGD4;ITSN1;ARHGAP10;STARD8;ARHGAP17;ARHGAP19;CGNL1;ARHGEF18;ARHGEF6;ARHGAP18;ARAP1;ARHGAP30;PLEKHG5;RACGAP1;FGD1;ARHGAP24;ABR;GNA13;RHOJ;ARHGDIB;ARHGAP39;ARHGEF26;ARHGAP28
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.417164530363751,1.1467650248201449,0.26475548060708265,0.919348099013485,1.0,6/18,11.20%,SELPLG;ADD2;JAM2;PODXL2;CX3CR1;SLC39A8
prerank,regulation of innate immune response (GO:0045088),-0.29084139903600204,-1.1467210672110202,0.21005917159763313,0.6250855541263596,1.0,21/57,24.93%,FCGR2B;PTPN22;PTPN1;IFNAR2;USP18;TLR8;ERAP1;ADAM8;ACOD1;BIRC2;PARP9;MUL1;POLR3G;APPL2;NLRC3;TRIM21;SLC15A4;XIAP;PLSCR1;APPL1;DHX58
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4778030655742993,1.1460856930764882,0.2981878088962109,0.9202815599121354,1.0,3/11,9.53%,TGFBR1;TGFBR3;TGFB1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.42122203092942123,-1.1459057957633667,0.27149321266968324,0.6263700346281175,1.0,8/13,30.73%,CAV1;CAMK2D;CALM3;CALM2;PDE4D;CASQ2;CALM1;SRI
prerank,nuclear migration (GO:0007097),-0.4166754868986226,-1.1457631399948942,0.27842227378190254,0.6259080840896551,1.0,6/13,23.59%,PCM1;DOCK7;TMEM201;PAFAH1B1;SYNE2;HOOK3
prerank,regulation of cellular senescence (GO:2000772),0.3795382904485237,1.1452931852266353,0.24961715160796324,0.9217160745288149,1.0,11/28,22.00%,ABI3;EEF1E1;VASH1;NEK4;CGAS;RBL1;AKT3;ARG2;FBXO5;NUAK1;ING2
prerank,gene expression (GO:0010467),-0.21969205592032476,-1.145203260694677,0.07462686567164178,0.6265758135778347,1.0,95/348,19.53%,APOBEC1;SRSF4;EPC1;RPS26;RPL39;CPSF1;RPL5;RPS23;RPS24;LMF2;RPS16;RRAGC;AGFG1;NCBP1;EEF1A1;RPL28;POLR2E;RANBP2;RPS29;RBM8A;RPS14;SNRNP40;BCL3;RPS20;RPS12;FIP1L1;RPL35A;RPL18A;RPS13;RPL27;RPL21;RPS7;HSPD1;RPS5;ATXN1;RPL30;RPL6;RPL37A;DHX38;DHPS;EIF4EBP2;IGHMBP2;HNRNPK;RNGTT;NUP153;RPL10;RPL15;NDC1;NUP43;NUP210;RPS10;YARS2;RPL14;RPL9;XRN2;RPL32;RPL36;RBPMS;RPL23A;CPSF4;TSPAN5;PRPF4;MRPL35;RPL31;HNRNPA2B1;NXT1;POLR2B;AGO2;CPSF2;PTMA;SCX;RPL3;POLR2H;TESC;SYNCRIP;RPL41;POLR2J;NUP62;RPL8;DDX20;UPF3B;MLF1;UPF2;RPL37;HNRNPD;MAGOHB;MAGOH;SRBD1;MRPS33;RPL36A;RPL26;DKC1;SMG6;HNRNPU;CELF2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.3847872580526246,-1.145071791460567,0.25609756097560976,0.626109393848936,1.0,7/18,24.58%,CCT6A;EXOSC10;CCT3;NOP10;DKC1;NAF1;NHP2
prerank,autophagy of nucleus (GO:0044804),-0.3996631997584304,-1.1449450221757063,0.28940568475452194,0.6256604746317833,1.0,5/16,16.18%,ATG13;ATG7;ATG2B;ATG3;ATG9B
prerank,peptidyl-arginine modification (GO:0018195),-0.40954080927630915,-1.144670709310183,0.27602905569007263,0.6255447009230194,1.0,2/15,6.06%,NDUFAF5;PADI4
prerank,pyruvate metabolic process (GO:0006090),0.32853493612501844,1.1439088818871586,0.2573099415204678,0.925649929419699,1.0,15/52,20.83%,HOGA1;GAPDH;VDAC1;PGAM2;ALDOC;BSG;PFKM;HK2;DLD;DLAT;PDHX;PFKFB2;ALDOA;PGM1;ENO3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.4645677469293185,-1.1434828355506466,0.29802955665024633,0.6271583565360339,1.0,2/10,3.81%,ASCC3;ASCC1
prerank,DNA dealkylation (GO:0035510),-0.4645677469293185,-1.1434828355506466,0.29802955665024633,0.6271583565360339,1.0,2/10,3.81%,ASCC3;ASCC1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.30916564756447157,1.1433148745723842,0.23919308357348704,0.926359427974922,1.0,24/75,24.07%,GUCY2F;C3;MRAP;RGS11;CNGB1;GNG4;DGKQ;ADCYAP1;MGRN1;GUCY2D;USP33;RIC8B;RGS2;NMT1;ROCK1;RGS20;CCL5;YWHAB;METAP2;GUCA1B;GIT2;TULP3;RGS5;RGS3
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.34728697729751357,-1.1431391043419734,0.2556390977443609,0.6272872364106821,1.0,3/25,6.25%,ITGA4;ITGAX;ITGB7
prerank,response to progesterone (GO:0032570),-0.37564902723072424,-1.1430569547113094,0.2548076923076923,0.626662068860231,1.0,7/18,13.14%,THBS1;CATSPER3;CAV1;YAP1;CATSPER2;ACOD1;NR1H3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4283332438040113,1.1430082267648156,0.2862129144851658,0.9258340914931733,1.0,6/16,18.40%,PQBP1;DDX5;SRSF6;SRSF1;SRSF9;PUF60
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3294878092710948,-1.1428207525267198,0.26519337016574585,0.626495556007575,1.0,12/30,22.36%,SMCHD1;KLHL15;HSF1;CYREN;MAD2L2;TRIP12;RMI2;SHLD1;PARPBP;HMGA2;FBH1;TWIST1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.38007956486997285,-1.1427500337529772,0.26555023923444976,0.6258695028003972,1.0,13/19,30.39%,NFKB1;TNF;MAPK7;KLF2;MAPK8;GATA3;WFS1;KLF4;APP;EGF;MTPN;TMEM106A;PAX8
prerank,positive regulation of type 2 immune response (GO:0002830),-0.40980380828766444,-1.1426341750516535,0.28992628992628994,0.625359495827883,1.0,4/14,5.93%,CD74;DENND1B;RARA;NOD2
prerank,iron ion transmembrane transport (GO:0034755),0.49299277041957423,1.1423854573092735,0.2927689594356261,0.9266289864091602,1.0,4/10,24.96%,ABCB6;SLC39A8;ABCB7;ABCC5
prerank,regulation of neuron apoptotic process (GO:0043523),0.2921430638967091,1.1419947671788522,0.20933521923620935,0.9265138158651417,1.0,22/96,16.80%,FAIM2;NTRK1;SIX4;PPARGC1A;PLA2G3;PRNP;BACE1;MEF2C;LGMN;PRKCI;NRBP2;GRID2;SIGMAR1;CLCF1;PRKN;KDM2B;MAG;NDNF;SNX6;NTRK2;KIF14;PRKCG
prerank,B cell activation (GO:0042113),-0.2776347437981293,-1.1419526054755291,0.221875,0.626355665455567,1.0,22/68,21.09%,ITGA4;BCL2;PTPRC;CEBPG;KLF6;LYL1;GPR183;HSPD1;DNAJB9;BLNK;BANK1;FCRL1;CD79B;NHEJ1;CHRNB2;ADAM17;ZAP70;CD79A;CHRNA4;PIK3CD;LAX1;HDAC4
prerank,negative regulation of axon extension (GO:0030517),0.36487151182721295,1.141098403828588,0.25848142164781907,0.9283258751155468,1.0,10/30,17.54%,DIP2B;SEMA7A;SEMA6C;SEMA6B;SEMA3D;MAG;SEMA4F;SEMA4B;SEMA3C;PTPRS
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.37964197711955844,-1.1399096256371255,0.28365384615384615,0.6310288100496354,1.0,4/18,6.42%,ITGA4;PPARG;FLT1;SP1
prerank,cellular calcium ion homeostasis (GO:0006874),0.2824950338327463,1.1389766694813646,0.2054973821989529,0.9351407453718158,1.0,32/133,19.68%,YWHAE;ATP2A3;ATP13A4;ADCY8;TRPC3;ATP2A2;CDH23;SLC24A5;ATP1B1;TNNI3;ATP13A5;CCR1;MICU2;SMDT1;BAK1;SLC8A1;HERPUD1;CCDC47;RMDN3;ATP2C1;TRPC6;ATP2B3;SLC8A3;DMPK;SLC24A3;ANK2;CHRNA7;SELENOK;SLC24A4;CCL15;CCL5;CAV2
prerank,second-messenger-mediated signaling (GO:0019932),0.30115495265563147,1.1388855957176536,0.24380165289256198,0.9337735997257536,1.0,23/82,17.85%,ACKR4;P2RY12;ACKR3;KSR2;NMUR1;PLCG1;CCR1;RCAN3;SAMD14;CXCR6;CX3CR1;BTK;CXCR4;CCR6;NDNF;RCAN2;PPP1R9A;CCR9;ACKR2;DDAH2;AGT;PPP2R1A;INPP5A
prerank,regulation of platelet aggregation (GO:0090330),0.40748173872567905,1.1387511737699179,0.29623567921440264,0.9326391519334797,1.0,6/17,15.75%,F11R;ALOX12;PRKCA;SH2B3;PRKG1;SERPINE2
prerank,platelet degranulation (GO:0002576),-0.24883008109144475,-1.138703694621832,0.1487603305785124,0.6334855428409059,1.0,54/118,32.51%,F13A1;GAS6;IGF1;OLA1;PSAP;ACTN1;CD36;TUBA4A;PF4;THBS1;LYN;SRGN;LAMP2;SERPING1;IGF2;TAGLN2;FAM3C;VCL;FLNA;F8;FN1;ITGB3;F5;TIMP1;TLN1;PHACTR2;APOH;TMSB4X;APP;SERPINF2;VEGFB;ANXA5;EGF;TIMP3;BLK;PDGFA;CTSW;TOR4A;CLEC3B;ITIH3;PLG;PLEK;ACTN4;CD109;CALM1;VWF;VEGFC;HGF;RAB27B;PROS1;BRPF3;TGFB2;ABCC4;TTN
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.3252044522447125,-1.1385818647561372,0.2335958005249344,0.6329931209155351,1.0,14/31,28.43%,RAB1A;FBXW7;CDC14B;BMI1;UBE2L3;DCUN1D1;MAGEC2;UBE2C;ARRDC4;PLK1;GORASP1;DCUN1D4;TRIB3;CDC20
prerank,L-amino acid transport (GO:0015807),0.3727457849049845,1.13846399350532,0.29333333333333333,0.9320784411704212,1.0,7/28,11.69%,SLC38A2;SLC1A1;SLC25A18;SFXN1;SLC1A3;CTNS;SLC1A4
prerank,mRNA transport (GO:0051028),0.28981069245452123,1.1380624431849744,0.22,0.9319152810629698,1.0,34/101,24.11%,HHEX;RNPS1;AAAS;SRSF5;CASC3;MCM3AP;DDX25;SRSF6;SRSF11;NUP54;SRSF1;CPSF3;NUP88;YTHDC1;RAE1;FYTTD1;UPF1;CDC40;THOC5;DDX39B;SARNP;NUP133;SRSF9;SMG1;NXF1;CHTOP;ALYREF;SRSF2;POM121;SMG7;ALKBH5;RBM15B;GLE1;EIF4E
prerank,Notch signaling involved in heart development (GO:0061314),-0.4388010049759853,-1.1380499824529442,0.3060747663551402,0.6337503390619545,1.0,7/11,27.00%,RBPJ;NOTCH1;HEY2;NOTCH2;HEYL;GALNT11;DLL4
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.4297127974204639,1.138021935934338,0.29401993355481726,0.9303449039218243,1.0,2/15,1.42%,WHRN;LHFPL5
prerank,copper ion transport (GO:0006825),-0.4584525303064747,-1.1375614745935037,0.29398148148148145,0.6341757201319428,1.0,3/11,3.65%,STEAP3;ATP7A;SLC31A2
prerank,histone H3-K4 methylation (GO:0051568),-0.34915357693315463,-1.1374535066930813,0.2731707317073171,0.633677241289965,1.0,14/26,25.67%,TET2;PRDM9;WDR82;KMT2C;KDM6A;PAXIP1;TET3;DPY30;KMT2D;RBBP5;KMT2B;SETD1A;KMT2A;DYDC2
prerank,cortical cytoskeleton organization (GO:0030865),0.34016538541582547,1.1373780338798596,0.25949367088607594,0.9312532029608527,1.0,15/41,27.57%,NCKAP1;NCKAP1L;RHOBTB1;FMNL3;FMNL1;RHOQ;ROCK1;RHOBTB2;LLGL2;RHOBTB3;RHOA;FHOD1;LLGL1;EPB41L3;RAB13
prerank,regulation of isotype switching (GO:0045191),-0.41300276142566256,-1.1372497046406642,0.2511520737327189,0.633401162596775,1.0,4/14,12.09%,TFRC;MAD2L2;PAXIP1;SHLD1
prerank,glycogen metabolic process (GO:0005977),-0.3446572724271367,-1.137126483747317,0.2591623036649215,0.6329367874070707,1.0,8/27,17.97%,PHKB;GYG1;AGL;PRKAG2;PPP1R3C;GAA;PGM2L1;PER2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.4297130501394889,-1.1367669854409803,0.2951945080091533,0.6331457810724986,1.0,4/12,14.90%,FCGR2B;GPR183;LFNG;PTK2B
prerank,regulation of pH (GO:0006885),0.46308328381811914,1.136488110381105,0.304857621440536,0.9331386146574159,1.0,4/11,22.22%,LACC1;SLC26A4;ATP1A4;SLC9A1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.36552893517024587,-1.1360462988715314,0.2825,0.6342950924971014,1.0,10/21,27.48%,CHST11;CHST9;UGDH;CSPG4;CHST7;CHPF;CHST12;CHSY3;CHST3;NCAN
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.41189316580792557,-1.1357991067508797,0.29698375870069604,0.6341199434377641,1.0,8/14,30.65%,RCC1L;TRUB2;TRMT10C;UQCC2;MRPS27;RPUSD3;C1QBP;MPV17L2
prerank,regulation of BMP signaling pathway (GO:0030510),-0.2710052837679375,-1.1350948368609415,0.19463087248322147,0.6352017510221232,1.0,23/73,22.46%,RBPJ;UBE2D3;PPARG;SMURF2;SOX11;SMAD9;LEMD3;NOTCH1;CCN1;SMAD6;GREM1;BMP2;NUMA1;HIPK2;SMAD4;FBXL15;TFAP2B;ACVR2A;GDF3;BAMBI;TRIM33;SKIL;XIAP
prerank,dendritic cell differentiation (GO:0097028),-0.35928406961121484,-1.1349834218553343,0.28165374677002586,0.63468890814973,1.0,5/22,14.75%,GAS6;AXL;LYN;BATF2;LILRB1
prerank,positive regulation of rRNA processing (GO:2000234),0.4703078015925978,1.134673293604803,0.29225352112676056,0.9387368626224071,1.0,3/10,8.21%,RIOK1;WDR75;DIMT1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2988855342665339,1.1345925764789395,0.20704225352112676,0.9373528075353842,1.0,14/86,8.17%,CTTN;BIN1;PAK1;LMOD1;PSRC1;STMN2;TENM1;NCKAP1;NCKAP1L;CDC42EP5;CLU;NAV3;FCHSD2;LIMK1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.34368033797250225,-1.13439057571552,0.25263157894736843,0.6354516802338969,1.0,8/29,15.08%,PPP2R1B;THBS1;RIPK1;CAV1;WWOX;RET;PMAIP1;TNF
prerank,nuclear export (GO:0051168),0.30106293023567604,1.1343798618114973,0.23480662983425415,0.9364771410465673,1.0,38/80,31.48%,RNPS1;STRADB;SRSF5;CASC3;SRSF6;SRSF11;TGFB1;SRSF1;RAE1;PKD1;CDC40;THOC5;DDX39B;SARNP;HNRNPA1;XPO6;SRSF9;NXF1;CHTOP;STRADA;ALYREF;SRSF2;RANBP3L;POM121;RANBP17;EIF4E;CCHCR1;SRSF3;NUP155;THOC7;SRRM1;ZC3H11A;U2AF1;SRSF7;TPR;U2AF2;POLDIP3;RITA1
prerank,RNA stabilization (GO:0043489),-0.3231139362106475,-1.1343265116897867,0.257372654155496,0.6347910420920279,1.0,15/33,26.50%,NOCT;ZCCHC17;TENT2;EIF4ENIF1;TRDMT1;TENT5A;SLC11A1;NSUN2;LARP1;DKC1;HNRNPU;NAF1;TENT5C;VIP;PAIP1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.44228928327462635,1.133859783171442,0.3003472222222222,0.9367488043220862,1.0,6/13,10.90%,ZFPM2;MEF2C;TGFBR3;ERBB4;TBX2;FGF2
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.33744528636055204,-1.133068810333003,0.26520681265206814,0.6373297257631201,1.0,8/27,15.40%,KAT6B;PHF20;BAG6;TRRAP;EP300;KAT5;MSL3;KAT7
prerank,regulation of organelle organization (GO:0033043),-0.26287721002973863,-1.1330522697613394,0.20962199312714777,0.6365391642345642,1.0,24/80,17.60%,ZEB2;MYO5A;MARK2;STX5;VPS35;CAPN2;CLIC4;MSN;SPEF1;PDCD10;PARL;TMED9;EP300;MTM1;USP6NL;RBSN;CDT1;CLN3;ARHGEF5;PDE2A;MUL1;RAB33B;STX18;SQSTM1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3583155799780752,1.1328155504841668,0.29635499207606975,0.9391832905732577,1.0,13/30,22.17%,THY1;PRKCZ;SOCS3;SRCIN1;MVP;INPP5F;SH2B3;SFRP1;PTPN2;CADM4;PPP2R1A;SH3BP5L;SFRP2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3577237006746695,1.132724257659705,0.2591414944356121,0.9378584867373919,1.0,12/31,27.17%,SH3BP1;DLG2;SCRIB;PRKCI;CAMSAP3;MTCL1;LIN7A;CDC42;OPHN1;RHOA;MYO9A;PARD3B
prerank,regulation of T cell mediated immunity (GO:0002709),-0.451144534701863,-1.1325449665146303,0.2863636363636364,0.6371195132066207,1.0,5/10,14.78%,CCR2;IL1B;TRPM4;TNFRSF1B;AGER
prerank,protein localization to condensed chromosome (GO:1903083),-0.4211443405646277,-1.132534863220017,0.2866817155756208,0.6363242849887295,1.0,5/12,14.07%,BUB3;MIS12;ZWILCH;CDK1;SPDL1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4498434473085755,-1.132495919357019,0.31627906976744186,0.6355971900774953,1.0,5/11,22.37%,PARP4;PARP14;PARP9;TIPARP;PARP16
prerank,cellular response to cadmium ion (GO:0071276),0.38213154757350476,1.1324800203379206,0.27741935483870966,0.9371095849126458,1.0,10/24,17.76%,MAPK3;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3997488521610979,-1.1320591615034965,0.28465346534653463,0.6359819612035518,1.0,3/17,2.75%,PID1;GIT1;CBFA2T3
prerank,ventricular septum development (GO:0003281),0.3496934287999452,1.1320530326490619,0.28213166144200624,0.9371173352010124,1.0,8/37,9.96%,ZFPM1;SOX4;ZFPM2;DAND5;TGFBR1;TGFBR3;HEY1;GJA5
prerank,amide biosynthetic process (GO:0043604),0.33110670896798833,1.1318739057551892,0.2641509433962264,0.9360992959814838,1.0,12/47,18.99%,OTC;SLC25A2;PM20D1;DMD;TLCD3B;CERS4;SPTSSA;CERS6;CERS5;CERS1;ASMT;ARG2
prerank,regulation of endothelial cell migration (GO:0010594),-0.26459534961085035,-1.1315315289123362,0.19661016949152543,0.6365305613125231,1.0,33/85,25.12%,SASH1;SP100;APOE;NRP1;NRP2;PROX1;THBS1;FGF1;ZC3H12A;PRCP;RHOJ;CEACAM1;KDR;EMP2;GPI;PTN;FOXP1;PTK2B;WNT5A;EPHA2;BCAR1;AAMP;GATA3;ITGB3;BCAS3;PIK3CD;APOH;ADGRB1;EGF;ANXA3;BMPR2;ANGPT1;RAC1
prerank,peptide cross-linking (GO:0018149),-0.34626747032709093,-1.1310368283164745,0.2670157068062827,0.6370864234368704,1.0,15/25,36.43%,F13A1;THBS1;ANXA1;CD247;FN1;COL3A1;DSP;EVPL;KRT10;TGM6;TGM5;EPB42;TGM7;CD3G;SPRR1A
prerank,RNA polyadenylation (GO:0043631),-0.34651153510825594,-1.1303662759640574,0.2853470437017995,0.63725200600046,1.0,11/26,25.49%,CDC73;CPSF1;FIP1L1;TENT2;AHCYL1;CPSF2;PCF11;TENT4B;APP;LEO1;WDR33
prerank,mRNA polyadenylation (GO:0006378),-0.34651153510825594,-1.1303662759640574,0.2853470437017995,0.63725200600046,1.0,11/26,25.49%,CDC73;CPSF1;FIP1L1;TENT2;AHCYL1;CPSF2;PCF11;TENT4B;APP;LEO1;WDR33
prerank,response to alcohol (GO:0097305),0.3679589067975109,1.1302535493523096,0.2857142857142857,0.9411261957025187,1.0,8/27,20.91%,TGFBR1;TGFBR3;GRIN1;TGFB1;GRIN2B;ABCA2;SDF4;SMAD2
prerank,cellular response to dsRNA (GO:0071359),-0.39233856299036257,-1.1301567638265388,0.2815533980582524,0.6370056696442724,1.0,6/15,16.17%,IFIH1;IFIT1;CAV1;RALB;NPM1;MUL1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.38227333014416454,-1.129914926170528,0.2875318066157761,0.6368271895360142,1.0,4/17,12.65%,ATP5MG;ATP5PO;ATP5MC1;STOML2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.43857506163618665,-1.1296292677894448,0.3190045248868778,0.636809277224463,1.0,3/11,11.91%,DAB2;MLLT3;PLEKHA4
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.35254223476300534,1.1294587294208078,0.27124183006535946,0.942507464271819,1.0,8/35,12.04%,GGT7;HMGCLL1;ALOX12;AWAT2;GGT5;CBR4;PPT2;ACSS3
prerank,digestive tract morphogenesis (GO:0048546),-0.4088618868636666,-1.129364534545499,0.2966751918158568,0.6366830829237853,1.0,7/14,37.45%,SOX11;BBS7;PDGFRA;ID2;GLI1;SOX17;STRA6
prerank,regulation of dopamine secretion (GO:0014059),0.3762534895469415,1.1287308436206422,0.2909967845659164,0.9437847447364299,1.0,5/25,10.07%,SYT4;SYT13;SYT1;SYT6;PRKN
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.2834353482976004,1.1284725339155663,0.22056833558863329,0.9431646558794659,1.0,33/118,19.72%,BCL9L;ABI3;TANC2;ARHGAP44;CHN1;PAK1;FLT4;IL6;MEF2C;CLASP2;SHANK3;SRCIN1;VASH1;HECW2;TGFB1;NEDD4;CFL1;FGF2;VASH2;SFRP1;CAMSAP1;ARHGAP35;LZTS3;EPHA4;NEDD4L;FITM2;SARM1;PHLDB2;ZMYM6;NSMF;SDC2;ZMYM3;LRRC4C
prerank,regulation of protein localization to membrane (GO:1905475),0.36839565394777796,1.1281021857808962,0.28314238952536824,0.9429486338975375,1.0,11/28,23.66%,GPC1;AR;GPC2;GPC5;PRKN;ZDHHC2;GPC4;SPTBN1;ACTB;VTI1B;PDZK1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4092718504234506,1.127974820169225,0.27454242928452577,0.9417649979002347,1.0,4/18,10.49%,CD34;PRNP;NAV3;HOMER2
prerank,positive regulation of MAPK cascade (GO:0043410),-0.22775452376944436,-1.1277079102675136,0.10989010989010989,0.6404520578562458,1.0,51/245,15.28%,IQGAP1;CD74;ARL6IP5;APOE;NRP1;PTPN22;GAS6;IGF1;GCNT2;CD44;PTPRC;LILRA5;BRAF;CD36;FBXW7;DHX33;CCL25;C5AR1;CRKL;GPR183;FLT1;PDGFD;NOD2;BCAR3;PDCD10;CD24;GLIPR2;CIB1;MID1;TAOK3;FGF1;RET;PDGFC;ADAM8;SPRY2;NOTCH1;IGF2;GRM4;PIK3R6;KDR;PIK3R5;TRIM5;SLAMF1;BMP2;LRRK2;EGFR;SHC1;AGER;PTK2B;TNF;SCIMP
prerank,endochondral bone morphogenesis (GO:0060350),0.4593996576335553,1.1269558537385909,0.32582322357019067,0.9443299787976565,1.0,6/11,23.82%,MEF2C;BMP4;FOXC1;BMPR1B;INPPL1;COL13A1
prerank,regulation of interleukin-4 production (GO:0032673),-0.35835777312047384,-1.1266944600653943,0.2912621359223301,0.642434623457723,1.0,8/21,17.77%,RARA;IRF4;CEBPB;SYK;PRKCQ;CD28;FCER1G;GATA3
prerank,striated muscle cell development (GO:0055002),0.4253662141207489,1.1263368241422405,0.3246527777777778,0.9451944063722076,1.0,4/14,12.97%,CAPN3;LMOD1;TMOD2;LMOD3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3056568875542569,-1.1260302745360906,0.25217391304347825,0.6434083825958469,1.0,14/38,20.36%,CD47;P2RX4;CD36;SMAD3;CAV1;IL1B;ZC3H12A;PTGIS;GLA;TNF;TLR4;KLF2;MMP8;KLF4
prerank,response to cadmium ion (GO:0046686),0.36914223744125435,1.126016764827717,0.279874213836478,0.9448419181277262,1.0,10/26,17.76%,MAPK3;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,cellular response to starvation (GO:0009267),-0.24155493300718053,-1.1258479035579494,0.14545454545454545,0.6430931573705455,1.0,35/147,17.48%,ATP6V0D1;PIK3C3;MAP1LC3B;ATP6V0D2;PIK3R4;ATP6V1B2;RRAGC;NUAK2;LAMTOR5;ATP6V0B;SH3GLB1;STK24;ATG7;FAS;CEBPB;PRKAG2;LAMP2;CPEB4;ZC3H12A;EIF2S1;FOXO1;SZT2;RRAGA;ATP6V1A;SIK2;RALB;LRRK2;SIK1;PMAIP1;MTMR3;MFSD2A;SESN2;MAPK8;MAP1LC3A;NUPR2
prerank,positive regulation of signal transduction (GO:0009967),-0.22655730323404888,-1.1257313048127942,0.1144578313253012,0.6426146953340448,1.0,48/238,13.93%,RBPJ;SASH1;CD74;NRP1;GAS6;IGF1;AXL;PTPRC;CDC73;CCBE1;RWDD3;DLG5;TLR2;ASXL2;BAX;SMARCA4;IL6ST;NPTN;VPS35;LIMS1;ERN1;TUBD1;FAS;NOD2;PDCD10;ZMIZ1;YAP1;TEDC2;HIF1A;CLEC6A;IL1B;CD226;FGF1;SNW1;PTGIS;NOTCH1;EP300;TRIM44;CUX2;SORBS1;F7;IGF2;TSPAN5;EMP2;CCN3;BMP2;RIMS2;LRRK2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.4161337777815406,1.125445846723095,0.30833333333333335,0.94536417413328,1.0,2/17,3.05%,NOS1AP;KCNE2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4049762901479511,-1.1252905036352643,0.288135593220339,0.6430316457119508,1.0,10/14,39.20%,ETNPPL;PISD;ETNK2;ALOX15;LPIN3;CHKA;LPIN1;CEPT1;ETNK1;SLC27A1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4139016095580322,1.12524836311732,0.2866779089376054,0.944474103777048,1.0,7/17,24.16%,NDUFA4;COX7B;COX6C;COX7C;COX4I1;COX6B1;COX10
prerank,phosphorylation (GO:0016310),-0.2157660197486524,-1.125187593384921,0.1282051282051282,0.6425527587559526,1.0,75/384,14.18%,PEAK1;MAP3K1;STK3;FNIP2;GAS6;PRKCH;CSK;STK38;PRKCE;STK17B;GMFG;CDK6;LIMD1;MARK2;TEC;CDK17;PIK3R4;CDK8;RUNX3;FAM20A;PRKAB1;BRAF;PPP4R1;BIRC6;RARA;NUAK2;TBK1;PRKACA;MKNK1;DGKK;MAPKAPK2;NADK;PIM1;LMTK2;STK24;ERN1;TAF1;TESK2;DYRK1A;FAM20B;SYK;CERKL;LYN;FYN;PRKAG2;HCK;CDKL3;TAOK3;PIK3CA;HCST;RET;HASPIN;CAMK2D;GNPTAB;MAP3K11;BIRC5;HIPK1;LCK;CERK;CDK1;HK1;PANK3;DAPK1;SHPK;FRK;FAM20C;NLK;SIK2;BMP2;LRRK2;GK5;SPHK2;SIK1;CDK12;GK
prerank,regulation of urine volume (GO:0035809),-0.4403868057678262,-1.125109539779738,0.27388535031847133,0.6419610245894931,1.0,4/10,18.87%,ADCY6;INPP5K;HAS2;TFAP2B
prerank,B cell differentiation (GO:0030183),-0.3008324497863998,-1.1247982305034145,0.28328611898017,0.6420117073164475,1.0,8/46,7.64%,ITGA4;IRF2BP2;PTPRC;CEBPG;KLF6;LYL1;DNAJB9;BLNK
prerank,oligodendrocyte differentiation (GO:0048709),0.40106715653085845,1.124765117432254,0.31443298969072164,0.9448113355638578,1.0,8/19,22.14%,TPPP;SOX10;EIF2B3;MYRF;SLC8A3;EIF2B1;SOX13;EIF2B5
prerank,negative regulation of DNA recombination (GO:0045910),-0.29639927786520215,-1.124742039818228,0.25671641791044775,0.6413491191309121,1.0,14/43,17.07%,POLR2E;SMCHD1;RTEL1;ZRANB3;KLHL15;H1-0;MAD2L2;RMI2;SHLD1;POLR2B;POLR2H;POLR2J;TERF2;PARPBP
prerank,cellular response to amyloid-beta (GO:1904646),-0.3172177007067666,-1.1247164929733726,0.25,0.6406356163893453,1.0,10/35,16.57%,ITGA4;FCGR2B;IGF1;CD36;FYN;PSEN1;LRP1;AGER;GJA1;TLR4
prerank,negative regulation of protein depolymerization (GO:1901880),0.3821509531594482,1.1242753104022378,0.30377668308702793,0.9451724085029638,1.0,9/24,17.62%,STMN2;NAV3;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,regulation of Golgi organization (GO:1903358),-0.39399400912411053,-1.124143950567081,0.3291139240506329,0.6414075960100604,1.0,7/17,16.58%,MYO5A;STX5;PDCD10;USP6NL;RBSN;RAB33B;STX18
prerank,embryonic appendage morphogenesis (GO:0035113),-0.424999324052063,-1.1241244501906966,0.3161592505854801,0.6406602758419632,1.0,7/12,32.06%,MBNL1;FBXW4;LRP6;PTCH1;SHH;CYP26B1;TGFB2
prerank,phospholipid transport (GO:0015914),-0.2886977086510535,-1.1240042445095102,0.24079320113314448,0.6401918956379762,1.0,12/52,12.77%,OSBPL8;ATP8B4;APOE;NPC2;PLTP;TMEM30A;LDLR;PCTP;OSBPL2;ABCG1;ATP11C;APOC1
prerank,ribosomal large subunit assembly (GO:0000027),-0.3485287656831515,-1.1238178251817825,0.29336734693877553,0.639868109775761,1.0,9/24,20.04%,RPL5;RPF2;RPL6;RPL10;RPL23A;MDN1;RPL3;NOP53;RPL11
prerank,modulation by symbiont of entry into host (GO:0052372),-0.3859474084319446,-1.1236279885794573,0.3047858942065491,0.639560296108065,1.0,5/16,13.32%,TRIM25;TRIM14;CAV1;TRIM62;TRIM5
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4398609032708597,1.1232794243692938,0.3133561643835616,0.9476972017350139,1.0,4/13,12.68%,RAB3A;GRIK2;SYNGR1;SLC4A10
prerank,ESCRT III complex disassembly (GO:1904903),0.47265227134190524,1.1231500587155618,0.3315508021390374,0.9449121195789271,1.0,6/10,29.20%,CHMP1A;CHMP2A;CHMP5;VTA1;CHMP7;CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.47265227134190524,1.1231500587155618,0.3315508021390374,0.9449121195789271,1.0,6/10,29.20%,CHMP1A;CHMP2A;CHMP5;VTA1;CHMP7;CHMP2B
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.38178214195493093,1.122920017741993,0.28771384136858474,0.9442613131952022,1.0,10/24,25.71%,ABCB6;FLVCR1;TSPO;PGRMC1;UROD;ALAD;ABCG2;SLC25A38;COX10;CPOX
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4080983126008353,1.1227664896873992,0.3210702341137124,0.9432654750330646,1.0,4/18,9.72%,POLD3;GINS3;MCM3;LIG3
prerank,cell cycle checkpoint signaling (GO:0000075),-0.42417075894929857,-1.1225775491930843,0.2981651376146789,0.6415979653657535,1.0,5/12,13.08%,PRCC;ZWILCH;WEE1;BUB1;BUB1B
prerank,embryonic heart tube development (GO:0035050),0.43657415650246084,1.1220399528750395,0.31198686371100165,0.9445238444248999,1.0,3/14,13.12%,MEGF8;TBX2;NDRG4
prerank,organic substance transport (GO:0071702),0.2811932693939123,1.1217667974871217,0.24057217165149544,0.9439031889158873,1.0,34/121,22.94%,SCAMP5;SLCO2B1;ABCA9;SLC48A1;SLC50A1;ABCG8;DISP1;ABCB6;LRP2;FLVCR1;SLC18A1;LRP1B;SCAMP2;HSP90B1;RAB38;CHMP1A;ARRDC1;ABCA2;CHMP2A;SPNS2;SLC19A1;SLC22A4;MIA3;ATP8A1;VPS33B;ABCD2;LMAN2L;ABCG2;ABCA7;SLC22A18;SCAMP3;SLC22A5;SLC19A2;PEX3
prerank,histone H4-K5 acetylation (GO:0043981),0.42188560576496137,1.1213493417994924,0.2994652406417112,0.9422289775286619,1.0,9/15,30.67%,JADE2;MEAF6;OGT;KAT8;WDR5;JADE1;MCRS1;ING4;KANSL3
prerank,histone H4-K8 acetylation (GO:0043982),0.42188560576496137,1.1213493417994924,0.2994652406417112,0.9422289775286619,1.0,9/15,30.67%,JADE2;MEAF6;OGT;KAT8;WDR5;JADE1;MCRS1;ING4;KANSL3
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.42474455541480266,-1.1213120736321571,0.3047619047619048,0.6442357913223528,1.0,4/12,9.97%,EML2;DYRK1A;STMN1;MAPRE1
prerank,T cell receptor signaling pathway (GO:0050852),-0.2450828603093694,-1.1213096265350442,0.16071428571428573,0.6434451859947333,1.0,40/138,19.04%,RFTN1;PSMA6;PTPN22;CSK;PTPRC;DENND1B;TEC;PSMB2;PSME2;GRAP2;NFKB1;NFKBIZ;NCK1;PSMD11;PSMC6;FYN;PSMA3;PRKCQ;THEMIS;EIF2B2;PIK3CA;ZC3H12A;CD28;LCP2;LCK;RC3H1;SKAP1;SPPL3;STOML2;PSMD10;PSMB5;EIF2B4;RC3H2;BCAR1;ZAP70;PSMD5;GATA3;CD247;PSMD1;THEMIS2
prerank,cellular lipid catabolic process (GO:0044242),-0.34311331809656165,-1.1212298425701548,0.2889447236180904,0.6428242325531515,1.0,4/27,5.61%,AOAH;ACOT8;PLBD1;PPARD
prerank,lipid translocation (GO:0034204),0.3880527384628364,1.1210697250276556,0.2857142857142857,0.9416496458712947,1.0,6/21,16.74%,ATP8A2;ATP9A;ABCB4;ATP11A;ATP8B1;ATP8A1
prerank,negative regulation of cell growth (GO:0030308),0.2819906955362997,1.1209525654626755,0.2503401360544218,0.9404680900037751,1.0,39/121,24.41%,WFDC1;DIP2B;DCC;CDHR2;PSRC1;STK11;SIPA1;MINAR1;APBB1;FHL1;GNG4;TGFB1;ADAM15;CGRRF1;FGF13;ACVR1B;MAG;SFRP1;DCBLD2;FLCN;EI24;CCAR2;SH3BP4;NDRG3;PTPRS;PPP2R1A;BTG1;TCHP;ULK2;MAP2;FRZB;SFRP2;ULK1;NPR1;JADE1;PRDM11;SMARCA2;CRLF3;CDKN2AIP
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.20882935077684178,-1.1207283613335344,0.07894736842105263,0.6434308415261044,1.0,106/509,15.36%,IQGAP1;OSBPL8;SASH1;BCL2;CD74;DDX60;HIP1;GAS6;ANKRD17;IGF1;AXL;BCL2L1;CASS4;GCNT2;ALPK1;PTPRC;TRIM25;DLG5;TLR2;TRIM14;LILRA5;P2RX4;RRAGC;FRS2;MET;LGALS1;TBK1;BAX;LAMTOR5;SOX11;SHISA5;DHX33;GAB1;RPS20;ESR1;TLR7;KITLG;LIMS1;CD14;PUM2;OASL;BST2;THBS1;FLT1;PDGFD;NOD2;RIPK1;TFRC;LITAF;BCAR3;CAV1;TRIM62;LYN;RNF13;FYN;GAB2;PLEKHG5;CLEC6A;IL1B;TXN;CCDC22;S100A4;SMCR8;FGF1;EEF1D;PIK3CA;HCST;RET;HPSE;NRG2;GPRC5B;PDGFC;ADAM8;CD28;SPRY2;TNFRSF19;LCK;EP300;TRIM44;GRB2;BIRC2;F7;GPR61;IGF2;GRM4;RRAGA;CBL;KDR;PIK3R5;ZDHHC17;RACK1;TRIM5;MYOC;IRAK4;PELI1;BMP2;SPHK2;CHD5;PMAIP1;EGFR;SHC1;AGER;DDX21;TNF;GJA1;WNT5A
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.38703795299922666,-1.120579950899285,0.29974811083123426,0.6430004677984189,1.0,4/16,12.65%,ATP5MG;ATP5PO;ATP5MC1;STOML2
prerank,translational termination (GO:0006415),0.28941294504573356,1.1195794468617881,0.2599431818181818,0.9442957654590187,1.0,33/95,26.19%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;GSPT1;N6AMT1;DAP3;MRPS5;MRPL58;APEH;MRPL19;MRPL15;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;TRMT112;MRPS25;MRPS9
prerank,amino acid import (GO:0043090),0.3835627732840651,1.1194099655517418,0.291866028708134,0.9433094554837927,1.0,7/21,15.66%,SLC1A1;SFXN1;SLC1A3;SFXN2;SLC6A1;SLC22A4;SH3BP4
prerank,RNA processing (GO:0006396),0.2669729122156529,1.1193513636792913,0.22564734895191121,0.9419235186826067,1.0,38/176,15.67%,ADARB2;RNPS1;IVNS1ABP;SMU1;SRSF5;FUS;DHX15;TSEN54;BCAS2;HNRNPH1;PPARGC1A;SF3B2;CPSF6;LSM1;SRSF11;PTBP1;ADAR;MTPAP;RBM5;PPIG;AKAP8L;PRMT9;SON;RNASEL;SF3A1;SRSF1;SNRPD2;MPHOSPH10;DROSHA;SF3B3;RP9;NUDT21;NOVA1;RBM3;DDX39B;DDX47;CCAR2;SETX
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.43384439345208814,1.1188204238220374,0.3148148148148148,0.9424807503327205,1.0,4/13,14.80%,GTPBP1;CNOT8;NUDT21;UPF1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.4525717158564501,1.1187582557479492,0.32867132867132864,0.9410914918567985,1.0,4/12,14.77%,IFT20;F3;NDRG4;APOD
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.43857649175511493,-1.118211638480587,0.28693790149892934,0.6484456091866102,1.0,4/10,20.67%,NCK1;VHL;DNAJB1;SIRT2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.4174058413200796,-1.1181952335339973,0.2936893203883495,0.6476947373502696,1.0,9/13,26.65%,PRPF19;PRPF6;LSM2;CD2BP2;DDX20;USP4;PRPF3;PRPF31;AAR2
prerank,receptor clustering (GO:0043113),0.36285333727958935,1.1178344223023786,0.3105691056910569,0.9431777730939673,1.0,6/27,9.68%,AGRN;DLG2;SCRIB;THY1;NRXN1;ITGB1BP1
prerank,positive regulation of axonogenesis (GO:0050772),0.333995774118993,1.1178208352343983,0.27099841521394613,0.9416343751821685,1.0,18/43,28.52%,MAP6;SEMA7A;PLXNB2;LIMK1;TWF2;ARHGDIA;CDKL5;MAP3K13;NTRK2;PLXNB1;ZFYVE27;BDNF;TIAM1;RHOA;MAPT;NGFR;SLITRK1;ROBO1
prerank,icosanoid secretion (GO:0032309),-0.4199244940871726,-1.1178173133330018,0.3062645011600928,0.6479507141005638,1.0,5/12,34.67%,ANXA1;DRD2;DRD3;ABCC4;NOS2
prerank,establishment of melanosome localization (GO:0032401),-0.36912594293767303,-1.117702879736401,0.2923076923076923,0.6474586448078895,1.0,6/19,26.16%,MYO5A;BBS7;MLPH;SHROOM2;BLOC1S3;MREG
prerank,negative regulation of hormone secretion (GO:0046888),-0.4423525847515201,-1.1176520864794555,0.30114942528735633,0.6467832343206933,1.0,4/10,15.26%,IL1B;RAB11FIP1;RAB11FIP5;GJA1
prerank,regulation of interleukin-17 production (GO:0032660),0.35779949263019234,1.1176030464627211,0.2992248062015504,0.9408213880806873,1.0,7/31,9.53%,VSIR;NCKAP1L;SLAMF6;PRNP;IL6;IL2;TGFB1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.4134462646318564,1.1174340248148122,0.31085526315789475,0.9398943055425183,1.0,5/16,21.05%,GNB3;PRKN;SCARB2;RORA;PDK1
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.22693067545498896,-1.1172076481177147,0.15675675675675677,0.6472585797745068,1.0,46/199,17.77%,RBPJ;FCGR2B;IL15;PAEP;GAS6;NOVA2;PTPN23;MCC;DOCK7;CORO1C;PTGER4;NPTN;RPS6KA6;NRDC;NR1H2;SRGN;IL1B;PCTP;RAB11FIP1;MAD2L2;BMP5;SPRY2;NOTCH1;ARHGDIB;ID1;SLC11A1;PROCR;SPRY1;SMAD6;NR1H3;RB1;BMP2;ALDH1A1;RAB11FIP5;EGFR;AGER;TNF;GJA1;TRPV3;PFN2;TLR4;IL18R1;ADAM17;HEY2;PGAM5;GATA3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.30041106682424645,-1.1170947467907688,0.25956284153005466,0.6467791124037312,1.0,15/43,23.57%,PTPN22;GAS6;CD274;IGF1;RARA;ZC3H12A;SLAMF1;LBP;LILRB1;TLR4;CD33;LTF;NLRC3;NR1H4;GSTP1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2661930703936434,-1.1169422268028772,0.2108843537414966,0.6464233967264252,1.0,33/82,24.71%,SUCO;IGF1;NBR1;NOCT;CDK6;LIMD1;PPARG;PRKACA;IL6ST;SOX11;YAP1;NOTCH1;CCN1;TRPM4;SMAD6;GREM1;BMP2;SMOC1;RIOX1;ACVR2A;BMP7;BAMBI;LTF;ACVR1;PTCH1;IFITM1;FFAR4;SEMA4D;TWIST1;TNN;GDF10;BMPR2;TMEM119
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.330256111111925,-1.1166977810806105,0.2638190954773869,0.6462869396946697,1.0,12/26,27.80%,ALOX5;CD36;CYBA;SLC5A3;SPHK2;SLC25A33;TLR4;MMP8;ADGRB1;CCN6;ABCD1;SLC30A10
prerank,pancreas development (GO:0031016),0.4481006721931391,1.116065279292281,0.307426597582038,0.9436271187046469,1.0,3/12,8.49%,DNAAF1;CCDC39;TCF7L2
prerank,kidney development (GO:0001822),0.30492371248550276,1.1154468692311355,0.2706222865412446,0.9444961432323403,1.0,13/65,17.32%,WNT4;FGF10;VANGL2;SOX4;TGFBR1;BMP4;FOXC1;C1GALT1;PKD1;IFT27;IFT88;AGT;PYGO2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.42749871734552414,1.1152582979864054,0.3140794223826715,0.9436637692506515,1.0,6/15,16.13%,FGF16;SMOC2;LGMN;PRKD2;FGF2;PRKD1
prerank,dendritic cell chemotaxis (GO:0002407),0.43225918368506605,1.1148397302205968,0.3197969543147208,0.9437640475295257,1.0,7/14,19.40%,TRPM2;PIK3CG;CCR1;CXCR4;CCR6;HMGB1;CCL5
prerank,response to interleukin-4 (GO:0070670),-0.4344009454864259,-1.1146010147549876,0.29310344827586204,0.6513626815701745,1.0,8/10,40.87%,TCF7;SHPK;GATA3;LEF1;DCSTAMP;CITED1;RUFY4;JAK3
prerank,cell-cell junction organization (GO:0045216),0.29954974489198405,1.114177309477325,0.26675977653631283,0.9448135849320857,1.0,18/79,16.57%,ANG;FSCN1;DCHS1;PARD6B;CADM1;PKP4;MARVELD2;PRKCI;CDH18;SDK1;NECTIN3;TGFB1;CTNND2;CDH4;CADM3;FLCN;CADM2;CXADR
prerank,cellular zinc ion homeostasis (GO:0006882),0.36869026590117016,1.1140627604285422,0.28921568627450983,0.9436697535598085,1.0,11/26,17.76%,SLC39A4;SLC39A8;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.347222857387956,-1.1138491065591811,0.293398533007335,0.6527224591273179,1.0,9/22,15.36%,CCR2;NOD2;TRPM4;TNFRSF1B;SPHK2;LILRB1;TNF;SCIMP;WNT5A
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.34486875023273,-1.1137420615939806,0.30402010050251255,0.6522458594893575,1.0,8/25,19.83%,RBPJ;SOX11;NOTCH1;CCN1;NUMA1;SMAD4;FBXL15;ACVR2A
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.31572221691324587,-1.1135480903407995,0.2874617737003058,0.6519630508495771,1.0,13/37,22.19%,APOE;SDCBP;MTMR2;NFKB1;ANKRD13A;EDNRB;BRCA1;OPTN;PTX3;ITGB3;SIRT2;NCOR1;WDR54
prerank,cardiac myofibril assembly (GO:0055003),0.4178928848294484,1.1132528440723943,0.31993006993006995,0.945197768260322,1.0,2/15,1.83%,NEBL;OBSL1
prerank,peptidyl-lysine methylation (GO:0018022),0.3705083617435786,1.1130084177656336,0.325,0.9445739286735022,1.0,9/26,17.15%,SMYD2;METTL21C;EEF1AKMT2;METTL21A;SETD6;SETD4;SUV39H2;SMYD1;N6AMT1
prerank,positive regulation of cell junction assembly (GO:1901890),0.3137359234176316,1.1129181359965556,0.2791728212703102,0.9433449433595041,1.0,16/56,18.82%,PTPRD;SRPX2;THY1;IL1RAP;NRXN1;GRID2;MAP4K4;CLSTN2;IL1RAPL1;SFRP1;TEK;EPHB2;WNT7A;AGT;ROCK1;GHRL
prerank,sulfate transport (GO:0008272),-0.39390602515278356,-1.1121122931852718,0.3176470588235294,0.6549024063098539,1.0,4/14,12.51%,SLC26A11;RACGAP1;SLC13A4;SLC25A11
prerank,regulation of RNA metabolic process (GO:0051252),-0.28536646935031695,-1.1121050309457041,0.2579710144927536,0.6541325406885596,1.0,10/59,6.90%,AHNAK;HNRNPLL;OAS2;NOVA2;CELF1;MITF;MBNL1;RASA1;OASL;MBNL3
prerank,organelle assembly (GO:0070925),-0.21240306170924989,-1.1120534844577228,0.1391304347826087,0.6534892128868008,1.0,72/384,13.44%,EHD4;ATP6V0D1;RAB8B;VPS37C;ACTR3;EIF2A;PIK3C3;CHMP4A;CHMP4B;KIF3A;PTPN23;PCM1;MAP1LC3B;MIS12;LIMD1;RILPL2;FAM161A;RPS23;PIBF1;ATG13;STX12;RAB1A;DHX29;MKS1;RAB7A;TMOD1;CDC14B;RPGR;SCLT1;SH3PXD2B;CPLANE1;GBF1;EXOC4;ARL13B;ATG7;CEP250;TCTN1;SSX2IP;BBS7;UBAP2L;FHDC1;ASAP1;UBQLN1;HPS1;DNAH5;DDX6;EIF4ENIF1;HAUS2;KIF24;TMEM231;CEP164;CENPA;WDPCP;TUBGCP4;MAPRE1;SNAP29;EIF2S1;CCDC28B;TMEM138;RC3H1;NOTCH1;ATG2B;HAUS8;FOXJ1;EXOC8;PGM5;ATG3;IFT52;CHMP1B;PDCD6IP;SYNPO;STAM
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.44037638139327323,-1.111959938251182,0.33774834437086093,0.652192484812773,1.0,3/10,10.81%,AP2A2;AP2B1;CLTA
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.44037638139327323,-1.111959938251182,0.33774834437086093,0.652192484812773,1.0,3/10,10.81%,AP2A2;AP2B1;CLTA
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4118761664073751,1.1116080135051754,0.3338983050847458,0.94703978646181,1.0,5/16,31.56%,CLDN16;CLDN14;CLDN18;CLDN5;CLDN10
prerank,pre-miRNA processing (GO:0031054),0.42815902204535145,1.1113894472813137,0.33275862068965517,0.9463329282048076,1.0,4/14,20.86%,ADAR;DROSHA;AGO4;LIN28B
prerank,histone methylation (GO:0016571),0.36486912311874925,1.1113875509324576,0.33444259567387685,0.9447675283242453,1.0,7/26,17.15%,SMYD2;NSD1;SETD6;SUV39H2;SMYD1;FBLL1;N6AMT1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3195349126100945,1.1111884506177652,0.3020833333333333,0.9439800480659978,1.0,13/46,18.90%,TOMM40L;TIMM21;FIS1;FBXO7;TOMM34;PITRM1;TIMM13;TSPO;TIMM22;HK2;TOMM70;MFF;TIMM23
prerank,DNA duplex unwinding (GO:0032508),-0.286163180970611,-1.1110650213745492,0.25483870967741934,0.6538683342372673,1.0,11/50,12.14%,ASCC3;CUL4A;RTEL1;CHD1L;ANXA1;UBC;NBN;UBA52;RAD23B;RPA1;MCM2
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2507348846597029,-1.1105431107438826,0.22058823529411764,0.654568766897038,1.0,20/98,14.50%,PID1;APOE;IFNAR1;CHCHD2;XDH;PPARG;RAB1A;PPARD;DHRS4;THBS1;RIPK1;NR1H2;ZC3H12A;ACOD1;CDK1;GRB2;APOC1;NR1H3;GREM1;IFNLR1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.37266387265738166,-1.1104748491607606,0.30848329048843187,0.6539662850817992,1.0,5/20,11.54%,APOE;DLG5;PSEN1;CAPRIN1;CUX2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.21487078156560735,-1.11032654823021,0.10236220472440945,0.6535818612416847,1.0,109/348,25.02%,PID1;RBPJ;ITCH;CD74;PTPN22;GAS6;STAP1;ITGAX;IGF1;CELF1;SETDB2;MITF;ADAM19;MED26;RPL5;TLR2;FAM98B;PPHLN1;AFDN;PRKAB1;BRAF;DTX3L;CD36;PTPN1;FAM98A;ZPR1;LAMTOR5;TYROBP;SOX11;VPS35;LIMS1;MSN;RPS7;PF4;TFRC;SMAD3;SP1;PDCD10;YAP1;DNMT1;HIF1A;IL1B;PSEN1;FGF1;HINFP;BRCA1;ZC3H12A;KRAS;CTCF;CD28;SPRY2;NOTCH1;CUX2;SLC11A1;ATF7IP;AGO2;SCX;GREM1;BMP2;RIMS2;TESC;LILRB1;TNF;GJA1;RAMP2;TERF2;WNT5A;PDE2A;MAPK7;TLR4;KLF2;HEY2;MAPK8;GSN;HMGA2;NWD1;MMP8;FN1;PPM1F;WFS1;MYD88;RGCC;HSPA1B;BMP7;RPL11;KLF4;WARS1;DTNBP1;PIK3CD;POU3F1;CDH3;APP;ID2;HMGN5;CD3E;TWIST1;PLSCR1;MAPK11;TASOR;PAX6;EGF;FGFR4;ANGPT1;TMEM119;RAMP3;MTPN;TLR9;ATP13A2;RNF207
prerank,positive regulation of exocytosis (GO:0045921),0.34256250382954073,1.1100197428860297,0.2957074721780604,0.9471442555966203,1.0,11/35,22.31%,RAB3A;CADPS2;SYTL4;CLASP2;CFTR;RAB5A;RAB3D;CHMP2A;STXBP5;SNF8;RAB2B
prerank,nucleotide biosynthetic process (GO:0009165),0.40694839464082927,1.109814051948577,0.3099315068493151,0.9463960544687906,1.0,8/18,19.08%,PNP;GART;PRPSAP2;HPRT1;PRPSAP1;ADSL;NMNAT2;RRM2B
prerank,regulation of B cell activation (GO:0050864),-0.3430408308446238,-1.1091198911952058,0.3161953727506427,0.6560532258860353,1.0,6/25,12.01%,FCGR2B;AHR;NOD2;BANK1;IKZF3;FOXJ1
prerank,UV-damage excision repair (GO:0070914),0.4468627570972112,1.109097248492511,0.3383838383838384,0.9478079563728378,1.0,4/12,21.84%,POLD3;DDB2;ACTR5;POLA1
prerank,mesonephros development (GO:0001823),0.45618016220604374,1.1090849913718817,0.32,0.9463078521300469,1.0,2/11,8.34%,FGF10;BMP4
prerank,microtubule nucleation (GO:0007020),0.3990059295918521,1.1089477149053024,0.32019704433497537,0.945306654098669,1.0,3/19,8.24%,TPPP;CLASP2;CCDC57
prerank,negative regulation of viral release from host cell (GO:1902187),0.44196362085534563,1.1089027656214763,0.3338983050847458,0.9439326928980327,1.0,3/13,13.59%,TRIM26;MID2;TRIM8
prerank,protein insertion into ER membrane (GO:0045048),0.3396158319320477,1.108866193539452,0.3003048780487805,0.942534656684173,1.0,10/37,15.41%,PRNP;SGTA;EMC6;EMC2;OTOF;EMD;TRAM2;CCDC47;GET3;TRAM1
prerank,regulation of neurogenesis (GO:0050767),-0.2821465544089705,-1.1088612275853067,0.27848101265822783,0.655961304412143,1.0,21/55,23.59%,PCM1;HMGB2;DOCK7;SOX11;YAP1;IL1B;SNW1;NOTCH1;CTNNB1;SPEN;LIG4;B2M;TNF;HEY2;PER2;HES1;APPL2;BHLHE40;HEYL;PAX6;HOOK3
prerank,regulation of RNA splicing (GO:0043484),0.3006631701999015,1.1085081983566718,0.2786885245901639,0.9424290738476105,1.0,29/69,25.40%,PQBP1;FUS;FAM50A;TRA2B;HNRNPH1;CWC22;SLC38A2;PTBP1;SNRNP70;SON;YTHDC1;KHDRBS2;METTL16;METTL4;QKI;SETX;RRP1B;SRRM4;RBM20;TIA1;RBM38;CLK3;FASTK;RBM39;TMBIM6;ESRP1;SF1;HNRNPH3;SRSF3
prerank,Rho protein signal transduction (GO:0007266),0.321746823397121,1.1083551744111608,0.3058470764617691,0.9414718335464908,1.0,22/53,25.20%,RHOV;EPS8L3;ARHGDIG;CDC42EP5;ADRA2A;CTNNAL1;LIMK1;ARHGDIA;ARHGAP5;CFL1;EPS8L2;RIPOR1;ROCK1;RHOU;CDC42;ARHGAP1;CDC42EP4;CDC42EP1;ARHGAP4;EPS8L1;ARHGEF1;RHOA
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.26473136282371085,-1.1083488362510876,0.22818791946308725,0.6566956146530305,1.0,28/76,24.63%,CUL3;RWDD3;FBXW7;CAV1;UBQLN1;UBE2L3;BRCA1;UBA2;ZC3H12A;PTTG1IP;PAXIP1;DCUN1D1;BIRC2;CRY1;PSMD10;LRRK2;FANCI;MUL1;CENPX;WFS1;TNIP1;HDAC4;NDFIP1;XIAP;PHF23;PIAS4;PIAS3;ANGPT1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.43904689227708305,-1.1080408205396404,0.34101382488479265,0.656787924986128,1.0,2/10,2.79%,ZEB2;ATP7A
prerank,protein localization to organelle (GO:0033365),0.27518065254343366,1.1079704664146297,0.266754270696452,0.9414950159805533,1.0,29/133,18.60%,IFT20;HHEX;YWHAE;LAMP5;OBSL1;ROPN1;SIX4;SYS1;PRNP;SGTA;DDX1;MTCH2;BMP4;OTOF;ARFRP1;BBS9;EMD;EHD1;TRAM2;CCDC47;SCG3;BICD2;MICALL1;TRAM1;PAF1;RIPOR1;BICD1;ANK2;UBAC2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.24742346641425342,-1.107551973021517,0.23045267489711935,0.6573381750050316,1.0,34/112,21.18%,NR3C1;NRROS;PXN;GCNT2;SOX6;ARHGEF18;ADAM9;LIMS1;CRKL;SMAD9;SMAD3;ZMIZ1;WWOX;UBC;UBA52;USP9X;ID1;CBL;SMAD6;NLK;FOS;WNT5A;PDE2A;MAPK7;PARD6A;SMAD4;COL3A1;APPL2;USP15;BAMBI;CGN;ACVR1;USP9Y;ZMIZ2
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.4010129154772952,-1.1072528546808316,0.3293269230769231,0.657340563857974,1.0,4/13,12.01%,TOX;TESPA1;ADAM8;FOXJ1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.43278245913900176,1.1071722758915337,0.3398576512455516,0.9430371813790176,1.0,6/14,16.77%,SEC31A;SEC24D;SEC24B;MIA3;SEC24C;SCAP
prerank,peptidyl-glutamic acid modification (GO:0018200),0.37197099395897215,1.1066141916630945,0.3190394511149228,0.9437586982177292,1.0,12/24,26.99%,VKORC1L1;TTLL6;PARP1;AGBL4;TTLL7;TPGS1;TTLL5;TTLL10;TTLL1;TTLL8;TTLL11;CFAP20
prerank,cellular response to sterol (GO:0036315),-0.40360012336519446,-1.1061081479198929,0.31353919239904987,0.659626677636512,1.0,8/13,32.36%,GRAMD1C;GRAMD1B;LRP6;MLC1;PTCH1;INSIG1;RORC;INSIG2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.45289842884906734,1.1060727936270645,0.36795774647887325,0.9443144960363496,1.0,3/11,10.96%,TSC2;GIGYF1;IRS1
prerank,protein targeting to peroxisome (GO:0006625),0.3563332039162314,1.1055721411850243,0.31561461794019935,0.9447952846542432,1.0,16/29,28.35%,PEX5;FIS1;ATAD1;PEX26;PEX14;PEX2;ABCD2;PEX6;PEX11B;ZFAND6;PEX3;HACL1;ABCD3;PXMP4;ACBD5;LONP2
prerank,midbody abscission (GO:0061952),-0.3796414245426806,-1.1055037474532468,0.30656934306569344,0.6605555226023205,1.0,5/17,16.16%,CHMP4A;CHMP4B;CHMP1B;PDCD6IP;KIF20A
prerank,sodium ion import across plasma membrane (GO:0098719),0.3963802330814782,1.105484329851647,0.3300813008130081,0.9435691043312022,1.0,5/17,14.30%,SLC12A2;SLC9A4;SLC8A1;SLC9A5;SLC6A1
prerank,positive regulation of glucose import (GO:0046326),-0.35499148413260206,-1.10530135379136,0.3145780051150895,0.6602866145332877,1.0,7/21,24.64%,OSBPL8;IGF1;SORBS1;ARPP19;IRS2;CAPN10;APPL1
prerank,DNA replication (GO:0006260),-0.2520749427386062,-1.104972482990355,0.2571428571428571,0.660470568326896,1.0,28/105,17.31%,BAZ1A;RBBP8;CLSPN;TOPBP1;ORC5;IGHMBP2;NBN;RMI1;ATRIP;PCLAF;BRCA1;ORC2;POLD4;GRWD1;RHNO1;BARD1;RPA1;CDK1;RMI2;MCM2;KAT5;TICRR;ORC4;MCM9;MCM8;KAT7;RPA2;RNASEH2A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3807837080179197,1.104678743596153,0.32972136222910214,0.9451786747151887,1.0,7/22,22.48%,ATP1B1;PKD2;GSTO1;HAP1;ANK2;SLC9A1;VMP1
prerank,amino acid transmembrane transport (GO:0003333),-0.29211343683139684,-1.1046104876833076,0.2522255192878338,0.6607135611531085,1.0,10/45,17.35%,SLC38A6;LRRC8D;SLC7A1;SLC6A6;SLC7A11;SFXN3;SLC7A6;SLC38A11;SLC3A2;SLC25A22
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.3962877748565402,-1.104470805015314,0.33016627078384797,0.6602961066013155,1.0,9/16,19.52%,PDS5B;BOD1;PDS5A;HASPIN;MAU2;RAD21;RB1;DSCC1;REC8
prerank,histone H3-K36 demethylation (GO:0070544),-0.4321628727005945,-1.104467159826507,0.34278959810874704,0.6595252365343033,1.0,4/10,14.55%,RIOX2;KDM7A;KDM8;RIOX1
prerank,protein complex oligomerization (GO:0051259),0.29087503411828886,1.1041007271791266,0.2841068917018284,0.945984222270064,1.0,23/85,18.95%,GLRA3;ADCY8;MPP2;IKZF4;NACC2;FUS;C9;CPSF6;ATL1;KCNC1;TRMT61B;MAT2A;PKD2;EHD1;DNM1L;RNF135;CHMP2A;NUDT21;OXA1L;KCNC3;EHD3;ALS2;ALAD
prerank,cognition (GO:0050890),-0.2957709491405329,-1.1037415799352015,0.254601226993865,0.6606542456256721,1.0,14/42,22.52%,MAGT1;C5AR1;SLC8A2;SHROOM4;CBR3;CUX2;TNF;DGCR2;MFSD2A;DOP1B;CHRNB2;CHRNA4;APP;SOBP
prerank,histone ubiquitination (GO:0016574),0.38536910993426643,1.103564157345116,0.34318555008210183,0.9464783663140661,1.0,6/21,16.32%,CTR9;UBE2B;PHC1;UBE2N;RNF8;PAF1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.30540271207797604,-1.1035411341859953,0.2918918918918919,0.6604351192487802,1.0,8/37,11.74%,IGF1;PPARG;MEF2D;ERN1;LDLRAP1;DNMT1;EFEMP2;HTR1B
prerank,cellular response to peptide (GO:1901653),-0.27641652837348923,-1.1033941501005724,0.254601226993865,0.6600599085737819,1.0,10/56,9.68%,ITGA4;FCGR2B;PTPN22;IGF1;CD36;NOD2;CAV1;FYN;PSEN1;VIM
prerank,positive regulation of chromosome organization (GO:2001252),-0.39575232024464424,-1.1031649317974441,0.32018561484918795,0.6598882834530063,1.0,4/15,12.94%,RTEL1;NBN;LIG4;RAD21
prerank,supramolecular fiber organization (GO:0097435),0.24632813660820083,1.1031183956719512,0.23536165327210104,0.9466906372185783,1.0,77/333,20.73%,TPPP;P3H2;STMN4;SH3BP1;LTBP3;LTBP2;PLOD3;STMN3;P4HA3;COL5A1;DST;GGA3;CAPN3;PPIB;LAMB3;CST3;COL2A1;LMOD1;STMN2;BFSP2;RHOBTB1;NCKAP5;TMOD2;BACE1;TSPAN15;RIPK3;TGFBR1;SERPINH1;MYO6;SAMD14;FSD1;CKAP5;PLK3;MYO1C;PRKN;CAMSAP3;PXDN;COL4A5;FGF13;MYO1H;NCKAP5L;CAMSAP1;COL28A1;PSENEN;DCTN1;ADAMTS14;COL4A2;LMOD3;CORO1A;EVL;KIF2A;HOOK2;TCHH;TUBGCP2;COL15A1;COL18A1;ITGA6;PPP1R9A;CLIP1;SIAH1;KIF14;PLOD1;RHOBTB2;HDGFL3;ARHGAP12;PIN1;ADAMTS3;P4HA2;HOOK1;ALDOA;COL4A4;INPPL1;CDC42;CCDC13;CALB1;TUBGCP6;HSP90AB1
prerank,cellular glucan metabolic process (GO:0006073),-0.43661500457484775,-1.1029615743432892,0.33183856502242154,0.6596182207386341,1.0,5/11,26.07%,PHKB;PRKAG2;PPP1R3C;PHKA1;GBE1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3015709140863242,1.1028795747683404,0.27365356622998543,0.9461097866543142,1.0,18/68,22.37%,ACSF2;GTPBP1;ACSL6;ACOT13;HPRT1;AMPD3;OXSM;DBI;ACOT4;ACBD6;TPST2;GNAI3;ACOT11;ACLY;RHOQ;AK4;AK3;SULT1A1
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23372426007791766,-1.1021633698269395,0.19004524886877827,0.6610557779019909,1.0,25/144,9.35%,BCL2;GAS6;UBE2D3;PCM1;ATG13;FBXW7;ZPR1;TOMM7;SH3GLB1;PPP3R1;SEC16A;TMEM30A;SMAD3;ARIH2;KIF20B;PDCD10;FYN;CIB1;YWHAG;ANP32B;IL1B;PSEN1;TM9SF4;UBE2L3;ZC3H12A
prerank,mitochondrial translational elongation (GO:0070125),0.28762946915595217,1.1020129604941962,0.2922636103151863,0.9478255720187785,1.0,29/88,26.19%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,nucleotide metabolic process (GO:0009117),0.3764674847749549,1.1017937943075748,0.32605042016806723,0.9471395282458179,1.0,8/23,22.69%,FHIT;REXO2;PNP;DCK;NMNAT2;AK5;AK4;AK1
prerank,regulation of dendrite development (GO:0050773),0.33602289789445433,1.1014428051708756,0.32190760059612517,0.9469620277572756,1.0,10/37,19.49%,CSMD3;DCC;DAB2IP;CDKL5;HECW2;NEDD4;NEDD4L;SARM1;NSMF;SDC2
prerank,regulation of actin filament polymerization (GO:0030833),0.2992632338681202,1.1009884668768586,0.296875,0.9471806815392724,1.0,20/69,22.02%,CTTN;BIN1;LMOD1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;FCHSD2;TWF2;EVL;ARFGEF1;PLEKHG2;TWF1;SSH1;SSH2;SSH3;CDC42EP4;CDC42EP1;GBA2;LATS1
prerank,cell junction organization (GO:0034330),0.298870447780852,1.1008636391187951,0.30027932960893855,0.9461695998304077,1.0,27/71,27.55%,AGRN;SH3BP1;CBLN2;MARVELD2;PPFIBP1;PRKCI;SDK1;TGFB1;CTNND2;PPFIA4;SLC6A1;SLC8A3;CXADR;SNCB;CHRNA7;PIN1;ACTB;CDC42;GRHL2;VMP1;OPHN1;LIMS2;RHOA;MAPT;SDK2;MYO9A;CBLN1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.40095901388589017,1.1008083583586914,0.3459552495697074,0.9448707097248963,1.0,3/17,4.92%,CTR9;CPSF6;ZC3H14
prerank,sympathetic nervous system development (GO:0048485),-0.3924217972234957,-1.1002841360938622,0.3082706766917293,0.6654291546405243,1.0,6/15,18.87%,NRP1;NRP2;SOX11;CTNNB1;GATA3;TFAP2B
prerank,osteoclast differentiation (GO:0030316),-0.34480236757488564,-1.0999674980505019,0.3065326633165829,0.6654776286168538,1.0,9/22,31.53%,TYROBP;GPR183;GAB2;FOXP1;EPHA2;OSCAR;CSF1;GLO1;DCSTAMP
prerank,macromolecule catabolic process (GO:0009057),-0.33221522099296236,-1.0997515824914046,0.2897727272727273,0.665262588625815,1.0,7/26,8.39%,KIF16B;PIK3R4;SH3GLB1;CLN8;CLN5;SNX25;UVRAG
prerank,regulation of lymphocyte migration (GO:2000401),0.46051833956510385,1.099678263627308,0.3385146804835924,0.9479494572925523,1.0,4/10,15.36%,ADTRP;JAM2;CCR6;MIA3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3628047399114078,1.099601764679009,0.31699346405228757,0.946737261076413,1.0,11/27,19.50%,P2RY12;TNFAIP8L3;TGFB1;FGF2;IRS1;PDGFB;TEK;PRKD1;PTK2;FLT3;PDGFRB
prerank,digestive tract development (GO:0048565),0.35090508958411304,1.0992492057181158,0.337442218798151,0.9465796362688802,1.0,4/32,4.98%,DNAAF1;CCDC39;MEGF8;RARRES2
prerank,tRNA modification (GO:0006400),0.301611637958526,1.0990484390660644,0.30185979971387694,0.9458892086186348,1.0,11/62,10.29%,TYW5;ADAT2;ELP5;CTU1;METTL2B;METTL2A;TRMT44;METTL1;TRMT61B;DTWD2;FTSJ1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.26897235787546503,-1.0987969152966974,0.23492063492063492,0.6671987560075019,1.0,13/65,15.79%,IL15;CBFA2T3;PPARG;RARA;TYROBP;GPR183;GAB2;DEK;EP300;FOXP1;BATF2;EPHA2;MYH9
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.3423527626870094,-1.0985945831515644,0.27956989247311825,0.6670186196344045,1.0,4/22,7.65%,IL15;RFTN1;NOD2;PRKCQ
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.4688694106155759,1.0984584137427889,0.36363636363636365,0.9467258435570719,1.0,4/10,13.35%,ADTRP;CST3;TGFB1;CHADL
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.40731180231711406,1.0984391996354284,0.3321976149914821,0.9453048211911395,1.0,9/15,26.83%,NTRK1;DDIT4;CASP3;SORT1;HAP1;NTRK2;ZFYVE27;BDNF;NGFR
prerank,proton transmembrane transport (GO:1902600),-0.3087147923265494,-1.098392733280488,0.3185840707964602,0.6667914670878822,1.0,8/36,20.04%,ATP6V0D1;ATP5PO;SLC46A1;UCP2;ATP6V1A;SLC25A27;ATP6V0A4;HVCN1
prerank,negative regulation of organelle assembly (GO:1902116),-0.31222764656115737,-1.0982859420044093,0.2869822485207101,0.6663216217250195,1.0,16/35,29.66%,CHMP4A;CHMP4B;CDK5RAP2;YAP1;SMCR8;BRCA1;MTM1;LRRK2;SMAD4;TRIM37;PHF23;KAT2B;CEP97;TESK1;CCP110;SCFD1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.38997694319222836,-1.09798087707101,0.32642487046632124,0.6664050028374442,1.0,5/15,19.50%,NR3C1;ANXA1;UBE2L3;BCL2L11;HNRNPU
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.20943826980389205,-1.0975303261079248,0.13821138211382114,0.6668695079654734,1.0,69/390,12.87%,VAV3;NEDD9;ITSN1;MTSS1;CYBB;ATP6V0D1;NRP1;NRP2;ACTR3;STAP1;PXN;IGF1;AXL;AP2A2;CASS4;KIF16B;CRK;ATP6V0D2;SDCBP;HNRNPM;GIT1;ATP6V1B2;ATP6V0A1;FRS2;MET;NCBP1;NAMPT;POLR2E;MAPKAPK2;ATP6V0B;GAB1;SHOC2;LMTK2;RASA1;NCK1;AP2B1;RASGRP4;ARPC2;FLT1;PDGFD;SYK;BCAR3;STMN1;LYN;FYN;AP3S1;BLNK;HCK;PSEN1;FGF1;PIK3CA;RET;ARPC5;PDGFC;LCP2;GHR;LCK;FOXO1;MAPKAPK3;GRB2;SORBS1;CYBA;IGF2;ATP6V1A;CBL;FRK;KDR;POLR2B;APH1B
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3414836907302402,1.0974184494459136,0.3359497645211931,0.9476511115750583,1.0,12/35,23.10%,POLG;POLD3;OGG1;XRCC1;LIG3;ADPRS;PARP1;APEX1;FEN1;UNG;MPG;RFC4
prerank,membrane assembly (GO:0071709),-0.31342399072622673,-1.0973844451982027,0.3047091412742382,0.6664657357266504,1.0,9/34,14.68%,RFTN1;FLOT2;CHMP4B;GAK;PICALM;NRXN2;S100A10;EMP2;UBXN2B
prerank,acyl-CoA biosynthetic process (GO:0071616),0.4119092921490062,1.0971887374591616,0.33220910623946037,0.9470553947519199,1.0,11/16,32.74%,CBR4;PPT2;ACLY;PPCS;ACSS1;SLC25A1;FASN;DIP2A;ACAT1;MLYCD;GCDH
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.3483167716237749,1.0971058576701858,0.32967032967032966,0.9458976460541718,1.0,10/33,15.34%,RELA;THY1;SLA2;PRNP;CD81;PRKD2;KCNN4;PVRIG;PTPN2;DGKZ
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.29506568993550464,1.0969978167694077,0.2767857142857143,0.9448117278706086,1.0,18/69,16.80%,NTRK1;SIX4;PPARGC1A;PLA2G3;MEF2C;LGMN;PRKCI;NRBP2;CX3CR1;CLCF1;PRKN;KDM2B;MAG;NDNF;SNX6;NTRK2;KIF14;PRKCG
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.44197587067001354,1.096902365252681,0.3543441226575809,0.9437205358686367,1.0,4/12,14.23%,MYCBP2;NFIB;EPHA4;EPHB2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.34247707203823796,-1.0968940133455063,0.319672131147541,0.6670438530069548,1.0,12/24,29.63%,GNL3L;EXOSC10;TERF2;SLX4;TENT4B;NAT10;HNRNPU;HNRNPC;TINF2;PIF1;TNKS;PINX1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3921985678493871,-1.0967856705493908,0.31685393258426964,0.6665356087759864,1.0,6/13,22.37%,NAMPT;NAXE;PTGIS;PARP9;NAXD;PARP16
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.34644294530302544,-1.0967141295961538,0.33773087071240104,0.6659438457233781,1.0,7/23,14.66%,KPNB1;DNASE2;HMGB2;DNASE1L1;H1-0;ENDOG;DFFA
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.44118893706343887,-1.0964861681258244,0.34174311926605505,0.6658108951977213,1.0,4/10,16.04%,STOML2;E2F8;CDT1;E2F7
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4466981133988701,1.0962110387886435,0.34941763727121466,0.9447912512942866,1.0,2/12,7.52%,MCM5;MCM3
prerank,peptidyl-lysine monomethylation (GO:0018026),0.46051351493284665,1.0960020885929516,0.3345132743362832,0.9441145225129632,1.0,4/10,10.66%,SMYD2;EEF1AKMT2;SETD6;SETD4
prerank,signal transduction in response to DNA damage (GO:0042770),-0.28138338201162744,-1.0957742289958978,0.27492447129909364,0.6669269526062511,1.0,12/49,11.50%,PRPF19;CLSPN;USP28;DOT1L;BCL3;NBN;ATRIP;HINFP;MAD2L2;RHNO1;PAXIP1;GRB2
prerank,regulation of cell migration (GO:0030334),0.2427920017585189,1.095716339303692,0.22271714922049,0.9437024021019179,1.0,87/382,18.22%,FGF10;ABI3;FRMD5;SEMA7A;F3;FGF16;SRGAP3;SRGAP2;PLXNB2;FGF9;LDB2;LDB1;LDLRAD4;STK26;PAK1;CTNNA2;ELP5;SLURP1;ARSB;PARD6B;LRRC15;ROBO4;VSIR;NUMB;THY1;SEMA6C;BEX4;PTPRT;PTPRU;DNAI3;FGF7;MAPK15;NTRK3;NAV3;TRIP6;SEMA6B;ADRA2A;TGFBR1;CCR1;MAZ;SEMA3D;PRKCA;SRCIN1;EPHA1;ENPP2;MAP4K4;ERBB4;IGSF10;SST;TGFB1;ADAM15;MYO1C;SNAI2;CAMSAP3;MINK1;FGF2;SCAI;DOCK10;SFRP1;PDGFB;SEMA4F;HACE1;EPHA4;CBLL1;FLCN;EPHB2;RFFL;KIF2A;INSR;RCC2;MIA3;ADORA3;SERPINE2;SEMA4B;ITGA6;KIF14;HRAS;SEMA3C;RIPOR1;ANGPTL3;PTK2;ROCK1;ENG;XBP1;ULK4;NTNG2;NTNG1
prerank,neurotrophin signaling pathway (GO:0038179),0.3699245894358665,1.0957078858427527,0.3468013468013468,0.9422665576273963,1.0,11/21,26.83%,NTRK1;DDIT4;CASP3;SORT1;HAP1;NTRK2;MAGI2;ZFYVE27;BDNF;RAPGEF2;NGFR
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.42287349735148505,1.0953464955895855,0.33671742808798644,0.9421755561794363,1.0,7/14,24.26%,SELENOS;PRKN;HERPUD1;TXNDC12;XBP1;CREB3;TMBIM6
prerank,triglyceride catabolic process (GO:0019433),-0.3534153737287715,-1.095041863871,0.3162162162162162,0.6682029889743869,1.0,4/19,12.43%,FABP4;LPL;FABP7;PNPLA2
prerank,limb morphogenesis (GO:0035108),-0.35556941624258764,-1.09500513570336,0.3188405797101449,0.6675495835811025,1.0,7/20,22.21%,MBNL1;FBXW4;IQCE;LRP6;TFAP2B;PTCH1;SHH
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.42082515884389954,1.0947454985441027,0.3602811950790861,0.9430514660931489,1.0,6/14,16.35%,PELI3;CCDC3;RFFL;TRAIP;PTPN2;CARD16
prerank,positive regulation of vasoconstriction (GO:0045907),0.4340127283087671,1.0944211727235182,0.3523489932885906,0.9428676734440088,1.0,2/13,3.31%,AVPR2;AVPR1A
prerank,gluconeogenesis (GO:0006094),0.3317455589142283,1.0942999455727465,0.33748055987558323,0.941922580566566,1.0,15/39,27.31%,GAPDH;PPARGC1A;SLC37A4;PGAM2;ALDOC;MDH1;ALDOA;PGM1;ENO3;SLC25A10;RBP4;SLC25A1;CRTC2;ATF4;PFKFB1
prerank,regulation of peptide hormone secretion (GO:0090276),0.2993402460879461,1.0942721820284003,0.30547550432276654,0.9405567072551961,1.0,16/67,17.41%,SNAP25;ITPR2;KCNA5;IL6;RFX6;SLC2A2;ADRA2A;PRKCA;RAPGEF3;CACNA2D2;CACNA1D;ITPR3;CRHBP;ABCC8;CACNA1A;MTNR1B
prerank,negative regulation of response to stimulus (GO:0048585),-0.2682230298387014,-1.094246686808408,0.2824675324675325,0.6688874653580329,1.0,21/60,22.71%,FCGR2B;MCTP1;ALOX5;CDK6;PTPN1;NR1H2;LYN;PDCD1;SOCS5;NR1H3;TERF2;MAPK7;AQP11;HMGA2;COL3A1;APPL2;WFS1;KLF4;ACVR1;TWIST1;VPS13C
prerank,transcription by RNA polymerase I (GO:0006360),0.34342819905697647,1.09415419277879,0.3590551181102362,0.9395400528248051,1.0,15/34,27.27%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;POLR1E;RRN3;MAPK3;POLR1F;GTF2H3;POLR1G;ERCC2;POLR1A;TAF1A;GTF2H1
prerank,hexose biosynthetic process (GO:0019319),0.32781445635051126,1.094045444049965,0.32674772036474165,0.9385399116802737,1.0,16/42,27.31%,GAPDH;PPARGC1A;SLC37A4;AKR1B1;PGAM2;ALDOC;MDH1;ALDOA;PGM1;ENO3;SLC25A10;RBP4;SLC25A1;CRTC2;ATF4;PFKFB1
prerank,regulation of protein kinase activity (GO:0045859),-0.2437703272097603,-1.0936327491757256,0.2744360902255639,0.6697939344280593,1.0,36/106,21.35%,IQGAP1;GAS6;PTPRC;C5AR1;SNX9;PRKAG2;YWHAG;UVRAG;TAB1;SMCR8;LCP2;AGAP2;CCN1;CEACAM1;INPP5K;RB1;QARS1;DEPTOR;PRKRIP1;PTK2B;TNF;HSPB1;CHP1;RAP1A;ECT2;PYDC1;TRAF4;LRP6;PPM1F;TAF7;DBNDD1;PLCE1;WARS1;DTNBP1;GSKIP;DUSP19
prerank,substantia nigra development (GO:0021762),0.3336054287388797,1.0934294692623916,0.29878048780487804,0.9395251539052928,1.0,5/37,6.86%,PLP1;YWHAE;FGF9;NDRG2;SYNGR3
prerank,regulation of multicellular organism growth (GO:0040014),-0.3723511660218395,-1.0933442260699546,0.30294906166219837,0.6697648347721298,1.0,6/15,21.52%,IGF1;STAT5B;GHR;MFSD2A;PTCH1;APP
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2976859411211104,1.0932155477066843,0.30140845070422534,0.938918857887945,1.0,12/72,9.86%,POLR2L;CDK7;POLR2F;COPS8;XAB2;GTF2H2;ISY1;POLD3;GTF2H4;XRCC1;LIG3;COPS3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.42425704913049583,1.0927965157887034,0.352622061482821,0.9390147681768921,1.0,6/13,23.28%,NCKAP1L;PNP;NKAP;ZBTB7B;GLI3;RUNX1
prerank,response to peptide (GO:1901652),-0.3079372150730558,-1.0927851707983947,0.2991913746630728,0.6705672099533808,1.0,11/33,15.40%,STAT5B;STAT4;STAT2;NOD2;FYN;ANXA1;EIF2B2;STAT1;AGER;EIF2B4;KAT7
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.38625754649300315,-1.0924334031527592,0.32425742574257427,0.6707747872842525,1.0,10/15,39.58%,TACC3;CDC27;UBE2C;PLK1;ANAPC7;CDC23;CENPE;ANAPC1;PTTG1;CDC16
prerank,leukocyte tethering or rolling (GO:0050901),0.4064962418001269,1.0917211470732975,0.3298611111111111,0.9415469874463257,1.0,5/17,9.53%,SELPLG;ADD2;JAM2;PODXL2;CX3CR1
prerank,phosphate ion transmembrane transport (GO:0035435),0.4414211215757579,1.091498838714394,0.36524822695035464,0.9409669577932743,1.0,6/12,25.04%,SLC37A4;SLC20A1;SLC37A1;SLC25A10;XPR1;SLC37A3
prerank,long-chain fatty acid transport (GO:0015909),-0.31713874543616627,-1.09146856152128,0.2981029810298103,0.6727091269752355,1.0,10/30,16.48%,APOE;PPARG;CD36;FABP4;SLC27A4;PRKAG2;MID1IP1;PRKAB2;MFSD2A;ACACA
prerank,positive regulation of programmed cell death (GO:0043068),-0.21656027090095437,-1.0913993327587408,0.18181818181818182,0.6721363318851813,1.0,63/272,18.00%,VAV3;ARHGEF3;FGD4;ITSN1;STK3;ARL6IP5;STK17B;TNFAIP8;IFIT2;ZBP1;BAX;TOP2A;PTPA;NLRC4;ARHGEF18;ATG7;ARHGEF6;SLC27A4;HIP1R;FAS;HSPD1;RIPK1;SYK;UBC;PLEKHG5;PSEN1;FGD1;PIDD1;PNMA2;UBA52;ABR;GNA13;UTP11;MAP3K11;DNM2;PRMT2;FOXO1;CTNNB1;BARD1;STPG1;ARHGEF26;GADD45G;DAPK1;RPS6KA2;APH1B;RYBP;RACK1;BMP2;LRRK2;SPHK2;PMAIP1;LILRB1;TNF;DDX20;ARHGEF5;BCL2L11;KLF11;SAP18;MAPK8;SQSTM1;ECT2;HMGA2;ARHGEF2
prerank,negative regulation of RNA splicing (GO:0033119),0.39697019186927024,1.0911580045128868,0.3416252072968491,0.9408277321387633,1.0,4/19,6.10%,SRSF12;RNPS1;SRSF6;PTBP1
prerank,nuclear membrane reassembly (GO:0031468),-0.2729560852144037,-1.0910154638866345,0.3105590062111801,0.6724156633612607,1.0,15/54,23.87%,CHMP4A;CHMP4B;KPNB1;PPP2R2A;NDC1;NUP43;CDK1;AHCTF1;BANF1;UBXN2B;SIRT2;LMNA;RCC1;CCNB1;NUP98
prerank,actin filament organization (GO:0007015),-0.2328194232524571,-1.0908248674610364,0.21929824561403508,0.672148908554962,1.0,33/151,18.70%,NEDD9;MYO5A;SVIL;HIP1;CASS4;EPS8;ACTN1;ARHGAP17;CORO1C;TMOD1;MYO1F;CGNL1;PROX1;HIP1R;MYO15A;CARMIL1;SHROOM4;GAS2L3;LCP1;MAD2L2;NEB;COBL;EMP2;VILL;ELMO2;CORO7;PLS1;BCAR1;GSN;CARMIL2;ARHGEF2;TPM4;FLNA
prerank,tryptophan metabolic process (GO:0006568),0.4498647938365652,1.0906720417808926,0.3526315789473684,0.9412079899196131,1.0,3/11,11.74%,IL4I1;IDO2;KYAT1
prerank,embryonic limb morphogenesis (GO:0030326),-0.3078363192048365,-1.0904889979221326,0.300531914893617,0.672250096140776,1.0,11/34,22.36%,MBNL1;FBXW4;WDPCP;CTNNB1;HDAC2;HDAC1;LRP6;PTCH1;SHH;MAP3K20;TWIST1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.43925456482233516,1.0903812910997437,0.3396880415944541,0.9409052825902807,1.0,3/12,9.53%,SELENOS;AR;TGFB1
prerank,microtubule bundle formation (GO:0001578),0.32072082609824476,1.0898151117788544,0.32794117647058824,0.9416108519162317,1.0,10/42,16.20%,TPPP;AAAS;PSRC1;NCKAP5;MAP1S;NCKAP5L;LRGUK;MTCL1;SPAG16;CLIP1
prerank,membrane depolarization (GO:0051899),0.3428287422696418,1.0897039972125466,0.335559265442404,0.9405927374159099,1.0,14/32,28.70%,CACNB4;CACNG2;KCNH2;CACNA1G;CACNA1B;SCN2A;CACNA1A;SCN3B;SCN1B;SCN8A;SCN7A;CACNA1H;SCN1A;ATP5IF1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.39487230978682625,1.0895499203011827,0.35714285714285715,0.9397153583105191,1.0,4/18,11.27%,SLC4A8;SNAPIN;RAB5A;RIMS1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.36870233514674045,-1.0893956833531007,0.3333333333333333,0.6742981859091576,1.0,7/17,19.50%,PTPRC;SOX11;N4BP2L2;GJA1;KAT7;HMGA2;HNRNPU
prerank,mRNA destabilization (GO:0061157),-0.2985857832620586,-1.0893255856865516,0.2653061224489796,0.673702199184702,1.0,12/38,25.42%,DIS3L2;CELF1;ZC3H12D;ZC3H12A;RC3H1;TRIM71;RC3H2;MEX3D;CPEB3;PUM1;RIDA;GIGYF2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3129799289015311,1.0891681492848266,0.3303834808259587,0.9396856562084983,1.0,12/53,15.55%,FGF10;WRAP53;NACC2;DDX5;HIC1;NSMCE4A;EEF1E1;UBE2N;RNF168;RNF8;ERCC6;CCAR2
prerank,regulation of spindle assembly (GO:0090169),-0.33589408325813314,-1.0891660055783634,0.31218274111675126,0.6733305994930299,1.0,8/25,19.79%,CHMP4B;CHMP1B;CCSAP;PDCD6IP;NUMA1;PLK1;HNRNPU;HSPA1B
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2988451040417338,1.0888544838291463,0.31486880466472306,0.9393887144068451,1.0,22/72,22.02%,PSMB1;RELA;CARD14;COPS8;PSMF1;BTRC;PSMA1;PSMD7;ZFP91;PSMA8;PSME3;MAP3K7;PSMD14;PSMC4;TLR3;PSMB4;REL;PSME1;PSMD2;PSMD4;TIRAP;PSMD8
prerank,regulation of chemotaxis (GO:0050920),0.3468520868621928,1.0887233152360487,0.33539412673879443,0.9384610969245019,1.0,8/30,15.32%,P2RY12;MYCBP2;RARRES2;TGFB1;STX3;CXCR4;PDGFB;PTPN2
prerank,positive regulation of cell death (GO:0010942),-0.272104476722153,-1.0886971976222055,0.2908496732026144,0.6738878479065478,1.0,15/59,15.36%,FCGR2B;CELF1;SLC6A6;CD36;TYROBP;RIPK1;PICALM;FYN;ZC3H12A;EIF2S1;LRP1;LRRK2;FOS;TNF;WNT5A
prerank,positive regulation of growth (GO:0045927),-0.2672092302182586,-1.0886286947271935,0.2703583061889251,0.673286674462543,1.0,19/64,19.65%,BCL2;RFTN1;SDCBP;NCBP1;ZPR1;CXCL16;DDX49;CIB1;H3-3A;BRAT1;PSMD10;EXOSC9;EGFR;SLC25A33;MFSD2A;ADAM17;ADNP2;PPM1F;WFS1
prerank,neutral amino acid transport (GO:0015804),-0.3242980647766803,-1.0885989563705987,0.31139240506329113,0.672607145562053,1.0,4/28,3.14%,SLC38A6;SLC1A5;SLC43A2;SLC6A6
prerank,protein import into peroxisome membrane (GO:0045046),0.36763009109325595,1.0884127401106656,0.33818770226537215,0.9382204287622534,1.0,12/22,27.81%,PEX5;FIS1;ATAD1;PEX26;PEX14;PEX2;ABCD2;PEX11B;PEX3;ABCD3;PXMP4;ACBD5
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3616474151824312,1.087888594292706,0.3577371048252912,0.9387432206149474,1.0,5/26,8.68%,SMOC2;LGMN;RPS6KB1;CCDC57;PRKCA
prerank,positive regulation of protein kinase activity (GO:0045860),-0.23163717808602932,-1.0878830339874237,0.2396694214876033,0.673745191872023,1.0,31/148,15.08%,IQGAP1;NEDD9;STK3;GAS6;CASS4;PTPRC;MARK2;ETAA1;LILRA5;CLSPN;PTPN1;BORA;PDCD10;SLC8A2;SNX9;PRKAG2;CIB1;TAOK3;GPRC5B;LCP2;AGAP2;CALM3;CCN1;SLC11A1;EMP2;CALM2;RALB;MTCP1;INCENP;PTK2B;TNF
prerank,positive regulation of GTPase activity (GO:0043547),0.2546749749012064,1.0878434888701407,0.2748466257668712,0.9374897611869609,1.0,50/188,21.51%,AGRN;SH3BP1;SRGAP2;F11R;SGSM2;SCRIB;NTRK1;SGSM3;THY1;SIPA1;PKP4;NTRK3;MAPRE2;RAPGEF3;CDKL5;ADCYAP1;EPHA1;MAP4K4;RGS10;RASGRF1;RAP1GAP;TBC1D16;DOCK10;SFRP1;RAP1GDS1;TBC1D8;DOCK9;RALBP1;FLCN;RSU1;SYDE2;APC2;TBC1D25;ITGA6;HRAS;ARHGAP22;ALS2;ZC3H15;ASAP3;PIN1;CCL15;PLXNB1;SIPA1L2;CCL5;CAV2;ARHGAP45;GMIP;GARNL3;SNX13;TBC1D8B
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.265425305630242,-1.0877334334892907,0.2787456445993031,0.6733802269275044,1.0,18/73,16.17%,HIP1;VCP;XDH;PPARG;BAX;NLRC4;HIP1R;FAS;HSPD1;RIPK1;SMAD3;ANP32B;PIDD1;LCK;SENP1;RACK1;TNF;MUL1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4138331985073972,-1.0877123832099187,0.37299771167048057,0.6726738604964495,1.0,5/12,20.03%,IGF1;SORBS1;IGF2;PPP1R3E;IRS2
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2597550694334751,-1.0876207760616758,0.304635761589404,0.6721613673623008,1.0,21/78,19.63%,DAB2;PID1;BCL2L1;PRKCH;PRKCE;PPP2R5A;PICALM;LDLRAP1;CIB1;SORBS1;LRP1;EGFR;TNF;CLN3;EPHA2;PLS1;RSC1A1;AKAP5;SQSTM1;NKD2;ZDHHC7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.27256383505297965,-1.0868512307064007,0.27044025157232704,0.6735508905603719,1.0,15/58,12.31%,NSD2;HMGB2;PRPF19;NSMCE2;IFFO1;MDC1;NBN;CYREN;ABRAXAS1;UVRAG;BRCA1;PAXIP1;BARD1;LIG4;KAT5
prerank,regulation of trophoblast cell migration (GO:1901163),-0.39050274721585243,-1.0867998378039139,0.3392857142857143,0.6729350240074836,1.0,7/14,29.63%,SMURF2;ARHGDIB;AGO2;GJA1;TIMP1;C1QBP;SYDE1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3030845324476026,-1.086792791530947,0.31085043988269795,0.672195821869039,1.0,9/36,16.95%,NRP1;CCR2;FBXW7;TAF1;HIF1A;HDAC2;HDAC1;GREM1;ADAM17
prerank,lipid homeostasis (GO:0055088),0.30386307248684974,1.086624903811001,0.3079136690647482,0.940644072936645,1.0,17/57,18.23%,TLCD3A;DGAT2;USF2;TLCD3B;PNPLA3;ABCB4;ORMDL2;TLCD2;USF1;ABCA2;ABHD5;ACOX1;FITM2;ANGPTL3;FABP3;XBP1;ABHD8
prerank,mesenchymal cell differentiation (GO:0048762),-0.2758472017703987,-1.086479004349891,0.2869822485207101,0.6723318320529721,1.0,16/51,19.95%,RBPJ;FBXL17;DLG5;LIMS1;HNRNPAB;HIF1A;S100A4;NOTCH1;CTNNB1;BMP2;NOTCH4;WNT5A;HEY2;HMGA2;LRP6;BMP7
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.29959524377327906,-1.086313782130307,0.32460732984293195,0.6720122790201103,1.0,9/34,16.57%,CD300A;CD300LF;RAB7B;CD14;GRAMD4;LYN;ACOD1;GPR108;TLR4
prerank,nuclear pore complex assembly (GO:0051292),-0.43208102908568813,-1.0861620702520427,0.3621495327102804,0.6716540283818037,1.0,3/10,12.26%,NUP153;NDC1;AHCTF1
prerank,myoblast differentiation (GO:0045445),-0.38758664236194906,-1.0856967192144864,0.32671081677704195,0.6721611527594313,1.0,7/14,18.55%,IGF1;MBNL1;HINFP;RB1;PLEKHM3;SDC1;MAPK12
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.24814922371849196,-1.0856842098577033,0.2775800711743772,0.6714450832204941,1.0,30/85,20.88%,DENND1A;STARD8;IGF1;EPS8;RAF1;DENND4C;KANK2;ARHGAP17;SHOC2;ARHGEF18;RASGRP4;CRKL;PDCD10;LYN;SPRY2;NOTCH1;ARHGDIB;GRB2;SPRY1;ARHGEF28;SHC1;SPRY4;NUP62;SQSTM1;ARHGEF2;MYO9B;IRS2;PLCE1;EPO;NOTCH2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3803524523184241,1.0848077151142508,0.33553719008264465,0.9460184456065619,1.0,6/20,18.56%,AGRN;LY6H;RGS10;LY6G6D;GNA11;CHRNA7
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3949480373715998,1.0847451480522616,0.3565365025466893,0.9448376928770772,1.0,7/18,21.77%,MISP;AR;ZDHHC2;SPTBN1;ABCA2;ACTB;VTI1B
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2490033493036289,-1.0845085231040295,0.2762237762237762,0.6738654566836931,1.0,22/93,16.01%,FNIP2;GAS6;RAF1;CD44;CNOT9;DOCK7;BRAF;TBK1;NCK1;TFRC;BCAR3;PDCD10;CAV1;TXN;MAD2L2;SPRY2;RACK1;INPP5K;MTCP1;EGFR;TNF;PFN2
prerank,RNA splicing (GO:0008380),0.2795055167359649,1.084387857711805,0.29435483870967744,0.9448219921213868,1.0,21/95,15.55%,RNPS1;IVNS1ABP;SMU1;FUS;DHX15;BCAS2;TRA2B;PPARGC1A;SF3B2;LSM1;SRSF11;PTBP1;PPIG;SNRPD2;MPHOSPH10;SF3B3;RP9;NOVA1;DDX39B;DDX47;CCAR2
prerank,DNA metabolic process (GO:0006259),-0.2149298788541449,-1.0843571393874831,0.1987179487179487,0.6735837022401759,1.0,66/270,18.77%,SP100;RAD51B;PARP4;RBBP8;VCP;DNASE2;HMGB2;PDS5B;DNASE1L1;PCNA;TOP2A;KPNA2;TOPBP1;POLE4;DOT1L;RTEL1;UHRF2;ORC5;ZRANB3;NT5E;CHD1L;CDC34;POLI;UBC;IGHMBP2;NBN;DNMT1;USP45;UVRAG;ATRIP;HINFP;PDS5A;BRCA1;UBA52;TRRAP;ORC2;POLD4;BARD1;RPA1;CDK1;LIG4;RMI2;MCM2;KAT5;TICRR;RAD21;TYMS;ENDOG;ORC4;CDT1;NPM1;PRIM2;DDX21;MNAT1;MCM8;TERF2;NTHL1;NOP53;RPA2;MUTYH;RNASEH2A;SLX4;XPC;WDHD1;RNASEH1;CBS
prerank,regulation of protein transport (GO:0051223),-0.3285462827629125,-1.0842116780074476,0.3064516129032258,0.6732483070515846,1.0,13/27,30.22%,DNAJC1;PTPN1;GAPVD1;LCP1;TNF;CHP1;PPM1F;NDFIP1;ATP13A2;SNX3;RHBDF2;SCFD1;NDFIP2
prerank,negative regulation of T cell proliferation (GO:0042130),0.35807619890008946,1.0841800986692145,0.3624801271860095,0.9441681471012005,1.0,5/28,5.56%,CD80;IL4I1;SCRIB;CD86;PRNP
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3381156414503352,1.083756081819905,0.3478964401294498,0.9442792891193394,1.0,6/32,15.07%,GAPDH;ANG;DEFA6;RNASE7;FAM3A;GALP
prerank,positive regulation of ion transport (GO:0043270),0.31093100470526713,1.0837249216992197,0.32305433186490456,0.9429977553608293,1.0,9/48,11.57%,CACNB2;PLA2G3;CNKSR3;ADRA2A;CCR1;FHL1;ACTN2;CACNA1D;TRPC6
prerank,proteasome assembly (GO:0043248),-0.42543718004427505,-1.0833465703096945,0.36633663366336633,0.6748620837913001,1.0,5/11,17.76%,OTUD6B;PSMG1;PSMD11;PSMD10;PSMD5
prerank,regulation of extracellular matrix organization (GO:1903053),-0.38558199467966026,-1.0832822139824758,0.3611111111111111,0.6742868677781405,1.0,5/15,13.54%,RIC1;NOTCH1;EFEMP2;LRP1;RB1
prerank,activation of protein kinase activity (GO:0032147),0.2765058134734602,1.0829300971321578,0.31550068587105623,0.9446600124910924,1.0,28/106,17.64%,ANG;ADCY8;STRADB;PAK1;CARD14;COPS8;STK11;PRLR;CD86;NTRK3;ADRA2A;RIPK3;MAP4K4;ZFP91;ITGB1BP1;PRR5;MINK1;MAP3K7;PAK5;PDGFB;TOM1L1;INSR;KIF14;TAOK1;PAK6;PRKAR1A;TLR3;IL18
prerank,regulation of TOR signaling (GO:0032006),0.2937598424919126,1.0824716695688816,0.3029411764705882,0.944957218190111,1.0,18/67,18.88%,TSC2;RPTOR;SLC38A9;MINAR1;DGKQ;ITFG2;EPM2A;DDIT4;PDCD6;FLCN;WDR59;RFFL;SH3BP4;HTR6;WDR24;MAPKAPK5;FBXO9;HDAC3
prerank,mitotic nuclear membrane organization (GO:0101024),-0.27182081747826187,-1.0824208131651747,0.30930930930930933,0.6751437454319287,1.0,14/51,23.87%,CHMP4A;CHMP4B;KPNB1;PPP2R2A;NDC1;NUP43;CDK1;AHCTF1;BANF1;SIRT2;LMNA;RCC1;CCNB1;NUP98
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.27182081747826187,-1.0824208131651747,0.30930930930930933,0.6751437454319287,1.0,14/51,23.87%,CHMP4A;CHMP4B;KPNB1;PPP2R2A;NDC1;NUP43;CDK1;AHCTF1;BANF1;SIRT2;LMNA;RCC1;CCNB1;NUP98
prerank,cell differentiation in spinal cord (GO:0021515),0.44404935955584157,1.0823864867442874,0.3707052441229656,0.9438755430684054,1.0,2/10,4.50%,MDGA2;SOX4
prerank,protein acetylation (GO:0006473),-0.32346009546365384,-1.082228034790006,0.32981530343007914,0.6749553897511796,1.0,12/30,25.94%,NAA10;NAA16;HAT1;FOXO1;EP300;KAT5;DSCC1;NAT10;ESCO2;KAT2B;NAA40;NAT9
prerank,DNA conformation change (GO:0071103),0.3924268566280598,1.0820369981811353,0.3472222222222222,0.9437855616849053,1.0,5/17,15.30%,TOP3A;HHEX;TOP1MT;HMGB1;HMGB3
prerank,integrin-mediated signaling pathway (GO:0007229),-0.26435304602912046,-1.0817259733751199,0.3103448275862069,0.6755775595393237,1.0,34/73,30.08%,DAB2;NEDD9;NRP1;CUL3;CD47;TEC;ADAM9;ITGB7;SYK;HCK;ADAM11;CEACAM1;PTN;PTK2B;MYH9;BCAR1;FN1;ITGB3;COL3A1;PRAM1;LAMA5;DOCK1;ITGA11;ITGA2;LAMA3;ILK;FBLN1;FYB2;LAT;PLEK;PLPP3;FGR;ITGB8;ITGB2
prerank,mitochondrial translational termination (GO:0070126),0.28339124078934264,1.0814493619655883,0.3237410071942446,0.9446129777418325,1.0,29/88,26.19%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.3281960077536156,-1.081375691399046,0.35751295336787564,0.6758079590511559,1.0,6/27,8.00%,PID1;PTPN1;NCK1;SLC27A4;PRKCQ;IL1B
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3599892312487547,-1.0812079656387956,0.3463414634146341,0.6755642113024749,1.0,7/20,18.32%,MCUB;YME1L1;PARL;MICU3;STOML2;MICU1;SLC8B1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.33458505410879524,-1.0808518196183492,0.32114882506527415,0.6758224758424605,1.0,5/24,6.26%,DAB2;PID1;BCL2L1;PPP2R5A;PICALM
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3471132559046855,-1.080820461754968,0.3425,0.675170755507184,1.0,6/20,13.69%,FLOT2;SDCBP;RIPK1;BIRC2;PDCD6IP;PELI1
prerank,cellular response to calcium ion (GO:0071277),0.2968435882909128,1.0808119400558363,0.32200886262924666,0.9455682916699286,1.0,12/67,8.89%,SYT4;ADCY8;CAPN3;NEUROD2;SYT13;SYT1;SYT6;TRPM2;MEF2C;LGMN;PKD2;CPNE6
prerank,protein import into peroxisome matrix (GO:0016558),0.4380571989361193,1.0807412643585428,0.38605442176870747,0.9444548827451833,1.0,5/12,18.42%,PEX5;PEX26;PEX14;PEX2;PEX6
prerank,protein-DNA complex assembly (GO:0065004),-0.23776514938342094,-1.0806749010038623,0.27459016393442626,0.674877876705418,1.0,29/116,15.29%,PSMA6;HMGB2;KAT6B;CUL4A;PSMB2;PSME2;ORC5;PSMD11;PADI4;CHD1L;PSMC6;UBC;PSMA3;ANP32B;H3-3A;UBA52;ORC2;RAD23B;CCNH;GRWD1;RPA1;MCM2;PSMD10;ORC4;CDT1;NPM1;PSMB5;MNAT1;MCM8
prerank,cellular amino acid catabolic process (GO:0009063),0.28408321895740574,1.0806567455792355,0.3079056865464632,0.9433992651803914,1.0,22/87,21.25%,HOGA1;HMGCLL1;IL4I1;IDO2;OTC;ACADSB;BCAT1;KYAT1;ALDH6A1;BCKDHB;AMT;ALDH5A1;ALDH4A1;SLC25A44;DAO;DLD;HSD17B10;ECHS1;BCKDHA;ABAT;QDPR;ASPA
prerank,positive regulation of cell migration (GO:0030335),-0.2143100216674698,-1.080354666966462,0.1912568306010929,0.6749917491300337,1.0,54/253,14.90%,DAB2;NEDD9;NRP1;PLAU;ITGAX;IGF1;CASS4;PRKCE;GCNT2;PTPRC;SDCBP;CCR2;SMURF2;CXCL16;GAB1;ADAM9;CRKL;THBS1;FLT1;PDGFD;KIF20B;PDCD10;CAV1;CARMIL1;GLIPR2;CIB1;HIF1A;IL1B;FGF1;SEMA6D;RET;MAPRE1;PDGFC;SPRY2;ELP6;NOTCH1;MIEN1;CCN1;PPP3CA;SEMA6A;F7;SHTN1;SEMA3B;SEMA5B;FAM83H;KDR;AGO2;RACK1;MYOC;BMP2;HAS2;FAM89B;EGFR;PTK2B
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.4041644312487625,-1.0802855465942363,0.3436754176610978,0.6744560122922724,1.0,5/13,22.94%,CDK5RAP2;MAD2L1;DUSP1;NDC80;CCNB1
prerank,regulation of cytoskeleton organization (GO:0051493),0.2746564243737639,1.0801984532035336,0.3234100135317997,0.9436674675854154,1.0,30/108,20.68%,TPPP;SH3BP1;STMN3;MAP6;FSCN1;ARHGAP44;F11R;PAK1;CORO2B;RHOBTB1;TWF2;CAMSAP3;GRHL3;ARHGAP35;BICD2;CORO1A;MAPK3;PHLDB2;TAOK1;PTK2;RHOQ;ROCK1;BICD1;CDK10;RHOBTB2;PLXNB1;PDGFRB;EPHA5;CYLD;IQGAP3
prerank,regulation of synapse organization (GO:0050807),0.35567136269732075,1.0801303893882452,0.337248322147651,0.942528161274163,1.0,9/26,19.14%,CTNNA2;MEF2C;CDKL5;NEDD4;IL1RAPL1;SLITRK4;EPHA4;ARHGAP22;ABHD17C
prerank,glycoprotein biosynthetic process (GO:0009101),0.2853308075057605,1.0800183982575318,0.3314121037463977,0.9415873986600148,1.0,19/79,19.54%,ST3GAL5;B3GNT9;FUT10;B3GNT6;B3GALT2;DDOST;ALG1;SERP2;CHST10;ST6GALNAC2;B3GALNT1;GAL3ST4;CSGALNACT1;ST3GAL6;ALG5;ALG3;CANT1;ST3GAL3;BMPR1B
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.32918574174989884,1.0799718208441569,0.34231378763866877,0.9404094511853257,1.0,8/37,15.78%,IFT20;WDR19;IFT81;DYNC2I2;CLUAP1;IFT27;IFT88;DYNLRB1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3915820077961908,-1.0796409483602996,0.3409090909090909,0.6755363916804367,1.0,6/14,10.78%,PRDM9;DNMT1;BRCA1;SNW1;PAXIP1;CTNNB1
prerank,positive regulation of gene expression (GO:0010628),-0.20243864851811885,-1.0796406321302594,0.2,0.6747995832432465,1.0,122/442,21.55%,PID1;RBPJ;IL15;CD74;HNRNPLL;PTPN22;GAS6;STAP1;ITGAX;IGF1;CCDC88B;CELF1;MITF;ADAM19;MED26;UPF3A;NIBAN1;RPL5;TLR2;BAZ1B;FAM98B;AFDN;PRKAB1;BRAF;CD36;POLR2E;FAM98A;ZPR1;LAMTOR5;PTGER4;TYROBP;SOX11;VPS35;BCL3;SAMD4A;LIMS1;ERN1;MSN;RPS7;PF4;DYRK1A;THBS1;RIPK1;TFRC;SMAD3;SP1;PDCD10;YAP1;DNMT1;HIF1A;CLEC6A;IL1B;PSEN1;DEK;FGF1;HINFP;LARP6;BRCA1;ZC3H12A;VIM;KRAS;CTCF;CD28;SPRY2;NOTCH1;EP300;C1QTNF3;CUX2;PIWIL2;SLC11A1;PLD1;AGO2;SCX;BMP2;RIMS2;SPHK2;POLR2H;TESC;NPM1;ZCCHC4;EGFR;LILRB1;DDX21;TNF;GJA1;RAMP2;TERF2;WNT5A;PDE2A;UPF3B;LARP4B;TLR4;FXR2;HEY2;MAPK8;GSN;HMGA2;AGPAT2;TENT4B;HNRNPD;NWD1;MMP8;FN1;PPM1F;NAT10;RPL26;TENT4A;MYD88;RGCC;HSPA1B;BMP7;RPL11;KLF4;WARS1;DTNBP1;PIK3CD;CPEB3;POU3F1;POLR1B;CDH3;APP;ID2
prerank,protein kinase A signaling (GO:0010737),0.42671641863355686,1.0794295626454233,0.366723259762309,0.9410720527351168,1.0,2/12,3.21%,MYOM1;TCP11
prerank,positive regulation of viral transcription (GO:0050434),0.35892246237341774,1.0789648311513869,0.3376835236541599,0.9414543992947165,1.0,5/25,6.91%,POLR2L;POLR2F;NELFB;NELFCD;GTF2F1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.37049339916907587,-1.0787804802501544,0.3405275779376499,0.6764237481223195,1.0,11/16,31.67%,RTEL1;HNRNPA2B1;TERF2;SLX4;SMG6;NAF1;TINF2;TNKS;PINX1;SMG5;ATM
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3454292461781444,1.078470994154876,0.34731543624161076,0.9419286631711307,1.0,10/29,18.02%,SHANK3;TWF2;PRKN;CORO1A;ARFGEF1;TWF1;SSH1;SSH2;SSH3;SHANK1
prerank,atrial septum development (GO:0003283),0.4308287188090804,1.0782472625049382,0.36619718309859156,0.9414428280815282,1.0,5/13,21.71%,ZFPM1;DAND5;GJA5;ANK2;MDM4
prerank,regulation of vasculogenesis (GO:2001212),-0.3965633715663688,-1.0782034378783956,0.3581395348837209,0.6773061163995916,1.0,7/14,17.19%,XDH;CEACAM1;KDR;EMP2;ASB4;RAP1A;HEY2
prerank,calcium ion homeostasis (GO:0055074),0.2811044662927565,1.0774949669995357,0.3392857142857143,0.942947513204483,1.0,22/95,19.40%,ATP2A3;ATP13A4;ATP2A2;SLC24A5;ATP1B1;TNNI3;ATP13A5;CCR1;GRIN1;SLC8A1;RMDN3;ATP2C1;ATP2B3;SLC8A3;DMPK;SLC24A3;ANK2;CHRNA7;SLC24A4;TRPV6;CCL15;CCL5
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3438745514342769,1.0774583786120524,0.3443396226415094,0.9417194836651763,1.0,6/32,14.98%,CAPN3;THY1;PLCG1;PKD2;GSTO1;HAP1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.3820516184173849,1.0769930503669944,0.3694581280788177,0.9421289724680695,1.0,5/19,8.20%,FPGS;MTHFD1L;MTHFD2L;GGH;ALDH1L1
prerank,ncRNA catabolic process (GO:0034661),-0.3209046518494959,-1.0769770615057506,0.336,0.6798949636448017,1.0,8/28,18.02%,DIS3L2;EXOSC8;EXOSC10;EXOSC9;RBM7;TRIR;POP1;TENT4B
prerank,lipid transport (GO:0006869),-0.2426896488142236,-1.076856667999446,0.2673992673992674,0.6794961564498606,1.0,17/97,9.63%,OSBPL8;APOE;NPC2;OSBP;CD36;ABCA6;SLC27A4;PLEKHA3;PPARD;NCOA1;PLTP;CLN8;LDLR;PCTP;OSBPL2;ABCG4;ABCG1
prerank,blood vessel diameter maintenance (GO:0097746),-0.30687217844434406,-1.076702962708341,0.33620689655172414,0.6791188612304749,1.0,20/34,40.31%,EDNRB;GCLC;ADCY6;EDNRA;KLF2;PER2;SERPINF2;AGTR2;KEL;NOS1;EDN3;CRP;EDN2;GPER1;ACE2;AGTR1;EDN1;KCNMB4;ECE1;SCPEP1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.34055650670173093,-1.0765935620863847,0.3502673796791444,0.6786908288586858,1.0,12/23,24.14%,CDK5RAP2;CENPA;MAD2L1;SPDL1;NUMA1;UBXN2B;GJA1;NDC80;PLK1;PAFAH1B1;NDE1;PKHD1
prerank,sulfation (GO:0051923),0.44340494927535845,1.07580445721837,0.3602058319039451,0.9452657850022492,1.0,1/11,1.13%,HS3ST5
prerank,positive regulation of cellular senescence (GO:2000774),0.46154294544064056,1.0756811306990957,0.389948006932409,0.9443858410711036,1.0,4/10,18.99%,ABI3;EEF1E1;CGAS;ARG2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.32851498433475185,1.0754937504659945,0.34055727554179566,0.9437403557514314,1.0,9/41,9.53%,TNNI3;TNNC1;SOX4;MYBPC3;MEF2C;TGFBR3;BMP4;HEY1;TGFB1
prerank,cell-cell junction assembly (GO:0007043),0.3010128191572048,1.0752329309490276,0.32946298984034833,0.9433487567574854,1.0,12/63,16.15%,CNTNAP1;FSCN1;DCHS1;PARD6B;PKP4;CDH18;PRKCA;GJA5;CTNND2;FLCN;PATJ;JAM3
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.39170479208641473,-1.0751233574150039,0.3553921568627451,0.6819158497447494,1.0,2/14,5.87%,ITGA4;THBS1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3769055660479341,1.0749446844000885,0.3552188552188552,0.9430841163334199,1.0,3/21,2.76%,GUCY2F;ADCY8;GUCY2C
prerank,protein transport (GO:0015031),-0.20623775594971783,-1.0748908123404144,0.2013888888888889,0.6817914433531761,1.0,78/332,18.25%,ATP6V0D1;CD74;VIPAS39;STX6;ARL6IP5;APOE;RAB8B;RIC1;TBC1D1;KIF3A;VPS26A;GOLPH3L;ATP6V0D2;SNX8;STEAP3;ATP6V1B2;ATP6V0A1;PPARG;STX12;STX5;CD36;RAB1A;RAB7A;SNX1;AP3B1;RPGR;ATP6V0B;VPS35;AP3D1;LMTK2;DNAJC27;RABGAP1;ARF3;TFRC;TBC1D2;GGA2;SNX9;TXNIP;NDC1;RAB6A;AP4M1;LAMP2;CTSA;TMED9;RAB15;ABCG1;RAB10;VPS45;TMED10;DNM2;VPS26B;HIKESHI;RAB21;TBC1D10C;ATP6V1A;TBC1D10A;CHMP1B;ZDHHC17;LRP1;USP6NL;NPM1;RAMP2;ADPRH;CALCRL;MYH9;OPTN;SEC23IP;USO1;RAB3GAP2;RAB31;ARRDC4;NAPG;MCOLN1;GCC2;RILP;TBCK;ARHGEF2;STX19
prerank,lipid catabolic process (GO:0016042),-0.35692590037168775,-1.074759446172815,0.35175879396984927,0.6814059560728777,1.0,6/18,21.92%,PLAAT3;LPL;HSD11B1;ACADL;SIRT2;PLA1A
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.4541617202130402,1.0744840739088577,0.3791208791208791,0.9434711648994497,1.0,3/10,8.06%,GABRG1;GABRG2;GABRA2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.29653438729225934,-1.0744118861936964,0.33229813664596275,0.6816211711493574,1.0,10/37,16.13%,BCL2;BCL2L1;BAX;NCK1;RPS7;CAV1;LCK;RACK1;PMAIP1;BCL2L11
prerank,regulation of protein catabolic process (GO:0042176),-0.24554379649445446,-1.0738151861050749,0.3210332103321033,0.6825845814566772,1.0,29/99,22.73%,ITCH;WWP1;VCP;STX5;EEF1A1;RAB7A;SMURF2;ATG7;HECW1;CTSA;MAD2L2;AGAP2;FOXO1;BARD1;WDR91;MAD2L1;EGFR;TNF;WNT5A;ODC1;TIPARP;DTL;RILP;FLNA;FMN2;SIRT2;ADGRB1;ASB11;NDUFA13
prerank,positive regulation of cell communication (GO:0010647),0.3557657496204304,1.0735344488826302,0.36276083467094705,0.9456228599933821,1.0,7/28,11.34%,CD80;SYT1;LGI1;GRIK2;CLSTN2;RIMS1;KCTD13
prerank,regulation of gluconeogenesis (GO:0006111),0.350536151807514,1.0735176017781325,0.3652892561983471,0.9443390334708701,1.0,4/27,8.77%,SELENOS;PPARGC1A;DGKQ;OGT
prerank,artery morphogenesis (GO:0048844),0.34932675983884165,1.0735150199577146,0.36597110754414125,0.9430115158703389,1.0,10/30,19.50%,LRP2;TGFBR1;BMP4;PKD2;TBX2;GJA5;ANGPTL3;ENG;HPGD;PDGFRB
prerank,diol biosynthetic process (GO:0034312),-0.36993275139705417,-1.0735091384163689,0.3438320209973753,0.6826780531340644,1.0,6/15,20.76%,ACER3;ASAH2;SPHK2;SPTLC2;SPTLC3;DHFR
prerank,mRNA metabolic process (GO:0016071),0.2822851240969005,1.073493062838916,0.3231197771587744,0.9417429252531065,1.0,42/90,31.08%,NUDT12;SRSF5;DHX15;DDX5;PPARGC1A;SF3B2;CPSF6;SRSF11;PTBP1;AKAP8L;PRMT9;ZFP36L2;SON;SF3A1;SRSF1;CPSF3;METTL16;TBRG4;NUDT21;AGO4;SRSF9;DXO;SNRPD3;SRSF2;SRRM4;CNOT10;LSM3;ALKBH5;NUDT16L1;USP39;NONO;NUDT16;HIPK3;METTL3;PCBP2;KIN;SFPQ;LSM10;RNASE4;U2AF1;SRSF7;U2AF2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.2404154177194602,-1.0732469762667745,0.26720647773279355,0.6827186938601492,1.0,23/108,15.08%,ARL6IP5;HIP1;VCP;XDH;PPARG;BAX;NLRC4;GRAMD4;HIP1R;FAS;HSPD1;RIPK1;UACA;SMAD3;SYK;ANP32B;PIDD1;LCK;DAPK1;SENP1;RACK1;PMAIP1;TNF
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.30929822646807176,-1.0728683968814254,0.3163841807909605,0.6829753799285034,1.0,8/31,16.57%,TLR2;IL16;HSPD1;SYK;LTB;AGER;SCIMP;TLR4
prerank,presynapse assembly (GO:0099054),0.4024182980993482,1.0728674510925866,0.369281045751634,0.9427495948687531,1.0,9/16,32.33%,PTPRD;LRRTM3;IL1RAPL1;WNT7A;PCLO;PTEN;CEL;NLGN3;NLGN1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2794009541475465,-1.0723979780932689,0.32710280373831774,0.6835874579439832,1.0,11/49,16.13%,BCL2;BCL2L1;MCL1;BAX;PLAUR;CAV1;UBQLN1;LCK;RACK1;PMAIP1;BCL2L11
prerank,regulation of blood coagulation (GO:0030193),0.3482356914737933,1.072345023599153,0.35545023696682465,0.9433044382128261,1.0,7/27,15.75%,ADTRP;CD34;THBD;ENPP4;VTN;EPHB2;SERPINE2
prerank,endothelial tube morphogenesis (GO:0061154),-0.42309165121286413,-1.072021588094684,0.37587006960556846,0.683884918815423,1.0,2/10,10.78%,RBPJ;CTNNB1
prerank,NAD biosynthetic process (GO:0009435),-0.35142786738751197,-1.0716136268468404,0.3241206030150754,0.6842414232662278,1.0,9/20,24.36%,NAMPT;NAXE;PTGIS;PARP9;NMNAT3;NAXD;KYNU;PARP16;NMNAT1
prerank,cellular response to metal ion (GO:0071248),0.269148900795064,1.0712345435032846,0.32309746328437916,0.9460287958913712,1.0,46/123,27.53%,SYT4;ADCY8;DLG2;CAPN3;NEUROD2;SYT13;SYT1;SYT6;PRNP;SLC12A2;TRPM2;MEF2C;LGMN;PKD2;CPNE6;GLRA2;PRKN;CRHBP;AOC1;MAPK3;HPCA;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;CPNE5;ALOX5AP;RYR3;MEF2A;GPLD1;SYT11;SYT12;MAPK1;ANK3;HFE;ADD1;DLG4;PLCG2;PRKAA2;DMTN;CACNA1H
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.37375163331320427,1.0711495279851881,0.35148514851485146,0.9450037528546708,1.0,7/20,16.66%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;SEMA4F;SEMA4B;SEMA3C
prerank,sphingosine metabolic process (GO:0006670),-0.360589123760935,-1.0710549248564698,0.3469945355191257,0.6850246677562998,1.0,6/17,20.25%,ACER3;SGPP1;ASAH2;SPHK2;SPTLC2;SPTLC3
prerank,negative regulation of histone modification (GO:0031057),-0.38623373878767164,-1.0705156530753996,0.3591549295774648,0.6857597538075839,1.0,6/14,22.41%,BRCA1;SPHK2;THAP7;TAF7;TWIST1;AASS
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.36660722934525164,1.0701651968475707,0.35596026490066224,0.9472173049485635,1.0,4/21,9.74%,BEX3;USP50;GRIN1;GRIN2B
prerank,nucleotide-excision repair (GO:0006289),0.2780572072897447,1.0700098752567337,0.324585635359116,0.946436787970523,1.0,31/101,24.48%,POLR2L;CDK7;POLR2F;COPS8;XAB2;GTF2H2;ISY1;POLD3;GTF2H4;COMMD1;OGG1;XRCC1;LIG3;COPS3;FAN1;POLR2G;PARP1;DDB2;COPS6;ERCC6;BRIP1;HUS1;COPS5;POLA1;POLR2C;GTF2H3;RFC4;ERCC4;POLR2D;ERCC2;USP7
prerank,synaptonemal complex assembly (GO:0007130),-0.3840564877977727,-1.0698732957222314,0.37028301886792453,0.6860468227381774,1.0,6/15,19.52%,STAG3;BAG6;RAD21;TEX11;TRIP13;REC8
prerank,synaptonemal complex organization (GO:0070193),-0.3840564877977727,-1.0698732957222314,0.37028301886792453,0.6860468227381774,1.0,6/15,19.52%,STAG3;BAG6;RAD21;TEX11;TRIP13;REC8
prerank,negative regulation of kinase activity (GO:0033673),-0.26346105517989454,-1.0694573076606897,0.2953846153846154,0.6864483457695306,1.0,25/62,21.35%,PTPRC;PPP2R5A;PRKAG2;YWHAG;TAB1;SMCR8;CEACAM1;INPP5K;RB1;QARS1;DEPTOR;PRKRIP1;HSPB1;CHP1;PYDC1;LRP6;PPM1F;TAF7;DBNDD1;HNRNPU;IRS2;WARS1;DTNBP1;GSKIP;DUSP19
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3395580362836012,1.0688760773411758,0.3518225039619651,0.9494278507193769,1.0,13/31,21.30%,YWHAE;E2F1;ZNF205;BAK1;PPP3CC;PPP1R13B;CHCHD10;BBC3;NMT1;YWHAQ;CASP8;YWHAB;TFDP2
prerank,protein ADP-ribosylation (GO:0006471),-0.31733541455913167,-1.06861282839013,0.3388888888888889,0.6879742691194298,1.0,8/28,22.37%,PARP4;PARP14;PARP9;TIPARP;ZC3HAV1;HPF1;SIRT2;PARP16
prerank,positive regulation of epithelial cell migration (GO:0010634),0.27543811511868654,1.0685497830364616,0.3232876712328767,0.9493565011876037,1.0,18/92,10.90%,FGF10;INSL3;FLT4;SMOC2;FGF7;PLCG1;PIK3CG;CLASP2;MAPRE2;BMP4;PRKCA;PRKD2;ENPP2;MAP4K4;ITGB1BP1;IQSEC1;PDCD6;FGF2
prerank,regulation of cytokine production (GO:0001817),-0.2367751364884168,-1.0685223703298412,0.3053435114503817,0.6874944429957782,1.0,22/126,11.89%,FCGR2B;IL15;CCDC88B;ALOX5;PTPRC;CD47;IFIH1;IRF7;ZBP1;CCR2;TBK1;PTGER4;MAPKAPK2;NPTN;LYN;ANXA1;SRGN;CLEC6A;CD28;C1QTNF3;TNFRSF1B;SLC11A1
prerank,protein O-linked glycosylation (GO:0006493),0.27911387329149817,1.0681211009657996,0.3425034387895461,0.9496187767686475,1.0,28/96,23.62%,PLOD3;TET1;B3GNT6;B4GAT1;TMTC4;ST6GALNAC2;GALNTL6;POFUT1;OGT;GXYLT1;FKRP;C1GALT1;SDF2L1;SLC35C1;MGAT5B;POMGNT1;PLOD1;DPM3;GCNT4;ST3GAL3;GALNT4;GALNT2;GCNT1;LARGE1;OGA;ST6GALNAC4;GALNT9;PGM3
prerank,regulation of platelet activation (GO:0010543),-0.3404531957727087,-1.0678927991427907,0.33668341708542715,0.688507976595411,1.0,8/21,18.49%,APOE;TEC;SYK;LYN;PRKCQ;FCER1G;TLR4;PDGFRA
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.27917118285890535,-1.0676838051429018,0.3171428571428571,0.6883400176571931,1.0,14/49,14.14%,HMGB2;RAB7B;PF4;THBS1;CIB1;PRKCQ;KMT2C;H3-3A;EP300;NFE2;HDAC1;DPY30;KMT2D;TESC
prerank,spliceosomal complex assembly (GO:0000245),0.31176842478380745,1.0674330643990906,0.34457478005865105,0.9507870732827426,1.0,15/46,18.87%,SRSF5;SRSF6;DDX1;RBM5;SF3A1;SRSF1;SNRPD2;YTHDC1;CELF6;CRNKL1;DDX39B;SETX;SRSF9;PUF60;GCFC2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2625753714886569,-1.0673565138900292,0.3032258064516129,0.6884806188583542,1.0,17/59,20.39%,TLR2;TBK1;BCL3;TLR7;CD14;RIPK1;UBC;TLR8;TAB1;UBA52;BIRC2;TNF;RELB;TLR4;ERC1;NKIRAS1;NLRC3
prerank,negative regulation of autophagy (GO:0010507),-0.2757858922321672,-1.0672229123062873,0.32926829268292684,0.6881389653345406,1.0,11/54,15.63%,BCL2;PTPN22;MCL1;MET;ATG7;SMCR8;CTSA;PIK3CA;RRAGA;LRRK2;FOXK2
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2407921401931709,-1.0667986611165878,0.3088803088803089,0.6885798464351527,1.0,25/103,16.35%,IGF1;RRAGC;SIAH2;USP28;CCDC88C;SHOC2;ARHGEF18;GRAP2;CRKL;ARHGAP18;ARHGAP30;DNMT1;USP8;RASGRP2;ABR;KRAS;CCNA2;GRB2;SHTN1;PLD1;RALB;RB1;SHC1;CHP1;PLD2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3939912453313433,-1.0667199744171003,0.3592233009708738,0.6880435651175488,1.0,3/14,8.05%,ACOT8;ACOX3;CROT
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3555062084136534,1.066656411286163,0.3536184210526316,0.9522646446121724,1.0,5/26,12.65%,YWHAE;CBARP;ADRA2A;PKD2;GSTO1
prerank,embryonic organ morphogenesis (GO:0048562),0.3200417218362505,1.0666460534403537,0.3403298350824588,0.9509734026514622,1.0,13/42,26.13%,HOXD4;MEGF8;HOXB9;MFAP2;FBN2;RBPMS2;DSCAML1;MFAP5;HOXB3;RBP4;HOXC9;FBN1;FUZ
prerank,regulation of cellular component movement (GO:0051270),-0.2667535722321642,-1.0665347917651171,0.313953488372093,0.68787555071899,1.0,9/49,9.45%,SP100;ABL2;RAF1;CDK6;ACTN1;ARHGAP18;ARAP1;LYN;NRG2
prerank,lymphocyte chemotaxis (GO:0048247),-0.31002921776447956,-1.0664578401250329,0.32967032967032966,0.6873511738997091,1.0,5/34,10.07%,GAS6;CXCL16;CCL25;GPR183;ADAM8
prerank,response to amino acid starvation (GO:1990928),-0.25445650996489405,-1.0663848136002125,0.28664495114006516,0.686817885742958,1.0,14/72,13.25%,ATP6V0D1;ATP6V0D2;ATP6V1B2;RRAGC;LAMTOR5;ATP6V0B;SH3GLB1;FAS;CEBPB;EIF2S1;SZT2;RRAGA;ATP6V1A;LARP1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.35809438974323066,-1.0662663060354454,0.3468354430379747,0.6864215316043364,1.0,8/19,22.50%,PRKCE;CD14;TNIP3;LBP;SCIMP;TLR4;NR1H4;TICAM2
prerank,amide transport (GO:0042886),-0.3304995906636925,-1.065970787479555,0.36752136752136755,0.6864729995027603,1.0,12/26,29.10%,PLEKHA3;PLTP;SLC46A1;SLC14A2;AQP11;ABCA13;CERT1;PDPN;CPTP;GLTP;FOLR2;FOLR1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.31664380349270776,-1.0656771954060147,0.32065217391304346,0.6864958276863301,1.0,10/27,21.13%,LIMD1;PUM2;RIPK1;DDX6;EIF4ENIF1;AJUBA;AGO2;EGFR;WTIP;PUM1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.24990519204530445,-1.0653678770845438,0.3269961977186312,0.6866653906637402,1.0,26/87,21.18%,NRROS;PXN;GCNT2;ARHGEF18;ADAM9;SMAD9;SMAD3;ZMIZ1;UBC;UBA52;USP9X;ID1;CBL;SMAD6;NLK;FOS;PARD6A;SMAD4;COL3A1;APPL2;USP15;BAMBI;CGN;ACVR1;USP9Y;ZMIZ2
prerank,aminoglycan metabolic process (GO:0006022),-0.4237549273870647,-1.0653571075435804,0.3632286995515695,0.6859647904669481,1.0,2/10,3.97%,XYLT1;CHST9
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.30906773091853634,1.065244585086364,0.3521341463414634,0.9547045492826844,1.0,17/49,25.35%,LDLRAD4;TMC8;PEX5;PRKCZ;CLU;PPM1A;ANKRD27;HMGB1;JAM3;KIF14;OPRD1;CDC42;IMPACT;ULK1;AIDA;CRYAB;DDX3X
prerank,liver development (GO:0001889),0.3388728396586222,1.0651953029564651,0.35348837209302325,0.9535536728678652,1.0,6/32,8.85%,WNT4;DNAAF1;CCDC39;IL6;TGFBR3;PKD2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.26498733165146976,-1.0645461538118002,0.2899022801302932,0.6874457194547752,1.0,18/57,19.67%,AKAP12;PSAP;ADCY9;CHRM2;DRD2;NPY1R;ADCY5;ADCY6;ADCY1;HTR1B;GRM4;ADCY3;PDE2A;AKAP5;OPRK1;FLNA;GPR37;DRD3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.4603881271916317,1.0643402662655066,0.3927272727272727,0.955407130153591,1.0,2/10,2.36%,NOS1AP;CACNB2
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3446976189370118,-1.064301602188721,0.3634085213032581,0.685965508950851,1.0,10/20,21.67%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;TRIP13;PLK1;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3446976189370118,-1.064301602188721,0.3634085213032581,0.685965508950851,1.0,10/20,21.67%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;TRIP13;PLK1;ZWINT
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3446976189370118,-1.064301602188721,0.3634085213032581,0.685965508950851,1.0,10/20,21.67%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;TRIP13;PLK1;ZWINT
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.35800945345741647,-1.063941679332075,0.3470873786407767,0.6862478555117583,1.0,7/19,19.79%,CHMP4B;CHMP1B;CCSAP;PDCD6IP;PLK1;HNRNPU;HSPA1B
prerank,regulation of epithelial cell proliferation (GO:0050678),0.2799932016017316,1.063810517285626,0.33709449929478136,0.9560392636364667,1.0,19/85,16.53%,FGF10;MAGED1;FGF16;FGF9;SIX4;FGF7;SRSF6;TGFBR3;DAB2IP;BMP4;NME1;TCF7L2;TGFB1;FGF2;SFRP1;HPN;PRKD1;PEX2;HRAS
prerank,regulation of protein kinase B signaling (GO:0051896),0.25025286817643916,1.062846217522883,0.3324905183312263,0.9582743071943196,1.0,38/193,15.27%,FGF10;TPTE;TSC2;F3;FGF16;P2RY12;CD80;FGF9;NTRK1;KLB;NRG4;PPARA;LRP2;CD86;FGF7;NTRK3;AREG;ARRB2;PIK3CG;TNFAIP8L3;TGFBR1;MAZ;TCF7L2;ERBB4;CX3CR1;TGFB1;ITGB1BP1;SH2B3;PDCD6;FGF2;IRS1;PDGFB;VAV1;TEK;FLCN;THPO;INSR;NTRK2
prerank,positive regulation of T cell differentiation (GO:0045582),0.32656902505289465,1.0623298361481055,0.358814352574103,0.9587481572880538,1.0,10/36,21.67%,IL4I1;VSIR;NCKAP1L;SOX4;PNP;NKAP;IL7;XBP1;GLI3;SART1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.34027294959109866,1.0622512946184686,0.3857374392220421,0.9577213080052228,1.0,5/28,6.03%,FGF10;THY1;NCKAP1L;IL6;XRCC6
prerank,positive regulation of organelle assembly (GO:1902117),-0.2868290820444176,-1.062222002037902,0.3575418994413408,0.6901271273246108,1.0,17/44,22.99%,SDCBP;SH3GLB1;ASAP1;KCTD17;LCP1;PDCD6IP;RALB;NUMA1;TNF;NUP62;SDC1;STX18;RAB3GAP2;SDC4;CNOT6L;G3BP1;MARK4
prerank,alcohol catabolic process (GO:0046164),-0.42295895099454256,-1.0621606790278262,0.3840749414519906,0.6895848948549355,1.0,1/10,0.51%,APOE
prerank,regulation of cellular component size (GO:0032535),-0.31213615118632076,-1.0620512124193067,0.3788300835654596,0.6891637878330393,1.0,13/30,25.12%,VAV3;EPS8;LAMTOR5;MSN;PICALM;NEB;HP1BP3;PPP1R15A;LAMTOR4;LARS1;MTPN;ATP13A2;RAC1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.29617472191256733,-1.0619882331290418,0.33618233618233617,0.6886335558893423,1.0,10/32,17.71%,CD300A;PPP2R5A;PTPA;CDCA2;CALM3;SPPL3;CALM2;ITGA1;CAMTA1;PPP1R15A
prerank,integrated stress response signaling (GO:0140467),0.38893043771659225,1.0618712105914743,0.3833049403747871,0.9578093382253683,1.0,8/14,31.23%,NFE2L2;HERPUD1;EIF2AK4;OMA1;IMPACT;ATF4;DDIT3;CCL2
prerank,regulation of rRNA processing (GO:2000232),0.3864697471370362,1.0617120556952464,0.35451505016722407,0.9571123367273106,1.0,3/16,8.21%,RIOK1;WDR75;DIMT1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3750427807802389,-1.0616164589564803,0.3533487297921478,0.6889370242674706,1.0,4/15,16.64%,CUL3;CDC73;NPM1;CRNN
prerank,positive regulation of DNA replication (GO:0045740),-0.3620054358281384,-1.0608297187722289,0.39902676399026765,0.6903586949549116,1.0,5/16,15.40%,PCNA;BCAR3;CDT1;EGFR;KAT7
prerank,regulation of intracellular signal transduction (GO:1902531),-0.203965439623438,-1.0605536923729288,0.28846153846153844,0.6903729476929098,1.0,95/420,18.00%,VAV3;ARHGAP15;ARHGEF3;FGD4;ITSN1;PPP2R5C;ARHGAP10;STK3;PTPN22;STARD8;CRK;RBBP8;AKAP12;RPL5;RBBP7;PJA2;PRKAB1;RRAGC;ARHGAP17;ARHGAP19;TTI1;TOPBP1;BCL3;ARHGEF18;TAF1;ARHGEF6;ARHGAP18;RPF2;ARAP1;PHF20;CD24;TAF12;GNA12;ARHGAP30;LYN;PRKAG2;NBN;MOB3B;PLEKHG5;CLEC6A;IL1B;RACGAP1;FGD1;RMI1;ARHGAP24;TAOK3;ATRIP;FGF1;BRCA1;PIDD1;ABR;GNA13;RHOJ;HIPK1;RHNO1;EP300;BARD1;ARHGDIB;RPA1;CDK1;ARHGAP39;BIRC2;HDAC2;RMI2;ARHGEF26;ARHGAP28;CEACAM1;KAT5;HDAC1;MYOC;ENTPD5;LRRK2;SPHK2;EHMT1;EGFR;AGER;PRKAB2;TNF;ARAP2;HSPB1;WNT5A;OPTN;BST1;ARHGEF5;TRAF1;PDE2A;CRNN;NOP53;RPA2;AKAP5;HIPK2;SQSTM1;ECT2;TBCK;ARHGEF2
prerank,erythrocyte differentiation (GO:0030218),0.31138147166341973,1.06055040958918,0.3674074074074074,0.9600891124117313,1.0,11/44,16.99%,ZFPM1;NCKAP1L;FLVCR1;TGFBR3;HSPA9;SH2B3;CASP3;SLC25A5;INHA;PTPN2;KMT2E
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3395402080186382,1.0604763262667878,0.3852327447833066,0.9590017576003637,1.0,9/31,18.90%,TOMM40L;PEX5;TIMM21;PEX26;PEX14;TOMM70;PEX2;PEX6;TIMM23
prerank,regulation of hemopoiesis (GO:1903706),-0.43407780928899675,-1.0604524919297924,0.3839479392624729,0.6899644399002925,1.0,3/10,13.40%,PURB;MYSM1;PTN
prerank,intraciliary retrograde transport (GO:0035721),0.42807602518291843,1.0601600804824853,0.38528896672504376,0.958836097964212,1.0,2/12,6.51%,WDR19;DYNC2I2
prerank,metal ion homeostasis (GO:0055065),0.3147417244635184,1.0600736751933237,0.35669781931464173,0.9578480161376439,1.0,7/40,9.62%,KCNH2;SCNN1A;CLDN16;SLC12A2;GRIN1;SLC12A6;SLC8A1
prerank,protein localization to kinetochore (GO:0034501),-0.37656315755457515,-1.0599212836876366,0.35469107551487417,0.6907114210267663,1.0,5/14,14.07%,BUB3;MIS12;ZWILCH;CDK1;SPDL1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.24843573338427752,1.059831487509589,0.33046683046683045,0.9574477443591671,1.0,53/198,21.80%,PLCH1;INPP4B;TPTE;ITPK1;IP6K1;PTPRD;PAK1;INPP5D;PLA2G3;NUDT10;PLCD1;INPP5B;PFKFB4;PLA2G4C;PLCG1;PIK3CG;TNFAIP8L3;SLC20A1;NUDT3;PLD4;LIMK2;PPM1A;ALDOC;TGFB1;ALPL;OCRL;PPA1;IPMK;AGPAT1;COQ8A;PFKM;EPHB2;HK2;MAPK3;PLPPR4;PRKCG;TAOK1;ANGPTL3;INPP5A;PFKFB2;ALDOA;PFKP;NT5C;PLCB2;FRA10AC1;INPPL1;PLA2G15;PLPP1;PSPH;PIP4P1;INPP5J;TOP1;PIP4K2B
prerank,C-terminal protein amino acid modification (GO:0018410),-0.41419731392823567,-1.0586326874871546,0.38534278959810875,0.6934287978674886,1.0,4/11,16.21%,ATG7;AGTPBP1;ICMT;AGBL1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3771565515850324,1.058536822981118,0.3758169934640523,0.9609262119781821,1.0,3/18,6.25%,POLR2L;MAF1;WDR75
prerank,carbohydrate catabolic process (GO:0016052),0.3221042060029612,1.0584094971129978,0.37422360248447206,0.9601179480955647,1.0,14/38,24.81%,GAPDH;PGAM2;NEU1;NAGA;ALDOC;MAN2B2;PFKM;HK2;PFKFB2;ALDOA;PGM1;ENO3;MANBA;PKM
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3073886931597258,-1.0580161312004892,0.37595907928388744,0.6944702778723921,1.0,6/29,9.05%,CNOT9;UBA5;KANK2;ESR1;YAP1;BRCA1
prerank,sprouting angiogenesis (GO:0002040),-0.27555804092222647,-1.05744999750723,0.3648293963254593,0.695280235082601,1.0,16/51,16.59%,NRP1;CCBE1;RNF213;THBS1;JMJD6;NAXE;EGR3;ADGRA2;KDR;E2F8;GREM1;PTK2B;RAMP2;OTULIN;E2F7;EPHB4
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.24714407468809235,-1.0574237294981848,0.3389830508474576,0.6946326518445375,1.0,27/76,24.82%,ITCH;RWDD3;CCDC22;ZC3H12A;ANXA4;PTGIS;PRMT2;ACOD1;BRMS1;FOXJ1;NLRC5;PSMD10;CHP1;OTULIN;PYDC1;NWD1;TRIM37;CDKN2A;BMP7;KLF4;NLRC3;TRIM21;AIM2;TMSB4X;CYP1B1;PKHD1;TLR9
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.2425905125430119,-1.0572023087763718,0.3554006968641115,0.6945754087334335,1.0,27/101,15.36%,ETAA1;PROX1;FLT1;PDGFD;NOD2;CCND1;PDCD10;CD24;SLC8A2;CIB1;IL1B;FGF1;PDGFC;ADAM8;CALM3;PIK3R6;CCND2;CALM2;PIK3R5;PSMD10;RALB;MTCP1;LRRK2;EGFR;INCENP;TNF;WNT5A
prerank,female gamete generation (GO:0007292),-0.30333683923256505,-1.0569586451129545,0.35694050991501414,0.6945266491949207,1.0,12/29,26.45%,PRDM9;DIAPH2;USP9X;PIWIL2;PTN;KMT2D;MCM9;MCM8;TRIP13;FMN2;M1AP;GDF9
prerank,regulation of microtubule nucleation (GO:0010968),-0.4188215652640565,-1.0569031745859427,0.40043763676148797,0.6939835149980899,1.0,3/10,4.91%,MECP2;GIT1;EML2
prerank,regulation of MAPK cascade (GO:0043408),-0.2210311492382711,-1.0568003707145694,0.2794759825327511,0.6935667261520566,1.0,36/157,16.20%,IQGAP1;STK3;CD74;IGF1;NBR1;PTPRC;LILRA5;DHX33;FLT1;FAS;SYK;BCAR3;CAV1;CD24;LYN;IL1B;DAG1;TAOK3;RET;CCN1;IGF2;GRM4;CEACAM1;KDR;PSMD10;ZDHHC17;TRIM5;MYOC;GREM1;BMP2;DUSP1;EGFR;SHC1;EPHA2;ARHGEF5;PEBP1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.31700921041540747,-1.0565552929216273,0.3785900783289817,0.6935010795538383,1.0,6/28,8.00%,PID1;PTPN1;NCK1;SLC27A4;PRKCQ;IL1B
prerank,DNA strand elongation (GO:0022616),0.3821309828767606,1.0559645643320992,0.3904448105436573,0.967823322432678,1.0,3/18,7.52%,POLD3;GINS3;MCM3
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.3431302654245065,-1.0558504018046937,0.36923076923076925,0.6947408604332009,1.0,4/20,8.69%,APOE;KPNB1;LDLRAP1;MBTPS1
prerank,protein localization to plasma membrane (GO:0072659),0.26111263311623933,1.0558112725345323,0.3687002652519894,0.9670629248421512,1.0,28/129,12.86%,F11R;CACNB2;ATP1B1;RAB3A;KCNIP3;RAB40B;MRAP;TMED2;KCNIP4;RAB8A;CLASP2;ATP1B3;TSPAN15;ZDHHC22;TSPAN32;CD81;ACTN2;NECTIN3;ITGB1BP1;BSG;EHD1;RAB3D;FGF13;ZDHHC2;EHD2;P2RY1;RAB34;RAB12
prerank,protein localization to membrane (GO:0072657),0.24919821212300453,1.055763680906877,0.3462986198243413,0.9659315565683981,1.0,38/187,12.86%,AGRN;WDR19;DLG2;CAPN3;F11R;CACNB2;SCRIB;ATP1B1;RAB3A;KCNIP3;RAB40B;THY1;ARL5A;MRAP;NRXN1;TMED2;KCNIP4;RAB8A;CLASP2;ATP1B3;TSPAN15;ZDHHC22;TSPAN32;NUP54;SHANK3;CD81;ACTN2;ITGB1BP1;BSG;EHD1;RAB38;RAB3D;FGF13;ZDHHC2;EHD2;P2RY1;RAB34;RAB12
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.24707216310638683,-1.055734781229918,0.3521594684385382,0.6943231885088973,1.0,32/84,25.12%,SASH1;NRP1;NRP2;P2RX4;MET;PROX1;THBS1;SP1;HIF1A;FGF1;ZC3H12A;KDR;GPI;FOXP1;PTK2B;HSPB1;WNT5A;BCAR1;AAMP;ADAM17;NUS1;GATA3;ITGB3;BCAS3;PIK3CD;TMSB4X;EGF;MAP2K3;ANXA3;BMPR2;ANGPT1;RAC1
prerank,phagosome-lysosome fusion (GO:0090385),-0.432508008177543,-1.0555134733100193,0.4110854503464203,0.6941793671047082,1.0,3/10,15.69%,RAB7B;RAB7A;CLN3
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.37455919674772153,-1.0554670123955765,0.37163814180929094,0.6935956131062686,1.0,5/15,15.08%,ORMDL1;RACK1;SPHK2;ORMDL3;TNF
prerank,aggrephagy (GO:0035973),-0.3077182124133097,-1.0553395273369186,0.33419689119170987,0.6932357038008838,1.0,8/27,13.10%,ARL13B;UBQLN1;UBC;WDFY3;UBA52;VIM;WDR81;DYNC1LI2
prerank,nucleic acid-templated transcription (GO:0097659),0.31407312821914873,1.0553056035202317,0.3606060606060606,0.9662567871604526,1.0,9/42,13.57%,POLR2L;RNPS1;POLR2F;XAB2;E2F1;FUBP3;POLR2G;THAP1;PPP5C
prerank,positive regulation of translation (GO:0045727),-0.23830510189059423,-1.055139443719299,0.3436293436293436,0.6930630353219368,1.0,27/94,19.32%,RCC1L;UPF3A;NIBAN1;RPL5;TRUB2;BCL3;SAMD4A;TRMT10C;THBS1;LARP6;VIM;UHMK1;CD28;PIWIL2;JMJD4;UQCC2;PLD1;AGO2;LARP1;NPM1;ZCCHC4;UPF3B;LARP4B;FXR2;HNRNPD;NAT10;RPL26
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.35931546059734754,-1.0549195001602887,0.3613861386138614,0.6930025090003941,1.0,3/18,5.93%,ABL2;ATP7A;NOD2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3414165874167264,-1.0548753722575444,0.37669376693766937,0.692415430322931,1.0,6/20,24.31%,SP100;BCL3;BARD1;HNRNPU;SYNE1;ARL2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3189568125036043,-1.0546286738302488,0.35501355013550134,0.6924025136397565,1.0,10/26,20.15%,IGF1;HOMER3;CIB1;SPPL3;FHL2;TNF;CHP1;CAMTA1;CHP2;STIMATE
prerank,glycogen catabolic process (GO:0005980),-0.3750934664273834,-1.0545714906872548,0.3759213759213759,0.6918530086090017,1.0,4/15,14.62%,PHKB;AGL;GAA;PGM2L1
prerank,RNA transport (GO:0050658),0.28424384017560944,1.0540973182895803,0.38376891334250346,0.9693100534550134,1.0,32/71,31.45%,RNPS1;SRSF5;CASC3;SRSF6;SRSF11;CKAP5;SRSF1;RAE1;CDC40;THOC5;DDX39B;SARNP;HNRNPA1;SRSF9;ATXN2;NXF1;CHTOP;ALYREF;SRSF2;POM121;RBFOX1;EIF4E;SRSF3;NUP155;THOC7;SRRM1;ZC3H11A;U2AF1;SRSF7;TPR;U2AF2;POLDIP3
prerank,negative regulation of cell adhesion (GO:0007162),0.2864664082439572,1.0539194019686036,0.3708513708513709,0.9686376640772776,1.0,18/72,17.09%,PLXNB2;ARHGDIG;PTPRO;CORO2B;SIPA1;DSCAM;PDE3B;ADAM22;SPINT2;ARHGDIA;TGFB1;ITGB1BP1;SNAI2;CBLL1;EPHB2;MIA3;JAM3;PTK2
prerank,axoneme assembly (GO:0035082),0.33738904877036435,1.0535879522675164,0.3860182370820669,0.968546143969136,1.0,8/30,16.62%,DNAAF1;CCDC39;CCDC65;SPAG1;LRGUK;SPAG16;DNAAF2;DNAAF3
prerank,regulation of DNA replication (GO:0006275),-0.2710813233081497,-1.0535091540698058,0.3392330383480826,0.6940413275581623,1.0,12/49,20.24%,ANKRD17;OBI1;PCNA;ORC5;BCAR3;PDS5A;CCNA2;CDT1;EGFR;KAT7;DSCC1;ESCO2
prerank,ncRNA metabolic process (GO:0034660),0.31932471698740444,1.0534473488536145,0.3719806763285024,0.9678005727626605,1.0,7/37,17.49%,NIFK;DTD1;MEPCE;EXD1;DROSHA;TDRKH;DTD2
prerank,regulation of cell differentiation (GO:0045595),-0.22604943234746544,-1.0534085573234597,0.3177966101694915,0.6936299642611556,1.0,30/148,15.47%,TRPS1;PHLDB1;MOSMO;FLOT2;ALOX5;RAF1;CDK6;CDK5RAP2;RUNX3;SLC6A6;PRKACA;PURB;VHL;CEBPB;CD24;ST7;YWHAG;ANP32B;DAG1;BIRC2;IGF2;UQCC2;NSUN2;EMP2;GREM1;SMOC1;SIK1;NOTCH4;TNF;KLHL41
prerank,lamellipodium assembly (GO:0030032),0.34805231428479966,1.0531681477600408,0.3665594855305466,0.9675296974155713,1.0,4/26,8.16%,P2RY12;SRGAP2;PTPRO;ABLIM2
prerank,cellular response to amino acid starvation (GO:0034198),-0.2529498678991752,-1.0531623991252972,0.3190789473684211,0.6936556528466241,1.0,13/71,12.27%,ATP6V0D1;ATP6V0D2;ATP6V1B2;RRAGC;LAMTOR5;ATP6V0B;SH3GLB1;FAS;CEBPB;EIF2S1;SZT2;RRAGA;ATP6V1A
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.34897805972412593,1.0531613648864848,0.3802588996763754,0.9662492445625416,1.0,7/25,18.03%,ATP2A2;NOS1AP;GJA5;FGF13;CXADR;CTNNA3;ANK2
prerank,negative regulation of lymphocyte migration (GO:2000402),0.437045975276413,1.0531533890456397,0.38235294117647056,0.9649765045840623,1.0,4/10,22.90%,ADTRP;APOD;MIA3;WASL
prerank,hyaluronan metabolic process (GO:0030212),-0.3298157011341574,-1.0530448789519666,0.36675461741424803,0.6932729176651077,1.0,10/23,18.62%,LYVE1;CD44;IL1B;HMMR;CEMIP2;STAB2;HAS2;CHP1;HYAL3;HAS3
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.23402243629020267,-1.0528823409516435,0.326271186440678,0.6929936293496105,1.0,27/113,16.92%,FNIP2;VCP;CUL4A;CD36;GNL3L;BAX;SH3GLB1;DHX33;ESR1;MTLN;TFRC;SYK;CHD1L;ASAP1;PSMC6;LCP1;RPA1;AJUBA;SKAP1;RACK1;CDT1;ICE1;TNF;RAP1B;BCL2L11;TLR4;RPA2
prerank,plasma membrane organization (GO:0007009),0.2934195089850606,1.0528741742989867,0.3826086956521739,0.9646625874268435,1.0,21/61,24.53%,COL5A1;BIN1;RAB3A;SYTL4;OTOF;BIN2;EHD2;CXCR4;TLCD2;MICALL1;SPTBN1;ABCD2;ANK2;SNX33;ABCA7;PACSIN3;PLSCR4;FA2H;SYT11;FNBP1L;ANK3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3393337030567166,1.0528637344584775,0.38636363636363635,0.9634060307199149,1.0,7/28,11.86%,LACC1;RELA;UBE2V1;INAVA;NOD1;UBE2N;MAP3K7
prerank,regulation of response to oxidative stress (GO:1902882),-0.39816387684901494,-1.0525371971908788,0.38967136150234744,0.6931839952206975,1.0,2/11,1.22%,MCTP1;ALOX5
prerank,neural crest cell development (GO:0014032),0.3077001665731834,1.052523087148593,0.3795180722891566,0.9633468140897935,1.0,12/44,16.66%,SEMA7A;SOX10;CYP26C1;SEMA6C;SEMA6B;SEMA3D;ERBB4;SNAI2;PDCD6;SEMA4F;SEMA4B;SEMA3C
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.3554538400128351,1.05237246502057,0.3977635782747604,0.9625865473649122,1.0,8/24,25.44%,BOC;CTNNA2;MEF2C;TCF3;OLFM2;CDC42;MEF2A;CAMK1
prerank,double-strand break repair (GO:0006302),-0.22518006136337707,-1.0522333907269406,0.3080568720379147,0.6932974684994127,1.0,42/158,18.31%,NSD2;RAD51B;RBBP8;VCP;HMGB2;BAZ1B;PRPF19;NSMCE2;DTX3L;KPNA2;IFFO1;YY1;MDC1;NBN;CIB1;EYA1;CYREN;ABRAXAS1;RMI1;BRCA1;EYA3;MAD2L2;PAXIP1;BARD1;RPA1;LIG4;KAT5;RAD21;SWI5;PARP9;NHEJ1;MCM9;MCM8;MMS22L;EME1;BRCC3;RPA2;MAPK8;UIMC1;SLX4;TRIP13;HPF1
prerank,regulation of secretion by cell (GO:1903530),0.3006885690324335,1.052185921463555,0.3881278538812785,0.9619596805011069,1.0,15/54,18.49%,LGI3;RAB3A;DISP1;SYT1;RAB26;MEF2C;RAB8A;RAB3D;RIMS1;CPLX2;RAB12;VAMP3;HAP1;STXBP5;LLGL2
prerank,ERBB signaling pathway (GO:0038127),-0.25780757327989334,-1.052140522403045,0.35855263157894735,0.6928279178930739,1.0,15/64,16.95%,IQGAP1;KIF16B;REPS2;BRAF;GAB1;PIK3CA;NRG2;GRB2;CBL;EGFR;SHC1;PTK2B;BCAR1;AAMP;ADAM17
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.2728716806039504,-1.0521150476533059,0.3416149068322981,0.6922011463718003,1.0,17/51,23.89%,CCT6A;GNL3L;PKIB;PRKCQ;EXOSC10;CTNNB1;CCT3;TERF2;MAP2K7;TENT4B;NAT10;SMG6;HNRNPU;HNRNPC;NAF1;TINF2;PIF1
prerank,RNA catabolic process (GO:0006401),-0.2846972254140193,-1.0520573575584196,0.31845238095238093,0.691661446996196,1.0,14/46,19.79%,DIS3L2;RNASE3;ZC3H12D;NCBP1;ZPR1;ERN1;XRN2;LSM2;LSM5;RNASEH2A;HNRNPD;RNH1;RNASEH1;HSPA1B
prerank,regulation of ion transport (GO:0043269),0.27961240363684936,1.0517453860761903,0.38636363636363635,0.9622686991813479,1.0,15/76,15.88%,SYT4;KCNJ3;KCNA5;KCNJ8;SYT13;SYT1;SYT6;KCNJ13;NEDD4;PRKN;NKAIN2;VAMP3;SNX6;NEDD4L;KCNJ5
prerank,positive regulation of autophagy (GO:0010508),0.2753060930446522,1.051669656269778,0.36363636363636365,0.961240311642601,1.0,23/81,19.28%,TSC2;MID2;STK11;FBXO7;SCOC;PLK3;PRKN;EPM2A;MAP3K7;TFEB;TRIM8;HMGB1;FLCN;GNAI3;EIF2AK4;SH3BP4;RNF152;PRKD1;PLK2;ROCK1;TRIM68;TMEM59;DCN
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.445677065250999,1.0515899658681311,0.39372822299651566,0.9602347112349876,1.0,6/10,26.73%,SH3BP1;CAMSAP3;CDC42;OPHN1;RHOA;MYO9A
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.3946574826933383,1.0510542185572622,0.39145299145299145,0.9609346883209305,1.0,6/16,18.47%,PRDX6;TRA2B;CIRBP;RBM3;RBMXL1;TRA2A
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.36660348631560685,-1.0509149248973015,0.3643031784841076,0.6941559507398702,1.0,10/16,37.53%,SLC2A5;DRD2;PRCP;KLK3;KLK1;BMPR2;SPX;DDAH1;NPPA;GSK3A
prerank,regulation of centriole replication (GO:0046599),-0.3568895432225686,-1.0505835772624845,0.37037037037037035,0.6943304135717474,1.0,7/17,23.28%,CDK5RAP2;BRCA1;NPM1;NUP62;TRIM37;CEP295;KAT2B
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.3949038500320117,1.0495740857192204,0.39965397923875434,0.9649467419975013,1.0,3/15,16.89%,SIX4;BMP4;AGT
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2460304665390582,-1.0486919860956232,0.33114754098360655,0.6988244195444892,1.0,27/73,24.62%,MECP2;EPC1;RBBP7;BAZ1B;PPHLN1;POLR2E;DNMT1;BMI1;H3-3A;DEK;CTCF;EP300;IGF2;SPHK2;POLR2H;DDX21;GPX1;PHF19;EED;POLR1B;HDAC4;TFAP2C;KAT2B;TASOR;MTF2;TDG;EZH2
prerank,neuron remodeling (GO:0016322),0.43140745597696006,1.0481608227348214,0.4028776978417266,0.9687715887365085,1.0,2/10,11.55%,C3;FARP2
prerank,cellular response to radiation (GO:0071478),-0.2872336005710326,-1.0479775368788935,0.3785310734463277,0.7000792023030893,1.0,21/40,35.00%,EEF1D;RHNO1;GRB2;LIG4;SWI5;GPR88;ECT2;OPN3;TRPM1;NET1;RRH;RAD51AP1;TNKS1BP1;GPR52;FIGNL1;SPIDR;CLOCK;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,response to calcium ion (GO:0051592),0.26925692394087336,1.0474571993830273,0.3670360110803324,0.9699067016109751,1.0,19/102,12.75%,KCNMA1;SYT4;ADCY8;TRPC3;CAPN3;NEUROD2;SYT13;SYT1;SYT6;TRPM2;MEF2C;LGMN;SEC31A;PKD2;CPNE6;NEDD4;PDCD6;ITPR3;CRHBP
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3194210073000804,-1.0474202445657428,0.344559585492228,0.7009506341130524,1.0,9/26,23.66%,CBLB;FBXW7;SOCS5;CBL;SHC1;ADAM17;APP;TGFA;EGF
prerank,negative regulation of cell motility (GO:2000146),0.2646231598914706,1.0473836437581847,0.375,0.9688690352926702,1.0,22/108,15.71%,SPOCK3;FRMD5;SRGAP3;SRGAP2;LDLRAD4;STK26;SLURP1;THY1;PTPRT;PTPRU;DNAI3;MAPK15;NAV3;SPINT2;EPHA1;ADAM15;SCAI;SFRP1;EPHA4;FLCN;MIA3;ADORA3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3121945170382933,1.0473040787656154,0.3811659192825112,0.9678822640517946,1.0,10/42,17.26%,WRAP53;PPP4C;FUS;USP51;TIMELESS;CGAS;PARP1;ERCC6;SHLD3;MRNIP
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3294582152370379,1.0468636085789245,0.3804511278195489,0.9681798002100399,1.0,5/33,10.96%,TPTE;PIK3C2G;NYAP2;PIK3CG;IRS1
prerank,epithelial to mesenchymal transition (GO:0001837),-0.2699072150480604,-1.0467142094920292,0.3609467455621302,0.7021601714328995,1.0,13/47,17.80%,RBPJ;DLG5;LIMS1;HNRNPAB;HIF1A;S100A4;NOTCH1;CTNNB1;BMP2;NOTCH4;WNT5A;HEY2;HMGA2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.4043347493015363,-1.0465512323918804,0.3778280542986425,0.701871306039699,1.0,4/11,13.84%,SOX6;FRS2;GREM1;BMP2
prerank,glutamine family amino acid catabolic process (GO:0009065),0.4109522108980084,1.046458882228226,0.39829059829059826,0.9683335164009234,1.0,6/13,29.58%,ALDH4A1;DAO;PRODH;GLUL;GLS2;GAD1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3257983250492087,-1.0464006027481236,0.3564356435643564,0.7015897724084944,1.0,7/24,18.87%,MCL1;BAX;FBXW7;TYROBP;CTNNB1;TNF;TFAP2B
prerank,negative regulation of secretion (GO:0051048),-0.42175122076411187,-1.0458918942452498,0.41975308641975306,0.7022658937704921,1.0,4/10,26.44%,CD74;NR1H3;EGF;SPX
prerank,glutamate receptor signaling pathway (GO:0007215),0.3168427943178667,1.0458847195309486,0.39384615384615385,0.969132249619138,1.0,19/37,29.36%,GRIA2;GRM3;GRIK2;GRID2;GRIA4;GRIN1;GRIN2B;HOMER2;DAGLA;DAGLB;GRIK3;GRIK4;GRM8;GNAQ;GRM7;KCNB1;PLCB1;GRM1;GRIN2A
prerank,protein localization to cell surface (GO:0034394),0.3467372205802348,1.0456713672322517,0.3927392739273927,0.9686730588793192,1.0,7/26,18.03%,FGF10;GGA3;PTPRU;FGF7;UNC50;JAM3;ANK2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.38423226271756794,1.045585611578455,0.4182776801405975,0.9676909398071775,1.0,5/16,13.93%,PFAS;NUDT2;GART;AMPD3;ADSL
prerank,positive regulation of mitochondrion organization (GO:0010822),0.29488650225918694,1.0455839340137265,0.36874051593323215,0.9664299386804955,1.0,13/57,14.48%,PPARGC1A;FIS1;MLLT11;PDCD5;FBXO7;ZNF205;BAK1;PRKN;DNM1L;RALBP1;CHCHD10;BIK;BBC3
prerank,ketone body metabolic process (GO:1902224),0.450833089095262,1.0451446734194199,0.41742286751361163,0.9667114807393993,1.0,3/10,14.92%,HMGCLL1;ACSS3;OXCT1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.32914525179053833,-1.0451043811476393,0.38726790450928383,0.7037767906605209,1.0,9/23,23.66%,IGF1;NFKB1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;APP;EGF
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.32528198130247127,1.0451002680670094,0.38817891373801916,0.9655969707816483,1.0,11/35,16.66%,SH3BP1;SEMA7A;PLXNB2;SEMA6C;SEMA6B;SEMA3D;ARHGDIA;FARP2;SEMA4F;SEMA4B;SEMA3C
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.34984600975408264,1.0449180143503505,0.3890675241157556,0.9650222850940593,1.0,12/25,27.93%,HSPA2;SDF2;SDF2L1;HSPA9;DNAJC7;HSPE1;HSPA14;DNAJB4;DNAJB13;ST13;HSPA8;PTGES3
prerank,epithelial cell differentiation (GO:0030855),-0.2449529339955288,-1.044842748854601,0.35507246376811596,0.7037744296408184,1.0,25/88,21.42%,DAB2;PPARG;PCNA;PROX1;ANXA1;CTSB;SCUBE1;RAB10;ANXA4;CDK1;HDAC2;HDAC1;KDR;MAF;TAGLN2;E2F8;E2F7;TAGLN;GATA3;CASP6;ZDHHC7;EHF;DHRS9;BASP1;ANXA7
prerank,nitric oxide metabolic process (GO:0046209),0.3988584952506406,1.0447317669497094,0.4013961605584642,0.964369543982401,1.0,4/14,18.99%,GCHFR;DDAH2;CYB5B;ARG2
prerank,neuron fate commitment (GO:0048663),-0.3830428906191764,-1.0445766297449781,0.38724373576309795,0.7038528275706483,1.0,8/14,30.81%,MYT1L;ID2;SHH;PAX6;DLL4;ISL1;EPOP;DLL1
prerank,regulation of cell size (GO:0008361),-0.3223219311558546,-1.0444164881764926,0.3819628647214854,0.7036110623201866,1.0,3/23,5.36%,VAV3;LAMTOR5;MSN
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.38959684737818634,-1.0441358647922543,0.37264150943396224,0.7037136450630738,1.0,4/12,18.47%,STAP1;IL1B;TNF;MMP8
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.3847811342381555,-1.0441112800354204,0.3891509433962264,0.7030913931301052,1.0,5/12,16.17%,IFIH1;IFIT1;CAV1;RALB;MUL1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.32561240564386873,-1.0439971770633514,0.39018087855297157,0.7026969297475,1.0,6/24,11.52%,PCNA;UBC;UBA52;POLD4;RPA1;LIG4
prerank,telomere organization (GO:0032200),-0.27557138077511645,-1.04361820664483,0.3473389355742297,0.702998321758664,1.0,8/43,10.88%,SP100;PCNA;DOT1L;RTEL1;NBN;H3-3A;POLD4;RPA1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.32506749861035794,-1.0434225559684294,0.3798449612403101,0.7028107710313505,1.0,8/24,13.50%,MET;CGNL1;ARHGEF18;ARAP1;STMN1;ARHGAP28;MYOC;INPP5K
prerank,vesicle organization (GO:0016050),0.3065235765211595,1.0433125625263402,0.38650306748466257,0.9681295458044212,1.0,16/46,24.06%,ANXA8;ANXA8L1;CD34;USP50;PI4K2A;CORO1A;SORT1;HOOK2;VPS33B;ALS2;SNX33;HOOK1;CAV2;SNX11;WASL;FNBP1L
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2909482648790224,-1.0432657487148445,0.3878116343490305,0.7025527488793335,1.0,10/39,19.72%,ITGA4;GAS6;THBS1;KDR;TNF;RAMP2;MAPK7;ECSCR;GATA3;RGCC
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3496373095458101,-1.04305798442525,0.3975,0.70244078307999,1.0,6/18,17.69%,ESR1;LCOR;KAT5;EGFR;FAM210B;NRIP1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.2816715970029049,1.043010130266726,0.3982808022922636,0.9679072637700552,1.0,14/75,13.02%,WNT4;HOXA5;HHEX;IL17F;PDE3B;YJEFN3;GTF2I;MINAR1;DAB2IP;FOXC1;VASH1;EFNA3;COL4A2;TEK
prerank,neuron apoptotic process (GO:0051402),-0.34197250913428595,-1.0429978142432987,0.3713592233009709,0.701927505348002,1.0,5/19,11.52%,BCL2;TRPC5;FAS;CIT;LIG4
prerank,response to UV-B (GO:0010224),0.41653012374030707,1.042982045767613,0.41360294117647056,0.9667665344955503,1.0,2/12,4.84%,RELA;STK11
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.33615100020186367,-1.042912738309919,0.37433155080213903,0.7014845355544632,1.0,3/22,1.19%,FCGR2B;PTPN22;CD300A
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.21989685688576732,-1.042875294159652,0.3252032520325203,0.7009066348788195,1.0,23/161,7.62%,DAB2;STK3;APOE;PSMA6;MCC;LIMD1;CUL3;DVL3;IGFBP4;PSMB2;SIAH2;PSME2;CCDC88C;DKK2;HECW1;PSMD11;MLLT3;TMEM131L;PSMC6;CAV1;PFDN5;ZNRF3;PSMA3
prerank,positive regulation of protein modification process (GO:0031401),-0.21371799704864705,-1.0428210666173239,0.3602150537634409,0.7003710995193989,1.0,48/203,16.95%,DAB2;CD74;GAS6;FAM161A;NIBAN1;PPP2R5A;DVL3;FAM20A;PTPA;NPTN;ATG7;DYRK1A;CRKL;FAS;RIPK1;TFRC;CCND1;PLAUR;LYN;CIB1;IL1B;TXN;FGF1;KRAS;CDCA2;CALM3;BRMS1;CCN1;IGF2;AKTIP;BRAT1;SPPL3;KAT5;KDR;CCND2;CALM2;RACK1;RALB;BMP2;LRRK2;EGFR;AGER;TNF;CHP1;CAMTA1;RAB3GAP2;FXR2;ADAM17
prerank,mRNA 3'-end processing (GO:0031124),0.27553141231532363,1.042594851053294,0.3915574963609898,0.9668343831762652,1.0,22/78,20.18%,RNPS1;SRSF5;CASC3;CPSF4L;CPSF6;SRSF6;SRSF11;MTPAP;SRSF1;CPSF3;CSTF1;NUDT21;CDC40;THOC5;DDX39B;SARNP;PAF1;SRSF9;CHTOP;SSU72;ALYREF;SRSF2
prerank,protein localization to cell periphery (GO:1990778),0.2566416744393427,1.0423531586922894,0.3968042609853529,0.9664329562260574,1.0,28/133,12.86%,WDR19;F11R;CACNB2;ATP1B1;RAB3A;KCNIP3;RAB40B;MRAP;TMED2;KCNIP4;RAB8A;CLASP2;ATP1B3;TSPAN15;ZDHHC22;TSPAN32;CD81;ACTN2;ITGB1BP1;BSG;EHD1;RAB3D;FGF13;ZDHHC2;EHD2;P2RY1;RAB34;RAB12
prerank,peptidyl-lysine modification (GO:0018205),-0.23493299417174807,-1.0418321941521873,0.3535714285714286,0.7022881892997594,1.0,21/99,13.92%,VIPAS39;IFIH1;NSMCE2;ATP7A;RANBP2;EGR2;NUP153;EYA1;NDC1;NUP43;UBA2;USPL1;NUP210;LOX;VCPKMT;PIAS2;EP300;TRPM4;KAT5;SENP1;ETFBKMT
prerank,regulation of lipid catabolic process (GO:0050994),0.3757704736035405,1.0417901654111013,0.3925686591276252,0.9672217405029516,1.0,6/19,19.62%,RARRES2;PDE3B;ADRA2A;ANGPTL3;TYSND1;HCAR2
prerank,intracellular protein transmembrane transport (GO:0065002),0.3137725155083853,1.0415479794321723,0.4050235478806907,0.966846445977944,1.0,11/42,18.90%,TOMM40L;PEX5;TIMM21;SEC62;PEX26;PEX14;SEC61A2;TOMM70;PEX2;PEX6;TIMM23
prerank,B cell activation involved in immune response (GO:0002312),-0.388847108192344,-1.0414723880102235,0.39371980676328505,0.7025873271155687,1.0,3/13,11.52%,FCGR2B;GPR183;LIG4
prerank,microtubule anchoring at centrosome (GO:0034454),-0.4231654437048572,-1.0413006244293996,0.40425531914893614,0.7023766309237495,1.0,2/10,1.42%,KIF3A;PCM1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3172975881078615,-1.0411823532724558,0.33962264150943394,0.7019994120408133,1.0,9/26,24.64%,OSBPL8;IGF1;BRAF;SORBS1;ARPP19;IRS2;CLIP3;CAPN10;APPL1
prerank,regulation of intracellular transport (GO:0032386),0.3225227407315267,1.0410049383334845,0.4073482428115016,0.9675539283968488,1.0,8/38,14.98%,DNAJC30;AAAS;ATP9A;PLA2G3;MYBPC3;INPP5F;WWC1;HAP1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.3666536064497296,-1.0408447932540117,0.41044776119402987,0.7022436891991592,1.0,11/16,36.41%,THBS1;PDCD10;HMOX1;FGFBP1;APLNR;DLL4;JCAD;GATA2;IL12A;IL12B;AGTR1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.30328298369282286,1.0402962229655788,0.3828125,0.9688661716505271,1.0,15/46,20.94%,ANG;IL6;XRCC6;TRIB1;CCN4;BMP4;TCF7L2;RBPMS2;PDGFB;NDRG4;APOD;IL18;CCL5;PDGFRB;XRCC5
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.2527733193233459,-1.039737788662547,0.35,0.7045621664226809,1.0,14/74,10.79%,RBPJ;PSMA6;LIMD1;PSMB2;PSME2;VHL;PSMD11;PSMC6;UBC;PSMA3;HIF1A;UBA52;NOTCH1;EP300
prerank,protein deubiquitination (GO:0016579),-0.20981804087922604,-1.0395205024010892,0.3246753246753247,0.704486431404731,1.0,63/242,18.89%,VCPIP1;PSMA6;VCP;OTUD6B;IFIH1;PSMB2;ASXL2;CLSPN;SIAH2;SMURF2;ATXN7;USP28;PSME2;ESR1;YY1;INO80C;USP18;PSMD11;TNIP3;RIPK1;SMAD3;PSMC6;INO80B;UBC;PSMA3;HIF1A;USP45;ABRAXAS1;USP8;TAB1;BRCA1;ZC3H12A;UBA52;MYSM1;TRRAP;USP9X;RAD23B;USP38;NFRKB;EP300;BARD1;JOSD1;TOMM20;CDK1;CCNA2;BIRC2;PSMD10;STAM;TADA2B;PSMB5;UCHL3;CDC25A;FOXK2;OTULIN;BRCC3;USP5;UIMC1;PSMD5;GATA3;SMAD4;INO80E;USP4;PSMD1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3731407868489438,1.0392798086141717,0.4098639455782313,0.9712601802788543,1.0,4/19,12.37%,VDAC1;FBXO7;PRKN;DNM1L
prerank,peroxisome organization (GO:0007031),0.34960602698455834,1.0390050400996782,0.42356687898089174,0.9709437566788086,1.0,12/25,23.09%,SEC16B;FIS1;PEX11G;PEX14;DNM1L;PEX2;MFF;ABCD2;PEX6;PEX11B;PEX3;PEX11A
prerank,defense response to Gram-positive bacterium (GO:0050830),0.31835907020774823,1.0387901784786708,0.4330708661417323,0.970404349821414,1.0,9/40,11.47%,ANG;MBL2;RARRES2;DEFA6;IL6;MR1;PGLYRP2;RNASE7;DROSHA
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.302591666153309,1.0387200040770017,0.4006069802731411,0.9694111810206796,1.0,13/48,19.58%,GUCY2F;ADCY8;NUDT2;PPCDC;GUCY2C;AMPD3;GUCY2D;COASY;DCAKD;ADSL;PPCS;AK5;SLC35B2
prerank,cellular protein localization (GO:0034613),-0.2049149940060562,-1.0385907995228767,0.3076923076923077,0.7063877835501728,1.0,76/285,19.80%,ITSN1;CD74;VIPAS39;STX6;RIC1;TBC1D1;VPS26A;SNX8;PRPF19;ATG13;STX12;STX5;RRAGC;TM9SF3;RAB1A;SNX1;AP3B1;RPGR;SH3PXD2B;VPS35;AP3D1;DNAJC27;CEP250;RABGAP1;ARF3;TBC1D2;GGA2;SNX9;TM9SF2;CPE;RAB6A;TM9SF1;AP4M1;CTSA;TM9SF4;TMED9;VPS45;TMED10;CTNNB1;VPS26B;ID1;RAB21;FOXJ1;TBC1D10C;RRAGA;REEP1;CEP68;TBC1D10A;EMP2;USP6NL;LRRK2;NPM1;EGFR;GJA1;WNT5A;ADPRH;RTP4;ATG9B;VCL;SEC23IP;USO1;RAB3GAP2;RAB31;HEY2;NAPG;TBCK;ARHGEF2;RAP2A;STX19;USP4;FLNA;FBLN5;HPS6;TBC1D22A;NAPA;GRIN3B
prerank,regulation of muscle cell differentiation (GO:0051147),0.3273884641695831,1.0384869552980462,0.3929663608562691,0.9689735386593594,1.0,4/31,6.19%,BOC;CTNNA2;PTBP1;MEF2C
prerank,mitotic chromosome condensation (GO:0007076),-0.3209813436672828,-1.0384138867444512,0.36813186813186816,0.7061561644405653,1.0,12/26,22.94%,NCAPD2;NCAPH;NCAPG2;NUSAP1;SMC2;CDK1;RB1;MCPH1;PLK1;TENT4A;NCAPH2;CCNB1
prerank,positive regulation of innate immune response (GO:0045089),-0.30396507026228736,-1.038314970551397,0.4112903225806452,0.7057563989880725,1.0,14/30,28.39%,UBE2K;ZBP1;TRIM62;TLR8;ADAM8;NLRC5;LBP;WNT5A;POLR3G;SLC15A4;PLSCR1;FADD;FPR2;RPS19
prerank,entry into host (GO:0044409),-0.3839747091757829,-1.0381594685546416,0.3788235294117647,0.7055047875179968,1.0,5/13,18.64%,MET;CTNNB1;GRB2;CBL;CDH1
prerank,cation transmembrane transport (GO:0098655),0.3081190971518815,1.0380461789696076,0.3925925925925926,0.9692909482936048,1.0,9/44,14.48%,ATP1B1;KCNJ8;TRPM3;TRPM2;PKD2;SFXN1;ASIC2;SFXN2;ABCC8
prerank,positive regulation of cell motility (GO:2000147),-0.21056455922274156,-1.0380453085808434,0.3230769230769231,0.7051616413651071,1.0,71/205,25.66%,DAB2;NEDD9;PLAU;ITGAX;IGF1;CASS4;GCNT2;SDCBP;CXCL16;ADAM9;THBS1;FLT1;PDGFD;PDCD10;CAV1;CARMIL1;CIB1;IL1B;FGF1;SEMA6D;RET;MAPRE1;PDGFC;SPRY2;ELP6;NOTCH1;MIEN1;PHPT1;CCN1;PPP3CA;SEMA6A;F7;SEMA3B;SEMA5B;FAM83H;KDR;RACK1;MYOC;BMP2;HAS2;FAM89B;EGFR;PTK2B;BCAR1;ADAM17;SEMA4A;CLDN1;CARMIL2;PDGFRA;MYADM;PPM1F;MYLK;F10;ACVR1;PIK3CD;SEMA4D;CCAR1;SEMA4G;TWIST1;GTSE1;SYNE2;EGF;CCL7;SEMA3F;SEMA3E;TJP1;CXCL12;CSF1;PDGFA;PDPN;GPNMB
prerank,protein neddylation (GO:0045116),0.4109608982145914,1.0378275130425945,0.3985890652557319,0.9688151071540227,1.0,7/13,32.94%,UBE2M;DCUN1D2;UBA3;NAE1;RBX1;RNF7;NEDD8
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.2561772421512851,-1.0370693577884553,0.3507692307692308,0.7071739633278283,1.0,18/66,16.00%,SASH1;DVL3;FLT1;PDGFD;NOD2;PDCD10;CD24;TAOK3;FGF1;PDGFC;ADAM8;MAP3K11;PIK3R6;PIK3R5;LRRK2;EGFR;TNF;ARHGEF5
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.4425263328695863,1.036963788738669,0.426497277676951,0.9706601863346535,1.0,3/10,15.32%,NDRG4;APOD;PTPN2
prerank,positive regulation of calcium ion transport (GO:0051928),0.3214967566871746,1.0365611704579794,0.4119496855345912,0.9708177652939031,1.0,10/36,19.50%,TRPC3;CACNB2;CCR1;GRIN1;CACNA1D;TRPC6;PDGFB;ANK2;CCL5;PDGFRB
prerank,positive regulation of translational initiation (GO:0045948),0.3652409845629384,1.036215878164531,0.4154103852596315,0.9708015340221432,1.0,7/18,25.35%,RPS6KB1;CDC123;POLR2G;CCL5;EIF2B5;POLR2D;DDX3X
prerank,protein monoubiquitination (GO:0006513),-0.2883870675334034,-1.036083086086251,0.38292011019283745,0.7090813642450079,1.0,6/36,3.64%,UBE2D3;TRIM25;CUL3;CDC73;DTX3L;OBI1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3180954789473329,1.0359390238851103,0.4235474006116208,0.9705557679825291,1.0,16/40,27.06%,SMYD2;UBE2V1;NSMCE4A;USP51;NEK4;UBE2N;RFWD3;WRNIP1;SMG1;FBXO5;ING2;NPAS2;FXR1;MAPT;FEM1B;RADX
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.38646878447166505,-1.035557904171973,0.4064039408866995,0.7099062960114528,1.0,7/13,39.64%,IDH1;GOT1;PHYH;GPT2;TAT;GOT2;ADHFE1
prerank,protein targeting to lysosome (GO:0006622),-0.34107936869684535,-1.035379514588316,0.4068627450980392,0.7096715361196585,1.0,7/20,10.16%,RAB7A;NAGPA;M6PR;ZFYVE16;AP4M1;LAMP2;GNPTAB
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3126109272361359,1.0352864758632507,0.4104803493449782,0.9715857703173103,1.0,7/39,9.39%,RNF126;AREG;LGMN;DAB2IP;SH3GL2;MVP;PTPN3
prerank,positive regulation of JNK cascade (GO:0046330),-0.2449119603650958,-1.0351868846399388,0.38064516129032255,0.7095274993365779,1.0,21/70,21.87%,FCGR2B;SDCBP;PJA2;NOD2;RIPK1;IL1B;TAOK3;SH3RF1;MAP3K11;TNFRSF19;GADD45G;SLAMF1;AGER;PTK2B;TRAF1;HIPK2;MMP8;TRAF4;DUSP19;APP;SERPINF2
prerank,negative regulation of catabolic process (GO:0009895),-0.27379266273890834,-1.0351716967740974,0.40119760479041916,0.7088883850175163,1.0,17/47,21.86%,GIT1;CBFA2T3;IL1B;MAD2L2;AGAP2;MAD2L1;APOC1;EGFR;TNF;RILP;FLNA;ZDHHC7;FMN2;SIRT2;NCOR1;HDAC4;ADGRB1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.30965467854467416,1.0351268593651182,0.3929712460063898,0.9709388936659159,1.0,9/39,11.29%,FGF14;FGF12;FGF11;DMD;HECW2;PTPN3;NEDD4;FGF13;STK39
prerank,cardiac muscle cell differentiation (GO:0055007),0.35952978192193896,1.0350428960886424,0.41778523489932884,0.9699977435297548,1.0,5/21,16.57%,KDM6B;MEF2C;SLC8A1;AKAP13;CXADR
prerank,organophosphate biosynthetic process (GO:0090407),-0.2882851091053333,-1.034999189133861,0.39436619718309857,0.7086683401470733,1.0,11/37,18.75%,MOCS2;MOCS1;AGPAT4;AGPAT5;TKT;IPPK;GK5;GK;ITPKA;GPAM;IP6K3
prerank,positive regulation of bone mineralization (GO:0030501),0.32171335250114264,1.034824954565521,0.40350877192982454,0.9694937631401102,1.0,6/35,9.62%,WNT4;MEF2C;FBN2;BMP4;TGFB1;SLC8A1
prerank,ion homeostasis (GO:0050801),0.32587179456470766,1.034812954439008,0.4130781499202552,0.9683226842991836,1.0,8/30,19.06%,SLC4A8;FHL1;SLC30A3;UNC80;SLC4A10;SLC4A7;NEDD4L;WNK1
prerank,positive regulation of ERAD pathway (GO:1904294),0.41385035922009306,1.0346765819938932,0.41454545454545455,0.9675902511164495,1.0,5/13,17.11%,TMEM259;SGTA;NFE2L2;HERPUD1;UBQLN2
prerank,protein modification by small protein removal (GO:0070646),-0.20464202915372215,-1.0345750058779801,0.3503184713375796,0.709155753088984,1.0,65/252,18.92%,VCPIP1;PSMA6;VCP;OTUD6B;IFIH1;PSMB2;ASXL2;CLSPN;SIAH2;SMURF2;ATXN7;USP28;PSME2;ESR1;YY1;INO80C;USP18;PSMD11;TNIP3;RIPK1;SMAD3;PSMC6;INO80B;UBC;PSMA3;HIF1A;USP45;ABRAXAS1;USP8;TAB1;BRCA1;ZC3H12A;UBA52;MYSM1;TRRAP;USPL1;USP9X;RAD23B;USP38;NFRKB;EP300;BARD1;JOSD1;TOMM20;CDK1;CCNA2;BIRC2;PSMD10;SENP1;STAM;TADA2B;PSMB5;UCHL3;CDC25A;FOXK2;BRCC3;USP5;UIMC1;PSMD5;GATA3;SMAD4;INO80E;USP4;PSMD1;COPS4
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.3377909031537824,-1.0344322215568196,0.4105011933174224,0.7088576798060341,1.0,7/19,20.36%,IFIH1;LIFR;CD24;PARP9;WNT5A;MAPK7;KLF4
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.39311734320233815,1.034255059661404,0.42439862542955326,0.9678267590507887,1.0,5/15,28.20%,SAT2;MOXD1;ASMT;AANAT;SRM
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4331630816133603,1.034019767177852,0.40878378378378377,0.9674067908217935,1.0,4/11,24.48%,MEF2C;TGFB1;DHX36;EFNB2
prerank,nuclear envelope organization (GO:0006998),-0.3390745670304313,-1.0336482271919636,0.4097938144329897,0.710222817507266,1.0,5/20,12.22%,TOR1AIP1;CTDNEP1;LEMD3;TOR1B;NEMP1
prerank,glucose homeostasis (GO:0042593),0.27257583988596207,1.0335497694931612,0.3767313019390582,0.9678400494704962,1.0,15/83,15.32%,NUCKS1;ADCY8;PPARGC1A;SOX4;STK11;IL6;RFX6;ADRA2A;TCF7L2;KLF7;IRS1;USF1;HK2;INSR;PTPN2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4163010009585824,-1.0335275468730494,0.3953488372093023,0.7098501505503108,1.0,3/10,18.54%,PRKCH;NUMA1;TRIM16
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4149467923676815,-1.0334825304287658,0.415929203539823,0.7093144612809286,1.0,5/10,18.82%,XYLT1;DSEL;DSE;XYLT2;PXYLP1
prerank,response to interleukin-6 (GO:0070741),0.43015652688057154,1.0334422335821287,0.4028268551236749,0.9669856244243504,1.0,3/10,4.46%,SELPLG;RELA;PTPRT
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.354320874270158,1.0331403411080742,0.4114671163575042,0.9668522964026119,1.0,6/20,18.27%,ZC3H7B;SPOUT1;DROSHA;TSN;AGO4;TSNAX
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2822684995579131,1.033096610193474,0.37626628075253254,0.9658088391149614,1.0,17/69,17.37%,NDUFA6;UQCRC1;COA6;NDUFA4;CYC1;SDHC;COX7B;UQCC3;COX6C;NDUFS1;UQCR11;NDUFA8;NDUFS6;SDHAF2;COX7C;NDUFAB1;NDUFS2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.38773420931899916,-1.0329265913229364,0.4231678486997636,0.7101819076691037,1.0,4/13,12.68%,IGF1;SORBS1;IGF2;PPP1R3E
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.36823365056021357,1.0323823542654385,0.4132231404958678,0.967085877532685,1.0,3/18,5.63%,CTR9;SOCS3;IL6
prerank,regulation of biomineral tissue development (GO:0070167),-0.31322660258460705,-1.0323648766919513,0.38242894056847543,0.7110528834968862,1.0,5/26,10.70%,GAS6;NBR1;CEBPB;ANKH;NOTCH1
prerank,negative regulation of growth (GO:0045926),0.25863505100171713,1.0317793415201286,0.39377537212449254,0.9680629333246777,1.0,39/121,24.41%,WFDC1;PSRC1;STK11;SIPA1;MINAR1;APBB1;FHL1;GNG4;TGFB1;ADAM15;CGRRF1;ACVR1B;SFRP1;DCBLD2;FLCN;EI24;CCAR2;SH3BP4;NDRG3;MT2A;PPP2R1A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;BTG1;TCHP;FRZB;SFRP2;NPR1;JADE1;PRDM11;SMARCA2;CRLF3;CDKN2AIP
prerank,pigment granule transport (GO:0051904),-0.3459464685707735,-1.031515108072563,0.383248730964467,0.7120221899765928,1.0,8/18,38.19%,MYO5A;BBS7;MLPH;BLOC1S3;MREG;RAB27B;GPR143;BBS2
prerank,melanosome transport (GO:0032402),-0.3459464685707735,-1.031515108072563,0.383248730964467,0.7120221899765928,1.0,8/18,38.19%,MYO5A;BBS7;MLPH;BLOC1S3;MREG;RAB27B;GPR143;BBS2
prerank,negative regulation of cellular component movement (GO:0051271),-0.367863478110242,-1.0313055642375957,0.4005102040816326,0.7119150657439729,1.0,4/15,3.66%,SP100;CRK;ACTN1;CCDC125
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.20596073659422498,-1.0312078177555417,0.3,0.7115045095212248,1.0,63/234,21.09%,STK3;PSMA6;FLOT2;PRKCH;TRIM25;TLR2;TRIM14;PPARG;CD36;SMARCA4;RAB7B;LAMTOR5;NLRC4;DHX33;ESR1;NFKB1;CEBPG;TAF1;NOD2;RIPK1;TFRC;SMAD3;CAV1;TRIM62;TAF12;UBC;CIB1;PRKCQ;IL1B;HSF1;TAB1;PIDD1;UBA52;ADAM8;CTNNB1;EP300;ADCY1;FZD2;EDA;TRIM5;NPM1;RIPK4;AGER;TNF;WNT5A;ARHGEF5;TRAF1;TLR4;CRNN;IL18R1;HIPK2;ARID5B;ERC1;ARHGEF2;TRIM37;LRP6;MYD88;RGCC;HSPA1B;LTF;TRIM21;AIM2;HDAC4
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4169556913395387,1.0311711433489237,0.42327150084317033,0.9689822200982492,1.0,4/12,19.06%,ADTRP;PPARA;MIA3;WNK1
prerank,regulation of phosphorylation (GO:0042325),-0.22494225447958802,-1.0311484704411849,0.3879310344827586,0.7109901766178626,1.0,32/120,16.71%,FNIP2;NRP1;STAP1;NDUFS4;SDCBP;CORO1C;RANBP2;STAT2;CCDC88C;KCTD20;THBS1;CD24;LYN;PRKAG2;HIF1A;NUP153;PSEN1;NDC1;CDKN2C;NUP43;NUP210;EP300;BARD1;PGAM1;NLRC5;EMP2;PRKRIP1;EGFR;HSPB1;NUP62;SESN2;NOP53
prerank,regulation of supramolecular fiber organization (GO:1902903),0.35368080330697216,1.0306522538713982,0.4,0.9696130309319582,1.0,12/22,27.64%,MAP1S;AEBP1;CAMSAP3;CAMSAP1;AKAP13;CHRNA7;MAP2;GBA2;MAPRE3;MAPT;MAP1B;HSPA8
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4053321428292823,-1.0306105504933796,0.4175,0.711769012593397,1.0,7/10,43.57%,SOX6;PKDCC;SOX5;GDF6;ZBTB16;SOX9;ACVRL1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3948698570379684,-1.030569013858373,0.41119221411192214,0.7112051582924341,1.0,4/12,15.69%,TMEM165;CLN5;LRRK2;CLN3
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3610253389519458,1.0305355472441293,0.42833333333333334,0.9675791099210663,1.0,9/20,20.02%,ACADSB;BCAT1;ALDH6A1;BCKDHB;SLC25A44;DLD;HSD17B10;ECHS1;BCKDHA
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3610253389519458,1.0305355472441293,0.42833333333333334,0.9675791099210663,1.0,9/20,20.02%,ACADSB;BCAT1;ALDH6A1;BCKDHB;SLC25A44;DLD;HSD17B10;ECHS1;BCKDHA
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.35820078911105807,1.0304641479861518,0.41402337228714525,0.9666136186743636,1.0,3/20,1.89%,HOXA5;CTR9;LDB1
prerank,polyamine metabolic process (GO:0006595),0.40321948882993985,1.0299874276098997,0.4178321678321678,0.9670753411244718,1.0,3/13,14.75%,SMS;SAT2;AOC1
prerank,protein glycosylation (GO:0006486),0.2561409849361339,1.0298738501359905,0.3970976253298153,0.9662648782869072,1.0,26/125,17.21%,PLOD3;ST3GAL5;TET1;B3GNT9;FUT10;B3GNT6;B4GAT1;B3GALT2;DDOST;ALG1;SERP2;ST6GALNAC2;POFUT1;OGT;B3GALNT1;SLC39A8;MGAT5B;ST3GAL6;MGAT4B;GAL3ST1;TMEM258;POMGNT1;PLOD1;ALG5;DPM3;ALG3
prerank,amino acid import across plasma membrane (GO:0089718),-0.31610941544492044,-1.029768860304251,0.4340659340659341,0.7126838172247388,1.0,3/24,3.14%,SLC1A5;SLC7A1;SLC6A6
prerank,generation of neurons (GO:0048699),0.24304308690049806,1.029768077055421,0.38567839195979897,0.9654319308079878,1.0,36/190,16.72%,WNT4;PLXNB2;LDB1;PTPRD;NEUROG2;SIX4;ATOH7;NEUROD2;WNT3;MEF2C;ITM2C;RYK;NRBP2;LHX3;ADGRL3;CDKL5;HEY1;CX3CR1;WNT8B;IL1RAPL1;DDIT4;FGF13;CASP3;NRCAM;LHX5;TUBB2A;NDNF;LMX1B;TAFA1;NTRK2;ERCC6;TUBGCP2;WNT7A;LHX2;EN2;BHLHE41
prerank,hippo signaling (GO:0035329),0.34156134744076183,1.029495272181754,0.41185897435897434,0.9652124906231903,1.0,12/26,22.93%,YWHAE;WWTR1;DCHS1;CASP3;WWC1;FAT4;TEAD3;DVL2;YWHAB;TEAD2;LATS1;AMOT
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.20149068750162527,-1.0294846257876034,0.32592592592592595,0.7127721386880185,1.0,59/314,13.71%,PPP2R5C;ITCH;WWP1;PSMA6;UBE2D3;KLHL20;BUB3;FBXL17;VCP;TRIM25;CUL3;UBE2K;CUL4A;PSMB2;FBXL14;SIAH2;FBXW7;SMURF2;FBXL8;OS9;PSME2;TAF1;RNF216;RMND5B;HECW1;PSMD11;CDC34;PSMC6;UBQLN1;UBC;DNAJB9;TBL1X;PSMA3;NHLRC3;ERLIN2;KLHL15;FBXW4;BAG6;SPOPL;KCTD17;UBA52;DNAJC10;DCAF12;RAD23B;CDC27;SPSB2;CTNNB1;CDK1;MAD2L1;BIRC2;RNF103;KAT5;EDEM1;PSMD10;BUB1B;RB1;FBXO2;PELI1;KCTD2
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.25754146370028114,-1.0293453562284607,0.3838383838383838,0.7124890067893596,1.0,17/62,15.60%,LIMD1;PPARG;POLR2E;RANBP2;PUM2;NUP153;NDC1;H3-3A;NUP43;NUP210;AJUBA;POLR2B;AGO2;POLR2H;POLR2J;TRIM71;NUP62
prerank,positive regulation of apoptotic process (GO:0043065),-0.20512747521085883,-1.0293425941752061,0.3591549295774648,0.7118226406806742,1.0,65/293,18.00%,VAV3;ARHGEF3;FGD4;ITSN1;STK3;ARL6IP5;STK17B;TNFAIP8;IFIT2;ZBP1;BAX;TOP2A;PTPA;NLRC4;ARHGEF18;ATG7;ARHGEF6;SLC27A4;HIP1R;FAS;HSPD1;RIPK1;UBC;PLEKHG5;PSEN1;FGD1;PIDD1;PNMA2;ZC3H12A;UBA52;ABR;GNA13;UTP11;MAP3K11;DNM2;PTGIS;PRMT2;FOXO1;CTNNB1;BARD1;STPG1;BRMS1;ARHGEF26;GADD45G;DAPK1;RPS6KA2;APH1B;RYBP;RACK1;BMP2;SPHK2;SIK1;PMAIP1;LILRB1;TNF;DDX20;ARHGEF5;BCL2L11;KLF11;SAP18;MAPK8;SQSTM1;ECT2;HMGA2;ARHGEF2
prerank,DNA repair (GO:0006281),-0.20393598319821787,-1.028860859556133,0.34615384615384615,0.7124385502922679,1.0,70/284,18.46%,ASCC3;VCPIP1;NSD2;RAD51B;PARP4;RBBP8;VCP;BAZ1B;PDS5B;DTX3L;PCNA;ASCC1;KPNA2;TOPBP1;DOT1L;ZRANB3;APEX2;MDC1;ERCC6L2;CHD1L;POLI;UBC;IGHMBP2;NBN;CIB1;USP45;EYA1;ABRAXAS1;UVRAG;ATRIP;HINFP;PDS5A;BRCA1;UBA52;EYA3;TRRAP;MAD2L2;POLD4;RAD23B;RHNO1;BARD1;RPA1;CDK1;LIG4;RMI2;KAT5;TICRR;RAD21;PARP9;NPM1;FAAP20;FANCI;MNAT1;EME1;PMS1;NOP53;BRCC3;RPA2;MUTYH;MAPK8;UIMC1;RNASEH2A;CENPX;SLX4;HMGA2;FANCM;TRIP13;HPF1;XPC;WDHD1
prerank,skeletal muscle organ development (GO:0060538),0.338905104400493,1.0287900283483482,0.41373801916932906,0.9664416755824883,1.0,9/26,24.05%,SIX4;DISP1;MEF2C;MYL6;IGSF8;LARGE1;FXR1;CFLAR;POPDC3
prerank,protein prenylation (GO:0018342),0.4368221313872663,1.0286462816044608,0.4175257731958763,0.9657491912662994,1.0,6/10,31.16%,CHM;PGGT1B;RABGGTB;RCE1;FNTA;RABGGTA
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.40480473219590035,1.02861886507,0.4189655172413793,0.96465195600272,1.0,4/12,9.53%,ZC3H10;IL6;NCOR2;TGFB1
prerank,response to growth factor (GO:0070848),0.3066896588462889,1.0283788172819701,0.3952451708766716,0.9642680815328006,1.0,10/41,14.75%,LRP2;RPS6KB1;TGFBR1;TWF2;MAP2K5;EMD;ACVR1B;SFRP1;PDGFB;AMHR2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.32706605496937907,-1.0283244642484517,0.4293193717277487,0.7133107952983151,1.0,10/22,25.66%,PDGFD;NBN;PDGFC;CALM3;CALM2;GREM1;RAP2A;PDGFA;TNKS1BP1;GPNMB
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.2694213523937026,-1.0282580347004056,0.3723404255319149,0.7128068046027474,1.0,16/50,23.49%,GAS6;RAF1;CD44;SIAH2;LAMTOR5;THBS1;PLAUR;SH3RF1;DNAJB6;TNF;GPX1;KLF4;DHCR24;XIAP;CAAP1;RPS6KA3
prerank,negative regulation of protein binding (GO:0032091),0.2760153991762796,1.0282287506287184,0.4008559201141227,0.963591508734688,1.0,24/71,25.44%,ATP2A3;ZFPM1;ATP2A2;TMC8;EFHB;ARRB2;GTF2F1;STYX;ITGB1BP1;ADAM15;PEX14;USP33;PDGFB;MITD1;CARD16;ROCK1;PIN1;ACTB;MAP2;PPP1CA;AURKA;TMBIM6;HFE;CAMK1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2780733676356304,-1.0280235939844542,0.4017857142857143,0.7127704794436402,1.0,10/46,15.99%,TALDO1;STAT4;IL12RB2;PSME2;LMNB1;MSN;LCP1;HNRNPA2B1;AIP;RAP1B
prerank,negative regulation of blood coagulation (GO:0030195),0.3176651269557423,1.0277843867759981,0.401854714064915,0.9639498738387883,1.0,8/38,15.75%,F3;ADTRP;PLAT;CD34;THBD;PDGFB;VTN;SERPINE2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.31585007538954113,1.0277252942690325,0.43898573692551507,0.9629989141951849,1.0,18/33,32.33%,SLC4A8;GRIK5;GRIK2;GRID2;CX3CR1;NRG3;CACNA1B;CACNA1A;LRRC4C;GRIK3;BDNF;GRIK4;PSMC5;FABP5;CEL;GRID1;NLGN3;NLGN1
prerank,regulation of filopodium assembly (GO:0051489),0.31307427191129067,1.027577650670423,0.3923076923076923,0.9623089367092355,1.0,14/38,24.06%,AGRN;FSCN1;ARHGAP44;TENM1;TRPM2;RAB5A;RHOQ;PALM;CDC42;GPM6A;PPP1R16B;FXR1;WASL;FNBP1L
prerank,extracellular transport (GO:0006858),0.41862159107220376,1.0272219439614692,0.45233968804159447,0.9624275977247437,1.0,5/12,15.34%,ROPN1L;SPA17;SPEF2;ARRDC1;DNAAF2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2618221247958539,1.027034121603082,0.4035812672176309,0.9618897903299358,1.0,18/107,12.48%,SELENOS;TMEM117;ATP2A3;SCAMP5;TMEM259;UBXN6;ATP2A2;DAB2IP;BAK1;CFTR;PRKN;HSP90B1;RASGRF1;HERPUD1;CCDC47;DERL1;CASP4;ERP27
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.31507781540049595,-1.0265023380449685,0.3973684210526316,0.7163226319863711,1.0,10/27,23.43%,MAP3K8;CCDC88C;NFKB1;UBC;UBA52;KAT7;MAP2K7;MAPK8;MAP3K20;MAPK11
prerank,renal absorption (GO:0070293),-0.41749846454911776,-1.0264038252667431,0.4191343963553531,0.7159052927295159,1.0,4/10,24.36%,HAS2;GSN;KCNQ1;SLC15A2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.28209723607114234,-1.026011224764098,0.4326647564469914,0.7163022309089051,1.0,5/36,5.87%,SP100;APOE;MECP2;PPARG;THBS1
prerank,substrate-dependent cell migration (GO:0006929),-0.3738034760573179,-1.0251831150193542,0.41784037558685444,0.7179226128260618,1.0,3/14,2.04%,NRP1;PTPRC;SDCBP
prerank,nitric oxide biosynthetic process (GO:0006809),0.3988704140367885,1.025164963293929,0.4318181818181818,0.967091485421264,1.0,4/13,18.99%,GCHFR;DDAH2;CYB5B;ARG2
prerank,prostaglandin biosynthetic process (GO:0001516),0.36848530002166424,1.0248372435015265,0.4383116883116883,0.9670110873905334,1.0,3/18,4.40%,PTGS1;PTGDS;PRXL2B
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3117380827253284,1.0247590150983015,0.42746913580246915,0.9660874127345864,1.0,8/34,14.23%,LACC1;CD86;IL6;INAVA;IL2;CLCF1;VAMP3;EPHB2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3870905505159342,-1.0246858656992628,0.3968957871396896,0.7185549041033621,1.0,5/12,17.01%,MIS12;BOD1;CDT1;NDC80;NUF2
prerank,establishment of spindle orientation (GO:0051294),-0.3091688197077713,-1.0246710358219784,0.4421052631578947,0.717910713422838,1.0,13/28,24.14%,CDK5RAP2;CENPA;MAD2L1;SPDL1;NUMA1;UBXN2B;GJA1;NDC80;PLK1;PAFAH1B1;MAP4;NDE1;PKHD1
prerank,negative regulation of proteolysis (GO:0045861),0.3184299900563234,1.0245130358913277,0.41321044546851,0.9658035864808242,1.0,12/34,24.24%,PLAT;CST3;PRNP;PTPN3;EFNA1;EPHA4;SERPINE2;ROCK1;TMEM59;TIMP2;ACP4;CST7
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2522398412507592,1.0242485136956059,0.39947437582128775,0.9655636722918666,1.0,21/138,9.44%,POLR2L;CDK7;WWTR1;POLR2F;ESRRG;NR1I2;NR1I3;PPARGC1A;GTF2H2;PPARA;AR;NR2F6;GTF2H4;RXRG;GTF2F1;MAZ;NCOR2;GTF2E2;HDAC5;MAML3;TAF9
prerank,protein targeting to membrane (GO:0006612),0.2691966110751902,1.0242053411957672,0.4092178770949721,0.9645414926925437,1.0,26/83,19.71%,CHM;PEX5;FIS1;SGTA;ATAD1;PRKCI;SEC62;ZDHHC22;SSR1;PEX26;MYO1C;ZDHHC1;PEX14;ZDHHC2;SGTB;SRP14;GET3;MICALL1;TRAM1;SRP19;ZDHHC23;PEX2;SRPRA;ABCD2;GOLGA7;SSR2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.3074471810870632,-1.0240973269533629,0.41131105398457585,0.7187387270061583,1.0,9/26,16.57%,CDK6;TCTA;RARA;GPR137B;CEACAM1;GPR137;LILRB3;C1QC;TLR4
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3155109151341811,1.0240448551197534,0.41009463722397477,0.9639184842274361,1.0,7/38,10.24%,OTUD7A;USP10;MAPKBP1;CACTIN;DAB2IP;PPM1A;PPM1N
prerank,chordate embryonic development (GO:0043009),-0.25649818749916603,-1.0239961016509662,0.3987915407854985,0.7183240082206075,1.0,17/55,21.06%,XYLT1;MBNL1;PROX1;FUT8;HINFP;BRCA1;BMP5;LIG4;IGF2;BMP2;TRIM71;WNT5A;DEAF1;EGFL8;GATA3;BMP7;PTCH1
prerank,negative regulation of cell population proliferation (GO:0008285),0.22962656093666817,1.0238944742640106,0.4131944444444444,0.9632443426895765,1.0,69/351,17.86%,ATP8A2;P3H2;MN1;TPTE;TSC2;MAGED1;ANG;SMYD2;AVPR2;NACC2;PAK1;SLURP1;NTRK1;COPS8;TENM1;SOX4;IGFBP6;PTPRU;STK11;E2F1;IL6;PDCD5;AR;CTBP1;TRIB1;GSDME;RBM5;EEF1E1;TGFBR3;MINAR1;DAB2IP;BMP4;NME1;PKD2;ERBB4;SST;TGFB1;ITGB1BP1;NMI;EMD;BTG3;SH2B3;CGRRF1;THAP12;BTG2;KDM2B;SFRP1;NDRG4;FLCN;BAP1;IFI35;ZBTB49;APOD;PTPN2;HPN;SH3BP4;ADORA3;REST;COL18A1;DNAJA3;MED25;PEX2;HRAS;OPRM1;CDK10;UTP20;IL1A;FABP3;BTG1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.4104223558689384,-1.023754358365711,0.42494226327944573,0.718361443215899,1.0,4/11,5.93%,GAS6;AXL;IRF7;NOD2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.24133909467885256,-1.0235722770796358,0.4158730158730159,0.7181619291273259,1.0,21/76,20.67%,DAB2;VCP;ARIH1;CBFA2T3;FBXW7;TAF1;BBS7;ARIH2;RNF14;CCDC22;SOCS5;PSMD10;RACK1;LRRK2;NOP53;USP5;RNF144A;PLK1;NKD2;HSPA1B;SIRT2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.389710554714511,-1.0233136581850575,0.4441747572815534,0.7182121009935293,1.0,3/12,4.88%,PTPN1;BAX;ERN1
prerank,cellular response to hydroxyurea (GO:0072711),0.430908043569477,1.0232911954869104,0.4337979094076655,0.9640649413160927,1.0,2/10,14.58%,TIMELESS;NSMCE3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3621078558582775,-1.022871450753012,0.39344262295081966,0.7187287327811374,1.0,2/15,5.22%,DAB2;HIP1R
prerank,tyrosine metabolic process (GO:0006570),0.43081026041988646,1.0227569731125452,0.44194107452339687,0.9647365315564336,1.0,2/11,13.19%,IL4I1;DCT
prerank,regulation of lamellipodium organization (GO:1902743),-0.36130444267857575,-1.0224551636768653,0.42574257425742573,0.7191724003716226,1.0,7/14,25.45%,CD44;CARMIL1;EPHA2;CAPZB;CARMIL2;RAC1;PDPN
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.29515458886248314,-1.022393971847376,0.39331619537275064,0.7186939678311604,1.0,10/33,16.97%,ALOX5;THBS1;FGF1;CEMIP2;RHOJ;S100A1;SEMA6A;CEACAM1;CREB3L1;KLF2
prerank,cell-substrate junction assembly (GO:0007044),0.3226473553642435,1.0223433999579672,0.40032679738562094,0.964976432711258,1.0,6/33,9.08%,CTTN;DST;LAMB3;THY1;TRIP6;ACTN2
prerank,skeletal system development (GO:0001501),-0.21716873825759317,-1.022128767505624,0.4088888888888889,0.71873463279427,1.0,36/148,19.95%,TRPS1;IGF1;EXT1;XYLT1;SOX6;CD44;PAPSS2;ATP7A;PTGER4;SOX11;SH3PXD2B;TCOF1;COL11A2;DYM;WWOX;ANKH;BMP5;IGF2;MYOC;BMP2;GJA1;WNT5A;DEAF1;BMP3;RAB33B;HYAL3;ANKRD11;PTHLH;COL9A2;TRAPPC2;BPNT2;TEAD4;PKDCC;RFLNA;GDF3;BMP7
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.2089094300483366,-1.0220357506614592,0.41702127659574467,0.7183141806224014,1.0,26/186,7.62%,DAB2;STK3;APOE;PSMA6;MCC;LIMD1;CUL3;DVL3;IGFBP4;PSMB2;RNF213;SIAH2;PSME2;CCDC88C;DKK2;HECW1;PSMD11;MLLT3;HMGXB4;TMEM131L;PSMC6;CAV1;PFDN5;WWOX;ZNRF3;PSMA3
prerank,regulation of protein export from nucleus (GO:0046825),-0.32141373054396205,-1.0220074526257534,0.39641943734015345,0.717723351418753,1.0,6/23,10.80%,SP100;GAS6;ANP32B;IL1B;UHMK1;BARD1
prerank,sister chromatid segregation (GO:0000819),-0.2977586177473713,-1.0218249956483691,0.41687344913151364,0.7174907023888119,1.0,13/31,21.98%,MIS12;TOP2A;CDCA8;NCAPG2;KIFC1;NUSAP1;ESPL1;RB1;NDC80;KIF18B;PLK1;ZWINT;TOP2B
prerank,protein K63-linked deubiquitination (GO:0070536),0.3216763772706726,1.02163536504541,0.40879478827361565,0.9661758287448202,1.0,11/31,25.21%,OTUD7A;USP50;USP33;PSMD14;OTUD7B;OTUD5;ABRAXAS2;STAMBP;CYLD;USP7;BABAM1
prerank,positive regulation of developmental process (GO:0051094),-0.21453011160381744,-1.021604826797391,0.39800995024875624,0.71744439845376,1.0,46/164,22.32%,APOE;PHLDB1;DDHD1;B4GALT5;SOX6;DLG5;DVL3;CORO1C;SLC6A6;SMURF2;VPS35;VHL;CEBPB;TFRC;PSEN1;DAG1;MAD2L2;BMP5;PAXIP1;COBL;TRPM4;SHLD1;KDR;AGO2;PTN;SCX;BMP2;NUMA1;LHX1;TNF;GJA1;WNT5A;MUL1;MIEF1;NIBAN2;PA2G4;BMP7;ESRRB;ACVR1;CPEB3;BASP1;LMNA;SERPINF2;FZD4;SHH;RREB1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.32450969734331075,1.0214543086423824,0.41798107255520506,0.9656476226768308,1.0,5/32,6.64%,C3;STAR;PPARA;THRSP;EIF6
prerank,apical junction assembly (GO:0043297),0.29238274223692573,1.021293478103938,0.43125,0.9650028624715525,1.0,6/53,6.89%,F11R;CLDN16;PARD6B;MARVELD2;PARD6G;PRKCI
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3163061478698985,1.021223158962133,0.4348484848484849,0.9640758866423903,1.0,8/35,16.30%,DDX5;WBP2;AR;UBE3A;TADA3;NEDD4;RBFOX2;CALCOCO1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.34813017127784723,1.0211017560979019,0.4157303370786517,0.962182188620785,1.0,10/23,21.30%,YWHAE;E2F1;PPP3CC;PPP1R13B;BBC3;NMT1;YWHAQ;CASP8;YWHAB;TFDP2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.34813017127784723,1.0211017560979019,0.4157303370786517,0.962182188620785,1.0,10/23,21.30%,YWHAE;E2F1;PPP3CC;PPP1R13B;BBC3;NMT1;YWHAQ;CASP8;YWHAB;TFDP2
prerank,regulation of presynapse organization (GO:0099174),0.3658395265879615,1.0205226069631395,0.42276422764227645,0.9618682314185173,1.0,9/18,30.84%,PTPRD;IL1RAPL1;GPC4;WNT7A;IL1RAPL2;LRRC4B;SLITRK1;LRFN5;MDGA1
prerank,regulation of presynapse assembly (GO:1905606),0.3658395265879615,1.0205226069631395,0.42276422764227645,0.9618682314185173,1.0,9/18,30.84%,PTPRD;IL1RAPL1;GPC4;WNT7A;IL1RAPL2;LRRC4B;SLITRK1;LRFN5;MDGA1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.39224605445097804,-1.020431332996315,0.4238095238095238,0.7199646866881492,1.0,4/12,15.40%,NBN;TICRR;CDT1;KAT7
prerank,positive regulation of glycolytic process (GO:0045821),-0.3337469277452776,-1.019876075312086,0.4177545691906005,0.720060682039967,1.0,7/20,21.52%,IGF1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;APP
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3337469277452776,-1.019876075312086,0.4177545691906005,0.720060682039967,1.0,7/20,21.52%,IGF1;HIF1A;PSEN1;ENTPD5;ZBTB20;GAPDHS;APP
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3471344779524305,1.0197967990914987,0.41818181818181815,0.9631712238277124,1.0,6/21,20.61%,HOGA1;CYP26C1;ACOX1;LDHD;AGXT;PLA2G15
prerank,negative regulation of locomotion (GO:0040013),0.4168535909568617,1.0196567508520575,0.45254237288135596,0.9624857773432202,1.0,5/12,18.67%,SPOCK3;FRMD5;SPINT2;PTPN2;PIN1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3226161627022495,-1.0194195092725065,0.4174757281553398,0.7206779985428129,1.0,7/23,14.06%,PARP14;PPARG;NR1H2;STAT1;NLRC5;NR1H3;PARP9
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.32479778255006986,1.0193669737846174,0.44157814871016693,0.9623384088932663,1.0,9/33,17.14%,MN1;SUSD2;E2F1;TCIM;PSME3;PKD1;PAF1;KIF14;STXBP4
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.41966742463342804,1.0189768955791438,0.44505494505494503,0.9625034779569003,1.0,4/10,23.37%,ACADS;ACADM;ETFB;ETFA
prerank,regulation of chromosome organization (GO:0033044),-0.3221999948664156,-1.0186037710896791,0.4160756501182033,0.7222057104382212,1.0,9/22,19.46%,LIG4;RMI2;BUB1;YLPM1;RB1;CDT1;TERF2;HNRNPD;SMG6
prerank,T cell homeostasis (GO:0043029),0.43220639003538364,1.018315498123767,0.4404332129963899,0.963700956837178,1.0,3/10,9.89%,NCKAP1L;RIPK3;ZC3H8
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.21141419514212229,-1.0182977449941915,0.40186915887850466,0.7224189097573361,1.0,38/175,18.00%,PID1;PSMA6;TNFSF8;PSMB2;PSME2;LIMS1;CCL25;BAG4;PSMD11;RIPK1;PSMC6;GBP3;CIB1;PSMA3;BRCA1;ZC3H12A;STAT1;LTB;ACOD1;BIRC2;TNFRSF1B;PSMD10;EDA;INPP5K;TNFRSF17;HAS2;PTK2B;PSMB5;TNF;TRAF1;HYAL3;ADAM17;TNFRSF9;TNFRSF25;PSMD5;GATA3;PYDC1;ARHGEF2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.42995506454641785,1.0180212697788718,0.4469565217391304,0.9636098792359248,1.0,5/10,15.18%,COMMD1;HECW2;NEDD4;STK39;NEDD4L
prerank,in utero embryonic development (GO:0001701),-0.32164893296385333,-1.0178366423390555,0.43116883116883115,0.7229824295322286,1.0,7/25,16.18%,MBNL1;FUT8;HINFP;LIG4;IGF2;BMP2;EGFL8
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.42903191382004874,1.0177587219322324,0.44101633393829404,0.9633438558559823,1.0,3/10,13.19%,CX3CR1;SMARCD3;DCT
prerank,regulation of translation (GO:0006417),-0.21112281405439767,-1.0176516373657605,0.3791469194312796,0.7228029836157739,1.0,63/173,26.50%,EIF2A;UPF3A;NIBAN1;RPL5;CNOT9;NCBP1;MALSU1;ETF1;EIF4B;BCL3;TCOF1;SAMD4A;SHFL;THBS1;MTG2;RPL10;DDX6;EIF4ENIF1;CAPRIN1;EIF2B2;LARP6;VIM;CD28;PIWIL2;DAPK1;PLD1;PAIP2B;TYMS;LARP1;RACK1;MIF4GD;SYNCRIP;NPM1;ZCCHC4;TRIM71;EIF2B4;HSPB1;UPF3B;LARP4B;FXR2;EIF1B;IGFBP5;HNRNPD;NAT10;RPL26;DHFR;CPEB3;APP;RIDA;CTIF;RPS6KA3;MTG1;EIF3E;EIF4A2;PYM1;ILF3;MTPN;EIF2AK2;GIGYF2;CSDE1;PASK;PAIP2;PAIP1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.30190269092889066,-1.0174851521548234,0.42105263157894735,0.7225640690607159,1.0,8/27,14.16%,FXYD5;UTRN;SCN2B;CAMK2D;FXYD1;SLMAP;FXYD2;FXYD6
prerank,cytoplasmic microtubule organization (GO:0031122),0.2856726517930588,1.0174212473751596,0.4035608308605341,0.9633628783003841,1.0,19/54,25.59%,TPPP;STMN3;DST;LIMK2;FSD1;PLK3;CAMSAP3;CAMSAP1;DCTN1;HOOK2;TUBGCP2;CLIP1;HOOK1;CCDC13;TUBGCP6;SPAST;RHOA;TUBGCP5;MAPT
prerank,negative regulation of viral life cycle (GO:1903901),-0.3545604491040775,-1.0173713688783068,0.41237113402061853,0.7222260206496867,1.0,7/15,21.59%,CIITA;IFITM3;BST2;TRIM5;GSN;PTX3;IFITM1
prerank,regulation of receptor recycling (GO:0001919),0.37707746857934665,1.0171467958502054,0.4249146757679181,0.9631314149304185,1.0,4/16,13.68%,SCRIB;INPP5F;TBC1D16;VAMP3
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2755320711581062,1.0169204025350864,0.4340425531914894,0.9627240879123066,1.0,22/72,24.00%,DNASE1;RNASE1;GTF2H2;POLD3;DNASE1L2;DDX1;GTF2H4;OGG1;FAN1;PARP1;DDB2;FEN1;PNRC2;DXO;REXO4;HORMAD1;IHO1;EXD2;GTF2H3;RFC4;ERCC4;ERCC2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3568829692619518,-1.0166247627815224,0.42676767676767674,0.7236083691138468,1.0,4/15,11.94%,RIPOR2;TYROBP;ADAM9;CD53
prerank,carboxylic acid metabolic process (GO:0019752),0.32079920961477965,1.0166092419761181,0.4423076923076923,0.962566638705618,1.0,7/33,16.88%,SLC2A3;CYP2S1;GSTO1;CSGALNACT1;ACOT4;DAO;AGXT
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3615303881412595,-1.0165114050147845,0.41353383458646614,0.7232786801335221,1.0,3/15,9.05%,CELF1;STOX2;BRCA1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.26934857117512156,-1.0164137261978674,0.41590214067278286,0.7228701552815279,1.0,11/45,19.33%,ATP7A;MTHFR;KMO;RIMKLA;GOT1;PYCR2;MTHFD1;MTRR;GNMT;CBS;GADL1
prerank,organelle transport along microtubule (GO:0072384),0.32302727234272566,1.0162568212367438,0.42718446601941745,0.9626293196322175,1.0,12/31,20.43%,MAP1S;COPG1;RHOT1;LRPPRC;PEX14;BICD2;BORCS5;HAP1;UXT;BICD1;COPG2;CDC42
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3575335125716834,1.016088342009587,0.43094841930116473,0.9621012437802413,1.0,6/21,15.28%,NUDT10;PNP;NUDT3;HPRT1;AMPD3;FITM2
prerank,protein localization to cell-cell junction (GO:0150105),0.3823889252212369,1.0157263885040364,0.43882544861337686,0.962194980455696,1.0,2/15,2.50%,F11R;SCRIB
prerank,positive regulation of blood coagulation (GO:0030194),0.3674476365959827,1.0156936164712722,0.4450084602368866,0.9611731429169904,1.0,4/17,12.23%,F3;THBD;ENPP4;USF1
prerank,regulation of catecholamine secretion (GO:0050433),0.329566258059983,1.0156816988452477,0.4527687296416938,0.9600897443415729,1.0,5/29,10.07%,SYT4;SYT13;SYT1;SYT6;PRKN
prerank,glycerophospholipid metabolic process (GO:0006650),0.27213082039768044,1.0155826578682075,0.42715700141442714,0.9593227055375974,1.0,11/75,8.89%,PRDX6;PLA2G3;PLCD1;PLA2G4C;PIGQ;PLCG1;PNPLA3;ABHD12;PIGB;PIGP;CPNE6
prerank,positive regulation of cell aging (GO:0090343),0.42450932355728943,1.0155444979438544,0.4276094276094276,0.9583336872615864,1.0,3/11,10.59%,ABI3;EEF1E1;CGAS
prerank,establishment of endothelial barrier (GO:0061028),0.32940833365061145,1.0152528754035643,0.4380952380952381,0.9582096072331268,1.0,6/29,11.42%,RAB1B;F11R;ROBO4;MARVELD2;RAPGEF3;ICAM1
prerank,ncRNA 3'-end processing (GO:0043628),0.39575719019557937,1.0150653238824041,0.4268292682926829,0.9577140427244499,1.0,6/14,22.45%,INTS6L;ELAC2;PTCD1;INTS8;INTS5;TRNT1
prerank,regulation of signal transduction (GO:0009966),0.23726310144018348,1.0147358111651872,0.43223443223443225,0.9576757444245356,1.0,27/190,9.68%,TSC2;ANKRD54;NUCKS1;CD80;IFT81;FRRS1L;WWTR1;IGFBPL1;IGFBP6;PRNP;IGFBP2;RGS11;CLU;MTCH1;YJEFN3;UBASH3B;TSPAN15;PRAG1;POFUT1;KIF26A;GNG4;DGKQ;SOCS2;OGT;ADCYAP1;TGFB1;ITGB1BP1
prerank,electron transport chain (GO:0022900),0.38104695526056265,1.0144776269665232,0.44821731748726656,0.957360503209643,1.0,3/15,4.45%,CYB561;PPARGC1A;NDOR1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.3273647080113874,-1.0143427057896146,0.4095238095238095,0.7279523090866151,1.0,3/20,5.94%,HSPA4;PSMG1;HSPD1
prerank,MAPK cascade (GO:0000165),0.2299590932368019,1.0142170370683496,0.42374854481955765,0.957145278241531,1.0,66/295,19.50%,FGF10;YWHAE;IL5RA;FGF16;PSMB1;DLG2;FGF9;IL2RA;PAK1;KLB;RGL2;NRG4;FGF7;AREG;MEF2C;IL2;PSMF1;LYPLA1;RIT2;BTRC;DAB2IP;SHANK3;RASGEF1A;PPP1CC;PSMA1;ZFP36L2;PSMD7;MAP4K4;ACTN2;ERBB4;GRIN1;PTPN3;TGFB1;GRIN2B;PSMA8;RASGRF1;MINK1;FGF13;FGF2;IRS1;SPTAN1;PSME3;MAP3K7;PDGFB;PSMD14;TEK;SPTBN2;GFRA1;PSMC4;PPP5C;SPTBN1;RASAL3;SETX;MAPK3;HRAS;TAOK1;PTK2;FLT3;IL18;PSMB4;MBP;GOLGA7;ABHD17C;IL17RD;CCL5;PDGFRB
prerank,positive regulation of protein metabolic process (GO:0051247),-0.22694560194422767,-1.014007172791561,0.4330708661417323,0.7282167396158667,1.0,26/110,17.88%,PAEP;ITCH;APOE;WWP1;VCP;STX5;RAB1A;RAB7A;SMURF2;RANBP9;ATG7;HECW1;NR1H2;IL1B;PSEN1;FOXO1;BARD1;NR1H3;TNF;WNT5A;MAPK7;TIPARP;KLF2;MAPK8;DTL;RILP
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.28136031993351435,-1.0135989270557588,0.4148936170212766,0.7286118985520519,1.0,12/38,16.71%,PPP2R5C;XDH;CIB1;DAG1;BANK1;DRD2;RACK1;INPP5K;SFRP5;EPHA2;MUL1;NOP53
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.24328071549669464,-1.012850844013739,0.3867595818815331,0.7299487106154592,1.0,16/70,15.91%,CYBB;PSMA6;PSMB2;CD36;PSME2;TAPBP;PSMD11;PSMC6;PSMA3;SNAP23;CYBA;MFSD6;B2M;PSMD10;PSMB5;FCER1G
prerank,positive regulation of neuron death (GO:1901216),-0.2686495897463741,-1.012849105779918,0.43977591036414565,0.7292888544915889,1.0,11/46,16.57%,FCGR2B;BAX;TYROBP;PICALM;FYN;EIF2S1;CTNNB1;FOS;TNF;WNT5A;TLR4
prerank,snRNA metabolic process (GO:0016073),0.3674765350573001,1.0126854164928867,0.4434931506849315,0.9611985256589392,1.0,6/17,20.79%,MEPCE;INTS10;INTS8;INTS5;INTS9;INTS11
prerank,triglyceride biosynthetic process (GO:0019432),0.36656641948519586,1.012100177698028,0.4363929146537842,0.9620973942248433,1.0,2/18,6.63%,DGAT2;PNPLA3
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4135755679747174,1.01208000157028,0.4528985507246377,0.9610675933088753,1.0,4/11,18.62%,COMMD1;ACTN2;NEDD4L;SNX33
prerank,cell chemotaxis (GO:0060326),0.2819934420287185,1.0120604218888665,0.417027417027417,0.9600227845885516,1.0,14/60,16.11%,ACKR4;ACKR3;HOXB9;ARRB2;CCR1;CXCR6;BIN2;CX3CR1;CXCR4;PDGFB;CCR6;DOCK4;CCR9;ACKR2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.2601001190944233,-1.0117835841467653,0.423728813559322,0.7316916602493758,1.0,20/50,25.30%,SASH1;TLR2;TLR7;LIMS1;CD14;NOD2;IL1B;EP300;TRIM44;EGFR;AGER;TNF;TLR4;NR3C2;MMP8;PTP4A3;APP;EIF2AK2;TLR9;ILK
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.31047399971209316,-1.011709267780944,0.4275184275184275,0.731229986760509,1.0,9/26,13.92%,TET2;SETD3;PRDM9;WDR82;VCPKMT;EEF2KMT;TET3;KMT2D;ETFBKMT
prerank,chromatin remodeling (GO:0006338),-0.2343289837048704,-1.011692358296146,0.4014084507042254,0.7306015703128548,1.0,27/100,19.99%,BAZ1A;GATAD2B;ARID1B;BAZ1B;SMARCA4;ESR1;INO80C;MBD2;PADI4;CHD1L;INO80B;SMARCA1;SATB2;KDM6A;MYSM1;HDAC2;NUDT5;HDAC1;RB1;TADA2B;NPM1;KDM5C;SATB1;HMGA2;TADA2A;POLE3;HNRNPC
prerank,rRNA transcription (GO:0009303),0.37005066407271975,1.0115602209926993,0.42604501607717044,0.9606575803162484,1.0,4/17,12.58%,ANG;NIFK;SPIN1;POLR1E
prerank,RNA 3'-end processing (GO:0031123),0.27316316889638215,1.0115452367320599,0.44574780058651026,0.9596010441651567,1.0,19/69,20.86%,RNPS1;SRSF5;CASC3;SRSF6;SRSF11;MTPAP;SRSF1;CPSF3;CSTF1;NUDT21;CDC40;THOC5;DDX39B;SARNP;SRSF9;CHTOP;ALYREF;SRSF2;LIN28B
prerank,mitotic spindle assembly (GO:0090307),-0.2689866546723346,-1.0115067040093004,0.43352601156069365,0.7304027169937065,1.0,9/42,8.37%,KPNB1;PIBF1;KIF23;KIF11;PRC1;KIFC2;KIFC1;RACGAP1;ABRAXAS1
prerank,tRNA methylation (GO:0030488),0.3138368691929594,1.0104635294932618,0.44518272425249167,0.9621106399764878,1.0,8/34,12.61%,DALRD3;METTL2B;METTL2A;TRMT44;METTL1;TRMT61B;FTSJ1;PRORP
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.28759829856437524,-1.0104380048649406,0.4269005847953216,0.7325387326692682,1.0,18/33,38.85%,CD74;PF4;RIPK1;HSF1;TESC;TNF;ACIN1;ID2;FADD;CSF1;LEF1;CD4;DCSTAMP;IL23R;IL12B;POU4F2;POU4F1;CTNNBIP1
prerank,regulation of activated T cell proliferation (GO:0046006),0.3235205752101895,1.0103176304679566,0.45110410094637227,0.9614957141505992,1.0,10/30,17.92%,SCRIB;PRNP;IGFBP2;IL2;RIPK3;CRTAM;HMGB1;PRKAR1A;IL18;ICOSLG
prerank,negative regulation of translational initiation (GO:0045947),-0.3654928002622768,-1.010278628203682,0.41876430205949655,0.7323212807460991,1.0,7/13,26.33%,EIF4EBP2;PAIP2B;AGO2;LARP1;EIF3E;EIF2AK1;PAIP2
prerank,regulation of chromosome segregation (GO:0051983),-0.35111659330314055,-1.010249896526119,0.43364928909952605,0.7317395785273229,1.0,5/16,14.11%,MKI67;PUM2;RMI2;BUB1;NUMA1
prerank,phospholipid translocation (GO:0045332),0.32241779913608326,1.0102496432175336,0.439469320066335,0.9606174471139968,1.0,8/28,21.67%,ATP8A2;ATP9A;ABCB4;ATP11A;ATP8B1;ATP8A1;ABCA7;PLSCR4
prerank,cell part morphogenesis (GO:0032990),-0.3748164449103871,-1.010048671192703,0.44282238442822386,0.7316459070952362,1.0,4/13,15.87%,PID1;MTM1;PACSIN2;WASF1
prerank,acute-phase response (GO:0006953),0.403320128637611,1.009962955900528,0.4589285714285714,0.9604709299296152,1.0,2/12,5.63%,MBL2;IL6
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.29156471300451564,-1.0098185020204986,0.43820224719101125,0.731640643704497,1.0,10/32,17.43%,AEN;USP28;BCL3;BAG6;TMEM109;SNW1;HIPK1;EP300;PMAIP1;HIPK2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.28342071130399094,-1.0097367514386222,0.4340659340659341,0.7312374491224647,1.0,9/36,18.15%,PPP2R5C;PPP2R5A;PDGFD;NBN;PDGFC;CALM3;CALM2;CHP1;RAP2A
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.3525927048281999,-1.0095847440666383,0.430622009569378,0.730962207868583,1.0,6/16,21.28%,IGF1;IGFBP4;BMP5;BMP2;IGFBP5;CDH3
prerank,organelle disassembly (GO:1903008),-0.2880653769203043,-1.0094427372795804,0.4346590909090909,0.7306850180914622,1.0,7/33,11.23%,VCP;UBA5;STX5;GBF1;ATG2B;CDK1;UFC1
prerank,positive regulation of metabolic process (GO:0009893),0.25626488002123343,1.0093020502669208,0.4447592067988669,0.9615656023711406,1.0,25/103,18.88%,KSR2;G0S2;ESRRG;KDM6B;PPARGC1A;GATM;PRLR;MFAP2;OGT;ADCYAP1;ACHE;CXCR4;ELOVL6;EPAS1;AGPAT1;PRDM16;INSR;ACLY;ACACB;GNAS;ALMS1;IL18;ZBTB7B;GHRL;HDAC3
prerank,positive regulation of integrin activation (GO:0033625),0.4229221764266469,1.0090052760323442,0.4470588235294118,0.9614274024399903,1.0,1/11,1.15%,P2RY12
prerank,negative regulation of cell migration (GO:0030336),0.24671225175556064,1.0088926509227432,0.4484536082474227,0.9606890752697244,1.0,28/137,16.08%,ADTRP;SRGAP3;SRGAP2;LDLRAD4;STK26;SLURP1;THY1;PTPRT;PTPRU;DNAI3;MAPK15;NAV3;TRIB1;CLASP2;DAB2IP;EPHA1;ITGB1BP1;ADAM15;FGF2;SCAI;SFRP1;EVL;NDRG4;EPHA4;FLCN;MIA3;ADORA3;PHLDB2
prerank,protein O-linked mannosylation (GO:0035269),0.36783868979204615,1.0088833643178476,0.4400656814449918,0.9596340103903953,1.0,8/18,27.43%,B4GAT1;TMTC4;FKRP;SDF2L1;DPM3;LARGE1;DPM1;DPM2
prerank,regulation of protein processing (GO:0070613),-0.3155032919337075,-1.008878480646444,0.42424242424242425,0.731574503207885,1.0,6/21,19.31%,CCBE1;NLRC4;ADAM8;LRRK2;CLN3;NKD2
prerank,macrophage activation (GO:0042116),-0.28849107647559163,-1.008686467366542,0.45549738219895286,0.7314314644792165,1.0,16/34,30.08%,C5AR1;SYK;DYSF;SLC11A1;FOXP1;LBP;AGER;TNF;TLR4;TLR1;APP;FPR2;TMEM106A;CRTC3;CD93;ITGB2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.2996822061804659,1.0085947474505828,0.4494556765163297,0.9594668603920048,1.0,9/43,11.16%,WNT4;WWTR1;DNAI3;IL6;MEF2C;FBN2;CCN4;BMP4;NPNT
prerank,carbohydrate transport (GO:0008643),0.4093686771099882,1.008571637337861,0.4293193717277487,0.9584462776372302,1.0,2/11,6.74%,SLC50A1;SLC2A2
prerank,regulation of protein dephosphorylation (GO:0035304),-0.2775842550811012,-1.00839482183024,0.4233128834355828,0.7315349071081922,1.0,13/37,17.71%,ENSA;PPP2R5A;PPP6R1;PTPA;PPP6R3;CDCA2;CALM3;SPPL3;CALM2;ARPP19;PPP1R2;CAMTA1;PPP1R15A
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.34634004329025825,-1.008330200310748,0.42216358839050133,0.7310316806458759,1.0,5/16,20.83%,ZC3H12D;ZC3H12A;RC3H1;TRIM71;CPEB3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.3776236916774105,-1.0080700768906965,0.4423963133640553,0.7310111881987292,1.0,4/13,12.33%,SEC16A;TMEM30A;TM9SF4;EDEM1
prerank,cellular response to unfolded protein (GO:0034620),-0.3121413656714825,-1.008040589393919,0.44329896907216493,0.7304582753228569,1.0,11/26,19.79%,PTPN1;BAX;ERN1;HSPD1;HSF1;PACRG;HSPB8;OPTN;TM7SF3;HSPA13;HSPA1B
prerank,ureteric bud morphogenesis (GO:0060675),0.3722352439446521,1.0079810221680254,0.4656616415410385,0.9593410519821156,1.0,4/16,11.16%,BMP4;PKD2;FGF2;NPNT
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.22850120969210486,-1.0079338145816414,0.4356060606060606,0.7301176871498589,1.0,23/95,17.91%,ZEB2;DAB2;SDCBP;SMURF2;SOX11;THBS1;MTMR4;SMAD3;CAV1;UBC;SNX25;LEMD3;SNW1;UBA52;SPRY2;EP300;SPRY1;SMAD6;FAM89B;ASPN;ADAM17;HIPK2;SMAD4
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.38183120557745726,1.0077048422331378,0.4645390070921986,0.9592171282216823,1.0,2/13,5.63%,RELA;IL6
prerank,erythrocyte development (GO:0048821),0.42456025059402586,1.0076750725469383,0.43826086956521737,0.9582057011088625,1.0,5/10,27.19%,NCKAP1L;SH2B3;ZBTB7A;LYAR;DMTN
prerank,calcium ion import across plasma membrane (GO:0098703),0.3882791384448777,1.0076713126533516,0.4629948364888124,0.9571318785002327,1.0,5/14,18.75%,TRPM2;SLC8A1;SLC8A3;CACNA2D1;TRPV6
prerank,tRNA transport (GO:0051031),-0.28168277453403473,-1.0076313536352652,0.4173669467787115,0.7302679545435407,1.0,8/35,10.98%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB;TOMM20
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.24712657289929932,-1.007542387729765,0.41875,0.7298432774353516,1.0,18/54,20.16%,EXT1;XYLT1;GCNT2;FUCA1;HGSNAT;CHST9;IDUA;UGDH;HPSE2;HPSE;IDS;SDC3;SDC1;XYLT2;GALNT5;PXYLP1;SDC4;SLC35D2
prerank,regulation of gene expression (GO:0010468),-0.18313359253903203,-1.0071137186467898,0.4,0.7303169423342785,1.0,234/903,22.54%,PID1;RBPJ;AHNAK;CD74;NR3C1;APOE;NSD2;NFXL1;HNRNPLL;FLOT2;PTPN22;GAS6;MECP2;STAP1;ITGAX;NOVA2;IGF1;CELF1;SETDB2;AFF1;MITF;ADAM19;PARP14;GCNT2;SOX6;NOCT;SP3;LIN54;MED26;CDK6;MSR1;PTPRC;LIMD1;MBNL1;XDH;RPL5;TLR2;ZUP1;FAM98B;TRIM14;KAT6B;RUNX3;PEG3;AFDN;PRKAB1;BRAF;CD36;FBXW7;FAM98A;ZPR1;ASCC1;LAMTOR5;TYROBP;SOX11;PATZ1;VPS35;AHR;PROX1;ESR1;NFKB1;TRIM17;NFKBIZ;LIMS1;NAB1;TAF1;PUM2;LYL1;MSN;YY1;VHL;RPS7;PF4;TAPBP;CRKL;ATXN1;ZFP64;CEBPB;TFRC;PRDM9;HNRNPAB;SMAD3;PICALM;SP1;PDCD10;RPL6;SLC8A2;PFDN5;MBNL3;RO60;SRRT;YAP1;LYN;HNRNPK;DNMT1;PRKCQ;HIF1A;BMI1;IL1B;UTP4;RNF14;PSEN1;MYBL2;SMCR8;KDM6A;FGF1;HINFP;RNF6;UBE2L3;BRCA1;ZC3H12A;TRRAP;MZF1;KRAS;CTCF;CD28;SPRY2;DNM2;RC3H1;NOTCH1;ATF5;EP300;TRIM44;AJUBA;CUX2;ZNF148;IGF2;CPSF4;SLC11A1;HDAC1;TCF7;KDR;AGO2;NLK;RYBP;LARP1;RACK1;TRIM5;FOXP1;SCX;RB1;ZNHIT3;BMP2;RIMS2;KMT2D;ZBTB11;CREB3L1;PRDM4;PARP9;TESC;MSL3;IRF2;LILRB1;LHX1;TNF;TRIM71;GJA1;RAMP2;CRIP1;TERF2;WNT5A;KAT7;FOXK2;GPX1;THAP7;PDE2A;ZKSCAN5;TIPARP;MLF1;TLR4;CRNN;HP1BP3;TESMIN;HEY2;MAPK8;PTHLH;GSN;RFXANK;CLK4;ADNP2;ERC1;GATA3;HMGA2;SBNO1;FOXN2;TRAPPC2;HNRNPD;NWD1;RNF20;MMP8;PHF19;MYADM;CDH1;FN1;PPM1F;WTIP;MYD88;RGCC;HSPA1B;NFATC2;BMP7;RPL11;BHLHE40;ESRRB;LTF;PTP4A3;HMGA1;KLF4;WARS1;TRIM21;DTNBP1;PIK3CD;NOTCH2;POU3F1;HDAC4;PUM1;CDH3;ANXA7;PTBP3;ZC3H7A;APP;ID2;NDFIP1;RBAK;CCAR1;HMGN5;SPIN4;CD3E;SHH;RREB1;TAF6L;TWIST1;PSPC1;APLNR;PRDM8
prerank,actin cytoskeleton reorganization (GO:0031532),0.2808912187667356,1.0070820526859159,0.45375722543352603,0.9580438317604351,1.0,11/63,11.55%,FGF10;CTTN;MKLN1;THSD7A;PAK1;FGF7;PTK7;CDC42BPA;MINK1;ATP2C1;FARP2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3496616763154697,-1.0069836971528732,0.4182692307692308,0.7300733039794326,1.0,6/16,18.49%,NRP1;PTPN1;PDGFD;PDGFC;BCAR1;PDGFRA
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3136381536989419,-1.0069414292062382,0.4166666666666667,0.7295302295346938,1.0,5/23,12.35%,CBLB;PTPRC;CAV1;SOCS5;CBL
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.2588343753896104,-1.0068455833016645,0.4339622641509434,0.7291487966558835,1.0,13/51,16.01%,NRP1;PXN;ARHGEF10L;CD47;SYNPO2;CARMIL1;SORBS3;S100A10;GPR65;SYNPO;MYOC;ARHGEF5;PFN2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.29842532026457114,1.0066032694502418,0.4477848101265823,0.9585019233948114,1.0,9/45,9.53%,DDX5;RELA;SLC38A2;RIOK1;IL6;WDR75;DIMT1;BMP4;TGFB1
prerank,microtubule anchoring (GO:0034453),0.3991800145625697,1.0062906392061182,0.44768439108061747,0.95843695433353,1.0,5/12,17.24%,CLASP2;CAMSAP3;PEX14;BICD2;BICD1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.41186837034810936,-1.0062077584128077,0.4568764568764569,0.7302550704856072,1.0,3/10,8.15%,CDC73;NCBP1;HSF1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.33206299614722584,-1.0060996279019345,0.42606516290726815,0.7299038196655471,1.0,7/19,21.10%,GNPDA1;UAP1L1;UGDH;GNPNAT1;GMPPB;NAGK;RENBP
prerank,regulation of G0 to G1 transition (GO:0070316),-0.2793184910409847,-1.0060281189598632,0.44141689373297005,0.7294507796903035,1.0,9/38,13.96%,EPC1;RBBP8;RBBP7;BMI1;BRCA1;RHNO1;RYBP;L3MBTL2;EHMT1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3107172658228693,-1.0060200867820006,0.44751381215469616,0.7288227903085231,1.0,7/24,20.95%,TRPS1;SOX6;GREM1;PTHLH;PKDCC;WNT9A;ADAMTS12
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.3291998521649643,-1.0057403691763669,0.43509615384615385,0.7289440081483651,1.0,3/20,0.96%,NRP1;PLAU;IGF1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3850431573653115,1.0055054874380331,0.4641638225255973,0.9598774102089138,1.0,3/15,11.74%,IL4I1;IDO2;KYAT1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.37320841567105145,1.0052761705670854,0.4363327674023769,0.9595278311866091,1.0,5/16,15.55%,ACKR3;NACC2;CLU;SNAI2;CCAR2
prerank,Golgi ribbon formation (GO:0090161),-0.38153189045473085,-1.0052239667912937,0.4354066985645933,0.7297247213832362,1.0,4/13,17.81%,STX6;FHDC1;OPTN;GCC2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3429926150697076,1.005013492799346,0.4496753246753247,0.9592879107686253,1.0,4/23,9.08%,OCIAD2;PRLR;IL6;ERBB4
prerank,establishment of vesicle localization (GO:0051650),0.36091286782623955,1.0048105212951393,0.4609120521172638,0.9588622309315131,1.0,6/18,24.02%,SNAPIN;LIMK2;SPG11;TMEM230;CCDC186;SYT11
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.41139347753109956,1.004639425092847,0.4835924006908463,0.9583493598557161,1.0,4/12,17.84%,PPARGC1A;PPARA;IRS1;ABCD2
prerank,positive regulation of secretion (GO:0051047),0.42236722407397587,1.0043649654991786,0.44755244755244755,0.9581382513717642,1.0,4/11,23.75%,XBP1;NPR1;ACSL3;GPLD1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.362540014616718,-1.0041835937781027,0.4405940594059406,0.7318871375526612,1.0,6/15,24.58%,CCT6A;CCT3;NOP10;DKC1;NAF1;NHP2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4239551523990819,1.004132765484291,0.4450354609929078,0.9578014654595056,1.0,2/10,6.47%,WNT3;RYK
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.34491669301374217,1.0038456837132013,0.4660033167495854,0.9576695337204966,1.0,5/21,9.53%,WWTR1;SH2B1;TGFBR1;BMP4;TGFB1
prerank,protein targeting to mitochondrion (GO:0006626),0.28650334252482373,1.00371109560767,0.45176110260336905,0.9570158085709306,1.0,13/52,18.90%,TOMM40L;TIMM21;FIS1;FBXO7;TIMM29;TOMM34;PITRM1;TIMM13;TSPO;TIMM22;TOMM70;MFF;TIMM23
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.3406540454054987,-1.003548822762589,0.4601990049751244,0.7328761852936682,1.0,7/17,20.71%,PPARG;PPARD;CAV1;PRKAG2;PRKAB2;ADIPOR2;NCOR1
prerank,histone lysine methylation (GO:0034968),-0.2858798364736616,-1.0033216682154167,0.4605263157894737,0.7328220123980793,1.0,15/33,25.67%,SETDB2;DOT1L;SETD3;PRDM9;WDR82;KDM6A;PAXIP1;DPY30;KMT2D;SMYD3;RBBP5;KMT2B;KMT2A;EZH2;DYDC2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3578584838014306,-1.0031744762214985,0.46534653465346537,0.7325464132803068,1.0,3/15,5.68%,PCM1;PIBF1;CCDC14
prerank,positive regulation of organelle organization (GO:0010638),-0.2904490322651964,-1.0030994455362463,0.4266304347826087,0.7320918463058428,1.0,8/32,16.70%,ANXA1;UVRAG;SMCR8;TMED9;SORBS3;LIG4;STX18;RAB3GAP2
prerank,P-body assembly (GO:0033962),-0.3831913193289976,-1.0030179058337176,0.42650602409638555,0.7316524239954908,1.0,4/12,10.69%,LIMD1;DDX6;EIF4ENIF1;RC3H1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.23772132951306396,-1.002820645064946,0.4233576642335766,0.7315290581645523,1.0,16/94,9.75%,BCL2;FNIP2;ARL6IP5;BCL2L1;CUL3;CUL4A;MCL1;BAX;STK24;ERN1;CEBPB;ITPR1;CD24;BAG6;BRCA1;DNAJC10
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.40372172993139155,1.0024372867800506,0.4473229706390328,0.960206214306864,1.0,4/11,22.13%,STK26;PRKN;REST;LANCL1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3053782808810648,-1.0021172767817108,0.4329896907216495,0.7327554217702861,1.0,7/26,9.42%,CCBE1;CCR2;IL6ST;HIF1A;IL1B;BRCA1;HPSE
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3213098781349777,-1.0019760423344897,0.46547314578005117,0.7325085116105107,1.0,10/21,21.67%,BUB3;TEX14;MAD2L2;MAD2L1;BUB1;BUB1B;KNTC1;TRIP13;PLK1;ZWINT
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.38968629330216104,-1.0018420555901675,0.45622119815668205,0.7322274928839454,1.0,3/11,15.28%,RFTN1;RIPK1;SCIMP
prerank,regulation of type I interferon production (GO:0032479),-0.2361461798665077,-1.0017930472253591,0.43,0.7317089546022534,1.0,27/84,20.78%,ITCH;PTPN22;TRIM25;IFIH1;IRF7;ZBP1;TBK1;POLR2E;DHX33;NFKB1;CD14;RNF216;DDX41;CTNNB1;EP300;ACOD1;NLRC5;LRRFIP1;POLR2H;UBE2L6;DTX4;TRAF3IP1;POLR3G;NPLOC4;MYD88;TRIM21;RNF125
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.37308972780108757,-1.0016997080707115,0.4527027027027027,0.7313447088004957,1.0,3/13,8.34%,MPDU1;ALG12;ALG13
prerank,cardiolipin metabolic process (GO:0032048),0.3946320412737997,1.0014692205556426,0.45210084033613446,0.9622609791068754,1.0,7/13,33.63%,PTPMT1;PGS1;PNPLA8;PLA2G4A;TAMM41;CRLS1;LCLAT1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3351259640364471,1.0013659756849516,0.4576,0.9615203954601451,1.0,10/24,25.22%,UBE2B;TCP11;PDE3B;MGRN1;CGAS;PRKAR1A;PRKAR2B;PDE11A;RAPGEF2;GNAI1
prerank,GPI anchor metabolic process (GO:0006505),0.3322377985040673,1.0011229935634163,0.47194719471947194,0.961223568626265,1.0,11/26,28.18%,PIGQ;PIGB;PIGP;MPPE1;DPM3;PGAP2;GPLD1;PGAP3;DPM1;DPM2;PIGZ
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.2709930762805292,1.0008359176598174,0.44877344877344877,0.961098406995711,1.0,20/67,19.50%,ABI3;TXK;NTRK1;FLT4;PRLR;EPHA1;ERBB4;BTK;PDGFB;TEK;EPHA4;EPHB2;INSR;MAPK3;ITK;PTK2;AATK;FLT3;FES;PDGFRB
prerank,positive regulation of protein export from nucleus (GO:0046827),0.37424516998130736,1.0007838165960876,0.4691780821917808,0.9601978127702018,1.0,4/15,9.84%,YWHAE;TCF7L2;RAPGEF3;EMD
prerank,translational elongation (GO:0006414),0.25499953380242285,1.0005482465973323,0.45376955903271693,0.9598876109560875,1.0,32/101,26.19%,MRPS6;GADD45GIP1;MRPL45;GTPBP1;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;EEF1A2;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;LTN1;MRPS10;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,cellular response to pH (GO:0071467),-0.3507795646519378,-1.0003802993678947,0.45496535796766746,0.7342539821681401,1.0,6/17,20.04%,GPR68;RAB11FIP5;CHP1;PKD1L3;MCOLN1;HVCN1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.35695402368767176,-1.000024982190891,0.45742092457420924,0.7345967498746737,1.0,4/14,15.36%,CD74;GPRC5B;LILRB1;WNT5A
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3404719369236106,-0.9998558112464396,0.4413265306122449,0.7344159356461376,1.0,2/16,1.05%,CHMP4A;CHMP4B
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.37825231518464164,0.9998140645504192,0.4684838160136286,0.9611761550425068,1.0,3/15,4.80%,SLC45A3;PPARGC1A;PPARA
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3083747991010669,-0.9998121902269553,0.44919786096256686,0.7338847168932489,1.0,7/24,14.03%,CCR2;MOSPD2;LYN;CCN3;CXCL17;GREM1;DUSP1
prerank,positive regulation of nervous system process (GO:0031646),0.35817632415664025,0.9995465050652037,0.44084278768233387,0.9610428247075159,1.0,4/18,13.62%,TPPP;UNC13B;RIMS1;MYRF
prerank,lipid oxidation (GO:0034440),0.40190710673519914,0.9993324088723788,0.47909407665505227,0.9606704794774684,1.0,3/12,14.19%,ALOX12;PPARGC1A;ACOX1
prerank,keratan sulfate catabolic process (GO:0042340),0.410938239418298,0.9993029015642899,0.4536082474226804,0.9597052838121204,1.0,2/11,2.82%,HEXB;ACAN
prerank,camera-type eye development (GO:0043010),0.3351772404269135,0.9991688660475061,0.4533551554828151,0.9590824607291086,1.0,4/25,9.45%,PRSS56;FBN2;CRYBA4;TENM3
prerank,protein targeting (GO:0006605),0.24811421459588678,0.9990575629126498,0.45582047685834504,0.9583753890508198,1.0,41/118,25.91%,LTBP2;FUT10;SPCS2;GIPC1;CHM;FIS1;FBXO7;PRKCI;ZDHHC22;MYO1C;ZDHHC1;TOMM34;SRPRB;ZDHHC2;SRP14;PITRM1;TIMM13;TSPO;TIMM22;MICALL1;TOMM70;HAP1;RASSF9;ZDHHC23;SRPRA;CACNG3;MFF;PEX6;TIMM23;GOLGA7;AP4E1;GABARAP;ZFAND6;ZDHHC15;TIMM44;HACL1;TOMM22;TAOK2;TIMM10;ZDHHC19;SEC61G
prerank,actin filament depolymerization (GO:0030042),0.412694702923393,0.9989803864297169,0.4642857142857143,0.9575913289820507,1.0,4/11,16.15%,MICAL3;TWF2;CFL1;TWF1
prerank,vesicle transport along microtubule (GO:0047496),-0.3221487759615257,-0.9987565651617437,0.43882978723404253,0.7361802325815562,1.0,12/23,33.36%,TRAK1;KIF3A;RAB1A;CLN3;PAFAH1B1;NDE1;TRAK2;KIF3B;BICDL2;KIF5A;DYNC1H1;HTT
prerank,regulation of transport (GO:0051049),-0.2833082470785412,-0.9985422221563587,0.4378698224852071,0.7361002315369843,1.0,9/36,17.08%,ARL6IP5;NRP1;GAPVD1;ICA1;MBTPS1;LRRK2;YRDC;MUL1;RSC1A1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.276633824468059,0.9985040477108296,0.4510086455331412,0.958066959860257,1.0,13/61,12.62%,FGF10;F11R;NTRK1;PIK3CG;PRAG1;MAPRE2;RASGEF1A;GPR17;MAP4K4;RASGRF1;LPAR4;AKAP13;VAV1
prerank,regulation of tissue remodeling (GO:0034103),-0.32444984654459225,-0.9984984701561579,0.43209876543209874,0.7355736609086371,1.0,2/18,0.21%,SUCO;IL15
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.2513530470803134,-0.9984464035539458,0.4855305466237942,0.73507634464138,1.0,18/55,16.85%,GALNS;LYVE1;FUCA1;CD44;HGSNAT;IDUA;HMMR;HPSE2;HPSE;OGN;CEMIP2;IDS;STAB2;CSPG4;SDC3;CHP1;SDC1;HYAL3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2344683818445541,-0.9983199460545406,0.4823943661971831,0.7347887027348604,1.0,25/85,20.67%,DAB2;VCP;ARIH1;CBFA2T3;FBXW7;TAF1;BBS7;ARIH2;PSMC6;BAG6;RNF14;SOCS5;PSMD10;TMTC3;RACK1;LRRK2;NOP53;ECSCR;USP5;RNF144A;RNFT1;PLK1;NKD2;HSPA1B;SIRT2
prerank,skin development (GO:0043588),-0.24598436976560448,-0.9982298495511484,0.4612903225806452,0.7344131589256052,1.0,28/65,32.88%,ATP7A;MET;ST14;ADAM9;CLIC4;STMN1;ANXA1;TXNIP;ALOXE3;WNT5A;EPHA2;CLDN1;COL3A1;OPN3;DHCR24;BCR;ASCL4;DSP;EVPL;PDGFA;SCEL;KRT10;TMEM79;DLL1;KDF1;ASAH1;ITGA3;UGCG
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.34621915072170706,-0.9981658890639707,0.45305164319248825,0.7339452314593629,1.0,5/15,16.17%,STAT2;USP18;NLRC5;OAS3;MUL1
prerank,maturation of LSU-rRNA (GO:0000470),0.33672725013390026,0.9978905201019893,0.4626865671641791,0.9590013347708407,1.0,6/26,13.58%,RPL7A;NIFK;EIF6;RRP15;NOP2;NSA2
prerank,barbed-end actin filament capping (GO:0051016),-0.33402572582993006,-0.9978343561583672,0.4271604938271605,0.7336243102315779,1.0,6/18,17.33%,SVIL;EPS8;ADD3;VILL;CAPZB;GSN
prerank,actin filament capping (GO:0051693),-0.33402572582993006,-0.9978343561583672,0.4271604938271605,0.7336243102315779,1.0,6/18,17.33%,SVIL;EPS8;ADD3;VILL;CAPZB;GSN
prerank,calcineurin-mediated signaling (GO:0097720),-0.4074039011912518,-0.9978315358951604,0.4528735632183908,0.7323585847942867,1.0,8/10,38.83%,PPP3R1;PPP3CA;NFATC2;NFATC3;NFAT5;PPP3CB;NFATC4;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4074039011912518,-0.9978315358951604,0.4528735632183908,0.7323585847942867,1.0,8/10,38.83%,PPP3R1;PPP3CA;NFATC2;NFATC3;NFAT5;PPP3CB;NFATC4;NFATC1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.29550021665474985,0.9977706018975396,0.46189024390243905,0.9583557371804718,1.0,15/45,21.00%,SCRIB;BMP4;ZFP36L2;FOXC1;PTPN3;ZW10;TGFB1;BTG3;BTG2;TOM1L1;ANGEL2;PLK2;BTG1;HECA;NABP1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.27525259813252917,-0.9975616810973891,0.46865671641791046,0.7324326681314117,1.0,11/38,18.00%,SP100;BCL2L1;THBS1;FAS;RIPK1;BRCA1;BMP5;PMAIP1;GPX1;HMOX1;ARHGEF2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.38096016445099734,0.9973340190704343,0.46611570247933887,0.9587863890434651,1.0,4/14,9.68%,MEOX2;MAP2K5;HDAC5;ITGB1BP1
prerank,polarized epithelial cell differentiation (GO:0030859),0.39649489398737275,0.9972175244257171,0.45932203389830506,0.9581094589449918,1.0,7/13,26.73%,SH3BP1;SCRIB;CAMSAP3;CDC42;OPHN1;RHOA;MYO9A
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3793481863182823,0.997172502176045,0.4468802698145025,0.9572181265433519,1.0,3/14,6.15%,ZBTB8OS;TSEN54;DDX1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2818189945184023,0.9970321744261839,0.4452887537993921,0.9555909640523932,1.0,19/56,22.15%,NDUFA6;DMAC1;NDUFAF8;TIMM21;FOXRED1;NDUFS1;NDUFA8;NDUFS6;NDUFAF2;OXA1L;ECSIT;NDUFAB1;TIMMDC1;NDUFS2;NDUFAF6;BCS1L;NDUFB6;NUBPL;ACAD9
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2818189945184023,0.9970321744261839,0.4452887537993921,0.9555909640523932,1.0,19/56,22.15%,NDUFA6;DMAC1;NDUFAF8;TIMM21;FOXRED1;NDUFS1;NDUFA8;NDUFS6;NDUFAF2;OXA1L;ECSIT;NDUFAB1;TIMMDC1;NDUFS2;NDUFAF6;BCS1L;NDUFB6;NUBPL;ACAD9
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.2505692238097253,-0.9966352650688729,0.44694533762057875,0.7343588669385976,1.0,6/63,3.36%,BCL2;RIC1;PTPN22;MCL1;MET;MTMR2
prerank,negative regulation of neurogenesis (GO:0050768),0.30789007546958674,0.9965883768517428,0.45310015898251194,0.9559643836715364,1.0,9/34,15.79%,THY1;OMG;EFNB3;IL6;ARHGDIA;GDI1;MAG;WNT7A;REST
prerank,blood vessel endothelial cell migration (GO:0043534),-0.3159518330054324,-0.9965092635214116,0.4621026894865526,0.734071736603742,1.0,8/22,16.59%,NRP1;EGR3;ID1;KDR;EMP2;GREM1;MYH9;EPHB4
prerank,peptide hormone secretion (GO:0030072),0.3344433132932711,0.9962455321316729,0.4739413680781759,0.9560072380103357,1.0,8/26,20.17%,PTPRN;EXOC3L1;IL6;ADCYAP1;GAL;LTBP4;GHRL;SNX19
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.29323175197412077,-0.9962447028757486,0.43636363636363634,0.7341149128778429,1.0,8/29,19.52%,ZCWPW1;STAG3;PRDM9;BAG6;RAD21;TEX11;TRIP13;REC8
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.21186639416174244,-0.9957425680698879,0.4343891402714932,0.7347831821588333,1.0,34/151,17.23%,CD74;APOE;NRP1;PTPN22;GAS6;GCNT2;CD44;PTPRC;BRAF;CD36;FBXW7;CCL25;C5AR1;CRKL;GPR183;PDGFD;NOD2;GLIPR2;CIB1;PDGFC;SPRY2;NOTCH1;KDR;SLAMF1;BMP2;EGFR;SHC1;AGER;PTK2B;TNF;SCIMP;RAP1A;MAP2K7;ADRA1A
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3877615745242112,0.9955000875295723,0.4567062818336163,0.957391714726052,1.0,5/13,21.73%,GTPBP1;GNAI3;RHOQ;AK4;AK3
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.35190853455531523,-0.9951411127090298,0.4503464203233256,0.7357200010206602,1.0,3/16,3.73%,PID1;VCP;ENO1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.39362497488126014,0.9951287808999633,0.48336252189141854,0.9575474837203886,1.0,3/13,10.16%,NOP9;EIF6;NUP88
prerank,positive regulation of response to stimulus (GO:0048584),-0.27044924704960754,-0.9950185479842085,0.4883720930232558,0.7353906928765214,1.0,13/40,20.82%,FCGR2B;IL15;IFIH1;IER5;B2M;WNT5A;ECHDC3;FXR2;GATA3;HMGA2;CDKN2A;HMGA1;HOMER1
prerank,ncRNA transcription (GO:0098781),0.3943097605876348,0.994839727509596,0.4688581314878893,0.9574749051103603,1.0,5/13,22.78%,ANG;NIFK;SPIN1;SNAPC3;POLR1G
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.30737037950121215,-0.9947804187692088,0.44415584415584414,0.7353603250752259,1.0,8/24,16.99%,PTPN22;DTX3L;ZC3H12A;STAT1;TRIM44;PARP9;LILRB1;TRAF3IP2
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.2989337476465304,-0.994387431301072,0.45202020202020204,0.7358680199679994,1.0,8/27,16.57%,PTPN22;GAS6;ZC3H12A;C1QTNF3;FOXJ1;SLAMF1;TNF;TLR4
prerank,regulation of cell death (GO:0010941),-0.226825972534439,-0.9942506281556058,0.47843137254901963,0.7356383318889221,1.0,34/94,25.44%,ACER3;CHMP4B;CELF1;CD36;TBK1;SOX11;VPS35;NCK1;SPEF1;PACRG;TMEM109;ZC3H12A;SNCG;CCN1;TNFRSF1B;CCN3;LRP1;CCN5;LRRK2;CHP1;DUS2;ADNP2;HSPA1B;BMP7;DHCR24;EPHB1;HP;HPR;PARP16;NOA1;CCN6;RAMP3;OLFM4;TRIM13
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.304071822050024,-0.9942286520827499,0.4658536585365854,0.7350544660227445,1.0,9/23,26.03%,ALOX5;LTA4H;GSTM1;ASAH2;CYP1A1;ALOXE3;LTC4S;GSTP1;ALOX15
prerank,positive regulation of myelination (GO:0031643),0.4042905611520926,0.9942198657198572,0.48047538200339557,0.9584776926866697,1.0,1/11,0.01%,TPPP
prerank,carbohydrate homeostasis (GO:0033500),0.2722389072339252,0.9940007456764163,0.46285714285714286,0.9581363964836013,1.0,13/67,17.41%,ADCY8;SOX4;STK11;IL6;RFX6;ADRA2A;TCF7L2;KLF7;IRS1;USF1;INSR;PTPN2;MTNR1B
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2599487002507406,0.9939050527827743,0.473463687150838,0.9574124832923377,1.0,22/95,19.44%,NUCKS1;MCM5;RNF138;RAD21L1;SMC5;MCM3;XRCC1;LIG3;RECQL;UBE2N;FAN1;RAD52;PSMD14;PARP1;FEN1;XRCC3;RFWD3;TONSL;WRN;SEM1;HUS1;RECQL4
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4290643324181293,0.9938259123502295,0.47130434782608693,0.9566421605715527,1.0,3/10,20.32%,IL4I1;KYAT1;QDPR
prerank,connective tissue development (GO:0061448),-0.28127236515480225,-0.9937595263251766,0.48195876288659795,0.7356540414861461,1.0,6/35,5.21%,SOX6;CD44;ATP7A;NAMPT;SH3PXD2B;COL11A2
prerank,negative regulation of glycolytic process (GO:0045820),-0.4081603201823392,-0.9937128795713169,0.4430992736077482,0.7345368185689306,1.0,2/10,2.75%,GIT1;CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4081603201823392,-0.9937128795713169,0.4430992736077482,0.7345368185689306,1.0,2/10,2.75%,GIT1;CBFA2T3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.3029979501244625,-0.9936350763671825,0.4433249370277078,0.7341180859290494,1.0,4/25,3.04%,CHMP4A;CHMP4B;VCP;LYST
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3005905362716751,-0.9932380600699906,0.4742268041237113,0.7345312028719746,1.0,6/26,14.18%,B4GALT5;RRM1;ST8SIA6;TKT;GK5;GK
prerank,regulation of microtubule polymerization (GO:0031113),0.29779861852750455,0.9930958884976511,0.47317073170731705,0.9580146300522878,1.0,15/40,25.59%,PAK1;PSRC1;STMN2;NAV3;CAMSAP3;CAMSAP1;DCTN1;CLIP1;FES;MAP2;GBA2;MAPRE3;DRG1;TBCD;MAPT
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.4034640360463362,-0.9929467499094026,0.46710526315789475,0.7347169252048592,1.0,5/10,19.35%,PID1;IL1B;INPP5K;RSC1A1;APPL2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.25536264489655,-0.9927658663894746,0.44542772861356933,0.73455449625004,1.0,14/52,19.31%,PRKCH;PRKCE;CIB1;SORBS1;RACK1;LRP1;EGFR;TNF;CLN3;EPHA2;PLS1;AKAP5;SQSTM1;NKD2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.23545362271975037,0.9925210827146578,0.4742138364779874,0.958804554470058,1.0,41/173,20.21%,ACTR10;RAB1B;KDELR3;CNIH2;SEC16B;AREG;TMED2;COPG1;SEC31A;COG4;GRIA1;NRBP2;TRAPPC3;MPPE1;ZW10;BGLAP;PDCD6;SPTAN1;CNIH1;DCTN1;BET1L;TMED5;SPTBN2;SEC24D;SEC24B;SPTBN1;COPE;MIA3;IER3IP1;KDELR2;SEC24C;TMED3;COPG2;STX17;ANK2;PREB;DCTN3;LMAN2L;TRAPPC8;TFG;TMED7
prerank,positive regulation of DNA recombination (GO:0045911),0.3301622551860669,0.9924507833073822,0.4585365853658537,0.9579797169816041,1.0,10/27,24.09%,WRAP53;FUS;TIMELESS;PARP1;ERCC6;SHLD3;MRNIP;SHLD2;ERCC2;ARID2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.24181861601617266,0.9924418898459947,0.47668393782383417,0.9569664355213938,1.0,26/150,13.02%,FGF10;F3;FGF16;P2RY12;CD80;FGF9;KLB;NRG4;LRP2;CD86;FGF7;AREG;PIK3CG;TNFAIP8L3;TGFBR1;MAZ;TCF7L2;ERBB4;CX3CR1;TGFB1;ITGB1BP1;FGF2;IRS1;PDGFB;VAV1;TEK
prerank,cellular response to drug (GO:0035690),0.33338693953995835,0.9917742425146042,0.46589018302828616,0.9581298567462901,1.0,7/25,16.55%,KCNH2;PPM1E;KCNE2;MEF2C;CRHBP;REST;CERS1
prerank,positive regulation of cell differentiation (GO:0045597),-0.19816611211215732,-0.9917502019572714,0.5170454545454546,0.7366103575934513,1.0,61/237,21.87%,DAB2;SUCO;IGF1;PRKCH;GCNT2;SOX6;NOCT;BRINP1;RIPOR2;MSR1;SDCBP;PPARG;SLC6A6;CD36;ASXL2;IL6ST;SOX11;NFKB1;CTNNA1;KITLG;VHL;PPARD;PF4;CEBPB;SMAD3;YAP1;GLIPR2;IL1B;LPL;ZC3H12A;GPRC5B;CTNNB1;AAMDC;CCN1;TRPM4;CEACAM1;KDR;PTN;BMP2;CDH2;GJA1;ASB4;RAP1A;ECT2;SMAD4;ARHGEF2;MAPK12;PKDCC;RGCC;PA2G4;ACVR2A;GDF3;BMP7;BAMBI;LTF;ACVR1;ID2;IFITM1;HEYL;FFAR4;SERPINF2
prerank,acidic amino acid transport (GO:0015800),-0.33772143520295606,-0.99122892868966,0.46649484536082475,0.7373637325403797,1.0,3/17,3.14%,ARL6IP5;LRRC8D;SLC6A6
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3160876179107566,0.9906386383688908,0.48254931714719274,0.9607113827542323,1.0,10/33,13.89%,MEOX2;MEF2C;MAP2K5;HDAC5;VASH1;TGFB1;ITGB1BP1;FGF2;GADD45A;HMGB1
prerank,response to ethanol (GO:0045471),0.3849887260850213,0.9906184891050988,0.4759535655058043,0.9597494474097763,1.0,4/14,17.38%,GRIN1;GRIN2B;GLRA2;SDF4
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.2914771445042455,-0.9905749344059719,0.46883468834688347,0.7385146449907248,1.0,14/30,24.42%,CHST11;CHST9;IDUA;UGDH;IDS;DSEL;CSPG4;CHST7;CHPF;DSE;CHST12;CHSY3;HEXA;CHST3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.32731533331457635,-0.9901238192272637,0.47043010752688175,0.7391084966932613,1.0,5/20,11.37%,ITCH;ZMIZ1;UBQLN1;HIF1A;DCUN1D1
prerank,apoptotic mitochondrial changes (GO:0008637),0.3133609219611787,0.9900261950677934,0.4874446085672083,0.960572351803039,1.0,12/32,17.54%,FIS1;CLU;BAK1;ERBB4;GGCT;NDUFS1;DNM1L;BIK;BBC3;HK2;CCAR2;MFF
prerank,response to amyloid-beta (GO:1904645),-0.26405568999723344,-0.9898889003767923,0.46153846153846156,0.7390880195631863,1.0,10/44,16.57%,ITGA4;FCGR2B;IGF1;CD36;FYN;PSEN1;LRP1;AGER;GJA1;TLR4
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.20242266589399804,-0.9895090919885411,0.4972375690607735,0.7393998467225525,1.0,48/214,17.23%,CD74;APOE;NRP1;PTPN22;GAS6;GCNT2;CD44;PTPRC;BRAF;CD36;PTPN1;FBXW7;RANBP9;CCL25;C5AR1;CRKL;GPR183;RPS6KA6;PDGFD;NOD2;SYK;LYN;GLIPR2;CIB1;IL1B;PDGFC;SPRY2;NOTCH1;CCN1;SEMA6A;CEACAM1;KDR;SPRY1;ZDHHC17;SLAMF1;BMP2;EGFR;SHC1;AGER;PTK2B;TNF;SCIMP;EPHA2;ARHGEF5;RAP1A;TLR4;MAP2K7;ADRA1A
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.2371245748523264,-0.9892932275143455,0.47619047619047616,0.7392952989520645,1.0,18/77,16.27%,BCL2;IGF1;BCL2L1;MCL1;BIRC6;SIAH2;THBS1;RIPK1;PLAUR;ACAA2;SH3RF1;ASAH2;PSMD10;RB1;QARS1;TNF;GPX1;SLC35F6
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.29261240571970926,-0.9891804259863771,0.46216216216216216,0.7389728505739267,1.0,8/28,19.82%,ZPR1;SMAD3;PSEN1;ZC3H12A;ECT2;CDH1;FLNA;CHP2
prerank,cellular response to fatty acid (GO:0071398),-0.37535072117985957,-0.9890496770547071,0.44285714285714284,0.7386692962305987,1.0,3/12,9.35%,PID1;LPL;ZC3H12A
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.24693077990124754,0.9890293424558303,0.5040106951871658,0.962675482174162,1.0,34/119,22.09%,INPP4B;PIK3C2G;IP6K1;INPP5D;SLA2;MTMR9;SOCS3;PIGQ;PIK3CG;PI4K2A;PIGB;SACM1L;PIGP;SOCS2;MPPE1;OCRL;INPP5F;RAB5A;FGF2;MTMR1;SOCS6;SOCS4;VAC14;DPM3;SMG1;PTPN13;INPPL1;INPP5J;PLEKHA2;PIK3C2A;PIP4K2B;ARF1;PLEKHA1;PGAP2
prerank,B cell homeostasis (GO:0001782),0.41240149985560903,0.9890037062357392,0.4906303236797274,0.9617230079065251,1.0,3/10,11.52%,NCKAP1L;MEF2C;DOCK10
prerank,response to amino acid (GO:0043200),0.3156716297731003,0.9889915721478907,0.48717948717948717,0.9607480167456395,1.0,10/31,19.21%,GLRA3;RPTOR;GLRB;SLC38A9;GRIN1;GLRA2;IPO5;SH3BP4;XBP1;NSMF
prerank,lamellipodium organization (GO:0097581),0.3161691059289822,0.9889619505913295,0.4482225656877898,0.9598309242226664,1.0,4/29,8.16%,CTTN;P2RY12;PTPRO;ABLIM2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.2557115293043605,0.9885800630498296,0.48523206751054854,0.9600284134619872,1.0,21/90,18.88%,KSR2;G0S2;ESRRG;KDM6B;PPARGC1A;GATM;PRLR;MFAP2;OGT;ADCYAP1;ACHE;CXCR4;ELOVL6;EPAS1;PRDM16;GNAS;ALMS1;IL18;ZBTB7B;GHRL;HDAC3
prerank,negative regulation of hydrolase activity (GO:0051346),0.28858212978185127,0.9885758096839607,0.46417910447761196,0.9590228973671662,1.0,17/49,25.19%,F11R;CST3;GCHFR;TMED2;DAB2IP;ARFGEF1;RCC2;SH3BP4;RRP1B;HRAS;WNK1;GMIP;RDX;MAP2;GPSM1;CST7;URI1
prerank,regulation of cellular pH (GO:0030641),0.3225042812913339,0.9885374349493691,0.4777777777777778,0.9581392296927781,1.0,6/29,14.09%,LACC1;SLC4A8;SLC9A4;SLC4A10;SLC4A7;SLC9A5
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.2982410877671249,0.988421554869624,0.5,0.9575176569194686,1.0,10/39,21.11%,ADTRP;PPARA;SPINT2;MAP2K5;TGFB1;MIA3;PTK2;MBP;WNK1;RDX
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.25395399787143386,-0.9882205635721429,0.46264367816091956,0.7402121989305445,1.0,18/54,20.04%,RPL5;MALSU1;RPL35A;RPF1;RPF2;RPL6;RPL10;RPL14;MRPL1;RPL23A;MDN1;RPL3;NPM1;NOP53;GTF3A;RPL26;SDAD1;RPL11
prerank,cellular response to growth factor stimulus (GO:0071363),0.23707155144507963,0.9880539507249821,0.4803664921465969,0.9577016210950562,1.0,34/151,16.13%,WNT4;RELA;NTRK1;FLT4;STMN2;LRP2;NTRK3;PDCD5;PLCG1;MEF2C;LGMN;RPS6KB1;TGFBR1;DAB2IP;TWF2;BMP4;MAP2K5;ZFP36L2;PRKD2;FOXC1;TGFB1;ITGB1BP1;EMD;SNAI2;EHD1;ACVR1B;SFRP1;PDGFB;NDNF;AMHR2;NTRK2;WNT7A;SETX;PRKD1
prerank,ameboidal-type cell migration (GO:0001667),0.2838006664662145,0.9876907991959967,0.48244274809160304,0.9578146065960561,1.0,12/51,12.42%,SEMA7A;NANOS1;SRGAP2;PKN1;SOX10;SEMA6C;MEGF8;SEMA6B;SEMA3D;ERBB4;FAT2;SEMA4F
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.37043835492886695,-0.9874381134028225,0.44139650872817954,0.7416174028454475,1.0,2/12,8.69%,KPNB1;MBTPS1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.23750238353823847,-0.9871469199656671,0.46779661016949153,0.7417424949200946,1.0,13/67,13.03%,CYBB;PSMA6;PSMB2;CD36;PSME2;TAPBP;PSMD11;PSMC6;PSMA3;SNAP23;CYBA;B2M;PSMD10
prerank,intestinal absorption (GO:0050892),0.3918889606925329,0.9867993953994033,0.4848993288590604,0.9595340584420452,1.0,3/13,6.94%,F11R;SLC2A2;ADRA2A
prerank,positive regulation of histone acetylation (GO:0035066),-0.30486762918089455,-0.9867708264494041,0.46115288220551376,0.7421085368972818,1.0,9/23,19.19%,IL1B;BRCA1;PAXIP1;GLYR1;SPHK2;TADA2B;KAT7;SMAD4;TADA2A
prerank,regulation of hydrolase activity (GO:0051336),0.2670659414425177,0.9866981460495122,0.4907539118065434,0.958825591764093,1.0,23/71,20.04%,STMN3;PLXNB2;ARHGAP44;CHN1;CHN2;FGD2;DAB2IP;CFAP100;EPHA1;ITGB1BP1;OCRL;RAP1GAP;VAV1;PRKG1;RALBP1;EPHA4;NTRK2;PTK2;SCARB2;WRN;ARHGAP12;PLXNB1;EPHA5
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2685727009187553,0.986684209112174,0.492603550295858,0.9578514047548274,1.0,20/69,23.78%,POLR2L;CDK7;POU2F2;POLR2F;GTF2F1;GTF2E2;TAF9;ZC3H8;INTS10;POLR2G;CCNK;INTS8;SNAPC3;INTS5;INTS9;INTS11;NABP1;POLR2C;GTF2B;POLR2D
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.3354593615972955,-0.9863802250282241,0.4975124378109453,0.7425550431870122,1.0,7/18,19.20%,RIPOR2;KIF20B;SHTN1;RACK1;PTK2B;RAP1B;BCAS3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.30875705411830534,0.9863198160423157,0.4825291181364393,0.958013962246969,1.0,6/33,10.92%,RELA;IL6;TRPM2;RIPK3;SIGMAR1;NFE2L2
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2557154043557213,0.9861445850495127,0.47994467496542187,0.9575116305704636,1.0,27/98,21.30%,YWHAE;FIS1;E2F1;PRNP;PDCD5;PRKCI;ZDHHC8;CD81;ITGB1BP1;MYO1C;PRKN;STX3;PPP3CC;MTCL1;PPP1R13B;SPTBN1;EPHB2;BBC3;HRAS;NMT1;YWHAQ;MFF;CASP8;YWHAB;ITGAM;PDPK1;TFDP2
prerank,muscle tissue morphogenesis (GO:0060415),0.36271718707404527,0.9859812367478635,0.4842105263157895,0.9570120276014348,1.0,3/16,8.34%,ZFPM1;TGFBR3;BMP4
prerank,pre-replicative complex assembly (GO:0036388),-0.23855973296152644,-0.9859218958952881,0.4816053511705686,0.7431149003199465,1.0,16/64,15.29%,PSMA6;PSMB2;PSME2;ORC5;PSMD11;PSMC6;UBC;PSMA3;UBA52;ORC2;MCM2;PSMD10;ORC4;CDT1;PSMB5;MCM8
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.209059401450406,-0.985562459300892,0.49583333333333335,0.7433933617045344,1.0,27/153,13.93%,CSNK1G1;GAS6;PRKCH;STK38;PRKCE;MARK2;CLSPN;TBK1;PRKACA;MKNK1;MAPKAPK2;LMTK2;ERN1;TAF1;DYRK1A;RPS6KA6;RIPK1;PRKCQ;CAMK2D;UHMK1;HIPK1;MAPKAPK3;CDK1;RPS6KA2;NLK;PRKX;LRRK2
prerank,maturation of 5.8S rRNA (GO:0000460),-0.33973178954697025,-0.9854917484924459,0.46472019464720193,0.7429719462488338,1.0,4/17,10.41%,FTSJ3;RPF1;EXOSC10;MPHOSPH6
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.26730336157186524,0.9854555117203424,0.48755490483162517,0.9576520876165573,1.0,21/72,18.02%,STMN2;CLU;NAV3;CLASP2;SHANK3;TWF2;PRKN;CAMSAP3;FGF13;CAMSAP1;CORO1A;ARFGEF1;CHADL;APC2;TWF1;SSH1;SSH2;TAOK1;SSH3;HDGFL3;SHANK1
prerank,acylglycerol metabolic process (GO:0006639),0.30143679751979724,0.9847452298191478,0.4788519637462236,0.9588315939552976,1.0,12/37,20.67%,DGKI;DGAT2;AWAT2;PNPLA3;ABHD12;DGKQ;DGKZ;DGKE;LMF1;ABHD2;PGS1;DGKH
prerank,neuronal action potential (GO:0019228),0.33824810699874375,0.984564915362919,0.4662045060658579,0.9583821225480308,1.0,9/22,31.25%,CACNA1G;SCN2A;KCNMB3;SCN8A;ANK3;SCN7A;CACNA1H;SCN1A;CACNA1I
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.3650473398119104,0.9843789035550515,0.47692307692307695,0.9579560454989886,1.0,6/16,10.90%,ZFPM2;MEF2C;TGFBR3;ERBB4;TBX2;FGF2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2616564036634227,-0.984300143055226,0.48,0.7455627757769858,1.0,11/43,15.09%,CBLB;RAB7A;EPS15;SOCS5;SPRY2;GRB2;CBL;SPRY1;STAM;EGFR;ITGA1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3742018437810048,0.9838579242981483,0.47413793103448276,0.9585907709879051,1.0,10/15,35.02%,ENTPD6;AK5;AK4;AK1;ENTPD1;ENTPD2;NME2;ENTPD3;ENTPD7;AK7
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3531974244397629,0.9837828241296889,0.488135593220339,0.9578234983544687,1.0,5/18,12.46%,SLC25A4;HEBP2;SLC25A31;BAK1;SLC25A5
prerank,regulation of kinase activity (GO:0043549),0.2582797187262458,0.9835980838954284,0.4971590909090909,0.9573728175132308,1.0,22/89,20.04%,ANKRD54;MERTK;LDB2;LDB1;NTRK1;FLT4;NTRK3;RYK;EPHA1;ERBB4;TEK;EPHA4;RBL2;EPHB2;INSR;RBL1;NTRK2;VAC14;FLT3;PDGFRB;ROR1;EPHA5
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.3993165844859513,0.9834438144608515,0.4991596638655462,0.9568386178418098,1.0,2/12,2.50%,VANGL2;SCRIB
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.36302472225532334,-0.9834110405452762,0.48498845265588914,0.7473043272698375,1.0,5/14,18.59%,FASTKD1;EARS2;MTERF2;SLC25A33;FASTKD5
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.20975864428830135,-0.9831957018280095,0.4978165938864629,0.7472636083194584,1.0,34/148,18.44%,PPP2R5C;RBBP8;RPL5;RBBP7;PRKAB1;TOPBP1;RPS20;TAF1;RPF2;PHF20;TAF12;PRKAG2;NBN;RMI1;ATRIP;BRCA1;HIPK1;RHNO1;EP300;BARD1;RPA1;CDK1;HDAC2;RMI2;KAT5;HDAC1;EHMT1;CHD5;PRKAB2;NOP53;RPA2;HIPK2;RPL37;TPX2
prerank,regulation of small molecule metabolic process (GO:0062012),0.32187310758089427,0.9830775503363185,0.48562300319488816,0.956962315640342,1.0,10/28,26.11%,GNB3;PPARA;NCOR2;DGKQ;PRKN;TTC39B;RORA;PDK1;FMO5;PANK2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.29817892703471266,0.9830647836318616,0.4845679012345679,0.9559991458439416,1.0,9/39,13.95%,PIK3C2G;IP6K1;SLA2;SOCS3;PIK3CG;PI4K2A;SOCS2;SOCS6;SOCS4
prerank,necroptotic process (GO:0070266),0.37100657217880356,0.9829866425768867,0.48903878583473864,0.9552649836990377,1.0,6/16,20.09%,ITPK1;RIPK3;IPMK;DNM1L;TLR3;CYLD
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3246441466795946,0.982800211438908,0.46260869565217394,0.9548671368225177,1.0,7/26,18.76%,PAK1;PSRC1;STMN2;NAV3;DCTN1;CLIP1;FES
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.28669713490096754,-0.9825482533793601,0.4702549575070821,0.7483457594119441,1.0,12/29,21.96%,IGF1;SHOC2;RASGRP4;CRKL;LYN;NOTCH1;GRB2;SHC1;IRS2;EPO;NOTCH2;LRRC59
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.23580064558230174,-0.9824783291591463,0.4948805460750853,0.747916293221556,1.0,25/80,24.50%,ARL6IP5;GAS6;RAF1;CD44;SIAH2;LAMTOR5;GRAMD4;THBS1;UACA;SYK;SH3RF1;DAPK1;PMAIP1;DNAJB6;TNF;GPX1;PPM1F;KLF4;CASP1;DHCR24;TNFSF10;XIAP;NDUFA13;RPS6KA3;CTSD
prerank,regulation of wound healing (GO:0061041),-0.2651473038851243,-0.9824386269894887,0.4776536312849162,0.7473810056419787,1.0,6/42,7.26%,PLAU;ALOX5;CRK;PRKCE;CAV1;ANXA1
prerank,macrophage migration (GO:1905517),-0.36982276104927725,-0.9823530532877331,0.4738095238095238,0.7469711808811186,1.0,4/13,13.52%,P2RX4;CCR2;EDNRB;CXCL17
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.3750954555904745,-0.9823448330049963,0.46064814814814814,0.7463685527817405,1.0,6/12,21.86%,CD36;CYBA;SLC5A3;TLR4;MMP8;ADGRB1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.29621239780751785,-0.9819277923305186,0.4774011299435028,0.7468929665332642,1.0,6/26,10.18%,CUL4A;CHD1L;UBC;USP45;UBA52;RAD23B
prerank,lysosome organization (GO:0007040),-0.2731428918128218,-0.9817685945317661,0.5067024128686327,0.7466698292530333,1.0,11/36,15.69%,TMEM165;TPCN2;NAGPA;HPS1;CLN5;MBTPS1;GNPTAB;AKTIP;LRRK2;GAA;CLN3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.24803090589271257,0.9817426575711794,0.49736842105263157,0.9571505742733356,1.0,14/117,6.48%,HOGA1;CYP2S1;ACSF2;AKR1C1;ALOX12;CPT1B;GATM;BCO2;MECR;PPARA;ACADSB;VDAC1;MTHFD1L;GGT5
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3490615284788268,0.9813271509570541,0.49835526315789475,0.9574823191331067,1.0,8/20,20.67%,MRAP;ADA;MGRN1;APLP1;RGS2;BICD1;CCL5;YWHAB
prerank,cardiac conduction system development (GO:0003161),0.32984570783444894,0.9811161521649275,0.4819672131147541,0.9571228678232003,1.0,4/24,9.96%,BMP4;HEY1;CACNA1G;GJA5
prerank,negative regulation of neuron death (GO:1901215),0.2558652464863238,0.9809883993172106,0.485273492286115,0.9565826804075154,1.0,22/93,17.85%,CD34;NTRK1;SIX4;PPARGC1A;PLA2G3;PM20D1;MEF2C;FBXO7;LGMN;PRKCI;NRBP2;CLCF1;PRKN;KDM2B;MAG;NDNF;SNX6;NTRK2;REST;KIF14;PRKCG;INPP5A
prerank,icosanoid metabolic process (GO:0006690),0.2944343408236978,0.980644824829067,0.5046728971962616,0.956724486358775,1.0,5/40,6.48%,CYP2S1;PTGS1;ALOX12;PLA2G4C;GGT5
prerank,positive regulation of kinase activity (GO:0033674),-0.21972920150571584,-0.9803784459498646,0.5071942446043165,0.7497281318774942,1.0,23/107,16.59%,IQGAP1;CD74;GAS6;AXL;PTPRC;MET;LMTK2;FLT1;SNX9;PRKAG2;NBN;RET;LCP2;AGAP2;CCN1;KDR;LMO4;EGFR;PTK2B;TNF;EPHA2;RAP1A;EPHB4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.31135633065142526,-0.9802461526653811,0.45910290237467016,0.7494353443978674,1.0,5/22,10.61%,MED13;MED16;ESR1;PSMC6;PAXIP1
prerank,RNA modification (GO:0009451),0.28532508469284146,0.9802249977971025,0.5058309037900874,0.9569913799122566,1.0,10/54,11.44%,TYW5;ADAT2;ELP5;CTU1;ADAR;METTL1;MEPCE;DTWD2;FTSJ1;NOP2
prerank,regulation of stress fiber assembly (GO:0051492),-0.23483421491608034,-0.9801289144418712,0.479020979020979,0.7490979711282901,1.0,19/74,16.01%,NRP1;PXN;ARHGEF10L;CD47;MET;PTGER4;CGNL1;ARHGEF18;ARAP1;CARMIL1;STMN1;SORBS3;S100A10;ARHGAP28;GPR65;MYOC;INPP5K;ARHGEF5;PFN2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.33343408439428684,0.9801153715658095,0.5048543689320388,0.9563433051900744,1.0,7/25,15.09%,LDB1;NELFB;NELFCD;RNF168;RNF8;EAF2;BRD4
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2591545157073694,0.9800553575525044,0.4963924963924964,0.9555321919799387,1.0,24/80,24.06%,AGRN;P2RY12;FSCN1;EPS8L3;TENM1;NCKAP1;CDC42EP5;TWF2;ARHGAP35;CYFIP1;EPS8L2;HRAS;RHOQ;WASF2;PALM;CDC42;CDC42EP4;CDC42EP1;GPM6A;CEP120;WASL;EPS8L1;CLRN1;FNBP1L
prerank,regulation of necroptotic process (GO:0060544),-0.3074409497040028,-0.9799643732275911,0.48556430446194226,0.7489367933144567,1.0,7/23,13.69%,FLOT2;SDCBP;ZBP1;RIPK1;BIRC2;PDCD6IP;PELI1
prerank,regulation of ERAD pathway (GO:1904292),0.40385324865779665,0.979816143385146,0.5008695652173913,0.9553158557613984,1.0,3/11,14.83%,TMEM259;HERPUD1;UBXN1
prerank,non-motile cilium assembly (GO:1905515),-0.2890443689034805,-0.9796837493363882,0.4489247311827957,0.7491032388888581,1.0,5/30,5.44%,PCM1;PIBF1;ARL13B;CEP250;TBC1D32
prerank,endocrine system development (GO:0035270),0.34134090128487327,0.9796059102540586,0.47896440129449835,0.9549563302830198,1.0,2/21,7.48%,WNT4;TGFBR1
prerank,negative regulation of viral transcription (GO:0032897),-0.36041889160916984,-0.9795499520037412,0.4506024096385542,0.7488366674980795,1.0,8/13,32.12%,TRIM14;IFITM3;TRIM62;TRIM21;TRIM13;LARP7;TRIM11;TRIM32
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.37588438630029797,0.9794925872874667,0.4804088586030664,0.9543097551374147,1.0,6/14,24.53%,ATP1B1;DMD;WNK1;SLC9A1;GLRX;ANK3
prerank,establishment of skin barrier (GO:0061436),-0.3363298677633296,-0.9786334740654831,0.48148148148148145,0.750089056026872,1.0,4/15,17.29%,MET;STMN1;ALOXE3;CLDN1
prerank,regulation of water loss via skin (GO:0033561),-0.3363298677633296,-0.9786334740654831,0.48148148148148145,0.750089056026872,1.0,4/15,17.29%,MET;STMN1;ALOXE3;CLDN1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2936403820575516,0.9782313749701244,0.48787878787878786,0.9572235664698686,1.0,8/41,10.49%,LACC1;AAAS;EIF6;NUP54;OGT;NUP88;RAE1;JMJD8
prerank,phosphatidylinositol metabolic process (GO:0046488),0.24627932199986635,0.9781177910349865,0.508819538670285,0.9565914495116435,1.0,30/109,21.93%,INPP4B;TPTE;PIK3C2G;INPP5D;PLA2G3;MTMR9;PLCD1;INPP5B;PLA2G4C;PLCG1;PIK3CG;PI4K2A;SACM1L;OCRL;INPP5F;RAB5A;FGF2;MTMR1;VAC14;PTPN13;PDGFRB;PLCB2;INPPL1;PIP4P1;INPP5J;PLEKHA2;PIK3C2A;PIP4K2B;ARF1;PLEKHA1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2778751879292448,-0.9780359839444459,0.5160493827160494,0.7510153049123075,1.0,8/33,14.20%,CPSF1;NCBP1;FIP1L1;SNRPB;CPSF4;CSTF2;CPSF2;PCF11
prerank,regulation of chromatin binding (GO:0035561),-0.39051146755514143,-0.977918543529679,0.48409090909090907,0.7507368322028046,1.0,3/10,14.19%,DTX3L;PARP9;CDT1
prerank,apoptotic process (GO:0006915),-0.20071607826690688,-0.9777124272317115,0.5828220858895705,0.7506983633537289,1.0,38/203,12.71%,BCL2;STK3;PAEP;HIP1;BCL2L1;PRKCE;RAF1;TLR2;IFIT2;RRAGC;BAX;AHR;CD14;ARHGEF6;TRPC5;PPARD;FAS;HSPD1;RIPK1;DDX41;CIT;CIB1;IL1B;BAG6;PIK3CA;PIDD1;TNFRSF19;FOXO1;EP300;MRPS30;SEMA6A;LIG4;BRAT1;CD2;MCM2;ESPL1;DAPK1;AHCYL1
prerank,glycolipid biosynthetic process (GO:0009247),0.2972423354654945,0.97759958382764,0.49144634525660963,0.9572447884175113,1.0,17/38,32.51%,ST3GAL5;PIGQ;PIGB;PIGP;MPPE1;SCCPDH;DPM3;LARGE1;PGAP2;PGAP3;DPM1;DPM2;PIGZ;A4GALT;ST8SIA3;PIGG;PIGC
prerank,outer dynein arm assembly (GO:0036158),0.38301811497032356,0.9775834286779832,0.4805194805194805,0.9563175919554058,1.0,2/14,1.99%,DNAAF1;ODAD4
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4101349938257509,0.977485959423894,0.4770797962648557,0.9556510329136715,1.0,4/10,17.03%,SCRIB;PRNP;CRTAM;PRKAR1A
prerank,regulation of vasculature development (GO:1901342),-0.29504757651021374,-0.9774513486663086,0.4867021276595745,0.7507594993807296,1.0,11/26,27.28%,SP100;CTNNB1;ADGRA2;EMP2;EPHA2;HMOX1;RNH1;WARS1;HTATIP2;GPNMB;EGLN1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3794261193708862,0.9774234943896039,0.511986301369863,0.9548618663001911,1.0,4/14,13.69%,RELA;CD81;PRKD2;KCNN4
prerank,dopamine metabolic process (GO:0042417),0.3542711727066723,0.9768465195518473,0.48925619834710743,0.9555887707929259,1.0,5/18,14.77%,LRTOMT;PRKN;MOXD1;DAO;COMT
prerank,protein insertion into membrane (GO:0051205),0.30648421884261073,0.9765970599498117,0.48205928237129486,0.955332536515475,1.0,8/32,15.41%,PRNP;SGTA;OTOF;EMD;TRAM2;CCDC47;OXA1L;TRAM1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3474423304108579,-0.9765968686622445,0.47255369928400953,0.7523962406437648,1.0,6/15,13.19%,TSEN2;CPSF1;FAM98B;ERN1;CPSF4;CSTF2
prerank,negative regulation of cell cycle (GO:0045786),0.26340677233497195,0.9765688973251156,0.5007278020378457,0.954461290181309,1.0,17/73,18.17%,HHEX;SCRIB;SIPA1;BMP4;FOXC1;PTPN3;TGFB1;BTG3;HEXIM2;BTG2;CHMP1A;INHA;PPP1R13B;IPO5;ANGEL2;BTG1;HPGD
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.35326243267888335,-0.9765688193715685,0.501187648456057,0.7518439806095636,1.0,5/14,16.13%,PTPN1;BAX;DNAJB9;FICD;BCL2L11
prerank,organelle fusion (GO:0048284),0.33690476816855275,0.9763662029868753,0.505,0.954092943792015,1.0,5/22,17.54%,CYP26C1;FIS1;USP30;MIGA1;MFF
prerank,post-translational protein modification (GO:0043687),0.22011738852894266,0.976005534303549,0.5545350172215844,0.9542565960464463,1.0,80/332,20.61%,KLHL25;KLHL22;FBXW8;PSMB1;C3;OBSL1;RAB1B;CST3;FBXW9;RAB3A;AFP;COPS8;CHM;SOCS3;ELOC;UBE2M;FSTL1;IL6;FBXO7;NUB1;RAB8A;COMMD1;PSMF1;ASB2;BTRC;FBXO11;BMP4;PSMA1;SOCS2;PSMD7;COPS3;PSMA8;FBXW10;HSP90B1;RAB38;RAB5A;PSME3;FBXL20;SENP8;KLHL2;SCG3;CUL2;EPAS1;VCAN;PSMD14;SPSB3;NUCB1;FBXL4;FBXL19;PSMC4;DDB2;DCAF11;LRRC41;COPS6;SOCS6;KLHL11;FBXW5;MIA3;KLHL5;SKP2;FN3K;APLP2;UBA3;COP1;ESCO1;KLHL42;FBXO9;QSOX1;PSMB4;FBXL7;FBXL3;SDC2;WSB1;FBXL22;SPARCL1;RABGGTB;FBXO31;COPS5;PSME1;FBXO6
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.28476101439139545,0.9758356178614476,0.5007496251874063,0.9537982046007625,1.0,13/45,17.93%,NANOS1;DDX25;ZC3H10;ZC3H7B;SPOUT1;YTHDC1;METTL16;CYFIP1;NUDT21;RBM3;MAPKAPK5;GEMIN5;ATXN2
prerank,actin filament bundle organization (GO:0061572),-0.2786133349654696,-0.9758221998407006,0.5068119891008175,0.7533309834267928,1.0,10/33,22.53%,NEDD9;EPS8;LCP1;PLS1;MICAL1;RFLNA;LIMA1;AIF1L;SHROOM2;BAIAP2L2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.28118328218389116,-0.9754128658965694,0.4535211267605634,0.7531577153318165,1.0,7/32,10.06%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB
prerank,tRNA export from nucleus (GO:0006409),-0.28118328218389116,-0.9754128658965694,0.4535211267605634,0.7531577153318165,1.0,7/32,10.06%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB
prerank,regulation of protein import into nucleus (GO:0042306),-0.2745049528377591,-0.9751632259902577,0.480225988700565,0.7531853706579297,1.0,10/36,19.82%,MDFIC;ZPR1;SMAD3;PSEN1;ZC3H12A;CHP1;ECT2;CDH1;FLNA;CHP2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3197667573894443,-0.9748497619393326,0.4838709677419355,0.7534009130319523,1.0,7/19,13.91%,SUCO;CIITA;LARP6;VIM;HDAC2;SCX;CREB3L1
prerank,macrophage chemotaxis (GO:0048246),-0.3947809772083002,-0.974605797272848,0.48156182212581344,0.7533872126173141,1.0,5/10,34.75%,EDNRB;CXCL17;TAFA4;CKLF;EDN2
prerank,neuron projection regeneration (GO:0031102),0.41226518491278796,0.9745055492542156,0.4787234042553192,0.9569505696609036,1.0,4/10,18.81%,OMG;RTN4RL1;MTR;NREP
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.303533139764893,0.9744538988787033,0.48346456692913387,0.9561206776061956,1.0,6/33,14.77%,ANG;MEF2C;TRIB1;PRKG1;NDRG4;APOD
prerank,regulation of lipid kinase activity (GO:0043550),-0.37848514541125655,-0.9744177347342606,0.4823529411764706,0.7532725058856087,1.0,4/11,13.54%,PPP2R5A;WDR91;WDR81;RB1
prerank,proteolysis (GO:0006508),0.22317148405307982,0.9737974682071182,0.5035460992907801,0.9571430996680929,1.0,61/252,21.82%,RNF123;F3;PLAT;CAPN3;MMP16;ACAN;RNPEPL1;PRSS56;CAPN12;ASPRV1;XPNPEP1;CNDP1;PGPEP1;TMPRSS7;BACE1;UBE3A;GGT5;XPNPEP3;SPPL2B;LGMN;ATG4A;OGT;VASH1;PHEX;FBXL6;AEBP1;TRHDE;CAPN11;CASP3;VASH2;LAP3;CASP4;PSENEN;CASP7;PITRM1;MMP1;PSMC4;ENPEP;HPN;HM13;UBA3;THOP1;ERMP1;FBXL2;SUFU;TMPRSS6;TYSND1;PCSK2;MMP17;LACTB;FOLH1;ADAMTS3;CTSK;DPP8;NAALAD2;CASP8;FBXO6;APEH;METAP2;CASP2;CTSS
prerank,positive regulation of cellular process (GO:0048522),-0.17986602732909449,-0.9736824699689417,0.6216216216216216,0.75456235820889,1.0,142/565,21.94%,FCGR2B;IL15;BCL2;GAS6;ANKRD17;MECP2;ITGAX;IGF1;ACER3;CELF1;GCNT2;DPP4;CUL3;SDCBP;CD47;CAPN1;LIFR;TLR2;FAM98B;LILRA5;P2RX4;IL12RB2;SLC6A6;CD36;MEIS1;RARA;NCBP1;DOCK2;NAMPT;CDCA7L;FAM98A;IL6ST;SOX11;DOT1L;IER5;CXCL16;PROX1;KITLG;PRC1;DDX49;S1PR2;VHL;MTLN;CRKL;THBS1;FLT1;PDGFD;EGR2;CCND1;KIF20B;PDCD10;CAV1;LYN;DHPS;GAB2;CIB1;HCK;IL1B;HSF1;H3-3A;FGF1;VIPR1;ZC3H12A;KRAS;BMP5;PDGFC;ADAM8;BIRC5;NOTCH1;PPP3CA;HDAC2;CYBA;IGF2;TRPM4;TNFRSF1B;SLC11A1;BRAT1;HDAC1;KDR;CCND2;EMP2;PSMD10;LRP1;SLAMF1;PTN;SCX;GREM1;KMT2D;HAS2;EXOSC9;NUMA1;NPM1;LBP;CIAO1;EGFR;SHC1;PTK2B;TNF;WNT5A;SLC25A33;TUB;ECHDC3;FCER1G;BST1;MFSD2A;SLC35F6;ACACA;TLR4;FXR2;ADAM17;AQP11;MAPK8;PTHLH;ADNP2;HMGA2;PDGFRA;FN1;HES1;LRP6;TFAP2B;S1PR3;OSMR;CHP2;PA2G4;IRS2;BAMBI;EPO;TIMP1;MLC1;SIRT2;TRIM21;HDAC4;CNOT6L;CDH3;HP;HPR;LMNA;NOXO1;TGFA;CCAR1;SERPINF2;HMGN5
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3756788061995375,0.9734029731793628,0.48299319727891155,0.9573661996396604,1.0,3/14,5.53%,CD80;PRKCZ;CD86
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.36877045227488725,-0.9729363296433975,0.5122549019607843,0.7558988721727096,1.0,6/12,28.43%,RAB1A;CDC14B;UBE2C;PLK1;GORASP1;CDC20
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.25857601737408176,-0.9728763026871632,0.5127478753541076,0.7554335375964495,1.0,23/45,36.60%,DAB2;SDCBP;BMP5;RBPMS;BMP2;BMP3;SMAD4;ACVR2A;GDF3;BMP7;ACVR1;GDF10;BMPR2;GDF9;INHBB;GDF15;BMPR1A;TGFB2;BMP8B;LEFTY1;GDF6;BMP15;INHBC
prerank,sterol metabolic process (GO:0016125),0.2685202127305993,0.9728540099572391,0.5197657393850659,0.9580952408584337,1.0,7/60,7.01%,STARD3;TM7SF2;CYP26C1;FDX2;SOAT2;NSDHL;CYP39A1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3748043256676846,0.9724010969521851,0.49658703071672355,0.9585394519257323,1.0,8/14,29.09%,RARRES2;MAPK3;PTK2;CCL5;IL34;MAPK1;CSF1R;MDK
prerank,postsynaptic membrane organization (GO:0001941),0.35691432282252533,0.9723781990036984,0.5192926045016077,0.9576377774855878,1.0,3/17,7.99%,LHFPL4;NRXN1;SHANK3
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.3494259819255259,-0.9722987849819553,0.4671201814058957,0.7563090350259855,1.0,3/14,8.89%,CMPK1;ENPP3;SMPDL3A
prerank,negative regulation of protein phosphorylation (GO:0001933),0.23483120907947136,0.9722789985473929,0.5244845360824743,0.9570135175174305,1.0,24/150,11.58%,TSC2;PPM1E;WWTR1;LDLRAD4;THY1;DMD;PRKCZ;CNKSR3;PRNP;NTRK3;TRIB1;TRIB2;UBASH3B;CACTIN;DAB2IP;DGKQ;SH3GL2;EPHA1;MVP;TGFB1;ITGB1BP1;PRKN;DDIT4;SFRP1
prerank,negative regulation of response to wounding (GO:1903035),-0.3218790288325522,-0.9720806792030482,0.5111111111111111,0.756296348544068,1.0,6/19,16.96%,ALOX5;CRK;GIT1;AJAP1;CERS2;KLK8
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2895921903066574,0.9715989838289538,0.49608763693270735,0.958158142913829,1.0,9/42,19.40%,ACKR3;CCR1;FOXC1;SH2B3;STK39;THPO;CCL15;WNK1;CCL5
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.27521070441085366,-0.9714389563946225,0.5068870523415978,0.7574591702137372,1.0,8/36,10.59%,PRPF19;CLSPN;USP28;DOT1L;NBN;ATRIP;HINFP;RHNO1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2380734223879308,-0.9713076271170238,0.5217391304347826,0.757199402738731,1.0,9/63,7.25%,SP100;IGF1;BIRC6;SIAH2;THBS1;FAS;RIPK1;CAV1;WWOX
prerank,neurogenesis (GO:0022008),0.287792421708837,0.9713056788228638,0.5159817351598174,0.9581405052501564,1.0,15/43,25.77%,ROGDI;DCHS1;SIX4;RYK;BTBD3;CXCR4;HAP1;ERCC6;FAT4;NDUFS2;DAGLA;DAGLB;VXN;MAPT;METTL14
prerank,miRNA metabolic process (GO:0010586),-0.3143597230153178,-0.9711459751200888,0.47572815533980584,0.757000721829401,1.0,5/20,20.84%,DIS3L2;AGO2;TRIM71;TENT4B;DGCR8
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.25760225450798335,-0.9709880902491959,0.5079365079365079,0.75676489268747,1.0,11/47,15.23%,APOE;EIF2A;VPS35;TCOF1;NFKB1;NR1H2;EDNRB;RPL10;WDR91;NR1H3;EIF2B4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.3814599377773681,-0.9709237401899465,0.495260663507109,0.7563026003134588,1.0,2/11,2.61%,CD274;RUNX3
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3892988725827949,-0.9708368337598632,0.48491879350348027,0.7559191792062794,1.0,4/10,17.77%,RARA;IRF4;SPHK2;GATA3
prerank,bile acid metabolic process (GO:0008206),-0.2921237530240196,-0.9707515208642526,0.5465994962216625,0.7555099936927617,1.0,5/27,9.27%,ACOT8;OSBP;OSBPL9;OSBPL1A;OSBPL2
prerank,lipid modification (GO:0030258),0.29539113756061,0.970750862673172,0.5046583850931677,0.9588874682857066,1.0,9/37,20.72%,DGKI;PLPP5;ALOX12;DGKQ;DGKZ;DGKE;PLPPR4;DGKH;PLPP1
prerank,cilium organization (GO:0044782),-0.1992010257279886,-0.9705916653108113,0.5885714285714285,0.7552937117501248,1.0,34/209,10.70%,EHD4;ATP6V0D1;RAB8B;ACTR3;KIF3A;PTPN23;PCM1;RILPL2;FAM161A;PIBF1;RAB1A;MKS1;CDC14B;RPGR;SCLT1;CPLANE1;GBF1;EXOC4;ARL13B;CEP250;TCTN1;SSX2IP;BBS7;FHDC1;ASAP1;DNAH5;KIF24;TMEM231;CEP164;WDPCP;SNAP29;CCDC28B;TMEM138;NOTCH1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3069238234596441,0.9703834606309868,0.5058043117744611,0.9590640612999071,1.0,8/33,10.94%,P2RY12;NCKAP1L;ADA;PDE3B;PIK3CG;ITGB1BP1;SNAI2;EFNA1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.30741118918332433,-0.9703382437899256,0.48578811369509045,0.7553499922131955,1.0,5/22,10.70%,IGF1;P2RX4;IL6ST;CAMK2D;NOTCH1
prerank,positive regulation of mRNA processing (GO:0050685),0.34056944716305376,0.970027793839864,0.5132013201320133,0.9591926105956486,1.0,8/21,20.23%,PRDX6;TRA2B;CIRBP;RBM3;RBMXL1;PAF1;TRA2A;DHX36
prerank,protein-containing complex subunit organization (GO:0043933),0.24513375982752456,0.9699736127706928,0.5053763440860215,0.9583990356797047,1.0,39/109,27.19%,WDR19;CAPN3;ADD2;NIFK;PARD6B;PPARGC1A;NCKAP1L;IL1RAP;MAGI1;NUP54;TSPAN4;SH3BGR;ZW10;PEX14;RIMS1;DNM1L;WASF3;VAMP3;CHCHD10;TUBGCP2;NUP133;EPRS1;GEMIN5;PPP2R1A;SHANK1;LIN7A;CLDN14;CAPG;TEAD2;MDM4;WASL;LAMC1;IL2RB;CD40;HFE;ST13;DLG4;LLGL1;DMTN
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.26484694981927753,-0.969819904375685,0.4630681818181818,0.756110290978069,1.0,11/43,15.34%,PID1;PTPN1;NCK1;SLC27A4;PRKCQ;IL1B;SORBS1;IGF2;SIK2;INPP5K;TNS2
prerank,cellular response to organic substance (GO:0071310),-0.21083678916218898,-0.9697470695891212,0.5509433962264151,0.7556781643126527,1.0,44/116,28.17%,PID1;ARL6IP5;PTPN23;STAT5B;TBK1;NCOA1;SMAD3;LDLRAP1;CIB1;IL1B;PTPN7;GHR;CTNNB1;ASAH2;CYP1A1;RACK1;INPP5K;LRRK2;SHC1;TNF;RAMP2;MAPK7;TIPARP;CRNN;IL18R1;MAPK8;IGFBP5;ACVR2A;KLF4;CASP1;ACVR1;PTPN4;CDK9;NR1H4;CYP1B1;BMPR2;RAMP3;PTPN14;LEF1;PTPN20;SIGIRR;CLEC3B;SLIT3;SLIT2
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.305753625307367,-0.9693741735809306,0.4921052631578947,0.7560154062934644,1.0,10/22,35.12%,HSPD1;IL1B;B2M;CD55;FADD;IL12RB1;MALT1;IL12A;IL23R;IL12B
prerank,endodermal cell differentiation (GO:0035987),0.3050027933401706,0.9691828962135113,0.48613376835236544,0.959849519912814,1.0,8/31,16.32%,CTR9;RTF1;LAMB3;ITGB5;ITGA5;COL4A2;VTN;PAF1
prerank,regulation of viral transcription (GO:0046782),0.29041115559963826,0.9686869548821668,0.5091743119266054,0.9604048157135303,1.0,6/39,6.91%,POLR2L;POLR2F;NELFB;MID2;NELFCD;GTF2F1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.24630390461101978,0.9685054868306059,0.5250696378830083,0.9599821079399975,1.0,28/100,19.74%,TSC2;NTRK1;NTRK3;PIK3CG;MAZ;DAB2IP;NEDD4;FGF2;BECN1;PDGFB;TEK;PIK3IP1;INSR;NTRK2;DIPK2A;MAPK3;FBXL2;AGT;PTK2;FLT3;PTPN13;IL18;PLXNB1;DCN;STAMBP;CCL5;PDGFRB;ROR1
prerank,cellular amide metabolic process (GO:0043603),-0.2172531038867389,-0.9684941491691308,0.524904214559387,0.7576551655750519,1.0,20/102,12.78%,NLN;ACOT8;SGPL1;PLA2G4E;MTHFR;ORMDL1;CPD;PLAAT3;MCCC1;CLN8;SLC46A1;ST6GAL1;HLCS;MCCC2;CPE;MTHFD1;CPM;CERK;ASAH2;MTRR
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.34581302636075206,-0.968433995019984,0.5083135391923991,0.7572064405459186,1.0,6/15,24.64%,NOD2;HIF1A;TNF;TLR4;MYD88;APPL1
prerank,peroxisomal membrane transport (GO:0015919),0.31695728360535347,0.9683627216851813,0.5245098039215687,0.9594613866064756,1.0,13/27,27.81%,PEX5;FIS1;ATAD1;PEX26;PEX14;PEX2;ABCD2;PEX6;PEX11B;PEX3;ABCD3;PXMP4;ACBD5
prerank,mitochondrion organization (GO:0007005),-0.20123359347014672,-0.968331800987434,0.5450643776824035,0.7568753172211068,1.0,34/165,17.11%,PID1;VPS13D;TRAK1;BCL2L1;CHCHD2;ATAD3A;YME1L1;IFIT2;ATP7A;BAX;TOMM7;MTX3;HSPD1;NRF1;AGTPBP1;FMC1;MTX1;ALAS1;DNM2;TOMM20;MTM1;WDR81;STOML2;LRRK2;AIP;TIMM50;TIMM17A;SLC25A33;IMMP2L;WASF1;MUL1;MTFP1;MIEF1;MTFR2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.38000989045937883,-0.9682920153639406,0.4880952380952381,0.7563668204187864,1.0,5/10,22.50%,PTPN22;NR1H3;LBP;LTF;TICAM2
prerank,plasma membrane invagination (GO:0099024),-0.28227982227240356,-0.9682246236256985,0.5135135135135135,0.7559147603108638,1.0,4/29,6.85%,FCGR2B;MSR1;CD36;SNX9
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2633963117352428,-0.9681660101542207,0.5067024128686327,0.7554645161000234,1.0,15/44,23.49%,GAS6;RAF1;CD44;SIAH2;LAMTOR5;THBS1;SH3RF1;DNAJB6;TNF;GPX1;LTF;KLF4;DHCR24;XIAP;RPS6KA3
prerank,renal water homeostasis (GO:0003091),-0.3077360256510697,-0.9680931237955407,0.4845360824742268,0.7550454815959754,1.0,9/23,19.65%,PRKACA;ADCY9;ADCY5;ADCY6;ADCY1;ADCY3;PRKACB;TFAP2B;WFS1
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.33771672795252694,-0.9680175247718383,0.49748743718592964,0.7546282071084948,1.0,6/17,19.48%,PPP1R12A;S1PR2;IL1B;TNF;VCL;S1PR3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3763364273845953,0.9680127837132775,0.5026833631484794,0.9595650686821587,1.0,6/14,22.69%,PNP;NMNAT2;AK5;AK4;AK3;AK1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3173152740535613,0.9678020664382307,0.49216300940438873,0.9592596956829831,1.0,7/28,22.02%,CTTN;SH3BP1;FCHSD2;ARHGAP35;PLEKHG2;GBA2;LATS1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2400608290399425,-0.9675639034631687,0.5154061624649859,0.7551932315394996,1.0,16/62,14.90%,CDK6;CDC73;MEIS1;PURB;PF4;THBS1;LYN;PRKCQ;KMT2C;H3-3A;EP300;NFE2;HDAC1;DPY30;KMT2D;PTK2B
prerank,secondary alcohol metabolic process (GO:1902652),-0.2631174768643434,-0.9674635363476293,0.5185185185185185,0.7548492827523242,1.0,7/42,6.30%,APOE;IDH3A;IDH1;PPARD;OSBPL1A;CLN8;LDLRAP1
prerank,transition metal ion homeostasis (GO:0055076),0.31285964674934086,0.9672560341787507,0.49838709677419357,0.959914531889637,1.0,5/28,10.07%,IREB2;TMC8;COMMD1;NEO1;PRKN
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.4093545622731547,0.9670208255600928,0.5105633802816901,0.9596653462903614,1.0,3/10,9.34%,UBE2B;PDE3B;MGRN1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.21921063285057732,-0.9666838667322128,0.5547445255474452,0.7562608747315749,1.0,23/102,17.31%,MYO5A;RAB8B;DENND4C;PPARG;PRKACA;ADCY9;NFKB1;CAV1;GOT1;RAB15;ADCY5;ADCY6;RAB10;FOXO1;ADCY1;SORBS1;CEACAM1;INPP5K;ADCY3;PRKACB;SLC25A33;RAB31;CPEB2
prerank,response to thyroid hormone (GO:0097066),0.38057308612500074,0.9666806609731999,0.5045045045045045,0.9597503145542517,1.0,7/13,25.92%,BRD8;LMO2;HPN;RDX;CTSS;GAS2L1;CTSH
prerank,positive regulation of macrophage migration (GO:1905523),0.34963418584953837,0.9663567550471147,0.5008547008547009,0.9597903036338775,1.0,9/19,29.09%,P2RY12;RARRES2;MAPK3;PTK2;CCL5;IL34;MAPK1;CSF1R;MDK
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.31603749810658843,0.9662589807571492,0.5201288244766505,0.9591280911702361,1.0,9/26,18.56%,PRKCZ;NRXN1;SHANK3;GRIN1;RIMS1;SLC8A3;WNT7A;SHANK1;CHRNA7
prerank,histone H4 deacetylation (GO:0070933),-0.3945466039163337,-0.9660231183922178,0.5035799522673031,0.7573437845756882,1.0,5/10,21.09%,RCOR1;HDAC2;HDAC1;SIRT2;HDAC4
prerank,antibacterial humoral response (GO:0019731),0.35824939021270674,0.9659064089069861,0.5220338983050847,0.9592557070692513,1.0,3/16,10.32%,ANG;DEFA6;RNASE7
prerank,regulation of cellular component organization (GO:0051128),-0.20737876423393195,-0.9659013643475746,0.5578512396694215,0.7570639584661603,1.0,30/135,16.96%,ITCH;APOE;HIP1;ABL2;ATAD3A;CD36;PTPN1;MKI67;ZFYVE16;HIP1R;MLLT3;TFRC;PICALM;NUBP1;PRKCQ;OGFR;RASGRP2;MAD2L2;CAMK2D;ATF5;CEACAM1;PACSIN2;RAB4B;TNF;WNT5A;RAP1B;BCAR1;RAB33B;RAP1A;KLK8
prerank,myeloid cell development (GO:0061515),-0.323565355838027,-0.9656589018934377,0.46329113924050636,0.757148379225842,1.0,6/18,22.64%,NRROS;TLR2;ALAS1;FOXP1;APP;ALAS2
prerank,androgen receptor signaling pathway (GO:0030521),0.40609742176400393,0.9654748789836528,0.5184534270650264,0.9595774573831742,1.0,2/11,6.00%,DDX5;AR
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.2890784089232192,-0.9652757997379638,0.4960212201591512,0.7575052979238458,1.0,8/27,18.52%,ZC3H12D;ERN1;ZC3H12A;ZC3H12B;PCF11;TRIR;POP1;RNASEH1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.25740580292191784,0.9652259213834528,0.5470914127423823,0.9593559226819258,1.0,25/84,23.23%,GAPDH;RTN1;NANOS1;GGA3;BIN1;ENC1;PRNP;CLU;ORMDL2;BTG2;CNOT8;HAP1;NTRK2;EPRS1;ROCK1;CHRNA7;PIN1;TOB1;DHX36;PUS7;ABCA7;CNOT10;FXR1;IGF2BP3;RNF139
prerank,negative regulation of JNK cascade (GO:0046329),-0.27938067574861386,-0.9646839981714427,0.5108695652173914,0.7584345848592148,1.0,9/31,25.49%,ITCH;PTPN22;TAOK3;NCOR1;DUSP19;MECOM;GSTP1;FKTN;DUSP3
prerank,inner ear morphogenesis (GO:0042472),0.3336698265937072,0.964570127039749,0.49592169657422513,0.9603833290895781,1.0,4/22,15.59%,MYO6;POU3F4;EPHB2;HPN
prerank,positive regulation of sodium ion transport (GO:0010765),0.3859635815268543,0.9641756001575421,0.5068027210884354,0.960577975580659,1.0,7/12,33.20%,CNKSR3;SCN3B;SCN1B;ANK3;PKP2;WNK3;SCN4B
prerank,peptide catabolic process (GO:0043171),0.3230719274556917,0.9638820152258677,0.5016501650165016,0.9604560432524408,1.0,9/23,25.92%,GGT7;XPNPEP1;GGT5;TRHDE;ENPEP;CHAC2;NPEPPS;TPP1;CTSH
prerank,cellular response to glucose stimulus (GO:0071333),0.30906133849320866,0.9637553774466733,0.5024077046548957,0.9598663745579896,1.0,4/30,4.50%,ADCY8;PTPRN;TRA2B;SOX4
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3370889102286303,-0.9635908947862525,0.49742268041237114,0.7606661362129571,1.0,6/15,24.09%,ZDHHC3;DRD2;CLN3;ADRA1A;NPAS4;NLGN2
prerank,melanosome localization (GO:0032400),-0.3091704406979001,-0.9634849599133025,0.493573264781491,0.7603383704836171,1.0,6/21,26.16%,MYO5A;BBS7;MLPH;SHROOM2;BLOC1S3;MREG
prerank,DNA recombination (GO:0006310),-0.26107642391715796,-0.9633916483097019,0.5167597765363129,0.7599820080904208,1.0,8/37,13.70%,RAD51B;RTEL1;IGHMBP2;RHNO1;RPA1;LIG4;RAD21;ENDOG
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.2618866311997087,-0.9633302994637267,0.4986449864498645,0.7595098332956561,1.0,8/40,10.78%,DAB2;GCNT2;SDCBP;SMAD3;GLIPR2;IL1B;NOTCH1;CTNNB1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.2630822453175473,-0.9633253048389081,0.5181818181818182,0.7589242752902022,1.0,8/40,10.18%,RPL5;FBXW7;TAF1;RPS7;GNA12;CCDC22;XPO1;RAD23B
prerank,regulation of JNK cascade (GO:0046328),-0.2124796585133129,-0.96301301790503,0.5629370629370629,0.7591497758649088,1.0,28/101,22.05%,FCGR2B;ITCH;SDCBP;PJA2;NOD2;RIPK1;IL1B;TAOK3;SH3RF1;MAP3K11;TNFRSF19;GADD45G;MAPK8IP3;SLAMF1;EGFR;AGER;PTK2B;TRAF1;HIPK2;RAP2A;MMP8;TRAF4;NCOR1;EPHB1;DUSP19;APP;SERPINF2;MECOM
prerank,peptidyl-tyrosine modification (GO:0018212),0.26710099638093615,0.9629517824134373,0.5387994143484627,0.9614089603330626,1.0,16/56,19.50%,ABI3;NTRK1;FLT4;EPHA1;ERBB4;BTK;PDGFB;TEK;EPHA4;EPHB2;TPST2;INSR;PTK2;FLT3;FES;PDGFRB
prerank,mitotic recombination (GO:0006312),0.36270463776247597,0.9625606265765365,0.496742671009772,0.9616485402073135,1.0,4/15,15.95%,SMC5;DMC1;RAD52;XRCC3
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3472603148032102,-0.9619273589373618,0.5085158150851582,0.761329300259947,1.0,4/15,6.30%,PRKCE;PPARG;PPARD;LDLRAP1
prerank,mitochondrial translation (GO:0032543),0.24389388296111628,0.9618433041995209,0.5230125523012552,0.9628332897636948,1.0,31/104,26.19%,MRPS6;GADD45GIP1;MRPL45;MRPL10;MRPL30;MRPL53;MRPL14;MRPS7;GFM2;MRPL34;MRPL42;MRPL18;MRPL23;MRPL41;OXA1L;PTCD3;HARS1;DAP3;MRPS5;MRPL58;MRPL19;MRPL15;MRPS10;FASTKD2;MRPS34;MRPS2;MRPL40;MRPL22;MRPL54;MRPS25;MRPS9
prerank,cellular response to heat (GO:0034605),-0.26995779818114407,-0.961260051115139,0.5082872928176796,0.7625214372586633,1.0,8/35,11.21%,VCP;RBBP7;PRKACA;IER5;THBS1;HSF1;FGF1;HIKESHI
prerank,regulation of actin filament bundle assembly (GO:0032231),0.31893384122060087,0.9612336750391963,0.5274193548387097,0.9636769870177453,1.0,10/26,22.22%,SHANK3;LIMK1;PRKN;ALMS1;ROCK1;SHANK1;ASAP3;CDC42;RDX;SLC9A1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.21593323441106113,-0.9610839295269636,0.5498154981549815,0.7623882891147501,1.0,26/110,17.33%,FNIP2;APOE;RAF1;VCP;CD36;GNL3L;BAX;SH3GLB1;MTLN;TFRC;SYK;HCK;HSF1;EP300;AJUBA;ATF7IP;RACK1;RALB;FBLIM1;RB1;CDT1;ICE1;TNF;BCL2L11;NOP53;GSN
prerank,response to glucose (GO:0009749),0.27980098691988714,0.9607600252583083,0.5212765957446809,0.9641441554522348,1.0,9/46,15.26%,SELENOS;ADCY8;TRA2B;SOX4;TCF7L2;UNC13B;EIF2B3;KHK;EIF2B1
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.18989909927968174,-0.9605827711763165,0.6,0.7630457601830388,1.0,78/291,22.76%,PID1;STAP1;PXN;CD274;AXL;ABL2;VCP;BRINP1;CDC73;TLR2;HMGB2;GIT1;P2RX4;RRAGC;LAMTOR5;AHR;ESR1;NFKB1;ADAM9;CAPN2;TAF1;CD14;LCOR;PF4;NOD2;ERCC6L2;TNIP3;LYN;IL1B;CPEB4;RET;SNW1;LPL;ZC3H12A;ADCY6;VIM;FOXO1;ACOD1;TNFRSF1B;RRAGA;KAT5;DAPK1;SHPK;NR1H3;INPP5K;FOS;TESC;LBP;EGFR;LILRB1;PTK2B;WNT5A;FAM210B;RAP1B;PDE2A;SESN2;RAP1A;TLR4;MAPK8;ADNP2;NRIP1;IGFBP5;PDGFRA;KCNQ1;MYD88;CASP1;WNT9A;CPEB3;AKAP9;CD68;P2RY2;LAMTOR4;FZD4;LARS1;NR1H4;TICAM2;NDUFA13;INSIG1
prerank,regulation of intracellular pH (GO:0051453),-0.2720833736273102,-0.9601216594355029,0.5494505494505495,0.7636368237372062,1.0,17/34,27.12%,TMEM165;TM9SF4;SLC9A9;SLC9A2;SLC4A9;LRRK2;CHP1;CLN3;GPR89B;GPR89A;SLC9A6;SLC26A6;CA2;SLC26A3;SLC9A3;SLC4A1;SLC4A5
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4113822791331322,0.9598421736260064,0.5290215588723052,0.9658820355285836,1.0,2/10,8.34%,EMC6;EMC2
prerank,intracellular protein transport (GO:0006886),0.2165474451637452,0.959749627901292,0.5814506539833532,0.9651942697529287,1.0,71/304,20.51%,CTTN;TSC2;LTBP2;FUT10;STRADB;RAB6B;GGA3;RAB1B;SCFD2;SGSM2;RAB43;GIPC1;SGSM3;ARL5A;HERC2;NAPB;FAM53C;TMED2;STX16;ARL4C;SEC31A;ARL4A;NXT2;MYO6;PRICKLE1;HEATR3;RAB24;ARFRP1;FAM53B;TGFB1;MYO1C;CAMSAP3;NUP88;EHD1;ARL4D;STX3;RAB38;RAB5A;PDCD6;TBC1D16;RAB28;SNX15;TBC1D8;PKD1;IFT27;TMED5;IPO5;STXBP2;SNX6;HAP1;OXA1L;RASSF9;TBC1D25;NUP133;XPO6;TMED3;SRPRA;CACNG3;VPS33B;STX17;PREB;BCS1L;SYNRG;STRADA;AP4E1;ERP29;IPO8;TMED7;SNF8;RANBP3L;GABARAP
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.30317305625090785,-0.9594879883636818,0.4896907216494845,0.7647505631480983,1.0,9/23,28.18%,PLBD1;PLA2G4E;PLAAT3;LPCAT4;PLA2G4F;PLA2G2D;MBOAT1;ABHD4;PLA2G12A
prerank,regulation of epithelial cell migration (GO:0010632),-0.2511347417433998,-0.959387184547851,0.5,0.7643956713973077,1.0,11/51,13.40%,SASH1;PRKCE;PTPN23;MCC;CORO1C;GLIPR2;HIF1A;RHOJ;CEACAM1;EMP2;PTN
prerank,response to metal ion (GO:0010038),0.26412985130839145,0.9593186212696108,0.5292439372325249,0.9655479247976944,1.0,18/67,18.75%,KCNMA1;TRPC3;CAPN3;SEC31A;NEDD4;PDCD6;ITPR3;SLC30A3;PPP5C;KHK;NDRG1;NEDD4L;MT2A;IL1A;MT1X;MT1A;SNCB;TRPV6
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.348180979917283,0.959184611112284,0.5231560891938251,0.9649994409401512,1.0,5/18,14.18%,TMEM14A;ZNF205;BAK1;SLC25A5;CHCHD10
prerank,cAMP-mediated signaling (GO:0019933),-0.2958126171222879,-0.9591657285477521,0.5401662049861495,0.764337476124818,1.0,7/24,16.08%,ADGRG6;PDE7B;AHR;ADCY1;RIMS2;PDE2A;MAPK7
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.31512257266335053,0.959067267899195,0.5271565495207667,0.9644358067193224,1.0,14/29,32.76%,LDLRAD4;DAB2IP;EFNA1;SFRP1;SDHAF2;HPN;ZNF750;IL17RD;SFRP2;FUZ;PTEN;NKX2-1;USF3;ADIPOR1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.37803936343079103,-0.9589725901634585,0.5179856115107914,0.7642515981181603,1.0,4/10,16.06%,MECP2;PCGF3;IGF2;PCGF5
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3949996244306462,0.9589033840785977,0.508833922261484,0.9639805234540877,1.0,3/11,11.95%,IP6K1;FGF2;IPMK
prerank,regulation of telomere capping (GO:1904353),-0.30624376591890534,-0.9583114047983525,0.5269121813031161,0.7652983718646443,1.0,8/23,19.46%,RTEL1;PKIB;NBN;PRKCQ;TERF2;MAP2K7;HNRNPD;SMG6
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4010856712025091,0.9576719100831655,0.49070631970260226,0.9666920317586999,1.0,3/10,18.27%,DROSHA;TSN;TSNAX
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.38610010500249037,0.9572563044746203,0.473967684021544,0.9669816743652649,1.0,3/12,14.40%,CRMP1;ALDH6A1;DPYSL2
prerank,isotype switching (GO:0045190),0.40043438659149155,0.9570302758601872,0.5053003533568905,0.9667260482142982,1.0,4/10,15.43%,RNF168;RNF8;CCR6;BATF
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.20882699374592298,-0.9570025528887216,0.5570175438596491,0.7680990669875897,1.0,35/128,21.18%,NRROS;PXN;GCNT2;SMURF2;ARHGEF18;ADAM9;ZFYVE16;SMAD9;SMAD3;ZMIZ1;UBC;UBA52;BMP5;USP9X;ID1;CBL;SMAD6;NLK;SCX;BMP2;FOS;PARD6A;SMAD4;HIVEP1;COL3A1;APPL2;ACVR2A;GDF3;USP15;BMP7;BAMBI;CGN;ACVR1;USP9Y;ZMIZ2
prerank,regulation of developmental growth (GO:0048638),-0.28342497773458686,-0.956963995104964,0.4986301369863014,0.7675916053863693,1.0,5/29,10.51%,APOE;IGF1;STAT5B;DNM2;GHR
prerank,regulation of steroid metabolic process (GO:0019218),0.32691455686930204,0.9566343886416173,0.514820592823713,0.966955912757522,1.0,10/23,26.11%,STAR;GNB3;DGKQ;ABCA2;TTC39B;RORA;FMO5;NR5A1;STUB1;PANK2
prerank,fatty acid metabolic process (GO:0006631),0.24262332198574893,0.954759228842686,0.5387700534759359,0.9715998063250451,1.0,35/115,23.88%,ACSF2;ALOX12;CPT1B;PPARGC1A;MECR;PPARA;ACADSB;GGT5;PNPLA3;CBR4;ACSL6;OXSM;ACOT4;ACOX1;ELOVL4;ACSBG1;ACOT11;NDUFAB1;ACSF3;ACLY;PEX2;ANGPTL3;ACADM;ABCD2;LIPC;XBP1;HPGD;PLA2G15;ALOX5AP;FA2H;ACAD9;PNPLA8;ACSL3;GPAT2;HACL1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.3295696304307443,-0.9547031464623449,0.4975609756097561,0.7728651709809783,1.0,2/16,3.16%,APOE;CD36
prerank,membrane lipid catabolic process (GO:0046466),-0.3794314037597521,-0.9545064797968611,0.5057736720554272,0.7727654929693138,1.0,2/10,1.58%,SGPL1;FUCA1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3496606765047836,0.9544885579850821,0.5262321144674086,0.9714716303097287,1.0,7/17,17.54%,FIS1;CLU;BAK1;GGCT;DNM1L;BBC3;MFF
prerank,histone H3-K4 trimethylation (GO:0080182),-0.37537304190629855,-0.9542418439716046,0.4874715261958998,0.772856287984013,1.0,7/11,23.43%,TET2;PRDM9;WDR82;TET3;KMT2D;SETD1A;KMT2A
prerank,regulation of metal ion transport (GO:0010959),-0.33301710259913986,-0.9536670401386372,0.4879807692307692,0.7737012374877711,1.0,2/16,3.69%,BCL2;IL16
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.25944213544714523,0.9536458332620411,0.5449358059914408,0.9730649984334424,1.0,19/67,21.48%,IFT20;FSCN1;SGSM3;MAPK15;TRPM2;TWF2;CDKL5;RAB5A;TBC1D16;RABEP2;TBC1D8;IFT88;TWF1;ATP8B1;CYLD;CDC42;CDKL1;RDX;PPP1R16B
prerank,regulation of heart contraction (GO:0008016),0.24842398014605854,0.9535631271590476,0.5473537604456824,0.9723905169734811,1.0,20/90,20.12%,ATP2A3;ATP2A2;ITPR2;ATP1B1;ASPH;ATP1B3;TBX2;SLC8A1;GJA5;ITPR3;ATP2B3;SLC8A3;ADORA3;DMPK;AGT;ANK2;TMEM65;ATP1A4;ATP1A3;ATP1A1
prerank,aerobic electron transport chain (GO:0019646),0.261383951020188,0.953337045204434,0.5466472303206997,0.9721403292342449,1.0,21/68,24.16%,NDUFA6;UQCRC1;NDUFA4;CYC1;SDHC;COX7B;UQCC3;COX6C;NDUFS1;UQCR11;NDUFA8;NDUFS6;SDHAF2;COX7C;NDUFAB1;NDUFS2;NDUFB6;COX4I1;COX6B1;UQCR10;COX10
prerank,adipose tissue development (GO:0060612),0.3826565487820109,0.9532068424598091,0.5333333333333333,0.9716048259767163,1.0,3/11,6.75%,DGAT2;PGRMC2;DYRK1B
prerank,regulation of phospholipase C activity (GO:1900274),0.36077891183955535,0.9529111625380865,0.5175600739371534,0.9715719278256194,1.0,6/15,19.50%,NTRK3;PLCG1;FGF2;HRAS;BICD1;PDGFRB
prerank,regulation of store-operated calcium entry (GO:2001256),0.40586415578736657,0.9528761562999293,0.5051369863013698,0.970740551420484,1.0,2/10,10.49%,EFHB;HOMER2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.37939696628396247,0.9526359758919359,0.5473321858864028,0.9704715775234735,1.0,4/13,12.59%,FSTL1;DAND5;FBN2;GREM2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.3164918780499162,-0.9522658382606665,0.5190839694656488,0.7767263672300291,1.0,5/19,18.47%,IGF1;IL1B;TNFRSF1B;TNF;MMP8
prerank,fatty acid oxidation (GO:0019395),0.2672691466391206,0.952144957376054,0.54,0.9710252483630081,1.0,12/57,19.20%,ECHDC1;ALOX12;PPARGC1A;MECR;ACAT2;ACADS;ACOX1;PEX2;ACADM;ABCD2;HSD17B10;ECHS1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.23539051311456854,-0.9521029655795693,0.5342019543973942,0.7765667027028191,1.0,14/61,11.47%,MECP2;PCNA;SMCHD1;RTEL1;ZCWPW1;CEBPG;TOX;NBN;EYA1;ABRAXAS1;BRCA1;EYA3;USP9X;EYA2
prerank,endoderm development (GO:0007492),-0.35449245296114673,-0.9518059057389519,0.49877750611246946,0.7767411560656667,1.0,3/13,14.77%,KIF16B;DUSP1;LHX1
prerank,negative regulation of cell activation (GO:0050866),-0.33913911263097213,-0.951784834732732,0.5454545454545454,0.7761813999349874,1.0,2/14,6.61%,APOE;LDLR
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3790021288888282,0.9516136258346461,0.5174129353233831,0.9716174024457539,1.0,6/13,23.38%,ASPH;LGMN;BAK1;CASP8;CIDEB;RIPK2
prerank,GPI anchor biosynthetic process (GO:0006506),0.30603434850844663,0.951174264989736,0.5398373983739837,0.9719759314521161,1.0,12/30,28.18%,PIGQ;PIGB;PIGP;MPPE1;PIGS;DPM3;PGAP2;PGAP3;PIGX;DPM1;DPM2;PIGZ
prerank,Rap protein signal transduction (GO:0032486),0.4011240334681556,0.9508758818390619,0.5208333333333334,0.9719011195867113,1.0,5/10,24.98%,SGSM3;RAPGEF3;PLK2;RAP2C;RAPGEF2
prerank,regulation of chromatin organization (GO:1902275),-0.3381757464426458,-0.9507706415327137,0.5358024691358024,0.7782141620467097,1.0,7/14,22.23%,MKI67;MLLT3;IGF2;HPF1;HNRNPU;CDK9;SETD1A
prerank,regulation of feeding behavior (GO:0060259),0.3849714410699995,0.9507458765419927,0.5347593582887701,0.9713623616263075,1.0,2/11,15.58%,GNB3;EIF2AK4
prerank,cell cycle G1/S phase transition (GO:0044843),-0.23753329851304683,-0.9506101297301995,0.5701492537313433,0.7780051942983958,1.0,16/61,15.35%,CDK6;CUL3;CUL4A;GPR132;CDC34;CCND1;CDKN2C;HINFP;MAP3K11;CCNH;CDKN3;CCNA2;RB1;TRIM71;MNAT1;CDC25A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.2898040308955701,0.9505321325384783,0.5179968701095462,0.971064790092918,1.0,9/35,18.96%,MKLN1;C3;CLU;SNAP91;BMP2K;AAK1;VTN;BICD1;RSPO1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3163851437736399,-0.9503918316717138,0.4948186528497409,0.777946588941054,1.0,4/18,8.09%,MSRA;MTHFR;GOT1;MTHFD1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.3538799403826122,-0.9503722487435204,0.5390070921985816,0.7774013622447067,1.0,4/13,16.95%,ITGA4;SP1;IGF2;ADAM17
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.25123555184343915,-0.9502463370735018,0.5337620578778135,0.7771154473741819,1.0,6/49,7.08%,IL15;IGF1;PARP14;PIBF1;IL6ST;LYN
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.25338307173833147,0.949869440700801,0.5491329479768786,0.9721074420367762,1.0,20/72,19.74%,NTRK1;NTRK3;PIK3CG;MAZ;NEDD4;FGF2;BECN1;PDGFB;TEK;INSR;NTRK2;AGT;PTK2;FLT3;IL18;PLXNB1;DCN;CCL5;PDGFRB;ROR1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.33898392114392584,-0.9494803227849156,0.5099009900990099,0.7784607235484083,1.0,11/16,34.66%,PROX1;NOTCH1;BMP2;HEY2;NOTCH2;BMPR2;DLL4;ISL1;SHOX2;TGFB2;MYH6
prerank,regulation of endopeptidase activity (GO:0052548),0.2638172969347544,0.9493941307558336,0.5457184325108854,0.9725681409270217,1.0,17/59,26.37%,GAPDH;SPOCK3;VSIR;SPOCK2;SERPINH1;PSME3;PSENEN;VTN;SERPINE2;AGT;PRELID1;PSME1;TIMP2;SERPINI1;SERPINF1;SERPINB8;PSMB8
prerank,positive regulation of biomineral tissue development (GO:0070169),0.28774507162047935,0.9487189242514587,0.5226209048361935,0.9736224803310354,1.0,6/40,9.62%,WNT4;MEF2C;FBN2;BMP4;TGFB1;SLC8A1
prerank,sensory perception of smell (GO:0007608),-0.3676401771279461,-0.948603048709463,0.4908256880733945,0.7800925195053678,1.0,2/11,13.83%,DRD2;ADCY3
prerank,protein-containing complex assembly (GO:0065003),0.2182837923703943,0.9485857716743192,0.5995260663507109,0.9730582338261689,1.0,53/259,18.38%,BCL9L;TLE3;ADCY8;WDR19;PLEKHA7;TLE2;CAPN3;RAB1B;ADD2;NIFK;CNIH2;PARD6B;SEC16B;PPARGC1A;NCKAP1L;DMD;PDE4DIP;IL1RAP;MAGI1;AREG;TMED2;SEC31A;CDC123;GRIA1;TRAPPC3;TCF7L2;TSPAN4;SH3BGR;BIN2;ZW10;ITGB1BP1;PEX14;PDCD6;CNIH1;RIMS1;FARP2;DNM1L;SEC24D;WASF3;SEC24B;VAMP3;TRAPPC9;CHCHD10;TUBGCP2;TCF7L1;SEC24C;EPRS1;GEMIN5;PYGO2;PPP2R1A;SHANK1;PREB;FBXL7
prerank,regulation of immune effector process (GO:0002697),-0.25253211574003154,-0.9485782592494146,0.5324324324324324,0.7795631074335304,1.0,12/41,20.53%,FCGR2B;C3AR1;IRF4;C5AR1;C4B;SERPING1;CD55;CFHR2;C1QC;CFP;C2;C1QB
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.30315807654786564,0.9484389652203048,0.5163934426229508,0.9725689517505048,1.0,7/30,13.92%,GGA3;RAB26;SYS1;ARFRP1;RAB34;SPTBN1;BLZF1
prerank,negative regulation of nuclear division (GO:0051784),0.38430380956583854,0.9483470372269337,0.5355285961871751,0.9719156337428048,1.0,3/11,20.05%,BMP4;TOM1L1;FBXO5
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3234285720155046,0.9481846727925461,0.5447284345047924,0.9714404069421404,1.0,7/25,18.74%,ABI3;ARHGAP44;LIMK2;RAP1GAP;EVL;CDK10;TCHP
prerank,regulation of neuron death (GO:1901214),0.25459956127549155,0.9480929111612132,0.566145092460882,0.9707758662213865,1.0,25/82,22.13%,DCC;FAIM2;CD34;PPARGC1A;PM20D1;PRNP;CLU;MEF2C;GRID2;SIGMAR1;GRIN2B;PRKN;DDIT4;SARM1;REST;KIF14;RRAS2;INPP5A;SNCB;CHRNA7;NSMF;CCL5;ITGAM;BTBD10;LANCL1
prerank,anion transport (GO:0006820),0.3009826720010633,0.9479921578222604,0.5434439178515008,0.9701486394366147,1.0,9/33,22.04%,SLCO2B1;VDAC1;SLC26A4;SLC26A7;TSPO;SLC19A1;SLC13A3;ABCG2;LRRC8B
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3183577769816383,-0.9473274432463948,0.4937655860349127,0.7821453958029716,1.0,4/19,6.58%,GAS6;AXL;SYK;ZMIZ1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2883672376367904,0.9473062435884317,0.5407066052227343,0.9713228502129673,1.0,11/41,18.75%,ITPR2;TRPM2;PKD2;GRIN1;SLC8A1;GRIN2B;FGF2;ITPR3;SLC8A3;CACNA2D1;TRPV6
prerank,snRNA transcription (GO:0009301),0.2583368877633792,0.9472881413390678,0.5703592814371258,0.9704631339513453,1.0,20/70,23.78%,POLR2L;CDK7;POU2F2;POLR2F;GTF2F1;GTF2E2;TAF9;ZC3H8;INTS10;POLR2G;CCNK;INTS8;SNAPC3;INTS5;INTS9;INTS11;NABP1;POLR2C;GTF2B;POLR2D
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3936830093344154,0.9469220049614206,0.5418803418803418,0.9688057714127667,1.0,7/11,28.10%,PPCDC;COASY;DCAKD;PPCS;PANK2;SLC25A16;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),0.3936830093344154,0.9469220049614206,0.5418803418803418,0.9688057714127667,1.0,7/11,28.10%,PPCDC;COASY;DCAKD;PPCS;PANK2;SLC25A16;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3936830093344154,0.9469220049614206,0.5418803418803418,0.9688057714127667,1.0,7/11,28.10%,PPCDC;COASY;DCAKD;PPCS;PANK2;SLC25A16;ACOT7
prerank,fibrinolysis (GO:0042730),-0.3508479751824446,-0.9462871960569651,0.518957345971564,0.7841730284620184,1.0,2/13,6.57%,PLAU;PLAUR
prerank,cellular glucose homeostasis (GO:0001678),0.2838239084318627,0.9462239287434998,0.5503759398496241,0.9698509853282271,1.0,5/41,4.50%,NUCKS1;ADCY8;TRA2B;PPARGC1A;SOX4
prerank,skeletal system morphogenesis (GO:0048705),0.28336133649633666,0.9458600177293421,0.5415384615384615,0.9699525554257517,1.0,7/42,15.29%,HOXD4;MEGF8;HOXB9;TGFBR1;FBN2;SPEF2;DSCAML1
prerank,inhibitory synapse assembly (GO:1904862),0.3867020016871083,0.9453421142746286,0.5391304347826087,0.9704982375763991,1.0,4/11,19.11%,GABRG2;GABRA2;FGF13;PLXNB1
prerank,base-excision repair (GO:0006284),0.275920476964947,0.9452464655600977,0.5591397849462365,0.9698676399170532,1.0,14/48,23.10%,POLG;POLD3;OGG1;XRCC1;LIG3;ADPRS;PARP1;APEX1;FEN1;ERCC6;WRN;UNG;MPG;RFC4
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2582325996850767,-0.9451482788314209,0.5537190082644629,0.7864862876217165,1.0,13/41,23.57%,PTPN22;GAS6;IGF1;RARA;ZC3H12A;SLAMF1;LBP;LILRB1;TLR4;CD33;NLRC3;NR1H4;GSTP1
prerank,inner mitochondrial membrane organization (GO:0007007),0.2767544416019163,0.944919279774471,0.5608695652173913,0.9699413774834345,1.0,21/47,30.76%,TIMM29;ATP5F1C;UQCC3;HSPA9;MICOS13;APOO;TIMM13;TIMM22;TOMM70;MTX2;ATP5MC3;ATP5ME;ATP5MF;TIMM10;DNAJC11;TIMM10B;ATP5F1A;APOOL;MICOS10;SPG7;TMEM11
prerank,cellular response to retinoic acid (GO:0071300),-0.25326735082924606,-0.9448828760012786,0.5685714285714286,0.78657681896918,1.0,23/42,35.94%,ABL2;BRINP1;LYN;RET;SNW1;TESC;PTK2B;WNT5A;ADNP2;WNT9A;FZD4;NDUFA13;WNT6;FZD10;LTK;AQP1;CREB1;FZD7;ATM;TBX1;WNT10B;WNT11;WNT2
prerank,protein localization to vacuole (GO:0072665),-0.34480224326605907,-0.9446345450930766,0.530562347188264,0.7865780936295709,1.0,6/13,25.72%,LAMTOR5;SH3GLB1;SZT2;LAMTOR4;ATP13A2;LMBRD1
prerank,regulation of glycolytic process (GO:0006110),-0.23043214060962772,-0.9443995750526379,0.559322033898305,0.786553175748952,1.0,16/68,15.60%,IGF1;GIT1;CBFA2T3;RANBP2;PRKAG2;HIF1A;NUP153;PSEN1;NDC1;NUP43;NUP210;EP300;PGAM1;ENTPD5;ZBTB20;NUP62
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2786759462576683,0.9430248635170506,0.5621212121212121,0.9744663189636144,1.0,11/44,20.23%,NANOS1;GTPBP1;ZFP36L2;METTL16;BTG2;POLR2G;CNOT8;UPF1;ROCK1;TOB1;DHX36
prerank,purine nucleotide metabolic process (GO:0006163),0.3189589472203424,0.9429817360817525,0.5409309791332263,0.9736651869338532,1.0,7/24,13.93%,FHIT;PNP;GART;PRPSAP2;HPRT1;PRPSAP1;ADSL
prerank,eye development (GO:0001654),0.26918537946924215,0.9429219671105514,0.5428571428571428,0.9729219460142745,1.0,8/54,11.72%,COL5A1;PRSS56;MAB21L2;PBX2;FBN2;CRYBA4;FOXC1;PBX3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.28225629221065274,0.9428108125155374,0.5317829457364341,0.9723239060731441,1.0,9/43,12.26%,DDX5;RELA;FOSL1;NFIB;PPARA;BMP4;TGFB1;FGF2;PDGFB
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.24927539854914413,0.9427320668980772,0.5744089012517385,0.971629965605938,1.0,21/87,17.50%,SH3BP1;ABI3;FSCN1;ARHGAP44;F11R;PAK1;CORO2B;RHOBTB1;TRPM2;TWF2;ARHGDIA;RAPGEF3;GRHL3;ARHGAP35;CORO1A;TWF1;TAOK1;RHOQ;ROCK1;CDK10;RHOBTB2
prerank,negative regulation of cell junction assembly (GO:1901889),-0.2900180617409123,-0.9419612522061743,0.5509138381201044,0.792211452491556,1.0,5/25,8.00%,TLR2;CORO1C;SLIT1;THBS1;IL1B
prerank,regulation of calcium ion transport (GO:0051924),-0.23987241425769448,-0.9419339284259536,0.5705521472392638,0.7916675939974956,1.0,17/54,20.82%,BCL2;LILRA5;P2RX4;IL16;HOMER3;CTNNB1;INPP5K;LILRB1;STIM2;CRACR2A;FFAR1;SLC8B1;CD33;MYLK;WFS1;GRIN3B;HOMER1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3415701711677057,-0.9419305320416674,0.5318181818181819,0.7910618614032033,1.0,8/14,25.17%,NRP1;GAB1;PIK3CA;KDR;NUS1;PIK3CD;VEGFB;PGF
prerank,myeloid dendritic cell activation (GO:0001773),-0.36103626842433306,-0.9418852349500603,0.5428571428571428,0.7905792558669655,1.0,3/12,14.41%,DOCK2;SLAMF1;BATF2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.32246209660294023,0.9416011775772115,0.5537459283387622,0.974047148659036,1.0,7/23,12.41%,TPTE;MTMR9;INPP5B;SACM1L;OCRL;INPP5F;MTMR1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2957423470398094,-0.9415435518570601,0.5380952380952381,0.7908279083054315,1.0,5/23,9.26%,VCP;OS9;TECPR2;SEC16A;TMED9
prerank,regulation of actin filament-based process (GO:0032970),0.25807250160856776,0.9414549336351216,0.5739130434782609,0.9735428739789656,1.0,19/70,20.68%,SH3BP1;FSCN1;ARHGAP44;F11R;PAK1;CORO2B;RHOBTB1;TWF2;GRHL3;ARHGAP35;CORO1A;TAOK1;RHOQ;ROCK1;CDK10;RHOBTB2;PDGFRB;EPHA5;IQGAP3
prerank,activation of protein kinase B activity (GO:0032148),-0.2817728698555181,-0.941054136773254,0.5681233933161953,0.791443241079368,1.0,5/29,8.74%,OSBPL8;GAS6;IGF1;TXN;FGF1
prerank,cell proliferation in forebrain (GO:0021846),-0.371469885191429,-0.9406881812732373,0.5247058823529411,0.7917689972688113,1.0,2/10,2.87%,PCM1;DOCK7
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.20960407036974352,-0.9401756689695837,0.6144578313253012,0.792447217140124,1.0,26/114,17.91%,PSMA6;TNFSF8;PSMB2;PSME2;LIMS1;BAG4;PSMD11;RIPK1;PSMC6;PSMA3;STAT1;LTB;BIRC2;TNFRSF1B;PSMD10;EDA;TNFRSF17;PTK2B;PSMB5;TNF;TRAF1;ADAM17;TNFRSF9;TNFRSF25;PSMD5;PYDC1
prerank,phospholipid catabolic process (GO:0009395),-0.2920851734298986,-0.9398409150481692,0.5397260273972603,0.7926895127859266,1.0,6/24,12.09%,PLBD1;PLA2G4E;PNPLA6;GDPD3;SMPDL3A;GDE1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.28872576252845844,-0.9397932912260143,0.5831062670299727,0.7922213936200367,1.0,11/25,26.18%,SDCBP;MTMR2;ANKRD13A;PICALM;PSEN1;APOC1;ITGB3;APP;WDR54;RAC1;ANKRD13B
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.33931270886519943,-0.9396850297238555,0.5484633569739953,0.7918828024197797,1.0,5/14,23.77%,CCR2;PTK2B;WNT5A;ADAM17;CCL7
prerank,regulation of DNA recombination (GO:0000018),-0.270981647038242,-0.9396095283968448,0.5483870967741935,0.7915052851748736,1.0,6/32,10.19%,KPNA2;RTEL1;ZCWPW1;ZRANB3;H1-0;PPP4R2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2866579112207433,-0.9391992697605978,0.5443037974683544,0.7919166253379354,1.0,5/24,9.36%,ITCH;NOD2;UBC;TAB1;UBA52
prerank,"DNA-templated transcription, termination (GO:0006353)",0.25293417218258896,0.9388044547546104,0.597953216374269,0.980320681981895,1.0,24/68,27.27%,POLR2L;CDK7;POLR2F;GTF2H2;GTF2H4;MAZ;CPSF3;POLR1E;CSTF1;NUDT21;SETX;POLR1F;SNRPD3;SSU72;PRMT5;SCAF8;GTF2H3;POLR1G;POLR3K;ERCC2;POLR1A;TAF1A;PAPOLA;GTF2H1
prerank,import into cell (GO:0098657),0.2853342996297036,0.9387140321332023,0.5496987951807228,0.9796528695098959,1.0,7/41,14.93%,SNAP25;SLC29A2;LRP2;SLC12A6;SLC1A3;SLC19A1;SLC22A4
prerank,nucleus organization (GO:0006997),-0.2487517523314407,-0.9385238004161529,0.55,0.7930466113725076,1.0,9/47,14.11%,CHMP4A;CHMP4B;ATXN7;CTDNEP1;LEMD3;NDC1;CHMP1B;PDCD6IP;NUMA1
prerank,smooth muscle cell differentiation (GO:0051145),0.3831664923579454,0.9384655389002664,0.5437062937062938,0.979452180496849,1.0,3/12,9.10%,MEF2C;BMP4;HEY1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.34836490128120146,-0.9383729049626146,0.5012531328320802,0.7928606613018823,1.0,7/13,24.82%,TLR2;NAMPT;NOD2;KDR;TLR4;GSTP1;TLR9
prerank,toxin transport (GO:1901998),-0.37955846664739856,-0.9376107456743538,0.5141509433962265,0.7942075888941073,1.0,1/10,0.75%,ANTXR2
prerank,nuclear body organization (GO:0030575),0.3839036894486141,0.9375158982879724,0.5180102915951973,0.9812992467227426,1.0,2/12,7.13%,WRAP53;USP50
prerank,nucleic acid metabolic process (GO:0090304),0.25330962917513555,0.9374206717256592,0.5641399416909622,0.9806596098806981,1.0,17/69,18.98%,POLR2L;POLR2F;HNRNPH1;POLG;DNASE1L2;LSM1;PTBP1;DDX1;GTF2F1;POLR2G;LSM8;RBFOX2;FEN1;HNRNPA1;WRN;ATXN2;DXO
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.2257143500902657,0.9372115724513459,0.6198453608247423,0.9803534258802948,1.0,22/166,9.44%,POLR2L;CDK7;WWTR1;POLR2F;ESRRG;NR1I2;NR1I3;TFAM;PPARGC1A;GTF2H2;PPARA;AR;NR2F6;GTF2H4;RXRG;GTF2F1;MAZ;NCOR2;GTF2E2;HDAC5;MAML3;TAF9
prerank,central nervous system neuron differentiation (GO:0021953),0.28991639822651905,0.9371701238952378,0.5524590163934426,0.979553544228084,1.0,5/33,7.89%,MDGA2;FAIM2;SOX4;RYK;GRID2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.2638247190979943,-0.9369974201140844,0.546916890080429,0.7951522864678028,1.0,4/35,1.17%,IQGAP2;NRP1;STAP1;ABL2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3285742183800501,-0.9367386215020624,0.5307125307125307,0.7951563108302635,1.0,3/17,7.93%,NRP1;STAP1;HCK
prerank,secretion (GO:0046903),0.36054573100113996,0.9366170491554682,0.5534804753820034,0.9802974669165871,1.0,5/14,22.81%,PRKCI;RIMS1;SLC22A4;GUCA1B;NPR1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.37748248538439944,0.9366157354628661,0.5360824742268041,0.9793935559944487,1.0,2/12,10.57%,SNAP25;STX3
prerank,regulation of cardiac muscle contraction (GO:0055117),0.29018102473491025,0.9364365317327893,0.5515625,0.9789673658076676,1.0,6/34,9.96%,ATP2A2;ATP1B1;TNNI3;PIK3CG;SLC8A1;GJA5
prerank,calcium ion import into cytosol (GO:1902656),0.35680488942133437,0.93640383347499,0.5574912891986062,0.9781651329333795,1.0,5/15,18.75%,TRPM2;SLC8A1;SLC8A3;CACNA2D1;TRPV6
prerank,"transcription, DNA-templated (GO:0006351)",0.21954887819004,0.9360650442015207,0.6245353159851301,0.9781962960092118,1.0,22/207,7.01%,POLR2L;RNPS1;CDK7;CTR9;IVNS1ABP;DRAP1;RTF1;POLR2F;NELFB;DDX5;TFAM;XAB2;GTF2H2;MED4;NELFCD;ELOC;E2F1;SSRP1;ARRB2;GTF2H4;GTF2F1;FUBP3
prerank,protein processing (GO:0016485),0.23877246949433625,0.935956842478538,0.6061884669479606,0.9775956407029864,1.0,26/102,21.82%,F3;MMP16;SPCS2;MYRFL;ASPRV1;VSIR;BACE1;XPNPEP3;LGMN;OGT;PHEX;AEBP1;CASP4;PSENEN;PITRM1;MYRF;KLK2;HM13;SEC11C;TYSND1;PCSK2;ADAMTS3;OMA1;METAP2;CASP2;CTSS
prerank,regulation of mitotic spindle organization (GO:0060236),-0.26306372301416364,-0.9355916486594966,0.582010582010582,0.7974875268622311,1.0,12/35,19.79%,CHMP4B;TACC3;BORA;CHMP1B;CCSAP;PDCD6IP;NUMA1;NUP62;TPX2;PLK1;HNRNPU;HSPA1B
prerank,lymphocyte migration (GO:0072676),-0.2696711626442711,-0.9354371919219235,0.519280205655527,0.7973081919092686,1.0,9/32,27.27%,CCL25;MSN;RET;ADAM8;ZAP70;GATA3;CCL7;TBX21;CCL24
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.22990220258818167,0.9353691490146102,0.600263852242744,0.9783861452043974,1.0,27/140,16.45%,ACKR4;ADCY8;TRPC3;ACKR3;FIS1;GNA15;CCR1;GPR17;ADCYAP1;GRIN1;CXCR6;CX3CR1;SLC8A1;CXCR4;LPAR4;ITPR3;P2RY1;JPH1;TAC1;CCR6;HMGB1;P2RY10;CACNA2D1;CCR9;ACKR2;PTGER1;CACNA1A
prerank,neuron cell-cell adhesion (GO:0007158),-0.3423698435005824,-0.9351750988284683,0.5503685503685504,0.7973229397377543,1.0,3/14,9.22%,NINJ2;RET;NRXN2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.3461908261966504,-0.9351199740416906,0.5331695331695332,0.7968442363766272,1.0,3/14,13.77%,FTSJ3;RPF2;ZNHIT3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.24905696130765592,0.9350145038527574,0.5805515239477503,0.9784891915006575,1.0,13/78,14.40%,HHEX;CDK7;PSRC1;CCNI;SERTAD1;CCND3;PKD2;HEXIM2;PDGFB;PKD1;GADD45A;IPO5;CCNK
prerank,manganese ion transport (GO:0006828),0.3588647287276939,0.9349302317945329,0.5428082191780822,0.9778316555590714,1.0,4/14,11.57%,TRPC3;SLC39A8;ATP2C1;TRPC6
prerank,regulation of immunoglobulin production (GO:0002637),0.31411532476448634,0.9341442858390833,0.5812101910828026,0.9790978492850924,1.0,9/23,20.24%,CD86;IL6;IL2;CLCF1;VAMP3;EPHB2;CD22;XBP1;TNFRSF4
prerank,ureteric bud development (GO:0001657),0.33875958265801753,0.9341439173864704,0.5751211631663974,0.9782010483958792,1.0,4/17,11.16%,BMP4;PKD2;FOXC1;NPNT
prerank,RNA metabolic process (GO:0016070),0.2339776819889419,0.9341393322444161,0.6094364351245085,0.9773196920182899,1.0,44/127,28.03%,POLR2L;ADARB2;POLR2F;RNASE1;HNRNPH1;LSM1;PTBP1;ADAR;RBM5;GTF2F1;RNASEL;MPHOSPH10;DROSHA;POLR2G;LSM8;SND1;TBRG4;RBFOX2;AGO4;NOVA1;RBM3;DDX39B;SETX;HNRNPA1;BICD1;ATXN2;DHX36;POLR2C;FASTKD2;RBM39;POLR2D;FTO;LAGE3;HNRNPH3;DDX3X;METTL14;RNASEH2C;PAPOLA;ELAVL4;METTL3;PPP1R8;PCBP2;DDX24;PABPC4
prerank,homeostasis of number of cells (GO:0048872),0.3744062320331873,0.9340484656762955,0.5425170068027211,0.9767011938095701,1.0,3/12,15.56%,OCIAD2;CX3CR1;NAPEPLD
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.2608566279865927,-0.9338743699497225,0.5681159420289855,0.7992916470065886,1.0,13/35,23.66%,PTPRC;DOT1L;BCL3;VHL;CAV1;GHR;NOTCH1;NLK;TNF;HES1;SOCS1;CYP1B1;EGF
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.3477424528151434,-0.9337569978468753,0.5677570093457944,0.7989983464266389,1.0,6/13,21.10%,GNPDA1;UAP1L1;SLC35A3;GNPNAT1;NAGK;RENBP
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.20631495141840572,-0.9335605475811953,0.6460905349794238,0.7988976853921347,1.0,30/138,16.59%,NEDD9;MTSS1;STAP1;AXL;CASS4;LIFR;FRS2;MET;IL6ST;LMTK2;RASGRP4;FLT1;SYK;LYN;FYN;BLNK;HCK;RET;LCP2;LCK;FRK;KDR;PTN;EGFR;SHC1;PTK2B;EPHA2;GFRA2;BCAR1;EPHB4
prerank,ganglioside biosynthetic process (GO:0001574),-0.33268594528288475,-0.9334021698835467,0.5406032482598608,0.7986800983574788,1.0,6/15,22.14%,B4GALT5;ST8SIA6;ST8SIA4;ST8SIA2;ST6GALNAC5;B4GALNT1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.297816496281007,-0.9331896828025591,0.5470297029702971,0.7986044597812,1.0,7/20,26.80%,ITGA4;THBS1;ECSCR;GSN;RGCC;PIAS4;PLA2R1
prerank,phagolysosome assembly (GO:0001845),-0.35944088945149144,-0.9331248842450496,0.5377358490566038,0.7981679768026749,1.0,2/12,3.64%,RAB7B;RAB7A
prerank,positive regulation of filopodium assembly (GO:0051491),0.3104184380635852,0.9330523959671023,0.5400313971742543,0.9786612512019107,1.0,9/24,24.06%,AGRN;FSCN1;TENM1;RHOQ;PALM;CDC42;GPM6A;WASL;FNBP1L
prerank,ganglioside metabolic process (GO:0001573),0.3299699515039468,0.9327383554476157,0.5592417061611374,0.9786909515820867,1.0,3/20,8.02%,ST3GAL5;HEXB;NEU1
prerank,hexose metabolic process (GO:0019318),0.2814790644136885,0.9326780943106477,0.5587301587301587,0.9779520394478084,1.0,12/39,20.50%,SLC37A4;GALT;ALDOC;CHST1;FPGT;KHK;APOD;GALK1;GHRL;ALDOA;PGM1;OMA1
prerank,cellular response to organic cyclic compound (GO:0071407),-0.2025899001587445,-0.9325500165456049,0.6394849785407726,0.799046813080055,1.0,38/141,18.79%,ARL6IP5;NR3C1;HRH1;P2RX4;AHR;ESR1;CTNNA1;TAF1;MSN;LCOR;GABRB2;EPG5;IL1B;UBE2L3;BRCA1;ZC3H12A;ADCY5;ADCY6;CTNNB1;ADCY1;KAT5;CYP1A1;LARP1;INPP5K;ADCY3;LRRK2;EGFR;TNF;FAM210B;RAP1B;PDE2A;TIPARP;RAP1A;NRIP1;IGFBP5;CASP6;CDH1;KCNQ1
prerank,positive regulation of phosphorylation (GO:0042327),0.2144081517697586,0.9325495087712242,0.6467065868263473,0.9774487371594731,1.0,56/240,20.44%,FGF10;ANG;ADTRP;FGF16;MERTK;FGF9;C3;PAK1;NTRK1;FLT4;CARD14;NCKAP1L;RARRES2;PFKFB4;FGF7;DSCAM;NTRK3;AR;RYK;CCND3;LIMK2;BMP4;EPHA1;ERBB4;TGFB1;FGF2;EFNA1;P2RY1;TEK;RALBP1;EPHA4;FLCN;EPHB2;THPO;INSR;NTRK2;MAPK3;ITGA6;VAC14;HRAS;PTK2;ENG;FLT3;CHRNA7;PIN1;HDAC3;RSPO1;DVL2;PFKFB2;CCL5;PDGFRB;ERP29;ROR1;EPHA5;IL34;ARRB1
prerank,mitotic nuclear division (GO:0140014),-0.22599021614899623,-0.9321573414212944,0.593103448275862,0.7994215863737094,1.0,21/71,19.01%,CHMP4B;EPS8;KPNB1;MIS12;PIBF1;KIF11;KIFC2;CDCA8;NCAPG2;KIFC1;ABRAXAS1;NUSAP1;ESPL1;NUP62;NDC80;UBE2C;MZT1;KIF18B;TPX2;FLNA;PLK1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.36892430893649236,-0.932067763071801,0.5242718446601942,0.7990540244532486,1.0,4/11,14.03%,STAP1;CCN3;GREM1;DUSP1
prerank,striated muscle cell differentiation (GO:0051146),0.34446579638091324,0.9320595222155351,0.5425170068027211,0.9780169049860589,1.0,4/16,14.01%,KDM6B;MEF2C;AKAP13;SORT1
prerank,regulation of cholesterol transport (GO:0032374),-0.3019340633877148,-0.9316809239474476,0.5601023017902813,0.7994905914264663,1.0,8/20,21.01%,NFKB1;NAXE;NR1H2;APOC1;NR1H3;LRP1;NUS1;ABCA13
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.18613084473876595,-0.931451979283704,0.7183908045977011,0.7994678069648457,1.0,66/208,24.82%,CD74;ANKRD17;ALPK1;TRIM25;TRIM14;LGALS1;TBK1;LAMTOR5;SHISA5;ESR1;BST2;NOD2;TNIP3;RIPK1;TFRC;LITAF;TRIM62;PLEKHG5;CLEC6A;IL1B;CCDC22;S100A4;EEF1D;PIDD1;ZC3H12A;GPRC5B;STAT1;TNFRSF19;BIRC2;ZDHHC17;TRIM5;IRAK4;PELI1;SPHK2;DDX21;TNF;GJA1;HSPB1;WNT5A;NUP62;OPTN;TRAF1;MUL1;HMOX1;TRAF3IP2;SQSTM1;ECT2;TRAF4;FLNA;MYD88;LTF;NLRC3;CASP1;TRIM21;TNIP1;NDFIP1;GPR89A;NR1H4;TNFSF10;TICAM2;TMEM101;GSTP1;GOLT1B;PIM2;FADD;TLR9
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3205014009954647,0.9308572504041096,0.5515463917525774,0.9805225569305162,1.0,6/21,19.37%,SH3BP1;DAB2IP;EPHB2;RASAL3;ARHGAP12;STAMBP
prerank,activin receptor signaling pathway (GO:0032924),0.35416828407790335,0.9302942442722876,0.5781758957654723,0.9812484102978986,1.0,5/15,20.91%,TGFBR1;ACVR1B;AMHR2;ACVR1C;SMAD2
prerank,positive regulation of protein import (GO:1904591),-0.27071280683183097,-0.930230955912439,0.5877659574468085,0.8019042155636927,1.0,9/30,19.82%,ZPR1;SMAD3;PSEN1;ZC3H12A;ARHGEF5;ECT2;CDH1;FLNA;CHP2
prerank,regulation of cell population proliferation (GO:0042127),0.1994499573475993,0.9302222996658908,0.7270811380400422,0.9805660026941584,1.0,135/691,19.55%,ATP8A2;P3H2;FGF10;TPTE;HHEX;TSC2;TET1;FGF16;SMYD2;AVPR2;MATK;FGF9;ECRG4;NACC2;WWTR1;PAK1;RELA;SLURP1;NTRK1;FOSL1;SIX4;AVPR1A;FLT4;COPS8;TENM1;BEX4;SOX4;IGFBP6;PTPRU;STK11;PRLR;SERTAD1;HILPDA;CD86;FGF7;IL6;MAPK15;NTRK3;PDCD5;RNF126;CLU;AREG;AR;CTBP1;XRCC6;GSDME;RBM5;LGMN;IL2;ADRA2A;CDC123;S100A13;TGFBR1;EEF1E1;MAZ;HOXC10;MINAR1;DAB2IP;TIMELESS;BMP4;NME1;CD81;TCF7L2;SSR1;PKD2;EPHA1;ERBB4;SST;TGFB1;TBX2;ITGB1BP1;NMI;BTG3;CLCF1;CAPNS1;SH2B3;CGRRF1;STX3;SETD4;TRNP1;THAP12;FGF2;BTG2;IRS1;NOP2;SFRP1;TSPAN31;PDGFB;IL13RA1;SLC25A5;TBC1D8;TBRG4;TBX6;TSPO;INHA;CNOT8;RBFOX2;BAP1;IFI35;THPO;INSR;ZBTB49;NTRK2;PTPN2;SH3BP4;CADM4;ADORA3;REST;COL18A1;DNAJA3;KIF14;HRAS;IL7;AGT;PTK2;OPRM1;CDK10;UTP20;ENG;IL1A;FLT3;FABP3;BTG1;XBP1;POU3F3;CHTOP;CHRNA7;FES;GHRL;MCTS1;MAGI2;STAMBP;TOB1;PDGFRB;COX17
prerank,positive regulation of protein acetylation (GO:1901985),0.36898546367358026,0.9302211635903844,0.5516014234875445,0.9796782676872471,1.0,7/12,28.02%,DIP2B;RAPGEF3;TAOK1;DDX3X;CAMK1;PRKAA2;DIP2A
prerank,mesoderm development (GO:0007498),0.3383533853695378,0.9302040884842674,0.5619694397283531,0.9788475139431766,1.0,4/18,17.26%,GDF11;BTK;TBX6;MEST
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.38947767776829145,0.9301836789674859,0.5302245250431779,0.9780103637052293,1.0,2/11,2.26%,RAB1B;F11R
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3379413736673165,0.9300803054600036,0.5544715447154471,0.9774223675504407,1.0,4/17,9.53%,WNT4;VSIR;BMP4;TGFB1
prerank,nerve growth factor signaling pathway (GO:0038180),0.3814937980074383,0.9297925187625633,0.5557586837294333,0.9773302624426851,1.0,4/10,24.98%,NTRK1;MAGI2;BDNF;RAPGEF2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.20986067575056946,0.9296290061480205,0.669047619047619,0.9769108871003047,1.0,67/308,20.91%,GAPDH;BCL9L;SCAMP5;AVPR2;PPIB;WWTR1;KSR2;G0S2;TXK;ESRRG;KDM6B;SIX4;AVPR1A;IL17F;CADM1;PPARGC1A;GATM;PLA2G3;PRLR;HILPDA;MFAP2;IL6;FOXD1;PIK3CG;IL2;ADRA2A;S100A13;TGFBR1;BMP4;OGT;ADCYAP1;ACHE;FOXC1;TGFB1;CFL1;FGF2;CRTAM;ACVR1B;CXCR4;PDGFB;ELOVL6;EPAS1;AGPAT1;PRDM16;MAP3K13;HAP1;BATF;SHLD3;REST;AGT;ITK;GNAS;ALMS1;ROCK1;IL1A;IL18;XBP1;ZBTB7B;GHRL;HDAC3;BMPR1B;HCAR2;FBXO5;SHLD2;OMA1;ABCA7;SMAD2
prerank,ceramide catabolic process (GO:0046514),0.3625189761476886,0.9295303923323706,0.5508196721311476,0.976305433984788,1.0,3/14,8.91%,HEXB;NEU1;NAGA
prerank,regulation of peptidase activity (GO:0052547),-0.3032038368312263,-0.9294348776317095,0.5439429928741093,0.8033087460859236,1.0,7/19,24.95%,NRDC;CAV1;PSMA3;HDAC1;MAPK12;NDUFA13;ATP13A2
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.29598418259332604,-0.9292249823661243,0.5592783505154639,0.8032362571184858,1.0,10/22,31.68%,STAP1;CDKN2C;INPP5K;PRKRIP1;CDKN2A;BMP7;TESK1;PLEK;CDKN2D;CDA
prerank,response to light stimulus (GO:0009416),0.26484609271944176,0.9291046238141671,0.6029411764705882,0.9766265407011561,1.0,11/55,15.55%,UBE2B;CPT1B;GTF2H2;CIRBP;COPS3;USF1;DCT;DDB2;MAPK10;ERCC6;CCAR2
prerank,cellular response to light stimulus (GO:0071482),-0.2266969432385734,-0.9288755183229807,0.5884244372990354,0.8035397117076051,1.0,28/66,35.00%,PCNA;USP28;TAF1;YY1;EIF2S1;RHNO1;EP300;NPM1;CDC25A;GPR88;PDE6B;RPL26;OPN3;CASP9;TRPM1;PDE6A;RRH;GPR52;AQP1;RHBDD1;USP47;RUVBL2;PTPRK;MAPK13;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,atrioventricular valve morphogenesis (GO:0003181),0.33496297417093435,0.9285272254195517,0.5523648648648649,0.9773729423131343,1.0,4/19,10.94%,ZFPM1;SOX4;HEY1;EFNA1
prerank,positive regulation of wound healing (GO:0090303),0.28505610214725474,0.9285224256400784,0.5806451612903226,0.9765074182573984,1.0,9/36,18.05%,INSL3;SMOC2;ADRA2A;ENPP4;ARFGEF1;VTN;HRAS;PTK2;XBP1
prerank,cellular response to organonitrogen compound (GO:0071417),0.23872436902471447,0.928479262215989,0.6195652173913043,0.9757518689373432,1.0,24/99,19.21%,HCN1;P2RY12;RPTOR;RELA;GABRG2;TRPM2;MEF2C;SLC38A9;RAPGEF3;PKD2;GLRA2;CFTR;HSP90B1;SFRP1;P2RY1;CRHBP;IPO5;AOC1;GABRB1;SH3BP4;SSH1;XBP1;ACTB;NSMF
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2503613680967128,0.9284388168492941,0.5806451612903226,0.9749805754969016,1.0,10/76,8.17%,CTTN;BIN1;LMOD1;TENM1;NCKAP1;NCKAP1L;CDC42EP5;NTRK3;FCHSD2;LIMK1
prerank,heart trabecula morphogenesis (GO:0061384),-0.3117353898514948,-0.9282000371350936,0.5325,0.8045978875692128,1.0,4/18,10.70%,RBPJ;ADGRG6;BMP5;NOTCH1
prerank,negative regulation of vascular permeability (GO:0043116),-0.3476694756355298,-0.9281936680298478,0.5279805352798054,0.8040110126508129,1.0,7/12,31.73%,CEACAM1;RAMP2;PDE2A;ANGPT1;SLIT2;DDAH1;PDE3A
prerank,response to purine-containing compound (GO:0014074),0.3441730704285739,0.9281000796304819,0.5544217687074829,0.9750486751309356,1.0,4/17,12.17%,TRPC3;TRPM2;DGKQ;P2RY1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3105328346633963,0.9278483339652085,0.5770491803278689,0.9748555883313373,1.0,8/25,20.83%,GAPDH;PGAM2;ALDOC;PFKM;HK2;ALDOA;PFKP;ENO3
prerank,response to insulin (GO:0032868),0.24708423667079343,0.9275155046362019,0.5977175463623395,0.9749485527085473,1.0,19/80,18.53%,SELENOS;PDE3B;RAB8A;EIF6;RPS6KB1;PRKCI;HDAC5;OGT;IRS1;USF1;RAB12;PARP1;KHK;SORT1;INSR;EPRS1;RHOQ;XBP1;ZBTB7B
prerank,response to X-ray (GO:0010165),0.36278221572193625,0.9274509395460472,0.5564924114671164,0.9742467802465704,1.0,5/14,23.97%,NUCKS1;XRCC6;XRCC4;XRCC5;IKBIP
prerank,regulation of ruffle assembly (GO:1900027),-0.2923619328438963,-0.9272051155187451,0.5384615384615384,0.8058995453887525,1.0,6/23,8.51%,STAP1;EPS8;P2RX4;FAM98A;CAV1;ARHGAP24
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.27629798027180086,0.9268666165364926,0.5798722044728435,0.9749892571562546,1.0,8/39,11.57%,YWHAE;FGF12;FHL1;PTPN3;NEDD4;CACNA1D;STK39;TRPC6
prerank,endocardial cushion development (GO:0003197),0.32308403756017956,0.9267762203566453,0.5576271186440678,0.9743886446973838,1.0,6/21,21.71%,BMP4;HEY1;TBX2;CRELD1;ENG;MDM4
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.25857495907923644,-0.9265522030748155,0.595108695652174,0.806930222890143,1.0,8/40,13.78%,DAB2;HIP1;LDLRAP1;HNRNPK;RAB21;CBL;B2M;GREM1
prerank,recombinational repair (GO:0000725),0.24874587358500588,0.9264868657149128,0.5905172413793104,0.9743195235708038,1.0,21/77,21.89%,NUCKS1;RNF138;SMC5;XRCC1;LIG3;RECQL;UBE2N;FAN1;RAD52;PSMD14;PARP1;FEN1;XRCC3;RFWD3;TONSL;WRN;SEM1;HUS1;RECQL4;NABP1;EXD2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3932021943613838,0.9261575528472212,0.5652920962199313,0.9743962782358583,1.0,5/10,17.70%,SOCS3;INPP5F;SH2B3;PTPN2;PPP2R1A
prerank,nucleosome organization (GO:0034728),0.2597427147176353,0.9261031964022963,0.5966767371601208,0.9736790421308921,1.0,13/55,16.32%,ASF1A;SMARCC2;BPTF;MCM3AP;SMARCE1;ZNHIT1;VPS72;SMARCD3;RNF8;SPTY2D1;DMAP1;NAA60;PAF1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3310873709865317,0.925595265079909,0.55668358714044,0.974280286517762,1.0,3/20,4.50%,DIP2B;PPARGC1A;SOX4
prerank,ncRNA export from nucleus (GO:0097064),-0.2626689675383604,-0.9255885070432321,0.5393586005830904,0.8086818344684651,1.0,9/36,15.60%,XPOT;RANBP2;NUP153;NDC1;NUP43;NUP210;SSB;NPM1;NUP62
prerank,negative regulation of translation (GO:0017148),-0.21333334123533826,-0.9251314504965638,0.6366782006920415,0.8092718773466311,1.0,30/87,26.33%,CELF1;CNOT9;MALSU1;SAMD4A;EIF4EBP2;DDX6;EIF4ENIF1;CAPRIN1;CPEB4;DAPK1;PAIP2B;AGO2;TYMS;LARP1;RACK1;SYNCRIP;TRIM71;FXR2;CPEB2;IGFBP5;MEX3D;DHFR;CPEB3;PUM1;RIDA;EIF3E;ILF3;EIF2AK2;GIGYF2;PAIP2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.2762861030515087,-0.9250427400782637,0.5724815724815725,0.8089116727093362,1.0,3/28,3.58%,BCL2;ZDHHC3;BAX
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.32356047136178806,0.9247796055974549,0.5538971807628524,0.9756587872311364,1.0,6/21,15.65%,FIS1;MICU2;SMDT1;RAP1GDS1;SLC8A3;SLC25A23
prerank,positive regulation of tissue remodeling (GO:0034105),-0.37277885898712676,-0.9243845586596008,0.5393518518518519,0.8099046275762686,1.0,1/10,0.21%,IL15
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.24677003111084542,0.9242389737428025,0.6014492753623188,0.9762705957875168,1.0,18/80,17.53%,RAB6B;KLC1;RAB1B;ATP9A;KDELR3;TMED2;COPG1;COG4;KIF26A;ZW10;BICD2;KIF1C;KIF2A;COPE;NBAS;KDELR2;TMED3;COPG2
prerank,autonomic nervous system development (GO:0048483),0.33841708585465535,0.9242370909069207,0.5608465608465608,0.9754098436136723,1.0,4/17,8.37%,NTRK1;SOX10;SOX4;KIF26A
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.31596029263662334,-0.9242043451393888,0.5586034912718204,0.8097437905559673,1.0,9/17,27.00%,RBPJ;NOTCH1;BMP2;HEY2;ACVR1;NOTCH2;HEYL;GALNT11;DLL4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.27351652049407227,-0.9240352815605337,0.5953757225433526,0.8095478105894951,1.0,10/29,18.45%,CUL4A;CHD1L;UBC;UBA52;RAD23B;CCNH;RPA1;MNAT1;RPA2;XPC
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.38091782389774304,0.9235412733277417,0.5660714285714286,0.976465566397348,1.0,1/11,2.18%,CD34
prerank,mitotic cytokinetic process (GO:1902410),-0.29980942311986974,-0.9235211105587064,0.5571776155717761,0.8102360299193639,1.0,5/20,16.16%,CHMP4A;CHMP4B;CHMP1B;PDCD6IP;KIF20A
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.3600497826615029,0.9233473065165589,0.5545774647887324,0.9761932915540102,1.0,4/13,9.53%,SH2B1;TGFBR1;BMP4;TGFB1
prerank,adenine nucleotide transport (GO:0051503),0.335674427402436,0.9230142431772747,0.5691318327974276,0.9762790810018985,1.0,5/17,19.70%,SLC25A4;SLC25A5;SLC19A1;SLC35B2;ABCC6
prerank,hemopoiesis (GO:0030097),0.24030231129617674,0.922824245714366,0.6326241134751773,0.9759899062777377,1.0,17/87,14.05%,SELPLG;FUT10;ZFPM1;CD34;FLT4;YJEFN3;TGFBR3;PLD4;BMP4;ZFP36L2;TGFB1;SH2B3;KAT8;SFRP1;PDGFB;TEK;FLCN
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.23247281687298585,-0.9227799396267462,0.6090651558073654,0.8115278726722851,1.0,14/56,20.58%,DAB2;SDCBP;SNX25;BMP5;RBPMS;SMAD6;GREM1;BMP2;BMP3;SMAD4;ACVR2A;GDF3;BMP7;ACVR1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.27739250995730963,-0.9226971429548413,0.5741239892183289,0.8110959814515275,1.0,9/25,20.36%,P2RX4;CD36;SMAD3;IL1B;TNF;TLR4;KLF2;MMP8;KLF4
prerank,cochlea morphogenesis (GO:0090103),0.39442643956587575,0.9226428225857101,0.5509181969949917,0.9756381286752904,1.0,2/10,15.59%,POU3F4;HPN
prerank,regulation of actomyosin structure organization (GO:0110020),0.36230589841339944,0.9225968502171089,0.5359019264448336,0.9748967086885538,1.0,7/13,26.42%,AKAP13;ALMS1;ROCK1;ASAP3;CDC42;SLC9A1;FHOD1
prerank,response to axon injury (GO:0048678),0.3412943122699395,0.9225611531693539,0.5844370860927153,0.9741243970048171,1.0,6/18,18.81%,P2RY12;RTN4RL1;APOD;SARM1;MTR;NREP
prerank,axonal transport (GO:0098930),0.2853983387343682,0.9225185952860655,0.5894245723172629,0.973396113092187,1.0,8/36,14.98%,DST;BLOC1S2;AP3M1;SNAPIN;AP3B2;DCTN1;SYBU;HAP1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3118078256059606,-0.9225101496589662,0.5614457831325301,0.8109741659955906,1.0,5/17,15.28%,SASH1;CD36;TRIM5;CD55;SCIMP
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.38782770171502345,0.9223570537792574,0.5462633451957295,0.9729619111343443,1.0,3/10,18.53%,NCKAP1L;CD81;ZBTB7B
prerank,leukotriene metabolic process (GO:0006691),-0.3097033450874097,-0.9223485366042237,0.562962962962963,0.8107578564755645,1.0,3/19,3.94%,ALOX5;MGST3;MAPKAPK2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.20853182030280348,-0.9223113099551635,0.6680497925311203,0.8102570473573697,1.0,35/101,24.48%,UPF3A;NIBAN1;RPL5;VPS35;BCL3;SAMD4A;ATG7;MSN;THBS1;NR1H2;LARP6;VIM;CD28;PTTG1IP;PIWIL2;HDAC2;PLD1;TBC1D10A;NR1H3;NPM1;ZCCHC4;UPF3B;LARP4B;FXR2;HNRNPD;NAT10;PLK1;RPL26;KLF4;CPEB3;PERP;EIF3E;FGFR4;PYM1;FADD
prerank,protein localization to Golgi apparatus (GO:0034067),0.3052857654058714,0.9221061734140243,0.5849923430321593,0.9728028610110977,1.0,6/27,12.55%,IFT20;OBSL1;ARL5A;SYS1;ARFRP1;BICD2
prerank,canonical glycolysis (GO:0061621),0.3109804873757798,0.9220542345691524,0.5840130505709625,0.9712443197996916,1.0,8/24,20.83%,GAPDH;PGAM2;ALDOC;PFKM;HK2;ALDOA;PFKP;ENO3
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3109804873757798,0.9220542345691524,0.5840130505709625,0.9712443197996916,1.0,8/24,20.83%,GAPDH;PGAM2;ALDOC;PFKM;HK2;ALDOA;PFKP;ENO3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2577972126198029,-0.9214364598581372,0.59375,0.8118407640213262,1.0,7/33,10.79%,UBA5;ESR1;RNF14;H3-3A;RNF6;PRMT2;EP300
prerank,positive regulation of ossification (GO:0045778),0.2818108796807029,0.9213917775401704,0.5634028892455859,0.9721825481431674,1.0,6/39,9.62%,WNT4;MEF2C;FBN2;BMP4;TGFB1;SLC8A1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2923241212282439,0.9213103926552533,0.5958466453674122,0.9715377276499555,1.0,10/31,20.27%,CD86;IL6;IL2;CLCF1;VAMP3;EPHB2;SHLD3;XBP1;TNFRSF4;SHLD2
prerank,protein autophosphorylation (GO:0046777),0.2203159080906922,0.920940787869809,0.6419270833333334,0.9717059418811348,1.0,35/157,17.58%,TXK;STK26;PAK1;NTRK1;FLT4;STK16;STK11;MAPK15;MAP3K10;RIPK3;CDKL5;PRKD2;EPHA1;ERBB4;AAK1;MINK1;STK39;VRK2;ACVR1B;STK25;TEK;EPHA4;MAP3K13;INSR;NTRK2;EIF2AK4;MAPK3;PRKD1;MAPKAPK5;TAOK1;ITK;PTK2;AATK;FLT3;SMG1
prerank,mitotic DNA replication (GO:1902969),0.39058904868109384,0.9209211882365688,0.5493197278911565,0.9709119599178416,1.0,2/10,7.52%,GINS3;MCM3
prerank,histone lysine demethylation (GO:0070076),-0.2813346179189503,-0.9206007731595047,0.5893333333333334,0.8133055611705416,1.0,7/25,15.17%,RIOX2;KDM7A;KDM8;KDM6A;HR;RIOX1;KDM5C
prerank,endomembrane system organization (GO:0010256),0.21989558308423837,0.9205502751859953,0.6443883984867591,0.9710714067400836,1.0,44/178,20.66%,FBXW8;ANXA8;ANXA8L1;OBSL1;RAB43;SEC16B;ATL1;MAPK15;TMED2;CLASP2;SEC31A;COG4;USP50;PI4K2A;OTOF;TANGO2;ZW10;TLCD2;DNM1L;SYNGR1;LYSMD3;HACE1;TMED5;ARFGEF1;SPTBN1;BLZF1;HOOK2;MIA3;PRKD1;DMPK;ATP8B1;TMED3;VPS33B;ALS2;STX17;SNX33;LMAN2L;HOOK1;CAV2;TRAPPC8;TMED7;SYNGR2;CDC42;LEMD2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.21137289906119644,-0.9205031960234367,0.65,0.8129536038648794,1.0,21/84,19.01%,PSMA6;BUB3;CUL3;PSMB2;PSME2;PSMD11;PSMC6;UBC;PSMA3;UBA52;CDC27;CDK1;MAD2L1;PSMD10;BUB1B;RB1;PSMB5;UBE2C;PSMD5;PSMD1;PLK1
prerank,sulfur compound catabolic process (GO:0044273),0.2801402305656513,0.9202441732114656,0.581039755351682,0.9710697293465996,1.0,5/38,6.48%,HEXB;GGT7;ACAN;ARSB;GGT5
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2661734983059225,0.92023616319902,0.5835820895522388,0.9702437510173643,1.0,13/48,20.20%,POLR2L;ASF1A;POLR2F;WBP2;SERTAD1;MYO1C;POLR1E;ERCC6;PHF2;POLR1F;ACTB;ELOF1;ATAD2
prerank,regulation of cellular response to stress (GO:0080135),0.2308282602946524,0.9199266920827904,0.6479057591623036,0.970251104445509,1.0,40/115,28.32%,YWHAE;ADCY8;AAAS;RPTOR;DNAJC2;SLC38A2;CORO2B;USP51;MANF;NUP54;CHORDC1;VASH1;PRKN;NUP88;NEK4;RAE1;DNAJC7;CRHBP;CCAR2;MAPK3;NUP133;OPRM1;SMG1;HSP90AB1;POM121;NUAK1;ING2;NPAS2;CAMK2B;MAPK1;CRYAB;MAPT;FKBP4;ATF4;AMFR;HSPA8;HSBP1;PTGES3;NUP107;NUP155
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.25702118945427127,-0.9197620148596841,0.5885416666666666,0.8142177303413985,1.0,8/36,13.96%,EPC1;RBBP8;RBBP7;BMI1;BRCA1;RYBP;L3MBTL2;EHMT1
prerank,cellular response to ATP (GO:0071318),0.35284132258337464,0.9195157536647751,0.55,0.9705391873167349,1.0,4/14,16.33%,P2RY12;HSP90B1;P2RY1;SSH1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.25369895881136784,-0.9192370135993752,0.6187845303867403,0.8149224793669337,1.0,13/38,27.10%,RBBP7;CABIN1;H3-3A;CENPA;HAT1;NPM1;CENPW;CENPX;MIS18BP1;UBN1;CENPH;HJURP;OIP5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.3878739063683083,0.9190870060134443,0.5452898550724637,0.9699845513414241,1.0,3/10,19.06%,MAP2K5;MBP;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.3878739063683083,0.9190870060134443,0.5452898550724637,0.9699845513414241,1.0,3/10,19.06%,MAP2K5;MBP;WNK1
prerank,dephosphorylation (GO:0016311),-0.19874629963058532,-0.9188495954395453,0.7198275862068966,0.8152754968000964,1.0,31/147,15.62%,PPP2R5C;PTPN22;DUSP16;PPP2R1B;PPP2R2A;PTPRC;PPP2R5A;PPP4R1;MTMR2;PTPN1;CDC14B;PTPN21;PPM1H;PPP1R12A;MTMR4;CTDNEP1;SGPP1;PTPN7;TAB1;DUSP18;PPP4R2;PHPT1;PPP3CA;MTM1;CTDSP1;INPP5K;DUSP1;PPP2CB;TIMM50;MTMR3;ACP6
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3241812364393235,0.9186948922517616,0.5666131621187801,0.9701796971731749,1.0,1/20,0.11%,WNT4
prerank,zinc ion transport (GO:0006829),0.3188740942403886,0.9185864508581164,0.6050847457627119,0.9696516605058351,1.0,5/21,17.98%,SLC39A4;TRPM2;SLC39A8;SLC30A3;SLC39A3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.2701041527112593,-0.9183594345610819,0.5938303341902313,0.8159293645153494,1.0,10/31,20.36%,CDK6;CDC73;KANK2;CDKN2C;WEE1;PRMT2;RB1;E2F7;CDKN2A;KLF4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.31585793723116334,0.9182672562055779,0.5947712418300654,0.9696581130563953,1.0,8/23,23.30%,DGAT2;ACSL6;TECR;ELOVL6;ACSBG1;ACSF3;ELOVL5;ACSL3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3181967367596128,0.9181211571657716,0.5877342419080068,0.9692256857122867,1.0,3/22,9.08%,OCIAD2;IL6;ERBB4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.22089894028835838,-0.918051725893309,0.6735395189003437,0.8160870226414297,1.0,15/74,13.84%,DAB2;PHLDB1;GCNT2;SDCBP;SMAD3;GLIPR2;IL1B;DAG1;MAD2L2;BMP5;SPRY2;CTNNB1;SPRY1;GREM1;BMP2
prerank,positive regulation of immune system process (GO:0002684),-0.3097993869789667,-0.9176859908568153,0.5463414634146342,0.8163474234822127,1.0,2/16,7.26%,IL15;ANXA1
prerank,protein homotrimerization (GO:0070207),0.35279967521907907,0.9175060382867629,0.5728476821192053,0.9692090811715951,1.0,5/14,21.95%,DISP1;SIGMAR1;ASIC1;ALOX5AP;STEAP4
prerank,protein trimerization (GO:0070206),0.35279967521907907,0.9175060382867629,0.5728476821192053,0.9692090811715951,1.0,5/14,21.95%,DISP1;SIGMAR1;ASIC1;ALOX5AP;STEAP4
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.19201869955583312,-0.9174974734928322,0.751219512195122,0.8162018379517243,1.0,49/158,24.82%,CD74;ANKRD17;ALPK1;TRIM25;TRIM14;LGALS1;TBK1;LAMTOR5;SHISA5;BST2;NOD2;RIPK1;TFRC;LITAF;TRIM62;PLEKHG5;CLEC6A;CCDC22;S100A4;EEF1D;GPRC5B;TNFRSF19;BIRC2;ZDHHC17;TRIM5;IRAK4;PELI1;DDX21;TNF;GJA1;NUP62;MUL1;HMOX1;TRAF3IP2;ECT2;FLNA;MYD88;LTF;CASP1;TRIM21;NDFIP1;GPR89A;TNFSF10;TICAM2;TMEM101;GOLT1B;PIM2;FADD;TLR9
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.24683088605687967,-0.9174014521321556,0.6268221574344023,0.8158657939117633,1.0,15/43,21.87%,IGF1;MEF2D;ERN1;THBS1;LDLRAP1;DNMT1;STAT1;HTR1B;FOXP1;TNF;GJA1;HMOX1;IGFBP5;ID2;SERPINF2
prerank,autophagosome organization (GO:1905037),-0.23805273915164105,-0.917227539740494,0.6483180428134556,0.8157088059848144,1.0,14/50,17.21%,PIK3C3;MAP1LC3B;ATG13;STX12;RAB1A;RAB7A;ATG7;UBQLN1;ATG2B;ATG3;UBXN2B;ATG9B;AMBRA1;MAP1LC3A
prerank,protein localization to lysosome (GO:0061462),-0.2715861459341049,-0.9165930907102987,0.5679347826086957,0.8165917317304278,1.0,7/28,11.59%,RAB7A;LAMTOR5;NAGPA;M6PR;ZFYVE16;AP4M1;SZT2
prerank,glucan biosynthetic process (GO:0009250),-0.34743159102940824,-0.9163020851276916,0.5547785547785548,0.8161181246129101,1.0,6/12,30.49%,GYG1;PPP1R3C;PGM2L1;PER2;GBE1;GYS1
prerank,glycogen biosynthetic process (GO:0005978),-0.34743159102940824,-0.9163020851276916,0.5547785547785548,0.8161181246129101,1.0,6/12,30.49%,GYG1;PPP1R3C;PGM2L1;PER2;GBE1;GYS1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3615634292187713,-0.9162728147058948,0.5818181818181818,0.8155904160811234,1.0,5/11,25.12%,NRP1;STMN1;BCAR1;SIRT2;RAC1
prerank,autophagy of mitochondrion (GO:0000422),-0.25123542842294855,-0.9162457127113595,0.591715976331361,0.815060499052713,1.0,11/38,17.60%,MAP1LC3B;MARK2;ATG13;ATG7;CISD2;ATG2B;ATG3;ATG9B;AMBRA1;MAP1LC3A;SQSTM1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.27116831914711514,-0.916151310922561,0.6108247422680413,0.8147091355086907,1.0,7/28,9.75%,BCL2;BAX;ERN1;CEBPB;ITPR1;BAG6;DNAJC10
prerank,negative regulation of telomere maintenance (GO:0032205),-0.3197218049534573,-0.9153438968935314,0.5995145631067961,0.8161020110420307,1.0,8/15,31.67%,RTEL1;NBN;TERF2;SLX4;SMG6;TNKS;PINX1;ATM
prerank,regulation of ATP metabolic process (GO:1903578),-0.23428233146998323,-0.9152868160634668,0.6147058823529412,0.8156304018439646,1.0,14/54,15.60%,ATP7A;RANBP2;PRKAG2;HIF1A;NUP153;NDC1;NUP43;NUP210;EP300;PGAM1;UQCC2;SPHK2;SLC25A33;NUP62
prerank,T cell proliferation (GO:0042098),0.3526805552797984,0.9150548907311381,0.5906735751295337,0.97506760100386,1.0,3/13,11.30%,CADM1;PIK3CG;CRTAM
prerank,response to histamine (GO:0034776),-0.36747952259617367,-0.9150475192911482,0.585081585081585,0.8156212851279951,1.0,5/10,21.75%,HRH1;GABRB2;DRD2;DRD3;DIAPH1
prerank,iron ion homeostasis (GO:0055072),-0.22925487878415285,-0.9147845840832476,0.6090909090909091,0.8157013061361614,1.0,18/58,22.81%,ATP6V0D1;TFRC;PICALM;SLC46A1;NUBP1;SLC11A1;ATP6V1A;CP;B2M;LCN2;HMOX1;FTL;SMAD4;CYBRD1;HEPH;NDFIP1;ALAS2;FBXL5
prerank,melanocyte differentiation (GO:0030318),0.37488549013004185,0.9147214165863112,0.5891608391608392,0.9751399472559237,1.0,3/11,15.83%,SLC24A5;MEF2C;LRMDA
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.25922141593458664,-0.9144454659733203,0.6253369272237197,0.815941517345294,1.0,8/33,16.27%,IGF1;BCL2L1;TFRC;ACAA2;PSMD10;GPX1;MUL1;SLC35F6
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2965523049124459,0.9138824516581839,0.5946843853820598,0.9765621246137596,1.0,10/30,20.82%,ACSL6;TECR;ELOVL6;ACOT4;ACOX1;ELOVL4;ACSBG1;PEX2;ABCD2;ELOVL5
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3196582028522994,0.9138627139936001,0.5669934640522876,0.9757708148702373,1.0,6/20,12.39%,ATP2A2;FIS1;BAK1;HERPUD1;CCDC47;RAP1GDS1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.29564864017828313,0.9137184598188486,0.6,0.9753090597683775,1.0,12/29,25.98%,CBR4;ACSL6;PPT2;TECR;ELOVL6;ACSBG1;ACSF3;ACLY;ELOVL5;ACSL3;SLC25A1;FASN
prerank,response to muramyl dipeptide (GO:0032495),0.368518763789585,0.9137063273894623,0.5714285714285714,0.974498334165935,1.0,6/12,23.38%,TRIM41;INAVA;NOD1;IRF5;CHMP5;RIPK2
prerank,T cell differentiation in thymus (GO:0033077),0.3503444494645191,0.9136889252812392,0.5816326530612245,0.9737101641981725,1.0,4/14,13.67%,MR1;RIPK3;ZFP36L2;CCR6
prerank,dendritic cell migration (GO:0036336),-0.3161600186069611,-0.9135567251561489,0.5564102564102564,0.8175766143254422,1.0,4/16,5.85%,EPS8;ALOX5;CCR2;GPR183
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.36814913257749515,-0.9135166778460747,0.5333333333333333,0.8170977437067606,1.0,2/10,1.19%,STAP1;CD300A
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.31827044452328696,-0.9135127357836759,0.5528255528255528,0.8165168817412687,1.0,5/17,11.68%,ADAM9;SYK;CIB1;RET;SKAP1
prerank,negative regulation of angiogenesis (GO:0016525),0.24384041570098075,0.9134267422443973,0.6183644189383071,0.9735528018720182,1.0,14/84,13.02%,HOXA5;HHEX;IL17F;SLC12A2;PDE3B;YJEFN3;GTF2I;MINAR1;DAB2IP;FOXC1;VASH1;EFNA3;COL4A2;TEK
prerank,"wound healing, spreading of cells (GO:0044319)",-0.27826383289385653,-0.9133493933018844,0.5683646112600537,0.8163117993768654,1.0,9/24,18.70%,CD44;PDCD10;ARHGAP24;LCP1;CCN1;CEACAM1;ADAM17;CARMIL2;FLNA
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.3312175707834214,-0.912592210411127,0.5893271461716937,0.8175898887628755,1.0,6/14,17.77%,THBS1;SPRY2;SPRY1;CREB3L1;SPRY4;GATA3
prerank,mitochondrial membrane organization (GO:0007006),-0.26406028679844734,-0.9124759088458859,0.5911602209944752,0.8172769341745759,1.0,8/32,14.64%,BCL2;BCL2L1;RCC1L;MTX3;MTX1;IMMT;PMAIP1;TIMM50
prerank,leukotriene biosynthetic process (GO:0019370),-0.3326145829224063,-0.9122665921812467,0.5791962174940898,0.8171987500958782,1.0,4/14,11.83%,ALOX5;MGST3;GGTA1;LTA4H
prerank,positive regulation of DNA repair (GO:0045739),0.2703284425027907,0.9122416637561418,0.5990922844175491,0.9758084617641759,1.0,11/46,16.80%,FGF10;WRAP53;TIMELESS;XRCC1;UBE2N;RNF168;RNF8;PARP1;HMGB1;ERCC6;PRKCG
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2859043597995732,0.9120086707504445,0.5868167202572347,0.9755842112808452,1.0,6/33,14.67%,HOXA5;ANKRD54;NCKAP1L;MTURN;ACVR1B;THPO
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.30635700654762654,0.9118099964814085,0.5877342419080068,0.9752623961090222,1.0,8/23,22.02%,IL17F;TGFBR3;TGFB1;ENG;LTBP4;NREP;SMAD2;LATS1
prerank,pore complex assembly (GO:0046931),-0.29506936659629,-0.9117710176911282,0.5666666666666667,0.8178378756633683,1.0,4/19,12.26%,AFDN;NUP153;NDC1;AHCTF1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.37588169037746083,0.9111994100055926,0.5825932504440497,0.9761535797607437,1.0,5/11,26.43%,FBXO7;PRKN;REST;NONO;ATF4
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.2680681520997281,0.9111891938958553,0.6036036036036037,0.9753442772938107,1.0,7/48,12.78%,CAPN3;THY1;DMD;PLCG1;UBASH3B;GSTO1;JPH1
prerank,positive regulation of macroautophagy (GO:0016239),-0.23621694437605903,-0.910921326854682,0.6648199445983379,0.8193195708148022,1.0,15/48,17.95%,VPS13D;PAFAH1B2;TBK1;SH3GLB1;UVRAG;SMCR8;KDR;LARP1;RALB;WAC;HSPB8;OPTN;SESN2;RAB3GAP2;SPTLC2
prerank,pulmonary valve development (GO:0003177),-0.3115101676619767,-0.9108333954503062,0.5670588235294117,0.8189394681193343,1.0,13/18,38.83%,NOTCH1;TNFRSF1B;SMAD6;HEY2;NOTCH2;HEYL;BMPR2;SLIT2;ROBO2;TGFB2;STRA6;TNFRSF1A;NFATC1
prerank,regulation of mRNA stability (GO:0043488),-0.19619650935363273,-0.9108176947544337,0.7379912663755459,0.8183753610352342,1.0,46/145,26.50%,PSMA6;CELF1;NOCT;PSMB2;MAPKAPK2;PSME2;SAMD4A;PUM2;PSMD11;PSMC6;UBC;PSMA3;EIF4ENIF1;EXOSC8;UBA52;VIM;XPO1;FASTKD1;TENT5A;RC3H1;SLC11A1;PSMD10;LARP1;EXOSC9;NPM1;PSMB5;HSPB1;RC3H2;FXR2;PSMD5;HNRNPD;MEX3D;PSMD1;HNRNPU;PUM1;EXOSC1;TENT5C;RIDA;PSMB7;PSMA7;EXOSC7;GIGYF2;PSMB3;VIP;SERBP1;PAIP1
prerank,hyaluronan catabolic process (GO:0030214),-0.3007729927107803,-0.9107851829129122,0.5905707196029777,0.817870927496512,1.0,7/18,16.85%,LYVE1;CD44;HMMR;CEMIP2;STAB2;CHP1;HYAL3
prerank,regulation of protein neddylation (GO:2000434),-0.37398739915403445,-0.910624474044623,0.5694760820045558,0.8176730621820256,1.0,5/10,26.13%,RPL5;HIF1A;DCUN1D1;RPL11;DCUN1D4
prerank,regulation of focal adhesion assembly (GO:0051893),-0.23199635720784623,-0.9105908680969498,0.6328358208955224,0.817159089132664,1.0,6/54,5.87%,PEAK1;SLK;NRP1;CORO1C;LIMS1;THBS1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3102355001346057,0.9102867804824158,0.6074766355140186,0.976974741985529,1.0,5/24,11.94%,ITPR2;TRPM2;PKD2;FGF2;ITPR3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.322471806381409,-0.9102383322672196,0.5932642487046632,0.8174739560279335,1.0,8/16,21.87%,SUCO;LARP6;VIM;HDAC2;SCX;CREB3L1;RGCC;SERPINF2
prerank,regulation of protein localization to nucleus (GO:1900180),-0.24708531418975366,-0.9101112072198771,0.6388059701492538,0.8172024667205837,1.0,14/43,22.77%,DTX3L;LAMTOR5;CTNNA1;TFRC;YAP1;BYSL;CDK1;PARP9;ORMDL3;KAT7;SESN2;PLK1;SHH;GTSE1
prerank,positive regulation of cation channel activity (GO:2001259),0.2738851560971137,0.9094464399891462,0.6232980332829047,0.978361092411252,1.0,11/40,24.53%,SHANK3;PKD2;ACTN2;GSTO1;EPHB2;HAP1;GAL;ANK2;CTSS;LRRC55;ANK3
prerank,T cell migration (GO:0072678),-0.3338349663956899,-0.90935547501446,0.6026200873362445,0.818379918599201,1.0,3/13,5.85%,CXCL16;MSN;GPR183
prerank,regulation of lamellipodium assembly (GO:0010591),0.27741859127801477,0.9090836345579296,0.6180124223602484,0.9784758143748616,1.0,12/34,28.64%,ABI3;FSCN1;NCKAP1;TWF2;CYFIP1;TWF1;WASF2;CDC42;CLRN1;BRK1;DMTN;AUTS2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.3568356063649428,0.908689207322976,0.5808080808080808,0.9786756072169939,1.0,2/13,2.86%,HEXB;ARSB
prerank,phospholipid metabolic process (GO:0006644),0.24524166472411144,0.9085566836905281,0.6312684365781711,0.9781982396095058,1.0,24/71,26.16%,PLA2G3;PLCD1;PLA2G4C;PNPLA3;TNFAIP8L3;LPCAT1;ABHD12;ENPP2;AGPAT1;ABCA2;FITM2;PLPPR4;ANGPTL3;PLCB2;PLA2G15;PLPP1;PIP4P1;PIP4K2B;GPAT2;PIP4K2A;PLA2G4A;PLPP2;PLPPR1;SMPD2
prerank,Golgi organization (GO:0007030),-0.2031744327636008,-0.908439062477358,0.6936619718309859,0.8199668764976308,1.0,14/112,6.54%,VCPIP1;STX6;ATP8B4;GOLPH3L;GOLGB1;STX5;RAB1A;GAK;GBF1;TRAPPC12;DYM;SEC16A;FHDC1;PDCD10
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.3401554306086286,0.9082666869417608,0.5746140651801029,0.9772823936337055,1.0,10/16,30.54%,CLASP2;ITGB1BP1;APOD;RCC2;PHLDB2;DMTN;PTEN;DLC1;ARHGAP6;FAM107A
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.3401554306086286,0.9082666869417608,0.5746140651801029,0.9772823936337055,1.0,10/16,30.54%,CLASP2;ITGB1BP1;APOD;RCC2;PHLDB2;DMTN;PTEN;DLC1;ARHGAP6;FAM107A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3095202572529983,0.908021539613405,0.5909822866344605,0.9771244065593178,1.0,6/23,21.97%,GUCY2F;CNGB1;GUCY2D;NMT1;METAP2;GUCA1B
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.28953080799123654,0.9078442219091694,0.5873261205564142,0.9767840765668947,1.0,10/28,28.70%,KCNE2;CLU;DAB2IP;PRKN;PTK2;AXIN1;RNF139;PSMC5;PTEN;ATP5IF1
prerank,triglyceride homeostasis (GO:0070328),0.30593673629687007,0.9076891394870413,0.6031496062992125,0.9763527600129547,1.0,9/26,22.66%,DGAT2;ANGPTL4;FITM2;ANGPTL3;IL18;LIPC;XBP1;RORA;PNPLA8
prerank,positive regulation of intracellular transport (GO:0032388),0.2742719702702189,0.9073522415871877,0.6253869969040248,0.9763997923963623,1.0,8/38,11.40%,TENM1;STK11;OAZ1;ACTN2;PLK3;NEDD4;EHD1;EHD2
prerank,actin filament polymerization (GO:0030041),-0.2725283832391858,-0.9072838328830715,0.5763239875389408,0.8221566851213317,1.0,17/29,33.28%,PSTPIP2;DIAPH3;GAS7;COBL;CORO7;WASF1;GSN;MSRB1;DIAPH1;TTC17;WASHC3;RAC1;MICALL2;PSTPIP1;WAS;WASHC5;SPIRE1
prerank,muscle cell migration (GO:0014812),0.39051397762317963,0.907040844492393,0.5953177257525084,0.9763882697783992,1.0,3/10,17.22%,PLAT;ITGB1BP1;ROCK1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.21299882559150532,-0.9069342651585219,0.6793103448275862,0.8224307405273342,1.0,31/83,26.63%,CDK6;CUL3;CDK17;CUL4A;PCNA;GPR132;CDC34;CCND1;CDKN2C;HINFP;CCNH;CDKN3;TYMS;RB1;CDT1;CDK14;TRIM71;MNAT1;CDC25A;KLF11;CDKN2A;CUL5;ACVR1;DHFR;RCC1;CDC45;PIM2;USP26;NPAT;POLE;E2F3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.26762218922101844,-0.9065317373039232,0.6077922077922078,0.8227667778836841,1.0,8/29,19.01%,DTX3L;FBXW7;BMI1;UBE2L3;DCUN1D1;MAGEC2;ARRDC4;PLK1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.23774711465327572,0.9064155302740293,0.6235795454545454,0.9771557755247461,1.0,27/87,22.95%,NDUFA6;DMAC1;NDUFAF8;TIMM21;FOXRED1;TTC19;UQCC3;NDUFS1;NDUFA8;NDUFS6;SDHAF2;NDUFAF2;OXA1L;ECSIT;NDUFAB1;TIMMDC1;NDUFS2;NDUFAF6;BCS1L;NDUFB6;SDHAF4;COX17;OMA1;NUBPL;ACAD9;SMIM20;COX18
prerank,glycolytic process (GO:0006096),0.2928348460179504,0.9062530869293736,0.6117274167987322,0.9767584836349037,1.0,9/28,20.83%,GAPDH;PGAM2;ALDOC;PFKM;HK2;PFKFB2;ALDOA;PGM1;ENO3
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.37694172774883933,0.9060382220719004,0.612736660929432,0.9765066753562033,1.0,3/11,17.85%,PLA2G3;AGT;LIPC
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.36066373569234145,-0.9058817373474027,0.597254004576659,0.8237499900954021,1.0,3/11,10.39%,CABIN1;H3-3A;HAT1
prerank,phospholipid dephosphorylation (GO:0046839),0.279962810225508,0.9058297440143905,0.6109375,0.9762171109788942,1.0,8/37,12.41%,TPTE;PLPP5;MTMR9;INPP5B;SACM1L;OCRL;INPP5F;MTMR1
prerank,response to organophosphorus (GO:0046683),0.33529878866845547,0.9057914414760578,0.5983471074380166,0.9755077212598705,1.0,3/16,8.56%,TRPC3;AKR1C1;DGKQ
prerank,focal adhesion assembly (GO:0048041),0.31249725025043407,0.9057761214962432,0.6029654036243822,0.9747313187959274,1.0,4/21,9.08%,CTTN;THY1;TRIP6;ACTN2
prerank,positive regulation of lipid localization (GO:1905954),0.3743754072733807,0.9057092253261992,0.593103448275862,0.9740818400494574,1.0,2/11,5.43%,C3;HILPDA
prerank,L-glutamate transmembrane transport (GO:0015813),0.3840668821345058,0.9055760660398657,0.5795847750865052,0.9736210509436478,1.0,3/10,11.07%,SLC1A1;SLC25A18;SLC1A3
prerank,presynaptic endocytosis (GO:0140238),-0.2821829151461035,-0.905390997141126,0.5702702702702702,0.824325958043781,1.0,4/24,10.60%,SYNJ2;FCHO2;AMPH;SNCG
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.27505472054327784,-0.9053585621955246,0.601078167115903,0.8237943673718793,1.0,7/25,15.36%,NOD2;CD226;B2M;CD55;SPHK2;SCIMP;WNT5A
prerank,AMP metabolic process (GO:0046033),0.3536845691238164,0.9050874462969956,0.5685920577617328,0.9740882190834178,1.0,6/13,23.59%,NUDT2;AMPD3;ADSL;AK4;AK3;AK9
prerank,positive regulation of positive chemotaxis (GO:0050927),0.34011517858188756,0.9048613488303652,0.6134020618556701,0.9738514691755024,1.0,2/15,5.82%,F3;NTRK3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.20848740442763505,0.9045972286381875,0.7291414752116082,0.9737469685314721,1.0,67/248,22.17%,FGF10;HHEX;TLE3;UBE2B;PSMB1;TLE2;WWTR1;SOX4;IGFBP6;PTPRO;PTPRU;TMEM198;STK11;IGFBP2;ANKRD6;PTK7;PSMF1;BTRC;DAB2IP;PRICKLE1;PSMA1;TCF7L2;GPC5;PPM1A;PSMD7;FAM53B;TGFB1;EMD;SNAI2;TPBG;PRKN;PSMA8;CTNND2;PPM1N;PSME3;SFRP1;LRRK1;AMER2;PSMD14;PSMC4;SDHAF2;TMEM9;CCAR2;APC2;AMER3;PRDM15;CSNK1G3;FRMD8;PSMB4;UBAC2;PIN1;RBMS3;RSPO1;WNK1;DVL2;BICC1;CYLD;PSME1;GLI3;PSMD2;PSMD4;FRZB;AXIN1;LATS1;PSMD8;SOX13;SFRP2
prerank,endothelial cell development (GO:0001885),0.29919350495698216,0.9045188326847381,0.583596214511041,0.973126991804167,1.0,8/25,21.48%,ROBO4;MARVELD2;RAPGEF3;ICAM1;COL15A1;COL18A1;RDX;PPP1R16B
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.24960573523983448,-0.9045052266392992,0.5977011494252874,0.8252723064170064,1.0,9/37,16.92%,CUL4A;PCNA;CHD1L;UBC;UBA52;POLD4;RPA1;NTHL1;RPA2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.31546463297858696,0.9044673371888117,0.6032786885245902,0.9724468938281201,1.0,5/22,10.92%,PSMB1;ENC1;PSMA1;PSMA8;NFE2L2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.2624148459718319,0.9043239045693067,0.6275659824046921,0.9719672084273681,1.0,9/46,14.17%,YWHAE;CPSF6;TCF7L2;RAPGEF3;TGFB1;EMD;NEDD4;IPO5;DMAP1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.30622711945367276,-0.9041058875892026,0.5935334872979214,0.8256439523011931,1.0,3/17,2.87%,NRP1;IGF1;DOCK7
prerank,DNA-dependent DNA replication (GO:0006261),-0.19808830407858918,-0.9040242422513415,0.7577092511013216,0.8252755931137038,1.0,30/128,20.20%,BAZ1A;PSMA6;PSMB2;TOPBP1;POLE4;PSME2;ORC5;PSMD11;CDC34;PSMC6;UBC;PSMA3;UBA52;ORC2;POLD4;RPA1;MCM2;PSMD10;ORC4;CDT1;PRIM2;PSMB5;DDX21;MCM8;RPA2;PSMD5;WDHD1;PSMD1;POLE3;HMGA1
prerank,regulation of coagulation (GO:0050818),0.36964556549431965,0.9036735429203065,0.6097560975609756,0.9728747647143814,1.0,2/11,14.23%,HS3ST5;EPHB2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2974698110223072,0.9034224954138178,0.5971337579617835,0.9727197945189064,1.0,5/27,9.95%,SMYD2;DDX5;HIC1;EEF1E1;SNAI2
prerank,proteasomal protein catabolic process (GO:0010498),0.21353838277571813,0.9033871419071193,0.7046035805626598,0.9720058699442147,1.0,49/201,18.32%,KLHL22;UBXN6;UBE2B;PSMB1;HECTD3;ENC1;RNF126;UBE2G1;ARRB2;PSMF1;BTRC;PSMA1;FAF1;PSMD7;HECW2;NEDD4;PRKN;PSMA8;NHLRC1;NFE2L2;CCDC47;KCTD10;TRIM9;PSME3;GID4;KCTD13;IFI27;DERL1;APPBP2;PSMD14;HACE1;SPSB3;FBXL19;PSMC4;DCAF11;SOCS6;KCTD5;RFFL;UBXN1;FBXW5;NEDD4L;SKP2;COP1;SIAH1;KIF14;KLHL42;ARMC8;SIAH3;PSMB4
prerank,serine family amino acid metabolic process (GO:0009069),-0.31814341680612174,-0.9033771029973339,0.5784061696658098,0.8262295214025225,1.0,6/16,21.67%,MTHFD1;GCLC;CBS;THNSL2;CTH;SEPHS2
prerank,adherens junction organization (GO:0034332),0.2615017582152252,0.9032803040941341,0.612094395280236,0.9714553335519417,1.0,10/48,16.15%,ANG;DCHS1;CADM1;INAVA;CDH18;NECTIN3;CDH4;CADM3;CADM2;JAM3
prerank,striated muscle tissue development (GO:0014706),0.2906413549747864,0.9032625703761226,0.6026272577996716,0.9707019837592011,1.0,11/29,24.05%,SIX4;MEF2C;MYL6;TBX2;SGCZ;SGCG;SGCD;IGSF8;CFLAR;RBP4;POPDC3
prerank,lytic vacuole organization (GO:0080171),-0.2600939028194362,-0.9030687240241506,0.616,0.8263990935834976,1.0,10/32,15.69%,TPCN2;NAGPA;HPS1;CLN5;MBTPS1;GNPTAB;AKTIP;LRRK2;GAA;CLN3
prerank,phosphatidylserine metabolic process (GO:0006658),-0.25974716548297083,-0.9028590159353043,0.628808864265928,0.8262895361570559,1.0,10/32,24.86%,OSBPL8;PLA2G4E;PLAAT3;ABHD16A;LPCAT4;PLA1A;PLA2G4F;PLA2G2D;PLSCR1;MBOAT1
prerank,acylglycerol homeostasis (GO:0055090),-0.29953717313882255,-0.9023065049649079,0.5947368421052631,0.826981364780747,1.0,4/20,13.14%,APOE;MTLN;LPL;NR1H3
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.325917840245776,0.9022720470046933,0.5804195804195804,0.9724699688293545,1.0,6/17,20.41%,ADTRP;AR;BMP4;ATP1A3;ATP1A1;ABHD2
prerank,response to estradiol (GO:0032355),0.28539411699656075,0.9020993910040127,0.6,0.9721000417671414,1.0,7/31,12.75%,GGT7;GGT5;SOCS2;TGFB1;WNT8B;SFRP1;CRHBP
prerank,autophagosome assembly (GO:0000045),-0.23263487208171724,-0.901750093177522,0.6840490797546013,0.827701216563595,1.0,14/52,17.21%,PIK3C3;MAP1LC3B;ATG13;STX12;RAB1A;RAB7A;ATG7;UBQLN1;ATG2B;ATG3;UBXN2B;ATG9B;AMBRA1;MAP1LC3A
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.18379131168668408,-0.9014221645986964,0.7752808988764045,0.8279175719345199,1.0,54/184,24.13%,PSMA6;BUB3;PCM1;CUL3;CDK5RAP2;PSMB2;PRKACA;CDC14B;PSME2;TUBA4A;CEP250;PSMD11;PSMC6;UBC;PSMA3;YWHAG;HMMR;HAUS2;CEP164;UBA52;MAPRE1;CDC27;CDK1;MAD2L1;HAUS8;PSMD10;BUB1B;KNTC1;PSMB5;UBE2C;KCNH5;MAD2L1BP;PSMD5;DCTN2;TPX2;XPC;PSMD1;PLK1;ODF2;PAFAH1B1;APPL2;RGCC;SIRT2;AKAP9;CEP78;ID2;CDC14A;OFD1;ANAPC7;ANAPC10;CCNB1;NDE1;PSMB7;PSMA7
prerank,respiratory chain complex IV assembly (GO:0008535),0.31516655516526626,0.9013328178250418,0.5920398009950248,0.9733083527939637,1.0,9/21,26.11%,COA6;TIMM21;OXA1L;BCS1L;COX17;SMIM20;COX18;COX10;FASTKD3
prerank,RNA methylation (GO:0001510),0.24917507456796464,0.9012743935690581,0.6622023809523809,0.9726390361315114,1.0,13/60,14.78%,METTL2B;METTL2A;TRMT44;METTL1;TRMT61B;DIMT1;MEPCE;FTSJ1;METTL16;NOP2;METTL5;CBLL1;FBLL1
prerank,negative regulation of DNA binding (GO:0043392),-0.2736721658320582,-0.9012727280202414,0.6325966850828729,0.8277000637593518,1.0,6/28,17.97%,SP100;SOX11;MAD2L2;HEY2;HMGA2;PER2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.2776969974419032,0.9012152155239737,0.622257053291536,0.9719846653325427,1.0,10/35,14.65%,STMN3;ARHGAP44;DAB2IP;KCTD10;SCAI;KCTD13;ARHGAP35;FLCN;EPHB2;RASAL3
prerank,regulation of actin filament depolymerization (GO:0030834),0.3719951656900292,0.9009478188929572,0.6050269299820467,0.9718809557954857,1.0,1/12,0.34%,SH3BP1
prerank,glycerophospholipid catabolic process (GO:0046475),0.3012964698600174,0.9005155365583182,0.6092307692307692,0.9721936960115612,1.0,5/27,10.31%,PRDX6;PLA2G4C;ABHD12;ENPP2;INPP5F
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.1830629222842308,-0.9004026467764832,0.8037383177570093,0.8291241868043357,1.0,41/190,16.71%,PPP2R5C;BCL2;BCL2L1;LIMD1;XDH;DLG5;MCL1;CGNL1;ESR1;THBS1;TNIP3;RIPK1;UACA;ITPR1;CDC34;PLAUR;CAV1;LYN;CIT;CIB1;CCDC22;DAG1;BANK1;DRD2;ZC3H12A;RNF157;STAT1;C1QTNF3;AJUBA;PSMD10;CCN3;RACK1;INPP5K;DUSP1;DEPTOR;SFRP5;EPHA2;PDE2A;MUL1;PEBP1;NOP53
prerank,regulation of dendrite extension (GO:1903859),0.3243419014139118,0.9002859775031449,0.5804794520547946,0.9719993079218199,1.0,5/18,15.18%,SYT4;SYT1;CPNE6;RIMS1;NEDD4L
prerank,glucose transmembrane transport (GO:1904659),0.32707812696094507,0.9000895039862757,0.6134020618556701,0.971690347978276,1.0,4/18,14.01%,SLC2A3;SLC2A2;SLC45A1;SORT1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.32887368033483033,0.9000242249092382,0.5958549222797928,0.9710309430914532,1.0,2/18,4.01%,CD34;ITGB6
prerank,chromosome organization (GO:0051276),-0.20716618552864127,-0.8997991966386666,0.7275747508305648,0.8299590694215678,1.0,29/99,19.82%,SETD7;HMGB2;CUL4A;MTHFR;SMARCA4;TOP2A;DOT1L;PADI4;CDCA8;UBC;H3-3A;UBA52;RAD23B;LIG4;HDAC2;HDAC1;HMGN3;EHMT1;CDT1;HMGN2;CENPW;NDC80;NUF2;SATB1;HMGA2;XPC;PHF19;COPS4;POLE3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3716435110614422,0.899607718211574,0.5763888888888888,0.9713551497857936,1.0,3/11,10.44%,PTPRT;SOCS3;SH2B3
prerank,vesicle transport along actin filament (GO:0030050),-0.3049984753945031,-0.8994143551106248,0.5876543209876544,0.8302946132539599,1.0,3/19,6.66%,MYO5A;MYO1F;MYO15A
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.27338100843190516,0.8990315341105275,0.646795827123696,0.9720920682487456,1.0,5/39,8.81%,NNAT;SOX4;DOC2B;TCF7L2;ADCYAP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.32998418515854466,-0.8988030607346181,0.6219512195121951,0.8311736974663568,1.0,6/13,26.43%,CIAO2A;CIAO2B;NFU1;CIAO1;LTO1;GLRX5
prerank,placenta development (GO:0001890),-0.32967737003599096,-0.8987109616830696,0.6192893401015228,0.8308228328366426,1.0,4/12,16.04%,ADAM19;PPARG;E2F8;E2F7
prerank,homotypic cell-cell adhesion (GO:0034109),-0.24413997088897807,-0.8986902630144206,0.6608695652173913,0.830281127718348,1.0,19/39,33.10%,ACTN1;MEGF11;HSPB1;MYH9;VCL;PDGFRA;FLNA;FN1;ITGB3;FIBP;TLN1;MYL12A;ILK;CLIC1;PLEK;PLPP3;RAP2B;PPIA;MYL9
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.35699526952566235,-0.898347024169243,0.5803571428571429,0.8304819395442365,1.0,5/10,24.46%,GNPDA1;ST6GAL1;NAGK;RENBP;NPL
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.2421948933395937,-0.8979513748443712,0.6695402298850575,0.8308005638184485,1.0,26/44,39.86%,ACOT8;OSBP;OSBPL9;OSBPL1A;PRKAG2;OSBPL2;HSD17B1;SC5D;PER2;HSD3B7;INSIG1;SRD5A2;PMVK;ALOX15;ABCB11;INSIG2;EBP;BAAT;SLC27A5;AKR1D1;ACOX2;HMGCR;CH25H;OSBPL3;LBR;SLC27A2
prerank,histone exchange (GO:0043486),0.27554373103365565,0.8979407740586529,0.615625,0.9740854655588614,1.0,9/37,20.14%,CENPP;ZNHIT1;VPS72;RNF8;SPTY2D1;DMAP1;CENPN;CENPS;CENPC
prerank,negative regulation of protein catabolic process (GO:0042177),-0.2452817491040675,-0.8977402980989952,0.6183431952662722,0.8307426304293423,1.0,14/40,21.86%,RIC1;CTSA;MAD2L2;AGAP2;MAD2L1;TIMP4;EGFR;RGP1;RILP;FLNA;TIMP1;FMN2;SIRT2;ADGRB1
prerank,cilium assembly (GO:0060271),-0.17621627559575295,-0.8974384784789694,0.9,0.8308353071575942,1.0,46/296,12.36%,EHD4;ATP6V0D1;RAB8B;ACTR3;KIF3A;PTPN23;PCM1;RILPL2;FAM161A;CDK5RAP2;PIBF1;RAB1A;PRKACA;MKS1;CDC14B;RPGR;SCLT1;CPLANE1;GBF1;EXOC4;TUBA4A;ARL13B;CEP250;TCTN1;SSX2IP;TBC1D32;BBS7;FHDC1;ASAP1;DNAH5;YWHAG;HAUS2;KIF24;TMEM231;CEP164;WDPCP;CCDC40;MAPRE1;SNAP29;CCDC28B;TMEM138;NOTCH1;CDK1;HAUS8;FOXJ1;EXOC8
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.28308422866825295,-0.8974331820941075,0.6091370558375635,0.8302610143781535,1.0,8/22,17.75%,CIAPIN1;NUBP1;CIAO2A;IBA57;CIAO2B;NFU1;CIAO1;LYRM4
prerank,cellular response to interleukin-4 (GO:0071353),-0.3481745526844803,-0.8973579625845337,0.5768321513002365,0.829866570705549,1.0,6/10,36.22%,TCF7;SHPK;GATA3;LEF1;DCSTAMP;RUFY4
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2814371696882097,-0.8972731626053005,0.6070460704607046,0.8295023426242999,1.0,5/22,10.18%,CUL4A;CHD1L;UBC;UBA52;RAD23B
prerank,retinol metabolic process (GO:0042572),-0.3270542237053347,-0.8971008547217056,0.585956416464891,0.8293183701643629,1.0,6/14,24.26%,RDH11;CYP1A1;DHRS9;CYP1B1;DHRS3;RDH12
prerank,"phagocytosis, engulfment (GO:0006911)",-0.24707566941707015,-0.8969483852186501,0.6666666666666666,0.8290954853151367,1.0,4/36,5.87%,FCGR2B;MSR1;CD36;THBS1
prerank,regulation of protein phosphorylation (GO:0001932),0.20452645243555792,0.8965749182913162,0.7391304347826086,0.9768555907161148,1.0,57/256,20.44%,FGF10;ANKRD54;ADTRP;FGF16;PLXNB2;FGF9;C3;WWTR1;PAK1;NTRK1;ROPN1;FLT4;ROPN1L;CARD14;NSD1;RARRES2;PRNP;FGF7;NTRK3;CACTIN;AKAP8L;DAB2IP;CCND3;LIMK2;BMP4;SH3GL2;ERBB4;TGFB1;PRKN;FGF2;EFNA1;AKAP8;P2RY1;TEK;RALBP1;FLCN;EPHB2;THPO;INSR;BRD4;NTRK2;CADM4;MAPK3;TWF1;HRAS;PTK2;ENG;PTPN13;CHRNA7;PIN1;HDAC3;RSPO1;DVL2;ERP29;IL34;PPIL4;ARRB1
prerank,negative regulation of protein modification process (GO:0031400),0.23538188631838547,0.8965412025144308,0.6568627450980392,0.9761404226470434,1.0,12/79,10.07%,TPPP;WWTR1;BEX4;DMD;PRNP;NTRK3;CACTIN;DAB2IP;XRCC1;SH3GL2;TGFB1;PRKN
prerank,regulation of RNA export from nucleus (GO:0046831),0.3635693510663689,0.8963750639241087,0.5742753623188406,0.9757580304156432,1.0,2/11,7.47%,CPSF6;AKAP8L
prerank,COPII-coated vesicle budding (GO:0090114),0.24552864204465913,0.8961631471010532,0.6539589442815249,0.9754851873760219,1.0,17/68,18.15%,RAB1B;CNIH2;SEC16B;AREG;TMED2;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9;MIA3;SEC24C;SCAP;PREB
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.22857734853223804,-0.8958453255811255,0.6758409785932722,0.8311585383289392,1.0,16/51,22.42%,UBE2D3;PPARG;SMURF2;SMAD9;LEMD3;NOTCH1;SMAD6;GREM1;BMP2;HIPK2;SMAD4;ACVR2A;GDF3;BAMBI;TRIM33;SKIL
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.20129545940610596,0.8958370683270994,0.7549132947976879,0.9755399352712252,1.0,80/327,24.22%,ZFHX3;SCRT2;CTR9;MAGED1;DRAP1;DENND4A;LDB1;PQBP1;FUS;WWTR1;ESRRG;RELA;NR1I2;SOX21;HIC1;SKOR1;PPARGC1A;UBE2V1;NSD1;SOX4;HOXB7;E2F1;MEF2C;ZNF35;ZNF205;TGFBR1;OGG1;APBB1;POFUT1;FOXC1;SNAI2;SPIN1;SLC39A8;MLLT6;ACVR1B;THAP1;WWC1;MLF2;TFEB;PLAG1;SPTY2D1;LMX1B;INSR;APBB3;CCAR2;EDF1;REST;TCF7L1;TCF3;ELAVL2;SUFU;BACH1;PAK6;ENG;PPP2R1A;BTG1;PHF1;HMG20A;GCFC2;DVL2;REXO4;RORA;MED23;ACTR5;PRMT5;ZFAT;TEAD2;ING2;ZNF628;SOX13;NFYB;SKOR2;TULP3;SSBP2;YAF2;SMARCA2;HES6;NAB2;MAFB;NIF3L1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.34316166330258413,-0.8957702086060875,0.5970149253731343,0.830739090830612,1.0,7/12,29.66%,LYN;FOXP1;ORMDL3;IRS2;BCL6;BLK;FNIP1
prerank,carboxylic acid transport (GO:0046942),-0.22747409081092923,-0.8955464211880555,0.6626865671641791,0.830697774652725,1.0,5/55,3.14%,SLC38A6;SLC1A5;SLC7A1;PSAP;SLC6A6
prerank,organelle organization (GO:0006996),0.19829752373060133,0.8954709854799967,0.7672811059907834,0.975704636221318,1.0,108/388,24.06%,FBXW8;ARMC2;CFAP126;CNTNAP1;DST;OBSL1;BIN1;RAB43;ROPN1;SEC16B;CATIP;CYP26C1;THY1;TFAM;PPARGC1A;ATL1;SIPA1;BRWD1;FMNL3;FGD2;HILPDA;GABPB1;MAPK15;TMED2;MICAL3;PNPLA3;CLASP2;NDP;PRKCI;SEC31A;COG4;PI4K2A;RHOT1;PKD2;TANGO2;ARAP3;ZW10;PRKN;CFL1;PEX14;RAB38;CAMSAP1;PAK5;GABPA;DNM1L;LYSMD3;CHMP1A;RAB34;HACE1;TMED5;WASF3;ARFGEF1;PARP1;BLZF1;SORT1;CHCHD10;CHMP2A;DPYSL2;FITM2;MIA3;MSTO1;CFAP61;PRKD1;DNAJA3;PEX2;CXADR;ATP8B1;PAK6;CDC42BPB;TMED3;MAST2;ABCD2;STX17;HSD17B10;BCS1L;ZMYM6;PEX6;LMAN2L;PYROXD2;RHOU;IQCG;MTX2;HPS3;ZMYM3;CAV2;TRAPPC8;SSBP1;TMED7;CDC42;SNX11;CHMP5;ARHGAP4;KIF9;PACSIN3;PEX11B;VMP1;WASL;ATL2;PEX3;PEX11A;CHMP7;PCLO;CHGA;FGD5;TMED1;SEC31B;VAPA;FNBP1L
prerank,folic acid metabolic process (GO:0046655),0.3191183604128678,0.8953577387705574,0.5785123966942148,0.9751976397134225,1.0,4/18,8.20%,FPGS;MTHFD1L;MTHFD2L;ALDH1L1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.2040529264637207,-0.8953376441212261,0.7302158273381295,0.8305717245249596,1.0,29/94,25.01%,PCM1;CDK5RAP2;PRKACA;MKS1;SCLT1;TUBA4A;CEP250;TCTN1;YWHAG;HAUS2;KIF24;CEP164;MAPRE1;CDK1;HAUS8;DCTN2;PLK1;ODF2;PAFAH1B1;CC2D2A;AKAP9;CEP78;B9D2;OFD1;MARK4;NDE1;RAB3IP;CEP97;NPHP1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3375390636827398,0.8950882951851833,0.577054794520548,0.975126374433773,1.0,8/15,28.95%,GRM3;HOMER2;DAGLA;DAGLB;GRIK3;GRM8;GRM7;GRM1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.343271627838657,0.8950747071920144,0.6090468497576736,0.974358268488352,1.0,7/15,29.81%,REEP2;ATL1;ZFYVE27;TMEM33;ATL2;RTN3;TMEM170A
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.31180985427857355,-0.8950623026293999,0.5863636363636363,0.8306524462207935,1.0,5/16,14.06%,DTX3L;SMCHD1;MAD2L2;SHLD1;PARP9
prerank,response to organic cyclic compound (GO:0014070),0.261276669230547,0.8950264776023885,0.6200607902735562,0.9736809839473723,1.0,15/52,19.40%,GGT7;TRPM2;SLC1A1;GGT5;ABCB4;SOCS2;TGFB1;WNT8B;ALPL;BGLAP;SFRP1;ABCA2;TLR3;IL18;CCL5
prerank,protein autoprocessing (GO:0016540),0.3255436538816665,0.8943673490942499,0.6023489932885906,0.9746182209628176,1.0,4/17,20.50%,MYRFL;CASP4;MYRF;OMA1
prerank,organelle fission (GO:0048285),-0.2782945566626863,-0.894342277817772,0.6417910447761194,0.8317805269943958,1.0,9/24,18.65%,TMCC1;ACOT8;CORO1C;DNM2;MUL1;MTFP1;MIEF1;MTFR2;GDAP1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.34695898397574704,0.8942931863332928,0.6061120543293718,0.9740221769608752,1.0,2/14,3.59%,CD80;IL17F
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.20864863606467257,-0.894197093091083,0.6872852233676976,0.8315475029164375,1.0,24/80,22.61%,CUL3;FBXW7;CAV1;UBQLN1;BMI1;UBE2L3;BRCA1;PTTG1IP;PAXIP1;DCUN1D1;BIRC2;CRY1;PSMD10;LRRK2;FANCI;MAGEC2;CENPX;ARRDC4;FANCM;PLK1;WFS1;NDFIP1;XIAP;PHF23
prerank,catecholamine metabolic process (GO:0006584),0.3489273471530424,0.8941893120245867,0.5949820788530465,0.9734853745356619,1.0,4/14,14.77%,LRTOMT;RNF180;PRKN;COMT
prerank,regulation of myotube differentiation (GO:0010830),0.3000044416856616,0.8938233245822467,0.6096774193548387,0.9735969852256495,1.0,7/24,18.88%,HDAC5;ATP11A;SMYD1;DMPK;BHLHE41;XBP1;HDAC3
prerank,regulated exocytosis (GO:0045055),0.21348288512016902,0.8938004756118213,0.7155727155727156,0.9728545694152698,1.0,29/173,14.71%,SNAP25;SYT4;RAB3A;SYTL4;PCDH7;SYT13;SYT1;SNAPIN;TEX264;RAB26;RARRES2;SYT6;CLU;SYNGR3;MANF;OTOF;ACTN2;TGFB1;ISLR;RIMS1;SCG3;CPLX2;PDGFB;SYNGR1;CRHBP;LY6G6F;SCCPDH;STXBP2;ENDOD1
prerank,regulation of DNA metabolic process (GO:0051052),0.26397849497336234,0.8935669102634866,0.6280864197530864,0.9726855738905035,1.0,14/44,22.82%,NUCKS1;UBE2V1;KDM1B;UBE2N;SUB1;TOM1L1;UPF1;WRNIP1;SMG1;ALYREF;XRCC5;GRHL2;MPHOSPH8;HDAC8
prerank,cellular response to reactive oxygen species (GO:0034614),0.24935960809484056,0.8935210916355876,0.6472346786248132,0.9720141575306364,1.0,8/59,10.92%,PRDX5;RELA;PJVK;IL6;TRPM2;RIPK3;PKD2;NFE2L2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3346879068862293,0.8933867642614245,0.6167557932263814,0.9715707978999795,1.0,3/16,8.08%,PIGQ;PIGB;PIGP
prerank,protein phosphorylation (GO:0006468),0.19522264707628506,0.8931892213287113,0.8008800880088008,0.9712872914437211,1.0,114/478,21.07%,CDK7;ABI3;STRADB;DCLK3;MERTK;MATK;CDK15;NIM1K;TXK;STK26;PAK1;PKN1;NTRK1;FLT4;PNCK;COPS8;STK16;STK11;PRKCZ;MAPK15;CTBP1;TRIB1;RYK;TRIB2;GTF2H4;RPS6KB1;DYRK1B;PRKCI;MAP3K10;RIPK3;TGFBR1;CDC42BPA;TGFBR3;NRBP2;PRAG1;BMP2K;DAB2IP;LIMK2;LIMK1;BMP4;STK36;DGKQ;PRKCA;CDKL5;PRKD2;EPHA1;MAP4K4;ERBB4;RNASEL;TGFB1;NEK4;BTK;AAK1;MINK1;NEK1;PRDX4;STK39;VRK2;ACVR1B;CAMKV;STK25;MAP3K7;PAK5;PDGFB;PKD1;STK32B;COQ8A;TEK;PRKG1;EPHA4;EPHB2;MAP3K13;GLYCTK;INSR;AMHR2;MAPK10;NTRK2;ERG;EIF2AK4;MAPK3;PRKD1;DMPK;PRKCG;MAPKAPK5;TAOK1;PAK6;CSNK1G3;PLK2;PTK2;CDC42BPB;TLR3;ROCK1;CDK10;AATK;FLT3;SMG1;MAST2;PLK4;AKT3;FES;MAP4K2;WNK1;STRADA;PDGFRB;BMPR1B;ACVR1C;CDKL1;SBK1;ULK2;LIPE;SMAD2;PDPK1;PDK1;NUAK1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2651130087091489,-0.893155934499789,0.6303191489361702,0.8333992152891262,1.0,9/26,20.36%,P2RX4;CD36;SMAD3;IL1B;TNF;TLR4;KLF2;MMP8;KLF4
prerank,positive regulation of dendrite extension (GO:1903861),0.3243514246713627,0.8929004233492318,0.6226415094339622,0.9712301972217202,1.0,5/17,15.18%,SYT4;SYT1;CPNE6;RIMS1;NEDD4L
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3676660287587764,0.8926811390881947,0.6092150170648464,0.9709866635372858,1.0,2/11,7.44%,SLC25A4;RIPK3
prerank,regulation of histone modification (GO:0031056),0.3462287924600588,0.8926304259775766,0.6179966044142614,0.9703270600504174,1.0,4/13,14.05%,AKAP8L;UBE2N;AKAP8;FLCN
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.3411516799899556,-0.8925890644685647,0.6028708133971292,0.8341309094962805,1.0,2/12,1.42%,KIF3A;PCM1
prerank,regulation of fibroblast migration (GO:0010762),-0.2911659894887697,-0.8924863298688995,0.6231155778894473,0.8338066021196094,1.0,4/20,7.00%,PRKCE;CORO1C;THBS1;GNA12
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2947592280186935,0.8922648247080834,0.6184419713831478,0.970419224466154,1.0,13/26,30.61%,FGF10;RPTOR;CCND3;MTBP;KMT2E;CDK10;RDX;DDX3X;UBE2E2;ADAMTS1;PLCB1;LSM10;TFDP1
prerank,actin crosslink formation (GO:0051764),-0.3420867325861347,-0.8922022967925696,0.5823095823095823,0.8338932573144605,1.0,5/12,22.53%,EPS8;GAS2L3;LCP1;FLNA;BAIAP2L2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.26157441658888836,-0.8921030055245086,0.5956873315363881,0.8335439891363544,1.0,6/29,12.80%,STAP1;TYROBP;CD226;RAET1E;LAMP1;KLRD1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.3202358431302257,-0.8918015829516975,0.5962877030162413,0.8336174523559595,1.0,6/15,15.34%,P2RX4;MET;THBS1;FGF1;NOTCH1;HSPB1
prerank,response to ketone (GO:1901654),0.30074668669314686,0.8917712724289447,0.6192052980132451,0.9709013639459295,1.0,5/24,9.53%,WBP2;UBE3A;ABCB4;TGFBR3;TGFB1
prerank,regulation of membrane depolarization (GO:0003254),0.32595546684205157,0.8910988486879874,0.6205128205128205,0.9718097176451167,1.0,6/18,22.55%,FHL1;PTPN3;GJA5;NEDD4L;SCN3B;SCN1B
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.1988453508373655,0.8906071955838847,0.7677345537757437,0.9722688132341568,1.0,90/366,24.12%,ZFHX3;NUCKS1;SCRT2;CTR9;MAGED1;DRAP1;DENND4A;LDB1;PQBP1;FUS;WWTR1;ESRRG;RELA;NR1I2;SOX21;HIC1;SKOR1;PPARGC1A;DDX25;UBE2V1;NSD1;SOX4;HOXB7;E2F1;MEF2C;ZNF35;ZNF205;TGFBR1;OGG1;APBB1;POFUT1;FOXC1;SNAI2;SPIN1;SLC39A8;MLLT6;ACVR1B;THAP1;WWC1;MLF2;TFEB;PLAG1;CYFIP1;TOM1L1;SPTY2D1;LMX1B;INSR;RBM3;APBB3;CCAR2;EDF1;REST;TCF7L1;TCF3;ELAVL2;ESCO1;MAPKAPK5;SUFU;BACH1;PAK6;GEMIN5;ENG;PPP2R1A;BTG1;ATXN2;PHF1;HMG20A;GCFC2;DVL2;REXO4;RORA;FBXO5;MED23;ACTR5;PRMT5;ZFAT;TEAD2;ING2;ZNF628;SOX13;NFYB;SKOR2;TULP3;SSBP2;YAF2;SMARCA2;HES6;NAB2;EIF4E;MAFB
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.36367188415410656,0.890570194285649,0.6129032258064516,0.9715705119657043,1.0,1/11,2.32%,NOS1AP
prerank,interstrand cross-link repair (GO:0036297),-0.22546070755950448,-0.8903528072585954,0.6719242902208202,0.8364826806502549,1.0,16/53,19.58%,VCP;ERCC6L2;UBC;ATRIP;UBA52;RPA1;FAAP20;FANCI;MCM9;MCM8;EME1;RPA2;CENPX;SLX4;FANCM;NEIL3
prerank,histone H2A acetylation (GO:0043968),-0.31793822007582134,-0.8900072601349416,0.6121951219512195,0.8366806793286382,1.0,5/16,14.24%,EP400;EPC1;TRRAP;SPHK2;MSL3
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.29121945475532424,0.8899476438965386,0.6393989983305509,0.9723175102699056,1.0,9/28,20.53%,ADCY8;LGMN;SHANK3;ZDHHC2;EPHA4;EPHB2;EIF2AK4;CHRNA7;CALB1
prerank,regulation of JUN kinase activity (GO:0043506),-0.25151084530396617,-0.8895919571128788,0.6684782608695652,0.8370616851818349,1.0,7/33,16.00%,SASH1;PTPN22;DVL3;TAOK3;MAP3K11;TNF;ARHGEF5
prerank,regulation of acute inflammatory response (GO:0002673),0.32231213004797993,0.8893042752561758,0.6116838487972509,0.9731451039983907,1.0,2/18,5.63%,DNASE1;IL6
prerank,Rac protein signal transduction (GO:0016601),0.3174087775564343,0.8891626705605353,0.6094771241830066,0.9727191682594081,1.0,4/18,13.87%,NCKAP1;FARP2;HACE1;CYFIP1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.22757335139969534,-0.8890769085235415,0.7169811320754716,0.8376130428493763,1.0,12/55,16.13%,BCL2;BCL2L1;BAX;FAS;RIPK1;CAV1;WWOX;LCK;RACK1;PMAIP1;TNF;BCL2L11
prerank,reticulophagy (GO:0061709),-0.33008359813195143,-0.888955512519183,0.6342042755344418,0.8372956657222685,1.0,3/12,11.23%,UBA5;ATG2B;UFC1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3524358380357367,-0.888884718270961,0.59375,0.836860881227418,1.0,4/10,27.04%,OS9;INSIG1;UBE2J1;YOD1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.36041959323892897,-0.8882780609054267,0.5731414868105515,0.8376665477480881,1.0,3/10,12.16%,ESR1;PSMC6;ATF7IP
prerank,stem cell differentiation (GO:0048863),0.2686255743584501,0.8882086242893064,0.6892307692307692,0.9743260612959148,1.0,8/39,15.59%,NELFB;SOX21;MEF2C;SETD6;SFRP1;METTL5;BATF;WNT7A
prerank,response to steroid hormone (GO:0048545),-0.25871154248781736,-0.8881733726023854,0.6613756613756614,0.8373224913347828,1.0,7/31,9.03%,NR3C1;THBS1;CATSPER3;CAV1;YAP1;CATSPER2;UBE2L3
prerank,positive regulation of cartilage development (GO:0061036),-0.3031236800053573,-0.8879588159130546,0.6076923076923076,0.8372348168923734,1.0,7/17,29.83%,SOX6;SCX;BMP2;PKDCC;BMPR2;TAPT1;SOX5
prerank,positive regulation of ATPase activity (GO:0032781),0.2677447614420667,0.887850826716417,0.6531881804043546,0.9744596052454578,1.0,5/41,8.63%,FGF10;ATP1B1;MYBPC3;ATP1B3;DNAL4
prerank,embryonic hemopoiesis (GO:0035162),0.34839049099820757,0.8874551898438332,0.6136752136752137,0.9746954930499223,1.0,5/12,26.43%,ZFPM1;SH2B3;THOC5;FLT3LG;ATF4
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.2850570293412873,0.8873628224626955,0.6282467532467533,0.9741143749725618,1.0,3/29,1.73%,BCL9L;TLE3;TLE2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2328562474248098,0.8870254655503088,0.667144906743185,0.9741937083704746,1.0,18/80,16.33%,PLXNB2;RELA;SOX4;IL6;CLU;CIRBP;EIF6;RPS6KB1;LRRTM3;EFNA1;CASP3;METTL5;NSMAF;PRR16;EPHA4;ABCA2;RBM3;IFNGR1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.29910332853236665,-0.8869180427723308,0.6172248803827751,0.8390567581624102,1.0,9/17,27.84%,PTPN22;BCL3;ANXA1;ANXA4;CD33;KLF4;TMSB4X;TLR9;SSC5D
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.24746864233574586,0.8868649325075854,0.6597938144329897,0.9722490398421535,1.0,13/61,14.16%,RAB1B;CNIH2;SEC16B;AREG;TMED2;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9
prerank,vesicle coating (GO:0006901),0.24746864233574586,0.8868649325075854,0.6597938144329897,0.9722490398421535,1.0,13/61,14.16%,RAB1B;CNIH2;SEC16B;AREG;TMED2;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9
prerank,COPII vesicle coating (GO:0048208),0.24746864233574586,0.8868649325075854,0.6597938144329897,0.9722490398421535,1.0,13/61,14.16%,RAB1B;CNIH2;SEC16B;AREG;TMED2;SEC31A;GRIA1;TRAPPC3;PDCD6;CNIH1;SEC24D;SEC24B;TRAPPC9
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.27091468107825634,-0.8866493027991066,0.6321243523316062,0.8390628959906777,1.0,12/24,32.42%,PRKACA;CAMK2D;CALM3;CALM2;SELENON;JPH4;PDE4D;CASQ2;FKBP1A;CALM1;SRI;NOS1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2593970978048499,-0.886140642374335,0.6571428571428571,0.8396379824315031,1.0,9/31,21.05%,RTEL1;PKIB;NBN;PRKCQ;HNRNPA2B1;MAP2K7;SLX4;HNRNPD;NAF1
prerank,long-term memory (GO:0007616),-0.2976027168757647,-0.8861009525373273,0.6301020408163265,0.8391567716518533,1.0,3/19,6.61%,APOE;PJA2;LDLR
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.27116216624022654,-0.8858329030705795,0.6311475409836066,0.8391815791456742,1.0,10/23,25.54%,UBE2K;S1PR2;PRKAG2;CALM3;CALM2;PLK1;BMP7;APP;EGF;TNKS1BP1
prerank,response to chemokine (GO:1990868),0.3494371308194553,0.8856677994339137,0.6226086956521739,0.9744406718579061,1.0,4/13,11.29%,SLC12A2;FOXC1;SH2B3;STK39
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.23427048983715754,-0.8856089798160883,0.6862170087976539,0.8391304612121757,1.0,13/44,19.72%,NRP1;PXN;ARHGEF10L;CD47;CARMIL1;SORBS3;S100A10;GPR65;MYOC;ARHGEF5;PFN2;PPM1F;RGCC
prerank,regulation of autophagosome assembly (GO:2000785),-0.2525722011468521,-0.8850283069107173,0.6551724137931034,0.8398293751825491,1.0,10/33,16.70%,CHMP4A;CHMP4B;SH3GLB1;SMCR8;MTM1;RALB;LRRK2;ADPRH;MTMR3;RAB3GAP2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3439883660945493,0.8848423255855543,0.6091205211726385,0.9756995358678994,1.0,5/13,18.46%,LTB4R2;GRM3;GABBR2;GNAI3;PALM
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.23583539544599483,0.8845243601768301,0.6997167138810199,0.9757265878257301,1.0,15/75,13.89%,F3;ANG;FLT4;PLCG1;TGFBR1;EGFL7;BMP4;PRKCA;PRKD2;PDCD6;FGF2;VASH2;PDGFB;TEK;HMGB1
prerank,gene silencing by miRNA (GO:0035195),0.2764320557619685,0.8842950652588555,0.636650868878357,0.9755246554327163,1.0,6/32,14.58%,ZC3H7B;ADAR;EIF6;SPOUT1;CNOT8;AGO4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3580709014445471,0.8841359762733352,0.6199649737302977,0.9751157721129212,1.0,5/12,12.71%,SGTA;SEC62;SGTB;SEC61A2;GET3
prerank,mitochondrial gene expression (GO:0140053),0.26062064353976233,0.884095643115453,0.6489028213166145,0.9744252928386569,1.0,7/42,16.64%,MRPS6;TFAM;MRPS7;GFM2;MRPL23;PTCD3;HARS1
prerank,negative regulation of chemotaxis (GO:0050922),0.27871231940543717,0.8839675029649278,0.6448,0.9739731403211905,1.0,8/31,16.66%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;SEMA4F;PTPN2;SEMA4B;SEMA3C
prerank,cellular response to cAMP (GO:0071320),0.28464704164567123,0.8839557893076863,0.6303317535545023,0.9732323436790475,1.0,5/30,12.75%,HCN1;RAPGEF3;PKD2;CFTR;CRHBP
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.30978071906996024,-0.8838442219692828,0.6206896551724138,0.8419981443309915,1.0,2/15,1.10%,IGF1;BCL2L1
prerank,visual perception (GO:0007601),0.23613924614700282,0.8837243381389313,0.6842105263157895,0.9730596532470865,1.0,8/84,8.53%,GUCY2F;ROM1;RDH10;COL2A1;CRYGN;CNGB1;CRYBA4;CABP1
prerank,canonical Wnt signaling pathway (GO:0060070),0.24151081034356217,0.8836194702882839,0.6911976911976911,0.9725530150228939,1.0,19/68,26.17%,WNT4;BCL9L;FRAT2;WNT3;RYK;TCF7L2;WNT8B;RAB5A;SFRP1;WNT7A;TCF7L1;DVL2;FRZB;AXIN1;SFRP2;PPP1CA;SCYL2;WNT5B;FZD5
prerank,regulation of adenylate cyclase activity (GO:0045761),0.30378648326773305,0.8834510025346439,0.6382306477093207,0.9722257944514658,1.0,6/22,18.46%,LTB4R2;GRM3;CACNA1D;GABBR2;GNAI3;PALM
prerank,cytoplasmic sequestering of protein (GO:0051220),0.351667399943421,0.8832494700574873,0.6271186440677966,0.9719619350563006,1.0,5/13,22.02%,PKD2;PKD1;SUFU;YWHAB;LATS1
prerank,fatty acid biosynthetic process (GO:0006633),0.2488358844960305,0.8831493017813234,0.6572280178837556,0.9714423008514055,1.0,17/63,20.82%,ALOX12;CBR4;TECR;OXSM;ELOVL6;ELOVL4;ACSBG1;NDUFAB1;ACSF3;ACLY;LIPC;XBP1;HPGD;DECR2;FADS3;ABHD2;ELOVL5
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3178624474772835,0.8827617560719836,0.662608695652174,0.9716487948594748,1.0,4/18,9.53%,FSCN1;IL6;CLASP2;TGFB1
prerank,cellular response to hormone stimulus (GO:0032870),0.23981437507776407,0.8821653935266758,0.68,0.972392241486369,1.0,21/69,25.92%,ADTRP;AKR1C1;WBP2;BRD8;AR;MEF2C;ADRA2A;LMO2;SOCS2;SFRP1;CRHBP;XBP1;NSMF;ATP1A3;ATP1A1;RDX;CTSS;GAS2L1;URI1;PELP1;CTSH
prerank,actin filament-based transport (GO:0099515),-0.2891322743505673,-0.8819897876963092,0.6403940886699507,0.8457823932109511,1.0,3/21,6.66%,MYO5A;MYO1F;MYO15A
prerank,exit from mitosis (GO:0010458),-0.3360418940727665,-0.8819730140390467,0.6180048661800487,0.8452260601620741,1.0,2/12,1.16%,CHMP4B;EPS8
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.24834291620337623,-0.8815153343617474,0.6787564766839378,0.8456611526385432,1.0,14/33,29.63%,RTEL1;PPP6R3;ANKRD28;RPA1;TERF2;NOP10;DKC1;TINF2;PIF1;NHP2;TERT;TNKS1BP1;HSP90AA1;PINX1
prerank,DNA methylation (GO:0006306),0.2970526441767734,0.8813876141062773,0.6389776357827476,0.9735366838447956,1.0,6/23,18.71%,ZFP57;METTL4;DMAP1;KMT2E;N6AMT1;SPOCD1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.31191585660656046,0.8811774536099465,0.6458684654300169,0.9725202961020885,1.0,2/19,2.31%,POLR2L;POLR2F
prerank,regulation of DNA recombination at telomere (GO:0072695),0.31191585660656046,0.8811774536099465,0.6458684654300169,0.9725202961020885,1.0,2/19,2.31%,POLR2L;POLR2F
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.29707509450530634,-0.8806789840739406,0.6430379746835443,0.846932602946122,1.0,14/19,38.83%,HRH1;PPP3R1;PPP3CA;NFATC2;PLCE1;NFATC3;GPR62;NFAT5;PPP3CB;EDN3;NFATC4;EDN2;EDN1;NFATC1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.2976812945420807,0.88051366557986,0.6314907872696818,0.9734013245247485,1.0,7/24,17.22%,THY1;MAPRE2;MAP4K4;IQSEC1;SFRP1;TEK;ROCK1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.33923818903746905,-0.8803274134474306,0.5873417721518988,0.8471300221197982,1.0,7/13,32.30%,IDUA;DSEL;CSPG4;DSE;CHST12;NCAN;CHST14
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.18589036504353576,0.8802696108601531,0.9074262461851476,0.9732312467751738,1.0,179/1082,16.30%,ZFHX3;WNT4;HOXA5;HHEX;AGRN;BCL9L;CDK7;MPND;TET1;CD80;ZFPM1;DRAP1;ASF1A;KCNH2;IL4I1;CAPN3;LDB2;LDB1;SMARCC2;MED24;ONECUT2;MYRFL;WWTR1;POU2F2;CSRNP3;TFCP2;USF2;HOXD4;BPTF;RPTOR;PTPRN;TXK;ESRRG;RELA;KDM6B;RAI1;DNAJC2;NR1I2;FOSL1;NRL;SIX4;NR1I3;PSRC1;NFIB;SOX10;TFAM;WBP2;PPARGC1A;UBE2V1;NSD1;MEOX2;SOX4;BCL11B;MED4;PPARA;PBX2;SERTAD1;MLLT11;BRD8;HOXB7;E2F1;CD86;KDM1B;FGF7;IL6;GABPB1;CRTC1;ZFPM2;AR;XRCC6;RFX6;MEF2C;WDR75;DPF2;BCLAF3;RXRG;DYRK1B;NDP;GTF2F1;FUBP3;TADA3;AKAP8L;TGFBR1;MAZ;BTRC;HOXC10;MYO6;DAB2IP;APBB1;LMO2;MACC1;LHX3;SS18;BMP4;CD81;TCF7L2;MAP2K5;HDAC5;OGT;ADCYAP1;PRKD2;PKD2;PPM1A;FOXC1;ERBB4;HEY1;ZNF462;GRIN1;RNASEL;MAML3;TAF9;TGFB1;SS18L1;LBH;ITGB1BP1;ZC3H8;AKIRIN2;MSANTD1;PRKN;NEK4;SPIN1;KLF7;GRHL3;HSF2;PTOV1;FGF2;NFE2L2;SMARCD3;HOXB2;MLLT6;RFXAP;KAT8;SFRP1;FANK1;USF1;PDGFB;TFEB;GABPA;EPAS1;HLF;PKD1;PHF8;PFKM;PARP1;MYRF;PRDM16;PLAG1;HMGB1;GPATCH3;FLCN;EAF2;CHCHD10;BARX2;PRDM10;CCNK;LMX1B;ZBTB49;APEX1;RBL1;GAL;BRD4;THOC5;ERG;DDX39B;ERCC6;IRF5;EDF1;WNT7A;SETX;REST;TCF3;RRP1B;MAPK3;ITGA6;LHX2;PRKD1;PRDM15;MED25;CALCOCO1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2496792559511355,0.8800744887441753,0.6637168141592921,0.9729297795067138,1.0,14/59,18.05%,HOGA1;GATM;CYP39A1;CBR4;OXSM;ELOVL4;NDUFAB1;CYP27A1;ACSF3;ACLY;AMACR;LIPC;HSD17B10;XBP1
prerank,anion transmembrane transport (GO:0098656),0.24296071639835234,0.8799972939478089,0.6742857142857143,0.9723550799528157,1.0,20/67,24.96%,SLC25A4;SLC35A1;SLC1A1;SLC25A18;SFXN1;SLC1A3;SLC39A8;SLC25A5;SFXN2;SLC19A1;SLC16A12;SLC13A3;SLC25A38;SLC6A9;LRRC8B;SLC25A10;SLC35B1;SLC16A7;SLC25A1;ABCC5
prerank,cardiac ventricle development (GO:0003231),0.3116686429201423,0.8798574915653825,0.616260162601626,0.9719002746152436,1.0,8/20,26.57%,DAND5;HEY1;GJA5;ENG;TMEM65;MDM4;HECTD1;SALL1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.18771824120250993,-0.8794774794146039,0.825,0.8484611463494602,1.0,25/151,14.52%,HACD4;APOE;B4GALT5;ACER3;SGPL1;MOCS2;PCYT1A;MGST3;MOCS1;PRKD3;GSTA3;GSTO2;RHD;PCTP;SGPP1;LCMT2;ALAS1;SPTSSB;GSTZ1;GSTM1;PEMT;GSTM5;SPHK2;PAM;STARD10
prerank,negative regulation of cell aging (GO:0090344),-0.3057533174253626,-0.8793736854419658,0.6177215189873417,0.8480920431660982,1.0,6/16,27.80%,CDK6;TERF2;HMGA2;TWIST1;TERT;SLC30A10
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.21011461349406335,-0.8792552813708651,0.7448979591836735,0.8478034694535147,1.0,22/72,22.94%,SP100;CNOT9;BAX;PCNA;BCL3;RPS6KA6;NBN;PIDD1;PAXIP1;EP300;CDK1;KAT5;E2F8;E2F7;SESN2;HIPK2;RPL26;RGCC;CDC25C;CNOT6L;GTSE1;CCNB1
prerank,renal system development (GO:0072001),0.25069058717104,0.8789799611702217,0.6696562032884903,0.9733230154479324,1.0,10/52,17.32%,WNT4;TGFBR1;BMP4;FOXC1;C1GALT1;PKD1;IFT27;IFT88;AGT;PYGO2
prerank,neural crest cell migration (GO:0001755),0.2698346551757524,0.8788937120917527,0.6614173228346457,0.9727873031028389,1.0,9/36,16.66%,SEMA7A;SOX10;SEMA6C;SEMA6B;SEMA3D;ERBB4;SEMA4F;SEMA4B;SEMA3C
prerank,regulation of Notch signaling pathway (GO:0008593),0.23905966231193163,0.8787828593407391,0.7122708039492243,0.9722922084722941,1.0,15/76,13.66%,ENHO;TCIM;YJEFN3;PRKCI;TSPAN15;PRAG1;BMP2K;EGFL7;POFUT1;HEY1;MAML3;ITGB1BP1;AAK1;BEND6;ARRDC1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3420138922877971,0.878557200749131,0.6274864376130199,0.9720450615829083,1.0,3/13,16.06%,STK11;ITFG2;RNF152
prerank,cellular senescence (GO:0090398),0.28701428609303,0.8785362774143236,0.6357723577235772,0.9713341317318027,1.0,6/27,20.22%,ECRG4;SMC5;TBX2;HRAS;MAPKAPK5;SRF
prerank,regulation of protein localization to centrosome (GO:1904779),-0.34846789061190186,-0.878453640027022,0.588495575221239,0.8489630896468898,1.0,5/10,22.99%,CEP250;UBXN2B;NUP62;PARD6A;MARK4
prerank,amino sugar biosynthetic process (GO:0046349),-0.3276948606741123,-0.8783282855874402,0.609375,0.8486297117299726,1.0,5/12,21.10%,GNPDA1;UAP1L1;GNPNAT1;NAGK;RENBP
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.21265474287980377,0.8781044964094533,0.7515923566878981,0.9716492779486376,1.0,24/142,16.45%,ACKR4;YWHAE;ADCY8;TRPC3;ACKR3;CDH23;FIS1;CCR1;ADCYAP1;CXCR6;CX3CR1;SLC8A1;TRPC6;CXCR4;ITPR3;P2RY1;ATP2B3;TAC1;CCR6;HMGB1;CCR9;ACKR2;PTGER1;CACNA1A
prerank,regulation of vesicle-mediated transport (GO:0060627),0.22918860975360386,0.8780406686653591,0.7001414427157001,0.9710277492909285,1.0,19/91,17.27%,LGI3;TSC2;ATP9A;RAB3A;SYT1;RAB26;PLA2G3;RAB8A;RIT2;INPP5F;RAB5A;RAB3D;CPLX2;BET1L;RAB12;HAP1;MAPK3;CD22;STXBP5
prerank,activation of GTPase activity (GO:0090630),-0.20207553903822723,-0.8778945147004207,0.734006734006734,0.8490145911316281,1.0,23/89,19.28%,TBC1D1;DOCK7;CORO1C;CCDC125;SLC27A4;RABGAP1;TBC1D2;ARHGAP24;ABR;RALGAPA2;ARHGEF26;FOXJ1;TBC1D10C;TBC1D10A;GPR65;USP6NL;ADPRH;EPHA2;ARHGEF5;ECT2;TBCK;BCAS3;TBC1D22A
prerank,telomere maintenance via telomerase (GO:0007004),-0.2598635856295578,-0.8774541540720215,0.6631853785900783,0.8494072956263482,1.0,14/28,29.63%,RTEL1;PPP6R3;ANKRD28;RPA1;TERF2;NOP10;DKC1;TINF2;PIF1;NHP2;TERT;TNKS1BP1;HSP90AA1;PINX1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.3584928251313421,-0.8774335506264078,0.6183908045977011,0.8482941642485978,1.0,3/10,15.08%,RACK1;SPHK2;TNF
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3584928251313421,-0.8774335506264078,0.6183908045977011,0.8482941642485978,1.0,3/10,15.08%,RACK1;SPHK2;TNF
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.30872687685853456,-0.8770921689847742,0.638755980861244,0.8484624508414328,1.0,3/15,7.62%,RNF213;SPEF1;ZNRF3
prerank,nuclear membrane organization (GO:0071763),-0.29272899705348865,-0.876994173220619,0.6444444444444445,0.8481289280152413,1.0,7/19,21.58%,CHMP4B;TOR1AIP1;TOR1B;NEMP1;UBXN2B;PLK1;TMEM43
prerank,linoleic acid metabolic process (GO:0043651),-0.296177802595889,-0.8767567889617772,0.6224489795918368,0.8480557267839515,1.0,7/17,29.52%,ALOX5;ALOXE3;ELOVL2;GSTP1;ALOX15;ABCD1;FADS2
prerank,ATP transport (GO:0015867),0.3702574186257585,0.8766950237658925,0.6175438596491228,0.9734772777603222,1.0,3/10,19.70%,SLC25A4;SLC25A5;ABCC6
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.3255926271224528,-0.8762458112909565,0.6298076923076923,0.8486544919648521,1.0,6/12,21.59%,CIITA;IFITM3;TRIM5;GSN;PTX3;IFITM1
prerank,response to tumor necrosis factor (GO:0034612),0.22861333166731546,0.8761732086680231,0.7247191011235955,0.9739916799195835,1.0,14/91,12.75%,GGT7;YTHDC2;RELA;NUB1;GSDME;GGT5;CACTIN;DAB2IP;ZFP36L2;NFE2L2;NPNT;CASP3;SFRP1;CRHBP
prerank,long-chain fatty acid import into cell (GO:0044539),-0.3512223646853686,-0.8760735068737707,0.6198547215496368,0.8484517378454101,1.0,2/10,5.14%,CD36;SLC27A4
prerank,negative regulation of cellular process (GO:0048523),0.19016185354464077,0.8759201232643362,0.8335135135135135,0.9738463551935324,1.0,96/521,17.86%,ATP8A2;P3H2;TPTE;TSC2;WFDC1;SMYD2;AVPR2;SRGAP2;PLXNB2;NACC2;CD34;SLURP1;NTRK1;PSRC1;SUSD2;ARHGDIG;COPS8;TENM1;SOX4;IGFBP6;PTPRU;JAM2;STK11;SIPA1;IL6;SRSF6;DSCAM;PDCD5;CLU;AR;CTBP1;GSDME;RBM5;PDE3B;EEF1E1;TGFBR3;ADAM22;MINAR1;DAB2IP;APBB1;CCN4;FHL1;BMP4;NME1;GNG4;ARHGDIA;PKD2;ERBB4;SST;TGFB1;ITGB1BP1;ADAM15;NMI;BTG3;PRKN;SH2B3;CGRRF1;THAP12;FGF2;BTG2;BECN1;ACVR1B;SFRP1;DCBLD2;CHMP1A;INHA;PPP1R13B;VAMP3;CBLL1;FLCN;BAP1;EI24;EPHB2;TXNDC12;IFI35;CHMP2A;ZBTB49;PTPN2;MIA3;CCAR2;SH3BP4;ADORA3;REST;COL18A1;PRKD1;DNAJA3;CTTNBP2NL;HRAS;OPRM1;CDK10;UTP20;NDRG3;IL1A;PPP2R1A;FABP3;BTG1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3234296996889513,0.8759098598897969,0.6327868852459017,0.9731064637558591,1.0,4/17,12.71%,SGTA;EMC6;EMC2;GET3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2462263690644967,0.875318596909392,0.6932153392330384,0.9737983135581638,1.0,19/60,24.36%,WRAP53;SMOC2;MAPK15;PRKD2;FGF2;CCT4;PDGFB;HNRNPA1;MAPK3;MAPKAPK5;PDGFRB;HSP90AB1;CCT7;XRCC5;GRHL2;RFC4;TNKS2;PARM1;MAPK1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2165080583306918,-0.87503985998152,0.740506329113924,0.8502575027884715,1.0,16/59,20.58%,MARK2;TBK1;LMTK2;TAF1;DYRK1A;CIT;CAMK2D;HIPK1;CAD;CDK1;NLK;LRRK2;MAPK8;HIPK2;CDC42BPG;ACVR1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.29679325307752935,0.8749337950975324,0.6420545746388443,0.9739636710665313,1.0,4/23,10.90%,LBX2;SIX4;BMP4;FGF2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3075019884984074,0.8747055113975651,0.6341059602649006,0.973739329656978,1.0,3/19,5.93%,FIS1;PRNP;TRPM2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.35221371945349655,0.874502210524746,0.6304728546409807,0.9734746989245159,1.0,5/12,19.84%,DCK;TK1;TK2;DHODH;UCK1
prerank,protein maturation (GO:0051604),0.22478376412450668,0.8744736611611568,0.7363387978142076,0.9727902644086313,1.0,34/95,28.67%,F3;MMP16;NNAT;ASPRV1;BACE1;XPNPEP3;TSPAN15;TSPAN32;OGT;PHEX;AEBP1;PSENEN;NAA35;PITRM1;NDUFAB1;NAA60;TYSND1;PCSK2;ADAMTS3;LMF1;GALNT2;METAP2;CASP2;CTSS;PCSK7;SDE2;STUB1;TMPRSS4;AANAT;EEF1AKMT4-ECE2;ECE2;BOLA2;LONP2;TSPAN33
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.31937759660917975,-0.8744156386196491,0.6487804878048781,0.8510426171311721,1.0,7/14,37.29%,TYROBP;TNF;CSF1;IL23R;IL12B;POU4F2;POU4F1
prerank,organic acid transport (GO:0015849),-0.19846243131886052,-0.8739051654673334,0.7945736434108527,0.8516017816697635,1.0,10/94,6.27%,LRRC8D;SLC1A5;SLC7A1;SLC43A2;SLC6A6;SLC7A11;SLC27A4;PPARD;NCOA1;SLC46A1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.1870126020306425,-0.8738250685709956,0.8258928571428571,0.8512078458575627,1.0,34/145,19.18%,PSMA6;RAD51B;MECP2;PCM1;CDK5RAP2;PSMB2;PRKACA;GPR132;PSME2;TUBA4A;CEP250;PSMD11;CCND1;PSMC6;PSMA3;YWHAG;HMMR;HAUS2;CEP164;MAPRE1;CDK1;HAUS8;PSMD10;PSMB5;CDC25A;KCNH5;DTL;PSMD5;DCTN2;TPX2;PSMD1;PLK1;ODF2;PAFAH1B1
prerank,negative regulation of cation channel activity (GO:2001258),-0.26046222290581234,-0.873784236926872,0.6896551724137931,0.8506975535812406,1.0,15/26,32.49%,UBQLN1;DRD2;CALM3;CALM2;KCNAB1;DRD3;EPO;GNB5;KCNE3;CASQ2;FKBP1A;CALM1;SRI;MMP9;GPR35
prerank,negative regulation of secretion by cell (GO:1903531),-0.2397887453618081,-0.8736766711963719,0.6958904109589041,0.8503387967187468,1.0,12/38,20.12%,APOE;ANXA1;DRD2;NOTCH1;HTR1B;TNFRSF1B;STXBP6;LILRB1;SLC30A1;DPH3;DRD3;SERGEF
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.18402877672819298,-0.873513763243252,0.8423423423423423,0.8501312672712729,1.0,73/152,36.88%,ADGRE5;ADGRG6;AKAP12;PSAP;ADCY9;PTGER4;S1PR2;CHRM2;PF4;GNA12;VIPR1;GNA13;NPY1R;ADCY5;ADCY6;ADCY1;HTR1B;GNA14;GPR65;ADCY3;PRKACB;RAMP2;CALCRL;PDE2A;AKAP5;PTHLH;OPRK1;GPR37;ADGRG5;S1PR3;ADGRL2;LPAR2;ADGRB1;VIPR2;RXFP2;PTH1R;CALCA;GLP1R;RAMP3;SCTR;S1PR4;ADORA2A;VIP;GRK5;LPAR3;ADGRG7;FPR2;GPR4;PTGIR;TBXA2R;ADGRG1;OPRL1;GPR26;ADGRG2;GIPR;LGR4;HTR1D;PTGFR;MC2R;CORT;CXCL9;CRHR2;ADGRD1;DRD1;GPER1;GPR3;CALCR;FPR1;FSHR;LHCGR;GHRH;CALCB;ADCY4
prerank,regulation of mitochondrion organization (GO:0010821),-0.23212204961725177,-0.8732472030639264,0.7163323782234957,0.8501527332876553,1.0,11/47,18.72%,PID1;FBXW7;STAT2;VPS35;PARL;EP300;LRRK2;PDE2A;MUL1;SQSTM1;PISD
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.20345685799194158,-0.8731397478001793,0.7406015037593985,0.8498051702540165,1.0,21/86,19.21%,PSMA6;LIMD1;ATF3;PSMB2;PSME2;VHL;PSMD11;PSMC6;UBC;PSMA3;HIF1A;UBA52;EP300;PSMD10;PSMB5;MAPK7;HMOX1;KLF2;PSMD5;PSMD1;DNAJB1
prerank,mitochondrion morphogenesis (GO:0070584),-0.33940035131558133,-0.8730302155243269,0.6305882352941177,0.8494837613328243,1.0,3/11,15.87%,PID1;MTM1;WASF1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.2748945252584334,-0.8729777646043193,0.65,0.8490243695727592,1.0,6/23,15.08%,MSN;THBS1;LYN;BMP5;CXCL17;TNF
prerank,stress granule assembly (GO:0034063),-0.28464536505360805,-0.8727410205057258,0.6246973365617433,0.8489878977416989,1.0,4/20,10.45%,RPS23;UBAP2L;DDX6;EIF2S1
prerank,copper ion homeostasis (GO:0055070),0.3231038692426283,0.8724545292317027,0.6326860841423948,0.976996781636773,1.0,4/17,6.68%,ABCB6;PRNP;SLC31A1;COMMD1
prerank,long-term synaptic potentiation (GO:0060291),0.2983921273787957,0.8719271479360762,0.6366559485530546,0.9774766090950364,1.0,5/21,17.07%,MPP2;PRKCZ;GRIN2B;SLC8A3;PLK2
prerank,regulation of cell morphogenesis (GO:0022604),0.2800699877666895,0.8712758715917468,0.6597444089456869,0.9782804033358903,1.0,8/30,19.60%,BCL9L;CFL1;CAMSAP1;FITM2;NTNG2;NTNG1;ZMYM6;ZMYM3
prerank,negative regulation of receptor internalization (GO:0002091),0.3515961999263397,0.8711460308646825,0.6279863481228669,0.9778114918859301,1.0,2/12,1.59%,RIN3;ANKRD13D
prerank,regulation of primary metabolic process (GO:0080090),-0.1923918116046574,-0.8709329163005008,0.8151260504201681,0.8524072345665327,1.0,38/126,24.25%,APOE;PSMA6;PSAP;SIN3B;PPARG;PSMB2;PRKAB1;PSME2;PPARD;PSMD11;NCOA1;SP1;PSMC6;LDLR;TBL1X;PSMA3;IDI1;PSMD10;PSMB5;PRKAB2;ODC1;ACACA;SC5D;CERS2;GPAM;HELZ2;GGPS1;PSMD5;PSMD1;IRS2;NCOR1;MVK;ID2;TBL1XR1;PMVK;PSMB7;PSMA7;FGFR4
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.18161209414270268,0.8706703818800833,0.9348044132397192,0.9782479008491672,1.0,296/1668,18.18%,ZFHX3;HOXA5;HHEX;AGRN;NUCKS1;BCL9L;DCAF1;CDK7;SCRT2;MPND;CTR9;TET1;SMYD2;MED12L;HSF4;ZFPM1;ZFP57;SALL3;IKZF4;DRAP1;IL4I1;LDB2;LDB1;RTF1;SMARCC2;NACC2;MED24;ONECUT2;BRD9;FUS;WWTR1;POU2F2;CSRNP3;TFCP2;USF2;HOXD4;BPTF;ZNF394;PTPRN;CNOT2;TXK;ESRRG;DDX5;PKN1;RELA;KDM6B;RAI1;LBX2;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;KCNIP3;DMRT2;ELP2;SP2;SOX10;TFCP2L1;SLA2;WBP2;PPARGC1A;NSD1;MEOX2;RIPPLY2;GTF2H2;SOX4;BCL11B;MED4;ZBTB12;PPARA;HOXB9;HOXC6;BRWD1;PBX2;BRD8;HOXB7;ELOC;TCF25;E2F1;KDM1B;IL6;HDGFL2;GABPB1;CRTC1;ZFPM2;SMARCE1;AR;CBX2;CTBP1;FOXD1;XRCC6;NR2F6;RFX6;MEF2C;DPF2;BCLAF3;GTF2H4;RXRG;MED31;GTF2F1;PCGF6;FUBP3;TADA3;ZNF35;ZNF205;AKAP8L;PHF6;MAZ;HOXC10;REPIN1;NCOR2;MYO6;DAB2IP;APBB1;LMO2;MACC1;LHX3;CBX6;SS18;SP4;BMP4;CD81;TCF7L2;EBF1;DGKQ;MAP2K5;ZBTB22;HDAC5;PRDM6;OGT;ADCYAP1;PRKD2;PKD2;PPM1A;FOXC1;HEY1;ZNF462;GRIN1;ZFP82;RNASEL;TSHZ2;HTATSF1;MAML3;TAF9;TGFB1;ZFP91;SS18L1;TBX2;ITGB1BP1;ZNF23;AEBP1;PLK3;SNAI2;ZKSCAN8;AKIRIN2;HEXIM2;PRKN;KLF7;DMRTA1;GBX1;VPS72;GRHL3;NKAP;HSF2;ZFP69;PTOV1;FGF2;NFE2L2;EFNA1;ZNF32;ZFP1;KDM2B;CBX4;SMARCD3;HOXB2;ZFP41;MLLT6;IFI27;NOP2;POU3F4;RFXAP;KAT8;PBX3;SUV39H2;ZNF383;THAP1;WWC1;USF1;TFEB;GABPA;EPAS1;HLF;HOXB5;PKD1;SAP130;PHF8;TBX6;PFKM;PARP1;FBXL19;LHX5;GADD45A;SMARCAL1;TEF;SUB1;PRDM16;PLAG1;ZSCAN12;HMGB1;FLCN;RNF2;ABCA2;ZBTB32;MYNN;DMAP1;EAF2;BARX2;TAF3;PRDM10;PPP1R13L;CCNK;LMX1B;AGO4;OTUD7B;ZBTB49;IKZF2;NKX2-2;APEX1;RBL1;PRDM1;GAL;BRD4;NEDD4L;HMGB3;ZNF740;ERG;IRF5;BATF;BHLHA9;WNT7A;UBE2I;SETX;UXT;REST;TCF7L1;TCF3;RRP1B;MAPK3;ITGA6;LHX2;PRKD1;DNAJA3;PRDM15;MED25;CALCOCO1;PEX2;PAF1;HRAS;EN2;KLF16;BHLHE41;IRF2BP1;SUFU;BRIP1;BACH1;PRKAR1A;RHOQ;TLR3;PSIP1;TMPRSS6;ENG;MAX;BACH2;ZIC5;HDGFL3;ZBTB34;IL18;ZNF750;ZFP30;ZEB1;KLF12;XBP1;RGMA;PHF2;POU3F3;ECD
prerank,smooth muscle tissue development (GO:0048745),-0.3499642293965891,-0.8702266748136903,0.6335540838852097,0.8534205688567679,1.0,5/10,22.21%,PROX1;EFEMP2;MYLK;PTCH1;SHH
prerank,plasma membrane repair (GO:0001778),0.34039038802786814,0.8700081619630332,0.636518771331058,0.9790853668726929,1.0,2/13,3.44%,RAB3A;SYTL4
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.33483819507164037,-0.8699912818862259,0.6474654377880185,0.8527928371229544,1.0,4/11,14.90%,STAT5B;SYK;SHC1;PTK2B
prerank,cellular response to interleukin-2 (GO:0071352),-0.33483819507164037,-0.8699912818862259,0.6474654377880185,0.8527928371229544,1.0,4/11,14.90%,STAT5B;SYK;SHC1;PTK2B
prerank,glial cell development (GO:0021782),0.293476304142205,0.8699313904455219,0.6499189627228525,0.978513505158039,1.0,6/25,15.26%,TPPP;SOX10;SOX4;EIF2B3;MYRF;EIF2B1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2463987449290671,0.8693195703191765,0.7004341534008683,0.9792161776159872,1.0,14/50,22.82%,IVNS1ABP;SOX4;NXN;ARRB2;MINAR1;LIMK1;OGT;UBXN1;PRKCG;PRMT3;FBXO5;ARRB1;CAMLG;HDAC8
prerank,secondary alcohol biosynthetic process (GO:1902653),0.28317398945955713,0.8691621355282926,0.6628849270664505,0.9788143381053211,1.0,6/30,18.86%,TM7SF2;ACAT2;NSDHL;LSS;ACLY;FDPS
prerank,blood circulation (GO:0008015),0.2508277907706765,0.8690722458294258,0.6870451237263464,0.9782824689447893,1.0,10/49,17.22%,AVPR1A;TNNI3;MEOX2;ITGB1BP1;SGCZ;HOXB2;SGCG;TBC1D8;SGCD;ROCK1
prerank,regulation of bone mineralization (GO:0030500),0.24741057909762837,0.8690681944247372,0.7015384615384616,0.9775342449657478,1.0,8/55,9.62%,WNT4;MEF2C;CCR1;FBN2;BMP2K;BMP4;TGFB1;SLC8A1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.2987824235712743,0.8689176439096961,0.649746192893401,0.9771498658025538,1.0,3/22,4.00%,RPP40;ERI3;NOP9
prerank,pharyngeal system development (GO:0060037),0.3280085628224027,0.868797969973743,0.6513605442176871,0.9766820216396624,1.0,3/15,8.34%,SIX4;TGFBR1;BMP4
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.34596960885863454,-0.8687609633497722,0.6187214611872146,0.8549578587362416,1.0,5/10,20.76%,MTHFR;MTHFD1;TYMS;MTHFD2;DHFR
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.25868579194828156,-0.8686753247431368,0.6585956416464891,0.8545516895343516,1.0,4/28,3.27%,MECP2;CDK5RAP2;GIT1;MET
prerank,negative regulation of cell differentiation (GO:0045596),-0.18106793298229132,-0.8685398409750673,0.8703703703703703,0.8542618574548692,1.0,52/181,23.30%,NBR1;NOCT;CDK6;LIMD1;CDC73;XDH;PPARG;MEIS1;SMAD3;CAV1;NR1H2;YAP1;ANP32B;MAD2L2;ABCG1;BMP5;SPRY2;FOXO1;NOTCH1;IGF2;TRPM4;SPRY1;SMAD6;NR1H3;RB1;GREM1;RIOX1;EGFR;NOTCH4;PTK2B;TNF;WNT5A;PTHLH;GATA3;NPHP3;HES1;ITGB3;NEPRO;HNRNPU;BMP7;ESRRB;BAMBI;WNT9A;SIRT2;ADAMTS12;PTCH1;ID2;SEMA4D;SHH;TWIST1;TNN;LEO1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.32395745256524905,0.8685077386118806,0.6650082918739635,0.9766494600140201,1.0,4/16,20.23%,LTBP3;FOXC1;NUDT21;DHX36
prerank,sulfur compound biosynthetic process (GO:0044272),-0.19088026257891916,-0.8682942380469075,0.8205128205128205,0.8542366421941181,1.0,30/104,24.63%,CHST11;B4GALT5;PAPSS2;MGST3;CHST9;GGTA1;GSTA3;GSTO2;UGDH;GCLC;OGN;DSEL;GSTZ1;CSPG4;GSTM1;CHST7;MPST;GSTM5;CHPF;LIAS;DSE;CBS;CTH;SLC35D2;LUM;CHST12;GSTP1;CHSY3;CHST3;ANGPT1
prerank,positive regulation of dendrite development (GO:1900006),-0.3431894976227993,-0.8679844500594597,0.6244131455399061,0.8543143493005749,1.0,6/10,30.91%,BMP5;COBL;PTN;BMP7;VLDLR;PACSIN1
prerank,regulation of gene silencing by RNA (GO:0060966),-0.22940790618300066,-0.8679208025344874,0.7348242811501597,0.8533010039191171,1.0,14/50,15.60%,POLR2E;RANBP2;PUM2;NUP153;NDC1;H3-3A;NUP43;NUP210;POLR2B;AGO2;POLR2H;POLR2J;TRIM71;NUP62
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.22940790618300066,-0.8679208025344874,0.7348242811501597,0.8533010039191171,1.0,14/50,15.60%,POLR2E;RANBP2;PUM2;NUP153;NDC1;H3-3A;NUP43;NUP210;POLR2B;AGO2;POLR2H;POLR2J;TRIM71;NUP62
prerank,protein lipidation (GO:0006497),0.24147203658955657,0.8678565499126482,0.7043478260869566,0.9774312823574522,1.0,23/59,28.18%,PIGQ;ZDHHC22;PIGB;PIGP;ZDHHC8;MPPE1;ZDHHC1;ZDHHC2;ZDHHC23;DPM3;SELENOK;PGAP2;ZDHHC15;WDR45B;GPLD1;PGAP3;GLUL;ZDHHC5;WIPI2;ZDHHC12;DPM1;DPM2;PIGZ
prerank,regulation of neuroblast proliferation (GO:1902692),0.3298396820594594,0.8674294649326192,0.6445993031358885,0.977604813883465,1.0,4/15,15.04%,CX3CR1;SMARCD3;DCT;TAFA1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.32557315073885623,0.8669477230964879,0.6485568760611206,0.9779827172287182,1.0,7/16,23.15%,TRPC3;PRKCA;PARP1;AGT;ROCK1;SLC9A1;MEF2A
prerank,peripheral nervous system development (GO:0007422),0.29190813927941994,0.8668397272602623,0.6514886164623468,0.9774705188298352,1.0,4/23,10.39%,SOX10;GPC1;NFASC;ASIC2
prerank,positive regulation of cell growth (GO:0030307),0.22498339212981444,0.8665228577558104,0.7166900420757363,0.9774538487049668,1.0,15/96,11.58%,KLHL22;SEMA7A;SYT4;RPTOR;SYT1;HDGFL2;LGI1;IL2;TGFBR1;LIMK1;TWF2;CDKL5;CPNE6;RIMS1;SFRP1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.2203364251377829,-0.8665043096047458,0.7815699658703071,0.85574449724512,1.0,16/58,22.43%,HACD4;ACER3;SGPL1;PRKD3;ST8SIA6;SGPP1;SPTSSB;SPHK2;CERS2;SPTLC2;HACD2;ALDH3A2;SPTLC3;HACD1;VAPB;ELOVL2
prerank,stem cell development (GO:0048864),-0.30209316733222313,-0.8655747472976197,0.6313253012048192,0.8571486001152989,1.0,5/16,14.94%,PTPRC;SOX11;TCOF1;KBTBD8;CDH2
prerank,extracellular matrix assembly (GO:0085029),0.2898339999862974,0.8655500847948859,0.6689536878216124,0.9789475656697199,1.0,7/23,18.22%,LTBP3;LAMB3;TGFB1;PXDN;QSOX1;NTNG2;NTNG1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.26967457722012134,-0.8653202022402221,0.6675062972292192,0.85712246259405,1.0,7/22,23.62%,PTPA;BOD1;CRY2;TNF;PPP1R15A;BOD1L1;MASTL
prerank,melanosome organization (GO:0032438),0.2866568641657647,0.8652365720638451,0.6711409395973155,0.9789346356621775,1.0,4/26,10.68%,BLOC1S2;ABCB6;SNAPIN;RAB38
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.29156675007603616,0.8648508281061011,0.6508972267536705,0.9790602511698119,1.0,7/24,13.98%,NUB1;UBE3A;EFNA1;PSME3;PKD1;PSMD14;EPHA4
prerank,cellular protein modification process (GO:0006464),0.18337627107488919,0.8645571589364449,0.9209445585215605,0.9789928540170388,1.0,234/982,22.57%,KLHL25;TPTE;KLHL22;CDK7;SLC35A1;FBXW8;ST3GAL5;B3GNT9;HS3ST5;FUT10;STRADB;PSMB1;PLAT;MERTK;MATK;B3GNT6;CDK15;C3;B3GALT2;OBSL1;DDOST;PPM1E;RAB1B;PTPRD;NIM1K;CST3;FBXW9;TXK;RAB3A;STK26;PAK1;PKN1;DUSP29;NTRK1;AFP;COPS8;ALG1;UBA7;CHM;PTPRT;PTPRO;PTPRU;STK11;PRKCZ;SOCS3;SERP2;ELOC;YES1;UBE2M;FSTL1;IL6;CTBP1;FBXO7;TRIB1;NUB1;RYK;TRIB2;METAP1D;RAB8A;COMMD1;DYRK1B;PRKCI;ST6GALNAC2;RIPK3;PSMF1;TGFBR1;CDC42BPA;ASB2;BTRC;NRBP2;FBXO11;PRAG1;BMP2K;LIMK2;LIMK1;PPP1CC;BMP4;STK36;PSMA1;PRKCA;SOCS2;CDKL5;PRKD2;PPM1A;PSMD7;MAP4K4;RNASEL;PHEX;PTPN3;TGFB1;COPS3;B3GALNT1;PSMA8;NEK4;FBXW10;HSP90B1;BTK;RAB38;AAK1;RAB5A;MINK1;NEK1;STK39;PSME3;FBXL20;VRK2;ACVR1B;SENP8;KLHL2;SCG3;STK25;NTAQ1;PPP2R3A;CUL2;PAK5;PPP3CC;PDGFB;TGM4;EPAS1;VCAN;PSMD14;COQ8A;PRKG1;SPSB3;NUCB1;ST3GAL6;FBXL4;PARP1;FBXL19;PSMC4;PPP5C;AGA;DDB2;DCAF11;LRRC41;PGGT1B;COPS6;SOCS6;SDHAF2;BAP1;MAP3K13;GLYCTK;TGM1;INSR;AMHR2;KLHL11;MAPK10;DUSP2;FBXW5;MIA3;ERG;KLHL5;EIF2AK4;UBE2I;SKP2;PDP2;FN3K;APLP2;MAPK3;UBA3;PRKD1;PIGS;DMPK;SSH1;COP1;CTTNBP2NL;SSH2;FBXL2;PRKCG;KLHL42;TAOK1;PAK6;CSNK1G3;ALG5;PLK2;CDC42BPB;ALG3;ROCK1;CDK10;AATK;FBXO9;PTPRS;PTPN13;QSOX1;PPP2R1A;MAST2;PARP6;PSMB4;FBXL7;PLK4;AKT3;UBL5;FBXL3;MAP4K2;WNK1;STRADA;ST3GAL3;SDC2;WSB1;BMPR1B;FBXL22;SPARCL1;RABGGTB;FBXO31;ACVR1C;COPS5;PSME1;CDKL1;FBXO6;UBE2S;LIPE;ABCA7;PSMD2;PDPK1;PDK1;NUAK1;PPM1L;PSMD4;FCGR3A;PPP6C;METAP2;PPP2R5D;CDK4;LATS1;PSMD8;LARGE1;OGA;CLK3;WDR5;PARP10;FBXO21;STT3A;ULK1;SIK3
prerank,mitochondrial fission (GO:0000266),0.31692011248621055,0.8645344521498015,0.65,0.9782943859588542,1.0,5/16,17.54%,FIS1;PRKN;DNM1L;SLC25A46;MFF
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.3425413061096419,0.8639638068463169,0.6365248226950354,0.9789326023661237,1.0,3/12,18.72%,GSS;GGCT;CHAC2
prerank,Ras protein signal transduction (GO:0007265),0.2138336872616314,0.8638109192640874,0.7582697201017812,0.9785506512933888,1.0,36/137,21.62%,KSR2;EPS8L3;ARHGDIG;SGSM3;RGL2;NCKAP1;CDC42EP5;ADRA2A;USP50;RIT2;CTNNAL1;LIMK1;ARHGDIA;RAPGEF3;ARHGAP5;GDI1;CFL1;FGF2;FARP2;HACE1;CYFIP1;EPS8L2;PRKD1;HRAS;RIPOR1;MAPKAPK5;RRAS2;PLK2;ROCK1;SETDB1;ARHGAP1;CDC42EP4;CDC42EP1;ARHGAP4;RAP2C;SHC3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.27127770919337274,-0.863237162737407,0.7128205128205128,0.8610203695320503,1.0,7/24,13.52%,CCBE1;IL6ST;HIF1A;IL1B;BRCA1;HPSE;CXCL17
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.30101743500089345,-0.863078482786907,0.6599496221662469,0.8607923033149416,1.0,4/16,15.08%,APOE;HDAC1;LRP1;TNF
prerank,positive regulation of viral process (GO:0048524),0.24093649083737206,0.8630489697724323,0.7022222222222222,0.979652921691727,1.0,7/60,6.91%,POLR2L;POLR2F;NELFB;PPARA;NELFCD;ADAR;GTF2F1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.19631964066144486,-0.8624619086795401,0.8048780487804879,0.8615526115332195,1.0,28/104,20.89%,UBE2D3;PPARG;SMURF2;MTMR4;SMAD9;SMAD3;CAV1;UBC;SNX25;LEMD3;UBA52;SPRY2;NOTCH1;SPRY1;SMAD6;CCN3;GREM1;BMP2;FAM89B;ASPN;ADAM17;HIPK2;SMAD4;ACVR2A;GDF3;BAMBI;ACVR1;TRIM33
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.240379129133562,-0.862260609128981,0.7254901960784313,0.8614222400651396,1.0,14/38,23.94%,NDUFS4;NDUFV2;NDUFA5;NDUFS8;NDUFB3;NDUFB11;NDUFB10;NDUFS7;NDUFA7;NDUFB2;NDUFB8;NDUFAF1;NDUFA13;NDUFA11
prerank,histone H2A monoubiquitination (GO:0035518),0.32204162175194795,0.8619820107015015,0.6621392190152802,0.9814490094789308,1.0,5/17,14.10%,PCGF6;KDM2B;RNF168;DDB2;RNF2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.30509937297997464,-0.861861723515729,0.6628175519630485,0.8616836683090802,1.0,4/15,14.63%,CCR2;SYK;CD55;EBI3
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.2881295016188093,0.8617961984019986,0.675,0.9811376201439587,1.0,5/25,12.79%,BCAS2;TRA2B;LSM1;MPHOSPH10;SF3B3
prerank,respiratory electron transport chain (GO:0022904),-0.31147938846345474,-0.8616952104239834,0.6454767726161369,0.8615027679094058,1.0,3/14,6.24%,GPD2;NDUFA5;SDHB
prerank,regulation of exosomal secretion (GO:1903541),-0.2898146464181445,-0.861680485652702,0.6635071090047393,0.860958101281535,1.0,6/19,19.93%,SDCBP;RAB7A;PDCD6IP;STAM;SDC1;SDC4
prerank,protein import into mitochondrial matrix (GO:0030150),0.3079913677402099,0.8615679535221095,0.6545768566493955,0.9809204974417524,1.0,5/18,23.11%,TOMM40L;TIMM21;TOMM70;TIMM23;TIMM44
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.24927439216622213,-0.8612320227705075,0.6921052631578948,0.8613736683853936,1.0,14/29,29.63%,RTEL1;PPP6R3;ANKRD28;RPA1;TERF2;NOP10;DKC1;TINF2;PIF1;NHP2;TERT;TNKS1BP1;HSP90AA1;PINX1
prerank,nucleocytoplasmic transport (GO:0006913),-0.2334504574635597,-0.8611677473711016,0.7306666666666667,0.8609380569642773,1.0,10/40,15.80%,RSRC1;NCBP1;ATXN1;SNRPD1;SNRPB;XPO1;NUTF2;NXT1;NPM1;DDX20
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.2845757417662133,-0.8606235490900738,0.6802030456852792,0.8615856574210883,1.0,7/18,20.54%,LYN;F7;PTN;PTK2B;ADAM17;SLC8B1;MTUS1
prerank,regulation of complement activation (GO:0030449),0.2598003576860484,0.8602824489591776,0.6802507836990596,0.9831092610856318,1.0,10/40,21.81%,C3;C9;CLU;CFH;CD81;C8G;VTN;CR1L;CR2;C5AR2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.2803302963011343,0.8601972028010668,0.6787974683544303,0.9825842033482771,1.0,6/28,13.66%,TCIM;TSPAN15;EGFL7;HEY1;BEND6;ARRDC1
prerank,cellular response to BMP stimulus (GO:0071773),0.237085296153466,0.8601933465942114,0.7280575539568346,0.9818493830583227,1.0,15/66,20.91%,DDX5;MEGF8;SLC33A1;TGFBR3;BMP4;TGFB1;SFRP1;AMHR2;MAPK3;GDF1;ENG;RGMA;BMPR1B;SMAD1;SMAD2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3454114224247353,-0.8601730345735205,0.6513317191283293,0.8619540369341919,1.0,7/11,38.64%,CTNNB1;WNT5A;LRP6;FZD1;LMX1A;WNT2;NR4A2
prerank,cellular response to interleukin-1 (GO:0071347),-0.18091726586392903,-0.8601543504043863,0.8874458874458875,0.8614207806927053,1.0,32/143,18.89%,PSMA6;CD47;MAP3K8;PSMB2;PSME2;NFKB1;CCL25;PSMD11;NOD2;PSMC6;UBC;GBP3;PSMA3;HIF1A;IL1B;TAB1;ZC3H12A;UBA52;PTGIS;RC3H1;ACOD1;PSMD10;IRAK4;PELI1;HAS2;PSMB5;RBMX;HYAL3;SQSTM1;PSMD5;IL1R2;PSMD1
prerank,cellular response to leucine starvation (GO:1990253),0.35403891435400664,0.8601107763399505,0.644927536231884,0.9813032945136266,1.0,6/10,31.60%,EIF2AK4;IMPACT;RRAGD;GCN1;SESN3;RRAGB
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2565838295231511,-0.8598416234416677,0.7194444444444444,0.8615305815279075,1.0,10/27,21.55%,FBXL17;FBXL8;CRY2;CRY1;SIK1;PDE6B;PER2;FBXL12;BHLHE40;ID2
prerank,reverse cholesterol transport (GO:0043691),-0.31699121455205026,-0.8594492878940312,0.6473429951690821,0.8618317352193698,1.0,2/13,9.63%,APOE;ABCG1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.23154410223171581,0.8593996543499818,0.7456896551724138,0.9822368934893796,1.0,14/78,11.03%,RNF19A;SGTA;CLU;TRIB1;NUB1;TRIB2;RNF180;PRICKLE1;SUMO2;PLK3;PRKN;NFE2L2;ZYG11B;HERPUD1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.34716555258014575,-0.8590663446772312,0.6226415094339622,0.8620417457689891,1.0,1/10,0.77%,PTPN22
prerank,regulation of cilium assembly (GO:1902017),0.23529617223004676,0.8589596470182447,0.6947674418604651,0.9824951490649223,1.0,22/62,29.05%,IFT20;SGSM3;MAPK15;LIMK2;CDKL5;TBC1D16;ARHGAP35;RABEP2;TBC1D8;IFT88;CDK10;TCHP;CYLD;CDKL1;CEP120;TBC1D30;FUZ;TBC1D24;TBC1D22B;ENTR1;TBC1D9B;DCDC2
prerank,regulation of protein ubiquitination (GO:0031396),0.21608967392256542,0.8589367713906308,0.7354085603112841,0.9818062732708127,1.0,29/108,23.38%,IVNS1ABP;MYCBP2;SOX4;INAVA;NXN;UBE3A;ARRB2;COMMD1;TGFBR1;MINAR1;PRICKLE1;OGT;PRKN;UBE2N;DERL1;NSMCE3;UBXN1;HSPBP1;PRKCG;CENPS;PRMT3;HDAC3;UBE2D1;ARRB1;HSP90AB1;AXIN1;CAMLG;HDAC8;RIPK2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.29353826163079694,0.8587959486390687,0.6718995290423861,0.9813933402831613,1.0,4/23,11.30%,CADM1;SLAMF6;ARRB2;CRTAM
prerank,muscle cell development (GO:0055001),0.28052030315332904,0.8587838374020428,0.7207062600321027,0.9806758775405109,1.0,8/30,18.03%,NEBL;BIN1;DMD;SLC8A1;SGCZ;CXADR;ENG;ANK2
prerank,spindle assembly (GO:0051225),0.23748702940511826,0.858309245670562,0.7414285714285714,0.9810658084159947,1.0,18/67,20.63%,CEP192;AAAS;HAUS4;MISP;CLASP2;SMC1A;MAPRE2;SAC3D1;KIF2A;TUBGCP2;MAP9;STAG2;STARD9;TOGARAM2;HDAC3;ABRAXAS2;HAUS5;TUBGCP6
prerank,glucose import (GO:0046323),0.33232265070725425,0.8580306677476207,0.6599664991624791,0.980986485929211,1.0,1/13,0.38%,SLC2A3
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.19130968651380975,-0.8579752187108098,0.8326848249027238,0.8638056799503943,1.0,55/116,36.88%,FCGR2B;CD163;PRKACA;ADCY9;PTGER4;SYK;LYN;FYN;HCK;VIPR1;ADCY5;ADCY6;ADCY1;ADCY3;NPSR1;PRKACB;RAMP2;GPR27;CALCRL;MYH9;ADAM17;PTHLH;CD247;VIPR2;RXFP2;PTH1R;CALCA;CRH;GLP1R;RAMP3;SCTR;ADORA2A;VIP;GPR83;PTGDR;CREB1;PTGIR;FGR;RHBDF2;GPR15;GGT1;GIPR;MC2R;CRHR2;CYSLTR2;DRD1;CALCR;CD3G;FSHR;LHCGR;POMC;NPS;GHRH;CALCB;ADCY4
prerank,positive regulation of response to wounding (GO:1903036),0.2909413781344387,0.8577603817959223,0.6990131578947368,0.9808673628135177,1.0,11/24,29.09%,INSL3;ADRA2A;ARFGEF1;VTN;HRAS;PTK2;GRN;DMTN;KANK1;HBEGF;MDK
prerank,negative regulation of lyase activity (GO:0051350),-0.2998539596084524,-0.857659008105907,0.6743002544529262,0.8638822085564953,1.0,7/16,19.67%,CCR2;EDNRB;DRD2;PHPT1;MTRR;AKAP5;DRD3
prerank,regulation of cytoplasmic transport (GO:1903649),0.3579862379752835,0.857650624300772,0.6370235934664247,0.9803822649669173,1.0,4/11,24.48%,ATP9A;MAPK3;MAPK1;USP7
prerank,iron-sulfur cluster assembly (GO:0016226),-0.2682682991478216,-0.8575121255589129,0.6827956989247311,0.8636143121980333,1.0,8/24,17.75%,CIAPIN1;NUBP1;CIAO2A;IBA57;CIAO2B;NFU1;CIAO1;LYRM4
prerank,positive regulation of viral genome replication (GO:0045070),-0.2505496922500752,-0.8567374082175048,0.6893732970027248,0.8646389233125993,1.0,8/29,22.26%,TOP2A;IFIT1;CD28;PPIH;LARP1;STAU1;TOP2B;VAPB
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.2907326158131087,-0.8563844097205845,0.6556291390728477,0.8647881807941075,1.0,9/18,23.43%,SETD7;SETD3;PRDM9;KMT2D;EHMT1;KMT2B;SETD2;SETD1A;KMT2A
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.20359000422931148,-0.8563064436729791,0.7804054054054054,0.8643707683083625,1.0,23/79,20.95%,UBE2D3;PPARG;PTPN1;SMURF2;THBS1;SMAD9;LEMD3;SPRY2;NOTCH1;SPRY1;SMAD6;GREM1;BMP2;CREB3L1;SPRY4;HIPK2;SMAD4;NIBAN2;ACVR2A;GDF3;BAMBI;TRIM33;ADAMTS12
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2966053784371263,0.8558120434739566,0.6712564543889845,0.9838719941005274,1.0,7/20,21.73%,PFAS;GART;HPRT1;AMPD3;ADSL;AK4;AK3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.3250948991035979,-0.8557413421538866,0.6490825688073395,0.8650396011817998,1.0,4/12,15.08%,UVRAG;SMCR8;JMJD4;TNF
prerank,nitrogen compound transport (GO:0071705),-0.18418789435867913,-0.8555347370034758,0.902542372881356,0.8648942648400841,1.0,29/141,18.60%,ARL6IP5;LRRC8D;KIF3A;SLC1A5;SLC7A1;SLC43A2;SLC6A6;RAB7A;SLC15A3;SLC7A11;TMEM30A;TXNIP;NDC1;SLC52A2;HIKESHI;SLC11A1;CHMP1B;SLC6A8;SLC16A10;RAMP2;SLC25A47;CALCRL;MYH9;SLC7A6;SLC3A2;ARRDC4;RILP;SLC52A1;TOM1
prerank,glucose metabolic process (GO:0006006),0.23871432361225092,0.8555284497756623,0.7384843982169391,0.983774753551995,1.0,19/58,28.13%,GAPDH;PPARGC1A;SLC37A4;PGAM2;ALDOC;MDH1;APOD;GHRL;ALDOA;PGM1;OMA1;ENO3;SLC25A10;RBP4;SLC25A1;CRTC2;ATF4;PFKFB1;DCXR
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.31500966734335484,0.8551599833099385,0.6639072847682119,0.9839319049151507,1.0,5/17,12.74%,PSRC1;CCND3;PKD2;PDGFB;PKD1
prerank,regulation of transmembrane transport (GO:0034762),0.267472931261149,0.8551034913663185,0.6838006230529595,0.9833219051096317,1.0,8/31,19.01%,KCNJ3;KCNJ8;KCNJ13;NEDD4;NEDD4L;KCNJ5;CTTNBP2NL;ACTB
prerank,rRNA catabolic process (GO:0016075),-0.30179058298595485,-0.8549841316900482,0.65,0.8655038187012597,1.0,6/16,25.39%,EXOSC8;EXOSC10;EXOSC9;TRIR;EXOSC7;ERN2
prerank,TOR signaling (GO:0031929),0.2806156981235418,0.8548702773054436,0.6766561514195584,0.9831179356440264,1.0,9/26,28.06%,RPTOR;RPS6KB1;PRR5;FLCN;SMG1;RHEBL1;MEAK7;EIF4EBP1;TIPRL
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.23892165349161354,0.8546351536060008,0.7191977077363897,0.9829379792971802,1.0,7/54,8.77%,IVNS1ABP;CAPN3;SOX4;NXN;ARRB2;MINAR1;OGT
prerank,cellular response to virus (GO:0098586),0.2708886361084732,0.8544858088752754,0.6742301458670988,0.9825438948673756,1.0,13/30,27.31%,POU2F2;IL6;GSDME;TOMM70;RRP1B;CCL5;EIF5A;ARF1;IRF3;IRGM;POU2AF1;DDX3X;LGALS8
prerank,positive regulation of transporter activity (GO:0032411),0.3321356986299254,0.8544227021634508,0.6649746192893401,0.9819610183255916,1.0,3/13,11.57%,SYNGR3;STK39;TRPC6
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.22456777478699255,0.854249060771875,0.7461212976022567,0.9816368504422766,1.0,14/86,12.26%,FGF10;CD80;PRKCZ;PRNP;FGF7;IL6;CD81;DGKQ;ENPP2;TGFB1;ITGA5;EFNA1;SFRP1;PDGFB
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2110285176310499,-0.8541908587806379,0.7932203389830509,0.8665784801245112,1.0,10/70,7.62%,ITCH;PSMA6;TCF12;PSMB2;PSME2;N4BP2L2;PSMD11;PSMC6;YAP1;PSMA3
prerank,cell differentiation in hindbrain (GO:0021533),-0.33945060895493095,-0.8541803786800465,0.6503340757238307,0.866033712423076,1.0,4/11,14.77%,ATP7A;PROX1;AGTPBP1;LHX1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.26976435841711366,-0.8541618153231998,0.6904761904761905,0.8655119449362861,1.0,8/21,19.82%,CD300A;PTPA;CALM3;CALM2;BMP2;ITGA1;PPP1R15A;CHP2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.2532805000049288,0.8540698219147357,0.7016011644832606,0.9812753463728365,1.0,19/42,27.78%,SMARCC2;SMARCE1;ZNHIT1;VPS72;RNF8;SPTY2D1;DMAP1;ERCC6;ACTB;ACTR5;SMARCA2;MBD3;ACTR6;ACTR8;PBRM1;CHD8;ACTL6B;MTA2;CHD4
prerank,axonal transport of mitochondrion (GO:0019896),0.3496421360284643,0.853808145582635,0.6363636363636364,0.9811086528660867,1.0,6/11,25.59%,ACTR10;SYBU;HAP1;SPAST;NEFL;MAPT
prerank,cellular component disassembly (GO:0022411),-0.21951905190032703,-0.8532707938513459,0.7760736196319018,0.8668125261443547,1.0,16/53,21.77%,CD44;CAPN1;SH3PXD2B;CAPN2;CTSL;SCUBE1;LCP1;ADAM8;EXOC8;GSN;TLL2;HTRA1;MMP8;MMP11;TIMP1;NOXO1
prerank,regulation of centrosome cycle (GO:0046605),-0.27496256992482027,-0.8532280404024839,0.6578313253012048,0.8663211993120287,1.0,8/21,24.14%,CHMP4B;ATF5;CHMP1B;PDCD6IP;NPM1;NAT10;MARK4;PKHD1
prerank,ether lipid metabolic process (GO:0046485),-0.3109558708402635,-0.8531631368531953,0.6550868486352357,0.865895459157882,1.0,5/14,25.62%,NCEH1;PLAAT3;TMEM86B;PAFAH1B1;PLA2G7
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.33160812022792313,0.8530085892563639,0.657608695652174,0.9821830872459351,1.0,6/15,24.81%,JMJD8;ITGA5;FGF2;SMAD1;PDPK1;PKM
prerank,microtubule-based transport (GO:0099111),0.3541314646533775,0.8529864581333947,0.6785109983079526,0.9814982860810627,1.0,4/12,15.34%,ROPN1L;SPA17;SPEF2;DNAAF2
prerank,chromatin disassembly (GO:0031498),0.33470474664156896,0.8526394582544626,0.6696113074204947,0.9808464630921695,1.0,3/14,11.25%,SMARCC2;SMARCE1;SMARCD3
prerank,nucleosome disassembly (GO:0006337),0.33470474664156896,0.8526394582544626,0.6696113074204947,0.9808464630921695,1.0,3/14,11.25%,SMARCC2;SMARCE1;SMARCD3
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.21577539858759484,-0.8524469509380248,0.7718120805369127,0.8667887200125602,1.0,11/53,16.84%,APOE;PRKACA;FBXW7;PSME2;PSMC6;GNA12;XPO1;RAD23B;TMTC3;GPX1;ECSCR
prerank,DNA double-strand break processing (GO:0000729),-0.28655858713564,-0.8522807805103099,0.6698795180722892,0.8665737952749237,1.0,5/18,12.31%,RBBP8;NBN;BRCA1;BARD1;KAT5
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.1974299074922295,-0.852059113713412,0.7815699658703071,0.8664754633617766,1.0,22/87,20.36%,PSMA6;CDK6;CDC73;PSMB2;KANK2;GPR132;PSME2;PSMD11;PSMC6;PSMA3;CDKN2C;WEE1;PRMT2;PSMD10;RB1;PSMB5;E2F7;PSMD5;PSMD1;CDKN2A;RGCC;KLF4
prerank,negative regulation of cyclase activity (GO:0031280),0.32828660932981374,0.851925461657322,0.6770491803278689,0.981763766935037,1.0,5/14,18.46%,LTB4R2;GRM3;GABBR2;GNAI3;PALM
prerank,positive regulation of phospholipid transport (GO:2001140),-0.34225799933955503,-0.8511255727079663,0.6302325581395349,0.8678217737720116,1.0,2/10,6.05%,APOE;TMEM30A
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.35023218136503276,0.8506967042245192,0.6443661971830986,0.983071484004042,1.0,2/12,10.49%,PRNP;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.35023218136503276,0.8506967042245192,0.6443661971830986,0.983071484004042,1.0,2/12,10.49%,PRNP;HOMER2
prerank,tetrapyrrole metabolic process (GO:0033013),0.3041315978438718,0.8504986833896458,0.6623586429725363,0.9827858753314628,1.0,5/18,24.52%,ABCB6;MTR;MMAA;MMAB;TCN2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.28773811974826746,0.850379748860686,0.6772655007949125,0.9823135774291031,1.0,5/23,14.06%,MEF2C;ATP11A;TGFB1;LMOD3;SMYD1
prerank,regulation of mitochondrial fission (GO:0090140),-0.2627356609271928,-0.850352809558956,0.6824146981627297,0.8688267130297361,1.0,7/24,16.99%,DDHD1;STAT2;VPS35;KDR;LRRK2;MUL1;MIEF1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.34221587817426047,0.850338915427933,0.6432432432432432,0.9816667270337339,1.0,2/13,4.00%,RPP40;NOP9
prerank,cellular response to fluid shear stress (GO:0071498),0.34102355679138613,0.8501141944857361,0.6389830508474577,0.9814530728220106,1.0,4/12,10.92%,MEF2C;MAP2K5;PKD2;NFE2L2
prerank,nuclear transport (GO:0051169),-0.2989211045270825,-0.8499892237667034,0.6791044776119403,0.8689956009653063,1.0,6/16,14.44%,RSRC1;XPO1;NUTF2;NXT1;NPM1;BANF1
prerank,regulation of double-strand break repair (GO:2000779),0.25791766265193716,0.8497151669244062,0.709480122324159,0.9816119586117187,1.0,4/39,7.97%,WRAP53;PPP4C;USP51;TIMELESS
prerank,tRNA wobble base modification (GO:0002097),0.33016103640276095,0.8495471624769033,0.648695652173913,0.9812787707265556,1.0,2/14,4.08%,ADAT2;CTU1
prerank,positive regulation of vacuole organization (GO:0044090),-0.3449755668929277,-0.8493436244453659,0.6470588235294118,0.8697637897704503,1.0,3/10,16.70%,SH3GLB1;RALB;RAB3GAP2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3039111969531137,0.849341918386478,0.6818923327895595,0.9810424994927767,1.0,5/20,17.64%,PRKCZ;IL6;CD81;MAP3K7;IL18
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.34405275565025323,0.8491732017647791,0.6551094890510949,0.9806973750965022,1.0,6/12,25.92%,BRD8;LMO2;RDX;CTSS;GAS2L1;CTSH
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.21246663421770368,0.8491064009456762,0.8038461538461539,0.9801351005683181,1.0,35/129,22.17%,FGF10;HHEX;UBE2B;PSMB1;SOX4;TMEM198;PTK7;PSMF1;PSMA1;GPC5;PPM1A;PSMD7;FAM53B;TGFB1;PSMA8;PPM1N;PSME3;SFRP1;LRRK1;PSMD14;PSMC4;TMEM9;CCAR2;PRDM15;CSNK1G3;PSMB4;PIN1;RSPO1;WNK1;PSME1;PSMD2;PSMD4;AXIN1;PSMD8;SFRP2
prerank,histone monoubiquitination (GO:0010390),0.2903881441093228,0.848574295617325,0.6926910299003323,0.9806074991135199,1.0,6/24,16.32%,CTR9;KDM2B;RNF168;DDB2;RNF2;PAF1
prerank,programmed necrotic cell death (GO:0097300),0.31228651114046324,0.8483808505512566,0.7022375215146299,0.9803368731115437,1.0,6/18,20.09%,ITPK1;RIPK3;IPMK;DNM1L;TLR3;CYLD
prerank,endoplasmic reticulum organization (GO:0007029),0.22842324542821468,0.8482576543727566,0.7572413793103449,0.9798849833074911,1.0,15/72,15.41%,SEC16B;REEP2;ATL1;PRNP;SGTA;MAPK15;SEC31A;OTOF;EMD;TRAM2;CCDC47;DNM1L;MOSPD3;MIA3;TRAM1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.28348261420754794,0.8479434623219402,0.6666666666666666,0.9798794318557773,1.0,5/26,11.94%,ITPR2;TRPM2;PKD2;FGF2;ITPR3
prerank,regulation of secretion (GO:0051046),0.3382158373783013,0.8476217562853664,0.6760797342192691,0.9798954001279735,1.0,2/13,7.93%,FGF10;MYO6
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.26311604162088204,-0.8475563637401183,0.7054455445544554,0.8729505068975523,1.0,6/23,16.00%,SASH1;DVL3;TAOK3;MAP3K11;TNF;ARHGEF5
prerank,mRNA stabilization (GO:0048255),-0.22965361488642372,-0.847524825075894,0.7885714285714286,0.8724424624627773,1.0,18/40,33.28%,NOCT;MAPKAPK2;EIF4ENIF1;TENT5A;SLC11A1;LARP1;SYNCRIP;HNRNPU;MYD88;HNRNPC;TENT5C;VIP;PAIP1;DAZL;THRAP3;HNRNPA0;YBX3;AXIN2
prerank,JNK cascade (GO:0007254),0.25436072100856616,0.8473255029279643,0.7188940092165899,0.9798410478876217,1.0,10/40,15.03%,UBE2V1;TRIB1;MAP3K10;NOD1;SH2D3C;MINK1;UBE2N;MAP3K7;MAP3K13;MAPK10
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.34030418995608686,-0.8472190800890591,0.6536796536796536,0.8725060310415083,1.0,3/10,11.42%,XDH;SPRY2;SEMA6A
prerank,regulation of humoral immune response (GO:0002920),-0.22330820953676953,-0.8471578209397017,0.7301136363636364,0.8720634147286632,1.0,11/44,20.53%,FCGR2B;C3AR1;C5AR1;C4B;SERPING1;CD55;CFHR2;C1QC;CFP;C2;C1QB
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.30152594913221104,-0.8470018927849396,0.6888361045130641,0.8718111495138636,1.0,4/15,19.63%,PRKCH;NUMA1;TRIM16;SULT2B1
prerank,T cell mediated immunity (GO:0002456),0.32983366345447307,0.8469526529877016,0.6660194174757281,0.9799620990105653,1.0,2/13,11.30%,CADM1;CRTAM
prerank,tRNA wobble uridine modification (GO:0002098),-0.31103393424335546,-0.8467429741846431,0.684331797235023,0.8717329862794105,1.0,7/14,24.39%,ALKBH8;MTO1;TRMT9B;KTI12;DPH3;URM1;CTU2
prerank,transcription by RNA polymerase III (GO:0006383),0.2781193482363806,0.8464903240228108,0.6945736434108527,0.9802506267542228,1.0,2/27,1.02%,POLR2L;IVNS1ABP
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.28624468652020163,-0.846362463335661,0.7069767441860465,0.871990786804338,1.0,2/18,4.57%,MDFIC;CTNNA1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3182947980765569,0.8459918912377543,0.6928327645051194,0.9806349613655029,1.0,5/15,17.44%,TXK;NTRK1;MAPK3;ITK;AATK
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.24358218682996663,-0.8456892332832249,0.7673716012084593,0.872781230672188,1.0,6/32,11.00%,EIF2A;TCOF1;PICALM;RPL10;TMED10;PGAM1
prerank,cell-cell junction maintenance (GO:0045217),-0.32796964791070615,-0.8456367111723048,0.6876456876456877,0.8723240249967257,1.0,6/11,27.51%,PARD6A;MYADM;NLGN2;TJP1;PRTN3;CD177
prerank,import into nucleus (GO:0051170),0.22696939601393967,0.8454663872195821,0.7606837606837606,0.9810812951383855,1.0,18/73,20.84%,TSC2;FAM53C;NXT2;PRICKLE1;HEATR3;FAM53B;SNUPN;SNRPD2;NUP88;IPO5;HNRNPA1;NUP133;GEMIN5;GEMIN6;BACH2;SNRPD3;IPO8;POM121
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.32868737870899173,-0.8454162711658694,0.6802721088435374,0.8721823853800079,1.0,5/11,21.10%,GNPDA1;UAP1L1;GNPNAT1;NAGK;RENBP
prerank,negative regulation of cellular component organization (GO:0051129),0.22869943137220614,0.8453319518069607,0.7540029112081513,0.980647131102762,1.0,24/74,25.35%,SCAMP5;HSPA2;TMC8;PEX5;PRKCZ;CLU;AR;RAPGEF3;PRKD1;SNX33;OPRD1;CDC42;ABCA7;XRCC5;RDX;IMPACT;PACSIN3;ULK1;WASL;AIDA;TMEFF2;SYT11;CRYAB;DDX3X
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2222962663740842,0.8450719822461492,0.7503526093088858,0.9805253710813902,1.0,28/88,22.02%,PSMB1;PSMF1;BTRC;PSMA1;PSMD7;FBXL6;PSMA8;PSME3;FBXL20;CUL2;PSMD14;FBXL4;PSMC4;FBXW5;SKP2;KIF14;FBXL2;FBXO9;PSMB4;FBXL7;FBXL3;FBXL22;FBXO31;PSME1;FBXO6;PSMD2;PSMD4;PSMD8
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.18017098901109474,0.8449980719443136,0.9403765690376569,0.9799778015956723,1.0,135/834,16.30%,ZFHX3;HOXA5;HHEX;AGRN;BCL9L;CDK7;MPND;TET1;ZFPM1;DRAP1;IL4I1;LDB2;LDB1;MED24;ONECUT2;WWTR1;POU2F2;CSRNP3;TFCP2;USF2;HOXD4;BPTF;PTPRN;TXK;RELA;KDM6B;NR1I2;FOSL1;NRL;NR1I3;NFIB;WBP2;PPARGC1A;MEOX2;SOX4;BCL11B;MED4;PPARA;PBX2;BRD8;HOXB7;E2F1;KDM1B;IL6;GABPB1;CRTC1;ZFPM2;AR;XRCC6;RFX6;MEF2C;DPF2;BCLAF3;RXRG;GTF2F1;FUBP3;AKAP8L;HOXC10;MYO6;DAB2IP;APBB1;LMO2;MACC1;LHX3;SS18;BMP4;CD81;TCF7L2;MAP2K5;HDAC5;OGT;ADCYAP1;PRKD2;PKD2;FOXC1;HEY1;ZNF462;GRIN1;RNASEL;MAML3;TAF9;TGFB1;MEPCE;SS18L1;ITGB1BP1;AKIRIN2;PRKN;KLF7;GRHL3;HSF2;PTOV1;FGF2;NFE2L2;SMARCD3;HOXB2;MLLT6;RFXAP;KAT8;WWC1;USF1;PDGFB;TFEB;GABPA;EPAS1;HLF;PKD1;PFKM;PARP1;SUB1;PLAG1;HMGB1;FLCN;EAF2;BARX2;PRDM10;CCNK;LMX1B;ZBTB49;APEX1;RBL1;GAL;BRD4;ERG;IRF5;WNT7A;SETX;REST;TCF3;RRP1B;MAPK3;ITGA6;PRKD1;PRDM15;MED25;CALCOCO1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2549089510363623,-0.8448518440185878,0.7203166226912929,0.8727170670719283,1.0,7/29,16.39%,PLBD1;PLA2G4E;PLAAT3;NR1H2;NR1H3;TMEM86B;LPCAT4
prerank,synaptic vesicle membrane organization (GO:0048499),0.3122894293952083,0.8440608515825526,0.6655112651646448,0.981400001185327,1.0,3/17,12.38%,SNAP25;STX3;SYNGR1
prerank,negative regulation of cellular senescence (GO:2000773),-0.3137529688034276,-0.8440543535992883,0.6798029556650246,0.8737931976275696,1.0,6/13,27.80%,CDK6;TERF2;HMGA2;TWIST1;TERT;SLC30A10
prerank,negative regulation of macroautophagy (GO:0016242),-0.25562574172774455,-0.8440487647980323,0.6975476839237057,0.8732399291521608,1.0,6/26,13.93%,CHMP4A;CHMP4B;SMCR8;PIK3CA;MTM1;LRRK2
prerank,regulation of integrin activation (GO:0033623),-0.300143994942518,-0.8438696244251443,0.706766917293233,0.873067349785449,1.0,4/15,15.99%,PTGER4;SKAP1;FBLIM1;RAP1B
prerank,regulation of protein metabolic process (GO:0051246),0.2499753973987504,0.8433539777905711,0.7222222222222222,0.9822833707539028,1.0,14/44,20.86%,IL17F;CNDP1;MAP2K5;FAF1;CENATAC;ZDHHC2;TMEM9;NEDD4L;SSH1;CHRNA7;LTBP4;SNF8;HSP90AB1;ABCA7
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3143286240258757,0.8430790873552556,0.6666666666666666,0.9821636580400568,1.0,3/16,11.30%,CADM1;SLAMF6;CRTAM
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3102697118227691,-0.8429846105088445,0.6712328767123288,0.8743463778795957,1.0,5/12,29.12%,MTLN;PTK2B;DIAPH1;RYR2;CASQ2
prerank,regulation of hormone secretion (GO:0046883),-0.3006227658069327,-0.8429682738509932,0.6730769230769231,0.8738157343502214,1.0,2/15,7.26%,SOX11;ANXA1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.2940493726881216,0.8428815954596385,0.7073578595317725,0.9818844788095137,1.0,4/20,10.90%,GPC1;SMOC2;PRKD2;FGF2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.17569731145128425,0.8427870746240376,0.9819639278557114,0.9813770725949774,1.0,282/1646,18.17%,ZFHX3;WNT4;POLR2L;HOXA5;HHEX;NUCKS1;SCRT2;CTR9;MAGED1;TSC22D4;MED12L;CD80;HSF4;ZFP57;SALL3;IKZF4;DRAP1;CDK15;KCNH2;TLE2;DENND4A;CAPN3;LDB1;SMARCC2;NACC2;MED24;PQBP1;ONECUT2;BRD9;MYRFL;FUS;WWTR1;POU2F2;CSRNP3;TFCP2;USF2;HOXD4;BPTF;ZNF394;CNOT2;ESRRG;DDX5;PKN1;RELA;RAI1;DNAJC2;LBX2;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;PSRC1;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;DMRT2;ELP2;SP2;SOX10;TFCP2L1;TFAM;TENM1;WBP2;PPARGC1A;UBE2V1;NSD1;MEOX2;GTF2H2;SOX4;BCL11B;MED4;ZBTB12;PPARA;HOXB9;SPINDOC;HOXC6;BRWD1;PBX2;MLLT11;HOXB7;ELOC;E2F1;CD86;FGF7;IL6;TCIM;HDGFL2;ZFPM2;SMARCE1;AR;CTBP1;FOXD1;XRCC6;NR2F6;RFX6;ZMYND15;MEF2C;DPF2;RXRG;DYRK1B;NDP;MED31;PCGF6;MAP3K10;FUBP3;TADA3;ZNF35;ZNF205;TGFBR1;PHF6;MAZ;BTRC;OGG1;HOXC10;REPIN1;NCOR2;DAB2IP;TIMELESS;APBB1;PRICKLE1;LHX3;POFUT1;SP4;BMP4;TCF7L2;EBF1;DGKQ;ZBTB22;HDAC5;OGT;PHC1;PPM1A;FOXC1;ERBB4;HEY1;ZFP82;TSHZ2;HTATSF1;TGFB1;ZFP91;SS18L1;TBX2;LBH;ZNF23;ZC3H8;SNAI2;ZKSCAN8;HEXIM2;MSANTD1;NEK4;SPIN1;KLF7;DMRTA1;GBX1;GRHL3;PEX14;NKAP;HSF2;ZFP69;FGF2;NFE2L2;ZNF32;ZFP1;SLC39A8;KDM2B;CBX4;SMARCD3;HOXB2;ZFP41;MLLT6;NOP2;POU3F4;RFXAP;KAT8;ACVR1B;SFRP1;PBX3;SUV39H2;ZNF383;POLR3F;METTL4;FANK1;THAP1;WWC1;MLF2;USF1;PDGFB;TFEB;GABPA;EPAS1;HLF;HOXB5;SAMD1;CHMP1A;PHF8;TBX6;SCML2;FBXL19;LHX5;SMARCAL1;TEF;SUB1;MYRF;RBFOX2;KDM4A;PRDM16;PLAG1;ZSCAN12;HMGB1;SPTY2D1;GPATCH3;BAP1;ABCA2;ZBTB32;MYNN;DMAP1;BARX2;PPP1R13L;CCNK;LMX1B;INSR;ZBTB49;SNX6;IKZF2;NKX2-2;PRDM1;BRD4;APBB3;HMGB3;ZNF740;ERG;ERCC6;IRF5;BATF;BHLHA9;CCAR2;EDF1;WNT7A;UBE2I;UXT;REST;TCF7L1;TCF3;LHX2;PRDM15;CALCOCO1;EN2;ATP8B1;KLF16;ELAVL2;BHLHE41;IRF2BP1;SUFU;BRIP1;BACH1;AGT;PAK6;KMT2E;PRKAR1A;YWHAQ;PSIP1;TMPRSS6;ENG;MAX;BACH2;ZIC5;HDGFL3;ZBTB34;PPP2R1A;BTG1;ZFP30;ZEB1;KLF12;PHF1;PHF2;POU3F3
prerank,ruffle organization (GO:0031529),-0.29451559433364394,-0.8426771827097052,0.7099056603773585,0.8738200365887407,1.0,10/16,38.67%,CARMIL1;INPP5K;LIMA1;AIF1L;RAC1;PLEK;ARF6;CCR7;PIP5K1A;TPM1
prerank,embryonic skeletal system development (GO:0048706),0.2652129614672811,0.8426071655979741,0.7496012759170654,0.9810608882101158,1.0,12/35,27.41%,HOXD4;MEGF8;HOXB9;DSCAML1;KIAA1217;SULF2;UCMA;HOXB3;RBP4;HOXC9;FUZ;SULF1
prerank,negative regulation of cell division (GO:0051782),0.33777543328644305,0.8423307517891906,0.6690777576853526,0.9809619623570258,1.0,2/11,11.35%,SUSD2;ZFYVE19
prerank,histone deubiquitination (GO:0016578),-0.28483146130752285,-0.8422161919892297,0.6930455635491607,0.8741884464418035,1.0,8/18,30.92%,ATXN7;TRRAP;BRCC3;UIMC1;USP15;ATXN7L3;EPOP;TAF10
prerank,fatty acid beta-oxidation (GO:0006635),-0.21658272992658267,-0.8421145113541982,0.7734138972809668,0.8738321232535128,1.0,8/51,9.95%,ACOT8;ACOX3;MTLN;PPARD;DECR1;ACAA2;CROT;ACAD10
prerank,regulation of protein kinase A signaling (GO:0010738),-0.2728575382203357,-0.8420685752158165,0.6925133689839572,0.873380103393001,1.0,4/20,17.10%,AKAP12;PJA2;LRRK2;AKAP5
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.26976552803127135,-0.8419418600092703,0.7303102625298329,0.873051840610777,1.0,8/21,23.62%,ENSA;PTPA;BOD1;CRY2;ARPP19;PPP1R15A;BOD1L1;MASTL
prerank,peptidyl-threonine modification (GO:0018210),0.22784471315449661,0.8418301484465899,0.7492877492877493,0.9813682958443161,1.0,23/66,27.05%,DYRK1B;MAP3K10;TGFBR1;CDC42BPA;GALNTL6;PRKCA;PRKD2;STK39;ACVR1B;PRKD1;CDC42BPB;ROCK1;CDK10;WNK1;GALNT4;GALNT2;SBK1;PDPK1;ULK1;MAPK1;GALNT3;DYRK4;HIPK3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.1873574823843919,-0.8416463218939992,0.875,0.8731046366223842,1.0,55/117,36.88%,CD163;PRKACA;ADCY9;PTGER4;SYK;LYN;FYN;HCK;VIPR1;ADCY5;ADCY6;ADCY1;ADCY3;NPSR1;PRKACB;RAMP2;GPR27;CALCRL;MYH9;ADAM17;PTHLH;CD247;VIPR2;PLA2G2D;RXFP2;PTH1R;CALCA;CRH;GLP1R;RAMP3;SCTR;ADORA2A;VIP;GPR83;PTGDR;CREB1;PTGIR;FGR;RHBDF2;GPR15;GGT1;GIPR;MC2R;CRHR2;CYSLTR2;DRD1;CALCR;CD3G;FSHR;LHCGR;POMC;NPS;GHRH;CALCB;ADCY4
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3110499828167196,-0.8413226498266325,0.6876456876456877,0.8731922630353013,1.0,5/13,22.32%,METRNL;PIM1;HNRNPU;BMP7;RREB1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.35345251207982664,0.8409225142728037,0.6731448763250883,0.9826141417113988,1.0,4/10,15.18%,HECW2;NEDD4;STK39;NEDD4L
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.2370888975233961,-0.840705796520629,0.7478510028653295,0.8738482536281313,1.0,7/35,12.53%,CCT6A;RTEL1;PKIB;PRKCQ;CTNNB1;CCT3;HNRNPA2B1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.21614245096757959,0.8406252104944416,0.7672176308539945,0.982529225246151,1.0,16/100,11.03%,FHIT;RNF19A;GIPC1;CLU;TRIB1;NUB1;TRIB2;COMMD1;RNF180;PRICKLE1;OGT;TAF9;SUMO2;PRKN;ZYG11B;HERPUD1
prerank,glutamate metabolic process (GO:0006536),0.2984077334877011,0.8405188769512036,0.6849087893864013,0.9820407574480314,1.0,10/19,33.11%,FPGS;ALDH5A1;PRODH;GLUL;GLS2;DGLUCY;GAD1;MTHFS;GCLM;ALDH18A1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.2938548779844106,0.8404959933013901,0.694006309148265,0.9813833921006033,1.0,5/20,9.95%,TGFBR1;TGFBR3;BMP4;HEY1;SNAI2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.31788246021595995,0.8403604807458741,0.6895368782161235,0.9809703199177171,1.0,2/15,9.03%,ROGDI;FOXC1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.27533439651456604,0.8402451760474315,0.7434640522875817,0.9805069220904081,1.0,6/28,15.28%,C3;NOS1AP;EIF6;CX3CR1;CTNS;FITM2
prerank,positive regulation of cell cycle (GO:0045787),0.23333170809552198,0.8398797356645338,0.7605042016806722,0.9806233716925222,1.0,11/62,14.69%,PSRC1;SMOC2;LGMN;RPS6KB1;CCND3;CCDC57;PRKCA;PKD2;PDGFB;PKD1;TGM1
prerank,positive regulation of isotype switching (GO:0045830),-0.30026799805344645,-0.8398551322647817,0.6666666666666666,0.8749948356340985,1.0,4/15,12.09%,TFRC;MAD2L2;PAXIP1;SHLD1
prerank,endosome organization (GO:0007032),0.25253593001252184,0.8396326920275694,0.726027397260274,0.9804676984760934,1.0,10/41,18.87%,ANXA8;ANXA8L1;USP50;PI4K2A;HOOK2;TMEM9;VPS33B;ALS2;SNX33;HOOK1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.28705978764145057,-0.8395633074731029,0.6895674300254453,0.8750009685488207,1.0,9/18,25.02%,RPS26;ESR1;RPS13;ZC3H12A;TNF;NCOR1;PTBP3;KAT2B;TERT
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.23284275918794567,0.8392924192874015,0.7625178826895566,0.9804709659457888,1.0,22/65,26.37%,PSMB1;PSMF1;FHL1;PSMA1;PSMD7;PSMA8;PSME3;ZFYVE19;PSMD14;PSMC4;PSMB4;FBXL7;PSME1;PSMD2;NABP1;PSMD4;PSMD8;AURKA;PSMC5;PABIR1;PSMD3;PSMB8
prerank,glutathione biosynthetic process (GO:0006750),0.3425530564061478,0.8392867254674194,0.6936936936936937,0.9797753525220569,1.0,3/11,18.72%,GSS;GGCT;CHAC2
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.27978526128371994,-0.8391703227609413,0.7225130890052356,0.8752524953954801,1.0,9/19,38.60%,GOT1;ALDH7A1;PIPOX;AASS;SDS;HYKK;PHYKPL;CRYM;GOT2
prerank,replication fork processing (GO:0031297),-0.23226141265079375,-0.8386533293390286,0.7381615598885793,0.8757602498597654,1.0,12/38,22.89%,ETAA1;PCNA;RTEL1;ZRANB3;MMS22L;EME1;CENPX;FANCM;ZGRF1;CDK9;FBH1;BOD1L1
prerank,transcription by RNA polymerase II (GO:0006366),0.18963719257983142,0.8385118045509721,0.8939213349225268,0.9807562660402676,1.0,37/305,9.89%,POLR2L;CDK7;CTR9;DRAP1;RTF1;WWTR1;POU2F2;POLR2F;NELFB;TFCP2;ESRRG;DDX5;NR1I2;NR1I3;ELP2;PPARGC1A;GTF2H2;MED4;PPARA;NELFCD;ELOC;SSRP1;AR;NR2F6;ARRB2;GTF2H4;RXRG;GTF2F1;GTF2I;MAZ;NCOR2;GTF2E2;HDAC5;MAML3;TAF9;CPSF3;ZC3H8
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3204160948705952,0.8384510053972897,0.682842287694974,0.9801674101799474,1.0,4/14,14.32%,PFAS;GART;ADSL;RFK
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.282132558874159,0.8380912419440165,0.7232,0.9802642461711243,1.0,8/25,22.91%,MLLT11;PDCD5;DNM1L;BIK;BBC3;MFF;CIDEB;HRK
prerank,protein import into nucleus (GO:0006606),-0.20324428626578633,-0.8375260127010655,0.8370607028753994,0.877394581917294,1.0,17/66,19.35%,CBLB;KPNB1;RANBP2;KPNA2;SYK;NUP153;EIF4ENIF1;NUTF2;PTTG1IP;HIKESHI;NXT1;RGPD1;NUP62;IPO13;IPO7;KPNA3;APPL2
prerank,macrophage activation involved in immune response (GO:0002281),-0.31497774338906115,-0.8372098553474844,0.6779661016949152,0.8774747264554077,1.0,4/13,14.52%,TYROBP;SYK;DYSF;LBP
prerank,protein localization to nucleus (GO:0034504),0.21405183704342656,0.8371555579816341,0.7956403269754768,0.981519737331937,1.0,17/102,16.32%,HHEX;TSC2;YWHAE;SIX4;FAM53C;NXT2;PRICKLE1;BMP4;HEATR3;FAM53B;NUP88;ARL2BP;IPO5;CHCHD10;TAF3;NUP133;PAF1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.24036775243180114,0.8368525731307385,0.7466467958271237,0.9814676634202019,1.0,10/52,15.84%,HOGA1;FPGS;MTHFD1L;MTHFD2L;ALDH1L1;MDH1;ACOT4;ALDH5A1;SLC19A1;ACLY
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.23098950533786144,-0.8368119838490307,0.7562326869806094,0.8777309708375237,1.0,5/39,6.66%,MYO5A;TRAK1;RAB1A;MYO1F;MYO15A
prerank,regulation of fat cell differentiation (GO:0045598),0.22262366532827801,0.8367705273721184,0.7645390070921986,0.980934519580026,1.0,11/74,11.58%,ZFPM1;WWTR1;GNB3;RARRES2;E2F1;IL6;ZFPM2;TRIB2;ZFP36L2;TGFB1;SFRP1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.1938650787733609,-0.8367386045034735,0.8515901060070671,0.8773293702064728,1.0,25/82,23.35%,PCM1;CDK5RAP2;PRKACA;TUBA4A;CEP250;YWHAG;HMMR;HAUS2;CEP164;MAPRE1;ATF5;CDK1;HAUS8;NPM1;KCNH5;DCTN2;TPX2;PLK1;ODF2;PAFAH1B1;AKAP9;CEP78;OFD1;GTSE1;NDE1
prerank,wound healing (GO:0042060),0.23341092768844257,0.8366732742330882,0.7750362844702468,0.9804231426227059,1.0,6/62,3.44%,FGF10;FUT10;DST;RAB3A;PAK1;SYTL4
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.2662744286008021,0.8364879316048587,0.7382445141065831,0.9801121676993115,1.0,6/32,10.90%,SRPX2;MEOX2;MAP2K5;HDAC5;ITGB1BP1;FGF2
prerank,regulation of viral release from host cell (GO:1902186),0.29241101007471254,0.8363184959050823,0.7065573770491803,0.9797636594915275,1.0,4/21,14.36%,TRIM26;MID2;TRIM8;CHMP2A
prerank,regulation of translational initiation (GO:0006446),-0.2045548808180262,-0.836198115353226,0.8338557993730408,0.8777899643504015,1.0,14/63,15.34%,ATF3;NCBP1;EIF4B;NCK1;CEBPB;EIF4EBP2;EIF2B2;UHMK1;PAIP2B;AGO2;LARP1;MIF4GD;NPM1;HSPB1
prerank,modulation by host of symbiont process (GO:0051851),0.26723706895303184,0.8361344369023589,0.7284552845528456,0.9794751249925688,1.0,8/31,19.40%,NUCKS1;CX3CR1;SAP30BP;NAPEPLD;HPN;REST;RRP1B;CCL5
prerank,photoperiodism (GO:0009648),-0.24804959199502113,-0.8360757532225184,0.7549295774647887,0.8774607442779858,1.0,10/28,21.55%,FBXL17;FBXL8;CRY2;CRY1;SIK1;PDE6B;PER2;FBXL12;BHLHE40;ID2
prerank,regulation of mRNA catabolic process (GO:0061013),-0.1839196148022334,-0.8359653290325103,0.8798283261802575,0.8771128973158524,1.0,26/121,18.89%,PSMA6;PSMB2;MAPKAPK2;PSME2;SAMD4A;PUM2;PSMD11;PSMC6;UBC;PSMA3;EXOSC8;ZC3H12A;UBA52;VIM;XPO1;RC3H1;PSMD10;EXOSC9;PSMB5;HSPB1;RC3H2;FXR2;ZC3HAV1;PSMD5;HNRNPD;PSMD1
prerank,regulation of neuron differentiation (GO:0045664),0.2226376575868457,0.8358811825827869,0.7765042979942693,0.9793115289748051,1.0,20/76,25.77%,ZFHX3;BIN1;NEUROD2;MEF2C;HEY1;NRCAM;BEND6;VWC2;EIF2AK4;REST;TCF3;ROCK1;ZEB1;NREP;IMPACT;ZC4H2;BDNF;TIAM1;RHOA;DISP3
prerank,negative regulation of signal transduction (GO:0009968),0.19228721051179973,0.8357149688706311,0.8787515006002401,0.9789841353737958,1.0,66/249,24.75%,HHEX;TSC2;DCC;HIC1;CYP26C1;PTPRT;MEGF8;PRKCZ;GPC1;TCIM;NXN;TRIB1;LGMN;RPS6KB1;UBASH3B;TSPAN15;CACTIN;MAZ;BTRC;DAB2IP;EGFL7;KIF26A;HEY1;MGRN1;CX3CR1;SNAI2;NEDD4;DDIT4;PDCD6;FGF2;IRS1;SFRP1;CRHBP;NDRG4;BEND6;ARRDC1;APOD;PTPN2;CADM4;CARD16;SIAH1;RGS2;SUFU;AGT;PALM;LRRC14;DCN;CCL5;ARRB1;SULF2;YWHAB;GLI3;RNF43;PIP4K2B;FRZB;SFRP2;TULP3;TMEM25;HIF1AN;PIP4K2A;BDNF;GPS2;TMBIM6;CXXC4;ZBTB7A;ASXL1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.2515918498319247,0.8354755828776359,0.7352941176470589,0.9787691225940488,1.0,7/39,12.74%,FGF10;PAK1;BMP4;PKD2;FGF2;NPNT;PKD1
prerank,glycerolipid catabolic process (GO:0046503),0.3067591539536471,0.8354280502723723,0.7175324675324676,0.9781663861727914,1.0,3/19,7.09%,PRDX6;PLA2G4C;ABHD12
prerank,regulation of myoblast differentiation (GO:0045661),0.263764374373143,0.8353155597994926,0.7278382581648523,0.9777276245656249,1.0,7/32,20.37%,BOC;MEF2C;BMP4;TGFB1;SMYD1;BTG1;RANBP3L
prerank,response to reactive oxygen species (GO:0000302),-0.21821554851574537,-0.8348862140357711,0.7848101265822784,0.8786914832555935,1.0,14/54,18.49%,APOE;PXN;ADAM9;STK24;ERCC6L2;PDCD10;FYN;HIF1A;FOS;EGFR;GPX1;HMOX1;MAPK8;PDGFRA
prerank,negative regulation of calcium ion transport (GO:0051926),0.31281853069901067,0.8347557960449689,0.6868512110726643,0.9782161629428906,1.0,2/15,6.94%,CBARP;ADRA2A
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3380694826143284,-0.8347424472599502,0.6513761467889908,0.8784159277999433,1.0,4/10,22.94%,RACGAP1;ECT2;SIRT2;CCNB1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3116247055781508,-0.8346630920248134,0.6682577565632458,0.878002463838989,1.0,1/13,0.96%,IGF1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.24183923377118194,-0.833975366276729,0.7768595041322314,0.8788132078080678,1.0,11/30,25.47%,BCL2L1;FAS;RIPK1;BRCA1;BMP5;GPX1;HMOX1;ARHGEF2;TNFSF10;FADD;TMBIM1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.35007420380087206,0.833808348557499,0.6728813559322034,0.9795668980454612,1.0,2/10,10.95%,WRAP53;CCT4
prerank,Wnt signaling pathway (GO:0016055),-0.18862328687138488,-0.8337340187160244,0.8745247148288974,0.8787141574152153,1.0,17/92,15.36%,CSNK1G1;VPS26A;DVL3;DIXDC1;CCDC88C;VPS35;CD24;UBC;CPE;UBA52;WNT2B;CTNNB1;FZD2;TCF7;LRRK2;SFRP5;WNT5A
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.20316368609874016,-0.833662550198078,0.8338762214983714,0.8783090546793919,1.0,20/66,21.55%,ANKRD17;CDK6;CDC73;KANK2;PSME2;CCND1;ANXA1;CDKN2C;WEE1;PRMT2;CCND2;RB1;EGFR;E2F7;ADAM17;CDKN2A;APPL2;RGCC;KLF4;ID2
prerank,fatty acid catabolic process (GO:0009062),-0.2043081829431635,-0.8336447516436917,0.8108974358974359,0.8777881066656275,1.0,10/67,9.95%,ACOT8;AIG1;SLC27A4;MTLN;PPARD;DECR1;ACAA2;CROT;PEX13;ACAD10
prerank,regulation of organelle assembly (GO:1902115),0.2236161668449647,0.8333216898297557,0.775886524822695,0.9798777124448559,1.0,18/72,21.35%,IFT20;RAB1B;SGSM3;MAPK15;CDKL5;RAB5A;TBC1D16;RABEP2;TBC1D8;IFT88;PLK2;UBQLN2;ALMS1;ATXN2;CYLD;CDKL1;RDX;KIF9
prerank,intracellular lipid transport (GO:0032365),-0.2695996201812079,-0.8330859201441339,0.7017543859649122,0.8782566830657914,1.0,10/21,26.60%,NPC2;PRKAG2;SGPP1;MID1IP1;PRKAB2;ACACA;SLC25A20;CERT1;ABCD4;ABCD1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.33796284866901083,0.8330311908477575,0.7011686143572621,0.9798093125238677,1.0,6/12,28.50%,IL5RA;MAPK3;PTK2;IL34;MAPK1;CSF1R
prerank,positive regulation of cellular component organization (GO:0051130),0.21249209892860324,0.8329016036749919,0.7997138769670958,0.9794080611531008,1.0,21/107,15.66%,TPPP;NEUROD2;FRMPD4;NRXN1;CLU;AR;ABCB4;TGFBR1;DAB2IP;SHANK3;RAPGEF3;BAK1;FAF1;TGFB1;DCTN1;MMP1;CBLL1;BIK;INSR;NEDD4L;ANAPC2
prerank,alanine transport (GO:0032328),-0.3367076690419072,-0.8324525585908947,0.6926503340757239,0.8788675629820383,1.0,2/10,9.15%,SLC6A6;SLC6A17
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.2787311187645885,0.8323524348232298,0.7058823529411765,0.9798768148997912,1.0,4/25,6.00%,ANG;NCKAP1L;DSCAM;AR
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2538337885568209,0.8323511850764538,0.7480438184663537,0.9791868522529238,1.0,8/36,13.92%,GGA3;RAB26;SYS1;ARFRP1;NECTIN3;RAB34;SPTBN1;BLZF1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.2575671731896948,-0.8320354075622672,0.7443037974683544,0.879103443577911,1.0,7/24,13.50%,IGF1;SORBS1;PPP1R3C;IGF2;PPP1R3F;PPP1R3E;INPP5K
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.2656254849567402,0.8317870105828732,0.7315875613747954,0.9796915778854414,1.0,9/30,22.02%,IL17F;FSTL1;TGFBR3;TGFB1;ENG;LTBP4;NREP;SMAD2;LATS1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2877850503373402,0.8315899966713546,0.6823899371069182,0.9794255819323675,1.0,7/21,20.23%,MED24;FOSL1;MED4;SUB1;SETX;SRF;DHX36
prerank,negative regulation of transposition (GO:0010529),-0.29091029452397066,-0.8312564414785109,0.6984924623115578,0.880001885696031,1.0,9/16,41.47%,PIWIL2;MYBL1;TDRD9;AICDA;PIWIL4;PIWIL1;TUT7;MOV10;UBR2
prerank,urogenital system development (GO:0001655),-0.324421488384829,-0.8312511189534249,0.6915887850467289,0.8794548801064945,1.0,6/11,40.73%,ANXA1;LHX1;SHH;PAX8;OSR1;SOX9
prerank,coenzyme A metabolic process (GO:0015936),0.32125955402761264,0.8309698315615327,0.7047308319738989,0.9800577620089598,1.0,5/14,16.16%,PPCDC;COASY;DCAKD;ACLY;PPCS
prerank,regulation of cell-substrate adhesion (GO:0010810),0.2474472700431927,0.8308741418057449,0.7269938650306749,0.9795566713554321,1.0,10/42,17.09%,THY1;PTPRO;CORO2B;MINK1;NPNT;PDGFB;FBLN2;NDNF;RSU1;PTK2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2773255053107638,-0.8308183261583536,0.7014563106796117,0.8797062555140547,1.0,7/20,27.22%,ADCY9;DRD2;ADRA1A;DRD3;GPR101;PDE4D;ZDHHC21
prerank,cardiocyte differentiation (GO:0035051),0.35524122873475245,0.8305467079000137,0.6946983546617916,0.9795661139227132,1.0,2/10,12.33%,KDM6B;AKAP13
prerank,DNA catabolic process (GO:0006308),0.3390187611059367,0.8301192545588711,0.6950092421441775,0.9797489068932781,1.0,2/11,5.25%,DNASE1;DNASE1L2
prerank,protein kinase B signaling (GO:0043491),0.2822279764777591,0.8300148978580151,0.7221297836938436,0.9792658594891959,1.0,4/23,9.78%,TSC2;ADTRP;TGFB1;PLK3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.2896959932161932,0.8297891579243785,0.7184942716857611,0.9790331198964646,1.0,8/21,22.39%,HS3ST5;GPC1;HS6ST3;HS6ST1;B3GAT3;SULF2;SGSH;EXT2
prerank,actin filament bundle assembly (GO:0051017),-0.2331197537513406,-0.8297657624888453,0.7564766839378239,0.8811766870038104,1.0,9/33,22.53%,NEDD9;EPS8;LCP1;PLS1;MICAL1;LIMA1;AIF1L;SHROOM2;BAIAP2L2
prerank,myotube cell development (GO:0014904),-0.3364427662534267,-0.8296213866672174,0.7027649769585254,0.8809215490356185,1.0,1/10,0.96%,IGF1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2002348213701552,-0.8291914333001165,0.8118811881188119,0.8812049455418874,1.0,18/75,19.95%,APOE;CD300A;STK38;PTPN1;PKIB;LYN;IL1B;SPRY2;SPRY1;INPP5K;RB1;DUSP1;SPRY4;LRP6;PLK1;CDKN2A;IPO7;BMP7
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.24920070227807709,-0.8290808362217995,0.751937984496124,0.8808618939608768,1.0,5/25,15.08%,CBLB;PPARG;SOCS5;CBL;TNF
prerank,GTP metabolic process (GO:0046039),0.3106675517712886,0.8290044136498154,0.6912751677852349,0.9799436075169053,1.0,7/15,29.99%,GTPBP1;GNAI3;RHOQ;AK4;AK3;IMPDH2;MFN1
prerank,dicarboxylic acid transport (GO:0006835),0.2695326553188954,0.8289680798130534,0.7278481012658228,0.9793209116654156,1.0,6/28,14.60%,GIPC1;SLC1A1;SLC25A18;SLC26A7;SLC1A3;SLC19A1
prerank,regulation of macrophage differentiation (GO:0045649),-0.2933022443743247,-0.8289130553568911,0.6979695431472082,0.880639963393129,1.0,7/15,25.36%,PF4;RIPK1;HSF1;C1QC;ID2;FADD;CSF1
prerank,positive regulation of histone methylation (GO:0031062),0.2763077253574086,0.8286524754399008,0.71160409556314,0.9793237929275148,1.0,6/24,18.54%,CTR9;TET1;OGT;PAF1;PHF1;CHTOP
prerank,gland development (GO:0048732),0.23174302256661727,0.8285380518634953,0.7657142857142857,0.9788728130653398,1.0,6/59,8.85%,WNT4;FGF10;RIPK3;TGFBR1;TGFBR3;PKD2
prerank,protein destabilization (GO:0031648),0.26204542567604744,0.828416010511879,0.7444794952681388,0.9784436131754481,1.0,9/32,18.77%,GGA3;CAPN3;PRNP;BTRC;PRKN;DERL1;SERF2;PEX2;FBXL3
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.28969067386010444,0.8282191058519884,0.712,0.9781612695138854,1.0,5/20,12.74%,PSRC1;CCND3;PKD2;PDGFB;PKD1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.2810298181687844,-0.8280521271638422,0.7054631828978623,0.8817356357285524,1.0,3/17,8.34%,MPDU1;ALG12;ALG13
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3284311558370999,-0.8278787692390029,0.6748166259168704,0.8815219829401889,1.0,4/11,21.18%,ARID1B;ZMIZ1;SERTAD2;ZMIZ2
prerank,cellular response to chemokine (GO:1990869),0.2430695365418642,0.8276691312338883,0.7368421052631579,0.9785872942074381,1.0,9/46,19.40%,ACKR3;SLC12A2;CCR1;FOXC1;SH2B3;STK39;CCL15;WNK1;CCL5
prerank,carnitine metabolic process (GO:0009437),0.32793093895183545,0.8276651265525937,0.6878306878306878,0.9779109691802159,1.0,2/12,7.00%,CPT1B;ALDH9A1
prerank,histone H3 acetylation (GO:0043966),0.24883211060480784,0.8276522289448299,0.7516129032258064,0.977262228026295,1.0,6/40,11.86%,LDB1;JADE2;MEAF6;TADA3;TAF9;MAP3K7
prerank,protein O-linked glycosylation via serine (GO:0018242),0.34986764726393527,0.8274725553610118,0.7120141342756183,0.9769310381211085,1.0,5/10,30.68%,MGAT5B;GALNT4;GALNT2;GALNT3;GALNT13
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.30531369321656965,-0.827241751165098,0.7071428571428572,0.8821432769459576,1.0,2/13,7.11%,ACOT8;GOT1
prerank,response to peptide hormone (GO:0043434),-0.21811977190007298,-0.8263163309648328,0.7976190476190477,0.8833879091450725,1.0,11/43,18.54%,STAT5B;STAT4;STAT2;CAV1;ANXA1;EIF2B2;STAT1;CRY1;EIF2B4;IGFBP5;TRIM16
prerank,regulation of cell-cell adhesion (GO:0022407),0.2500801396880349,0.8260663953354889,0.7361963190184049,0.9791189407168934,1.0,7/39,11.22%,MAGI1;ADA;SPINT2;TENM3;TGFB1;MINK1;ZDHHC2
prerank,regulation of superoxide anion generation (GO:0032928),-0.2975053675995015,-0.825784710216336,0.7011764705882353,0.8838075869994796,1.0,7/14,34.47%,TYROBP;SYK;GSTP1;CD177;FPR2;ITGB2;CRP
prerank,regulation of phospholipid metabolic process (GO:1903725),0.34906710386411377,0.8255301652491354,0.6736474694589878,0.9795134579919997,1.0,3/10,12.41%,GNB3;MTMR9;MTMR1
prerank,regulation of phosphatase activity (GO:0010921),-0.2546113754685217,-0.8254811062588662,0.7297297297297297,0.8838447203814944,1.0,12/24,28.47%,PPP6R1;PTPA;PPP6R3;PPP1R35;BMP2;PPP1R2;CHP1;CHP2;SH2D4A;PPP1R26;PPP1R17;TSC1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.2753289195071072,0.82547036864753,0.7452830188679245,0.9789390094348875,1.0,10/25,25.38%,SGTA;PSMF1;EFNA1;EPHA4;PRKCG;ALAD;HSP90AB1;OPHN1;HFE;TRIM39
prerank,regulation of response to interferon-gamma (GO:0060330),0.3191058306487886,0.8244675555201922,0.6893542757417103,0.9802389053921563,1.0,6/14,28.81%,SOCS3;PTPN2;IFNGR1;HSP90AB1;SUMO1;CDC37
prerank,acetyl-CoA metabolic process (GO:0006084),0.3119318348111032,0.8241125592577151,0.7005163511187608,0.9802925149339656,1.0,8/15,32.51%,ACLY;PPCS;ACACB;ACSS1;HMGCS1;DIP2A;ACAT1;MLYCD
prerank,superoxide anion generation (GO:0042554),-0.3041328698925859,-0.8240322094300406,0.7285714285714285,0.8859935108524706,1.0,4/13,24.01%,CYBB;CYBA;TAFA4;NOX4
prerank,O-glycan processing (GO:0016266),0.2370023166155679,0.8238750576613095,0.7816593886462883,0.9800837438282648,1.0,13/54,23.18%,B3GNT6;ST6GALNAC2;POFUT1;GXYLT1;C1GALT1;POMGNT1;GCNT4;ST3GAL3;GALNT4;GALNT2;GCNT1;ST6GALNAC4;GALNT9
prerank,central nervous system neuron development (GO:0021954),-0.2978729592041658,-0.8234265505994274,0.7181372549019608,0.8865870533626139,1.0,2/15,2.79%,B4GALT5;ATP7A
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.26396264344686887,-0.8231687076697897,0.7462311557788944,0.8865457731215777,1.0,2/22,1.34%,VPS37C;PTPN23
prerank,positive regulation of establishment of protein localization (GO:1904951),0.2909434414866149,0.8230872781171867,0.7208538587848933,0.9810137062225983,1.0,3/18,10.95%,WRAP53;CORO2B;CCT4
prerank,endocardial cushion morphogenesis (GO:0003203),0.29666182880484016,0.8230814431817939,0.7038327526132404,0.9803398477216362,1.0,5/18,21.71%,BMP4;HEY1;TBX2;ENG;MDM4
prerank,glutathione metabolic process (GO:0006749),0.2521410027373463,0.8230696750848614,0.753968253968254,0.979678498926827,1.0,5/38,11.35%,GGT7;GSS;GGT5;GGCT;CTNS
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.3139294027535964,-0.8228221290772718,0.6666666666666666,0.8866091657166641,1.0,2/12,8.00%,PAEP;IL1B
prerank,response to hydroxyurea (GO:0072710),0.33691841856572424,0.8227502845395153,0.6925734024179621,0.9796309850460141,1.0,2/11,14.58%,TIMELESS;NSMCE3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2457771062949134,-0.8226304401779341,0.7737789203084833,0.8864055647755612,1.0,7/28,14.06%,DTX3L;SMCHD1;HSF1;CYREN;MAD2L2;SHLD1;PARP9
prerank,transcription preinitiation complex assembly (GO:0070897),-0.31550190425898605,-0.8225741305660805,0.7188208616780045,0.8859550106417838,1.0,5/12,27.91%,TAF1;TAF12;TAF7;GTF2A2;TBP
prerank,cell-matrix adhesion (GO:0007160),0.21373608761479987,0.8225014294243613,0.8296703296703297,0.9794613693200929,1.0,14/95,11.16%,CTTN;MKLN1;CD34;STRC;THY1;ITGB6;ITGB5;TRIP6;SGCE;ACTN2;ITGB1BP1;ADAM15;ITGA10;NPNT
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.21485942786873244,-0.8224762682906719,0.8187311178247734,0.8855805797152971,1.0,15/46,25.49%,PTPRC;PTPN1;RANBP9;RPS6KA6;LYN;SPRY2;SEMA6A;SPRY1;TLR4;SMAD4;TNIP1;GSTP1;TIMP3;FBLN1;DUSP3
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2934045240566936,-0.8220698110971755,0.7042889390519187,0.8857385953099713,1.0,4/13,27.04%,OS9;EDEM1;UBE2J1;YOD1
prerank,L-serine metabolic process (GO:0006563),0.34330760035024194,0.8218971445125937,0.7005253940455342,0.9799848928434612,1.0,6/10,33.13%,SERINC3;PSPH;PHGDH;SRR;SERINC5;PSAT1
prerank,histone mRNA metabolic process (GO:0008334),-0.24844003447548618,-0.8215967194486851,0.7472826086956522,0.8860456472668162,1.0,6/27,13.37%,NCBP1;TENT2;SNRPB;EXOSC10;SSB;CPSF2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.23637410381519638,-0.8212489256811856,0.7738095238095238,0.8860786086256943,1.0,5/31,11.63%,ALOX5;MOCS2;MOCS1;PYCR2;HSD17B1
prerank,cellular copper ion homeostasis (GO:0006878),-0.3050465317541478,-0.8212244918100872,0.7244897959183674,0.8855737719687088,1.0,4/14,8.41%,COX19;ATP7A;SLC31A2;CCDC22
prerank,regulation of cellular response to heat (GO:1900034),0.21598457503522275,0.8211002121840846,0.8294360385144429,0.9809121534046887,1.0,31/77,31.13%,YWHAE;AAAS;CD34;RPTOR;DNAJC2;NUP54;CHORDC1;NUP88;RAE1;DNAJC7;CCAR2;MAPK3;NUP133;HSP90AB1;POM121;CAMK2B;MAPK1;CRYAB;MAPT;FKBP4;HSPA8;HSBP1;PTGES3;NUP107;NUP155;NUP85;BAG3;TPR;CREBBP;SEC13;NUP205
prerank,response to hexose (GO:0009746),0.2748688387684717,0.8209585487546774,0.7471264367816092,0.9805223378660991,1.0,5/25,15.26%,SELENOS;TCF7L2;EIF2B3;KHK;EIF2B1
prerank,BMP signaling pathway (GO:0030509),0.22713692485143544,0.8209464581625916,0.7753623188405797,0.979868549710359,1.0,14/62,20.91%,DDX5;MEGF8;SLC33A1;TGFBR3;BMP4;TGFB1;AMHR2;MAPK3;GDF1;ENG;RGMA;BMPR1B;SMAD1;SMAD2
prerank,negative regulation of cell cycle process (GO:0010948),-0.20485560215779156,-0.8208886824962446,0.8434782608695652,0.8856772322044765,1.0,15/61,19.95%,EPC1;RBBP8;RBBP7;BMI1;BRCA1;ESPL1;RYBP;E2F8;L3MBTL2;EHMT1;TERF2;E2F7;NME6;EED;BMP7
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.30123622776774545,0.8208263609129407,0.7045454545454546,0.97942405898326,1.0,3/17,11.30%,CADM1;SLAMF6;CRTAM
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.34876015824160517,0.8206649678540359,0.71875,0.9790777309845404,1.0,1/10,7.95%,CNGB1
prerank,morphogenesis of an epithelium (GO:0002009),-0.24688000371152008,-0.8206375886053171,0.7696335078534031,0.8855894114466604,1.0,10/25,23.41%,DAG1;PRKX;RIPK4;LHX1;VCL;TRAF3IP1;LRP6;LIN7C;LAMA5;LAMA3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3243492090520411,0.8202207838432883,0.7022375215146299,0.9793025261082393,1.0,2/13,8.71%,BLOC1S2;RHOT1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.2992705871543973,0.8198562850712614,0.7255892255892256,0.979338751509868,1.0,6/19,22.74%,PPARA;IRS1;ABHD5;ANGPTL3;ABCD2;DAGLB
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.34741837081424465,0.8196261387806818,0.6857142857142857,0.9791064051370065,1.0,2/10,6.94%,AREG;ADRA2A
prerank,synaptic vesicle transport (GO:0048489),0.3370555024960644,0.8195859047264771,0.7075812274368231,0.9785251591221912,1.0,3/11,21.12%,SNAPIN;SPG11;TMEM230
prerank,neutrophil migration (GO:1990266),-0.20665657582952143,-0.819221026773096,0.8126984126984127,0.8876884350526566,1.0,24/58,37.69%,GBF1;CCL25;PF4;SYK;JAML;IRAK4;FCER1G;PIK3CD;CCL7;PRTN3;CCL24;CD177;ITGB2;CXCR2;TGFB2;CKLF;PPIA;EDN3;CCL8;CXCL9;EDN2;EDN1;CXCL1;PECAM1
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.22819287106858457,-0.8192190471518255,0.8034682080924855,0.8871365472796795,1.0,10/37,18.52%,RNASE3;DNASE1L1;NCBP1;XRN2;NUDT5;ENTPD5;ADPRM;RNASEH2A;HNRNPD;RNASEH1
prerank,extracellular matrix disassembly (GO:0022617),-0.21138138393175188,-0.8189482014868171,0.8442367601246106,0.8870488265958212,1.0,16/53,21.77%,CD44;CAPN1;SH3PXD2B;CAPN2;CTSL;SCUBE1;LCP1;ADAM8;EXOC8;GSN;TLL2;HTRA1;MMP8;MMP11;TIMP1;NOXO1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2510949270728125,-0.818789739154398,0.7396907216494846,0.886764632620029,1.0,7/25,19.83%,STAT5B;HMGB2;HIF1A;STAT1;FAM210B;HSPA1B;ACVR2A
prerank,response to retinoic acid (GO:0032526),-0.20227526961946174,-0.8187730133189235,0.8382352941176471,0.886249761425743,1.0,24/59,31.67%,ABL2;BRINP1;RARA;LYN;RET;SNW1;RXRB;OVCA2;TESC;PTK2B;WNT5A;ADNP2;TRIM16;WNT9A;FZD4;NDUFA13;WNT6;FZD10;LTK;AQP1;CREB1;CDKN2D;FZD7;ATM
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.28232424015877317,0.8186410961642929,0.7320261437908496,0.979719648848996,1.0,7/21,24.26%,SELENOS;PRKN;HERPUD1;TXNDC12;XBP1;CREB3;TMBIM6
prerank,negative regulation of synaptic transmission (GO:0050805),0.27876084286219915,0.8186007211035551,0.734920634920635,0.9791142220128043,1.0,11/23,28.13%,ATAD1;PNKD;ACHE;PLK2;ARF1;GRIK3;TMEM25;SYT11;PRRT1;CBLN1;PTEN
prerank,cellular biogenic amine catabolic process (GO:0042402),0.3574187191281428,0.8185040267662276,0.6859649122807018,0.9786279764142475,1.0,2/10,14.77%,LRTOMT;COMT
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.25949992921601905,0.8180597287317911,0.7459807073954984,0.9788133031384935,1.0,9/32,17.62%,STMN2;NAV3;CLASP2;CAMSAP3;FGF13;CAMSAP1;APC2;TAOK1;HDGFL3
prerank,regulation of spindle organization (GO:0090224),0.2936450775547866,0.8173333583989675,0.7171381031613977,0.9795626141985238,1.0,5/18,16.34%,PSRC1;FSD1;RAE1;DCTN1;MAP9
prerank,cellular iron ion homeostasis (GO:0006879),-0.20927365221567965,-0.8171106655838155,0.8220858895705522,0.8887572841970656,1.0,16/55,22.81%,ATP6V0D1;TFRC;SLC46A1;NUBP1;SLC11A1;ATP6V1A;CP;LCN2;HMOX1;FTL;SMAD4;CYBRD1;HEPH;NDFIP1;ALAS2;FBXL5
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.2605600332241275,0.8169794504840862,0.7624398073836276,0.9795892095371962,1.0,7/30,17.53%,FLT4;PLD4;BMP4;TGFB1;SFRP1;BATF;FLT3
prerank,protein import (GO:0017038),0.2143363357037101,0.8168529530952818,0.8136986301369863,0.9791773972932987,1.0,35/84,31.09%,TSC2;PEX5;FIS1;FAM53C;CLU;ATAD1;NXT2;PRICKLE1;HEATR3;PEX26;FAM53B;NUP88;PEX14;IPO5;NUP133;PEX2;ABCD2;SNX33;IPO8;POM121;PEX11B;PEX3;RANBP17;TOMM22;IPO9;ABCD3;PXMP4;ACBD5;NUP107;NUP155;NUP85;MMP12;TPR;SEC13;PEX12
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.23044443574509363,0.8164552938824886,0.7735042735042735,0.9792862906219824,1.0,10/57,10.86%,FIS1;ASPH;PDCD5;LGMN;USP50;NOD1;BAK1;GRIN1;GRIN2B;PDCD6
prerank,cellular response to oxidative stress (GO:0034599),-0.1820914581466558,-0.8163764170485445,0.896551724137931,0.8895403799657889,1.0,28/118,20.91%,CYBB;MSRA;PXN;CHCHD2;ETV5;ERCC6L2;HIF1A;PYCR2;ZC3H12A;EIF2S1;FOXO1;CYBA;TXNRD1;DAPK1;LRRK2;FOS;EGFR;GPX1;HMOX1;SESN2;MAPK8;CPEB2;ADNP2;PDGFRA;HSPA1B;GSR;SIRT2;SOD3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.25750034408175154,-0.8158731243959653,0.7416879795396419,0.8898545702569904,1.0,5/23,13.08%,PRCC;ZWILCH;WEE1;BUB1;BUB1B
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.25220502795043903,-0.8153378475935642,0.7696335078534031,0.8902213593910074,1.0,6/24,15.91%,TAPBP;ERAP1;SEC23A;MFSD6;B2M;FCER1G
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.30225167386074514,-0.8151167723070408,0.7132701421800948,0.8900404863048339,1.0,7/13,34.47%,TYROBP;SYK;GSTP1;CD177;FPR2;ITGB2;CRP
prerank,heme catabolic process (GO:0042167),0.3111617824533597,0.8150601050092104,0.7163695299837926,0.9807102011199429,1.0,1/14,0.79%,SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.3111617824533597,0.8150601050092104,0.7163695299837926,0.9807102011199429,1.0,1/14,0.79%,SLCO2B1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.23576435024426426,-0.814901731439704,0.782051282051282,0.8898615172988307,1.0,10/33,20.36%,CDK6;CDC73;KANK2;CDKN2C;WEE1;PRMT2;RB1;E2F7;CDKN2A;KLF4
prerank,regulation of actin filament-based movement (GO:1903115),0.34349602993194706,0.814405977698297,0.7080979284369114,0.9813493694226253,1.0,2/10,18.03%,MYBPC3;ANK2
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3115866516880075,-0.8141784103146714,0.6995073891625616,0.8906549392027512,1.0,6/11,25.36%,PF4;RIPK1;HSF1;ID2;FADD;CSF1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.26510723240559764,0.8141583743935312,0.7411003236245954,0.9811513193331096,1.0,8/27,18.02%,F11R;RHPN2;CLASP2;SHANK3;PRKN;PHLDB2;WASF2;SHANK1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.2759551436257042,0.8140867236631095,0.747163695299838,0.980613381182647,1.0,7/24,18.05%,SELENOS;CLU;PRKN;HERPUD1;TXNDC12;UBXN1;XBP1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3132615052836774,-0.8137487326145437,0.7107231920199502,0.8909339084817371,1.0,1/12,1.07%,ACOT8
prerank,stress-activated MAPK cascade (GO:0051403),-0.2053116672058174,-0.8136689426537211,0.8193146417445483,0.8905300046687142,1.0,11/61,10.32%,MAP3K8;PTGER4;NFKB1;ARHGEF6;CRKL;NOD2;UBC;TAB1;UBA52;MAP3K11;TNFRSF19
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.21199343325753295,0.8135735964951878,0.8367071524966262,0.9809460215775727,1.0,24/94,22.02%,PSMB1;RELA;UBE2V1;IL1RAP;PSMF1;BTRC;PSMA1;NOD1;PSMD7;PELI3;PSMA8;UBE2N;PSME3;MAP3K7;PSMD14;PSMC4;MAPK3;IL1A;PSMB4;TNIP2;PSME1;PSMD2;PSMD4;PSMD8
prerank,cholesterol biosynthetic process (GO:0006695),0.26349592729677795,0.8135164564381806,0.7479806138933764,0.980378666725995,1.0,6/31,18.86%,TM7SF2;ACAT2;NSDHL;LSS;ACLY;FDPS
prerank,response to cAMP (GO:0051591),0.2506566749305068,0.8135063941603261,0.7647058823529411,0.9797293823972357,1.0,6/37,12.75%,HCN1;DGKQ;RAPGEF3;PKD2;CFTR;CRHBP
prerank,regulation of stem cell population maintenance (GO:2000036),-0.2728225012124746,-0.8130392896625911,0.7268170426065163,0.8911053474872945,1.0,6/18,26.38%,WDR43;PTN;HMGA2;ESRRB;TAF6L;ZC3H13
prerank,DNA modification (GO:0006304),0.28096398927446437,0.8129723180277857,0.7248764415156508,0.9800759897438679,1.0,10/22,30.47%,OGG1;EXOSC5;PARP1;UNG;MPG;EXOSC3;ACD;TERF1;PARP3;NEIL1
prerank,hepaticobiliary system development (GO:0061008),0.28782958892742017,0.812555103243962,0.7225806451612903,0.9802245546773729,1.0,5/20,18.14%,WNT4;TGFBR3;PKD2;XBP1;PHF2
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.2752352288364118,0.8122578753910511,0.7520259319286872,0.9801021175546941,1.0,9/24,29.12%,PLA2G3;LPCAT1;PGS1;PLA2G15;PNPLA8;PLA2G4A;ABCA3;CDS2;CRLS1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.32248677192556174,-0.812000408058572,0.6962616822429907,0.8919659978961861,1.0,1/10,4.96%,CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.32248677192556174,-0.812000408058572,0.6962616822429907,0.8919659978961861,1.0,1/10,4.96%,CEP250
prerank,centromere complex assembly (GO:0034508),-0.22534273722321058,-0.8119311267940871,0.7756756756756756,0.8915356884314924,1.0,7/36,17.83%,MIS12;RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.3369992302146777,0.8118284122185306,0.7244367417677643,0.9802817289259912,1.0,1/11,3.68%,NEUROD2
prerank,keratan sulfate metabolic process (GO:0042339),0.2621556920606443,0.8114151931179274,0.7591125198098256,0.9804093800900945,1.0,3/31,2.82%,HEXB;B4GAT1;ACAN
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3154058429360175,-0.8113765468660263,0.7341176470588235,0.8919944748290677,1.0,3/11,16.95%,CCR2;WNT5A;ADAM17
prerank,cholesterol homeostasis (GO:0042632),0.22606732541202665,0.8111855935783443,0.7851959361393324,0.9801826285121389,1.0,15/64,19.75%,DGAT2;ABCG8;AKR1C1;SOAT2;CYP39A1;EHD1;MTTP;ABCA2;ANGPTL3;IL18;FABP3;LIPC;XBP1;TTC39B;RORA
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.20873599908928667,-0.8109983959520498,0.8419243986254296,0.8921018328606204,1.0,5/57,3.85%,IL15;IGF1;PARP14;PIBF1;IL6ST
prerank,positive regulation of glial cell differentiation (GO:0045687),0.30267432837295033,0.8107890814981268,0.7352941176470589,0.9802655215474723,1.0,6/17,20.20%,BIN1;TGFB1;CLCF1;CXCR4;SERPINE2;IL34
prerank,regulation of angiogenesis (GO:0045765),0.19254971677096824,0.8104156749251524,0.8825757575757576,0.980290240018107,1.0,29/192,13.02%,HOXA5;HHEX;F3;FGF16;CD34;ANGPTL4;IL17F;SMOC2;IL6;PLCG1;PDE3B;YJEFN3;GTF2I;MINAR1;DAB2IP;PRKCA;RAPGEF3;PRKD2;EPHA1;FOXC1;VASH1;PDCD6;FGF2;VASH2;SFRP1;ADAM12;EFNA3;COL4A2;TEK
prerank,PERK-mediated unfolded protein response (GO:0036499),0.33271256639237,0.8100392605796725,0.7057793345008757,0.9803654262345426,1.0,5/10,31.23%,NFE2L2;HERPUD1;ATF4;DDIT3;CCL2
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.2707433155481708,-0.8090604169586718,0.7308641975308642,0.8949574668064129,1.0,5/19,13.46%,NRP1;LIMS1;S100A10;KDR;MYOC
prerank,peptidyl-serine modification (GO:0018209),0.1926070112530538,0.808360824237554,0.8946684005201561,0.9829622522933739,1.0,44/166,23.57%,DCLK3;PKN1;PNCK;PRKCZ;RPS6KB1;DYRK1B;PRKCI;MAP3K10;TGFBR1;DGKQ;PRKCA;PRKD2;STK39;VRK2;CAMKV;PDGFB;PKD1;MGAT5B;STK32B;PARP1;NDNF;MAP3K13;PRKD1;DMPK;PRKCG;MAPKAPK5;CSNK1G3;PLK2;ROCK1;SMG1;MAST2;AKT3;WNK1;GALNT4;GALNT2;SBK1;ULK2;PDPK1;TOP1;LATS1;ULK1;TLK2;AURKA;STK32A
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2772625106866313,0.8078413835730651,0.7805280528052805,0.9826036439130744,1.0,9/22,27.09%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;ZDHHC19;ZDHHC12
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2772625106866313,0.8078413835730651,0.7805280528052805,0.9826036439130744,1.0,9/22,27.09%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;ZDHHC19;ZDHHC12
prerank,aminoglycan catabolic process (GO:0006026),0.2617311794107152,0.8077810845755375,0.747588424437299,0.9820432177604099,1.0,5/28,8.63%,AGRN;OVGP1;GPC1;GPC2;GPC5
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.26394819066329966,-0.8077523604528929,0.7544303797468355,0.8967082312270779,1.0,9/19,35.47%,APOE;CHRNB2;COLQ;CHRNA4;CHRNA5;CHRNA3;RAPSN;CHRNB4;CHRNB3
prerank,negative regulation of protein secretion (GO:0050709),0.25020096478003895,0.8076634928267232,0.7701863354037267,0.9816077692680395,1.0,11/38,23.35%,ADTRP;RAB11FIP3;ADRA2A;PRKN;IRS1;SFRP1;REST;OPRM1;ERP29;MIDN;CHGA
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.28677217794592397,-0.8076441737559218,0.7362110311750599,0.8963522096752778,1.0,3/15,9.90%,IGF1;IL6ST;CAMK2D
prerank,retina homeostasis (GO:0001895),0.2785146854150915,0.8075887549029664,0.7483974358974359,0.9810808766253181,1.0,4/23,19.02%,WHRN;CNGB1;ACTB;POTEF
prerank,protein palmitoylation (GO:0018345),0.2536048132100536,0.8070282642417539,0.7753510140405616,0.9814754654278576,1.0,12/30,27.09%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;SELENOK;GOLGA7;ZDHHC15;ZDHHC19;GLUL;ZDHHC5;ZDHHC12
prerank,spinal cord development (GO:0021510),0.3266809213287276,0.8070130044957267,0.7243816254416962,0.9808441057621687,1.0,3/12,12.74%,SOX4;PKD2;PKD1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3094088451227824,-0.8069306192216016,0.7366071428571429,0.8970816294830251,1.0,3/12,16.15%,ATP7A;DDC;ODC1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.226195769464008,-0.8069063436615214,0.8091168091168092,0.8965717432223989,1.0,11/38,19.43%,PRPF19;CLNS1A;SNRPD1;PRPF6;SNRPB;LSM2;CD2BP2;DDX20;SNRPC;USP4;PRPF3
prerank,transition metal ion transport (GO:0000041),0.24764745461964163,0.8068216295099262,0.7765089722675367,0.9805115629773347,1.0,6/35,11.57%,IREB2;TRPC3;SLC31A1;SLC39A8;ATP2C1;TRPC6
prerank,sphingolipid metabolic process (GO:0006665),0.2058713016975487,0.8065119018895234,0.855807743658211,0.9804473501428286,1.0,30/108,22.10%,HEXB;ESYT2;TEX2;NEU1;ORMDL2;CERS4;PRKD2;ENPP2;B3GALNT1;SPTSSA;TECR;NSMAF;ELOVL6;ABCA2;GAL3ST1;SPNS2;ELOVL4;CERS6;CERS5;PRKD1;KDSR;CERS1;SERINC1;PPP2R1A;PLA2G15;PLPP1;ELOVL5;PPM1L;GBA2;FA2H
prerank,telomere maintenance (GO:0000723),-0.20679938621735297,-0.8061043710616994,0.8688046647230321,0.8973883586264008,1.0,7/50,10.88%,SP100;NSMCE2;PCNA;RTEL1;NBN;POLD4;RPA1
prerank,negative regulation of bone remodeling (GO:0046851),0.33124362790608236,0.80597747816849,0.7317073170731707,0.9808039741874846,1.0,3/11,11.58%,IL6;UBASH3B;SFRP1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.24151153665752512,-0.8057072992128684,0.7780979827089337,0.897516071095645,1.0,8/27,15.97%,PPP2R5A;PTPA;CDCA2;CALM3;SPPL3;CALM2;BMP2;CAMTA1
prerank,negative regulation of innate immune response (GO:0045824),-0.22392279106710827,-0.8054626004844735,0.784366576819407,0.8973668061844453,1.0,14/34,29.65%,STAT2;USP18;ACOD1;SERPING1;NLRC5;OAS3;MUL1;USP15;NLRC3;TRIM21;DHX58;RPS19;VSIG4;TNFAIP3
prerank,protein deacylation (GO:0035601),0.2717419221587666,0.8052769737035098,0.7533112582781457,0.9814841290222079,1.0,5/23,19.14%,LYPLA1;HDAC5;LYPLAL1;HDAC3;ABHD17C
prerank,sensory perception of taste (GO:0050909),0.3356076216536644,0.8051151875797065,0.710091743119266,0.9811115759593257,1.0,3/10,17.34%,ASIC1;ASIC2;ASIC3
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.28959065554375846,0.8049754429284651,0.7508417508417509,0.9807123813014416,1.0,3/18,10.92%,NME5;PRKN;NFE2L2
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.20503179552463832,-0.8048416187471238,0.8467966573816156,0.897858259199223,1.0,6/50,7.22%,MOSMO;FBXL17;VCP;DLG5;TUBD1;TEDC2
prerank,regulation of proteolysis (GO:0030162),0.23382072963082046,0.8045172123984116,0.803030303030303,0.9808907677256858,1.0,7/48,8.84%,PLAT;CAPN3;CST3;ASPH;BTRC;OGT;BAK1
prerank,regulation of lipid metabolic process (GO:0019216),0.21028132266719826,0.8044221554783779,0.8431911966987621,0.9804205065317055,1.0,22/88,20.86%,TM7SF2;GNB3;PPARA;RARRES2;THRSP;TNFAIP8L3;CHD9;NCOR2;LSS;ZFP69;SMARCD3;ELOVL6;CCDC3;EDF1;ACACB;LACTB;FDPS;HDAC3;RORA;RUBCNL;PLPP1;ABCA7
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.262490411036696,-0.8043647568233422,0.7857142857142857,0.8980967066521386,1.0,4/20,13.05%,CELF1;LIMD1;AJUBA;AGO2
prerank,positive regulation of T cell migration (GO:2000406),-0.2564139915214144,-0.8039170564949345,0.7878048780487805,0.8983497982609081,1.0,6/20,24.85%,CCR2;WNT5A;SPN;ADAM17;APP;CXCL12
prerank,regulation of establishment of planar polarity (GO:0090175),-0.18701287964968855,-0.8038431877129244,0.894927536231884,0.8979275616865907,1.0,29/88,25.74%,PSMA6;AP2A2;DVL3;PSMB2;SMURF2;PSME2;AP2B1;SPEF1;PSMD11;PSMC6;PSMA3;FZD2;PSMD10;PSMB5;WNT5A;PARD6A;PSMD5;NPHP3;PSMD1;DAAM1;FZD4;ARHGEF19;PSMB7;PSMA7;PKHD1;RAC1;AP2A1;FZD1;PSMB3
prerank,phosphate ion homeostasis (GO:0055062),-0.32023169159488685,-0.8035158813909683,0.7171492204899778,0.897935135978871,1.0,4/10,42.44%,TFAP2B;FGFR4;FGF23;ENPP1
prerank,positive regulation of phospholipase activity (GO:0010518),0.27567925649179376,0.8034210635041357,0.7615131578947368,0.9816356074488455,1.0,7/22,21.04%,NTRK3;PLCG1;FGF2;HRAS;CCL5;PDGFRB;PDPK1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.27630712304065264,-0.8032632229387964,0.7467018469656992,0.8978110094523652,1.0,6/15,30.59%,LEMD3;ACVR2A;ACVR1;FST;IGSF1;FKBP1A
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.28917372647574024,-0.8032300101651959,0.7430025445292621,0.8973178607760662,1.0,7/14,28.45%,LIMS1;EMP2;BST1;FLNA;TIMP1;CD177;PHACTR4
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.29136378058006496,0.8031107134246347,0.7420435510887772,0.9815444472982926,1.0,7/18,23.30%,ACSL6;TECR;ELOVL6;ACSBG1;ACSF3;ELOVL5;ACSL3
prerank,cellular response to hexose stimulus (GO:0071331),0.27526148979742343,0.8026663010492141,0.740432612312812,0.9817027042362859,1.0,3/23,4.50%,ADCY8;TRA2B;SOX4
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.27128121998717825,0.8025453259399162,0.7700170357751278,0.981283513885305,1.0,9/24,28.64%,FSCN1;NCKAP1;TWF2;CYFIP1;WASF2;CDC42;CLRN1;BRK1;AUTS2
prerank,positive regulation of telomerase activity (GO:0051973),0.25061973145597904,0.8022457100788091,0.7667731629392971,0.9811842966048557,1.0,13/33,29.14%,WRAP53;MAPK15;CCT4;MAPK3;MAPKAPK5;HSP90AB1;XRCC5;GRHL2;PARM1;MAPK1;ACD;PTGES3;MYC
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.22588680737321323,-0.8020639275369764,0.7934782608695652,0.8987850422459447,1.0,5/33,7.86%,NR3C1;PPARG;SMARCA4;SMAD3;HIF1A
prerank,macrophage differentiation (GO:0030225),-0.29934137625957385,-0.8018182600619042,0.7317073170731707,0.8986821198244062,1.0,1/13,0.21%,IL15
prerank,ribonucleoprotein complex assembly (GO:0022618),0.19772008206638192,0.8017324025888939,0.8910256410256411,0.9814626398920163,1.0,34/132,21.67%,SRSF5;XAB2;CPSF6;ISY1;SRSF6;DDX1;RBM5;EIF6;SNUPN;SRSF1;SNRPD2;MRPS7;YTHDC1;NOP2;CELF6;RAMAC;CRNKL1;NUDT21;TRAF7;RPS27;RSL24D1;DDX39B;SETX;GEMIN5;GEMIN6;SRSF9;PUF60;GCFC2;SNRPD3;MCTS1;HSP90AB1;XRCC5;PRMT5;SART1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.30359636433465453,0.8012313840039638,0.7442680776014109,0.9817443145500542,1.0,2/17,6.86%,PLA2G3;LPCAT1
prerank,rRNA modification (GO:0000154),-0.25583623171854136,-0.8010181623937814,0.7890625,0.8994361245328539,1.0,7/21,19.33%,FTSJ3;MRM2;ZCCHC4;FBL;NOP10;NAT10;DKC1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.20998268279962135,-0.8008680571817717,0.8515151515151516,0.8991289762224769,1.0,16/52,25.54%,CNOT9;SAMD4A;DDX6;EXOSC8;RC3H1;DCP1B;LSM2;LSM5;EXOSC9;RC3H2;PAN3;LSM7;CNOT6L;EXOSC1;EXOSC7;TNKS1BP1
prerank,histone mRNA catabolic process (GO:0071044),0.2974103532787634,0.8007566714838693,0.7353896103896104,0.9820071107891064,1.0,3/15,14.80%,LSM1;MTPAP;UPF1
prerank,positive regulation of ruffle assembly (GO:1900029),0.3139864326827807,0.8005963960713929,0.7431972789115646,0.9816614909902008,1.0,4/13,16.53%,P2RY12;EPS8L3;EPS8L2;HRAS
prerank,lysine metabolic process (GO:0006553),-0.30607875747091073,-0.8005626922757144,0.7308641975308642,0.8985364180097165,1.0,6/12,34.97%,ALDH7A1;PIPOX;AASS;HYKK;PHYKPL;CRYM
prerank,lysine catabolic process (GO:0006554),-0.30607875747091073,-0.8005626922757144,0.7308641975308642,0.8985364180097165,1.0,6/12,34.97%,ALDH7A1;PIPOX;AASS;HYKK;PHYKPL;CRYM
prerank,negative regulation of cartilage development (GO:0061037),0.31483896139931805,0.8005574472747192,0.7377049180327869,0.9810750624970161,1.0,3/13,13.35%,TGFBR1;SNAI2;CHADL
prerank,glycoprotein catabolic process (GO:0006516),-0.2729971880682291,-0.7998247519793303,0.7780548628428927,0.8992128503554935,1.0,5/17,24.65%,CTSL;EDEM1;FBXO2;ADAMTS12;NEU4
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.33913599016256135,0.7997475506998883,0.7294776119402985,0.9819107420426014,1.0,3/10,13.98%,DAB2IP;EFNA1;EPHA4
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.23317016458524525,-0.7993970187897034,0.8093922651933702,0.8993934038140595,1.0,7/31,13.98%,DIS3L2;DDX6;EXOSC8;DCP1B;LSM2;LSM5;EXOSC9
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2206207755898197,0.7992568731340145,0.8268398268398268,0.9821463662167758,1.0,17/70,21.74%,DCC;BLOC1S2;G0S2;MLLT11;DAB2IP;BAK1;TGFB1;CASP3;IFI27;ACVR1B;SORT1;DDX47;TLR3;CASP8;GABARAP;PDPK1;CASP2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.1967909476834339,0.7991573719788762,0.9156010230179028,0.981698829808578,1.0,39/152,22.17%,FGF10;HHEX;UBE2B;PSMB1;LBX2;SOX4;TMEM198;PTK7;PSMF1;PSMA1;GPC5;PPM1A;PSMD7;FAM53B;TGFB1;PSMA8;PPM1N;SPIN1;PSME3;SFRP1;LRRK1;PSMD14;PSMC4;TMEM9;CCAR2;PRDM15;CSNK1G3;PSMB4;PIN1;RSPO1;WNK1;PSME1;SULF2;PSMD2;PSMD4;RSPO2;AXIN1;PSMD8;SFRP2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.2924897614552366,0.7985333853575957,0.7805309734513274,0.9820806592915851,1.0,4/17,18.28%,SLA2;BACH2;IL18;IL18BP
prerank,skeletal muscle tissue development (GO:0007519),0.24982460967662545,0.798341255973445,0.779874213836478,0.981749522341831,1.0,9/32,24.05%,SIX4;MEF2C;MYL6;LMOD3;CAV2;IGSF8;LEMD2;CFLAR;POPDC3
prerank,lipid biosynthetic process (GO:0008610),0.21479409821735643,0.7982124395672127,0.8365921787709497,0.9813220704020238,1.0,15/77,18.05%,STAR;PRLR;LPCAT1;CBR4;ACSL6;LSS;OXSM;PDSS1;ELOVL4;FITM2;NDUFAB1;ACSF3;ACLY;LIPC;XBP1
prerank,replicative senescence (GO:0090399),-0.2980539861895794,-0.7981869410753327,0.7219730941704036,0.9008793699742911,1.0,12/12,70.22%,CDKN2A;TERT;PLA2R1;ATM;ROMO1;WNT16;ATR;CHEK2;SERPINE1;CHEK1;TP53;MME
prerank,cardiac muscle cell development (GO:0055013),0.2788952687384757,0.7981840602380064,0.7603305785123967,0.9807265028501864,1.0,4/20,19.50%,OBSL1;SLC8A1;CXADR;PDGFRB
prerank,cholesterol metabolic process (GO:0008203),0.2168703615890936,0.7978094835475268,0.8432203389830508,0.9807718733507061,1.0,15/68,21.72%,STARD3;TM7SF2;SOAT2;ACAT2;NSDHL;LSS;CYP27A1;ACLY;SCAP;ANGPTL3;FDPS;CLN6;PIP4P1;FDX1;GBA2
prerank,positive regulation of RNA splicing (GO:0033120),0.2591402536789952,0.7977712625116503,0.7774086378737541,0.9801863805091443,1.0,9/29,20.73%,PRDX6;TRA2B;SLC38A2;CIRBP;RBM3;SETX;RBMXL1;TRA2A;RBM20
prerank,embryonic organ development (GO:0048568),0.22023604322730284,0.7977597651134456,0.8076923076923077,0.9795576090599706,1.0,10/61,13.12%,ZFPM1;COL2A1;RARRES2;PBX2;HEY1;TGFB1;TBX2;SH2B3;PBX3;NDRG4
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.22807479749844028,-0.7977413352366803,0.8125,0.9010833755389872,1.0,5/32,9.01%,ACTR3;CORO1C;ARPC2;CARMIL1;PIK3CA
prerank,T-helper cell differentiation (GO:0042093),0.3052924619207502,0.7974381888866451,0.7512953367875648,0.9794867881964359,1.0,4/14,15.43%,ZFPM1;IL6;HMGB1;BATF
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.22547770867108183,0.7972866004321145,0.8107302533532041,0.9791206636116472,1.0,11/54,13.89%,SH3BP1;PLCG1;MEF2C;PRKCA;PRKD2;VASH1;TGFB1;FGF2;PDGFB;GADD45A;HMGB1
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.3171907321011409,-0.7972858907064678,0.7228637413394919,0.9012813782475076,1.0,3/10,16.95%,CCR2;WNT5A;ADAM17
prerank,cellular response to acid chemical (GO:0071229),-0.2361273963347642,-0.7971873670054932,0.7962962962962963,0.900878458495304,1.0,10/27,22.07%,RRAGC;LAMTOR5;CAPN2;CPEB4;RRAGA;SESN2;KLF2;CPEB3;LAMTOR4;LARS1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.27283988475922044,0.7971305782231174,0.7715231788079471,0.9787445545148006,1.0,3/22,7.55%,DDX5;HIC1;EEF1E1
prerank,neural crest cell differentiation (GO:0014033),0.28370142051795166,0.7970017788072874,0.7675213675213676,0.9783318044784721,1.0,4/18,10.86%,CYP26C1;MEF2C;SNAI2;PDCD6
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.32774643741863485,0.796750327230372,0.7318718381112985,0.9781433221394837,1.0,2/11,10.95%,WRAP53;CCT4
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.24289323307388083,0.7965302528723668,0.7872670807453416,0.9779148655638716,1.0,13/37,25.38%,FHIT;GIPC1;SGTA;OGT;TAF9;UBXN1;CCAR2;HSP90AB1;CAMLG;TLK2;USP7;HFE;TRIM39
prerank,platelet aggregation (GO:0070527),-0.22852736092989004,-0.7964658694219376,0.8050847457627118,0.9015362342283165,1.0,17/33,33.10%,ACTN1;HSPB1;MYH9;VCL;PDGFRA;FLNA;FN1;ITGB3;FIBP;TLN1;MYL12A;ILK;CLIC1;PLEK;RAP2B;PPIA;MYL9
prerank,protein polymerization (GO:0051258),0.22851163727416604,0.7961644721338313,0.8236151603498543,0.9779346737598303,1.0,15/55,22.97%,TPPP;ANG;CATIP;CKAP5;PRKN;FGF13;WASF3;RNF135;CHMP2A;HDGFL3;PIN1;UBE2S;MAP7D3;WASL;TPPP3
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.19858862700335733,-0.7961121972927516,0.8424242424242424,0.9015382691692209,1.0,17/54,24.48%,GAS6;UBE2K;RIPK1;SYK;HIPK1;BIRC2;RACK1;TNF;OTULIN;TRAF1;ADAM17;PYDC1;HSPA1B;CASP1;CLIP3;GSTP1;FADD
prerank,vasculature development (GO:0001944),0.2968488267140863,0.7960744342308056,0.7305785123966942,0.9774478994166022,1.0,2/16,4.84%,FLT4;STK11
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.22519199919044952,-0.7960374302267237,0.7906976744186046,0.9011195201759683,1.0,19/36,38.86%,PPP3R1;CTNNB1;PPP3CA;FZD2;AGO2;NLK;WNT5A;PDE6B;FZD4;PDE6A;LEF1;TNRC6A;CALM1;PPP3CB;WNT11;FZD6;AGO3;NFATC1;MOV10
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.29220173028688523,0.7955588160942144,0.7512355848434926,0.9777135409018793,1.0,5/17,20.17%,ANGPTL4;SORT1;ANGPTL3;LIPC;LMF1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.26171776136965624,0.7953855898032127,0.7587301587301587,0.9773828098248423,1.0,3/25,7.57%,NEUROD2;SLA2;RIT2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.31940734876120463,0.7953019377508703,0.7448630136986302,0.976892150978823,1.0,3/12,9.53%,ZC3H10;NCOR2;TGFB1
prerank,protein-DNA complex disassembly (GO:0032986),0.30127436912455496,0.7949960520969556,0.7517241379310344,0.9768006978937817,1.0,3/16,11.25%,SMARCC2;SMARCE1;SMARCD3
prerank,acylglycerol catabolic process (GO:0046464),0.2566026066332829,0.7948518828606327,0.7599388379204893,0.9764020603294827,1.0,7/30,20.78%,PNPLA3;ABHD12;FABP3;LIPC;DAGLA;ABHD2;LIPE
prerank,carnitine shuttle (GO:0006853),0.3242188075943888,0.7946996813973597,0.7482638888888888,0.9760392805990027,1.0,2/11,5.44%,CPT1B;THRSP
prerank,endothelial cell differentiation (GO:0045446),0.3206558342597807,0.7941791240367293,0.726148409893993,0.9763442669148962,1.0,2/12,5.54%,KDM6B;FSTL1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.23235824367005917,-0.7940773241331328,0.7663316582914573,0.9037638302690907,1.0,8/29,19.03%,UTP6;RPS16;RPS14;UTP4;TSR1;TBL3;KRI1;ABT1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.2545976075620228,-0.7935435935989248,0.798469387755102,0.9040897570848608,1.0,8/21,26.05%,DLG5;TUBD1;TEDC2;KIF7;UCHL5;SHH;ULK3;TEDC1
prerank,sterol homeostasis (GO:0055092),0.22105777516063296,0.7934230173581192,0.8294460641399417,0.977038067928436,1.0,15/65,19.75%,DGAT2;ABCG8;AKR1C1;SOAT2;CYP39A1;EHD1;MTTP;ABCA2;ANGPTL3;IL18;FABP3;LIPC;XBP1;TTC39B;RORA
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.28898206784176306,0.7934119163178931,0.7478849407783418,0.9757740520649414,1.0,4/17,16.68%,BRWD1;SOCS2;IRS1;IL7
prerank,cellular response to interleukin-7 (GO:0098761),0.28898206784176306,0.7934119163178931,0.7478849407783418,0.9757740520649414,1.0,4/17,16.68%,BRWD1;SOCS2;IRS1;IL7
prerank,regulation of lipid storage (GO:0010883),0.2708483300175256,0.7933704703297141,0.774247491638796,0.9751968896011645,1.0,3/22,5.63%,C3;HILPDA;IL6
prerank,negative chemotaxis (GO:0050919),0.24737122470940232,0.793132161045091,0.7928802588996764,0.9749802105728519,1.0,7/33,16.66%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;SEMA4F;SEMA4B;SEMA3C
prerank,positive regulation of cell development (GO:0010720),0.252974830491278,0.7929820333777022,0.7837398373983739,0.9746194992939701,1.0,6/31,17.12%,NUMB;LRP2;BMP4;CX3CR1;LMOD3;OPRM1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2537716252628448,0.7929054973981204,0.7963246554364471,0.9741186560756089,1.0,7/32,14.67%,SNAPIN;MEF2C;PNKD;RAB5A;RIMS1;CPLX2;BAIAP3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.22399293183778635,-0.7926411320878286,0.8104395604395604,0.904994966746511,1.0,12/37,26.60%,ALOX5;NOD2;HIF1A;ZC3H12A;TNF;TLR4;APPL2;MYD88;NLRC3;MEFV;APPL1;ABCD1
prerank,inositol phosphate catabolic process (GO:0071545),0.31210302446054294,0.7926344640371648,0.7222222222222222,0.9739459801713994,1.0,5/12,21.33%,INPP5B;NUDT3;OCRL;INPP5A;INPP5J
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.302402912754843,-0.7924663566395268,0.7511737089201878,0.9047502503418074,1.0,1/11,0.36%,VCPIP1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3007457014817848,-0.79202530231285,0.7378190255220418,0.904942515308234,1.0,4/12,13.67%,GMPS;ATIC;PAICS;IMPDH1
prerank,regulation of protein modification process (GO:0031399),0.22878165603969086,0.7917770369991722,0.8383404864091559,0.9748411292285922,1.0,5/50,3.63%,PPP1R16A;PLXNB2;PPIB;ROPN1;ROPN1L
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.23794755375663043,0.7917141575826054,0.7978395061728395,0.9743173880016,1.0,11/40,21.89%,NUCKS1;DONSON;TIMELESS;SMARCAL1;TRAIP;RFWD3;CENPS;TONSL;WRN;ALYREF;EXD2
prerank,regulation of phosphate metabolic process (GO:0019220),0.29183948892267875,0.7916542446636827,0.7457912457912458,0.9737969061646927,1.0,2/16,3.26%,SRPX2;GNB3
prerank,regulation of dephosphorylation (GO:0035303),0.30059795882169843,0.7914141084303228,0.75,0.9735883064711587,1.0,5/15,21.48%,PPP1R16A;MTMR9;MTMR1;SMG7;PPP1R16B
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.2322823490535365,-0.7912057169841038,0.8136482939632546,0.9057393299687384,1.0,4/29,9.18%,MCTP1;APOE;SLC8A2;DRD2
prerank,vitamin transport (GO:0051180),-0.2325971439031343,-0.7911740928885306,0.7945945945945946,0.9052479398417242,1.0,10/29,29.10%,SLC46A1;SLC2A8;SLC52A2;SLC52A1;AFM;PDPN;AMN;CD320;FOLR2;FOLR1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.20820715776001442,-0.7911173131474197,0.8787878787878788,0.9047922414483252,1.0,11/49,18.52%,RNASE3;DNASE1L1;NCBP1;SIAH2;RIPK1;XRN2;FBXO2;MAGEC2;RNASEH2A;HNRNPD;RNASEH1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.20641882431306932,0.7911108190346287,0.8640226628895185,0.973503040347778,1.0,15/88,13.02%,F3;ANG;FGF16;FLT4;TGFBR1;EGFL7;BMP4;PRKCA;PRKD2;VASH1;PDCD6;FGF2;VASH2;PDGFB;TEK
prerank,phospholipid homeostasis (GO:0055091),0.32228570112928234,0.7908720456874258,0.7316176470588235,0.9732804943845097,1.0,3/11,17.83%,TLCD2;ANGPTL3;FABP3
prerank,granulocyte chemotaxis (GO:0071621),-0.2014131302375995,-0.7906929779635002,0.8451612903225807,0.9048967283524055,1.0,6/55,9.12%,GBF1;CCL25;PF4;SYK;ANXA1;JAML
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.2780861736583343,-0.7906855731637589,0.7572815533980582,0.9043667804495948,1.0,5/15,18.52%,ZC3H12D;ZC3H12A;ZC3H12B;POP1;RNASEH1
prerank,response to interleukin-1 (GO:0070555),-0.19117362085055783,-0.7895809637456753,0.904320987654321,0.9055339197985596,1.0,20/73,23.77%,CD47;NFKB1;CCL25;ANXA1;GBP3;HIF1A;IL1B;ZC3H12A;PTGIS;RC3H1;ACOD1;HAS2;RBMX;HYAL3;MYD88;ADAMTS12;HDAC4;APP;MAPK11;CCL7
prerank,mesenchymal cell development (GO:0014031),0.28192955463645797,0.7888111966665148,0.7449324324324325,0.9761986858006686,1.0,4/18,10.86%,CYP26C1;FOXC1;SNAI2;PDCD6
prerank,cellular component assembly (GO:0022607),0.18007475522173674,0.7885266596828863,0.9395017793594306,0.9760363488186088,1.0,75/253,27.36%,SH3BP1;FSCN1;WDR19;CAPN3;ADD2;NIFK;RHOV;PARD6B;RAD21L1;PPARGC1A;NCKAP1;NCKAP1L;IL1RAP;MAGI1;LRRTM3;TSPAN4;SH3BGR;ZW10;TGFB1;PEX14;RIMS1;STK25;TLCD2;DNM1L;LRGUK;WASF3;VAMP3;SPTBN1;CYFIP1;CHCHD10;SPAG16;TUBGCP2;WNT7A;PAWR;EPRS1;GEMIN5;RHOQ;QSOX1;PPP2R1A;SHANK1;ACTB;RHOU;LIN7A;ESPN;HORMAD1;CLDN14;CDC42;CAPG;TEX12;GRHL2;ZFYVE27;TEAD2;MDM4;VMP1;DNAJB13;WASL;OPHN1;LIMS2;PCLO;LAMC1;ANK3;IL2RB;CD40;RHOA;HFE;SHROOM1;ACD;ADD1;ST13;DLG4;LLGL1;MYO9A;CFAP74;DMTN;ABCA3
prerank,regulation of myelination (GO:0031641),0.26291447578679356,0.7881873215927857,0.7938808373590982,0.9760046692826679,1.0,2/25,4.74%,TPPP;JAM2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.2612241824173485,0.7881098631218482,0.7863924050632911,0.9754987985416995,1.0,6/26,19.46%,B4GAT1;ACAN;CHST1;ST3GAL6;B4GALT2;ST3GAL3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.2639877250099593,-0.7879253020891567,0.8035264483627204,0.9076288070920933,1.0,5/18,16.33%,ANXA1;CIB1;RHOJ;KDR;HMOX1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.25067780302930376,-0.787463277762421,0.7851851851851852,0.9078135395411888,1.0,6/21,22.35%,MPDU1;ST8SIA6;FUT8;B3GALT5;ST6GALNAC5;FUT4
prerank,dopaminergic neuron differentiation (GO:0071542),0.286896593160032,0.7874498292757837,0.764808362369338,0.9760132401008773,1.0,3/19,14.53%,RYK;MANF;LMX1B
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.27241560261926206,0.787086079050408,0.7817258883248731,0.976010341152592,1.0,7/20,30.17%,HHEX;HEXIM2;IPO5;LATS1;HEXIM1;PTEN;CDK5RAP1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.24878424230987378,0.7865525539334893,0.7996768982229402,0.9762589572969572,1.0,16/33,33.11%,FPGS;SLC39A8;KYAT1;ALDH5A1;ALDH4A1;DDAH2;PRODH;PYCR3;ART4;GLUL;GLS2;DGLUCY;RIMKLB;MTHFS;GCLM;ALDH18A1
prerank,primary miRNA processing (GO:0031053),-0.3176802616664402,-0.7862721653598987,0.759009009009009,0.9091424371873751,1.0,4/10,20.84%,SMAD3;SRRT;HNRNPA2B1;DGCR8
prerank,UV protection (GO:0009650),0.32489917934787305,0.7859074431146669,0.750445632798574,0.9767376127031269,1.0,5/10,29.03%,FEN1;SDF4;ERCC2;CAT;SCARA3
prerank,negative regulation of heart contraction (GO:0045822),-0.3073920128281131,-0.785802709787362,0.7536945812807881,0.9093561173633201,1.0,6/11,30.73%,ZC3H12A;SPX;PDE4D;GRK2;AGTR2;SRI
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2657737126790301,0.7856662296366566,0.7787162162162162,0.9765306422221014,1.0,7/22,30.17%,HHEX;HEXIM2;IPO5;LATS1;HEXIM1;PTEN;CDK5RAP1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.31643094058594445,0.7853454830424519,0.7469244288224957,0.976424144118577,1.0,3/12,18.53%,PRKCZ;IRS1;ZBTB7B
prerank,regulation of stem cell differentiation (GO:2000736),-0.18581379741911053,-0.7851017694990965,0.9217081850533808,0.909977355508544,1.0,30/89,25.98%,ITCH;PSMA6;TCF12;PSMB2;PSME2;PSMD11;PSMC6;YAP1;PSMA3;NOTCH1;NSUN2;PSMD10;PTN;PSMB5;PSMD5;GATA3;PDGFRA;HES1;PSMD1;HNRNPU;LMO1;ESRRB;SETD1A;KMT2A;PSMB7;PSMA7;EIF2AK2;PSMB3;CBFB;MYB
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.3003518489841239,-0.7850827993272356,0.7482185273159145,0.9094547060645475,1.0,4/11,19.44%,ITM2B;NECAB1;AGO2;ITM2A
prerank,neuromuscular process (GO:0050905),0.29440744782074557,0.7849020948386931,0.7795138888888888,0.9765681351231247,1.0,4/16,18.02%,MYCBP2;NRXN1;DCTN1;SHANK1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.30223178622210894,-0.7848615213426552,0.7746478873239436,0.9092499417369505,1.0,3/12,11.42%,XDH;SPRY2;SEMA6A
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.2048991906792794,-0.7846139408610009,0.875,0.9091021867006026,1.0,13/52,19.31%,PRKCH;PRKCE;CIB1;SORBS1;LRP1;NUMA1;EGFR;TNF;EPHA2;PLS1;AKAP5;SQSTM1;NKD2
prerank,regulation of fatty acid oxidation (GO:0046320),0.29718955723870233,0.7838444805268439,0.7694974003466204,0.9777372109090251,1.0,4/16,17.83%,PPARGC1A;PPARA;TYSND1;FABP3
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.31533288137902427,-0.7835757520060236,0.746031746031746,0.9101491924314995,1.0,5/10,32.97%,CARMIL1;CFL2;CARMIL2;PLEK;PDXP
prerank,"phototransduction, visible light (GO:0007603)",0.3092648944957197,0.7835017348768485,0.7628524046434494,0.9776862706470729,1.0,5/14,31.83%,CNGB1;GNA11;GNAQ;ABCA4;PDE6G
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.23844590946149846,0.7833111318830611,0.8361669242658424,0.9773686995932352,1.0,12/41,25.99%,PTGS1;ALOX12;PLA2G4C;ACOX1;DAGLA;DECR2;FADS3;ELOVL5;PNPLA8;DAGLB;PLA2G4A;EPHX1
prerank,positive regulation of TOR signaling (GO:0032008),0.23245756994215339,0.7832589032287577,0.8309859154929577,0.9768293480203255,1.0,11/40,22.57%,KLHL22;RPTOR;NCKAP1L;SLC38A9;FLCN;WDR59;HTR6;WDR24;HDAC3;PIP4P1;SIK3
prerank,negative regulation by host of viral transcription (GO:0043922),-0.30289895889291507,-0.7826913240177606,0.7394366197183099,0.9109454824130706,1.0,3/12,17.80%,HDAC1;INPP5K;HMGA2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3044401384592964,0.7826763463012496,0.7701754385964912,0.9771447526291518,1.0,2/15,7.48%,MTHFD1L;TGFBR1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.251371786281208,0.7821925439288157,0.7881773399014779,0.977321825796118,1.0,8/30,20.44%,F11R;PRAG1;GPR17;LPAR4;AKAP13;P2RY10;GPR174;ARRB1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.2865983099371242,-0.7820905813553678,0.7561576354679803,0.9113320398385768,1.0,4/13,15.36%,CD74;GPRC5B;LILRB1;WNT5A
prerank,cellular response to amino acid stimulus (GO:0071230),0.24454036911354618,0.7820042949332954,0.8146964856230032,0.9769997090996825,1.0,8/33,19.21%,KLHL22;RPTOR;SLC38A9;GLRA2;IPO5;SH3BP4;XBP1;NSMF
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.3205478852095333,-0.7820007134371357,0.7422222222222222,0.9109212837926648,1.0,3/10,9.61%,RUNX3;IRF4;SH3RF1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.23281374741686695,-0.7818354690286631,0.8091397849462365,0.9106403781498102,1.0,10/31,19.79%,PTPN1;BAX;ERN1;HSF1;PACRG;HSPB8;OPTN;TM7SF3;HSPA13;HSPA1B
prerank,positive regulation of cilium assembly (GO:0045724),0.2775998623110068,0.7815202318867142,0.7892918825561313,0.9771822394426778,1.0,6/18,27.23%,SEPTIN9;ARHGAP35;HAP1;CEP120;FUZ;ENTR1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.29086386415258925,0.7813890918189097,0.7668918918918919,0.9767732536027112,1.0,4/15,17.36%,SPCS2;SRPRB;SRP14;SRPRA
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3023830314426835,0.7813729920013575,0.7587354409317804,0.9761754387068533,1.0,4/14,24.98%,PKIA;PRKAR1A;PRKAR2B;RAPGEF2
prerank,glucan catabolic process (GO:0009251),-0.2795583089014236,-0.7813044044618372,0.7822784810126582,0.910960976688012,1.0,4/15,14.62%,PHKB;AGL;GAA;PGM2L1
prerank,purine ribonucleotide transport (GO:0015868),0.2893099868352544,0.7811853565196697,0.7736156351791531,0.9758508222240575,1.0,4/16,19.70%,SLC25A4;SLC19A1;SLC35B2;ABCC6
prerank,cartilage development (GO:0051216),0.22671582874249832,0.7810474355583146,0.8345864661654135,0.9754520922094906,1.0,14/49,23.75%,COL2A1;IL17F;NFIB;MEF2C;BMP4;TGFB1;FGF2;PKD1;WNT7A;GHRL;SNX19;SULF2;RUNX1;GPLD1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.24903548521708022,0.7809592042569401,0.8115942028985508,0.9749839509015074,1.0,8/29,20.91%,ZC3H7B;ADAR;SPOUT1;DROSHA;AGO4;LIN28B;SMAD1;SMAD2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.22332561075709687,0.7808998241479054,0.8235294117647058,0.9744708362265614,1.0,16/54,24.20%,CNOT2;SOX4;E2F1;PLK3;BTG2;CNOT8;GADD45A;RBL2;PLK2;CNOT10;TFDP2;MDM4;CASP2;AURKA;TRIAP1;CNOT4
prerank,regulation of phospholipase activity (GO:0010517),0.34148728854456517,0.7807043060117481,0.7552816901408451,0.974153703721189,1.0,5/10,34.00%,RGS2;ANGPTL3;PDPK1;FGFR3;RASGRP1
prerank,cytoskeleton organization (GO:0007010),0.19517719690915925,0.7805152233394288,0.8978779840848806,0.9738561927766453,1.0,26/114,19.60%,CNTNAP1;DST;OBSL1;BIN1;THY1;RHOBTB1;SIPA1;BRWD1;FMNL3;FGD2;MICAL3;PRKCI;ARAP3;CFL1;CAMSAP1;PAK5;WASF3;DPYSL2;FITM2;PAK6;CDC42BPB;RHOBTB2;MAST2;ZMYM6;RHOU;ZMYM3
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.25926484634709884,0.7804867356702495,0.8112903225806452,0.9732800900783763,1.0,5/26,15.79%,NME5;FBXO7;PRKN;NFE2L2;REST
prerank,serine family amino acid catabolic process (GO:0009071),0.3268921684118835,0.7789809693509574,0.782608695652174,0.9752411358773108,1.0,3/10,15.77%,AMT;DAO;DLD
prerank,cellular response to chemical stress (GO:0062197),0.20253767811392215,0.7788978281822766,0.8961218836565097,0.9747506905458624,1.0,16/96,16.28%,SELENOS;PRDX5;PRDX6;NUDT2;PPARGC1A;VKORC1L1;PKD2;PRDX2;NFE2L2;PYROXD1;VRK2;RAD52;PARP1;SETX;PRKD1;ERMP1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.27484893394079696,-0.778854965776146,0.7841191066997518,0.9141681585339507,1.0,5/17,22.82%,ADCY9;DRD2;ADRA1A;DRD3;GPR101
prerank,positive regulation of transferase activity (GO:0051347),0.19006040010097108,0.7787252116397149,0.9257294429708223,0.9744126992800152,1.0,33/142,21.15%,WRAP53;MERTK;NTRK1;FLT4;MAPK15;NTRK3;RYK;DCUN1D2;EPHA1;ERBB4;TGFB1;UBE2N;CCT4;TEK;DBI;EPHA4;EPHB2;INSR;NTRK2;UBE2I;MAPK3;VAC14;SERINC1;MAPKAPK5;FLT3;CHRNA7;PIN1;PDGFRB;ROR1;EPHA5;HSP90AB1;XRCC5;GRHL2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.22711283491924122,0.7784727304756812,0.8257016248153619,0.9742147728159603,1.0,10/48,16.08%,AAAS;EIF6;NUP54;OGT;NUP88;RAE1;JMJD8;PRDM16;KHK;NUP133
prerank,muscle tissue development (GO:0060537),-0.2902552191978619,-0.7778994151170748,0.7476415094339622,0.9151512963127038,1.0,5/13,22.21%,PGM5;CSRP2;POGLUT1;PTCH1;SHH
prerank,Golgi to plasma membrane transport (GO:0006893),0.22858288870038965,0.7773794786417906,0.8456692913385827,0.9753863618196005,1.0,10/47,14.74%,GGA3;RAB26;SYS1;COMMD1;ARFRP1;RAB34;SPTBN1;BLZF1;EXOC5;EXOC6B
prerank,vasoconstriction (GO:0042310),-0.30870541103265026,-0.7770797669854494,0.7488038277511961,0.9157928872944973,1.0,8/11,36.46%,EDNRB;EDNRA;ACTA2;KEL;EDN3;CRP;EDN2;EDN1
prerank,regulation of vasoconstriction (GO:0019229),0.255254801599218,0.7767684429629864,0.7996688741721855,0.9757871811088338,1.0,2/27,3.31%,AVPR2;AVPR1A
prerank,histone H4-K16 acetylation (GO:0043984),0.2754705313278327,0.7766056129681205,0.7820945945945946,0.9754398305503494,1.0,8/19,25.80%,JADE2;MEAF6;OGT;KAT8;WDR5;JADE1;MSL1;MCRS1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.21506968402529653,0.776138915159575,0.8544668587896254,0.9756032803235181,1.0,19/64,25.99%,ADTRP;ALOX12;PLA2G4C;PNPLA3;ACSL6;ELOVL6;ACOT4;ACOX1;ACSBG1;HPGD;DAGLA;ELOVL5;ACAD9;PNPLA8;DAGLB;ACSL3;HACL1;PLA2G4A;EPHX1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.1973943263524635,0.7760996745285033,0.8743016759776536,0.9750524725381948,1.0,11/104,9.62%,CDK7;FGF16;RPTOR;THY1;CCNI;SERTAD1;TRIB1;TRIB2;DAB2IP;CCND3;SLC8A1
prerank,modified amino acid transport (GO:0072337),0.2973625663700091,0.7760616098172558,0.7777777777777778,0.9745008563216339,1.0,4/15,18.31%,CTNS;SLC1A4;SLC19A1;SLC16A12
prerank,cellular response to inorganic substance (GO:0071241),0.2723527231156321,0.7749166588809755,0.7672849915682968,0.9758093373255684,1.0,4/21,17.48%,TIMELESS;NSMCE3;AOC1;MTR
prerank,regulation of cell growth (GO:0001558),0.18303182141863222,0.7748087436443282,0.9518518518518518,0.9753542368379476,1.0,41/204,19.26%,KLHL22;WFDC1;RPTOR;PSRC1;TMC8;STK11;SIPA1;HDGFL2;LGI1;EBAG9;IL2;TGFBR1;MINAR1;APBB1;FHL1;KIF26A;GNG4;SOCS2;TGFB1;ADAM15;NRG3;CGRRF1;ACVR1B;SFRP1;PAK5;DCBLD2;FLCN;BAP1;EI24;CCAR2;HPN;SH3BP4;KIF14;AGT;N6AMT1;NDRG3;PPP2R1A;BTG1;LTBP4;TCHP;TAF9B
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.22749991889661506,-0.7747627096025481,0.8293963254593176,0.9181436526353329,1.0,9/29,27.10%,RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1;CENPH;HJURP;OIP5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.22749991889661506,-0.7747627096025481,0.8293963254593176,0.9181436526353329,1.0,9/29,27.10%,RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1;CENPH;HJURP;OIP5
prerank,zinc ion transmembrane transport (GO:0071577),0.2653530997410039,0.7743353495865187,0.8052373158756138,0.9754866489789534,1.0,5/22,17.98%,SLC39A4;TRPM2;SLC39A8;SLC30A3;SLC39A3
prerank,aortic valve morphogenesis (GO:0003180),0.2491860212026457,0.7741488958126236,0.8003246753246753,0.9751640672112508,1.0,5/30,10.94%,BMP4;HEY1;TGFB1;SNAI2;EFNA1
prerank,homologous chromosome segregation (GO:0045143),0.2699889224198744,0.7737020344856107,0.8104026845637584,0.9752683989379513,1.0,5/20,21.80%,SGO1;TERB1;FANCD2;CENPC;IHO1
prerank,ERBB2 signaling pathway (GO:0038128),0.24645369251383242,0.7736616875196761,0.8058551617873652,0.974707229470387,1.0,4/31,9.08%,MATK;NRG4;PRKCA;ERBB4
prerank,positive regulation of neuron migration (GO:2001224),-0.29822426450372946,-0.7733495389011881,0.7972350230414746,0.9197662143167419,1.0,4/11,18.00%,KIF20B;SEMA6A;SHTN1;ARHGEF2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.30098825568121274,0.7728489971440409,0.7986798679867987,0.9754486695638757,1.0,4/14,16.84%,PKD2;FAF1;PKD1;SUFU
prerank,negative regulation of actin filament polymerization (GO:0030837),0.265836426309019,0.7727545163883227,0.7993311036789298,0.9749840262958002,1.0,6/22,17.56%,TWF2;ARFGEF1;TWF1;SSH1;SSH2;SSH3
prerank,carboxylic acid catabolic process (GO:0046395),0.3125971114492365,0.7727142634242409,0.7690972222222222,0.974431087478105,1.0,2/12,3.78%,IL4I1;GNPDA2
prerank,regulation of cell communication (GO:0010646),-0.2162299828004061,-0.7716399660811133,0.8461538461538461,0.9216861880568644,1.0,16/35,30.73%,CRK;PTPN1;ANXA1;YWHAG;CAMK2D;NUP62;IGFBP7;CDC42SE2;VEPH1;GLRX2;RYR2;GRK5;GRK2;GRK4;CASQ2;SRI
prerank,pyroptosis (GO:0070269),-0.27629452766236084,-0.7715064811450275,0.7703349282296651,0.9213384771557743,1.0,2/15,4.14%,ZBP1;NLRC4
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.2337434032530497,-0.7714442764612583,0.8072625698324022,0.9208810692200564,1.0,2/27,1.33%,ARL6IP5;SLC7A1
prerank,odontogenesis (GO:0042476),0.2353075528512036,0.771061961477501,0.8416149068322981,0.9763854106908707,1.0,3/35,9.03%,ROGDI;BMP4;FOXC1
prerank,regulation of cellular localization (GO:0060341),0.2250881889021402,0.7706947256215304,0.8483483483483484,0.9763429583898526,1.0,13/46,21.69%,PARD6B;PARD6G;PRKN;WWC1;PARP1;STXBP2;STXBP4;FES;TRIM67;MAD1L1;EPHA5;HSP90AB1;MAP2
prerank,mitochondrion disassembly (GO:0061726),0.23968518196021127,0.7703912331181432,0.8434108527131783,0.9762043702275144,1.0,12/34,24.49%,FUNDC1;FIS1;FBXO7;USP30;PRKN;BECN1;CTSK;GABARAP;ULK2;ULK1;WDR45B;ATG2A
prerank,vasculogenesis (GO:0001570),-0.21930638968256488,-0.7697430065846392,0.8521739130434782,0.9227568106578117,1.0,14/32,30.89%,RASA1;AGGF1;CAV1;NOTCH1;KDR;HAS2;RAMP2;HEY2;SHH;APLNR;SPRED1;WT1;ITGB8;RASIP1
prerank,positive regulation of telomere capping (GO:1904355),-0.26485587262252713,-0.7691015616570025,0.8174807197943444,0.9231620763953011,1.0,5/17,18.18%,RTEL1;PKIB;PRKCQ;MAP2K7;HNRNPD
prerank,steroid biosynthetic process (GO:0006694),-0.19274631716299864,-0.7686847777299949,0.9109792284866469,0.9232635973570731,1.0,29/56,39.86%,ACOT8;OSBP;OSBPL9;OSBPL1A;PRKAG2;OSBPL2;HSD17B1;HSD11B1;SC5D;HSD3B7;INSIG1;SRD5A2;PMVK;HSD3B2;ABCB11;INSIG2;EBP;BAAT;HSD17B3;SLC27A5;AKR1D1;CYP19A1;ACOX2;HMGCR;CH25H;FDFT1;OSBPL3;LBR;SLC27A2
prerank,pseudouridine synthesis (GO:0001522),-0.28905895957270256,-0.7686451673065839,0.7780429594272077,0.9227628349546656,1.0,5/13,24.58%,TRUB2;NOP10;DKC1;PUS3;NHP2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2677867036813813,0.7683783604946269,0.7993579454253612,0.9780685984633707,1.0,8/21,27.27%,GTF2H2;GTF2H4;PARP1;DDB2;GTF2H3;ERCC4;ERCC2;GTF2H1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2677867036813813,0.7683783604946269,0.7993579454253612,0.9780685984633707,1.0,8/21,27.27%,GTF2H2;GTF2H4;PARP1;DDB2;GTF2H3;ERCC4;ERCC2;GTF2H1
prerank,tRNA 5'-end processing (GO:0099116),-0.27073990194927877,-0.7678864277255052,0.806615776081425,0.9233028057645662,1.0,4/15,10.06%,TRMT10C;RPP38;RPP21;SSB
prerank,response to laminar fluid shear stress (GO:0034616),0.3248614089382804,0.7677011545085856,0.7725694444444444,0.9785072265151602,1.0,2/10,10.92%,MAP2K5;NFE2L2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.265639011839701,0.7675609250386416,0.7986906710310966,0.9781120987754077,1.0,9/21,28.69%,DMD;CNKSR3;DDIT4;GADD45A;INPP5J;PAQR3;DMTN;PTEN;NLRP2B
prerank,regulation of axon guidance (GO:1902667),-0.30653785280684787,-0.7671993140909573,0.7663755458515283,0.923736424390514,1.0,1/10,0.72%,NRP1
prerank,positive regulation of double-strand break repair (GO:2000781),0.23431042321570753,0.7671407449633908,0.8387096774193549,0.9781308270564447,1.0,7/39,17.26%,WRAP53;FUS;TIMELESS;PARP1;ERCC6;SHLD3;MRNIP
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2309257661636674,-0.7668194808536396,0.839572192513369,0.9237045011481625,1.0,15/27,36.41%,C3AR1;GPR157;DRD2;GPR18;GPR65;DRD3;CALCA;GPR4;HTR2C;OPRL1;F2RL2;GPR35;GPR55;DRD1;AGTR1
prerank,polyol biosynthetic process (GO:0046173),0.2850852887391566,0.7666801459896616,0.7979274611398963,0.9782473455803539,1.0,4/16,15.72%,IP6K1;FGF2;IPMK;CYP27A1
prerank,regulation of cellular protein localization (GO:1903827),-0.20768652345728822,-0.7665504675476972,0.8820058997050148,0.9235414279622027,1.0,9/45,14.38%,VCPIP1;VCP;DVL3;PTPN1;GBF1;LCP1;CTNNB1;RALB;RAB11FIP5
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2613757811239217,0.7660591212302389,0.8099688473520249,0.9785909802549735,1.0,5/23,13.91%,COPS8;COPS3;PARP1;DDB2;COPS6
prerank,cellular transition metal ion homeostasis (GO:0046916),0.1997914657971551,0.7659101447141686,0.8998589562764457,0.9781878630514141,1.0,25/91,21.90%,IREB2;SLC39A4;ABCB6;PRNP;SLC31A1;FLVCR1;SLC39A8;FRRS1;ATOX1;CYB561A3;TMPRSS6;MT2A;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;ISCU;ABCB7;ABCG2;ATP6V1G1;ARF1
prerank,microvillus assembly (GO:0030033),0.2935149593117344,0.7657683263283245,0.7829716193656093,0.9778154807294707,1.0,6/14,24.98%,STK26;MAP4K4;MINK1;ESPN;RAP2C;RAPGEF2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.20213881981079804,-0.7656430746178643,0.8985074626865671,0.9242891238731306,1.0,12/48,17.09%,P2RX4;THBS1;SP1;ANXA1;CIB1;HIF1A;RHOJ;KDR;HSPB1;HMOX1;ADAM17;NUS1
prerank,mitochondrial fusion (GO:0008053),0.27808757508170123,0.7656087876162296,0.7920133111480865,0.9774435638854293,1.0,4/18,17.54%,FIS1;USP30;MIGA1;MFF
prerank,negative regulation of cell communication (GO:0010648),-0.25169877835668447,-0.7654996019893727,0.8201058201058201,0.9239445295203621,1.0,3/21,9.17%,PTPN1;IL1B;SOCS5
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2034235127025837,0.764203110056963,0.8995873452544704,0.9789831740593347,1.0,32/85,28.42%,VANGL2;PSMB1;RYK;ARRB2;PSMF1;PRICKLE1;PSMA1;PSMD7;PSMA8;PSME3;VANGL1;PSMD14;PSMC4;WNT7A;PSMB4;DVL2;MAGI2;CDC42;PSME1;PSMD2;PSMD4;PSMD8;TIAM1;RHOA;PSMC5;ROR2;FZD5;PSMD3;PSMB8;PSMA4;CLTC;CELSR2
prerank,histone acetylation (GO:0016573),-0.18931032151075086,-0.7640143880827256,0.9105431309904153,0.925569471060047,1.0,22/69,26.10%,EP400;EPC1;KAT6B;PHF20;TAF12;TRRAP;HAT1;EP300;KAT5;CHD5;MSL3;KAT7;TRIM16;TADA2A;POLE3;YEATS2;TAF6L;KAT2B;NAA40;ACTL6A;ATF2;LEF1
prerank,relaxation of cardiac muscle (GO:0055119),0.2952345718013862,0.7638105528404913,0.78839590443686,0.9789438965877398,1.0,5/13,23.35%,ATP1B1;SLC8A1;RGS2;ATP1A1;CHGA
prerank,organonitrogen compound catabolic process (GO:1901565),-0.18956586680061605,-0.7637479940935644,0.9347826086956522,0.925403290408133,1.0,15/57,21.23%,SGPL1;ANPEP;CPQ;GNPDA1;CLN8;CLN5;ERAP1;LTA4H;MPST;UCHL3;NAGK;GADL1;CTH;RENBP;ADO
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.18343209349519504,-0.763740592846464,0.9471947194719472,0.9248640409898499,1.0,10/68,10.02%,MTHFR;MCCC1;FLAD1;SLC46A1;HLCS;MCCC2;GSTO2;MTHFD1;SLC52A2;SLC25A19
prerank,positive regulation of interleukin-2 production (GO:0032743),0.2576562500935303,0.7629316452328093,0.8260869565217391,0.9796521224642876,1.0,7/25,17.51%,CD80;CD86;PNP;PRKD2;MAP3K7;SPTBN1;IL1A
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.19795316479046804,-0.762243903726004,0.9337175792507204,0.9264002879332964,1.0,20/52,31.11%,ATP6V0D1;ERN1;DNAJB9;EDEM1;SHC1;PDIA5;YIF1A;WFS1;TLN1;LMNA;VAPB;PARP16;EXTL1;GOSR2;HYOU1;ERN2;DNAJC3;HSPA5;PDIA6;GFPT1
prerank,regulation of DNA repair (GO:0006282),0.22758491765192407,0.7617366863355384,0.8398203592814372,0.9808633859779432,1.0,9/44,16.41%,FGF10;WRAP53;UBE2V1;UBE2N;RAD52;RNF168;RNF8;ERCC6;WRNIP1
prerank,sensory organ development (GO:0007423),-0.19538506414789863,-0.7613813533818906,0.9212827988338192,0.9270663971233604,1.0,27/51,39.27%,MEIS1;SMCHD1;SH3PXD2B;PBX4;HIPK1;SMOC1;HIPK2;GATA3;GDF3;SHROOM2;PAX6;BLOC1S3;CPAMD8;ADAMTS18;SALL2;MAB21L1;SIPA1L3;PAX8;TGFB2;MEIS3;SOX3;NTF4;STRA6;RAB18;AHI1;ECE1;FREM2
prerank,DNA replication checkpoint signaling (GO:0000076),-0.26748294986674376,-0.7613298869411684,0.7881136950904393,0.9265995724479327,1.0,4/16,14.19%,CLSPN;TOPBP1;TICRR;CDT1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.26119641237777863,0.7606658440856413,0.8224,0.9818771284850799,1.0,4/21,20.07%,PPARA;PRKN;ABCD2;ABCB7
prerank,regulation of glycogen metabolic process (GO:0070873),-0.29089731133015573,-0.7606559770846554,0.7986270022883295,0.9270205029283768,1.0,4/12,13.50%,PPP1R3C;PPP1R3F;PPP1R3E;INPP5K
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.27778825124957385,0.7603275167806225,0.7934426229508197,0.9817813767377078,1.0,3/18,11.78%,OPALIN;SLC45A3;CXCR4
prerank,negative regulation of cell death (GO:0060548),0.2005394398971017,0.7601449320250764,0.8963165075034106,0.9814569375812726,1.0,14/88,14.36%,SRGAP2;CD34;PPARGC1A;SOX4;PM20D1;SRSF6;CLU;CCN4;BMP4;PRKN;FGF2;BECN1;TXNDC12;CHMP2A
prerank,angiogenesis involved in wound healing (GO:0060055),-0.2914232831346375,-0.759822255087067,0.7734939759036145,0.9276484963865921,1.0,5/11,18.94%,HPSE;PRCP;KDR;ADIPOR2;ITGB3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.28747306602793754,-0.7596180110169108,0.7741935483870968,0.9273848173736675,1.0,5/13,22.76%,SEC16A;TMEM30A;TM9SF4;GCC2;INSIG1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2119161363317883,0.7594189584330057,0.8875912408759125,0.9819011942404097,1.0,19/63,24.76%,CNOT2;SOX4;E2F1;PLK3;BTG2;CNOT8;GADD45A;RBL2;RFWD3;PLK2;FBXO31;CNOT10;TFDP2;MDM4;CASP2;AURKA;TRIAP1;CNOT4;SDE2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.23225222203735074,0.7593382706567032,0.8360902255639098,0.9814145573548244,1.0,7/39,13.64%,GTF2H2;POLD3;GTF2H4;OGG1;FAN1;PARP1;DDB2
prerank,regulation of lymphocyte activation (GO:0051249),0.2997714183526133,0.759117122819817,0.7729636048526863,0.9811101463335945,1.0,3/12,19.40%,PAG1;CRTAM;CCL5
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.22901919103498777,-0.758890345121779,0.8315789473684211,0.9278132861162891,1.0,7/27,21.72%,RRM1;CMPK1;TXNRD1;TYMS;NME4;GSR;AK2
prerank,intermediate filament organization (GO:0045109),0.28077396631034224,0.7588215113176257,0.8033898305084746,0.9809566325616165,1.0,8/17,31.44%,BFSP2;TCHH;NEFL;KLHL24;GFAP;BFSP1;PKP2;DES
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.21124204372209082,0.7581496776009206,0.8815028901734104,0.9813612617497267,1.0,20/61,26.37%,PSMB1;PPARA;PSMF1;NCOR2;PSMA1;PSMD7;OAZ1;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;PSME1;PSMD2;PSMD4;PSMD8;PSMC5;PANK2;PSMD3;PSMB8
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.22655437160719838,0.7580368122409317,0.8543833580980683,0.9809090823727941,1.0,7/41,10.49%,AAAS;EIF6;NUP54;OGT;NUP88;RAE1;JMJD8
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.28435435216059785,-0.7577628957834193,0.7828162291169452,0.9287993225789295,1.0,2/13,4.49%,NR3C1;ESR1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.2418441929834818,-0.7575214704936742,0.8328912466843501,0.9285909694294262,1.0,4/21,12.08%,DVL3;CAV1;CTNNB1;FZD2
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.22857869600673636,-0.7572023769445752,0.8810679611650486,0.9285033823800548,1.0,14/27,31.67%,PARP4;DACH1;TERF2;NIBAN2;SMG6;RGCC;FGFR4;BMPR2;PDGFA;TNKS;PINX1;SMG5;HGF;ATM
prerank,positive regulation of protein depolymerization (GO:1901881),0.3142741708794414,0.7569756786383828,0.7887323943661971,0.9819038872965768,1.0,1/11,3.83%,STMN2
prerank,lipoxygenase pathway (GO:0019372),-0.2726384760169116,-0.7566924566966917,0.7915690866510539,0.9286781980706025,1.0,4/14,18.33%,ALOX5;ALOXE3;GPX1;LTC4S
prerank,positive regulation by host of viral transcription (GO:0043923),-0.2742436480880869,-0.7566146954551346,0.8179551122194514,0.9282437725869669,1.0,4/15,10.79%,SMARCA4;SP1;SNW1;EP300
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.24373668619713035,-0.7565634254035388,0.8206388206388207,0.9277742354502682,1.0,9/21,30.73%,PRKACA;CAMK2D;CALM3;CALM2;RYR2;PDE4D;CASQ2;CALM1;SRI
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.26571041553418506,-0.7565506659376732,0.8014354066985646,0.9272482894012465,1.0,4/16,15.69%,ETF1;SHFL;TNF;CLN3
prerank,protein export from nucleus (GO:0006611),0.25207505213116554,0.7565405657321964,0.845679012345679,0.9819234705163179,1.0,9/27,25.17%,STRADB;STYX;TGFB1;PKD1;XPO6;STRADA;RANBP3L;RANBP17;CCHCR1
prerank,positive regulation of vasculature development (GO:1904018),0.197283680442323,0.7563030066845117,0.9180790960451978,0.981666950457344,1.0,21/94,18.56%,F3;CD34;ANGPTL4;SMOC2;PLCG1;PRKCA;RAPGEF3;PRKD2;EPHA1;PDCD6;FGF2;VASH2;ADAM12;TEK;HK2;PRKD1;ANGPTL3;IL1A;BTG1;XBP1;CHRNA7
prerank,limb development (GO:0060173),0.2473473807704079,0.7562901574693417,0.8164251207729468,0.9810848524305206,1.0,2/28,4.59%,FGF10;MEGF8
prerank,protein localization to synapse (GO:0035418),0.30905893557231595,0.756161934767739,0.7903780068728522,0.9806504034781275,1.0,6/12,27.09%,NRXN1;SHANK1;ZDHHC15;PCLO;DLG4;ZDHHC12
prerank,outflow tract septum morphogenesis (GO:0003148),0.25300719241756886,0.7558008129293502,0.8410596026490066,0.9805977826137259,1.0,6/24,17.43%,LRP2;ZFPM2;BMP4;TBX2;SEMA3C;ENG
prerank,nuclear membrane disassembly (GO:0051081),0.2878198995333887,0.7557872771455659,0.7992957746478874,0.9800130200817991,1.0,3/14,12.28%,AKAP8L;PRKCA;DCTN1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.20865037590691365,0.7556619071062879,0.8742690058479532,0.9796015461695918,1.0,19/62,25.35%,SELENOS;ACKR3;NME5;CLU;SNAI2;PRKN;NFE2L2;HERPUD1;TXNDC12;CCAR2;XBP1;ARMC10;SFRP2;RTKN2;CREB3;TMBIM6;SOD2;URI1;DDX3X
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.2893772414524383,-0.7548587130498562,0.8131313131313131,0.928965101333415,1.0,5/11,25.54%,EXOSC10;FBL;TENT4B;DKC1;LARP7
prerank,cellular defense response (GO:0006968),0.22905241931741582,0.7547739680824528,0.8575851393188855,0.9802722455957756,1.0,9/40,19.24%,RELA;FOSL1;CX3CR1;BECN1;CCR6;CLEC5A;CCR9;ITK;NCF2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2944696594425043,0.7543655276865141,0.7996575342465754,0.9802478180293107,1.0,4/14,17.84%,PPARA;IRS1;TYSND1;ABCD2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.18159670047969312,-0.7543532668767043,0.9428571428571428,0.9291296573517298,1.0,16/69,19.65%,VCP;TRIM25;OS9;PSMC6;UBQLN1;DNAJB9;ERLIN2;BAG6;DNAJC10;RNF103;EDEM1;FBXO2;UBXN8;RNF121;NPLOC4;WFS1
prerank,membrane lipid metabolic process (GO:0006643),0.26069880202850937,0.753836946153184,0.8416801292407108,0.9803966448117845,1.0,5/22,16.59%,TEX2;TECR;ST3GAL6;GAL3ST1;SERINC1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.26563598273125,-0.7536825449494128,0.8226950354609929,0.9295482990276366,1.0,5/15,20.83%,EIF4ENIF1;AGO2;TENT4B;TENT4A;CPEB3
prerank,regulation of cellular amine metabolic process (GO:0033238),0.21858605238628423,0.752452153129211,0.8476331360946746,0.9817190749650784,1.0,17/50,26.37%,PSMB1;PSMF1;PSMA1;PSMD7;OAZ1;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;PSME1;PSMD2;PSMD4;PSMD8;PSMC5;PSMD3;PSMB8
prerank,positive regulation of angiogenesis (GO:0045766),0.19178369834067358,0.7522595968871154,0.9113233287858117,0.9813823825030117,1.0,23/108,18.56%,F3;CD34;ANGPTL4;SMOC2;PLCG1;PRKCA;RAPGEF3;PRKD2;EPHA1;JMJD8;ITGA5;PDCD6;FGF2;VASH2;ADAM12;TEK;HK2;PRKD1;ANGPTL3;IL1A;BTG1;XBP1;CHRNA7
prerank,establishment of spindle localization (GO:0051293),-0.2707189653365262,-0.7522344823726695,0.7834549878345499,0.9308945780385053,1.0,3/14,12.20%,KPNB1;NUSAP1;ESPL1
prerank,synaptic vesicle localization (GO:0097479),0.2925358965893695,0.751915191023519,0.7958833619210978,0.9812886577824979,1.0,3/13,21.12%,SNAPIN;SPG11;TMEM230
prerank,anterograde axonal transport (GO:0008089),0.232299805441815,0.751695007957567,0.8573619631901841,0.9809823354945116,1.0,7/37,14.98%,DLG2;BLOC1S2;AP3M1;SNAPIN;AP3B2;KIF1C;HAP1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.20910548077191882,0.7515425892970867,0.8954607977991746,0.9806131497576696,1.0,19/65,25.89%,BCL9L;LDLRAD4;PPARA;DAND5;TGFBR1;FBN2;PPM1A;TGFB1;PRDM16;SNX6;PIN1;IL17RD;SMAD2;PDPK1;SKOR2;HTRA3;ZBTB7A;FBN1;STUB1
prerank,positive regulation of embryonic development (GO:0040019),0.27229682610176065,0.7515187514090339,0.8172920065252854,0.9800480085624769,1.0,1/19,0.11%,WNT4
prerank,regulation of blood circulation (GO:1903522),-0.21468102629259994,-0.7513125358797128,0.8763736263736264,0.9314781357111712,1.0,17/34,39.12%,CAMK2D;S100A1;FXYD1;AGER;PER2;KCNQ1;CELF2;KCNG2;SRI;TNNT2;MYH6;ACE2;TH;AGTR1;KCNMB4;TPM1;ECE1
prerank,cellular response to hypoxia (GO:0071456),0.18668341995995602,0.7511854341493261,0.9351851851851852,0.9799286094530323,1.0,39/126,26.37%,PSMB1;KCND2;ELOC;HILPDA;PSMF1;PSMA1;PSMD7;PLK3;PSMA8;PSME3;SFRP1;SUV39H2;CUL2;EPAS1;PSMD14;PSMC4;NDNF;SCN2A;NDRG1;SLC8A3;CARD16;BACH1;PSMB4;OPRD1;RORA;PSME1;PSMD2;TBL2;PSMD4;MDM4;AK4;PSMD8;HIF1AN;NPEPPS;PSMC5;HIGD1A;STUB1;PSMD3;PSMB8
prerank,regulation of Wnt signaling pathway (GO:0030111),0.19097967003698024,0.7510286311674893,0.938101788170564,0.9795554068307845,1.0,36/108,29.44%,HHEX;TSC2;HIC1;NXN;PTK7;BTRC;FAM53B;EMD;PRKN;CTNND2;SPIN1;SFRP1;AMER2;TCF7L1;AMER3;PPP2R1A;RSPO1;SULF2;RNF43;FRZB;RSPO2;AXIN1;SFRP2;PPP1CA;RUNX1;CXXC4;TIAM1;GNAQ;SALL1;NKD1;SULF1;SENP2;SOX7;KANK1;DCDC2;DAAM2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3065866236142624,-0.7510060827840547,0.8012820512820513,0.9313073963389973,1.0,4/10,16.50%,CEACAM1;KDR;ASB4;RAP1A
prerank,microvillus organization (GO:0032528),0.29290250368735854,0.7509147667317673,0.8045977011494253,0.9791229735181699,1.0,3/13,10.76%,STK26;MAP4K4;MINK1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.1788773597719318,0.7506013039703384,0.965,0.9789592575852223,1.0,38/172,21.93%,INPP4B;PIK3C2G;INPP5D;MTMR9;PLA2G4C;PNPLA3;PIK3CG;LPCAT1;PI4K2A;SACM1L;DGKQ;CPNE6;ACHE;CHAT;PTDSS2;OCRL;INPP5F;RAB5A;FGF2;SLC44A2;LPCAT2;MTMR1;AGPAT1;ABHD5;DGKZ;DGKE;VAC14;PTPN13;ABHD8;INPPL1;PGS1;DGKH;INPP5J;PLEKHA2;PIK3C2A;PIP4K2B;ARF1;PLEKHA1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2042687747039579,-0.7502552746432235,0.8953488372093024,0.9317458606052355,1.0,13/37,25.54%,UBE2K;S1PR2;PRKAG2;SPRY2;CALM3;CALM2;INPP5K;PLK1;BMP7;SIRT2;APP;EGF;TNKS1BP1
prerank,cellular component maintenance (GO:0043954),-0.28232477655420934,-0.7500865954817952,0.7682926829268293,0.9314515439286893,1.0,2/12,7.14%,MTMR2;FYN
prerank,regulation of striated muscle contraction (GO:0006942),-0.22656542314793288,-0.7498343405478962,0.8713910761154856,0.9312575091158858,1.0,12/27,32.42%,P2RX4;PRKACA;CALM3;ASB3;CALM2;RNF207;RYR2;SCN10A;GRK2;CALM1;SRI;NOS1
prerank,mRNA catabolic process (GO:0006402),0.2197872282007992,0.7493302742815668,0.8588235294117647,0.9801348928514054,1.0,8/44,15.16%,NUDT12;DDX5;ZFP36L2;METTL16;NBDY;AGO4;UPF1;NBAS
prerank,pulmonary valve morphogenesis (GO:0003184),0.27445862646800634,0.7492990699518777,0.8282312925170068,0.9795788979058306,1.0,3/17,9.96%,BMP4;HEY1;GJA5
prerank,tRNA 5'-leader removal (GO:0001682),0.29330998427050625,0.7492336241298616,0.799347471451876,0.9790656972618687,1.0,3/13,13.32%,RPP40;PRORP;RPP30
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2145831275653197,-0.7490554825449723,0.8631578947368421,0.9317408553822462,1.0,13/33,28.40%,TYROBP;GBF1;PICALM;TM9SF4;CTNNB1;RAB11FIP5;TNF;GOPC;EGF;KCNAB2;RANGRF;GPD1L;TAX1BP3
prerank,response to hydrogen peroxide (GO:0042542),0.22152945593588438,0.7489681888829393,0.8649921507064364,0.9788288807530715,1.0,7/45,11.73%,STK26;RELA;IL6;TRPM2;RIPK3;NFE2L2;STK25
prerank,signal peptide processing (GO:0006465),0.30333034695132577,0.7487861287498563,0.7925801011804384,0.9784908203324716,1.0,3/11,16.27%,SPCS2;HM13;SEC11C
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.20627892611042278,-0.7485886190238663,0.8926553672316384,0.9318007624591316,1.0,8/39,15.21%,GCNT2;CORO1C;RASA1;THBS1;NOTCH1;MYOC;AJAP1;SPRY4
prerank,mitochondrial transcription (GO:0006390),0.31735361259105366,0.748409556269457,0.7870036101083032,0.9784261774319003,1.0,1/10,4.06%,TFAM
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.20976399485041813,-0.7482267204658882,0.8981723237597912,0.9317812580415442,1.0,8/36,16.05%,BCL2;FAS;ASAH2;RB1;QARS1;DEPTOR;TNF;TRAF1
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.2977844807884287,-0.7482095514605478,0.7875288683602771,0.9312577349946625,1.0,2/10,15.32%,RTEL1;TERF2
prerank,negative regulation of cellular protein localization (GO:1903828),-0.21585711205497,-0.7477088581315622,0.875,0.9313656816145771,1.0,7/34,17.51%,RIPOR2;CTNNA1;ANKRD13A;PICALM;CDT1;UBXN2B;GOPC
prerank,neuron migration (GO:0001764),0.21638841463717096,0.747527611126167,0.8713629402756509,0.9790598877041067,1.0,10/48,15.42%,MEF2C;ADGRL3;CDKL5;DDIT4;FGF13;NRCAM;TUBB2A;NDNF;NTRK2;TUBGCP2
prerank,aerobic respiration (GO:0009060),-0.24377866582690372,-0.7469261982180709,0.8606356968215159,0.9318122792519506,1.0,5/20,17.22%,NDUFS8;SDHB;NDUFS7;MTFR2;SURF1
prerank,regulation of mRNA processing (GO:0050684),0.23739901658032822,0.7463174070916535,0.8533123028391167,0.9801373067698735,1.0,6/32,11.99%,CWC22;SON;YTHDC1;KHDRBS2;METTL16;QKI
prerank,sphingoid metabolic process (GO:0046519),-0.2870684564811581,-0.745769862428134,0.8014888337468983,0.9327231247772839,1.0,4/12,20.25%,SGPP1;ASAH2;SPHK2;SPTLC3
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.2298656517103712,-0.7454675756855866,0.8244274809160306,0.932570766809274,1.0,5/24,18.54%,PRKCH;CTSL;SGPP1;NUMA1;TRIM16
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.3128620380154433,0.7453741117716376,0.8120437956204379,0.9808261170862825,1.0,3/10,12.38%,SHANK3;RAB5A;SYNGR1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.19768839748260125,-0.745069756194612,0.8994252873563219,0.9325070462403146,1.0,16/46,28.18%,DDHD1;AGPAT4;AGPAT5;PLD1;DGKA;ACP6;PLD2;LPCAT4;GPAM;AGPAT2;PLA2G2D;ABHD4;AGPAT3;GPD1L;GPAT3;PLA2G12A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2007963994929705,0.744292070372234,0.9246861924686193,0.9817015950107411,1.0,27/73,27.69%,PSMB1;LDB1;PSMF1;LMO2;PSMA1;PSMD7;FOXC1;PSMA8;PSME3;PSMD14;PSMC4;TCF3;PDCD2;PSMB4;DHX36;PUS7;PSME1;PSMD2;PSMD4;PSMD8;RUNX1;PSMC5;METTL14;PSMD3;PSMB8;METTL3;PSMA4
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.28541011644512515,-0.7441444889393849,0.7868131868131868,0.9331029575302613,1.0,6/11,40.73%,STAT1;WNT5A;PDGFA;TBX1;CTNNBIP1;SOX9
prerank,negative regulation of DNA replication (GO:0008156),-0.2758490802938038,-0.7441189674052703,0.813953488372093,0.9325893862701266,1.0,13/13,72.44%,PDS5A;WAPL;S100A11;TSPYL2;RAD17;MCIDAS;CDC6;GMNN;ATR;GMNC;CDAN1;GTPBP4;TERF1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.1869886448645734,0.7439749771875134,0.9440104166666666,0.9815508946245199,1.0,40/124,27.73%,WNT4;VANGL2;PSMB1;RYK;ARRB2;PSMF1;PRICKLE1;PSMA1;TCF7L2;PSMD7;PSMA8;PSME3;SFRP1;MAP3K7;VANGL1;PSMD14;PSMC4;AGO4;WNT7A;PSMB4;DVL2;PLCB2;CDC42;PSME1;PSMD2;PSMD4;FRZB;PSMD8;SFRP2;GNG2;TIAM1;RHOA;PSMC5;ROR2;FZD5;PSMD3;PSMB8;PLCB1;PSMA4;CLTC
prerank,positive regulation of heart contraction (GO:0045823),0.27035356155498297,0.7437832893844256,0.8190954773869347,0.9812087667002156,1.0,5/19,23.35%,ATP2A2;ADM;RGS2;SCN3B;CHGA
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.29239395372687854,0.7436285421003281,0.790893760539629,0.9808218269324696,1.0,9/14,35.40%,NUDT9;ENTPD6;ENTPD1;ENTPD2;NUDT16;ENTPD3;ENTPD7;NUDT1;NUDT18
prerank,cellular response to osmotic stress (GO:0071470),0.2608024710574903,0.7435107877564169,0.8180354267310789,0.9803959270905687,1.0,4/21,14.38%,CAPN3;PKD2;STK39;SCN2A
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3200919725423975,0.7435076951541633,0.8017543859649123,0.979807634666788,1.0,1/10,1.27%,CBARP
prerank,regulation of mitotic cell cycle (GO:0007346),0.17997444970127002,0.7434510827507926,0.969059405940594,0.9792978585268195,1.0,41/171,22.02%,PSMB1;OBSL1;SCRIB;SMOC2;LGMN;RPS6KB1;PSMF1;BTRC;CCDC57;PSMA1;PRKCA;PSMD7;FOXC1;PTPN3;TGFB1;BTG3;PSMA8;BTG2;PSME3;TTC28;THAP1;PSMD14;PSMC4;TTLL12;ANAPC2;ANGEL2;CDK10;BTG1;PSMB4;PIN1;UBE2D1;CAV2;FBXO5;CYLD;HECA;PSME1;UBE2S;PSMD2;PRMT5;PSMD4;PSMD8
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.22508304144425614,-0.7429222008640274,0.8661202185792349,0.9336003178112153,1.0,3/27,8.29%,FCGR2B;VPS35;PSEN1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2415043001816588,0.7429130659736636,0.8525121555915721,0.9794409870150509,1.0,12/30,27.93%,HSPA2;SDF2;SDF2L1;HSPA9;DNAJC7;HSPE1;HSPA14;DNAJB4;DNAJB13;ST13;HSPA8;PTGES3
prerank,activation of adenylate cyclase activity (GO:0007190),-0.20790764898384484,-0.7429091784707619,0.9132791327913279,0.9330792411197185,1.0,7/35,13.83%,RAF1;ADCY9;ADCY5;ADCY6;EDNRA;ADCY1;ADCY3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.2691450458793907,0.7425156694379798,0.8352941176470589,0.9793685635501842,1.0,7/18,23.40%,FIS1;PRKN;DNM1L;RALBP1;MFF;DCN;AURKA
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2759301198353612,-0.7421778199650217,0.8242009132420092,0.933476742112649,1.0,8/12,40.59%,CTDNEP1;CDK1;PLK1;CCNB1;LPIN1;CNEP1R1;PRKCB;VRK1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.19238330766640138,0.7421238203921755,0.9254742547425474,0.9793269089953541,1.0,20/95,19.49%,AGRN;HS3ST6;HS3ST5;B4GAT1;ACAN;GPC1;GPC2;GPC5;CHST1;HS6ST1;VCAN;CSGALNACT1;ST3GAL6;GPC4;B3GAT3;CHSY1;B4GALT2;DCN;ST3GAL3;SDC2
prerank,regulation of T cell differentiation (GO:0045580),0.23311225332529376,0.7421119475630679,0.8746081504702194,0.9787515816022152,1.0,7/33,18.05%,IL2RA;IL2;CRTAM;PRDM1;IL7;PRELID1;XBP1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.3176144685290351,0.7420043181922295,0.7944954128440367,0.978310060239707,1.0,3/10,13.96%,PRKD2;ITGA5;VTN
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2458953147755872,0.7419330353139202,0.8311258278145696,0.9778135630319451,1.0,4/25,10.07%,TMC8;GRIN1;SLC8A1;PRKN
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.296084261962521,0.7417472565776974,0.8032490974729242,0.9774597017208199,1.0,2/12,16.89%,SIX4;AGT
prerank,neural tube development (GO:0021915),0.28352143527581086,0.741746759326211,0.8033613445378152,0.9768701602843175,1.0,4/15,12.74%,SOX4;PKD2;TGFB1;PKD1
prerank,regulation of cell junction assembly (GO:1901888),-0.22568223018483458,-0.7415768573264504,0.8699186991869918,0.9336600262944845,1.0,3/27,3.50%,PRKCH;PDLIM5;PRKACA
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.29353196339205,-0.7414447187191499,0.83451536643026,0.9332949732697908,1.0,5/11,25.00%,LYN;ANXA1;CDKN2A;PIK3CD;BLK
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.27385155946855955,0.74137539546869,0.8219895287958116,0.9767804855778205,1.0,2/16,5.63%,RELA;IL6
prerank,regulation of sodium ion transport (GO:0002028),0.23045871780970378,0.7413738078933154,0.8625954198473282,0.9761939730925838,1.0,10/34,24.53%,FGF12;CNKSR3;NEDD4;NKAIN2;WNK1;ATP1A1;SCN3B;SCN1B;SNTA1;ANK3
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.23104840361736395,-0.7413474323899933,0.8871794871794871,0.9328641034821293,1.0,5/22,15.08%,PPP2R5A;IL1B;CEACAM1;APOC1;TNF
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.23092474385282993,0.7413077684740889,0.8591772151898734,0.9756954735807724,1.0,9/33,22.79%,PPARA;TCF7L2;NFE2L2;ICAM1;TEK;NDNF;TNIP2;PDPK1;CAST
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.2981717443614782,0.7403588845667238,0.8056537102473498,0.9763905251713614,1.0,3/11,20.07%,PPARA;ABCD2;ABCB7
prerank,sensory perception (GO:0007600),0.21710115770493257,0.7402376373766776,0.8944099378881988,0.9759530240538035,1.0,8/45,18.56%,WHRN;CDH23;NTSR2;NIPSNAP1;GNAS;OPRM1;ASIC3;CHRNA7
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.29669612282116303,-0.7400097350960156,0.8162291169451074,0.9340092431609077,1.0,4/10,19.24%,RIPK1;TXN;LRRK2;GPR37
prerank,monocyte differentiation (GO:0030224),0.31111302017121,0.7399083813398212,0.7992957746478874,0.975800355685597,1.0,5/10,28.50%,BMP4;THOC5;MT1G;PDE1B;CSF1R
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.1990611329789304,-0.7398024059897287,0.9088319088319088,0.9337528093569626,1.0,14/42,23.31%,AIMP1;FARS2;IARS2;YARS2;PARS2;EARS2;QARS1;NARS1;WARS2;VARS2;WARS1;LARS1;PPA2;FARSA
prerank,negative regulation of binding (GO:0051100),0.19674139950360384,0.7395730695603098,0.9183098591549296,0.9756426353633382,1.0,16/81,19.01%,ZFPM1;TMC8;EFHB;E2F1;GTF2F1;STYX;SUMO3;ITGB1BP1;PEX14;USP33;PDGFB;MITD1;CARD16;ROCK1;PIN1;ACTB
prerank,telomere capping (GO:0016233),-0.2582569383398217,-0.7392543458115601,0.8192771084337349,0.9339206295195712,1.0,16/16,74.21%,NBN;TERF2;TINF2;DCLRE1C;RAD50;TERF2IP;DCLRE1B;TFIP11;STN1;PRKDC;CTC1;DCLRE1A;TEN1;MRE11;TERF1;ACD
prerank,cell junction maintenance (GO:0034331),0.280221505699182,0.7388207079685242,0.7950963222416813,0.9760563651648279,1.0,3/14,14.18%,CBLN2;DCTN1;CHCHD10
prerank,estrogen metabolic process (GO:0008210),0.27610856028808284,0.7386207028475076,0.8210702341137124,0.975735628948074,1.0,5/15,24.77%,HSD17B2;HSD17B11;HSD17B10;SULT1A1;HSD17B14
prerank,negative regulation of myotube differentiation (GO:0010832),0.29097259231314626,0.7371275248737917,0.8359240069084629,0.9770756956969677,1.0,5/12,23.91%,HDAC5;BHLHE41;XBP1;HDAC3;BDNF
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.26445108227538056,0.7369519098421854,0.7936772046589018,0.9767176987374001,1.0,5/18,16.31%,DAB2IP;EMD;SFRP1;MED25;PEX2
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.22178649075627827,-0.7368471500667884,0.8627450980392157,0.9362418278107186,1.0,6/29,15.08%,GAS6;CCR2;MOSPD2;CXCL17;AGER;TNF
prerank,endoderm formation (GO:0001706),-0.20650639885316568,-0.736797496920578,0.9021164021164021,0.9357514508345601,1.0,15/35,32.04%,ITGA4;COL11A1;DUSP1;LHX1;HMGA2;MMP8;FN1;SETD2;LAMA3;COL12A1;ITGA7;ITGB2;DUSP4;COL7A1;MMP9
prerank,regulation of transposition (GO:0010528),-0.27350228093287027,-0.7366959532603776,0.8341346153846154,0.9353455050503381,1.0,6/13,35.53%,PIWIL2;MYBL1;TDRD9;AICDA;PIWIL4;PIWIL1
prerank,positive regulation of coagulation (GO:0050820),-0.29543312845919334,-0.7366510170734839,0.7962962962962963,0.9343294497809568,1.0,2/10,9.42%,THBS1;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.29543312845919334,-0.7366510170734839,0.7962962962962963,0.9343294497809568,1.0,2/10,9.42%,THBS1;HPSE
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.2759949957341183,-0.7365398542301652,0.824390243902439,0.9339211362711055,1.0,4/13,21.18%,ARID1B;ZMIZ1;SERTAD2;ZMIZ2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.2351386652069545,-0.7360908587521272,0.8467336683417085,0.9339138598091353,1.0,4/21,12.73%,IGF1;PTGER4;CDK1;KDR
prerank,positive regulation of peptidase activity (GO:0010952),0.26052277262540513,0.7360553387825752,0.8399311531841652,0.9773134311171193,1.0,7/20,25.92%,VSIR;PSME3;PSENEN;PRELID1;PSME1;GRN;CTSH
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.2416709891089016,0.7354978003523207,0.8569051580698835,0.9774456010040208,1.0,5/27,18.03%,ATP2A2;GJA5;FGF13;CTNNA3;ANK2
prerank,engulfment of apoptotic cell (GO:0043652),0.27457963275250385,0.7340818499285943,0.8430717863105175,0.9786639001905214,1.0,3/15,17.50%,RHOBTB1;XKR6;RHOBTB2
prerank,embryonic digit morphogenesis (GO:0042733),-0.2514391441561843,-0.7339996894178185,0.8256658595641646,0.935940824774897,1.0,7/18,27.33%,WDPCP;HDAC2;HDAC1;SHH;MAP3K20;TWIST1;MSX1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.300349447223299,0.7337982012777323,0.8184931506849316,0.9784275415267133,1.0,4/11,29.00%,GCHFR;QDPR;SPR;PTS
prerank,mitochondrion distribution (GO:0048311),-0.2804282725672389,-0.7335976252011597,0.8047619047619048,0.9359014479126762,1.0,3/12,13.93%,TRAK1;MTM1;LRRK2
prerank,phospholipid biosynthetic process (GO:0008654),-0.20718660089544105,-0.7335307284740378,0.9279279279279279,0.9354390262159968,1.0,8/36,17.16%,AGPAT4;AGPAT5;IDI1;SPHK2;CLN3;CPNE7;NUS1;GPAM
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.30732640157003915,0.7330388907526898,0.8315217391304348,0.9788196420179386,1.0,1/10,1.00%,ADTRP
prerank,organophosphate catabolic process (GO:0046434),0.3010365145946194,0.7324515046969725,0.8260869565217391,0.9789610052123141,1.0,3/11,17.04%,ABHD12;ENPP2;ANGPTL3
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.267111828938465,0.732207532646267,0.8466780238500852,0.9786998330937585,1.0,9/19,29.09%,RARRES2;MAPK3;JAM3;PTK2;CCL5;IL34;MAPK1;CSF1R;MDK
prerank,establishment of epithelial cell polarity (GO:0090162),0.2597118654625493,0.7321838761509495,0.8330658105939005,0.9781455286502426,1.0,6/19,26.73%,SH3BP1;CAMSAP3;CDC42;OPHN1;RHOA;MYO9A
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.30630146750565007,0.7311491712688123,0.8359788359788359,0.9788532718263001,1.0,1/10,3.05%,KCNE2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.23319095235862253,-0.730876836401328,0.8855721393034826,0.9380344741632112,1.0,9/23,27.06%,MOSMO;VCP;RACK1;KCTD21;GLIS2;KIF7;PTCH1;ULK3;PTCH2
prerank,glycosphingolipid metabolic process (GO:0006687),0.21732771916890012,0.7308410850384448,0.878419452887538,0.978651626957535,1.0,5/42,9.87%,ST3GAL5;HEXB;ESYT2;NEU1;B3GALNT1
prerank,response to nitric oxide (GO:0071731),-0.27491601639269064,-0.7300876610206438,0.8289156626506025,0.9384343497625777,1.0,4/13,27.71%,TXN;FOXO1;EGLN1;AQP1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.28663184847502066,-0.7295815894709982,0.8333333333333334,0.9379532358579171,1.0,6/11,30.73%,CALM3;CALM2;CASQ2;FKBP1A;CALM1;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.28663184847502066,-0.7295815894709982,0.8333333333333334,0.9379532358579171,1.0,6/11,30.73%,CALM3;CALM2;CASQ2;FKBP1A;CALM1;SRI
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.21091401191208473,0.7289086656554131,0.9104258443465492,0.9804256619094428,1.0,14/51,24.36%,PRSS56;RARRES2;IL6;LGMN;CCR1;CCR6;HMGB1;MAPK3;PTK2;CCL5;IL34;IL6R;CREB3;MAPK1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.25759008293010766,0.7288897173774648,0.8618968386023295,0.979869764145804,1.0,7/22,22.24%,CCNK;BRD4;THOC5;DDX39B;ERCC6;ALYREF;SCAF8
prerank,cranial nerve development (GO:0021545),0.29988744965488534,0.7287945377161192,0.8266897746967071,0.979402157487682,1.0,1/11,3.49%,ATOH7
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.24410672361561095,-0.7287446628142487,0.8705583756345178,0.9383486192760724,1.0,4/19,10.83%,EXT1;XYLT1;UGDH;NDST3
prerank,negative regulation of chemokine production (GO:0032682),0.2783182729398824,0.7286503073080371,0.8533568904593639,0.9789897250754195,1.0,3/14,14.77%,IL6;MAP2K5;APOD
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.2855839950715784,0.7284512410491076,0.8414023372287145,0.9786516619910433,1.0,3/14,13.35%,TGFBR1;SNAI2;CHADL
prerank,regulation of sensory perception of pain (GO:0051930),-0.2846351928395535,-0.7283059538250609,0.8071748878923767,0.9383319268824484,1.0,4/11,32.09%,CCN3;VIP;SPX;ATPSCKMT
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.2902853736340728,0.7280136003024024,0.8375209380234506,0.9785952340751396,1.0,2/12,12.82%,SOAT2;MTTP
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.29502085267839645,-0.7279872798405903,0.8169014084507042,0.9381842857120125,1.0,5/10,27.59%,NOP10;DKC1;NAF1;NHP2;RPUSD3
prerank,mesenchyme morphogenesis (GO:0072132),0.26779859175722426,0.7276691712839698,0.852112676056338,0.9784138499375153,1.0,5/17,21.71%,HEY1;TBX2;ENG;SMAD2;MDM4
prerank,sterol biosynthetic process (GO:0016126),0.22972997309276227,0.726497487863872,0.8849144634525661,0.9792411981614195,1.0,6/33,18.86%,TM7SF2;ACAT2;NSDHL;LSS;ACLY;FDPS
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.23695724573614635,0.7263027106408504,0.8566929133858268,0.9788789060830416,1.0,6/26,18.99%,GCHFR;PM20D1;ABCA2;DDAH2;CYB5B;ARG2
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.2784541019972698,-0.7258124576811534,0.8240534521158129,0.9401126275465459,1.0,4/11,15.36%,ETV6;ARIH2;WNT2B;WNT5A
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.26065541151644606,0.72557186636035,0.8512820512820513,0.9791879661743167,1.0,5/20,15.63%,RELA;SPPL2B;TGFB1;PSENEN;HM13
prerank,visual system development (GO:0150063),0.2217034718757917,0.725321087507559,0.8868217054263566,0.9789110051373532,1.0,5/37,11.72%,C3;MAB21L2;PBX2;FOXC1;PBX3
prerank,epidermis development (GO:0008544),-0.1815508247259185,-0.7244102708315524,0.9666666666666667,0.9411307429304687,1.0,30/56,37.02%,FLOT2;EMP1;HDAC2;HDAC1;PTHLH;ALDH3A2;LAMA3;DSP;EVPL;SCEL;FOXN1;CRABP2;SPINK5;KRTDAP;DLL1;WAS;SVEP1;COL7A1;GRHL1;UGCG;OVOL2;TGM5;EDAR;OVOL1;EDA2R;GLI1;RBP2;SPRR1A;NTF4;POU2F3
prerank,negative regulation of interferon-beta production (GO:0032688),-0.29858169181580263,-0.7241683072677632,0.8284424379232506,0.9408640957196616,1.0,4/10,20.39%,YY1;LILRB1;RELB;NLRC3
prerank,regulation of monooxygenase activity (GO:0032768),-0.2227624265837826,-0.7240725920604467,0.8756345177664975,0.9404509380323601,1.0,12/23,31.35%,CAV1;IL1B;NOSIP;DNM2;EGFR;POR;NOSTRIN;CYGB;ZDHHC21;HSP90AA1;CALM1;DDAH1
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.22717481611913193,-0.7237178432971777,0.864,0.94030021032724,1.0,13/26,29.65%,ITCH;ACOD1;MUL1;TRAF3IP1;LTF;NLRC3;SIRT2;TRIM21;DHX58;RNF26;SIGIRR;C1QBP;TNFAIP3
prerank,myelination in peripheral nervous system (GO:0022011),0.28422865959233024,0.7234062364631573,0.8453781512605042,0.9806592878933482,1.0,1/13,1.14%,CNTNAP1
prerank,histone H2B ubiquitination (GO:0033523),-0.29358481313382323,-0.7233685775970342,0.8260869565217391,0.9401527243550094,1.0,5/10,23.30%,CDC73;DTX3L;WAC;RNF20;LEO1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.2876215122638043,0.7232927803855557,0.8305084745762712,0.9802150537788374,1.0,2/13,5.63%,PTPRT;IL6
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.18066372238453268,-0.7231112078221688,0.9751552795031055,0.9398887682928008,1.0,26/65,29.40%,UBQLN1;ACAA2;HIF1A;CPEB4;ADAM8;PTGIS;PMAIP1;HMOX1;NOP53;HP1BP3;CPEB2;HIPK2;RGCC;BMP7;FMN2;SIRT2;LMNA;TWIST1;HYOU1;TERT;FAM162A;EGLN1;AQP1;MDM2;TSC1;ANGPT4
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.29496436713919094,-0.7231023997659565,0.8419753086419753,0.9393628259147722,1.0,3/10,19.18%,BRCA1;THAP7;TAF7
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2083943293292085,0.7230756144171636,0.908957415565345,0.9798874254490278,1.0,14/53,22.02%,PSMB1;PSMF1;PSMA1;PSMD7;OAZ1;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;PSME1;PSMD2;PSMD4;PSMD8
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.27595873853221975,-0.7230688814962,0.837037037037037,0.9388796342856636,1.0,6/12,28.99%,SNW1;KLF2;TRIM16;DHRS3;EZH2;CYP26B1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.21775499950734378,0.7218034755080521,0.9040247678018576,0.9807862673390259,1.0,12/40,23.61%,MLLT11;PDCD5;CLU;PRKN;DNM1L;BIK;BBC3;PRELID1;MFF;CIDEB;HRK;TRIAP1
prerank,regulation of fibrinolysis (GO:0051917),-0.26599680741766796,-0.7217190929939384,0.8398058252427184,0.9397697469946277,1.0,8/13,34.29%,THBS1;APOH;SERPINF2;F11;KLKB1;PLG;F12;HRG
prerank,negative regulation of leukocyte migration (GO:0002686),0.3052394434677939,0.7215062085435074,0.8260135135135135,0.9805685549077963,1.0,1/10,1.00%,ADTRP
prerank,embryonic axis specification (GO:0000578),0.27137607764555927,0.720802400874634,0.8384,0.980821610475541,1.0,5/15,26.17%,RIPPLY2;WNT7A;SMAD2;CXXC4;FZD5
prerank,myeloid cell differentiation (GO:0030099),0.2085280445597615,0.7201240205549239,0.9201183431952663,0.9810145962531528,1.0,12/47,23.28%,ZFPM1;FLVCR1;HSPA9;CASP3;KAT8;SLC25A5;INHA;PTPN2;KMT2E;SLC25A38;TIRAP;RUNX1
prerank,cellular respiration (GO:0045333),-0.19700801191546966,-0.7195754482263633,0.9329446064139941,0.9416036252749915,1.0,5/41,6.24%,NDUFS4;NDUFA5;MTLN;NDUFS8;SDHB
prerank,calcium import into the mitochondrion (GO:0036444),0.30274844132777157,0.7194893286524996,0.8153564899451554,0.981173286334,1.0,3/10,15.65%,MICU2;SMDT1;SLC25A23
prerank,regulation of brown fat cell differentiation (GO:0090335),0.27141434757641136,0.7193050801990315,0.8324697754749568,0.9808005422980933,1.0,6/16,24.27%,FNDC5;FLCN;NAPEPLD;ZBTB7B;SOX13;FTO
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.2700185609356629,0.718565454934866,0.84,0.9810463400011564,1.0,4/16,21.31%,PPARA;APOD;ABCD2;CUEDC2
prerank,regulation of transferase activity (GO:0051338),0.26858774351222,0.7185487014241159,0.8370118845500849,0.9804942841405598,1.0,2/17,1.89%,LDB2;LDB1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.2508015100263647,0.7183238746585773,0.870253164556962,0.980155653192673,1.0,10/23,29.64%,MAP6;KIF1C;HOOK2;HOOK1;KIF1B;CCDC186;TUBA1B;TUBA1A;DYNC1I1;TUBA1C
prerank,secretory granule organization (GO:0033363),-0.2896477198878259,-0.7182947453234125,0.8235294117647058,0.9424307479800781,1.0,2/10,7.48%,LYST;SRGN
prerank,regulation of smooth muscle contraction (GO:0006940),0.256094960432407,0.7182714456603186,0.8752052545155994,0.9796340838381646,1.0,1/20,0.22%,CTTN
prerank,peptidyl-amino acid modification (GO:0018193),0.299735614352352,0.7182628669124158,0.8408239700374532,0.9790689471929815,1.0,3/10,21.68%,METAP1D;FKBP10;METAP2
prerank,regulation of axon regeneration (GO:0048679),0.28544699505376003,0.7182616458272744,0.8378839590443686,0.9784970370773881,1.0,5/12,23.63%,RTN4RL1;INPP5F;EPHA4;PTPRS;GRN
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.26558309992326107,-0.7178351437793589,0.8380281690140845,0.9424149452433945,1.0,5/13,27.34%,ENPP3;SMPDL3A;ENTPD5;NUDT15;DCTPP1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.305925592039624,0.7168286577266202,0.8414634146341463,0.9795617726681675,1.0,1/10,3.99%,HSPA2
prerank,smooth muscle contraction (GO:0006939),-0.25659576247423643,-0.7166764255388812,0.8640552995391705,0.9430618275361844,1.0,5/14,19.13%,TPCN2;EDNRA;CHRNB2;ADRA1A;MYLK
prerank,fatty acid elongation (GO:0030497),-0.266485772667833,-0.7162533797112263,0.8521939953810623,0.942977700896874,1.0,5/13,26.60%,HACD4;HACD2;HACD1;ELOVL2;ABCD1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.21662335245721748,-0.7162429334885959,0.904891304347826,0.9424554418576335,1.0,13/27,33.40%,UBE2D3;UBE2L3;CDC27;UBE2E3;UBE2C;ANAPC7;ANAPC10;RNF26;CDC23;UBE2T;ANAPC11;UBE2A;ANAPC1
prerank,bone morphogenesis (GO:0060349),-0.25998106848750324,-0.7159080905397134,0.8422391857506362,0.9422771348775879,1.0,6/14,36.75%,LRP6;LTF;BMPR2;CYP26B1;TFAP2A;MMP13
prerank,regulation of centrosome duplication (GO:0010824),0.23316844584357027,0.714169524983839,0.8987341772151899,0.9820592661701703,1.0,9/29,22.30%,CENATAC;CHMP1A;CHMP2A;FBXW5;XRCC3;PLK2;ALMS1;CHMP5;CEP120
prerank,t-circle formation (GO:0090656),0.30162262655473704,0.713763277566606,0.8433734939759037,0.9807696484048823,1.0,3/10,17.69%,SMARCAL1;XRCC3;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.30162262655473704,0.713763277566606,0.8433734939759037,0.9807696484048823,1.0,3/10,17.69%,SMARCAL1;XRCC3;WRN
prerank,telomere maintenance via telomere trimming (GO:0090737),0.30162262655473704,0.713763277566606,0.8433734939759037,0.9807696484048823,1.0,3/10,17.69%,SMARCAL1;XRCC3;WRN
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.2055657718860189,0.7130528422955426,0.9252615844544095,0.9809777586722366,1.0,19/55,26.37%,PSMB1;PSMF1;FHL1;PSMA1;PSMD7;PSMA8;PSME3;PSMD14;PSMC4;PSMB4;FBXL7;PSME1;PSMD2;PSMD4;PSMD8;AURKA;PSMC5;PSMD3;PSMB8
prerank,chromatin organization (GO:0006325),0.1753195733968123,0.7129764519452743,0.9767441860465116,0.9804806689554216,1.0,22/132,18.88%,NUCKS1;MPND;SMARCC2;BPTF;FAM50A;PAK1;KDM6B;MCM3AP;BRWD1;SMARCE1;PWWP3A;HDAC5;SMARCD3;SUV39H2;KDM4A;PRDM16;NPM2;TCF7L1;PHF1;HMG20A;SETDB1;HDAC3
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.22505238461759094,0.7128402149960714,0.8985959438377535,0.980060951814766,1.0,7/32,16.08%,CLASP2;MAP4K4;ITGB1BP1;ADAM15;APOD;RCC2;PHLDB2
prerank,chondrocyte differentiation (GO:0002062),0.22751181764699893,0.7115447036607723,0.8906497622820919,0.9809062071900956,1.0,12/32,27.41%,NFIB;MEF2C;BMP4;TGFB1;WNT7A;BMPR1B;SNX19;SULF2;RUNX1;GPLD1;WNT5B;SULF1
prerank,insulin secretion (GO:0030073),0.2538004010485604,0.7113673837016212,0.8693548387096774,0.9805407928940656,1.0,5/19,22.61%,PTPRN;ADCYAP1;GAL;SNX19;RAB11FIP2
prerank,androgen metabolic process (GO:0008209),-0.23971489205465718,-0.7109832159235764,0.8542141230068337,0.9467913277770106,1.0,8/18,36.12%,DHRS9;SHH;SRD5A2;HSD17B7;HSD3B2;HSD17B3;AKR1D1;CYP19A1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.24767524193516735,0.7103797098972894,0.875,0.9810199655371007,1.0,4/21,13.19%,LRP2;CX3CR1;SMARCD3;DCT
prerank,negative regulation of cholesterol transport (GO:0032375),0.30507268554156686,0.7103487377480945,0.8330434782608696,0.9804813768801245,1.0,2/10,14.11%,ABCG8;ABCA2
prerank,RNA interference (GO:0016246),0.25976630658330113,0.7099939733732509,0.8739352640545145,0.9802912032134484,1.0,4/17,18.27%,DROSHA;TSN;AGO4;TSNAX
prerank,gliogenesis (GO:0042063),-0.2507168763026664,-0.7093003633745046,0.8644501278772379,0.9480025169563248,1.0,3/15,14.94%,CDK6;ANXA1;CDH2
prerank,cristae formation (GO:0042407),0.23333244046082244,0.7090242555441133,0.8726708074534162,0.9807540111741273,1.0,11/27,30.69%,ATP5F1C;UQCC3;MICOS13;APOO;ATP5MC3;ATP5ME;ATP5MF;DNAJC11;ATP5F1A;APOOL;SPG7
prerank,regulation of myoblast fusion (GO:1901739),-0.2695033731410368,-0.7079037728879493,0.8398058252427184,0.9489030766753,1.0,2/11,11.94%,RIPOR2;CD53
prerank,glycolipid metabolic process (GO:0006664),0.20599385262279182,0.7066091945698166,0.9084194977843427,0.9827541674923695,1.0,8/47,14.11%,HEXB;ESYT2;NEU1;NAGA;B3GALNT1;ST3GAL6;SCCPDH;ABCA2
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.27873823137031517,-0.7065533505344189,0.8402948402948403,0.9496952795916392,1.0,6/12,32.30%,DSEL;CSPG4;DSE;CHST12;NCAN;CHST14
prerank,dorsal/ventral pattern formation (GO:0009953),0.25327257348628873,0.7062092715683673,0.8814432989690721,0.9825777392127173,1.0,6/20,23.13%,WNT8B;SFRP1;LMX1B;DSCAML1;BMPR1B;AIDA
prerank,lipoprotein catabolic process (GO:0042159),-0.27242730685576094,-0.7054376511446889,0.8486997635933806,0.950296370719585,1.0,1/11,0.51%,APOE
prerank,N-terminal protein amino acid modification (GO:0031365),0.26556641846352025,0.7047434125216456,0.8534322820037106,0.983600299964374,1.0,4/14,21.68%,METAP1D;NAA35;NAA60;METAP2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.2076231585886518,0.7046962753327495,0.9259259259259259,0.9830740471391257,1.0,6/42,11.47%,RARRES2;DEFA6;IL6;MR1;RNASE7;DROSHA
prerank,bone development (GO:0060348),-0.18939578282570715,-0.7038581402620708,0.9553571428571429,0.9512914699220079,1.0,4/39,5.30%,PTPRC;PTGER4;SH3PXD2B;DYM
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.24924978190574143,0.7035504767856938,0.88,0.9837425806716826,1.0,6/19,19.28%,SMOC2;DAB2IP;MYO1C;CADM4;ADAMTS3;DCN
prerank,rRNA methylation (GO:0031167),0.2447669881091335,0.7035380787497018,0.8896,0.9831856172977375,1.0,5/22,14.78%,DIMT1;METTL16;NOP2;METTL5;FBLL1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.22411060590609855,0.7029877652377222,0.9017713365539453,0.9831572865722192,1.0,5/29,17.53%,RAB6B;COPG1;TRAPPC3;COPE;COPG2
prerank,regulation of dendritic spine development (GO:0060998),0.24945259844505313,0.7029511265215537,0.8627450980392157,0.9826260852029034,1.0,5/19,18.02%,TANC2;MEF2C;SHANK3;PTPRS;SHANK1
prerank,regulation of intracellular protein transport (GO:0033157),0.22574549137383562,0.7027577303505864,0.8973941368078175,0.982275265136289,1.0,8/32,18.04%,TENM1;BMP4;OAZ1;TGFB1;PLK3;IFI27;RIPOR1;B3GAT3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.24398075378341305,0.7027331108768672,0.8789915966386554,0.9817323553248563,1.0,6/23,20.09%,RELA;PPM1A;NMI;IFI35;TSPAN6;CYLD
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.22707972696530956,0.7022724207194383,0.9074675324675324,0.9816320989470235,1.0,3/29,6.31%,FUS;E2F1;CIRBP
prerank,negative regulation of stem cell differentiation (GO:2000737),0.27755382606806256,0.7019884054821045,0.868421052631579,0.9813534190593518,1.0,3/12,15.79%,NELFB;ZFP36L2;REST
prerank,ERAD pathway (GO:0036503),0.183843043137281,0.7018239065881826,0.9595375722543352,0.9809583911083755,1.0,10/83,12.03%,SELENOS;UBXN6;FOXRED2;SGTA;PRKN;HSP90B1;HERPUD1;CCDC47;SGTB;DERL1
prerank,actin polymerization or depolymerization (GO:0008154),-0.1794750228981934,-0.7005637051125712,0.953125,0.9539871840427948,1.0,13/50,18.02%,SVIL;PSTPIP2;DIAPH3;GAS7;COBL;VILL;CORO7;WASF1;CFL2;MICAL1;GSN;MSRB1;MICAL2
prerank,negative regulation of biosynthetic process (GO:0009890),0.2567227204302137,0.7005160791554672,0.8758620689655172,0.9817394470296062,1.0,4/16,20.07%,PPARA;IL6;ABCD2;ABCB7
prerank,ceramide metabolic process (GO:0006672),0.20441109856251966,0.7002013506092247,0.9222873900293255,0.9814799244270853,1.0,14/49,22.10%,TLCD3B;ORMDL2;CERS4;SPTSSA;NSMAF;ABCA2;CERS6;CERS5;CERS1;PPP2R1A;CLN6;PLA2G15;PLPP1;FA2H
prerank,regulation of DNA damage checkpoint (GO:2000001),0.29714508024859304,0.6994152201545237,0.8605442176870748,0.9817299635933819,1.0,4/10,16.09%,THOC5;DDX39B;CCAR2;RFWD3
prerank,relaxation of muscle (GO:0090075),0.27488787760569644,0.699380051416768,0.875,0.9811991430162054,1.0,4/13,20.12%,ATP1B1;SLC8A1;RGS2;ATP1A1
prerank,neuron maturation (GO:0042551),0.24985286850027047,0.698420281851967,0.8752136752136752,0.9815964123666941,1.0,3/18,11.55%,C3;MTCH1;FARP2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.24414889334377288,0.6969686936943824,0.9024793388429752,0.9825262293846971,1.0,9/23,27.18%,APLP1;PRKN;GABPA;MAPK3;SLC9A1;GNG2;MAPK1;ATF4;TGM2
prerank,response to UV-A (GO:0070141),-0.2577523549990686,-0.6967609290059616,0.864406779661017,0.9569966387293317,1.0,4/14,20.42%,CCND1;EGFR;OPN3;TIMP1
prerank,zymogen activation (GO:0031638),0.20957669628880757,0.6950874416415901,0.9237804878048781,0.9838095016657801,1.0,5/39,8.84%,PLAT;VSIR;ASPH;LGMN;BAK1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.2614814561950951,0.6949627416898058,0.8668885191347754,0.9833474754492041,1.0,4/16,18.03%,DMD;SLC8A1;GSTO1;ANK2
prerank,positive regulation of vascular permeability (GO:0043117),-0.26441831757510725,-0.6940454945349778,0.8651960784313726,0.9589223985812619,1.0,5/12,32.12%,PDE2A;TJP1;ANGPT1;PDE3A;TRPV4
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.26196982967563176,-0.6937504299130983,0.8781609195402299,0.9586569675862957,1.0,3/12,13.96%,FUT8;SLC35A3;GMDS
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.2596483858550595,-0.6934285353420567,0.8684807256235828,0.9583986583950486,1.0,6/13,27.89%,CHST7;NAGK;RENBP;CHST3;CHST2;CHST5
prerank,regulation of histone acetylation (GO:0035065),0.21662412594701935,0.6928432180525177,0.9177215189873418,0.9849073620337783,1.0,8/33,21.65%,PPARGC1A;CTBP1;HDAC5;RAPGEF3;FLCN;MAPK3;ARRB1;BRD7
prerank,cellular response to nutrient levels (GO:0031669),-0.17521989401810537,-0.692817359614645,0.9716088328075709,0.9584187934018343,1.0,13/62,17.48%,MAP1LC3B;RRAGC;STK24;ATG7;LAMP2;LPL;FOXO1;RRAGA;RALB;LRRK2;MFSD2A;MAP1LC3A;NUPR2
prerank,response to muscle stretch (GO:0035994),0.2591924677751581,0.6926819595389863,0.8920265780730897,0.9844984596257852,1.0,4/15,22.22%,DMD;SLC8A1;PTK2;SLC9A1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.22811005295589903,-0.6922417968099971,0.9152119700748129,0.9583866388419165,1.0,3/19,19.63%,PAPSS2;BPNT2;SULT2B1
prerank,response to cholesterol (GO:0070723),0.25728516097291687,0.6920451333383728,0.8772802653399668,0.9845560338825062,1.0,6/17,27.34%,TGFBR1;TGFB1;ABCA2;SMAD2;GPLD1;CCR5
prerank,protein acylation (GO:0043543),-0.19430374604044193,-0.6915298513520989,0.9575070821529745,0.9584824652073454,1.0,13/38,27.22%,ZDHHC14;ZDHHC3;NAA10;FOXO1;EP300;ZDHHC17;NAT10;ZDHHC7;KAT2B;HHAT;NAT9;ZDHHC13;ZDHHC21
prerank,histone H4 acetylation (GO:0043967),0.20064143227067616,0.6906787440166073,0.9544072948328267,0.9853082902745351,1.0,16/47,25.80%,JADE2;MEAF6;BRD8;TADA3;APBB1;OGT;KAT8;DMAP1;NAA60;MORF4L2;ING3;WDR5;JADE1;YEATS4;MSL1;MCRS1
prerank,anterior/posterior axis specification (GO:0009948),0.25692324692340746,0.6905966992558689,0.8824503311258278,0.9848299265574939,1.0,1/15,4.35%,RIPPLY2
prerank,maintenance of protein localization in organelle (GO:0072595),0.24602955378529295,0.6905943889129966,0.8856209150326797,0.9842663312043803,1.0,4/19,14.53%,ARL2BP;CHCHD10;TAF3;HK2
prerank,positive regulation of transmembrane transport (GO:0034764),-0.2552375164445685,-0.690462221009803,0.8547215496368039,0.958907326997017,1.0,2/13,5.45%,BRAF;ACSL5
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.16854225947007614,-0.6904527534594367,0.9863481228668942,0.9583803812832589,1.0,12/70,16.39%,PLBD1;PCYT1A;PLA2G4E;PLAAT3;NR1H2;PCTP;PEMT;NR1H3;TMEM86B;STARD10;MFSD2A;LPCAT4
prerank,gas transport (GO:0015669),-0.27659032854305865,-0.6903859054432676,0.8810068649885584,0.9579144871703623,1.0,5/10,36.36%,CA2;CYGB;AQP1;RHAG;NGB
prerank,negative regulation by host of viral process (GO:0044793),0.29060003307778726,0.6893835691866451,0.8628158844765343,0.9848110734142878,1.0,4/10,23.97%,PRKN;CCNK;EIF2AK4;VAPA
prerank,cellular response to superoxide (GO:0071451),0.29082479912277387,0.6883437701560083,0.8568965517241379,0.9852214567622453,1.0,2/10,10.91%,PRDX2;ADPRS
prerank,monocyte chemotaxis (GO:0002548),0.21714371975741606,0.687951634448505,0.9006514657980456,0.9850188042751968,1.0,8/32,28.27%,PTPRO;IL6;PDGFB;CCL15;CCL5;IL6R;CCL14;TNFRSF11A
prerank,chromatin remodeling at centromere (GO:0031055),-0.19748434043501734,-0.6879224094878145,0.9355670103092784,0.9595770317158575,1.0,9/31,27.10%,RBBP7;CENPA;NPM1;CENPW;CENPX;MIS18BP1;CENPH;HJURP;OIP5
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.25030783511606874,0.6879027827731539,0.8818493150684932,0.9845048412569224,1.0,7/18,26.11%,TIMM21;OXA1L;BCS1L;COX17;SMIM20;COX18;FASTKD3
prerank,regulation of telomere maintenance (GO:0032204),-0.21079090599840858,-0.68757214478284,0.9496021220159151,0.9593525789308797,1.0,8/26,23.89%,RTEL1;NBN;YLPM1;TERF2;HNRNPD;SMG6;TINF2;PIF1
prerank,establishment of protein localization to organelle (GO:0072594),0.1866233565118709,0.6865312919105467,0.9615384615384616,0.9852016221237752,1.0,11/72,16.08%,TSC2;LAMP5;FAM53C;NXT2;PRICKLE1;HEATR3;FAM53B;NUP88;IPO5;HK2;NUP133
prerank,lymphocyte mediated immunity (GO:0002449),0.2753121936332177,0.6865246980366491,0.8801431127012522,0.9846460770200052,1.0,1/12,4.04%,SLA2
prerank,ovarian follicle development (GO:0001541),0.2737448477865846,0.686422310718434,0.8803418803418803,0.9841720823178388,1.0,1/13,1.00%,ANG
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.22312670168556142,-0.6862429636708203,0.9032258064516129,0.9599327206320295,1.0,2/21,4.67%,CNOT9;SAMD4A
prerank,regulation of acrosome reaction (GO:0060046),-0.27542053728345467,-0.6861771681672826,0.862144420131291,0.9594571958941376,1.0,10/10,72.48%,GLRA1;PLA2G10;SERPINA10;ZP3;PRSS37;CCDC87;FAM170B;SPINK13;PLCB1;CACNA1H
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.25495957901866023,0.6857894015892154,0.908289241622575,0.9842150242939464,1.0,2/16,4.71%,CRMP1;NT5C3A
prerank,regulation of TORC1 signaling (GO:1903432),0.21166747238778116,0.6857828290941143,0.912396694214876,0.9836596364056052,1.0,6/33,16.06%,KLHL22;STK11;DGKQ;ITFG2;FLCN;RNF152
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.2528613163709651,-0.6852627027907303,0.8772727272727273,0.9597034966117741,1.0,4/13,22.43%,HACD4;HACD2;HACD1;ELOVL2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.20620367235916695,0.6852027138335172,0.9442724458204335,0.98364054526043,1.0,10/40,24.96%,SLC38A2;SLC38A9;SLC38A7;SLC19A1;SLC13A3;SLC38A3;SLC25A10;SLC38A10;SLC16A7;ABCC5
prerank,secondary palate development (GO:0062009),0.2613682084904715,0.6836138741703507,0.8902229845626072,0.9844896870254403,1.0,3/14,20.91%,TGFBR3;WNT7A;SMAD2
prerank,C4-dicarboxylate transport (GO:0015740),-0.2501019179723154,-0.6832010929754657,0.9044117647058824,0.9608775746049242,1.0,4/14,22.00%,LRRC8D;SLC25A11;SLC25A22;SLC13A5
prerank,nuclear pore organization (GO:0006999),-0.24487258460702466,-0.6819545140934613,0.8859223300970874,0.9613750251688997,1.0,3/14,12.26%,NUP153;NDC1;AHCTF1
prerank,positive regulation of lipid transport (GO:0032370),0.2763455104920713,0.6816505485751122,0.8668941979522184,0.9856813435871866,1.0,5/12,27.36%,ABCB4;DBI;PRELID1;TRIAP1;ABCA3
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.25540732952178563,0.6812858564822803,0.9009174311926605,0.9854543534064802,1.0,3/16,15.76%,NAA30;NAA35;NAA60
prerank,motor neuron axon guidance (GO:0008045),0.255166127174606,0.6807888934109675,0.8920741989881956,0.9853145194214913,1.0,4/15,24.30%,CHN1;EPHA4;LAMC2;SEMA3A
prerank,negative regulation of signaling (GO:0023057),-0.21230932144516695,-0.680154402605867,0.9259259259259259,0.9623000693371845,1.0,7/25,28.43%,PTPN1;IL1B;SOCS5;OPTN;ACVR1;GLRA1;TRAT1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.2750439367311072,-0.6796062569976382,0.8767441860465116,0.962208088289561,1.0,10/10,72.52%,STAT1;SHH;PDGFA;TBX1;SOX9;TGFBR2;FGFR2;LRP5;MYC;CHRD
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2740015937552984,0.6789461037359171,0.8720136518771331,0.9863826290395707,1.0,2/12,10.95%,WRAP53;CCT4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.194579271738296,0.6787432550962025,0.9487554904831625,0.9859892239197199,1.0,6/50,14.40%,CDK7;CCNI;SERTAD1;CCND3;GADD45A;CCNK
prerank,somite development (GO:0061053),-0.2650053455489123,-0.6786292129869745,0.8799076212471132,0.9624416600326244,1.0,4/11,22.21%,SOX11;MTHFD1;PTCH1;SHH
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.2680750978738912,0.6786210602759346,0.9076655052264808,0.9855221002557587,1.0,3/13,18.53%,PRKCZ;IRS1;ZBTB7B
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.27392781652033626,0.6784120482435354,0.8929824561403509,0.9851345705209742,1.0,1/12,1.86%,BIN1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.26758968552705775,0.6776174380847149,0.8796610169491526,0.9852889431800124,1.0,4/12,20.97%,KDELR3;KDELR2;RER1;ANKRD13C
prerank,regulation of protein acetylation (GO:1901983),-0.256777687755142,-0.6749866340243899,0.8792710706150342,0.9647775888128044,1.0,3/12,18.93%,FAM161A;KAT5;CEP295
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.2860839985674589,0.6733538394354196,0.8850987432675045,0.9883822588706844,1.0,2/10,8.74%,HDAC5;RAPGEF3
prerank,regulation of inclusion body assembly (GO:0090083),0.2756811543377405,0.6721713822148786,0.8924914675767918,0.988794729310513,1.0,1/11,3.99%,HSPA2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.22801660783987093,-0.6713625713532257,0.9056603773584906,0.9670591278854509,1.0,5/18,16.26%,IGF1;CD24;IGF2;AGER;IL27RA
prerank,ribosomal small subunit assembly (GO:0000028),-0.23094706635066536,-0.671119604049474,0.9278846153846154,0.9667005873490652,1.0,2/16,5.97%,RPS14;RPS5
prerank,negative regulation of establishment of protein localization (GO:1904950),0.280267644704145,0.6696638817816981,0.8796610169491526,0.9902349330466462,1.0,4/10,27.74%,CORO2B;MAPT;TERF1;DNAJA1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.2784151371744357,0.6694024935384052,0.8966725043782837,0.9898767437173731,1.0,2/10,10.44%,MAP2K5;SH2B3
prerank,sphingolipid biosynthetic process (GO:0030148),0.18199497335382203,0.6689972496565042,0.9635343618513323,0.9896380489781059,1.0,18/71,22.10%,ST3GAL5;TLCD3B;CERS4;PRKD2;SPTSSA;ELOVL6;SPNS2;ELOVL4;CERS6;CERS5;PRKD1;KDSR;CERS1;PLPP1;ELOVL5;PPM1L;LARGE1;FA2H
prerank,atrioventricular valve development (GO:0003171),0.2586146633582337,0.6684304680194306,0.8800675675675675,0.9895374394539848,1.0,2/14,9.96%,ZFPM1;GJA5
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.20946823892055266,0.6677956710100988,0.9393468118195957,0.9894982100099761,1.0,12/33,27.62%,FGF10;RPTOR;CCND3;PAF1;KMT2E;STXBP4;RDX;DDX3X;UBE2E2;ADAMTS1;PLCG2;PLCB1
prerank,I-kappaB phosphorylation (GO:0007252),0.284994706381543,0.6671692833141142,0.8953900709219859,0.989426844512588,1.0,4/10,17.22%,DAB2IP;PRDX4;MAP3K7;TLR3
prerank,quinone biosynthetic process (GO:1901663),0.254841353908814,0.6653409902514033,0.8982456140350877,0.9903038966567485,1.0,3/14,13.90%,COQ7;COQ8A;PDSS1
prerank,regulation of nuclear division (GO:0051783),-0.22076967497288402,-0.6642682433923941,0.9256410256410257,0.9713401545885764,1.0,7/20,24.83%,MKI67;BORA;KIF20B;CUL9;CDC25C;RCC1;CDK13
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.17873888288282738,0.6621423223588214,0.980225988700565,0.9922210705052841,1.0,15/76,19.13%,P2RY12;NMUR1;ADRA2A;GNA15;GPR17;ACTN2;CX3CR1;LPAR4;P2RY1;GNA11;P2RY10;AGT;OPRM1;OPRD1;GPR174
prerank,histone H3-K9 demethylation (GO:0033169),-0.25659437515775524,-0.6614401493620278,0.8973747016706444,0.9727852925399296,1.0,2/11,11.55%,KDM7A;HR
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.2263676818086093,-0.661357497259264,0.9058823529411765,0.9723065708923737,1.0,4/17,13.50%,SPRY2;CALM3;CALM2;INPP5K
prerank,negative regulation of protein polymerization (GO:0032272),0.2138506511637897,0.6612444148506286,0.9340836012861736,0.9923178460237019,1.0,12/27,29.91%,STMN2;TWF2;ARFGEF1;TWF1;SSH1;SSH2;SSH3;MAP2;TBCD;CYRIB;KANK1;PFN1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.28348001216882934,0.6609452187647438,0.9024822695035462,0.9919899752555321,1.0,3/10,19.81%,PFKM;HK2;PFKP
prerank,protein localization to mitochondrion (GO:0070585),0.2680976165706842,0.6607898154936999,0.8940170940170941,0.9915528331129579,1.0,4/11,27.74%,MTCH2;HK2;COX18;DNAJA1
prerank,neutrophil chemotaxis (GO:0030593),0.18882451297359337,0.660721249499983,0.9615952732644018,0.9910498116680335,1.0,7/53,19.40%,PPIB;NCKAP1L;PIK3CG;BSG;CXADR;CCL15;CCL5
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.23634867873827997,-0.659849255993001,0.9230769230769231,0.9728017071864464,1.0,7/15,27.89%,GNPDA1;CHST7;NAGK;RENBP;CHST3;CHST2;CHST5
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.22481168181019978,-0.6597557287887374,0.9326923076923077,0.9723332325108255,1.0,5/17,16.59%,NRP1;EGR3;KDR;GREM1;EPHB4
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2571811961320362,0.6592194004024865,0.9182282793867121,0.9916264984559173,1.0,3/13,21.23%,OGG1;NT5C;UNG
prerank,negative regulation of protein processing (GO:0010955),0.27192017710624616,0.6582824261148253,0.8867595818815331,0.9917669403508315,1.0,4/12,24.18%,PRNP;SERPINE2;TMEM59;ACP4
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.24407870367219184,0.6582480166758927,0.9261168384879725,0.9912366300370845,1.0,5/17,28.13%,MEF2C;PRKG1;TAFA5;SOD2;PTEN
prerank,regulation of cell cycle phase transition (GO:1901987),0.17240472905799398,0.6577740255493242,0.9906040268456375,0.9910402460478269,1.0,30/91,28.62%,MN1;PSMB1;TCIM;PSMF1;BTRC;PSMA1;PSMD7;PSMA8;PSME3;PSMD14;PSMC4;ANAPC2;PSMB4;UBE2D1;FBXO5;PSME1;UBE2S;PSMD2;PSMD4;PSMD8;ERCC2;PSMC5;TRIM39;DBF4;PSMD3;PSMB8;NEK10;PSMA4;NEK11;ANAPC4
prerank,tRNA metabolic process (GO:0006399),-0.22330282407698382,-0.6569991416769413,0.9111675126903553,0.973712561544427,1.0,4/17,10.07%,FARS2;RPP21;SSB;YARS2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.2372062978813591,-0.656352374146085,0.9348370927318296,0.9736178399931795,1.0,6/14,33.12%,MAPKAPK2;MYD88;HNRNPC;DAZL;HNRNPA0;YBX3
prerank,ubiquinone metabolic process (GO:0006743),0.2476051032615057,0.6560367842383258,0.9051724137931034,0.9917702242851858,1.0,3/15,13.90%,COQ7;COQ8A;PDSS1
prerank,positive regulation of neuron differentiation (GO:0045666),0.19704855885515085,0.6560122157853058,0.9534883720930233,0.9912314805857586,1.0,11/40,25.20%,NEUROD2;MEF2C;NRCAM;BEND6;VWC2;REST;TCF3;ZEB1;IMPACT;ZC4H2;RHOA
prerank,epithelial structure maintenance (GO:0010669),-0.2531470408202886,-0.6553677366678624,0.8969957081545065,0.9737578014494597,1.0,4/11,35.15%,NOD2;TLR9;PIWIL4;MUC6
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.16895345669824374,-0.6547124563678413,0.9895833333333334,0.9736691324994282,1.0,21/53,37.47%,HRH1;CHRM2;ANXA1;VIPR1;NPY1R;HTR1B;CALCRL;NPY;LPAR3;XCR1;HRH3;HTR1A;PTGIR;AGTR2;HTR2C;HTR1D;MC2R;CHRM1;DRD1;LHCGR;HRH2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.23898223781733596,-0.6544696036917458,0.9030732860520094,0.9732984808506271,1.0,5/14,23.01%,NT5E;CAD;DPYS;UMPS;UPB1
prerank,Golgi localization (GO:0051645),0.26822617355702466,0.6536432261400642,0.9,0.9923443308429204,1.0,4/11,20.43%,COPG1;STK25;RIPOR1;CDC42
prerank,mRNA modification (GO:0016556),-0.20630974331659938,-0.6521457535400274,0.9492753623188406,0.9742864000543052,1.0,4/22,12.34%,TRUB2;TRMT10C;METTL8;NSUN2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.24378594043730548,0.6520237833071156,0.9268707482993197,0.9928785674413352,1.0,1/16,0.65%,ST3GAL5
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.18674059069938856,-0.6517492636702864,0.9509536784741145,0.9739873772595075,1.0,5/32,11.52%,CCT6A;PKIB;PRKCQ;CTNNB1;CCT3
prerank,negative regulation of lipid catabolic process (GO:0050995),0.24182551300814173,0.6516864773929836,0.9148936170212766,0.9925639233496668,1.0,2/17,6.94%,PDE3B;ADRA2A
prerank,response to prostaglandin E (GO:0034695),0.27751019323200665,0.6516412148401779,0.8915441176470589,0.9920365713977205,1.0,2/10,11.58%,TGFBR3;SFRP1
prerank,regulation of osteoblast proliferation (GO:0033688),0.2389970784260982,0.6516194054350993,0.9267886855241264,0.9914974129560024,1.0,1/17,0.18%,MN1
prerank,ceramide biosynthetic process (GO:0046513),0.1968226336779496,0.651490471138223,0.9480916030534351,0.9910376138893072,1.0,7/40,16.55%,ST3GAL5;TLCD3B;CERS4;SPTSSA;CERS6;CERS5;CERS1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.27660218581713825,0.6513566477662597,0.8998211091234347,0.9905655039060479,1.0,3/10,20.82%,SLC45A3;ABCD2;ELOVL5
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.2517128541180197,-0.6502034743588069,0.9149888143176734,0.9739137742098489,1.0,3/11,13.50%,SYNJ2;IMPA2;INPP5K
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.2517128541180197,-0.6502034743588069,0.9149888143176734,0.9739137742098489,1.0,3/11,13.50%,SYNJ2;IMPA2;INPP5K
prerank,muscle organ development (GO:0007517),0.18394955771092372,0.6494447655843003,0.9769585253456221,0.9913694263384565,1.0,8/54,11.71%,CAPN3;DMD;MEF2C;SGCE;FHL1;EMD;ITGB1BP2;SGCG
prerank,cellular response to nitrogen compound (GO:1901699),0.2289352172873736,0.6487703412675488,0.9123711340206185,0.9912859268268783,1.0,3/20,14.75%,TIMELESS;NSMCE3;AOC1
prerank,response to acidic pH (GO:0010447),-0.24448662627009649,-0.6476858704885445,0.9379652605459057,0.9750271901518058,1.0,4/13,16.82%,GPR65;RAB11FIP5;CHP1;PKD1L3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2057884837657966,0.6474724163981492,0.968503937007874,0.9916461984687144,1.0,4/32,11.39%,LPCAT1;ACHE;CHAT;SLC44A2
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.20642567605009696,-0.6462674969751594,0.95,0.9753740260711387,1.0,4/21,14.90%,STAP1;THBS1;CXCL17;PTK2B
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.22411978297309992,-0.6461696531198593,0.9317647058823529,0.9749087090506002,1.0,8/16,30.42%,GBF1;SEC16A;LRRK2;PPP1R15A;GABARAPL2;RYR2;TAPT1;HSPA5
prerank,phosphatidic acid metabolic process (GO:0046473),0.18927721458758884,0.6451967511495174,0.9730941704035875,0.992575690335578,1.0,10/48,20.67%,PLA2G3;PNPLA3;LPCAT1;DGKQ;AGPAT1;ABHD5;DGKZ;DGKE;ABHD8;DGKH
prerank,aortic valve development (GO:0003176),0.20203434797732073,0.6444251555413804,0.9472843450479234,0.9925450174667982,1.0,5/34,10.94%,BMP4;HEY1;TGFB1;SNAI2;EFNA1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.270604186530591,0.6443691265114166,0.9165217391304348,0.9920335377473811,1.0,2/10,15.43%,SFRP1;BATF
prerank,ear morphogenesis (GO:0042471),0.22377841979650778,0.6434576720727095,0.9102990033222591,0.9920349155622343,1.0,20/20,77.65%,MYO6;EPHB2;CHD7;PAX2;TIFAB;FGFR2;HOXA1;USH1C;SIX1;OSR2;NIPBL;NOG;ZIC1;OSR1;ATP6V1B1;TFAP2A;TBX1;TMIE;PAX8;TWIST1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.21928796178895094,0.6433630340079789,0.9178981937602627,0.991544538788551,1.0,8/23,26.85%,TIMM29;TIMM13;TIMM22;TOMM70;COX18;TOMM22;TIMM10;TIMM10B
prerank,plasma membrane tubulation (GO:0097320),0.2511853728350012,0.6423910042299347,0.9153713298791019,0.9916240665906836,1.0,6/13,24.06%,BIN2;EHD2;MICALL1;SNX33;PACSIN3;FNBP1L
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.23755024388782897,0.6422650250302462,0.9329896907216495,0.9911564498633829,1.0,3/17,17.86%,BMP4;FGF2;BTG1
prerank,tRNA aminoacylation (GO:0043039),-0.17509809223242084,-0.6416911034381161,0.9721448467966574,0.9770881483508129,1.0,11/37,23.31%,AIMP1;FARS2;IARS2;YARS2;QARS1;NARS1;WARS2;WARS1;LARS1;PPA2;FARSA
prerank,artery development (GO:0060840),0.21988169805228405,0.6413970739489129,0.9434571890145396,0.9911622666892266,1.0,5/23,17.43%,TGFBR1;PKD2;GJA5;ANGPTL3;ENG
prerank,regulation of neutrophil migration (GO:1902622),-0.25828565562807526,-0.6404779300943224,0.9104477611940298,0.9773100204167774,1.0,4/10,25.12%,MPP1;BST1;OLFM4;RAC1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.216818354458641,0.6403116551633679,0.949238578680203,0.9912686695079828,1.0,6/24,21.04%,NFE2L2;ICAM1;TEK;NDNF;TNIP2;PDPK1
prerank,amino sugar metabolic process (GO:0006040),-0.25574170598428103,-0.639586582576613,0.9125799573560768,0.9772956423025964,1.0,7/10,39.57%,ST6GAL1;SLC35A3;B4GALNT2;GFPT1;ST3GAL1;GNE;GFPT2
prerank,regulation of osteoclast differentiation (GO:0045670),0.19941866351080934,0.6386304388252015,0.9556962025316456,0.991783247625423,1.0,4/33,10.06%,LRRC17;UBASH3B;CCR1;BGLAP
prerank,oogenesis (GO:0048477),0.2415141807123362,0.6381802538052403,0.9345335515548282,0.9915135915046647,1.0,1/15,1.01%,NANOS1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.22447513136652947,0.6372862034838281,0.9464594127806563,0.9915108655693858,1.0,3/19,9.95%,F11R;MYO1C;SNAI2
prerank,amyloid-beta metabolic process (GO:0050435),0.2325767070367316,0.6370152585360571,0.922365988909427,0.9911333991660217,1.0,4/16,21.61%,BACE1;PSENEN;ABCA7;APEH
prerank,telomere maintenance via recombination (GO:0000722),0.2609559793634761,0.6367075256260378,0.9182282793867121,0.990779128900807,1.0,3/11,23.59%,SMC5;XRCC3;ERCC4
prerank,regulation of cellular component biogenesis (GO:0044087),-0.17555653316184294,-0.6363656468572793,0.976063829787234,0.9786475943897669,1.0,6/39,16.50%,APOE;CD36;MSN;NOTCH1;RAP1B;RAP1A
prerank,regulation of calcium ion import (GO:0090279),0.22274017003623992,0.6358327487787081,0.9326765188834154,0.9907540470314422,1.0,3/21,12.26%,PRNP;PKD2;PDGFB
prerank,regulation of telomerase activity (GO:0051972),0.18755880147345874,0.6355108823347931,0.974320241691843,0.9903894382196419,1.0,16/45,29.14%,WRAP53;MAPK15;CCT4;MAPK3;CERS1;MAPKAPK5;HSP90AB1;XRCC5;GRHL2;ERCC4;PARM1;MAPK1;ACD;TERF1;PTGES3;MYC
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.2037155105221556,-0.6339426092803941,0.9637681159420289,0.9794220394947616,1.0,8/21,31.58%,CTSL;SGPP1;MAFG;SULT2B1;GDF3;CBFB;DLL1;KDF1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.18065107004587275,-0.6337707580035193,0.9719887955182073,0.9789938246822656,1.0,3/34,3.57%,PTPN22;DUSP16;PTPN1
prerank,fatty acid transmembrane transport (GO:1902001),-0.2055999864989278,-0.6331655830475648,0.9625935162094763,0.9788000884022452,1.0,8/19,26.60%,CD36;PRKAG2;MID1IP1;PRKAB2;ACACA;SLC25A20;ABCD4;ABCD1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.232500057811136,0.6331579350297047,0.9216666666666666,0.9912370703109905,1.0,5/17,23.70%,LGMN;CCR1;HMGB1;CCL5;CREB3
prerank,ubiquinone biosynthetic process (GO:0006744),0.23522497604258896,0.6331003854297372,0.9142857142857143,0.9907152457168925,1.0,3/15,13.90%,COQ7;COQ8A;PDSS1
prerank,snRNA 3'-end processing (GO:0034472),0.2249220552857446,0.6314982312789357,0.9239864864864865,0.99109302708361,1.0,4/19,19.53%,INTS6L;EXOSC5;INTS8;INTS5
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.25869572270654106,-0.6291938173146603,0.927400468384075,0.9804406237124871,1.0,4/10,31.58%,ZNHIT3;NAF1;PIH1D2;RUVBL2
prerank,cardiac cell development (GO:0055006),0.25981250070719586,0.6281476686009533,0.9342806394316163,0.992492486977607,1.0,2/11,16.57%,SLC8A1;CXADR
prerank,embryonic digestive tract development (GO:0048566),-0.2099739648688247,-0.6262716414778143,0.9389312977099237,0.9814372811251756,1.0,5/18,21.55%,SOX11;TNF;PDGFRA;PKDCC;ID2
prerank,regulation of tube diameter (GO:0035296),-0.22816134938616967,-0.6250185178820097,0.9330024813895782,0.9810228674655728,1.0,2/13,9.67%,GCLC;ADCY6
prerank,vascular process in circulatory system (GO:0003018),-0.22816134938616967,-0.6250185178820097,0.9330024813895782,0.9810228674655728,1.0,2/13,9.67%,GCLC;ADCY6
prerank,water transport (GO:0006833),-0.23434720331981262,-0.6249367348741331,0.919908466819222,0.9805272354886603,1.0,4/12,34.00%,AQP11;PDPN;AQP1;SLC5A1
prerank,positive regulation of heart rate (GO:0010460),0.23152851608047875,0.6241080805229504,0.9431438127090301,0.9941199339483598,1.0,1/17,1.41%,ATP2A2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.24489924037918254,0.6236017836297558,0.939443535188216,0.9938414656594998,1.0,13/13,75.53%,MR1;CYRIB;PVR;NECTIN2;STX7;IL23A;XCL1;SLC22A13;IL12B;IL23R;IL12A;IL12RB1;FADD
prerank,gastrulation (GO:0007369),0.23831961809724841,0.6206109942125164,0.9353233830845771,0.9949319845011685,1.0,2/15,9.75%,MEGF8;WNT8B
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.25579632093321175,0.6203089288074677,0.8972477064220183,0.9945557912652304,1.0,3/10,20.99%,GPATCH3;TSPAN6;SEC14L1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.25195609737316255,0.6199228098453964,0.9196581196581196,0.9942035233851272,1.0,4/12,20.73%,MYCBP2;ARHGAP35;EPHB2;HSP90AB1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.252607566611983,-0.6197443440476024,0.9033816425120773,0.9827019368237123,1.0,2/10,11.68%,DPP4;SKAP1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.24467528908554612,-0.6176121791748643,0.9422110552763819,0.983212922029442,1.0,6/10,34.43%,GATA3;BASP1;WT1;PAX8;FZD7;CITED1
prerank,regulation of plasminogen activation (GO:0010755),-0.2322787585812493,-0.6169266320994219,0.9267734553775744,0.982997090089993,1.0,2/12,5.87%,ENO1;THBS1
prerank,eosinophil migration (GO:0072677),0.2378201908588648,0.6162706499576568,0.928695652173913,0.9949715113346724,1.0,14/14,76.24%,CCL5;CCL2;CX3CL1;CCL1;CCL11;LGALS3;CCL26;CCL4;CCL3;SCG2;CCL13;CCL8;CCL24;CCL7
prerank,eosinophil chemotaxis (GO:0048245),0.2378201908588648,0.6162706499576568,0.928695652173913,0.9949715113346724,1.0,14/14,76.24%,CCL5;CCL2;CX3CL1;CCL1;CCL11;LGALS3;CCL26;CCL4;CCL3;SCG2;CCL13;CCL8;CCL24;CCL7
prerank,negative regulation of complement activation (GO:0045916),-0.24877940615262753,-0.6161490435667839,0.9292237442922374,0.9828257078859967,1.0,7/10,41.67%,SERPING1;CD55;VSIG4;C4BPB;C4BPA;SUSD4;CD46
prerank,SNARE complex assembly (GO:0035493),-0.24623721701412868,-0.6158691274319427,0.9292452830188679,0.9824423937215112,1.0,2/10,14.48%,UVRAG;STXBP6
prerank,negative regulation of cilium assembly (GO:1902018),0.24752354810996005,0.6156029592261962,0.9522998296422487,0.9947739100980769,1.0,4/12,24.63%,LIMK2;CDK10;TCHP;TBC1D30
prerank,regulation of cytoplasmic translation (GO:2000765),-0.22115494756463738,-0.6142510328730141,0.9467312348668281,0.982712435163754,1.0,6/14,36.21%,CPEB4;CPEB2;CPEB3;CPEB1;YBX3;RBM24
prerank,regulation of autophagosome maturation (GO:1901096),-0.22647658089914774,-0.6138851894415505,0.9548693586698337,0.9823538770001092,1.0,4/13,22.61%,UVRAG;SMCR8;CLN3;PHF23
prerank,cellular response to UV-A (GO:0071492),0.2485927944276003,0.6135661320588806,0.9506172839506173,0.9952468846044972,1.0,4/11,29.79%,MMP1;CERS1;PPID;MME
prerank,negative regulation of histone acetylation (GO:0035067),-0.24403698030131546,-0.6132998431422549,0.9408983451536643,0.9820971821449918,1.0,3/11,19.18%,BRCA1;THAP7;TAF7
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.25960487399709753,0.6124531308529644,0.9349736379613357,0.9952512584030163,1.0,2/10,10.96%,SLC45A3;IRS1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.2472107474162259,0.6113596121874109,0.9376083188908145,0.9952300228319566,1.0,5/12,33.77%,JAM2;CCL5;RHOA;AIF1;PYCARD
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.26173627755483925,0.6105459764291193,0.9483985765124555,0.9950648093649405,1.0,3/10,21.42%,MVP;ENG;IMPACT
prerank,negative regulation of transferase activity (GO:0051348),-0.18117642516960297,-0.6101083655850587,0.980246913580247,0.9829600562578749,1.0,7/28,24.18%,DTX3L;PHPT1;INPP5K;HNRNPU;IRS2;PIF1;EIF4A2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.25136101340436234,0.6091875400756228,0.9276094276094277,0.9951460052846877,1.0,2/11,12.70%,NT5C3A;DCK
prerank,female gonad development (GO:0008585),0.21643309767686156,0.6090986430968648,0.939443535188216,0.994644372215687,1.0,1/19,1.00%,ANG
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.23614315537546088,0.6076022983204529,0.9595782073813708,0.9948118815832695,1.0,3/15,18.44%,RAD9B;FANCD2;HUS1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.2376628494657264,-0.6075463488101644,0.9230769230769231,0.9835612388794178,1.0,1/10,4.97%,PRKD3
prerank,response to UV (GO:0009411),0.1567983272511553,0.6069785227199336,1.0,0.9945632959868129,1.0,16/95,17.69%,UBE2B;RELA;GTF2H2;CIRBP;BAK1;NEDD4;USF1;PARP1;DDB2;NSMCE3;FEN1;ERCC6;CCAR2;EIF2AK4;SDF4;WRN
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.23878283910181303,0.6069747766381791,0.9489981785063752,0.9940234399738007,1.0,3/13,19.43%,BTG2;POLR2G;TOB1
prerank,regulation of lipase activity (GO:0060191),0.24236383259607697,0.6065315549187794,0.947107438016529,0.9936877950693728,1.0,4/13,25.20%,ANGPTL3;LIPC;LMF1;RHOA
prerank,RNA destabilization (GO:0050779),-0.20430561839923927,-0.6059699495569758,0.9586374695863747,0.9837058763381807,1.0,6/18,25.42%,CELF1;ZC3H18;MEX3D;PUM1;RIDA;GIGYF2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.23572442500907434,-0.6057157470661874,0.9307875894988067,0.983283182016782,1.0,1/11,2.83%,ATG13
prerank,positive regulation of TORC1 signaling (GO:1904263),0.22236425384667433,0.605253119211812,0.9392857142857143,0.9936999108339161,1.0,1/16,0.41%,KLHL22
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.2479865115446828,0.6051785264289309,0.941696113074205,0.9931925009433683,1.0,1/12,1.00%,ADTRP
prerank,protein auto-ADP-ribosylation (GO:0070213),0.23417028558829858,0.6051329822579204,0.9483985765124555,0.9926774431548778,1.0,4/12,23.77%,PARP1;PARP6;PARP10;TNKS2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.22256213378064904,-0.604482499480233,0.9564220183486238,0.9832789461980815,1.0,3/13,15.08%,TYROBP;TM9SF4;TNF
prerank,eye photoreceptor cell differentiation (GO:0001754),0.24093801829700576,0.6036104536744298,0.928082191780822,0.9928186395568481,1.0,1/12,5.80%,DSCAM
prerank,male meiosis I (GO:0007141),0.22458047171773673,0.6028777487970347,0.9442567567567568,0.9926005405668136,1.0,5/16,29.53%,SLC25A31;ING2;FOXJ2;DDX4;ZSCAN21
prerank,rRNA 3'-end processing (GO:0031125),-0.2475020078466274,-0.602017236133581,0.9409090909090909,0.9838038975236342,1.0,5/10,26.22%,EXOSC8;EXOSC10;EXOSC9;EXOSC7;RPS21
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.25625631113341724,0.6018006026557151,0.9419014084507042,0.9925442693124771,1.0,2/10,15.36%,PRKN;OXA1L
prerank,synaptic vesicle recycling (GO:0036465),-0.17347797541642387,-0.6008281594327906,0.9917127071823204,0.9837708158959285,1.0,4/31,10.60%,SYNJ2;FCHO2;AMPH;SNCG
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.20980553792869677,-0.6007710004786698,0.9518987341772152,0.9832662661730779,1.0,6/17,24.48%,TERF2;NTHL1;MUTYH;NEIL3;TINF2;TDG
prerank,cellular response to UV (GO:0034644),-0.1430627649692643,-0.6004591904003101,1.0,0.9828427536568666,1.0,16/76,21.57%,PCNA;USP28;TAF1;YY1;EIF2S1;RHNO1;EP300;NPM1;CRIP1;CDC25A;HYAL3;XPC;RPL26;OPN3;TIMP1;CASP9
prerank,oligosaccharide metabolic process (GO:0009311),0.1728863384576373,0.5996806459358311,0.9908675799086758,0.992916149103592,1.0,6/46,13.21%,B3GALT2;NEU1;NAGA;MAN2B2;GAL3ST4;ST3GAL6
prerank,regulation of cell killing (GO:0031341),0.22199731717157462,0.5986819687513101,0.9480968858131488,0.9927896058288906,1.0,4/16,19.18%,CFH;ICAM1;CR1L;DVL2
prerank,chromatin assembly or disassembly (GO:0006333),0.24559427134590345,0.5984189366263657,0.948073701842546,0.9923715200743533,1.0,4/11,32.03%,SUV39H2;HDAC8;MTA2;TP53
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.19307399033978384,-0.5973922993830135,0.9733656174334141,0.9835342894543493,1.0,5/20,22.35%,MPDU1;FUT8;B3GALT5;ST6GALNAC5;FUT4
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.21786333856713702,0.596429558091453,0.9651741293532339,0.992665063167703,1.0,2/17,10.92%,NME5;NFE2L2
prerank,mRNA methylation (GO:0080009),0.22314262199152118,0.5949086865596712,0.9507042253521126,0.9927447072498011,1.0,3/15,14.03%,TRMT61B;METTL16;CBLL1
prerank,presynapse organization (GO:0099172),-0.23451161229747935,-0.5902504856591617,0.9501246882793017,0.9857462189130143,1.0,4/10,25.46%,C5AR1;WNT5A;NLGN2;FZD1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.19016621363954686,0.589798795538554,0.9761146496815286,0.9942102833971612,1.0,4/29,13.45%,PATL1;LSM1;EXOSC5;CNOT8
prerank,smoothened signaling pathway (GO:0007224),0.18738791315993686,0.588836370974016,0.9817880794701986,0.9940430300574989,1.0,9/32,26.39%,MAP3K10;GPC2;STK36;IFT27;GLI3;TCTN2;EVC2;DISP3;TMEM17
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.2432934599491482,0.5868662395312887,0.9466192170818505,0.9937163561705985,1.0,2/11,14.58%,EIF6;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.2432934599491482,0.5868662395312887,0.9466192170818505,0.9937163561705985,1.0,2/11,14.58%,EIF6;AGO4
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.22313388002523699,0.5861654788597248,0.9442622950819672,0.9934382111498767,1.0,4/16,20.00%,RECQL;WRN;RECQL4;SSBP1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2095052737317931,-0.5824449718136863,0.9703703703703703,0.9880419735714414,1.0,14/14,79.07%,TERF2;TINF2;TERT;TNKS;PINX1;TERF2IP;ATRX;ATR;NABP2;BRCA2;TPP1;ACD;TNKS2;XRCC5
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.2379567888829696,0.5808571147778107,0.9532374100719424,0.9947748027400363,1.0,1/12,5.64%,INAVA
prerank,cellular response to gamma radiation (GO:0071480),0.20888000378625557,0.5731091819632863,0.9607201309328969,0.9968043519375901,1.0,6/17,24.71%,XRCC6;HRAS;WRN;XRCC5;TLK2;CRYAB
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.23403048811986454,0.5692291021669209,0.9658703071672355,0.9974586316283486,1.0,4/12,24.76%,PLK3;RFWD3;FBXO31;SDE2
prerank,cellular response to ionizing radiation (GO:0071479),0.16694327944140958,0.5689010537081249,0.9879336349924586,0.9970212636916981,1.0,10/47,24.71%,NUCKS1;RAD9B;XRCC6;GADD45A;HRAS;WRN;HUS1;XRCC5;TLK2;CRYAB
prerank,catecholamine biosynthetic process (GO:0042423),0.23602804106558534,0.5688490906022449,0.9571917808219178,0.9965018751572979,1.0,2/11,14.76%,MOXD1;DAO
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.19380282454893802,-0.5676925592292793,0.9629629629629629,0.9920957173807964,1.0,8/17,36.93%,ZDHHC17;TFAP2B;XIAP;FST;SLIT2;PCSK6;ITGA3;FSTL3
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.22499280758483692,-0.5655278165241506,0.9575471698113207,0.9916409088221072,1.0,4/11,25.54%,CCT6A;CCT3;DKC1;LARP7
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.22499280758483692,-0.5655278165241506,0.9575471698113207,0.9916409088221072,1.0,4/11,25.54%,CCT6A;CCT3;DKC1;LARP7
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.21488175015633598,0.5610698198856426,0.9704347826086956,0.998185645397362,1.0,5/15,25.11%,VCAN;CSGALNACT1;B3GAT3;DCN;BCAN
prerank,mesoderm formation (GO:0001707),0.2074829144110057,0.560965265406302,0.9639794168096055,0.9976696048777964,1.0,1/17,2.87%,KDM6B
prerank,DNA biosynthetic process (GO:0071897),0.20774792960477023,0.5604648108248299,0.9790940766550522,0.9972654970058266,1.0,4/16,21.84%,POLD3;WRNIP1;WRN;POLA1
prerank,genitalia development (GO:0048806),-0.20921940536801073,-0.5601765016168704,0.9852579852579852,0.9925310658102238,1.0,6/12,39.44%,WNT5A;SHH;WT1;LHCGR;STRA6;PTPN11
prerank,meiosis I (GO:0007127),0.19312145218919413,0.5591470229869332,0.9853896103896104,0.9970682509132048,1.0,2/23,8.49%,SGO1;SLC25A31
prerank,positive regulation of bone resorption (GO:0045780),0.23269957676004185,0.5588260449461601,0.967128027681661,0.9966163062511791,1.0,2/11,11.82%,PRKCA;MC4R
prerank,glycine metabolic process (GO:0006544),0.2268047708725673,0.5573906648894055,0.9716814159292035,0.996440071343482,1.0,12/12,77.34%,AMT;DLD;GLYAT;GCSH;SHMT1;SDSL;BAAT;SHMT2;GCAT;SDS;RIDA;GLDC
prerank,regulation of T cell migration (GO:2000404),-0.18698496379944518,-0.5546560621315606,0.9849246231155779,0.9934319244269374,1.0,4/18,24.85%,RIPOR2;SPN;APP;CXCL12
prerank,regulation of neuron projection arborization (GO:0150011),0.2061243214684311,0.5512689569297345,0.9795918367346939,0.9974307564401048,1.0,6/15,26.73%,MAP3K13;NTNG2;NTNG1;DVL2;DLG4;MYO9A
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.19382906742358308,0.550626653042156,0.9802306425041186,0.9970568017954402,1.0,4/22,15.05%,PPM1E;PPM1A;PPP5C;DUSP2
prerank,epithelial cell development (GO:0002064),0.19526114950791837,0.5501439949542062,0.9798319327731092,0.9966436904075193,1.0,5/20,25.73%,LRTOMT;SLC4A7;WNT7A;GRHL2;WNT5B
prerank,negative regulation of ATPase activity (GO:0032780),-0.18754108578491,-0.5480174523272857,0.9906103286384976,0.9944512438239037,1.0,6/16,28.47%,IFIT1;VCPKMT;LTF;PPIF;TLR9;TSC1
prerank,RNA biosynthetic process (GO:0032774),-0.1569354534598705,-0.5470299664450586,0.9947229551451188,0.9941229874729897,1.0,31/31,84.34%,TAF12;PRIM2;NAT14;TAF7;BRF2;TERT;TBP;TAF10;HELB;NCOA6;TAF13;POLR2A;RSF1;TCEA2;SMARCA5;POLA2;BRF1;ELL3;TTF2;TBPL2;TAF6;SMN1;TAF5;TTF1;TBPL1;GTF2B;POLA1;TAF4;PRMT5;PRIM1;SETX
prerank,negative regulation of ion transport (GO:0043271),0.18111812961816753,0.544287262886764,0.9861351819757366,0.9974809008464487,1.0,6/24,24.02%,ADRA2A;ACTN2;NEDD4;WNK1;PACSIN3;SYT11
prerank,response to gamma radiation (GO:0010332),-0.1677208156654268,-0.5437992293146682,0.9975490196078431,0.994305744533361,1.0,4/24,11.52%,YAP1;HSF1;TMEM109;LIG4
prerank,receptor recycling (GO:0001881),-0.21574865385087239,-0.5429016833457951,0.966903073286052,0.9939691934086925,1.0,1/10,4.45%,LMTK2
prerank,positive regulation of lyase activity (GO:0051349),0.21032369177511695,0.5428137389354251,0.978984238178634,0.9972711076643627,1.0,2/14,17.95%,CACNA1D;ISCU
prerank,regulation of establishment of protein localization (GO:0070201),-0.20176394774401543,-0.5424409302347619,0.9753694581280788,0.993558883630461,1.0,6/13,32.73%,GAPVD1;CEP295;PTP4A3;CTSD;SCFD1;SPIDR
prerank,oxoacid metabolic process (GO:0043436),0.17489023721022387,0.5415826655683971,0.9904912836767037,0.9969838241620598,1.0,5/27,22.37%,PPA1;TPST2;DAO;AGXT;SULT1A1
prerank,detection of calcium ion (GO:0005513),0.21525149108522226,0.5407462955703026,0.9766606822262118,0.9966195993009659,1.0,2/13,16.27%,SYT1;KCNMB3
prerank,microglial cell activation (GO:0001774),0.18835189303964683,0.5401634031544704,0.9893238434163701,0.9962091003753029,1.0,6/21,25.59%,CLU;CX3CR1;IFNGR1;ITGAM;GRN;MAPT
prerank,positive regulation of behavior (GO:0048520),0.22587979834695593,0.5378467689881804,0.9670138888888888,0.9961717292059424,1.0,4/10,32.33%,MEF2C;NPAS2;CFAP20;NLGN1
prerank,aorta development (GO:0035904),-0.19178026978457435,-0.5364070809896623,0.9875,0.9942703734504391,1.0,5/14,22.45%,EFEMP2;LRP1;PDE2A;TFAP2B;APLNR
prerank,regulation of actin nucleation (GO:0051125),0.21229447371843457,0.5358273265684164,0.9842931937172775,0.9960487975328634,1.0,6/12,37.55%,CORO1A;ARF1;WHAMM;ARFIP1;ARFIP2;ARPIN
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.20338975286604485,-0.534329454571555,0.9766355140186916,0.9941427093179775,1.0,4/12,21.67%,MTHFD1;CBS;CTH;SEPHS2
prerank,regulation of protein kinase C signaling (GO:0090036),0.20353325686650975,0.5312904210152483,0.9931972789115646,0.9963834185515512,1.0,1/14,3.54%,FLT4
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.22175603503132685,0.5304411069610969,0.9761029411764706,0.996025990298466,1.0,1/10,4.71%,NT5C3A
prerank,regulation of tau-protein kinase activity (GO:1902947),0.2232554206776012,0.5282563116056724,0.9686956521739131,0.9958961408750215,1.0,3/10,23.86%,CLU;HSP90AB1;NAB2
prerank,steroid catabolic process (GO:0006706),0.22291579298676287,0.525232408615066,0.9806338028169014,0.9959211968659977,1.0,2/10,24.77%,HSD17B11;HSD17B14
prerank,positive regulation of chromatin organization (GO:1905269),-0.19727903471988578,-0.524038861502207,0.9880668257756563,0.9954132064693045,1.0,4/12,28.62%,H3-3A;TERF2;TINF2;MIER1
prerank,nucleoside catabolic process (GO:0009164),0.2127840102124663,0.5210315738355015,0.9766606822262118,0.9961195063485635,1.0,1/11,4.71%,NT5C3A
prerank,glycine transport (GO:0015816),-0.2090133065528496,-0.5209793284768965,0.9876847290640394,0.9953974592803098,1.0,10/10,79.12%,SLC6A17;SLC36A2;SLC38A5;SLC7A8;SLC6A20;SLC36A1;SLC36A3;SLC6A5;SLC6A9;SLC25A38
prerank,cobalamin metabolic process (GO:0009235),-0.17494505494505494,-0.5203479499879258,0.9948186528497409,0.9949512465642818,1.0,17/17,82.53%,MTRR;ABCD4;LMBRD1;AMN;CD320;CUBN;ABCC1;MMUT;MMADHC;CBLIF;TCN1;CTRC;MMACHC;TCN2;MMAB;MMAA;MTR
prerank,piRNA metabolic process (GO:0034587),-0.1752743838757603,-0.5186953362964435,0.9949622166246851,0.994656895460957,1.0,7/19,35.53%,PIWIL2;TDRD12;MYBL1;TDRD9;MOV10L1;PIWIL4;PIWIL1
prerank,detection of visible light (GO:0009584),0.19078771631782798,0.512642155258221,0.9868421052631579,0.9968612453025486,1.0,4/16,29.17%,CNGB1;GNA11;GNAQ;ABCA4
prerank,regulation of cell projection organization (GO:0031344),-0.18798462893151846,-0.5069880920248181,0.9858823529411764,0.9956970878773236,1.0,3/13,21.65%,SPRY2;MFSD2A;SEMA4D
prerank,positive regulation of calcium ion import (GO:0090280),-0.1972808480362148,-0.5054942781165471,0.9953488372093023,0.9953758813125527,1.0,6/12,38.33%,SPHK2;RAMP3;CXCL12;ATP2A1;CALCR;STC1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.16178668663961687,0.4981414094893142,0.9968503937007874,0.9982063397133799,1.0,2/27,4.64%,PLAAT5;PLA2G3
prerank,negative regulation of neuron differentiation (GO:0045665),0.1688212861670162,0.49546564079428107,0.9918300653594772,0.998003097965147,1.0,3/22,15.79%,HEY1;EIF2AK4;REST
prerank,positive regulation of hormone secretion (GO:0046887),-0.16956234663182349,-0.493574279918212,0.9897172236503856,0.9961708723871089,1.0,8/17,36.46%,SOX11;C1QTNF3;RASL10B;NMB;VAMP7;EDN3;CYP19A1;EDN1
prerank,diol metabolic process (GO:0034311),-0.1609210649607691,-0.48943329645675665,0.9922480620155039,0.9960152739399784,1.0,8/19,33.48%,SGPP1;ASAH2;SPHK2;HSP90AA1;GCH1;PLPP3;CALM1;NAAA
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.19684305096400578,0.48524183526590586,0.9913194444444444,0.9979732506120026,1.0,5/12,28.82%,ITGB1BP1;RCC2;DMTN;AP1AR;KANK1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.19684305096400578,0.48524183526590586,0.9913194444444444,0.9979732506120026,1.0,5/12,28.82%,ITGB1BP1;RCC2;DMTN;AP1AR;KANK1
prerank,regulation of microtubule-based movement (GO:0060632),0.19915520921348595,0.48370668495467084,0.9930795847750865,0.9976027848796596,1.0,3/11,21.69%,CCDC65;HAP1;MAP2
prerank,positive regulation of cyclase activity (GO:0031281),0.1846191509912195,0.478206399711437,0.9915682967959528,0.9975367201179897,1.0,2/14,15.93%,CACNA1D;MAPK3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.18563626090777827,0.4752574647903931,0.9965397923875432,0.9972455766086591,1.0,13/13,81.45%,TPST2;SULT1A1;ABHD14B;SULT1C4;SULT1C2;BPNT1;TPST1;ENPP1;SULT6B1;SULT4A1;SULT2A1;SULT2B1;BPNT2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.18164683328145137,0.47424069067283275,0.9932318104906938,0.9967986937358121,1.0,3/15,25.37%,TGFB1;CUEDC2;HFE
